{
 "cells": [
  {
   "cell_type": "code",
   "execution_count": 1,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "import matplotlib.pyplot as plt\n",
    "%matplotlib inline\n",
    "import psycopg2 as pg2"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 2,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "conn = pg2.connect(dbname='medicare', user='postgres')\n",
    "#cur = conn.cursor()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 3,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "query = '''\n",
    "        SELECT *\n",
    "        FROM util_payments_agg_2013\n",
    "        WHERE provider_type='Medical Oncology'\n",
    "        ;\n",
    "        '''"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 7,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "df_cancer_med = pd.read_sql_query(query, conn)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 8,
   "metadata": {
    "collapsed": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "Int64Index: 2769 entries, 0 to 2768\n",
      "Data columns (total 68 columns):\n",
      "index                                       2769 non-null int64\n",
      "npi                                         2769 non-null int64\n",
      "last_name                                   2769 non-null object\n",
      "first_name                                  2769 non-null object\n",
      "middle_initial                              1969 non-null object\n",
      "credentials                                 2706 non-null object\n",
      "gender                                      2769 non-null object\n",
      "entity_code                                 2769 non-null object\n",
      "street1                                     2769 non-null object\n",
      "street2                                     1344 non-null object\n",
      "city                                        2769 non-null object\n",
      "zip                                         2769 non-null object\n",
      "state                                       2769 non-null object\n",
      "country                                     2769 non-null object\n",
      "provider_type                               2769 non-null object\n",
      "medicare_participation_indicator            2769 non-null object\n",
      "num_hcpcs                                   2769 non-null int64\n",
      "num_services                                2769 non-null float64\n",
      "num_unique_bene                             2769 non-null int64\n",
      "total_submitted_charges                     2769 non-null float64\n",
      "total_medicare_allowed_amt                  2769 non-null float64\n",
      "total_medicare_payment_amt                  2769 non-null float64\n",
      "drug_suppress_indicator                     176 non-null object\n",
      "num_hcpcs_associated_drug_srvc              2593 non-null float64\n",
      "num_drug_srvc                               2593 non-null float64\n",
      "num_unique_bene_with_drug_srvc              2593 non-null float64\n",
      "total_drug_submitted_charges                2593 non-null float64\n",
      "total_drug_medicare_allowed_amt             2593 non-null float64\n",
      "total_drug_medicare_payment_amt             2593 non-null float64\n",
      "medical_suppress_indicator                  176 non-null object\n",
      "num_hcpcs_associated_med_srvc               2593 non-null float64\n",
      "num_med_srvc                                2593 non-null float64\n",
      "num_unique_bene_with_med_srvc               2593 non-null float64\n",
      "total_med_submitted_charges                 2593 non-null float64\n",
      "total_med_medicare_allowed_amt              2593 non-null float64\n",
      "total_med_medicare_payment_amt              2593 non-null float64\n",
      "avg_age_bene                                2769 non-null float64\n",
      "num_bene_le65                               1946 non-null float64\n",
      "num_bene_65to74                             2633 non-null float64\n",
      "num_bene_75to84                             2334 non-null float64\n",
      "num_bene_ge84                               1812 non-null float64\n",
      "num_female                                  2529 non-null float64\n",
      "num_male                                    2529 non-null float64\n",
      "num_non_his_white                           2240 non-null float64\n",
      "num_african_american                        1051 non-null float64\n",
      "num_asian                                   342 non-null float64\n",
      "num_hispanic                                685 non-null float64\n",
      "num_american_indian                         914 non-null float64\n",
      "num_no_race                                 181 non-null float64\n",
      "num_medicare_only                           2362 non-null float64\n",
      "num_medicare_medicaid                       2362 non-null float64\n",
      "pcnt_alzheimers_dementia                    1823 non-null float64\n",
      "pcnt_asthma                                 1930 non-null float64\n",
      "pcnt_artrial_fibrillation                   2178 non-null float64\n",
      "pcnt_cancer                                 2612 non-null float64\n",
      "pcnt_chronic_kidney                         2599 non-null float64\n",
      "pcnt_chronic_obstructive_pulmonary          2381 non-null float64\n",
      "pcnt_depression                             2554 non-null float64\n",
      "pcnt_diabetes                               2593 non-null float64\n",
      "pcnt_heart_failure                          2443 non-null float64\n",
      "pcnt_hyperlipidemia                         2690 non-null float64\n",
      "pcnt_hypertension                           2720 non-null float64\n",
      "pcnt_ischemic_heart                         2614 non-null float64\n",
      "pcnt_osteoporosis                           2029 non-null float64\n",
      "pcnt_rheumatoid_arthritis_osteoarthirtis    2604 non-null float64\n",
      "pcnt_schizophrenia_psychotic                1280 non-null float64\n",
      "pcnt_stroke                                 1567 non-null float64\n",
      "avg_hcc_risk_score                          2769 non-null float64\n",
      "dtypes: float64(48), int64(4), object(16)\n",
      "memory usage: 1.5+ MB\n"
     ]
    }
   ],
   "source": [
    "df_cancer_med.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 20,
   "metadata": {
    "collapsed": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>count</th>\n",
       "      <th>mean</th>\n",
       "      <th>std</th>\n",
       "      <th>min</th>\n",
       "      <th>25%</th>\n",
       "      <th>50%</th>\n",
       "      <th>75%</th>\n",
       "      <th>max</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>index</th>\n",
       "      <td>2769</td>\n",
       "      <td>4.732380e+05</td>\n",
       "      <td>2.726661e+05</td>\n",
       "      <td>3.670000e+02</td>\n",
       "      <td>2.398690e+05</td>\n",
       "      <td>4.823700e+05</td>\n",
       "      <td>7.004410e+05</td>\n",
       "      <td>9.554170e+05</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>npi</th>\n",
       "      <td>2769</td>\n",
       "      <td>1.495184e+09</td>\n",
       "      <td>2.844583e+08</td>\n",
       "      <td>1.003020e+09</td>\n",
       "      <td>1.255309e+09</td>\n",
       "      <td>1.508835e+09</td>\n",
       "      <td>1.730151e+09</td>\n",
       "      <td>1.992942e+09</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_hcpcs</th>\n",
       "      <td>2769</td>\n",
       "      <td>5.461069e+01</td>\n",
       "      <td>5.659609e+01</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>1.200000e+01</td>\n",
       "      <td>1.900000e+01</td>\n",
       "      <td>1.010000e+02</td>\n",
       "      <td>5.880000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_services</th>\n",
       "      <td>2769</td>\n",
       "      <td>3.104462e+04</td>\n",
       "      <td>6.072969e+04</td>\n",
       "      <td>1.300000e+01</td>\n",
       "      <td>3.890000e+02</td>\n",
       "      <td>1.182000e+03</td>\n",
       "      <td>3.808500e+04</td>\n",
       "      <td>5.310810e+05</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_unique_bene</th>\n",
       "      <td>2769</td>\n",
       "      <td>3.203301e+02</td>\n",
       "      <td>3.930237e+02</td>\n",
       "      <td>1.100000e+01</td>\n",
       "      <td>1.190000e+02</td>\n",
       "      <td>2.410000e+02</td>\n",
       "      <td>4.250000e+02</td>\n",
       "      <td>1.471800e+04</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_submitted_charges</th>\n",
       "      <td>2769</td>\n",
       "      <td>1.560459e+06</td>\n",
       "      <td>2.701031e+06</td>\n",
       "      <td>1.715000e+03</td>\n",
       "      <td>8.780500e+04</td>\n",
       "      <td>2.333300e+05</td>\n",
       "      <td>1.967238e+06</td>\n",
       "      <td>2.850965e+07</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_medicare_allowed_amt</th>\n",
       "      <td>2769</td>\n",
       "      <td>6.195892e+05</td>\n",
       "      <td>1.052509e+06</td>\n",
       "      <td>1.214040e+03</td>\n",
       "      <td>3.513613e+04</td>\n",
       "      <td>9.292333e+04</td>\n",
       "      <td>8.527557e+05</td>\n",
       "      <td>1.059430e+07</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_medicare_payment_amt</th>\n",
       "      <td>2769</td>\n",
       "      <td>4.817217e+05</td>\n",
       "      <td>8.224352e+05</td>\n",
       "      <td>3.259400e+02</td>\n",
       "      <td>2.635160e+04</td>\n",
       "      <td>7.007450e+04</td>\n",
       "      <td>6.676583e+05</td>\n",
       "      <td>8.362862e+06</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_hcpcs_associated_drug_srvc</th>\n",
       "      <td>2593</td>\n",
       "      <td>2.431238e+01</td>\n",
       "      <td>3.076948e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>5.400000e+01</td>\n",
       "      <td>1.180000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_drug_srvc</th>\n",
       "      <td>2593</td>\n",
       "      <td>2.949616e+04</td>\n",
       "      <td>5.743682e+04</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>3.804400e+04</td>\n",
       "      <td>5.062740e+05</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_unique_bene_with_drug_srvc</th>\n",
       "      <td>2593</td>\n",
       "      <td>6.838604e+01</td>\n",
       "      <td>1.165645e+02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.030000e+02</td>\n",
       "      <td>7.690000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_drug_submitted_charges</th>\n",
       "      <td>2593</td>\n",
       "      <td>1.175183e+06</td>\n",
       "      <td>2.152990e+06</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.682527e+06</td>\n",
       "      <td>2.146553e+07</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_drug_medicare_allowed_amt</th>\n",
       "      <td>2593</td>\n",
       "      <td>4.739262e+05</td>\n",
       "      <td>8.603293e+05</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>6.906847e+05</td>\n",
       "      <td>8.152356e+06</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_drug_medicare_payment_amt</th>\n",
       "      <td>2593</td>\n",
       "      <td>3.690495e+05</td>\n",
       "      <td>6.708822e+05</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>5.388935e+05</td>\n",
       "      <td>6.405225e+06</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_hcpcs_associated_med_srvc</th>\n",
       "      <td>2593</td>\n",
       "      <td>3.222908e+01</td>\n",
       "      <td>2.956716e+01</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>1.100000e+01</td>\n",
       "      <td>1.800000e+01</td>\n",
       "      <td>4.700000e+01</td>\n",
       "      <td>5.050000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_med_srvc</th>\n",
       "      <td>2593</td>\n",
       "      <td>3.517068e+03</td>\n",
       "      <td>6.499676e+03</td>\n",
       "      <td>1.400000e+01</td>\n",
       "      <td>3.780000e+02</td>\n",
       "      <td>9.600000e+02</td>\n",
       "      <td>4.134000e+03</td>\n",
       "      <td>1.812590e+05</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_unique_bene_with_med_srvc</th>\n",
       "      <td>2593</td>\n",
       "      <td>3.271527e+02</td>\n",
       "      <td>4.011905e+02</td>\n",
       "      <td>1.100000e+01</td>\n",
       "      <td>1.210000e+02</td>\n",
       "      <td>2.450000e+02</td>\n",
       "      <td>4.370000e+02</td>\n",
       "      <td>1.471800e+04</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_med_submitted_charges</th>\n",
       "      <td>2593</td>\n",
       "      <td>4.772022e+05</td>\n",
       "      <td>6.947907e+05</td>\n",
       "      <td>1.866500e+03</td>\n",
       "      <td>8.471000e+04</td>\n",
       "      <td>2.072330e+05</td>\n",
       "      <td>5.893010e+05</td>\n",
       "      <td>8.791787e+06</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_med_medicare_allowed_amt</th>\n",
       "      <td>2593</td>\n",
       "      <td>1.817468e+05</td>\n",
       "      <td>2.425417e+05</td>\n",
       "      <td>1.256820e+03</td>\n",
       "      <td>3.436395e+04</td>\n",
       "      <td>8.056639e+04</td>\n",
       "      <td>2.394403e+05</td>\n",
       "      <td>2.441943e+06</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_med_medicare_payment_amt</th>\n",
       "      <td>2593</td>\n",
       "      <td>1.408074e+05</td>\n",
       "      <td>1.921037e+05</td>\n",
       "      <td>3.259400e+02</td>\n",
       "      <td>2.574961e+04</td>\n",
       "      <td>6.065112e+04</td>\n",
       "      <td>1.836782e+05</td>\n",
       "      <td>2.046456e+06</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>avg_age_bene</th>\n",
       "      <td>2769</td>\n",
       "      <td>7.187505e+01</td>\n",
       "      <td>2.923072e+00</td>\n",
       "      <td>5.700000e+01</td>\n",
       "      <td>7.000000e+01</td>\n",
       "      <td>7.200000e+01</td>\n",
       "      <td>7.400000e+01</td>\n",
       "      <td>8.500000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_bene_le65</th>\n",
       "      <td>1946</td>\n",
       "      <td>5.275540e+01</td>\n",
       "      <td>4.307410e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>2.600000e+01</td>\n",
       "      <td>4.300000e+01</td>\n",
       "      <td>6.700000e+01</td>\n",
       "      <td>9.660000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_bene_65to74</th>\n",
       "      <td>2633</td>\n",
       "      <td>1.448990e+02</td>\n",
       "      <td>1.765837e+02</td>\n",
       "      <td>1.100000e+01</td>\n",
       "      <td>6.200000e+01</td>\n",
       "      <td>1.100000e+02</td>\n",
       "      <td>1.860000e+02</td>\n",
       "      <td>6.938000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_bene_75to84</th>\n",
       "      <td>2334</td>\n",
       "      <td>1.196367e+02</td>\n",
       "      <td>1.361143e+02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>4.600000e+01</td>\n",
       "      <td>8.900000e+01</td>\n",
       "      <td>1.560000e+02</td>\n",
       "      <td>4.561000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_bene_ge84</th>\n",
       "      <td>1812</td>\n",
       "      <td>5.486921e+01</td>\n",
       "      <td>6.821695e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>2.100000e+01</td>\n",
       "      <td>4.300000e+01</td>\n",
       "      <td>7.000000e+01</td>\n",
       "      <td>2.252000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_female</th>\n",
       "      <td>2529</td>\n",
       "      <td>2.012705e+02</td>\n",
       "      <td>2.448371e+02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>6.600000e+01</td>\n",
       "      <td>1.510000e+02</td>\n",
       "      <td>2.740000e+02</td>\n",
       "      <td>8.694000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_male</th>\n",
       "      <td>2529</td>\n",
       "      <td>1.416512e+02</td>\n",
       "      <td>1.659876e+02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>5.700000e+01</td>\n",
       "      <td>1.110000e+02</td>\n",
       "      <td>1.860000e+02</td>\n",
       "      <td>6.023000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_non_his_white</th>\n",
       "      <td>2240</td>\n",
       "      <td>3.034121e+02</td>\n",
       "      <td>3.281741e+02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.150000e+02</td>\n",
       "      <td>2.270000e+02</td>\n",
       "      <td>4.002500e+02</td>\n",
       "      <td>9.801000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_african_american</th>\n",
       "      <td>1051</td>\n",
       "      <td>5.411323e+01</td>\n",
       "      <td>6.348001e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.900000e+01</td>\n",
       "      <td>3.400000e+01</td>\n",
       "      <td>6.400000e+01</td>\n",
       "      <td>7.160000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_asian</th>\n",
       "      <td>342</td>\n",
       "      <td>2.634503e+01</td>\n",
       "      <td>1.679231e+02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.300000e+01</td>\n",
       "      <td>2.275000e+01</td>\n",
       "      <td>3.080000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_hispanic</th>\n",
       "      <td>685</td>\n",
       "      <td>3.838978e+01</td>\n",
       "      <td>6.039745e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.400000e+01</td>\n",
       "      <td>2.300000e+01</td>\n",
       "      <td>4.200000e+01</td>\n",
       "      <td>1.049000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_american_indian</th>\n",
       "      <td>914</td>\n",
       "      <td>3.002188e+00</td>\n",
       "      <td>1.506539e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.480000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_no_race</th>\n",
       "      <td>181</td>\n",
       "      <td>1.022099e+01</td>\n",
       "      <td>4.169607e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.300000e+01</td>\n",
       "      <td>5.560000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_medicare_only</th>\n",
       "      <td>2362</td>\n",
       "      <td>2.997202e+02</td>\n",
       "      <td>3.443555e+02</td>\n",
       "      <td>1.100000e+01</td>\n",
       "      <td>1.200000e+02</td>\n",
       "      <td>2.260000e+02</td>\n",
       "      <td>3.940000e+02</td>\n",
       "      <td>1.190200e+04</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_medicare_medicaid</th>\n",
       "      <td>2362</td>\n",
       "      <td>6.332515e+01</td>\n",
       "      <td>7.945680e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>2.400000e+01</td>\n",
       "      <td>4.400000e+01</td>\n",
       "      <td>8.100000e+01</td>\n",
       "      <td>2.815000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_alzheimers_dementia</th>\n",
       "      <td>1823</td>\n",
       "      <td>1.002359e+01</td>\n",
       "      <td>5.805292e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>7.000000e+00</td>\n",
       "      <td>9.000000e+00</td>\n",
       "      <td>1.200000e+01</td>\n",
       "      <td>6.600000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_asthma</th>\n",
       "      <td>1930</td>\n",
       "      <td>8.292746e+00</td>\n",
       "      <td>3.138714e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>6.000000e+00</td>\n",
       "      <td>8.000000e+00</td>\n",
       "      <td>1.000000e+01</td>\n",
       "      <td>3.400000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_artrial_fibrillation</th>\n",
       "      <td>2178</td>\n",
       "      <td>1.292975e+01</td>\n",
       "      <td>4.137189e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.000000e+01</td>\n",
       "      <td>1.300000e+01</td>\n",
       "      <td>1.500000e+01</td>\n",
       "      <td>3.900000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_cancer</th>\n",
       "      <td>2612</td>\n",
       "      <td>4.981815e+01</td>\n",
       "      <td>1.686058e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>4.000000e+01</td>\n",
       "      <td>4.850000e+01</td>\n",
       "      <td>6.200000e+01</td>\n",
       "      <td>7.500000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_chronic_kidney</th>\n",
       "      <td>2599</td>\n",
       "      <td>3.357484e+01</td>\n",
       "      <td>1.095008e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>2.700000e+01</td>\n",
       "      <td>3.200000e+01</td>\n",
       "      <td>3.900000e+01</td>\n",
       "      <td>7.500000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_chronic_obstructive_pulmonary</th>\n",
       "      <td>2381</td>\n",
       "      <td>2.129063e+01</td>\n",
       "      <td>9.306654e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.500000e+01</td>\n",
       "      <td>2.000000e+01</td>\n",
       "      <td>2.600000e+01</td>\n",
       "      <td>6.900000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_depression</th>\n",
       "      <td>2554</td>\n",
       "      <td>2.326625e+01</td>\n",
       "      <td>6.535358e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.900000e+01</td>\n",
       "      <td>2.200000e+01</td>\n",
       "      <td>2.700000e+01</td>\n",
       "      <td>5.800000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_diabetes</th>\n",
       "      <td>2593</td>\n",
       "      <td>3.249325e+01</td>\n",
       "      <td>8.229542e+00</td>\n",
       "      <td>1.000000e+01</td>\n",
       "      <td>2.700000e+01</td>\n",
       "      <td>3.200000e+01</td>\n",
       "      <td>3.700000e+01</td>\n",
       "      <td>7.500000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_heart_failure</th>\n",
       "      <td>2443</td>\n",
       "      <td>2.293451e+01</td>\n",
       "      <td>8.662796e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.700000e+01</td>\n",
       "      <td>2.200000e+01</td>\n",
       "      <td>2.700000e+01</td>\n",
       "      <td>7.300000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_hyperlipidemia</th>\n",
       "      <td>2690</td>\n",
       "      <td>5.250112e+01</td>\n",
       "      <td>9.085653e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>4.600000e+01</td>\n",
       "      <td>5.300000e+01</td>\n",
       "      <td>5.900000e+01</td>\n",
       "      <td>7.500000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_hypertension</th>\n",
       "      <td>2720</td>\n",
       "      <td>6.732316e+01</td>\n",
       "      <td>7.810955e+00</td>\n",
       "      <td>3.100000e+01</td>\n",
       "      <td>6.300000e+01</td>\n",
       "      <td>6.900000e+01</td>\n",
       "      <td>7.500000e+01</td>\n",
       "      <td>7.500000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_ischemic_heart</th>\n",
       "      <td>2614</td>\n",
       "      <td>3.865493e+01</td>\n",
       "      <td>1.043209e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>3.200000e+01</td>\n",
       "      <td>3.800000e+01</td>\n",
       "      <td>4.500000e+01</td>\n",
       "      <td>7.500000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_osteoporosis</th>\n",
       "      <td>2029</td>\n",
       "      <td>1.058797e+01</td>\n",
       "      <td>4.326855e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>8.000000e+00</td>\n",
       "      <td>1.000000e+01</td>\n",
       "      <td>1.200000e+01</td>\n",
       "      <td>5.300000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_rheumatoid_arthritis_osteoarthirtis</th>\n",
       "      <td>2604</td>\n",
       "      <td>3.558794e+01</td>\n",
       "      <td>7.226559e+00</td>\n",
       "      <td>1.500000e+01</td>\n",
       "      <td>3.100000e+01</td>\n",
       "      <td>3.500000e+01</td>\n",
       "      <td>4.000000e+01</td>\n",
       "      <td>7.500000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_schizophrenia_psychotic</th>\n",
       "      <td>1280</td>\n",
       "      <td>4.457813e+00</td>\n",
       "      <td>3.369797e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>3.000000e+00</td>\n",
       "      <td>4.000000e+00</td>\n",
       "      <td>6.000000e+00</td>\n",
       "      <td>3.100000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_stroke</th>\n",
       "      <td>1567</td>\n",
       "      <td>6.084237e+00</td>\n",
       "      <td>3.183699e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>4.000000e+00</td>\n",
       "      <td>6.000000e+00</td>\n",
       "      <td>7.000000e+00</td>\n",
       "      <td>3.000000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>avg_hcc_risk_score</th>\n",
       "      <td>2769</td>\n",
       "      <td>1.981499e+00</td>\n",
       "      <td>4.130090e-01</td>\n",
       "      <td>4.278000e-01</td>\n",
       "      <td>1.736300e+00</td>\n",
       "      <td>1.935900e+00</td>\n",
       "      <td>2.184900e+00</td>\n",
       "      <td>4.577600e+00</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                          count          mean           std  \\\n",
       "index                                      2769  4.732380e+05  2.726661e+05   \n",
       "npi                                        2769  1.495184e+09  2.844583e+08   \n",
       "num_hcpcs                                  2769  5.461069e+01  5.659609e+01   \n",
       "num_services                               2769  3.104462e+04  6.072969e+04   \n",
       "num_unique_bene                            2769  3.203301e+02  3.930237e+02   \n",
       "total_submitted_charges                    2769  1.560459e+06  2.701031e+06   \n",
       "total_medicare_allowed_amt                 2769  6.195892e+05  1.052509e+06   \n",
       "total_medicare_payment_amt                 2769  4.817217e+05  8.224352e+05   \n",
       "num_hcpcs_associated_drug_srvc             2593  2.431238e+01  3.076948e+01   \n",
       "num_drug_srvc                              2593  2.949616e+04  5.743682e+04   \n",
       "num_unique_bene_with_drug_srvc             2593  6.838604e+01  1.165645e+02   \n",
       "total_drug_submitted_charges               2593  1.175183e+06  2.152990e+06   \n",
       "total_drug_medicare_allowed_amt            2593  4.739262e+05  8.603293e+05   \n",
       "total_drug_medicare_payment_amt            2593  3.690495e+05  6.708822e+05   \n",
       "num_hcpcs_associated_med_srvc              2593  3.222908e+01  2.956716e+01   \n",
       "num_med_srvc                               2593  3.517068e+03  6.499676e+03   \n",
       "num_unique_bene_with_med_srvc              2593  3.271527e+02  4.011905e+02   \n",
       "total_med_submitted_charges                2593  4.772022e+05  6.947907e+05   \n",
       "total_med_medicare_allowed_amt             2593  1.817468e+05  2.425417e+05   \n",
       "total_med_medicare_payment_amt             2593  1.408074e+05  1.921037e+05   \n",
       "avg_age_bene                               2769  7.187505e+01  2.923072e+00   \n",
       "num_bene_le65                              1946  5.275540e+01  4.307410e+01   \n",
       "num_bene_65to74                            2633  1.448990e+02  1.765837e+02   \n",
       "num_bene_75to84                            2334  1.196367e+02  1.361143e+02   \n",
       "num_bene_ge84                              1812  5.486921e+01  6.821695e+01   \n",
       "num_female                                 2529  2.012705e+02  2.448371e+02   \n",
       "num_male                                   2529  1.416512e+02  1.659876e+02   \n",
       "num_non_his_white                          2240  3.034121e+02  3.281741e+02   \n",
       "num_african_american                       1051  5.411323e+01  6.348001e+01   \n",
       "num_asian                                   342  2.634503e+01  1.679231e+02   \n",
       "num_hispanic                                685  3.838978e+01  6.039745e+01   \n",
       "num_american_indian                         914  3.002188e+00  1.506539e+01   \n",
       "num_no_race                                 181  1.022099e+01  4.169607e+01   \n",
       "num_medicare_only                          2362  2.997202e+02  3.443555e+02   \n",
       "num_medicare_medicaid                      2362  6.332515e+01  7.945680e+01   \n",
       "pcnt_alzheimers_dementia                   1823  1.002359e+01  5.805292e+00   \n",
       "pcnt_asthma                                1930  8.292746e+00  3.138714e+00   \n",
       "pcnt_artrial_fibrillation                  2178  1.292975e+01  4.137189e+00   \n",
       "pcnt_cancer                                2612  4.981815e+01  1.686058e+01   \n",
       "pcnt_chronic_kidney                        2599  3.357484e+01  1.095008e+01   \n",
       "pcnt_chronic_obstructive_pulmonary         2381  2.129063e+01  9.306654e+00   \n",
       "pcnt_depression                            2554  2.326625e+01  6.535358e+00   \n",
       "pcnt_diabetes                              2593  3.249325e+01  8.229542e+00   \n",
       "pcnt_heart_failure                         2443  2.293451e+01  8.662796e+00   \n",
       "pcnt_hyperlipidemia                        2690  5.250112e+01  9.085653e+00   \n",
       "pcnt_hypertension                          2720  6.732316e+01  7.810955e+00   \n",
       "pcnt_ischemic_heart                        2614  3.865493e+01  1.043209e+01   \n",
       "pcnt_osteoporosis                          2029  1.058797e+01  4.326855e+00   \n",
       "pcnt_rheumatoid_arthritis_osteoarthirtis   2604  3.558794e+01  7.226559e+00   \n",
       "pcnt_schizophrenia_psychotic               1280  4.457813e+00  3.369797e+00   \n",
       "pcnt_stroke                                1567  6.084237e+00  3.183699e+00   \n",
       "avg_hcc_risk_score                         2769  1.981499e+00  4.130090e-01   \n",
       "\n",
       "                                                   min           25%  \\\n",
       "index                                     3.670000e+02  2.398690e+05   \n",
       "npi                                       1.003020e+09  1.255309e+09   \n",
       "num_hcpcs                                 1.000000e+00  1.200000e+01   \n",
       "num_services                              1.300000e+01  3.890000e+02   \n",
       "num_unique_bene                           1.100000e+01  1.190000e+02   \n",
       "total_submitted_charges                   1.715000e+03  8.780500e+04   \n",
       "total_medicare_allowed_amt                1.214040e+03  3.513613e+04   \n",
       "total_medicare_payment_amt                3.259400e+02  2.635160e+04   \n",
       "num_hcpcs_associated_drug_srvc            0.000000e+00  0.000000e+00   \n",
       "num_drug_srvc                             0.000000e+00  0.000000e+00   \n",
       "num_unique_bene_with_drug_srvc            0.000000e+00  0.000000e+00   \n",
       "total_drug_submitted_charges              0.000000e+00  0.000000e+00   \n",
       "total_drug_medicare_allowed_amt           0.000000e+00  0.000000e+00   \n",
       "total_drug_medicare_payment_amt           0.000000e+00  0.000000e+00   \n",
       "num_hcpcs_associated_med_srvc             1.000000e+00  1.100000e+01   \n",
       "num_med_srvc                              1.400000e+01  3.780000e+02   \n",
       "num_unique_bene_with_med_srvc             1.100000e+01  1.210000e+02   \n",
       "total_med_submitted_charges               1.866500e+03  8.471000e+04   \n",
       "total_med_medicare_allowed_amt            1.256820e+03  3.436395e+04   \n",
       "total_med_medicare_payment_amt            3.259400e+02  2.574961e+04   \n",
       "avg_age_bene                              5.700000e+01  7.000000e+01   \n",
       "num_bene_le65                             0.000000e+00  2.600000e+01   \n",
       "num_bene_65to74                           1.100000e+01  6.200000e+01   \n",
       "num_bene_75to84                           0.000000e+00  4.600000e+01   \n",
       "num_bene_ge84                             0.000000e+00  2.100000e+01   \n",
       "num_female                                0.000000e+00  6.600000e+01   \n",
       "num_male                                  0.000000e+00  5.700000e+01   \n",
       "num_non_his_white                         0.000000e+00  1.150000e+02   \n",
       "num_african_american                      0.000000e+00  1.900000e+01   \n",
       "num_asian                                 0.000000e+00  0.000000e+00   \n",
       "num_hispanic                              0.000000e+00  1.400000e+01   \n",
       "num_american_indian                       0.000000e+00  0.000000e+00   \n",
       "num_no_race                               0.000000e+00  0.000000e+00   \n",
       "num_medicare_only                         1.100000e+01  1.200000e+02   \n",
       "num_medicare_medicaid                     0.000000e+00  2.400000e+01   \n",
       "pcnt_alzheimers_dementia                  0.000000e+00  7.000000e+00   \n",
       "pcnt_asthma                               0.000000e+00  6.000000e+00   \n",
       "pcnt_artrial_fibrillation                 0.000000e+00  1.000000e+01   \n",
       "pcnt_cancer                               0.000000e+00  4.000000e+01   \n",
       "pcnt_chronic_kidney                       0.000000e+00  2.700000e+01   \n",
       "pcnt_chronic_obstructive_pulmonary        0.000000e+00  1.500000e+01   \n",
       "pcnt_depression                           0.000000e+00  1.900000e+01   \n",
       "pcnt_diabetes                             1.000000e+01  2.700000e+01   \n",
       "pcnt_heart_failure                        0.000000e+00  1.700000e+01   \n",
       "pcnt_hyperlipidemia                       0.000000e+00  4.600000e+01   \n",
       "pcnt_hypertension                         3.100000e+01  6.300000e+01   \n",
       "pcnt_ischemic_heart                       0.000000e+00  3.200000e+01   \n",
       "pcnt_osteoporosis                         0.000000e+00  8.000000e+00   \n",
       "pcnt_rheumatoid_arthritis_osteoarthirtis  1.500000e+01  3.100000e+01   \n",
       "pcnt_schizophrenia_psychotic              0.000000e+00  3.000000e+00   \n",
       "pcnt_stroke                               0.000000e+00  4.000000e+00   \n",
       "avg_hcc_risk_score                        4.278000e-01  1.736300e+00   \n",
       "\n",
       "                                                   50%           75%  \\\n",
       "index                                     4.823700e+05  7.004410e+05   \n",
       "npi                                       1.508835e+09  1.730151e+09   \n",
       "num_hcpcs                                 1.900000e+01  1.010000e+02   \n",
       "num_services                              1.182000e+03  3.808500e+04   \n",
       "num_unique_bene                           2.410000e+02  4.250000e+02   \n",
       "total_submitted_charges                   2.333300e+05  1.967238e+06   \n",
       "total_medicare_allowed_amt                9.292333e+04  8.527557e+05   \n",
       "total_medicare_payment_amt                7.007450e+04  6.676583e+05   \n",
       "num_hcpcs_associated_drug_srvc            0.000000e+00  5.400000e+01   \n",
       "num_drug_srvc                             0.000000e+00  3.804400e+04   \n",
       "num_unique_bene_with_drug_srvc            0.000000e+00  1.030000e+02   \n",
       "total_drug_submitted_charges              0.000000e+00  1.682527e+06   \n",
       "total_drug_medicare_allowed_amt           0.000000e+00  6.906847e+05   \n",
       "total_drug_medicare_payment_amt           0.000000e+00  5.388935e+05   \n",
       "num_hcpcs_associated_med_srvc             1.800000e+01  4.700000e+01   \n",
       "num_med_srvc                              9.600000e+02  4.134000e+03   \n",
       "num_unique_bene_with_med_srvc             2.450000e+02  4.370000e+02   \n",
       "total_med_submitted_charges               2.072330e+05  5.893010e+05   \n",
       "total_med_medicare_allowed_amt            8.056639e+04  2.394403e+05   \n",
       "total_med_medicare_payment_amt            6.065112e+04  1.836782e+05   \n",
       "avg_age_bene                              7.200000e+01  7.400000e+01   \n",
       "num_bene_le65                             4.300000e+01  6.700000e+01   \n",
       "num_bene_65to74                           1.100000e+02  1.860000e+02   \n",
       "num_bene_75to84                           8.900000e+01  1.560000e+02   \n",
       "num_bene_ge84                             4.300000e+01  7.000000e+01   \n",
       "num_female                                1.510000e+02  2.740000e+02   \n",
       "num_male                                  1.110000e+02  1.860000e+02   \n",
       "num_non_his_white                         2.270000e+02  4.002500e+02   \n",
       "num_african_american                      3.400000e+01  6.400000e+01   \n",
       "num_asian                                 1.300000e+01  2.275000e+01   \n",
       "num_hispanic                              2.300000e+01  4.200000e+01   \n",
       "num_american_indian                       0.000000e+00  0.000000e+00   \n",
       "num_no_race                               0.000000e+00  1.300000e+01   \n",
       "num_medicare_only                         2.260000e+02  3.940000e+02   \n",
       "num_medicare_medicaid                     4.400000e+01  8.100000e+01   \n",
       "pcnt_alzheimers_dementia                  9.000000e+00  1.200000e+01   \n",
       "pcnt_asthma                               8.000000e+00  1.000000e+01   \n",
       "pcnt_artrial_fibrillation                 1.300000e+01  1.500000e+01   \n",
       "pcnt_cancer                               4.850000e+01  6.200000e+01   \n",
       "pcnt_chronic_kidney                       3.200000e+01  3.900000e+01   \n",
       "pcnt_chronic_obstructive_pulmonary        2.000000e+01  2.600000e+01   \n",
       "pcnt_depression                           2.200000e+01  2.700000e+01   \n",
       "pcnt_diabetes                             3.200000e+01  3.700000e+01   \n",
       "pcnt_heart_failure                        2.200000e+01  2.700000e+01   \n",
       "pcnt_hyperlipidemia                       5.300000e+01  5.900000e+01   \n",
       "pcnt_hypertension                         6.900000e+01  7.500000e+01   \n",
       "pcnt_ischemic_heart                       3.800000e+01  4.500000e+01   \n",
       "pcnt_osteoporosis                         1.000000e+01  1.200000e+01   \n",
       "pcnt_rheumatoid_arthritis_osteoarthirtis  3.500000e+01  4.000000e+01   \n",
       "pcnt_schizophrenia_psychotic              4.000000e+00  6.000000e+00   \n",
       "pcnt_stroke                               6.000000e+00  7.000000e+00   \n",
       "avg_hcc_risk_score                        1.935900e+00  2.184900e+00   \n",
       "\n",
       "                                                   max  \n",
       "index                                     9.554170e+05  \n",
       "npi                                       1.992942e+09  \n",
       "num_hcpcs                                 5.880000e+02  \n",
       "num_services                              5.310810e+05  \n",
       "num_unique_bene                           1.471800e+04  \n",
       "total_submitted_charges                   2.850965e+07  \n",
       "total_medicare_allowed_amt                1.059430e+07  \n",
       "total_medicare_payment_amt                8.362862e+06  \n",
       "num_hcpcs_associated_drug_srvc            1.180000e+02  \n",
       "num_drug_srvc                             5.062740e+05  \n",
       "num_unique_bene_with_drug_srvc            7.690000e+02  \n",
       "total_drug_submitted_charges              2.146553e+07  \n",
       "total_drug_medicare_allowed_amt           8.152356e+06  \n",
       "total_drug_medicare_payment_amt           6.405225e+06  \n",
       "num_hcpcs_associated_med_srvc             5.050000e+02  \n",
       "num_med_srvc                              1.812590e+05  \n",
       "num_unique_bene_with_med_srvc             1.471800e+04  \n",
       "total_med_submitted_charges               8.791787e+06  \n",
       "total_med_medicare_allowed_amt            2.441943e+06  \n",
       "total_med_medicare_payment_amt            2.046456e+06  \n",
       "avg_age_bene                              8.500000e+01  \n",
       "num_bene_le65                             9.660000e+02  \n",
       "num_bene_65to74                           6.938000e+03  \n",
       "num_bene_75to84                           4.561000e+03  \n",
       "num_bene_ge84                             2.252000e+03  \n",
       "num_female                                8.694000e+03  \n",
       "num_male                                  6.023000e+03  \n",
       "num_non_his_white                         9.801000e+03  \n",
       "num_african_american                      7.160000e+02  \n",
       "num_asian                                 3.080000e+03  \n",
       "num_hispanic                              1.049000e+03  \n",
       "num_american_indian                       1.480000e+02  \n",
       "num_no_race                               5.560000e+02  \n",
       "num_medicare_only                         1.190200e+04  \n",
       "num_medicare_medicaid                     2.815000e+03  \n",
       "pcnt_alzheimers_dementia                  6.600000e+01  \n",
       "pcnt_asthma                               3.400000e+01  \n",
       "pcnt_artrial_fibrillation                 3.900000e+01  \n",
       "pcnt_cancer                               7.500000e+01  \n",
       "pcnt_chronic_kidney                       7.500000e+01  \n",
       "pcnt_chronic_obstructive_pulmonary        6.900000e+01  \n",
       "pcnt_depression                           5.800000e+01  \n",
       "pcnt_diabetes                             7.500000e+01  \n",
       "pcnt_heart_failure                        7.300000e+01  \n",
       "pcnt_hyperlipidemia                       7.500000e+01  \n",
       "pcnt_hypertension                         7.500000e+01  \n",
       "pcnt_ischemic_heart                       7.500000e+01  \n",
       "pcnt_osteoporosis                         5.300000e+01  \n",
       "pcnt_rheumatoid_arthritis_osteoarthirtis  7.500000e+01  \n",
       "pcnt_schizophrenia_psychotic              3.100000e+01  \n",
       "pcnt_stroke                               3.000000e+01  \n",
       "avg_hcc_risk_score                        4.577600e+00  "
      ]
     },
     "execution_count": 20,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_cancer_med.describe().T"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 10,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "query = '''\n",
    "        SELECT *\n",
    "        FROM util_payments_agg_2013\n",
    "        WHERE provider_type='Surgical Oncology'\n",
    "        ;\n",
    "        '''\n",
    "df_cancer_surgical = pd.read_sql_query(query, conn)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 11,
   "metadata": {
    "collapsed": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "Int64Index: 761 entries, 0 to 760\n",
      "Data columns (total 68 columns):\n",
      "index                                       761 non-null int64\n",
      "npi                                         761 non-null int64\n",
      "last_name                                   761 non-null object\n",
      "first_name                                  761 non-null object\n",
      "middle_initial                              565 non-null object\n",
      "credentials                                 746 non-null object\n",
      "gender                                      761 non-null object\n",
      "entity_code                                 761 non-null object\n",
      "street1                                     761 non-null object\n",
      "street2                                     440 non-null object\n",
      "city                                        761 non-null object\n",
      "zip                                         761 non-null object\n",
      "state                                       761 non-null object\n",
      "country                                     761 non-null object\n",
      "provider_type                               761 non-null object\n",
      "medicare_participation_indicator            761 non-null object\n",
      "num_hcpcs                                   761 non-null int64\n",
      "num_services                                761 non-null float64\n",
      "num_unique_bene                             761 non-null int64\n",
      "total_submitted_charges                     761 non-null float64\n",
      "total_medicare_allowed_amt                  761 non-null float64\n",
      "total_medicare_payment_amt                  761 non-null float64\n",
      "drug_suppress_indicator                     29 non-null object\n",
      "num_hcpcs_associated_drug_srvc              732 non-null float64\n",
      "num_drug_srvc                               732 non-null float64\n",
      "num_unique_bene_with_drug_srvc              732 non-null float64\n",
      "total_drug_submitted_charges                732 non-null float64\n",
      "total_drug_medicare_allowed_amt             732 non-null float64\n",
      "total_drug_medicare_payment_amt             732 non-null float64\n",
      "medical_suppress_indicator                  29 non-null object\n",
      "num_hcpcs_associated_med_srvc               732 non-null float64\n",
      "num_med_srvc                                732 non-null float64\n",
      "num_unique_bene_with_med_srvc               732 non-null float64\n",
      "total_med_submitted_charges                 732 non-null float64\n",
      "total_med_medicare_allowed_amt              732 non-null float64\n",
      "total_med_medicare_payment_amt              732 non-null float64\n",
      "avg_age_bene                                761 non-null float64\n",
      "num_bene_le65                               405 non-null float64\n",
      "num_bene_65to74                             704 non-null float64\n",
      "num_bene_75to84                             570 non-null float64\n",
      "num_bene_ge84                               348 non-null float64\n",
      "num_female                                  561 non-null float64\n",
      "num_male                                    561 non-null float64\n",
      "num_non_his_white                           532 non-null float64\n",
      "num_african_american                        183 non-null float64\n",
      "num_asian                                   86 non-null float64\n",
      "num_hispanic                                113 non-null float64\n",
      "num_american_indian                         234 non-null float64\n",
      "num_no_race                                 62 non-null float64\n",
      "num_medicare_only                           575 non-null float64\n",
      "num_medicare_medicaid                       575 non-null float64\n",
      "pcnt_alzheimers_dementia                    332 non-null float64\n",
      "pcnt_asthma                                 392 non-null float64\n",
      "pcnt_artrial_fibrillation                   446 non-null float64\n",
      "pcnt_cancer                                 700 non-null float64\n",
      "pcnt_chronic_kidney                         613 non-null float64\n",
      "pcnt_chronic_obstructive_pulmonary          516 non-null float64\n",
      "pcnt_depression                             644 non-null float64\n",
      "pcnt_diabetes                               684 non-null float64\n",
      "pcnt_heart_failure                          560 non-null float64\n",
      "pcnt_hyperlipidemia                         736 non-null float64\n",
      "pcnt_hypertension                           749 non-null float64\n",
      "pcnt_ischemic_heart                         678 non-null float64\n",
      "pcnt_osteoporosis                           452 non-null float64\n",
      "pcnt_rheumatoid_arthritis_osteoarthirtis    703 non-null float64\n",
      "pcnt_schizophrenia_psychotic                166 non-null float64\n",
      "pcnt_stroke                                 212 non-null float64\n",
      "avg_hcc_risk_score                          761 non-null float64\n",
      "dtypes: float64(48), int64(4), object(16)\n",
      "memory usage: 410.2+ KB\n"
     ]
    }
   ],
   "source": [
    "df_cancer_surgical.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 21,
   "metadata": {
    "collapsed": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>count</th>\n",
       "      <th>mean</th>\n",
       "      <th>std</th>\n",
       "      <th>min</th>\n",
       "      <th>25%</th>\n",
       "      <th>50%</th>\n",
       "      <th>75%</th>\n",
       "      <th>max</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>index</th>\n",
       "      <td>761</td>\n",
       "      <td>4.781349e+05</td>\n",
       "      <td>2.768328e+05</td>\n",
       "      <td>3.890000e+02</td>\n",
       "      <td>2.312360e+05</td>\n",
       "      <td>4.840690e+05</td>\n",
       "      <td>7.248780e+05</td>\n",
       "      <td>9.559230e+05</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>npi</th>\n",
       "      <td>761</td>\n",
       "      <td>1.499749e+09</td>\n",
       "      <td>2.888313e+08</td>\n",
       "      <td>1.003021e+09</td>\n",
       "      <td>1.245227e+09</td>\n",
       "      <td>1.508868e+09</td>\n",
       "      <td>1.750544e+09</td>\n",
       "      <td>1.992973e+09</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_hcpcs</th>\n",
       "      <td>761</td>\n",
       "      <td>4.961104e+01</td>\n",
       "      <td>3.401263e+01</td>\n",
       "      <td>2.000000e+00</td>\n",
       "      <td>2.300000e+01</td>\n",
       "      <td>4.000000e+01</td>\n",
       "      <td>6.700000e+01</td>\n",
       "      <td>1.990000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_services</th>\n",
       "      <td>761</td>\n",
       "      <td>5.917148e+02</td>\n",
       "      <td>2.534990e+03</td>\n",
       "      <td>1.300000e+01</td>\n",
       "      <td>1.650000e+02</td>\n",
       "      <td>3.040000e+02</td>\n",
       "      <td>5.340000e+02</td>\n",
       "      <td>5.856800e+04</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_unique_bene</th>\n",
       "      <td>761</td>\n",
       "      <td>1.720512e+02</td>\n",
       "      <td>1.630447e+02</td>\n",
       "      <td>1.100000e+01</td>\n",
       "      <td>7.000000e+01</td>\n",
       "      <td>1.320000e+02</td>\n",
       "      <td>2.170000e+02</td>\n",
       "      <td>1.459000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_submitted_charges</th>\n",
       "      <td>761</td>\n",
       "      <td>3.298795e+05</td>\n",
       "      <td>3.930856e+05</td>\n",
       "      <td>1.697000e+03</td>\n",
       "      <td>1.211410e+05</td>\n",
       "      <td>2.441320e+05</td>\n",
       "      <td>4.250122e+05</td>\n",
       "      <td>6.031294e+06</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_medicare_allowed_amt</th>\n",
       "      <td>761</td>\n",
       "      <td>9.404351e+04</td>\n",
       "      <td>1.110051e+05</td>\n",
       "      <td>1.144880e+03</td>\n",
       "      <td>3.652936e+04</td>\n",
       "      <td>6.942871e+04</td>\n",
       "      <td>1.191768e+05</td>\n",
       "      <td>1.796133e+06</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_medicare_payment_amt</th>\n",
       "      <td>761</td>\n",
       "      <td>7.251512e+04</td>\n",
       "      <td>8.607968e+04</td>\n",
       "      <td>7.306400e+02</td>\n",
       "      <td>2.795982e+04</td>\n",
       "      <td>5.305513e+04</td>\n",
       "      <td>9.125322e+04</td>\n",
       "      <td>1.387686e+06</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_hcpcs_associated_drug_srvc</th>\n",
       "      <td>732</td>\n",
       "      <td>2.622951e-01</td>\n",
       "      <td>3.002880e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>4.900000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_drug_srvc</th>\n",
       "      <td>732</td>\n",
       "      <td>1.490014e+02</td>\n",
       "      <td>2.266577e+03</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>5.389100e+04</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_unique_bene_with_drug_srvc</th>\n",
       "      <td>732</td>\n",
       "      <td>7.226776e-01</td>\n",
       "      <td>7.288908e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.210000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_drug_submitted_charges</th>\n",
       "      <td>732</td>\n",
       "      <td>8.539640e+03</td>\n",
       "      <td>1.368511e+05</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>3.024565e+06</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_drug_medicare_allowed_amt</th>\n",
       "      <td>732</td>\n",
       "      <td>2.674287e+03</td>\n",
       "      <td>4.301140e+04</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>9.563243e+05</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_drug_medicare_payment_amt</th>\n",
       "      <td>732</td>\n",
       "      <td>2.098897e+03</td>\n",
       "      <td>3.377218e+04</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>7.512820e+05</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_hcpcs_associated_med_srvc</th>\n",
       "      <td>732</td>\n",
       "      <td>4.817213e+01</td>\n",
       "      <td>3.292898e+01</td>\n",
       "      <td>2.000000e+00</td>\n",
       "      <td>2.200000e+01</td>\n",
       "      <td>3.900000e+01</td>\n",
       "      <td>6.400000e+01</td>\n",
       "      <td>1.990000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_med_srvc</th>\n",
       "      <td>732</td>\n",
       "      <td>4.305219e+02</td>\n",
       "      <td>5.526143e+02</td>\n",
       "      <td>1.300000e+01</td>\n",
       "      <td>1.602500e+02</td>\n",
       "      <td>2.950000e+02</td>\n",
       "      <td>5.115000e+02</td>\n",
       "      <td>7.967000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_unique_bene_with_med_srvc</th>\n",
       "      <td>732</td>\n",
       "      <td>1.710328e+02</td>\n",
       "      <td>1.650621e+02</td>\n",
       "      <td>1.100000e+01</td>\n",
       "      <td>6.900000e+01</td>\n",
       "      <td>1.295000e+02</td>\n",
       "      <td>2.142500e+02</td>\n",
       "      <td>1.459000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_med_submitted_charges</th>\n",
       "      <td>732</td>\n",
       "      <td>3.194721e+05</td>\n",
       "      <td>3.611688e+05</td>\n",
       "      <td>3.372000e+03</td>\n",
       "      <td>1.183754e+05</td>\n",
       "      <td>2.385073e+05</td>\n",
       "      <td>4.161766e+05</td>\n",
       "      <td>5.996764e+06</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_med_medicare_allowed_amt</th>\n",
       "      <td>732</td>\n",
       "      <td>9.014786e+04</td>\n",
       "      <td>9.975571e+04</td>\n",
       "      <td>1.188610e+03</td>\n",
       "      <td>3.601140e+04</td>\n",
       "      <td>6.737983e+04</td>\n",
       "      <td>1.151983e+05</td>\n",
       "      <td>1.792892e+06</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_med_medicare_payment_amt</th>\n",
       "      <td>732</td>\n",
       "      <td>6.948749e+04</td>\n",
       "      <td>7.711503e+04</td>\n",
       "      <td>7.306400e+02</td>\n",
       "      <td>2.714344e+04</td>\n",
       "      <td>5.171888e+04</td>\n",
       "      <td>8.942854e+04</td>\n",
       "      <td>1.385153e+06</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>avg_age_bene</th>\n",
       "      <td>761</td>\n",
       "      <td>7.104468e+01</td>\n",
       "      <td>2.752148e+00</td>\n",
       "      <td>5.800000e+01</td>\n",
       "      <td>7.000000e+01</td>\n",
       "      <td>7.100000e+01</td>\n",
       "      <td>7.300000e+01</td>\n",
       "      <td>7.900000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_bene_le65</th>\n",
       "      <td>405</td>\n",
       "      <td>3.348395e+01</td>\n",
       "      <td>3.044672e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.900000e+01</td>\n",
       "      <td>2.600000e+01</td>\n",
       "      <td>4.000000e+01</td>\n",
       "      <td>4.850000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_bene_65to74</th>\n",
       "      <td>704</td>\n",
       "      <td>8.904403e+01</td>\n",
       "      <td>8.444653e+01</td>\n",
       "      <td>1.100000e+01</td>\n",
       "      <td>3.900000e+01</td>\n",
       "      <td>6.600000e+01</td>\n",
       "      <td>1.100000e+02</td>\n",
       "      <td>7.870000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_bene_75to84</th>\n",
       "      <td>570</td>\n",
       "      <td>6.267368e+01</td>\n",
       "      <td>5.464381e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>3.000000e+01</td>\n",
       "      <td>4.850000e+01</td>\n",
       "      <td>7.600000e+01</td>\n",
       "      <td>4.340000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_bene_ge84</th>\n",
       "      <td>348</td>\n",
       "      <td>2.709770e+01</td>\n",
       "      <td>2.231518e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.400000e+01</td>\n",
       "      <td>2.000000e+01</td>\n",
       "      <td>3.100000e+01</td>\n",
       "      <td>1.460000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_female</th>\n",
       "      <td>561</td>\n",
       "      <td>1.105900e+02</td>\n",
       "      <td>1.125279e+02</td>\n",
       "      <td>1.100000e+01</td>\n",
       "      <td>4.700000e+01</td>\n",
       "      <td>7.600000e+01</td>\n",
       "      <td>1.370000e+02</td>\n",
       "      <td>1.175000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_male</th>\n",
       "      <td>561</td>\n",
       "      <td>5.863280e+01</td>\n",
       "      <td>5.761725e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>2.000000e+01</td>\n",
       "      <td>4.600000e+01</td>\n",
       "      <td>8.200000e+01</td>\n",
       "      <td>5.560000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_non_his_white</th>\n",
       "      <td>532</td>\n",
       "      <td>1.694624e+02</td>\n",
       "      <td>1.534434e+02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>7.300000e+01</td>\n",
       "      <td>1.280000e+02</td>\n",
       "      <td>2.145000e+02</td>\n",
       "      <td>1.221000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_african_american</th>\n",
       "      <td>183</td>\n",
       "      <td>3.645355e+01</td>\n",
       "      <td>3.526550e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.500000e+01</td>\n",
       "      <td>2.500000e+01</td>\n",
       "      <td>4.700000e+01</td>\n",
       "      <td>2.070000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_asian</th>\n",
       "      <td>86</td>\n",
       "      <td>9.697674e+00</td>\n",
       "      <td>2.231542e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.400000e+01</td>\n",
       "      <td>1.660000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_hispanic</th>\n",
       "      <td>113</td>\n",
       "      <td>3.039823e+01</td>\n",
       "      <td>6.227438e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.200000e+01</td>\n",
       "      <td>1.700000e+01</td>\n",
       "      <td>2.800000e+01</td>\n",
       "      <td>6.120000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_american_indian</th>\n",
       "      <td>234</td>\n",
       "      <td>1.068376e-01</td>\n",
       "      <td>1.634301e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>2.500000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_no_race</th>\n",
       "      <td>62</td>\n",
       "      <td>3.274194e+00</td>\n",
       "      <td>8.841351e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>4.900000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_medicare_only</th>\n",
       "      <td>575</td>\n",
       "      <td>1.652557e+02</td>\n",
       "      <td>1.481436e+02</td>\n",
       "      <td>1.100000e+01</td>\n",
       "      <td>7.300000e+01</td>\n",
       "      <td>1.270000e+02</td>\n",
       "      <td>2.010000e+02</td>\n",
       "      <td>1.187000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_medicare_medicaid</th>\n",
       "      <td>575</td>\n",
       "      <td>3.736696e+01</td>\n",
       "      <td>4.133634e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.800000e+01</td>\n",
       "      <td>2.700000e+01</td>\n",
       "      <td>4.400000e+01</td>\n",
       "      <td>7.480000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_alzheimers_dementia</th>\n",
       "      <td>332</td>\n",
       "      <td>8.804217e+00</td>\n",
       "      <td>5.350629e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>6.000000e+00</td>\n",
       "      <td>8.000000e+00</td>\n",
       "      <td>1.100000e+01</td>\n",
       "      <td>3.500000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_asthma</th>\n",
       "      <td>392</td>\n",
       "      <td>9.170918e+00</td>\n",
       "      <td>3.482344e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>7.000000e+00</td>\n",
       "      <td>9.000000e+00</td>\n",
       "      <td>1.100000e+01</td>\n",
       "      <td>2.200000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_artrial_fibrillation</th>\n",
       "      <td>446</td>\n",
       "      <td>1.179372e+01</td>\n",
       "      <td>5.092630e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>8.000000e+00</td>\n",
       "      <td>1.100000e+01</td>\n",
       "      <td>1.500000e+01</td>\n",
       "      <td>3.500000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_cancer</th>\n",
       "      <td>700</td>\n",
       "      <td>4.467429e+01</td>\n",
       "      <td>2.001472e+01</td>\n",
       "      <td>5.000000e+00</td>\n",
       "      <td>2.800000e+01</td>\n",
       "      <td>4.200000e+01</td>\n",
       "      <td>6.300000e+01</td>\n",
       "      <td>7.500000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_chronic_kidney</th>\n",
       "      <td>613</td>\n",
       "      <td>2.515824e+01</td>\n",
       "      <td>1.122495e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.600000e+01</td>\n",
       "      <td>2.400000e+01</td>\n",
       "      <td>3.300000e+01</td>\n",
       "      <td>7.500000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_chronic_obstructive_pulmonary</th>\n",
       "      <td>516</td>\n",
       "      <td>1.527132e+01</td>\n",
       "      <td>7.550479e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>9.000000e+00</td>\n",
       "      <td>1.400000e+01</td>\n",
       "      <td>2.000000e+01</td>\n",
       "      <td>5.100000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_depression</th>\n",
       "      <td>644</td>\n",
       "      <td>2.303106e+01</td>\n",
       "      <td>7.439479e+00</td>\n",
       "      <td>8.000000e+00</td>\n",
       "      <td>1.800000e+01</td>\n",
       "      <td>2.200000e+01</td>\n",
       "      <td>2.700000e+01</td>\n",
       "      <td>5.300000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_diabetes</th>\n",
       "      <td>684</td>\n",
       "      <td>3.263596e+01</td>\n",
       "      <td>9.531972e+00</td>\n",
       "      <td>8.000000e+00</td>\n",
       "      <td>2.600000e+01</td>\n",
       "      <td>3.200000e+01</td>\n",
       "      <td>3.800000e+01</td>\n",
       "      <td>7.500000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_heart_failure</th>\n",
       "      <td>560</td>\n",
       "      <td>1.813214e+01</td>\n",
       "      <td>8.045735e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.300000e+01</td>\n",
       "      <td>1.600000e+01</td>\n",
       "      <td>2.300000e+01</td>\n",
       "      <td>6.200000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_hyperlipidemia</th>\n",
       "      <td>736</td>\n",
       "      <td>5.632609e+01</td>\n",
       "      <td>8.938165e+00</td>\n",
       "      <td>2.700000e+01</td>\n",
       "      <td>5.000000e+01</td>\n",
       "      <td>5.700000e+01</td>\n",
       "      <td>6.300000e+01</td>\n",
       "      <td>7.500000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_hypertension</th>\n",
       "      <td>749</td>\n",
       "      <td>6.788518e+01</td>\n",
       "      <td>7.960138e+00</td>\n",
       "      <td>2.900000e+01</td>\n",
       "      <td>6.300000e+01</td>\n",
       "      <td>7.000000e+01</td>\n",
       "      <td>7.500000e+01</td>\n",
       "      <td>7.500000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_ischemic_heart</th>\n",
       "      <td>678</td>\n",
       "      <td>3.413717e+01</td>\n",
       "      <td>1.102208e+01</td>\n",
       "      <td>1.100000e+01</td>\n",
       "      <td>2.600000e+01</td>\n",
       "      <td>3.400000e+01</td>\n",
       "      <td>4.000000e+01</td>\n",
       "      <td>7.300000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_osteoporosis</th>\n",
       "      <td>452</td>\n",
       "      <td>1.237168e+01</td>\n",
       "      <td>5.129273e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>9.000000e+00</td>\n",
       "      <td>1.200000e+01</td>\n",
       "      <td>1.500000e+01</td>\n",
       "      <td>4.100000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_rheumatoid_arthritis_osteoarthirtis</th>\n",
       "      <td>703</td>\n",
       "      <td>3.760313e+01</td>\n",
       "      <td>7.092819e+00</td>\n",
       "      <td>1.700000e+01</td>\n",
       "      <td>3.300000e+01</td>\n",
       "      <td>3.700000e+01</td>\n",
       "      <td>4.200000e+01</td>\n",
       "      <td>6.500000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_schizophrenia_psychotic</th>\n",
       "      <td>166</td>\n",
       "      <td>2.584337e+00</td>\n",
       "      <td>3.725684e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>4.000000e+00</td>\n",
       "      <td>1.500000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_stroke</th>\n",
       "      <td>212</td>\n",
       "      <td>4.174528e+00</td>\n",
       "      <td>3.618372e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>4.000000e+00</td>\n",
       "      <td>6.000000e+00</td>\n",
       "      <td>2.000000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>avg_hcc_risk_score</th>\n",
       "      <td>761</td>\n",
       "      <td>1.462031e+00</td>\n",
       "      <td>4.747248e-01</td>\n",
       "      <td>6.652000e-01</td>\n",
       "      <td>1.132400e+00</td>\n",
       "      <td>1.402900e+00</td>\n",
       "      <td>1.710600e+00</td>\n",
       "      <td>7.604100e+00</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                          count          mean           std  \\\n",
       "index                                       761  4.781349e+05  2.768328e+05   \n",
       "npi                                         761  1.499749e+09  2.888313e+08   \n",
       "num_hcpcs                                   761  4.961104e+01  3.401263e+01   \n",
       "num_services                                761  5.917148e+02  2.534990e+03   \n",
       "num_unique_bene                             761  1.720512e+02  1.630447e+02   \n",
       "total_submitted_charges                     761  3.298795e+05  3.930856e+05   \n",
       "total_medicare_allowed_amt                  761  9.404351e+04  1.110051e+05   \n",
       "total_medicare_payment_amt                  761  7.251512e+04  8.607968e+04   \n",
       "num_hcpcs_associated_drug_srvc              732  2.622951e-01  3.002880e+00   \n",
       "num_drug_srvc                               732  1.490014e+02  2.266577e+03   \n",
       "num_unique_bene_with_drug_srvc              732  7.226776e-01  7.288908e+00   \n",
       "total_drug_submitted_charges                732  8.539640e+03  1.368511e+05   \n",
       "total_drug_medicare_allowed_amt             732  2.674287e+03  4.301140e+04   \n",
       "total_drug_medicare_payment_amt             732  2.098897e+03  3.377218e+04   \n",
       "num_hcpcs_associated_med_srvc               732  4.817213e+01  3.292898e+01   \n",
       "num_med_srvc                                732  4.305219e+02  5.526143e+02   \n",
       "num_unique_bene_with_med_srvc               732  1.710328e+02  1.650621e+02   \n",
       "total_med_submitted_charges                 732  3.194721e+05  3.611688e+05   \n",
       "total_med_medicare_allowed_amt              732  9.014786e+04  9.975571e+04   \n",
       "total_med_medicare_payment_amt              732  6.948749e+04  7.711503e+04   \n",
       "avg_age_bene                                761  7.104468e+01  2.752148e+00   \n",
       "num_bene_le65                               405  3.348395e+01  3.044672e+01   \n",
       "num_bene_65to74                             704  8.904403e+01  8.444653e+01   \n",
       "num_bene_75to84                             570  6.267368e+01  5.464381e+01   \n",
       "num_bene_ge84                               348  2.709770e+01  2.231518e+01   \n",
       "num_female                                  561  1.105900e+02  1.125279e+02   \n",
       "num_male                                    561  5.863280e+01  5.761725e+01   \n",
       "num_non_his_white                           532  1.694624e+02  1.534434e+02   \n",
       "num_african_american                        183  3.645355e+01  3.526550e+01   \n",
       "num_asian                                    86  9.697674e+00  2.231542e+01   \n",
       "num_hispanic                                113  3.039823e+01  6.227438e+01   \n",
       "num_american_indian                         234  1.068376e-01  1.634301e+00   \n",
       "num_no_race                                  62  3.274194e+00  8.841351e+00   \n",
       "num_medicare_only                           575  1.652557e+02  1.481436e+02   \n",
       "num_medicare_medicaid                       575  3.736696e+01  4.133634e+01   \n",
       "pcnt_alzheimers_dementia                    332  8.804217e+00  5.350629e+00   \n",
       "pcnt_asthma                                 392  9.170918e+00  3.482344e+00   \n",
       "pcnt_artrial_fibrillation                   446  1.179372e+01  5.092630e+00   \n",
       "pcnt_cancer                                 700  4.467429e+01  2.001472e+01   \n",
       "pcnt_chronic_kidney                         613  2.515824e+01  1.122495e+01   \n",
       "pcnt_chronic_obstructive_pulmonary          516  1.527132e+01  7.550479e+00   \n",
       "pcnt_depression                             644  2.303106e+01  7.439479e+00   \n",
       "pcnt_diabetes                               684  3.263596e+01  9.531972e+00   \n",
       "pcnt_heart_failure                          560  1.813214e+01  8.045735e+00   \n",
       "pcnt_hyperlipidemia                         736  5.632609e+01  8.938165e+00   \n",
       "pcnt_hypertension                           749  6.788518e+01  7.960138e+00   \n",
       "pcnt_ischemic_heart                         678  3.413717e+01  1.102208e+01   \n",
       "pcnt_osteoporosis                           452  1.237168e+01  5.129273e+00   \n",
       "pcnt_rheumatoid_arthritis_osteoarthirtis    703  3.760313e+01  7.092819e+00   \n",
       "pcnt_schizophrenia_psychotic                166  2.584337e+00  3.725684e+00   \n",
       "pcnt_stroke                                 212  4.174528e+00  3.618372e+00   \n",
       "avg_hcc_risk_score                          761  1.462031e+00  4.747248e-01   \n",
       "\n",
       "                                                   min           25%  \\\n",
       "index                                     3.890000e+02  2.312360e+05   \n",
       "npi                                       1.003021e+09  1.245227e+09   \n",
       "num_hcpcs                                 2.000000e+00  2.300000e+01   \n",
       "num_services                              1.300000e+01  1.650000e+02   \n",
       "num_unique_bene                           1.100000e+01  7.000000e+01   \n",
       "total_submitted_charges                   1.697000e+03  1.211410e+05   \n",
       "total_medicare_allowed_amt                1.144880e+03  3.652936e+04   \n",
       "total_medicare_payment_amt                7.306400e+02  2.795982e+04   \n",
       "num_hcpcs_associated_drug_srvc            0.000000e+00  0.000000e+00   \n",
       "num_drug_srvc                             0.000000e+00  0.000000e+00   \n",
       "num_unique_bene_with_drug_srvc            0.000000e+00  0.000000e+00   \n",
       "total_drug_submitted_charges              0.000000e+00  0.000000e+00   \n",
       "total_drug_medicare_allowed_amt           0.000000e+00  0.000000e+00   \n",
       "total_drug_medicare_payment_amt           0.000000e+00  0.000000e+00   \n",
       "num_hcpcs_associated_med_srvc             2.000000e+00  2.200000e+01   \n",
       "num_med_srvc                              1.300000e+01  1.602500e+02   \n",
       "num_unique_bene_with_med_srvc             1.100000e+01  6.900000e+01   \n",
       "total_med_submitted_charges               3.372000e+03  1.183754e+05   \n",
       "total_med_medicare_allowed_amt            1.188610e+03  3.601140e+04   \n",
       "total_med_medicare_payment_amt            7.306400e+02  2.714344e+04   \n",
       "avg_age_bene                              5.800000e+01  7.000000e+01   \n",
       "num_bene_le65                             0.000000e+00  1.900000e+01   \n",
       "num_bene_65to74                           1.100000e+01  3.900000e+01   \n",
       "num_bene_75to84                           0.000000e+00  3.000000e+01   \n",
       "num_bene_ge84                             0.000000e+00  1.400000e+01   \n",
       "num_female                                1.100000e+01  4.700000e+01   \n",
       "num_male                                  0.000000e+00  2.000000e+01   \n",
       "num_non_his_white                         0.000000e+00  7.300000e+01   \n",
       "num_african_american                      0.000000e+00  1.500000e+01   \n",
       "num_asian                                 0.000000e+00  0.000000e+00   \n",
       "num_hispanic                              0.000000e+00  1.200000e+01   \n",
       "num_american_indian                       0.000000e+00  0.000000e+00   \n",
       "num_no_race                               0.000000e+00  0.000000e+00   \n",
       "num_medicare_only                         1.100000e+01  7.300000e+01   \n",
       "num_medicare_medicaid                     0.000000e+00  1.800000e+01   \n",
       "pcnt_alzheimers_dementia                  0.000000e+00  6.000000e+00   \n",
       "pcnt_asthma                               0.000000e+00  7.000000e+00   \n",
       "pcnt_artrial_fibrillation                 0.000000e+00  8.000000e+00   \n",
       "pcnt_cancer                               5.000000e+00  2.800000e+01   \n",
       "pcnt_chronic_kidney                       0.000000e+00  1.600000e+01   \n",
       "pcnt_chronic_obstructive_pulmonary        0.000000e+00  9.000000e+00   \n",
       "pcnt_depression                           8.000000e+00  1.800000e+01   \n",
       "pcnt_diabetes                             8.000000e+00  2.600000e+01   \n",
       "pcnt_heart_failure                        0.000000e+00  1.300000e+01   \n",
       "pcnt_hyperlipidemia                       2.700000e+01  5.000000e+01   \n",
       "pcnt_hypertension                         2.900000e+01  6.300000e+01   \n",
       "pcnt_ischemic_heart                       1.100000e+01  2.600000e+01   \n",
       "pcnt_osteoporosis                         0.000000e+00  9.000000e+00   \n",
       "pcnt_rheumatoid_arthritis_osteoarthirtis  1.700000e+01  3.300000e+01   \n",
       "pcnt_schizophrenia_psychotic              0.000000e+00  0.000000e+00   \n",
       "pcnt_stroke                               0.000000e+00  0.000000e+00   \n",
       "avg_hcc_risk_score                        6.652000e-01  1.132400e+00   \n",
       "\n",
       "                                                   50%           75%  \\\n",
       "index                                     4.840690e+05  7.248780e+05   \n",
       "npi                                       1.508868e+09  1.750544e+09   \n",
       "num_hcpcs                                 4.000000e+01  6.700000e+01   \n",
       "num_services                              3.040000e+02  5.340000e+02   \n",
       "num_unique_bene                           1.320000e+02  2.170000e+02   \n",
       "total_submitted_charges                   2.441320e+05  4.250122e+05   \n",
       "total_medicare_allowed_amt                6.942871e+04  1.191768e+05   \n",
       "total_medicare_payment_amt                5.305513e+04  9.125322e+04   \n",
       "num_hcpcs_associated_drug_srvc            0.000000e+00  0.000000e+00   \n",
       "num_drug_srvc                             0.000000e+00  0.000000e+00   \n",
       "num_unique_bene_with_drug_srvc            0.000000e+00  0.000000e+00   \n",
       "total_drug_submitted_charges              0.000000e+00  0.000000e+00   \n",
       "total_drug_medicare_allowed_amt           0.000000e+00  0.000000e+00   \n",
       "total_drug_medicare_payment_amt           0.000000e+00  0.000000e+00   \n",
       "num_hcpcs_associated_med_srvc             3.900000e+01  6.400000e+01   \n",
       "num_med_srvc                              2.950000e+02  5.115000e+02   \n",
       "num_unique_bene_with_med_srvc             1.295000e+02  2.142500e+02   \n",
       "total_med_submitted_charges               2.385073e+05  4.161766e+05   \n",
       "total_med_medicare_allowed_amt            6.737983e+04  1.151983e+05   \n",
       "total_med_medicare_payment_amt            5.171888e+04  8.942854e+04   \n",
       "avg_age_bene                              7.100000e+01  7.300000e+01   \n",
       "num_bene_le65                             2.600000e+01  4.000000e+01   \n",
       "num_bene_65to74                           6.600000e+01  1.100000e+02   \n",
       "num_bene_75to84                           4.850000e+01  7.600000e+01   \n",
       "num_bene_ge84                             2.000000e+01  3.100000e+01   \n",
       "num_female                                7.600000e+01  1.370000e+02   \n",
       "num_male                                  4.600000e+01  8.200000e+01   \n",
       "num_non_his_white                         1.280000e+02  2.145000e+02   \n",
       "num_african_american                      2.500000e+01  4.700000e+01   \n",
       "num_asian                                 0.000000e+00  1.400000e+01   \n",
       "num_hispanic                              1.700000e+01  2.800000e+01   \n",
       "num_american_indian                       0.000000e+00  0.000000e+00   \n",
       "num_no_race                               0.000000e+00  0.000000e+00   \n",
       "num_medicare_only                         1.270000e+02  2.010000e+02   \n",
       "num_medicare_medicaid                     2.700000e+01  4.400000e+01   \n",
       "pcnt_alzheimers_dementia                  8.000000e+00  1.100000e+01   \n",
       "pcnt_asthma                               9.000000e+00  1.100000e+01   \n",
       "pcnt_artrial_fibrillation                 1.100000e+01  1.500000e+01   \n",
       "pcnt_cancer                               4.200000e+01  6.300000e+01   \n",
       "pcnt_chronic_kidney                       2.400000e+01  3.300000e+01   \n",
       "pcnt_chronic_obstructive_pulmonary        1.400000e+01  2.000000e+01   \n",
       "pcnt_depression                           2.200000e+01  2.700000e+01   \n",
       "pcnt_diabetes                             3.200000e+01  3.800000e+01   \n",
       "pcnt_heart_failure                        1.600000e+01  2.300000e+01   \n",
       "pcnt_hyperlipidemia                       5.700000e+01  6.300000e+01   \n",
       "pcnt_hypertension                         7.000000e+01  7.500000e+01   \n",
       "pcnt_ischemic_heart                       3.400000e+01  4.000000e+01   \n",
       "pcnt_osteoporosis                         1.200000e+01  1.500000e+01   \n",
       "pcnt_rheumatoid_arthritis_osteoarthirtis  3.700000e+01  4.200000e+01   \n",
       "pcnt_schizophrenia_psychotic              0.000000e+00  4.000000e+00   \n",
       "pcnt_stroke                               4.000000e+00  6.000000e+00   \n",
       "avg_hcc_risk_score                        1.402900e+00  1.710600e+00   \n",
       "\n",
       "                                                   max  \n",
       "index                                     9.559230e+05  \n",
       "npi                                       1.992973e+09  \n",
       "num_hcpcs                                 1.990000e+02  \n",
       "num_services                              5.856800e+04  \n",
       "num_unique_bene                           1.459000e+03  \n",
       "total_submitted_charges                   6.031294e+06  \n",
       "total_medicare_allowed_amt                1.796133e+06  \n",
       "total_medicare_payment_amt                1.387686e+06  \n",
       "num_hcpcs_associated_drug_srvc            4.900000e+01  \n",
       "num_drug_srvc                             5.389100e+04  \n",
       "num_unique_bene_with_drug_srvc            1.210000e+02  \n",
       "total_drug_submitted_charges              3.024565e+06  \n",
       "total_drug_medicare_allowed_amt           9.563243e+05  \n",
       "total_drug_medicare_payment_amt           7.512820e+05  \n",
       "num_hcpcs_associated_med_srvc             1.990000e+02  \n",
       "num_med_srvc                              7.967000e+03  \n",
       "num_unique_bene_with_med_srvc             1.459000e+03  \n",
       "total_med_submitted_charges               5.996764e+06  \n",
       "total_med_medicare_allowed_amt            1.792892e+06  \n",
       "total_med_medicare_payment_amt            1.385153e+06  \n",
       "avg_age_bene                              7.900000e+01  \n",
       "num_bene_le65                             4.850000e+02  \n",
       "num_bene_65to74                           7.870000e+02  \n",
       "num_bene_75to84                           4.340000e+02  \n",
       "num_bene_ge84                             1.460000e+02  \n",
       "num_female                                1.175000e+03  \n",
       "num_male                                  5.560000e+02  \n",
       "num_non_his_white                         1.221000e+03  \n",
       "num_african_american                      2.070000e+02  \n",
       "num_asian                                 1.660000e+02  \n",
       "num_hispanic                              6.120000e+02  \n",
       "num_american_indian                       2.500000e+01  \n",
       "num_no_race                               4.900000e+01  \n",
       "num_medicare_only                         1.187000e+03  \n",
       "num_medicare_medicaid                     7.480000e+02  \n",
       "pcnt_alzheimers_dementia                  3.500000e+01  \n",
       "pcnt_asthma                               2.200000e+01  \n",
       "pcnt_artrial_fibrillation                 3.500000e+01  \n",
       "pcnt_cancer                               7.500000e+01  \n",
       "pcnt_chronic_kidney                       7.500000e+01  \n",
       "pcnt_chronic_obstructive_pulmonary        5.100000e+01  \n",
       "pcnt_depression                           5.300000e+01  \n",
       "pcnt_diabetes                             7.500000e+01  \n",
       "pcnt_heart_failure                        6.200000e+01  \n",
       "pcnt_hyperlipidemia                       7.500000e+01  \n",
       "pcnt_hypertension                         7.500000e+01  \n",
       "pcnt_ischemic_heart                       7.300000e+01  \n",
       "pcnt_osteoporosis                         4.100000e+01  \n",
       "pcnt_rheumatoid_arthritis_osteoarthirtis  6.500000e+01  \n",
       "pcnt_schizophrenia_psychotic              1.500000e+01  \n",
       "pcnt_stroke                               2.000000e+01  \n",
       "avg_hcc_risk_score                        7.604100e+00  "
      ]
     },
     "execution_count": 21,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_cancer_surgical.describe().T"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 12,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "query = '''\n",
    "        SELECT *\n",
    "        FROM util_payments_agg_2013\n",
    "        WHERE provider_type='Hematology/Oncology'\n",
    "        ;\n",
    "        '''\n",
    "df_cancer_hema = pd.read_sql_query(query, conn)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 13,
   "metadata": {
    "collapsed": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "Int64Index: 7673 entries, 0 to 7672\n",
      "Data columns (total 68 columns):\n",
      "index                                       7673 non-null int64\n",
      "npi                                         7673 non-null int64\n",
      "last_name                                   7673 non-null object\n",
      "first_name                                  7673 non-null object\n",
      "middle_initial                              5333 non-null object\n",
      "credentials                                 7524 non-null object\n",
      "gender                                      7673 non-null object\n",
      "entity_code                                 7673 non-null object\n",
      "street1                                     7673 non-null object\n",
      "street2                                     4130 non-null object\n",
      "city                                        7673 non-null object\n",
      "zip                                         7673 non-null object\n",
      "state                                       7673 non-null object\n",
      "country                                     7673 non-null object\n",
      "provider_type                               7673 non-null object\n",
      "medicare_participation_indicator            7673 non-null object\n",
      "num_hcpcs                                   7673 non-null int64\n",
      "num_services                                7673 non-null float64\n",
      "num_unique_bene                             7673 non-null int64\n",
      "total_submitted_charges                     7673 non-null float64\n",
      "total_medicare_allowed_amt                  7673 non-null float64\n",
      "total_medicare_payment_amt                  7673 non-null float64\n",
      "drug_suppress_indicator                     603 non-null object\n",
      "num_hcpcs_associated_drug_srvc              7070 non-null float64\n",
      "num_drug_srvc                               7070 non-null float64\n",
      "num_unique_bene_with_drug_srvc              7070 non-null float64\n",
      "total_drug_submitted_charges                7070 non-null float64\n",
      "total_drug_medicare_allowed_amt             7070 non-null float64\n",
      "total_drug_medicare_payment_amt             7070 non-null float64\n",
      "medical_suppress_indicator                  603 non-null object\n",
      "num_hcpcs_associated_med_srvc               7070 non-null float64\n",
      "num_med_srvc                                7070 non-null float64\n",
      "num_unique_bene_with_med_srvc               7070 non-null float64\n",
      "total_med_submitted_charges                 7070 non-null float64\n",
      "total_med_medicare_allowed_amt              7070 non-null float64\n",
      "total_med_medicare_payment_amt              7070 non-null float64\n",
      "avg_age_bene                                7673 non-null float64\n",
      "num_bene_le65                               6365 non-null float64\n",
      "num_bene_65to74                             7331 non-null float64\n",
      "num_bene_75to84                             6684 non-null float64\n",
      "num_bene_ge84                               5985 non-null float64\n",
      "num_female                                  7335 non-null float64\n",
      "num_male                                    7335 non-null float64\n",
      "num_non_his_white                           6367 non-null float64\n",
      "num_african_american                        3292 non-null float64\n",
      "num_asian                                   1082 non-null float64\n",
      "num_hispanic                                2224 non-null float64\n",
      "num_american_indian                         2413 non-null float64\n",
      "num_no_race                                 566 non-null float64\n",
      "num_medicare_only                           6932 non-null float64\n",
      "num_medicare_medicaid                       6932 non-null float64\n",
      "pcnt_alzheimers_dementia                    6113 non-null float64\n",
      "pcnt_asthma                                 6133 non-null float64\n",
      "pcnt_artrial_fibrillation                   6558 non-null float64\n",
      "pcnt_cancer                                 7175 non-null float64\n",
      "pcnt_chronic_kidney                         7385 non-null float64\n",
      "pcnt_chronic_obstructive_pulmonary          6952 non-null float64\n",
      "pcnt_depression                             7198 non-null float64\n",
      "pcnt_diabetes                               7333 non-null float64\n",
      "pcnt_heart_failure                          7140 non-null float64\n",
      "pcnt_hyperlipidemia                         7505 non-null float64\n",
      "pcnt_hypertension                           7588 non-null float64\n",
      "pcnt_ischemic_heart                         7381 non-null float64\n",
      "pcnt_osteoporosis                           6222 non-null float64\n",
      "pcnt_rheumatoid_arthritis_osteoarthirtis    7383 non-null float64\n",
      "pcnt_schizophrenia_psychotic                4458 non-null float64\n",
      "pcnt_stroke                                 5302 non-null float64\n",
      "avg_hcc_risk_score                          7673 non-null float64\n",
      "dtypes: float64(48), int64(4), object(16)\n",
      "memory usage: 4.0+ MB\n"
     ]
    }
   ],
   "source": [
    "df_cancer_hema.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 14,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "query = '''\n",
    "        SELECT *\n",
    "        FROM util_payments_agg_2013\n",
    "        WHERE provider_type='Gynecological/Oncology'\n",
    "        ;\n",
    "        '''\n",
    "df_cancer_gyn= pd.read_sql_query(query, conn)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 16,
   "metadata": {
    "collapsed": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "Int64Index: 928 entries, 0 to 927\n",
      "Data columns (total 68 columns):\n",
      "index                                       928 non-null int64\n",
      "npi                                         928 non-null int64\n",
      "last_name                                   928 non-null object\n",
      "first_name                                  928 non-null object\n",
      "middle_initial                              694 non-null object\n",
      "credentials                                 909 non-null object\n",
      "gender                                      928 non-null object\n",
      "entity_code                                 928 non-null object\n",
      "street1                                     928 non-null object\n",
      "street2                                     532 non-null object\n",
      "city                                        928 non-null object\n",
      "zip                                         928 non-null object\n",
      "state                                       928 non-null object\n",
      "country                                     928 non-null object\n",
      "provider_type                               928 non-null object\n",
      "medicare_participation_indicator            928 non-null object\n",
      "num_hcpcs                                   928 non-null int64\n",
      "num_services                                928 non-null float64\n",
      "num_unique_bene                             928 non-null int64\n",
      "total_submitted_charges                     928 non-null float64\n",
      "total_medicare_allowed_amt                  928 non-null float64\n",
      "total_medicare_payment_amt                  928 non-null float64\n",
      "drug_suppress_indicator                     111 non-null object\n",
      "num_hcpcs_associated_drug_srvc              817 non-null float64\n",
      "num_drug_srvc                               817 non-null float64\n",
      "num_unique_bene_with_drug_srvc              817 non-null float64\n",
      "total_drug_submitted_charges                817 non-null float64\n",
      "total_drug_medicare_allowed_amt             817 non-null float64\n",
      "total_drug_medicare_payment_amt             817 non-null float64\n",
      "medical_suppress_indicator                  111 non-null object\n",
      "num_hcpcs_associated_med_srvc               817 non-null float64\n",
      "num_med_srvc                                817 non-null float64\n",
      "num_unique_bene_with_med_srvc               817 non-null float64\n",
      "total_med_submitted_charges                 817 non-null float64\n",
      "total_med_medicare_allowed_amt              817 non-null float64\n",
      "total_med_medicare_payment_amt              817 non-null float64\n",
      "avg_age_bene                                928 non-null float64\n",
      "num_bene_le65                               565 non-null float64\n",
      "num_bene_65to74                             869 non-null float64\n",
      "num_bene_75to84                             736 non-null float64\n",
      "num_bene_ge84                               497 non-null float64\n",
      "num_female                                  836 non-null float64\n",
      "num_male                                    836 non-null float64\n",
      "num_non_his_white                           659 non-null float64\n",
      "num_african_american                        233 non-null float64\n",
      "num_asian                                   98 non-null float64\n",
      "num_hispanic                                159 non-null float64\n",
      "num_american_indian                         270 non-null float64\n",
      "num_no_race                                 71 non-null float64\n",
      "num_medicare_only                           777 non-null float64\n",
      "num_medicare_medicaid                       777 non-null float64\n",
      "pcnt_alzheimers_dementia                    416 non-null float64\n",
      "pcnt_asthma                                 554 non-null float64\n",
      "pcnt_artrial_fibrillation                   551 non-null float64\n",
      "pcnt_cancer                                 725 non-null float64\n",
      "pcnt_chronic_kidney                         799 non-null float64\n",
      "pcnt_chronic_obstructive_pulmonary          635 non-null float64\n",
      "pcnt_depression                             825 non-null float64\n",
      "pcnt_diabetes                               841 non-null float64\n",
      "pcnt_heart_failure                          704 non-null float64\n",
      "pcnt_hyperlipidemia                         897 non-null float64\n",
      "pcnt_hypertension                           907 non-null float64\n",
      "pcnt_ischemic_heart                         824 non-null float64\n",
      "pcnt_osteoporosis                           638 non-null float64\n",
      "pcnt_rheumatoid_arthritis_osteoarthirtis    865 non-null float64\n",
      "pcnt_schizophrenia_psychotic                152 non-null float64\n",
      "pcnt_stroke                                 192 non-null float64\n",
      "avg_hcc_risk_score                          928 non-null float64\n",
      "dtypes: float64(48), int64(4), object(16)\n",
      "memory usage: 500.2+ KB\n"
     ]
    }
   ],
   "source": [
    "df_cancer_gyn.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 17,
   "metadata": {
    "collapsed": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>index</th>\n",
       "      <th>npi</th>\n",
       "      <th>last_name</th>\n",
       "      <th>first_name</th>\n",
       "      <th>middle_initial</th>\n",
       "      <th>credentials</th>\n",
       "      <th>gender</th>\n",
       "      <th>entity_code</th>\n",
       "      <th>street1</th>\n",
       "      <th>street2</th>\n",
       "      <th>...</th>\n",
       "      <th>pcnt_diabetes</th>\n",
       "      <th>pcnt_heart_failure</th>\n",
       "      <th>pcnt_hyperlipidemia</th>\n",
       "      <th>pcnt_hypertension</th>\n",
       "      <th>pcnt_ischemic_heart</th>\n",
       "      <th>pcnt_osteoporosis</th>\n",
       "      <th>pcnt_rheumatoid_arthritis_osteoarthirtis</th>\n",
       "      <th>pcnt_schizophrenia_psychotic</th>\n",
       "      <th>pcnt_stroke</th>\n",
       "      <th>avg_hcc_risk_score</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>283</td>\n",
       "      <td>1003015207</td>\n",
       "      <td>SWANEY</td>\n",
       "      <td>ROBERT</td>\n",
       "      <td>E</td>\n",
       "      <td>MD, MSPH</td>\n",
       "      <td>M</td>\n",
       "      <td>I</td>\n",
       "      <td>3550 LUTHERAN PKWY STE 100A</td>\n",
       "      <td>None</td>\n",
       "      <td>...</td>\n",
       "      <td>23</td>\n",
       "      <td>18</td>\n",
       "      <td>40</td>\n",
       "      <td>61</td>\n",
       "      <td>28</td>\n",
       "      <td>13</td>\n",
       "      <td>36</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>1.8417</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>486</td>\n",
       "      <td>1003027764</td>\n",
       "      <td>BUCK</td>\n",
       "      <td>TONDRE</td>\n",
       "      <td>None</td>\n",
       "      <td>M.D.</td>\n",
       "      <td>M</td>\n",
       "      <td>I</td>\n",
       "      <td>2500 N STATE ST</td>\n",
       "      <td>DEPT. OF MEDICINE</td>\n",
       "      <td>...</td>\n",
       "      <td>32</td>\n",
       "      <td>22</td>\n",
       "      <td>30</td>\n",
       "      <td>67</td>\n",
       "      <td>27</td>\n",
       "      <td>5</td>\n",
       "      <td>28</td>\n",
       "      <td>5</td>\n",
       "      <td>5</td>\n",
       "      <td>2.4639</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>538</td>\n",
       "      <td>1003031212</td>\n",
       "      <td>KAYALI</td>\n",
       "      <td>FADI</td>\n",
       "      <td>None</td>\n",
       "      <td>M.D.</td>\n",
       "      <td>M</td>\n",
       "      <td>I</td>\n",
       "      <td>600 N CATTLEMEN RD</td>\n",
       "      <td>SUITE 200</td>\n",
       "      <td>...</td>\n",
       "      <td>36</td>\n",
       "      <td>32</td>\n",
       "      <td>62</td>\n",
       "      <td>75</td>\n",
       "      <td>55</td>\n",
       "      <td>11</td>\n",
       "      <td>46</td>\n",
       "      <td>6</td>\n",
       "      <td>8</td>\n",
       "      <td>2.1231</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>840</td>\n",
       "      <td>1003051871</td>\n",
       "      <td>POPALZAI</td>\n",
       "      <td>MUHAMMAD</td>\n",
       "      <td>J</td>\n",
       "      <td>None</td>\n",
       "      <td>M</td>\n",
       "      <td>I</td>\n",
       "      <td>305 W JACKSON ST STE 303</td>\n",
       "      <td>None</td>\n",
       "      <td>...</td>\n",
       "      <td>39</td>\n",
       "      <td>31</td>\n",
       "      <td>59</td>\n",
       "      <td>75</td>\n",
       "      <td>48</td>\n",
       "      <td>8</td>\n",
       "      <td>44</td>\n",
       "      <td>NaN</td>\n",
       "      <td>6</td>\n",
       "      <td>2.1001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>1052</td>\n",
       "      <td>1003067455</td>\n",
       "      <td>FENG</td>\n",
       "      <td>YAN</td>\n",
       "      <td>None</td>\n",
       "      <td>None</td>\n",
       "      <td>F</td>\n",
       "      <td>I</td>\n",
       "      <td>11100 EUCLID AVE</td>\n",
       "      <td>None</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>75</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>63</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>3.0034</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows × 68 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "   index         npi last_name first_name middle_initial credentials gender  \\\n",
       "0    283  1003015207    SWANEY     ROBERT              E    MD, MSPH      M   \n",
       "1    486  1003027764      BUCK     TONDRE           None        M.D.      M   \n",
       "2    538  1003031212    KAYALI       FADI           None        M.D.      M   \n",
       "3    840  1003051871  POPALZAI   MUHAMMAD              J        None      M   \n",
       "4   1052  1003067455      FENG        YAN           None        None      F   \n",
       "\n",
       "  entity_code                      street1            street2  \\\n",
       "0           I  3550 LUTHERAN PKWY STE 100A               None   \n",
       "1           I              2500 N STATE ST  DEPT. OF MEDICINE   \n",
       "2           I           600 N CATTLEMEN RD          SUITE 200   \n",
       "3           I     305 W JACKSON ST STE 303               None   \n",
       "4           I             11100 EUCLID AVE               None   \n",
       "\n",
       "          ...         pcnt_diabetes pcnt_heart_failure pcnt_hyperlipidemia  \\\n",
       "0         ...                    23                 18                  40   \n",
       "1         ...                    32                 22                  30   \n",
       "2         ...                    36                 32                  62   \n",
       "3         ...                    39                 31                  59   \n",
       "4         ...                   NaN                NaN                 NaN   \n",
       "\n",
       "  pcnt_hypertension pcnt_ischemic_heart pcnt_osteoporosis  \\\n",
       "0                61                  28                13   \n",
       "1                67                  27                 5   \n",
       "2                75                  55                11   \n",
       "3                75                  48                 8   \n",
       "4                75                 NaN                 0   \n",
       "\n",
       "   pcnt_rheumatoid_arthritis_osteoarthirtis  pcnt_schizophrenia_psychotic  \\\n",
       "0                                        36                           NaN   \n",
       "1                                        28                             5   \n",
       "2                                        46                             6   \n",
       "3                                        44                           NaN   \n",
       "4                                        63                           NaN   \n",
       "\n",
       "   pcnt_stroke  avg_hcc_risk_score  \n",
       "0          NaN              1.8417  \n",
       "1            5              2.4639  \n",
       "2            8              2.1231  \n",
       "3            6              2.1001  \n",
       "4          NaN              3.0034  \n",
       "\n",
       "[5 rows x 68 columns]"
      ]
     },
     "execution_count": 17,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_cancer_hema.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 19,
   "metadata": {
    "collapsed": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>count</th>\n",
       "      <th>mean</th>\n",
       "      <th>std</th>\n",
       "      <th>min</th>\n",
       "      <th>25%</th>\n",
       "      <th>50%</th>\n",
       "      <th>75%</th>\n",
       "      <th>max</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>index</th>\n",
       "      <td>7673</td>\n",
       "      <td>4.773280e+05</td>\n",
       "      <td>2.753831e+05</td>\n",
       "      <td>2.830000e+02</td>\n",
       "      <td>2.391380e+05</td>\n",
       "      <td>4.730610e+05</td>\n",
       "      <td>7.161890e+05</td>\n",
       "      <td>9.562840e+05</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>npi</th>\n",
       "      <td>7673</td>\n",
       "      <td>1.499396e+09</td>\n",
       "      <td>2.872457e+08</td>\n",
       "      <td>1.003015e+09</td>\n",
       "      <td>1.245569e+09</td>\n",
       "      <td>1.497767e+09</td>\n",
       "      <td>1.740502e+09</td>\n",
       "      <td>1.992999e+09</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_hcpcs</th>\n",
       "      <td>7673</td>\n",
       "      <td>6.321100e+01</td>\n",
       "      <td>5.468443e+01</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>1.500000e+01</td>\n",
       "      <td>4.000000e+01</td>\n",
       "      <td>1.060000e+02</td>\n",
       "      <td>3.880000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_services</th>\n",
       "      <td>7673</td>\n",
       "      <td>3.877010e+04</td>\n",
       "      <td>6.393326e+04</td>\n",
       "      <td>1.200000e+01</td>\n",
       "      <td>6.710000e+02</td>\n",
       "      <td>3.890000e+03</td>\n",
       "      <td>5.784900e+04</td>\n",
       "      <td>9.195270e+05</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_unique_bene</th>\n",
       "      <td>7673</td>\n",
       "      <td>3.676657e+02</td>\n",
       "      <td>2.968132e+02</td>\n",
       "      <td>1.100000e+01</td>\n",
       "      <td>1.540000e+02</td>\n",
       "      <td>3.090000e+02</td>\n",
       "      <td>5.080000e+02</td>\n",
       "      <td>4.946000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_submitted_charges</th>\n",
       "      <td>7673</td>\n",
       "      <td>1.810274e+06</td>\n",
       "      <td>2.755069e+06</td>\n",
       "      <td>2.040000e+02</td>\n",
       "      <td>1.263760e+05</td>\n",
       "      <td>3.914500e+05</td>\n",
       "      <td>2.700639e+06</td>\n",
       "      <td>3.574462e+07</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_medicare_allowed_amt</th>\n",
       "      <td>7673</td>\n",
       "      <td>7.525986e+05</td>\n",
       "      <td>1.148817e+06</td>\n",
       "      <td>3.600000e+01</td>\n",
       "      <td>5.523646e+04</td>\n",
       "      <td>1.740097e+05</td>\n",
       "      <td>1.174963e+06</td>\n",
       "      <td>3.561484e+07</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_medicare_payment_amt</th>\n",
       "      <td>7673</td>\n",
       "      <td>5.857542e+05</td>\n",
       "      <td>8.994061e+05</td>\n",
       "      <td>3.582000e+01</td>\n",
       "      <td>4.185852e+04</td>\n",
       "      <td>1.315049e+05</td>\n",
       "      <td>9.140042e+05</td>\n",
       "      <td>2.804806e+07</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_hcpcs_associated_drug_srvc</th>\n",
       "      <td>7070</td>\n",
       "      <td>2.940071e+01</td>\n",
       "      <td>3.038660e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>2.300000e+01</td>\n",
       "      <td>5.800000e+01</td>\n",
       "      <td>1.100000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_drug_srvc</th>\n",
       "      <td>7070</td>\n",
       "      <td>3.752725e+04</td>\n",
       "      <td>6.076116e+04</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>5.514500e+03</td>\n",
       "      <td>5.711400e+04</td>\n",
       "      <td>9.192350e+05</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_unique_bene_with_drug_srvc</th>\n",
       "      <td>7070</td>\n",
       "      <td>8.286393e+01</td>\n",
       "      <td>1.187048e+02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>3.000000e+01</td>\n",
       "      <td>1.310000e+02</td>\n",
       "      <td>9.500000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_drug_submitted_charges</th>\n",
       "      <td>7070</td>\n",
       "      <td>1.396708e+06</td>\n",
       "      <td>2.220546e+06</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.781155e+05</td>\n",
       "      <td>2.176541e+06</td>\n",
       "      <td>3.556785e+07</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_drug_medicare_allowed_amt</th>\n",
       "      <td>7070</td>\n",
       "      <td>5.832374e+05</td>\n",
       "      <td>9.734480e+05</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>8.455719e+04</td>\n",
       "      <td>9.431559e+05</td>\n",
       "      <td>3.551663e+07</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_drug_medicare_payment_amt</th>\n",
       "      <td>7070</td>\n",
       "      <td>4.547502e+05</td>\n",
       "      <td>7.610643e+05</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>6.596858e+04</td>\n",
       "      <td>7.371104e+05</td>\n",
       "      <td>2.797682e+07</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_hcpcs_associated_med_srvc</th>\n",
       "      <td>7070</td>\n",
       "      <td>3.688444e+01</td>\n",
       "      <td>2.816218e+01</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>1.500000e+01</td>\n",
       "      <td>3.000000e+01</td>\n",
       "      <td>5.100000e+01</td>\n",
       "      <td>3.130000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_med_srvc</th>\n",
       "      <td>7070</td>\n",
       "      <td>4.396669e+03</td>\n",
       "      <td>6.165630e+03</td>\n",
       "      <td>1.200000e+01</td>\n",
       "      <td>6.080000e+02</td>\n",
       "      <td>1.883500e+03</td>\n",
       "      <td>6.071000e+03</td>\n",
       "      <td>9.189700e+04</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_unique_bene_with_med_srvc</th>\n",
       "      <td>7070</td>\n",
       "      <td>3.802509e+02</td>\n",
       "      <td>3.009837e+02</td>\n",
       "      <td>1.100000e+01</td>\n",
       "      <td>1.640000e+02</td>\n",
       "      <td>3.200000e+02</td>\n",
       "      <td>5.230000e+02</td>\n",
       "      <td>4.945000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_med_submitted_charges</th>\n",
       "      <td>7070</td>\n",
       "      <td>5.509083e+05</td>\n",
       "      <td>7.090353e+05</td>\n",
       "      <td>2.040000e+02</td>\n",
       "      <td>1.216345e+05</td>\n",
       "      <td>2.979365e+05</td>\n",
       "      <td>7.492692e+05</td>\n",
       "      <td>1.127809e+07</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_med_medicare_allowed_amt</th>\n",
       "      <td>7070</td>\n",
       "      <td>2.253785e+05</td>\n",
       "      <td>2.579490e+05</td>\n",
       "      <td>3.600000e+01</td>\n",
       "      <td>5.159169e+04</td>\n",
       "      <td>1.329815e+05</td>\n",
       "      <td>3.249799e+05</td>\n",
       "      <td>4.088326e+06</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_med_medicare_payment_amt</th>\n",
       "      <td>7070</td>\n",
       "      <td>1.747877e+05</td>\n",
       "      <td>2.039300e+05</td>\n",
       "      <td>3.582000e+01</td>\n",
       "      <td>3.896800e+04</td>\n",
       "      <td>1.005297e+05</td>\n",
       "      <td>2.511919e+05</td>\n",
       "      <td>3.283833e+06</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>avg_age_bene</th>\n",
       "      <td>7673</td>\n",
       "      <td>7.211156e+01</td>\n",
       "      <td>3.606139e+00</td>\n",
       "      <td>2.600000e+01</td>\n",
       "      <td>7.100000e+01</td>\n",
       "      <td>7.300000e+01</td>\n",
       "      <td>7.400000e+01</td>\n",
       "      <td>8.800000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_bene_le65</th>\n",
       "      <td>6365</td>\n",
       "      <td>5.619811e+01</td>\n",
       "      <td>3.857931e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>2.900000e+01</td>\n",
       "      <td>4.700000e+01</td>\n",
       "      <td>7.300000e+01</td>\n",
       "      <td>6.450000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_bene_65to74</th>\n",
       "      <td>7331</td>\n",
       "      <td>1.555739e+02</td>\n",
       "      <td>1.211446e+02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>7.200000e+01</td>\n",
       "      <td>1.290000e+02</td>\n",
       "      <td>2.060000e+02</td>\n",
       "      <td>2.431000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_bene_75to84</th>\n",
       "      <td>6684</td>\n",
       "      <td>1.360136e+02</td>\n",
       "      <td>1.045320e+02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>6.200000e+01</td>\n",
       "      <td>1.140000e+02</td>\n",
       "      <td>1.830000e+02</td>\n",
       "      <td>1.581000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_bene_ge84</th>\n",
       "      <td>5985</td>\n",
       "      <td>6.160602e+01</td>\n",
       "      <td>4.841109e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>2.900000e+01</td>\n",
       "      <td>5.100000e+01</td>\n",
       "      <td>8.100000e+01</td>\n",
       "      <td>8.400000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_female</th>\n",
       "      <td>7335</td>\n",
       "      <td>2.248281e+02</td>\n",
       "      <td>1.799207e+02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>9.300000e+01</td>\n",
       "      <td>1.890000e+02</td>\n",
       "      <td>3.110000e+02</td>\n",
       "      <td>3.096000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_male</th>\n",
       "      <td>7335</td>\n",
       "      <td>1.572288e+02</td>\n",
       "      <td>1.228544e+02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>7.100000e+01</td>\n",
       "      <td>1.320000e+02</td>\n",
       "      <td>2.110000e+02</td>\n",
       "      <td>1.849000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_non_his_white</th>\n",
       "      <td>6367</td>\n",
       "      <td>3.363446e+02</td>\n",
       "      <td>2.677510e+02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.440000e+02</td>\n",
       "      <td>2.830000e+02</td>\n",
       "      <td>4.580000e+02</td>\n",
       "      <td>4.375000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_african_american</th>\n",
       "      <td>3292</td>\n",
       "      <td>6.475729e+01</td>\n",
       "      <td>7.758338e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>2.200000e+01</td>\n",
       "      <td>4.100000e+01</td>\n",
       "      <td>7.800000e+01</td>\n",
       "      <td>1.418000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_asian</th>\n",
       "      <td>1082</td>\n",
       "      <td>2.824954e+01</td>\n",
       "      <td>5.691333e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.600000e+01</td>\n",
       "      <td>3.100000e+01</td>\n",
       "      <td>7.930000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_hispanic</th>\n",
       "      <td>2224</td>\n",
       "      <td>4.922797e+01</td>\n",
       "      <td>7.865060e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.600000e+01</td>\n",
       "      <td>2.600000e+01</td>\n",
       "      <td>5.000000e+01</td>\n",
       "      <td>1.184000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_american_indian</th>\n",
       "      <td>2413</td>\n",
       "      <td>1.207211e+00</td>\n",
       "      <td>8.247126e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>2.000000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_no_race</th>\n",
       "      <td>566</td>\n",
       "      <td>8.892226e+00</td>\n",
       "      <td>1.131796e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.100000e+01</td>\n",
       "      <td>1.400000e+01</td>\n",
       "      <td>7.700000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_medicare_only</th>\n",
       "      <td>6932</td>\n",
       "      <td>3.211910e+02</td>\n",
       "      <td>2.583815e+02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.400000e+02</td>\n",
       "      <td>2.660000e+02</td>\n",
       "      <td>4.340000e+02</td>\n",
       "      <td>4.595000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_medicare_medicaid</th>\n",
       "      <td>6932</td>\n",
       "      <td>7.822129e+01</td>\n",
       "      <td>7.279794e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>3.300000e+01</td>\n",
       "      <td>5.900000e+01</td>\n",
       "      <td>1.000000e+02</td>\n",
       "      <td>1.497000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_alzheimers_dementia</th>\n",
       "      <td>6113</td>\n",
       "      <td>1.120890e+01</td>\n",
       "      <td>6.284020e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>8.000000e+00</td>\n",
       "      <td>1.000000e+01</td>\n",
       "      <td>1.300000e+01</td>\n",
       "      <td>7.500000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_asthma</th>\n",
       "      <td>6133</td>\n",
       "      <td>8.817381e+00</td>\n",
       "      <td>3.428932e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>7.000000e+00</td>\n",
       "      <td>8.000000e+00</td>\n",
       "      <td>1.000000e+01</td>\n",
       "      <td>4.200000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_artrial_fibrillation</th>\n",
       "      <td>6558</td>\n",
       "      <td>1.407701e+01</td>\n",
       "      <td>4.572399e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.100000e+01</td>\n",
       "      <td>1.400000e+01</td>\n",
       "      <td>1.600000e+01</td>\n",
       "      <td>5.300000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_cancer</th>\n",
       "      <td>7175</td>\n",
       "      <td>4.313519e+01</td>\n",
       "      <td>1.456788e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>3.600000e+01</td>\n",
       "      <td>4.400000e+01</td>\n",
       "      <td>5.100000e+01</td>\n",
       "      <td>7.500000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_chronic_kidney</th>\n",
       "      <td>7385</td>\n",
       "      <td>3.599188e+01</td>\n",
       "      <td>1.011479e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>2.900000e+01</td>\n",
       "      <td>3.500000e+01</td>\n",
       "      <td>4.200000e+01</td>\n",
       "      <td>7.500000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_chronic_obstructive_pulmonary</th>\n",
       "      <td>6952</td>\n",
       "      <td>2.204704e+01</td>\n",
       "      <td>8.106431e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.600000e+01</td>\n",
       "      <td>2.100000e+01</td>\n",
       "      <td>2.700000e+01</td>\n",
       "      <td>6.800000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_depression</th>\n",
       "      <td>7198</td>\n",
       "      <td>2.363184e+01</td>\n",
       "      <td>6.620883e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.900000e+01</td>\n",
       "      <td>2.300000e+01</td>\n",
       "      <td>2.700000e+01</td>\n",
       "      <td>7.500000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_diabetes</th>\n",
       "      <td>7333</td>\n",
       "      <td>3.492841e+01</td>\n",
       "      <td>8.985087e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>2.900000e+01</td>\n",
       "      <td>3.400000e+01</td>\n",
       "      <td>3.900000e+01</td>\n",
       "      <td>7.500000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_heart_failure</th>\n",
       "      <td>7140</td>\n",
       "      <td>2.583053e+01</td>\n",
       "      <td>9.414406e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.900000e+01</td>\n",
       "      <td>2.400000e+01</td>\n",
       "      <td>3.000000e+01</td>\n",
       "      <td>7.500000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_hyperlipidemia</th>\n",
       "      <td>7505</td>\n",
       "      <td>5.404544e+01</td>\n",
       "      <td>9.296149e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>4.800000e+01</td>\n",
       "      <td>5.400000e+01</td>\n",
       "      <td>6.000000e+01</td>\n",
       "      <td>7.500000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_hypertension</th>\n",
       "      <td>7588</td>\n",
       "      <td>6.903940e+01</td>\n",
       "      <td>7.235583e+00</td>\n",
       "      <td>3.000000e+01</td>\n",
       "      <td>6.500000e+01</td>\n",
       "      <td>7.200000e+01</td>\n",
       "      <td>7.500000e+01</td>\n",
       "      <td>7.500000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_ischemic_heart</th>\n",
       "      <td>7381</td>\n",
       "      <td>4.048611e+01</td>\n",
       "      <td>1.087085e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>3.300000e+01</td>\n",
       "      <td>4.000000e+01</td>\n",
       "      <td>4.700000e+01</td>\n",
       "      <td>7.500000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_osteoporosis</th>\n",
       "      <td>6222</td>\n",
       "      <td>1.120235e+01</td>\n",
       "      <td>4.617054e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>8.000000e+00</td>\n",
       "      <td>1.100000e+01</td>\n",
       "      <td>1.300000e+01</td>\n",
       "      <td>5.900000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_rheumatoid_arthritis_osteoarthirtis</th>\n",
       "      <td>7383</td>\n",
       "      <td>3.771326e+01</td>\n",
       "      <td>7.655318e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>3.300000e+01</td>\n",
       "      <td>3.700000e+01</td>\n",
       "      <td>4.200000e+01</td>\n",
       "      <td>7.500000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_schizophrenia_psychotic</th>\n",
       "      <td>4458</td>\n",
       "      <td>4.994392e+00</td>\n",
       "      <td>3.388761e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>3.000000e+00</td>\n",
       "      <td>4.000000e+00</td>\n",
       "      <td>6.000000e+00</td>\n",
       "      <td>7.500000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_stroke</th>\n",
       "      <td>5302</td>\n",
       "      <td>6.694832e+00</td>\n",
       "      <td>3.268130e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>5.000000e+00</td>\n",
       "      <td>6.000000e+00</td>\n",
       "      <td>8.000000e+00</td>\n",
       "      <td>4.100000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>avg_hcc_risk_score</th>\n",
       "      <td>7673</td>\n",
       "      <td>2.007950e+00</td>\n",
       "      <td>4.109375e-01</td>\n",
       "      <td>8.220000e-01</td>\n",
       "      <td>1.760400e+00</td>\n",
       "      <td>1.947600e+00</td>\n",
       "      <td>2.194700e+00</td>\n",
       "      <td>5.672300e+00</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                          count          mean           std  \\\n",
       "index                                      7673  4.773280e+05  2.753831e+05   \n",
       "npi                                        7673  1.499396e+09  2.872457e+08   \n",
       "num_hcpcs                                  7673  6.321100e+01  5.468443e+01   \n",
       "num_services                               7673  3.877010e+04  6.393326e+04   \n",
       "num_unique_bene                            7673  3.676657e+02  2.968132e+02   \n",
       "total_submitted_charges                    7673  1.810274e+06  2.755069e+06   \n",
       "total_medicare_allowed_amt                 7673  7.525986e+05  1.148817e+06   \n",
       "total_medicare_payment_amt                 7673  5.857542e+05  8.994061e+05   \n",
       "num_hcpcs_associated_drug_srvc             7070  2.940071e+01  3.038660e+01   \n",
       "num_drug_srvc                              7070  3.752725e+04  6.076116e+04   \n",
       "num_unique_bene_with_drug_srvc             7070  8.286393e+01  1.187048e+02   \n",
       "total_drug_submitted_charges               7070  1.396708e+06  2.220546e+06   \n",
       "total_drug_medicare_allowed_amt            7070  5.832374e+05  9.734480e+05   \n",
       "total_drug_medicare_payment_amt            7070  4.547502e+05  7.610643e+05   \n",
       "num_hcpcs_associated_med_srvc              7070  3.688444e+01  2.816218e+01   \n",
       "num_med_srvc                               7070  4.396669e+03  6.165630e+03   \n",
       "num_unique_bene_with_med_srvc              7070  3.802509e+02  3.009837e+02   \n",
       "total_med_submitted_charges                7070  5.509083e+05  7.090353e+05   \n",
       "total_med_medicare_allowed_amt             7070  2.253785e+05  2.579490e+05   \n",
       "total_med_medicare_payment_amt             7070  1.747877e+05  2.039300e+05   \n",
       "avg_age_bene                               7673  7.211156e+01  3.606139e+00   \n",
       "num_bene_le65                              6365  5.619811e+01  3.857931e+01   \n",
       "num_bene_65to74                            7331  1.555739e+02  1.211446e+02   \n",
       "num_bene_75to84                            6684  1.360136e+02  1.045320e+02   \n",
       "num_bene_ge84                              5985  6.160602e+01  4.841109e+01   \n",
       "num_female                                 7335  2.248281e+02  1.799207e+02   \n",
       "num_male                                   7335  1.572288e+02  1.228544e+02   \n",
       "num_non_his_white                          6367  3.363446e+02  2.677510e+02   \n",
       "num_african_american                       3292  6.475729e+01  7.758338e+01   \n",
       "num_asian                                  1082  2.824954e+01  5.691333e+01   \n",
       "num_hispanic                               2224  4.922797e+01  7.865060e+01   \n",
       "num_american_indian                        2413  1.207211e+00  8.247126e+00   \n",
       "num_no_race                                 566  8.892226e+00  1.131796e+01   \n",
       "num_medicare_only                          6932  3.211910e+02  2.583815e+02   \n",
       "num_medicare_medicaid                      6932  7.822129e+01  7.279794e+01   \n",
       "pcnt_alzheimers_dementia                   6113  1.120890e+01  6.284020e+00   \n",
       "pcnt_asthma                                6133  8.817381e+00  3.428932e+00   \n",
       "pcnt_artrial_fibrillation                  6558  1.407701e+01  4.572399e+00   \n",
       "pcnt_cancer                                7175  4.313519e+01  1.456788e+01   \n",
       "pcnt_chronic_kidney                        7385  3.599188e+01  1.011479e+01   \n",
       "pcnt_chronic_obstructive_pulmonary         6952  2.204704e+01  8.106431e+00   \n",
       "pcnt_depression                            7198  2.363184e+01  6.620883e+00   \n",
       "pcnt_diabetes                              7333  3.492841e+01  8.985087e+00   \n",
       "pcnt_heart_failure                         7140  2.583053e+01  9.414406e+00   \n",
       "pcnt_hyperlipidemia                        7505  5.404544e+01  9.296149e+00   \n",
       "pcnt_hypertension                          7588  6.903940e+01  7.235583e+00   \n",
       "pcnt_ischemic_heart                        7381  4.048611e+01  1.087085e+01   \n",
       "pcnt_osteoporosis                          6222  1.120235e+01  4.617054e+00   \n",
       "pcnt_rheumatoid_arthritis_osteoarthirtis   7383  3.771326e+01  7.655318e+00   \n",
       "pcnt_schizophrenia_psychotic               4458  4.994392e+00  3.388761e+00   \n",
       "pcnt_stroke                                5302  6.694832e+00  3.268130e+00   \n",
       "avg_hcc_risk_score                         7673  2.007950e+00  4.109375e-01   \n",
       "\n",
       "                                                   min           25%  \\\n",
       "index                                     2.830000e+02  2.391380e+05   \n",
       "npi                                       1.003015e+09  1.245569e+09   \n",
       "num_hcpcs                                 1.000000e+00  1.500000e+01   \n",
       "num_services                              1.200000e+01  6.710000e+02   \n",
       "num_unique_bene                           1.100000e+01  1.540000e+02   \n",
       "total_submitted_charges                   2.040000e+02  1.263760e+05   \n",
       "total_medicare_allowed_amt                3.600000e+01  5.523646e+04   \n",
       "total_medicare_payment_amt                3.582000e+01  4.185852e+04   \n",
       "num_hcpcs_associated_drug_srvc            0.000000e+00  0.000000e+00   \n",
       "num_drug_srvc                             0.000000e+00  0.000000e+00   \n",
       "num_unique_bene_with_drug_srvc            0.000000e+00  0.000000e+00   \n",
       "total_drug_submitted_charges              0.000000e+00  0.000000e+00   \n",
       "total_drug_medicare_allowed_amt           0.000000e+00  0.000000e+00   \n",
       "total_drug_medicare_payment_amt           0.000000e+00  0.000000e+00   \n",
       "num_hcpcs_associated_med_srvc             1.000000e+00  1.500000e+01   \n",
       "num_med_srvc                              1.200000e+01  6.080000e+02   \n",
       "num_unique_bene_with_med_srvc             1.100000e+01  1.640000e+02   \n",
       "total_med_submitted_charges               2.040000e+02  1.216345e+05   \n",
       "total_med_medicare_allowed_amt            3.600000e+01  5.159169e+04   \n",
       "total_med_medicare_payment_amt            3.582000e+01  3.896800e+04   \n",
       "avg_age_bene                              2.600000e+01  7.100000e+01   \n",
       "num_bene_le65                             0.000000e+00  2.900000e+01   \n",
       "num_bene_65to74                           0.000000e+00  7.200000e+01   \n",
       "num_bene_75to84                           0.000000e+00  6.200000e+01   \n",
       "num_bene_ge84                             0.000000e+00  2.900000e+01   \n",
       "num_female                                0.000000e+00  9.300000e+01   \n",
       "num_male                                  0.000000e+00  7.100000e+01   \n",
       "num_non_his_white                         0.000000e+00  1.440000e+02   \n",
       "num_african_american                      0.000000e+00  2.200000e+01   \n",
       "num_asian                                 0.000000e+00  0.000000e+00   \n",
       "num_hispanic                              0.000000e+00  1.600000e+01   \n",
       "num_american_indian                       0.000000e+00  0.000000e+00   \n",
       "num_no_race                               0.000000e+00  0.000000e+00   \n",
       "num_medicare_only                         0.000000e+00  1.400000e+02   \n",
       "num_medicare_medicaid                     0.000000e+00  3.300000e+01   \n",
       "pcnt_alzheimers_dementia                  0.000000e+00  8.000000e+00   \n",
       "pcnt_asthma                               0.000000e+00  7.000000e+00   \n",
       "pcnt_artrial_fibrillation                 0.000000e+00  1.100000e+01   \n",
       "pcnt_cancer                               0.000000e+00  3.600000e+01   \n",
       "pcnt_chronic_kidney                       0.000000e+00  2.900000e+01   \n",
       "pcnt_chronic_obstructive_pulmonary        0.000000e+00  1.600000e+01   \n",
       "pcnt_depression                           0.000000e+00  1.900000e+01   \n",
       "pcnt_diabetes                             0.000000e+00  2.900000e+01   \n",
       "pcnt_heart_failure                        0.000000e+00  1.900000e+01   \n",
       "pcnt_hyperlipidemia                       0.000000e+00  4.800000e+01   \n",
       "pcnt_hypertension                         3.000000e+01  6.500000e+01   \n",
       "pcnt_ischemic_heart                       0.000000e+00  3.300000e+01   \n",
       "pcnt_osteoporosis                         0.000000e+00  8.000000e+00   \n",
       "pcnt_rheumatoid_arthritis_osteoarthirtis  0.000000e+00  3.300000e+01   \n",
       "pcnt_schizophrenia_psychotic              0.000000e+00  3.000000e+00   \n",
       "pcnt_stroke                               0.000000e+00  5.000000e+00   \n",
       "avg_hcc_risk_score                        8.220000e-01  1.760400e+00   \n",
       "\n",
       "                                                   50%           75%  \\\n",
       "index                                     4.730610e+05  7.161890e+05   \n",
       "npi                                       1.497767e+09  1.740502e+09   \n",
       "num_hcpcs                                 4.000000e+01  1.060000e+02   \n",
       "num_services                              3.890000e+03  5.784900e+04   \n",
       "num_unique_bene                           3.090000e+02  5.080000e+02   \n",
       "total_submitted_charges                   3.914500e+05  2.700639e+06   \n",
       "total_medicare_allowed_amt                1.740097e+05  1.174963e+06   \n",
       "total_medicare_payment_amt                1.315049e+05  9.140042e+05   \n",
       "num_hcpcs_associated_drug_srvc            2.300000e+01  5.800000e+01   \n",
       "num_drug_srvc                             5.514500e+03  5.711400e+04   \n",
       "num_unique_bene_with_drug_srvc            3.000000e+01  1.310000e+02   \n",
       "total_drug_submitted_charges              1.781155e+05  2.176541e+06   \n",
       "total_drug_medicare_allowed_amt           8.455719e+04  9.431559e+05   \n",
       "total_drug_medicare_payment_amt           6.596858e+04  7.371104e+05   \n",
       "num_hcpcs_associated_med_srvc             3.000000e+01  5.100000e+01   \n",
       "num_med_srvc                              1.883500e+03  6.071000e+03   \n",
       "num_unique_bene_with_med_srvc             3.200000e+02  5.230000e+02   \n",
       "total_med_submitted_charges               2.979365e+05  7.492692e+05   \n",
       "total_med_medicare_allowed_amt            1.329815e+05  3.249799e+05   \n",
       "total_med_medicare_payment_amt            1.005297e+05  2.511919e+05   \n",
       "avg_age_bene                              7.300000e+01  7.400000e+01   \n",
       "num_bene_le65                             4.700000e+01  7.300000e+01   \n",
       "num_bene_65to74                           1.290000e+02  2.060000e+02   \n",
       "num_bene_75to84                           1.140000e+02  1.830000e+02   \n",
       "num_bene_ge84                             5.100000e+01  8.100000e+01   \n",
       "num_female                                1.890000e+02  3.110000e+02   \n",
       "num_male                                  1.320000e+02  2.110000e+02   \n",
       "num_non_his_white                         2.830000e+02  4.580000e+02   \n",
       "num_african_american                      4.100000e+01  7.800000e+01   \n",
       "num_asian                                 1.600000e+01  3.100000e+01   \n",
       "num_hispanic                              2.600000e+01  5.000000e+01   \n",
       "num_american_indian                       0.000000e+00  0.000000e+00   \n",
       "num_no_race                               1.100000e+01  1.400000e+01   \n",
       "num_medicare_only                         2.660000e+02  4.340000e+02   \n",
       "num_medicare_medicaid                     5.900000e+01  1.000000e+02   \n",
       "pcnt_alzheimers_dementia                  1.000000e+01  1.300000e+01   \n",
       "pcnt_asthma                               8.000000e+00  1.000000e+01   \n",
       "pcnt_artrial_fibrillation                 1.400000e+01  1.600000e+01   \n",
       "pcnt_cancer                               4.400000e+01  5.100000e+01   \n",
       "pcnt_chronic_kidney                       3.500000e+01  4.200000e+01   \n",
       "pcnt_chronic_obstructive_pulmonary        2.100000e+01  2.700000e+01   \n",
       "pcnt_depression                           2.300000e+01  2.700000e+01   \n",
       "pcnt_diabetes                             3.400000e+01  3.900000e+01   \n",
       "pcnt_heart_failure                        2.400000e+01  3.000000e+01   \n",
       "pcnt_hyperlipidemia                       5.400000e+01  6.000000e+01   \n",
       "pcnt_hypertension                         7.200000e+01  7.500000e+01   \n",
       "pcnt_ischemic_heart                       4.000000e+01  4.700000e+01   \n",
       "pcnt_osteoporosis                         1.100000e+01  1.300000e+01   \n",
       "pcnt_rheumatoid_arthritis_osteoarthirtis  3.700000e+01  4.200000e+01   \n",
       "pcnt_schizophrenia_psychotic              4.000000e+00  6.000000e+00   \n",
       "pcnt_stroke                               6.000000e+00  8.000000e+00   \n",
       "avg_hcc_risk_score                        1.947600e+00  2.194700e+00   \n",
       "\n",
       "                                                   max  \n",
       "index                                     9.562840e+05  \n",
       "npi                                       1.992999e+09  \n",
       "num_hcpcs                                 3.880000e+02  \n",
       "num_services                              9.195270e+05  \n",
       "num_unique_bene                           4.946000e+03  \n",
       "total_submitted_charges                   3.574462e+07  \n",
       "total_medicare_allowed_amt                3.561484e+07  \n",
       "total_medicare_payment_amt                2.804806e+07  \n",
       "num_hcpcs_associated_drug_srvc            1.100000e+02  \n",
       "num_drug_srvc                             9.192350e+05  \n",
       "num_unique_bene_with_drug_srvc            9.500000e+02  \n",
       "total_drug_submitted_charges              3.556785e+07  \n",
       "total_drug_medicare_allowed_amt           3.551663e+07  \n",
       "total_drug_medicare_payment_amt           2.797682e+07  \n",
       "num_hcpcs_associated_med_srvc             3.130000e+02  \n",
       "num_med_srvc                              9.189700e+04  \n",
       "num_unique_bene_with_med_srvc             4.945000e+03  \n",
       "total_med_submitted_charges               1.127809e+07  \n",
       "total_med_medicare_allowed_amt            4.088326e+06  \n",
       "total_med_medicare_payment_amt            3.283833e+06  \n",
       "avg_age_bene                              8.800000e+01  \n",
       "num_bene_le65                             6.450000e+02  \n",
       "num_bene_65to74                           2.431000e+03  \n",
       "num_bene_75to84                           1.581000e+03  \n",
       "num_bene_ge84                             8.400000e+02  \n",
       "num_female                                3.096000e+03  \n",
       "num_male                                  1.849000e+03  \n",
       "num_non_his_white                         4.375000e+03  \n",
       "num_african_american                      1.418000e+03  \n",
       "num_asian                                 7.930000e+02  \n",
       "num_hispanic                              1.184000e+03  \n",
       "num_american_indian                       2.000000e+02  \n",
       "num_no_race                               7.700000e+01  \n",
       "num_medicare_only                         4.595000e+03  \n",
       "num_medicare_medicaid                     1.497000e+03  \n",
       "pcnt_alzheimers_dementia                  7.500000e+01  \n",
       "pcnt_asthma                               4.200000e+01  \n",
       "pcnt_artrial_fibrillation                 5.300000e+01  \n",
       "pcnt_cancer                               7.500000e+01  \n",
       "pcnt_chronic_kidney                       7.500000e+01  \n",
       "pcnt_chronic_obstructive_pulmonary        6.800000e+01  \n",
       "pcnt_depression                           7.500000e+01  \n",
       "pcnt_diabetes                             7.500000e+01  \n",
       "pcnt_heart_failure                        7.500000e+01  \n",
       "pcnt_hyperlipidemia                       7.500000e+01  \n",
       "pcnt_hypertension                         7.500000e+01  \n",
       "pcnt_ischemic_heart                       7.500000e+01  \n",
       "pcnt_osteoporosis                         5.900000e+01  \n",
       "pcnt_rheumatoid_arthritis_osteoarthirtis  7.500000e+01  \n",
       "pcnt_schizophrenia_psychotic              7.500000e+01  \n",
       "pcnt_stroke                               4.100000e+01  \n",
       "avg_hcc_risk_score                        5.672300e+00  "
      ]
     },
     "execution_count": 19,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_cancer_hema.describe().T"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 22,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "query = '''\n",
    "        SELECT *\n",
    "        FROM util_payments_agg_2013\n",
    "        ;\n",
    "        '''\n",
    "df_util_all = pd.read_sql_query(query, conn)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 23,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.axes._subplots.AxesSubplot at 0x7f859e69cc50>"
      ]
     },
     "execution_count": 23,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAY0AAAEACAYAAABPiSrXAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\nGmZmlpuLhpmZ5eaiYWZmublomJlZbv8fmhGw4qFOedgAAAAASUVORK5CYII=\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7f8584514c90>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "df_util_all['pcnt_cancer'].hist(bins=50)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 24,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.axes._subplots.AxesSubplot at 0x7f859e5bbbd0>"
      ]
     },
     "execution_count": 24,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAXoAAAEACAYAAAC9Gb03AAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\ndwHbPQAAAABJRU5ErkJggg==\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7f8584408a90>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "df_cancer_hema['pcnt_cancer'].hist(bins=50)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 25,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.axes._subplots.AxesSubplot at 0x7f859e651c50>"
      ]
     },
     "execution_count": 25,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAXoAAAEACAYAAAC9Gb03AAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\nm5k13P8H8h3tHkEPfLUAAAAASUVORK5CYII=\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7f857e947250>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "df_cancer_med['pcnt_cancer'].hist(bins=50)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Distribution of patients with cancer are higher for oncologists (of course). Doesn't approach close to 100%. Possible causes: people in remission, sent to oncologist for secondary screening, but negative"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 27,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.axes._subplots.AxesSubplot at 0x7f857e72c950>"
      ]
     },
     "execution_count": 27,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAXoAAAEACAYAAAC9Gb03AAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\nNzObcv8PP/WuTCFr3JIAAAAASUVORK5CYII=\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7f857e526dd0>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "df_cancer_gyn['pcnt_cancer'].hist(bins=50)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 28,
   "metadata": {
    "collapsed": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>count</th>\n",
       "      <th>mean</th>\n",
       "      <th>std</th>\n",
       "      <th>min</th>\n",
       "      <th>25%</th>\n",
       "      <th>50%</th>\n",
       "      <th>75%</th>\n",
       "      <th>max</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>index</th>\n",
       "      <td>7673</td>\n",
       "      <td>4.773280e+05</td>\n",
       "      <td>2.753831e+05</td>\n",
       "      <td>2.830000e+02</td>\n",
       "      <td>2.391380e+05</td>\n",
       "      <td>4.730610e+05</td>\n",
       "      <td>7.161890e+05</td>\n",
       "      <td>9.562840e+05</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>npi</th>\n",
       "      <td>7673</td>\n",
       "      <td>1.499396e+09</td>\n",
       "      <td>2.872457e+08</td>\n",
       "      <td>1.003015e+09</td>\n",
       "      <td>1.245569e+09</td>\n",
       "      <td>1.497767e+09</td>\n",
       "      <td>1.740502e+09</td>\n",
       "      <td>1.992999e+09</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_hcpcs</th>\n",
       "      <td>7673</td>\n",
       "      <td>6.321100e+01</td>\n",
       "      <td>5.468443e+01</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>1.500000e+01</td>\n",
       "      <td>4.000000e+01</td>\n",
       "      <td>1.060000e+02</td>\n",
       "      <td>3.880000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_services</th>\n",
       "      <td>7673</td>\n",
       "      <td>3.877010e+04</td>\n",
       "      <td>6.393326e+04</td>\n",
       "      <td>1.200000e+01</td>\n",
       "      <td>6.710000e+02</td>\n",
       "      <td>3.890000e+03</td>\n",
       "      <td>5.784900e+04</td>\n",
       "      <td>9.195270e+05</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_unique_bene</th>\n",
       "      <td>7673</td>\n",
       "      <td>3.676657e+02</td>\n",
       "      <td>2.968132e+02</td>\n",
       "      <td>1.100000e+01</td>\n",
       "      <td>1.540000e+02</td>\n",
       "      <td>3.090000e+02</td>\n",
       "      <td>5.080000e+02</td>\n",
       "      <td>4.946000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_submitted_charges</th>\n",
       "      <td>7673</td>\n",
       "      <td>1.810274e+06</td>\n",
       "      <td>2.755069e+06</td>\n",
       "      <td>2.040000e+02</td>\n",
       "      <td>1.263760e+05</td>\n",
       "      <td>3.914500e+05</td>\n",
       "      <td>2.700639e+06</td>\n",
       "      <td>3.574462e+07</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_medicare_allowed_amt</th>\n",
       "      <td>7673</td>\n",
       "      <td>7.525986e+05</td>\n",
       "      <td>1.148817e+06</td>\n",
       "      <td>3.600000e+01</td>\n",
       "      <td>5.523646e+04</td>\n",
       "      <td>1.740097e+05</td>\n",
       "      <td>1.174963e+06</td>\n",
       "      <td>3.561484e+07</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_medicare_payment_amt</th>\n",
       "      <td>7673</td>\n",
       "      <td>5.857542e+05</td>\n",
       "      <td>8.994061e+05</td>\n",
       "      <td>3.582000e+01</td>\n",
       "      <td>4.185852e+04</td>\n",
       "      <td>1.315049e+05</td>\n",
       "      <td>9.140042e+05</td>\n",
       "      <td>2.804806e+07</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_hcpcs_associated_drug_srvc</th>\n",
       "      <td>7070</td>\n",
       "      <td>2.940071e+01</td>\n",
       "      <td>3.038660e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>2.300000e+01</td>\n",
       "      <td>5.800000e+01</td>\n",
       "      <td>1.100000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_drug_srvc</th>\n",
       "      <td>7070</td>\n",
       "      <td>3.752725e+04</td>\n",
       "      <td>6.076116e+04</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>5.514500e+03</td>\n",
       "      <td>5.711400e+04</td>\n",
       "      <td>9.192350e+05</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_unique_bene_with_drug_srvc</th>\n",
       "      <td>7070</td>\n",
       "      <td>8.286393e+01</td>\n",
       "      <td>1.187048e+02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>3.000000e+01</td>\n",
       "      <td>1.310000e+02</td>\n",
       "      <td>9.500000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_drug_submitted_charges</th>\n",
       "      <td>7070</td>\n",
       "      <td>1.396708e+06</td>\n",
       "      <td>2.220546e+06</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.781155e+05</td>\n",
       "      <td>2.176541e+06</td>\n",
       "      <td>3.556785e+07</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_drug_medicare_allowed_amt</th>\n",
       "      <td>7070</td>\n",
       "      <td>5.832374e+05</td>\n",
       "      <td>9.734480e+05</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>8.455719e+04</td>\n",
       "      <td>9.431559e+05</td>\n",
       "      <td>3.551663e+07</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_drug_medicare_payment_amt</th>\n",
       "      <td>7070</td>\n",
       "      <td>4.547502e+05</td>\n",
       "      <td>7.610643e+05</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>6.596858e+04</td>\n",
       "      <td>7.371104e+05</td>\n",
       "      <td>2.797682e+07</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_hcpcs_associated_med_srvc</th>\n",
       "      <td>7070</td>\n",
       "      <td>3.688444e+01</td>\n",
       "      <td>2.816218e+01</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>1.500000e+01</td>\n",
       "      <td>3.000000e+01</td>\n",
       "      <td>5.100000e+01</td>\n",
       "      <td>3.130000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_med_srvc</th>\n",
       "      <td>7070</td>\n",
       "      <td>4.396669e+03</td>\n",
       "      <td>6.165630e+03</td>\n",
       "      <td>1.200000e+01</td>\n",
       "      <td>6.080000e+02</td>\n",
       "      <td>1.883500e+03</td>\n",
       "      <td>6.071000e+03</td>\n",
       "      <td>9.189700e+04</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_unique_bene_with_med_srvc</th>\n",
       "      <td>7070</td>\n",
       "      <td>3.802509e+02</td>\n",
       "      <td>3.009837e+02</td>\n",
       "      <td>1.100000e+01</td>\n",
       "      <td>1.640000e+02</td>\n",
       "      <td>3.200000e+02</td>\n",
       "      <td>5.230000e+02</td>\n",
       "      <td>4.945000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_med_submitted_charges</th>\n",
       "      <td>7070</td>\n",
       "      <td>5.509083e+05</td>\n",
       "      <td>7.090353e+05</td>\n",
       "      <td>2.040000e+02</td>\n",
       "      <td>1.216345e+05</td>\n",
       "      <td>2.979365e+05</td>\n",
       "      <td>7.492692e+05</td>\n",
       "      <td>1.127809e+07</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_med_medicare_allowed_amt</th>\n",
       "      <td>7070</td>\n",
       "      <td>2.253785e+05</td>\n",
       "      <td>2.579490e+05</td>\n",
       "      <td>3.600000e+01</td>\n",
       "      <td>5.159169e+04</td>\n",
       "      <td>1.329815e+05</td>\n",
       "      <td>3.249799e+05</td>\n",
       "      <td>4.088326e+06</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_med_medicare_payment_amt</th>\n",
       "      <td>7070</td>\n",
       "      <td>1.747877e+05</td>\n",
       "      <td>2.039300e+05</td>\n",
       "      <td>3.582000e+01</td>\n",
       "      <td>3.896800e+04</td>\n",
       "      <td>1.005297e+05</td>\n",
       "      <td>2.511919e+05</td>\n",
       "      <td>3.283833e+06</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>avg_age_bene</th>\n",
       "      <td>7673</td>\n",
       "      <td>7.211156e+01</td>\n",
       "      <td>3.606139e+00</td>\n",
       "      <td>2.600000e+01</td>\n",
       "      <td>7.100000e+01</td>\n",
       "      <td>7.300000e+01</td>\n",
       "      <td>7.400000e+01</td>\n",
       "      <td>8.800000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_bene_le65</th>\n",
       "      <td>6365</td>\n",
       "      <td>5.619811e+01</td>\n",
       "      <td>3.857931e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>2.900000e+01</td>\n",
       "      <td>4.700000e+01</td>\n",
       "      <td>7.300000e+01</td>\n",
       "      <td>6.450000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_bene_65to74</th>\n",
       "      <td>7331</td>\n",
       "      <td>1.555739e+02</td>\n",
       "      <td>1.211446e+02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>7.200000e+01</td>\n",
       "      <td>1.290000e+02</td>\n",
       "      <td>2.060000e+02</td>\n",
       "      <td>2.431000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_bene_75to84</th>\n",
       "      <td>6684</td>\n",
       "      <td>1.360136e+02</td>\n",
       "      <td>1.045320e+02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>6.200000e+01</td>\n",
       "      <td>1.140000e+02</td>\n",
       "      <td>1.830000e+02</td>\n",
       "      <td>1.581000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_bene_ge84</th>\n",
       "      <td>5985</td>\n",
       "      <td>6.160602e+01</td>\n",
       "      <td>4.841109e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>2.900000e+01</td>\n",
       "      <td>5.100000e+01</td>\n",
       "      <td>8.100000e+01</td>\n",
       "      <td>8.400000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_female</th>\n",
       "      <td>7335</td>\n",
       "      <td>2.248281e+02</td>\n",
       "      <td>1.799207e+02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>9.300000e+01</td>\n",
       "      <td>1.890000e+02</td>\n",
       "      <td>3.110000e+02</td>\n",
       "      <td>3.096000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_male</th>\n",
       "      <td>7335</td>\n",
       "      <td>1.572288e+02</td>\n",
       "      <td>1.228544e+02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>7.100000e+01</td>\n",
       "      <td>1.320000e+02</td>\n",
       "      <td>2.110000e+02</td>\n",
       "      <td>1.849000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_non_his_white</th>\n",
       "      <td>6367</td>\n",
       "      <td>3.363446e+02</td>\n",
       "      <td>2.677510e+02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.440000e+02</td>\n",
       "      <td>2.830000e+02</td>\n",
       "      <td>4.580000e+02</td>\n",
       "      <td>4.375000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_african_american</th>\n",
       "      <td>3292</td>\n",
       "      <td>6.475729e+01</td>\n",
       "      <td>7.758338e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>2.200000e+01</td>\n",
       "      <td>4.100000e+01</td>\n",
       "      <td>7.800000e+01</td>\n",
       "      <td>1.418000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_asian</th>\n",
       "      <td>1082</td>\n",
       "      <td>2.824954e+01</td>\n",
       "      <td>5.691333e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.600000e+01</td>\n",
       "      <td>3.100000e+01</td>\n",
       "      <td>7.930000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_hispanic</th>\n",
       "      <td>2224</td>\n",
       "      <td>4.922797e+01</td>\n",
       "      <td>7.865060e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.600000e+01</td>\n",
       "      <td>2.600000e+01</td>\n",
       "      <td>5.000000e+01</td>\n",
       "      <td>1.184000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_american_indian</th>\n",
       "      <td>2413</td>\n",
       "      <td>1.207211e+00</td>\n",
       "      <td>8.247126e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>2.000000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_no_race</th>\n",
       "      <td>566</td>\n",
       "      <td>8.892226e+00</td>\n",
       "      <td>1.131796e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.100000e+01</td>\n",
       "      <td>1.400000e+01</td>\n",
       "      <td>7.700000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_medicare_only</th>\n",
       "      <td>6932</td>\n",
       "      <td>3.211910e+02</td>\n",
       "      <td>2.583815e+02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.400000e+02</td>\n",
       "      <td>2.660000e+02</td>\n",
       "      <td>4.340000e+02</td>\n",
       "      <td>4.595000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_medicare_medicaid</th>\n",
       "      <td>6932</td>\n",
       "      <td>7.822129e+01</td>\n",
       "      <td>7.279794e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>3.300000e+01</td>\n",
       "      <td>5.900000e+01</td>\n",
       "      <td>1.000000e+02</td>\n",
       "      <td>1.497000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_alzheimers_dementia</th>\n",
       "      <td>6113</td>\n",
       "      <td>1.120890e+01</td>\n",
       "      <td>6.284020e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>8.000000e+00</td>\n",
       "      <td>1.000000e+01</td>\n",
       "      <td>1.300000e+01</td>\n",
       "      <td>7.500000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_asthma</th>\n",
       "      <td>6133</td>\n",
       "      <td>8.817381e+00</td>\n",
       "      <td>3.428932e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>7.000000e+00</td>\n",
       "      <td>8.000000e+00</td>\n",
       "      <td>1.000000e+01</td>\n",
       "      <td>4.200000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_artrial_fibrillation</th>\n",
       "      <td>6558</td>\n",
       "      <td>1.407701e+01</td>\n",
       "      <td>4.572399e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.100000e+01</td>\n",
       "      <td>1.400000e+01</td>\n",
       "      <td>1.600000e+01</td>\n",
       "      <td>5.300000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_cancer</th>\n",
       "      <td>7175</td>\n",
       "      <td>4.313519e+01</td>\n",
       "      <td>1.456788e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>3.600000e+01</td>\n",
       "      <td>4.400000e+01</td>\n",
       "      <td>5.100000e+01</td>\n",
       "      <td>7.500000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_chronic_kidney</th>\n",
       "      <td>7385</td>\n",
       "      <td>3.599188e+01</td>\n",
       "      <td>1.011479e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>2.900000e+01</td>\n",
       "      <td>3.500000e+01</td>\n",
       "      <td>4.200000e+01</td>\n",
       "      <td>7.500000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_chronic_obstructive_pulmonary</th>\n",
       "      <td>6952</td>\n",
       "      <td>2.204704e+01</td>\n",
       "      <td>8.106431e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.600000e+01</td>\n",
       "      <td>2.100000e+01</td>\n",
       "      <td>2.700000e+01</td>\n",
       "      <td>6.800000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_depression</th>\n",
       "      <td>7198</td>\n",
       "      <td>2.363184e+01</td>\n",
       "      <td>6.620883e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.900000e+01</td>\n",
       "      <td>2.300000e+01</td>\n",
       "      <td>2.700000e+01</td>\n",
       "      <td>7.500000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_diabetes</th>\n",
       "      <td>7333</td>\n",
       "      <td>3.492841e+01</td>\n",
       "      <td>8.985087e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>2.900000e+01</td>\n",
       "      <td>3.400000e+01</td>\n",
       "      <td>3.900000e+01</td>\n",
       "      <td>7.500000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_heart_failure</th>\n",
       "      <td>7140</td>\n",
       "      <td>2.583053e+01</td>\n",
       "      <td>9.414406e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.900000e+01</td>\n",
       "      <td>2.400000e+01</td>\n",
       "      <td>3.000000e+01</td>\n",
       "      <td>7.500000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_hyperlipidemia</th>\n",
       "      <td>7505</td>\n",
       "      <td>5.404544e+01</td>\n",
       "      <td>9.296149e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>4.800000e+01</td>\n",
       "      <td>5.400000e+01</td>\n",
       "      <td>6.000000e+01</td>\n",
       "      <td>7.500000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_hypertension</th>\n",
       "      <td>7588</td>\n",
       "      <td>6.903940e+01</td>\n",
       "      <td>7.235583e+00</td>\n",
       "      <td>3.000000e+01</td>\n",
       "      <td>6.500000e+01</td>\n",
       "      <td>7.200000e+01</td>\n",
       "      <td>7.500000e+01</td>\n",
       "      <td>7.500000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_ischemic_heart</th>\n",
       "      <td>7381</td>\n",
       "      <td>4.048611e+01</td>\n",
       "      <td>1.087085e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>3.300000e+01</td>\n",
       "      <td>4.000000e+01</td>\n",
       "      <td>4.700000e+01</td>\n",
       "      <td>7.500000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_osteoporosis</th>\n",
       "      <td>6222</td>\n",
       "      <td>1.120235e+01</td>\n",
       "      <td>4.617054e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>8.000000e+00</td>\n",
       "      <td>1.100000e+01</td>\n",
       "      <td>1.300000e+01</td>\n",
       "      <td>5.900000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_rheumatoid_arthritis_osteoarthirtis</th>\n",
       "      <td>7383</td>\n",
       "      <td>3.771326e+01</td>\n",
       "      <td>7.655318e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>3.300000e+01</td>\n",
       "      <td>3.700000e+01</td>\n",
       "      <td>4.200000e+01</td>\n",
       "      <td>7.500000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_schizophrenia_psychotic</th>\n",
       "      <td>4458</td>\n",
       "      <td>4.994392e+00</td>\n",
       "      <td>3.388761e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>3.000000e+00</td>\n",
       "      <td>4.000000e+00</td>\n",
       "      <td>6.000000e+00</td>\n",
       "      <td>7.500000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_stroke</th>\n",
       "      <td>5302</td>\n",
       "      <td>6.694832e+00</td>\n",
       "      <td>3.268130e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>5.000000e+00</td>\n",
       "      <td>6.000000e+00</td>\n",
       "      <td>8.000000e+00</td>\n",
       "      <td>4.100000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>avg_hcc_risk_score</th>\n",
       "      <td>7673</td>\n",
       "      <td>2.007950e+00</td>\n",
       "      <td>4.109375e-01</td>\n",
       "      <td>8.220000e-01</td>\n",
       "      <td>1.760400e+00</td>\n",
       "      <td>1.947600e+00</td>\n",
       "      <td>2.194700e+00</td>\n",
       "      <td>5.672300e+00</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                          count          mean           std  \\\n",
       "index                                      7673  4.773280e+05  2.753831e+05   \n",
       "npi                                        7673  1.499396e+09  2.872457e+08   \n",
       "num_hcpcs                                  7673  6.321100e+01  5.468443e+01   \n",
       "num_services                               7673  3.877010e+04  6.393326e+04   \n",
       "num_unique_bene                            7673  3.676657e+02  2.968132e+02   \n",
       "total_submitted_charges                    7673  1.810274e+06  2.755069e+06   \n",
       "total_medicare_allowed_amt                 7673  7.525986e+05  1.148817e+06   \n",
       "total_medicare_payment_amt                 7673  5.857542e+05  8.994061e+05   \n",
       "num_hcpcs_associated_drug_srvc             7070  2.940071e+01  3.038660e+01   \n",
       "num_drug_srvc                              7070  3.752725e+04  6.076116e+04   \n",
       "num_unique_bene_with_drug_srvc             7070  8.286393e+01  1.187048e+02   \n",
       "total_drug_submitted_charges               7070  1.396708e+06  2.220546e+06   \n",
       "total_drug_medicare_allowed_amt            7070  5.832374e+05  9.734480e+05   \n",
       "total_drug_medicare_payment_amt            7070  4.547502e+05  7.610643e+05   \n",
       "num_hcpcs_associated_med_srvc              7070  3.688444e+01  2.816218e+01   \n",
       "num_med_srvc                               7070  4.396669e+03  6.165630e+03   \n",
       "num_unique_bene_with_med_srvc              7070  3.802509e+02  3.009837e+02   \n",
       "total_med_submitted_charges                7070  5.509083e+05  7.090353e+05   \n",
       "total_med_medicare_allowed_amt             7070  2.253785e+05  2.579490e+05   \n",
       "total_med_medicare_payment_amt             7070  1.747877e+05  2.039300e+05   \n",
       "avg_age_bene                               7673  7.211156e+01  3.606139e+00   \n",
       "num_bene_le65                              6365  5.619811e+01  3.857931e+01   \n",
       "num_bene_65to74                            7331  1.555739e+02  1.211446e+02   \n",
       "num_bene_75to84                            6684  1.360136e+02  1.045320e+02   \n",
       "num_bene_ge84                              5985  6.160602e+01  4.841109e+01   \n",
       "num_female                                 7335  2.248281e+02  1.799207e+02   \n",
       "num_male                                   7335  1.572288e+02  1.228544e+02   \n",
       "num_non_his_white                          6367  3.363446e+02  2.677510e+02   \n",
       "num_african_american                       3292  6.475729e+01  7.758338e+01   \n",
       "num_asian                                  1082  2.824954e+01  5.691333e+01   \n",
       "num_hispanic                               2224  4.922797e+01  7.865060e+01   \n",
       "num_american_indian                        2413  1.207211e+00  8.247126e+00   \n",
       "num_no_race                                 566  8.892226e+00  1.131796e+01   \n",
       "num_medicare_only                          6932  3.211910e+02  2.583815e+02   \n",
       "num_medicare_medicaid                      6932  7.822129e+01  7.279794e+01   \n",
       "pcnt_alzheimers_dementia                   6113  1.120890e+01  6.284020e+00   \n",
       "pcnt_asthma                                6133  8.817381e+00  3.428932e+00   \n",
       "pcnt_artrial_fibrillation                  6558  1.407701e+01  4.572399e+00   \n",
       "pcnt_cancer                                7175  4.313519e+01  1.456788e+01   \n",
       "pcnt_chronic_kidney                        7385  3.599188e+01  1.011479e+01   \n",
       "pcnt_chronic_obstructive_pulmonary         6952  2.204704e+01  8.106431e+00   \n",
       "pcnt_depression                            7198  2.363184e+01  6.620883e+00   \n",
       "pcnt_diabetes                              7333  3.492841e+01  8.985087e+00   \n",
       "pcnt_heart_failure                         7140  2.583053e+01  9.414406e+00   \n",
       "pcnt_hyperlipidemia                        7505  5.404544e+01  9.296149e+00   \n",
       "pcnt_hypertension                          7588  6.903940e+01  7.235583e+00   \n",
       "pcnt_ischemic_heart                        7381  4.048611e+01  1.087085e+01   \n",
       "pcnt_osteoporosis                          6222  1.120235e+01  4.617054e+00   \n",
       "pcnt_rheumatoid_arthritis_osteoarthirtis   7383  3.771326e+01  7.655318e+00   \n",
       "pcnt_schizophrenia_psychotic               4458  4.994392e+00  3.388761e+00   \n",
       "pcnt_stroke                                5302  6.694832e+00  3.268130e+00   \n",
       "avg_hcc_risk_score                         7673  2.007950e+00  4.109375e-01   \n",
       "\n",
       "                                                   min           25%  \\\n",
       "index                                     2.830000e+02  2.391380e+05   \n",
       "npi                                       1.003015e+09  1.245569e+09   \n",
       "num_hcpcs                                 1.000000e+00  1.500000e+01   \n",
       "num_services                              1.200000e+01  6.710000e+02   \n",
       "num_unique_bene                           1.100000e+01  1.540000e+02   \n",
       "total_submitted_charges                   2.040000e+02  1.263760e+05   \n",
       "total_medicare_allowed_amt                3.600000e+01  5.523646e+04   \n",
       "total_medicare_payment_amt                3.582000e+01  4.185852e+04   \n",
       "num_hcpcs_associated_drug_srvc            0.000000e+00  0.000000e+00   \n",
       "num_drug_srvc                             0.000000e+00  0.000000e+00   \n",
       "num_unique_bene_with_drug_srvc            0.000000e+00  0.000000e+00   \n",
       "total_drug_submitted_charges              0.000000e+00  0.000000e+00   \n",
       "total_drug_medicare_allowed_amt           0.000000e+00  0.000000e+00   \n",
       "total_drug_medicare_payment_amt           0.000000e+00  0.000000e+00   \n",
       "num_hcpcs_associated_med_srvc             1.000000e+00  1.500000e+01   \n",
       "num_med_srvc                              1.200000e+01  6.080000e+02   \n",
       "num_unique_bene_with_med_srvc             1.100000e+01  1.640000e+02   \n",
       "total_med_submitted_charges               2.040000e+02  1.216345e+05   \n",
       "total_med_medicare_allowed_amt            3.600000e+01  5.159169e+04   \n",
       "total_med_medicare_payment_amt            3.582000e+01  3.896800e+04   \n",
       "avg_age_bene                              2.600000e+01  7.100000e+01   \n",
       "num_bene_le65                             0.000000e+00  2.900000e+01   \n",
       "num_bene_65to74                           0.000000e+00  7.200000e+01   \n",
       "num_bene_75to84                           0.000000e+00  6.200000e+01   \n",
       "num_bene_ge84                             0.000000e+00  2.900000e+01   \n",
       "num_female                                0.000000e+00  9.300000e+01   \n",
       "num_male                                  0.000000e+00  7.100000e+01   \n",
       "num_non_his_white                         0.000000e+00  1.440000e+02   \n",
       "num_african_american                      0.000000e+00  2.200000e+01   \n",
       "num_asian                                 0.000000e+00  0.000000e+00   \n",
       "num_hispanic                              0.000000e+00  1.600000e+01   \n",
       "num_american_indian                       0.000000e+00  0.000000e+00   \n",
       "num_no_race                               0.000000e+00  0.000000e+00   \n",
       "num_medicare_only                         0.000000e+00  1.400000e+02   \n",
       "num_medicare_medicaid                     0.000000e+00  3.300000e+01   \n",
       "pcnt_alzheimers_dementia                  0.000000e+00  8.000000e+00   \n",
       "pcnt_asthma                               0.000000e+00  7.000000e+00   \n",
       "pcnt_artrial_fibrillation                 0.000000e+00  1.100000e+01   \n",
       "pcnt_cancer                               0.000000e+00  3.600000e+01   \n",
       "pcnt_chronic_kidney                       0.000000e+00  2.900000e+01   \n",
       "pcnt_chronic_obstructive_pulmonary        0.000000e+00  1.600000e+01   \n",
       "pcnt_depression                           0.000000e+00  1.900000e+01   \n",
       "pcnt_diabetes                             0.000000e+00  2.900000e+01   \n",
       "pcnt_heart_failure                        0.000000e+00  1.900000e+01   \n",
       "pcnt_hyperlipidemia                       0.000000e+00  4.800000e+01   \n",
       "pcnt_hypertension                         3.000000e+01  6.500000e+01   \n",
       "pcnt_ischemic_heart                       0.000000e+00  3.300000e+01   \n",
       "pcnt_osteoporosis                         0.000000e+00  8.000000e+00   \n",
       "pcnt_rheumatoid_arthritis_osteoarthirtis  0.000000e+00  3.300000e+01   \n",
       "pcnt_schizophrenia_psychotic              0.000000e+00  3.000000e+00   \n",
       "pcnt_stroke                               0.000000e+00  5.000000e+00   \n",
       "avg_hcc_risk_score                        8.220000e-01  1.760400e+00   \n",
       "\n",
       "                                                   50%           75%  \\\n",
       "index                                     4.730610e+05  7.161890e+05   \n",
       "npi                                       1.497767e+09  1.740502e+09   \n",
       "num_hcpcs                                 4.000000e+01  1.060000e+02   \n",
       "num_services                              3.890000e+03  5.784900e+04   \n",
       "num_unique_bene                           3.090000e+02  5.080000e+02   \n",
       "total_submitted_charges                   3.914500e+05  2.700639e+06   \n",
       "total_medicare_allowed_amt                1.740097e+05  1.174963e+06   \n",
       "total_medicare_payment_amt                1.315049e+05  9.140042e+05   \n",
       "num_hcpcs_associated_drug_srvc            2.300000e+01  5.800000e+01   \n",
       "num_drug_srvc                             5.514500e+03  5.711400e+04   \n",
       "num_unique_bene_with_drug_srvc            3.000000e+01  1.310000e+02   \n",
       "total_drug_submitted_charges              1.781155e+05  2.176541e+06   \n",
       "total_drug_medicare_allowed_amt           8.455719e+04  9.431559e+05   \n",
       "total_drug_medicare_payment_amt           6.596858e+04  7.371104e+05   \n",
       "num_hcpcs_associated_med_srvc             3.000000e+01  5.100000e+01   \n",
       "num_med_srvc                              1.883500e+03  6.071000e+03   \n",
       "num_unique_bene_with_med_srvc             3.200000e+02  5.230000e+02   \n",
       "total_med_submitted_charges               2.979365e+05  7.492692e+05   \n",
       "total_med_medicare_allowed_amt            1.329815e+05  3.249799e+05   \n",
       "total_med_medicare_payment_amt            1.005297e+05  2.511919e+05   \n",
       "avg_age_bene                              7.300000e+01  7.400000e+01   \n",
       "num_bene_le65                             4.700000e+01  7.300000e+01   \n",
       "num_bene_65to74                           1.290000e+02  2.060000e+02   \n",
       "num_bene_75to84                           1.140000e+02  1.830000e+02   \n",
       "num_bene_ge84                             5.100000e+01  8.100000e+01   \n",
       "num_female                                1.890000e+02  3.110000e+02   \n",
       "num_male                                  1.320000e+02  2.110000e+02   \n",
       "num_non_his_white                         2.830000e+02  4.580000e+02   \n",
       "num_african_american                      4.100000e+01  7.800000e+01   \n",
       "num_asian                                 1.600000e+01  3.100000e+01   \n",
       "num_hispanic                              2.600000e+01  5.000000e+01   \n",
       "num_american_indian                       0.000000e+00  0.000000e+00   \n",
       "num_no_race                               1.100000e+01  1.400000e+01   \n",
       "num_medicare_only                         2.660000e+02  4.340000e+02   \n",
       "num_medicare_medicaid                     5.900000e+01  1.000000e+02   \n",
       "pcnt_alzheimers_dementia                  1.000000e+01  1.300000e+01   \n",
       "pcnt_asthma                               8.000000e+00  1.000000e+01   \n",
       "pcnt_artrial_fibrillation                 1.400000e+01  1.600000e+01   \n",
       "pcnt_cancer                               4.400000e+01  5.100000e+01   \n",
       "pcnt_chronic_kidney                       3.500000e+01  4.200000e+01   \n",
       "pcnt_chronic_obstructive_pulmonary        2.100000e+01  2.700000e+01   \n",
       "pcnt_depression                           2.300000e+01  2.700000e+01   \n",
       "pcnt_diabetes                             3.400000e+01  3.900000e+01   \n",
       "pcnt_heart_failure                        2.400000e+01  3.000000e+01   \n",
       "pcnt_hyperlipidemia                       5.400000e+01  6.000000e+01   \n",
       "pcnt_hypertension                         7.200000e+01  7.500000e+01   \n",
       "pcnt_ischemic_heart                       4.000000e+01  4.700000e+01   \n",
       "pcnt_osteoporosis                         1.100000e+01  1.300000e+01   \n",
       "pcnt_rheumatoid_arthritis_osteoarthirtis  3.700000e+01  4.200000e+01   \n",
       "pcnt_schizophrenia_psychotic              4.000000e+00  6.000000e+00   \n",
       "pcnt_stroke                               6.000000e+00  8.000000e+00   \n",
       "avg_hcc_risk_score                        1.947600e+00  2.194700e+00   \n",
       "\n",
       "                                                   max  \n",
       "index                                     9.562840e+05  \n",
       "npi                                       1.992999e+09  \n",
       "num_hcpcs                                 3.880000e+02  \n",
       "num_services                              9.195270e+05  \n",
       "num_unique_bene                           4.946000e+03  \n",
       "total_submitted_charges                   3.574462e+07  \n",
       "total_medicare_allowed_amt                3.561484e+07  \n",
       "total_medicare_payment_amt                2.804806e+07  \n",
       "num_hcpcs_associated_drug_srvc            1.100000e+02  \n",
       "num_drug_srvc                             9.192350e+05  \n",
       "num_unique_bene_with_drug_srvc            9.500000e+02  \n",
       "total_drug_submitted_charges              3.556785e+07  \n",
       "total_drug_medicare_allowed_amt           3.551663e+07  \n",
       "total_drug_medicare_payment_amt           2.797682e+07  \n",
       "num_hcpcs_associated_med_srvc             3.130000e+02  \n",
       "num_med_srvc                              9.189700e+04  \n",
       "num_unique_bene_with_med_srvc             4.945000e+03  \n",
       "total_med_submitted_charges               1.127809e+07  \n",
       "total_med_medicare_allowed_amt            4.088326e+06  \n",
       "total_med_medicare_payment_amt            3.283833e+06  \n",
       "avg_age_bene                              8.800000e+01  \n",
       "num_bene_le65                             6.450000e+02  \n",
       "num_bene_65to74                           2.431000e+03  \n",
       "num_bene_75to84                           1.581000e+03  \n",
       "num_bene_ge84                             8.400000e+02  \n",
       "num_female                                3.096000e+03  \n",
       "num_male                                  1.849000e+03  \n",
       "num_non_his_white                         4.375000e+03  \n",
       "num_african_american                      1.418000e+03  \n",
       "num_asian                                 7.930000e+02  \n",
       "num_hispanic                              1.184000e+03  \n",
       "num_american_indian                       2.000000e+02  \n",
       "num_no_race                               7.700000e+01  \n",
       "num_medicare_only                         4.595000e+03  \n",
       "num_medicare_medicaid                     1.497000e+03  \n",
       "pcnt_alzheimers_dementia                  7.500000e+01  \n",
       "pcnt_asthma                               4.200000e+01  \n",
       "pcnt_artrial_fibrillation                 5.300000e+01  \n",
       "pcnt_cancer                               7.500000e+01  \n",
       "pcnt_chronic_kidney                       7.500000e+01  \n",
       "pcnt_chronic_obstructive_pulmonary        6.800000e+01  \n",
       "pcnt_depression                           7.500000e+01  \n",
       "pcnt_diabetes                             7.500000e+01  \n",
       "pcnt_heart_failure                        7.500000e+01  \n",
       "pcnt_hyperlipidemia                       7.500000e+01  \n",
       "pcnt_hypertension                         7.500000e+01  \n",
       "pcnt_ischemic_heart                       7.500000e+01  \n",
       "pcnt_osteoporosis                         5.900000e+01  \n",
       "pcnt_rheumatoid_arthritis_osteoarthirtis  7.500000e+01  \n",
       "pcnt_schizophrenia_psychotic              7.500000e+01  \n",
       "pcnt_stroke                               4.100000e+01  \n",
       "avg_hcc_risk_score                        5.672300e+00  "
      ]
     },
     "execution_count": 28,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_cancer_hema.describe().T"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 29,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "drop_cols = ['index', \n",
    "             'middle_initial', \n",
    "             'street1',\n",
    "             'street2',\n",
    "             'country',\n",
    "             'medicare_participation_indicator',\n",
    "             'num_medicare_only',\n",
    "             'num_medicare_medicaid']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 31,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "df_cancer_hema = df_cancer_hema.drop(drop_cols, axis=1)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 32,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(7673, 60)"
      ]
     },
     "execution_count": 32,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_cancer_hema.shape"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Import already merged file"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 70,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "df_hema = pd.read_csv('../data/cancer_hema_util_pays.csv')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 34,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>npi</th>\n",
       "      <th>last_name</th>\n",
       "      <th>first_name</th>\n",
       "      <th>credentials</th>\n",
       "      <th>gender</th>\n",
       "      <th>city</th>\n",
       "      <th>state</th>\n",
       "      <th>provider_type</th>\n",
       "      <th>num_hcpcs</th>\n",
       "      <th>num_services</th>\n",
       "      <th>...</th>\n",
       "      <th>num_diabetes</th>\n",
       "      <th>num_heart_failure</th>\n",
       "      <th>num_hypertension</th>\n",
       "      <th>num_ischemic_heart</th>\n",
       "      <th>num_osteoporosis</th>\n",
       "      <th>num_rheumatoid_arthritis_osteoarthirtis</th>\n",
       "      <th>num_schizophrenia_psychotic</th>\n",
       "      <th>num_stroke</th>\n",
       "      <th>county</th>\n",
       "      <th>county_fips</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1093893331</td>\n",
       "      <td>ZAMAN</td>\n",
       "      <td>QAMAR</td>\n",
       "      <td>MD</td>\n",
       "      <td>M</td>\n",
       "      <td>CUMBERLAND</td>\n",
       "      <td>MD</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>21</td>\n",
       "      <td>15174</td>\n",
       "      <td>...</td>\n",
       "      <td>522.90</td>\n",
       "      <td>385.95</td>\n",
       "      <td>933.75</td>\n",
       "      <td>709.65</td>\n",
       "      <td>161.85</td>\n",
       "      <td>622.50</td>\n",
       "      <td>99.60</td>\n",
       "      <td>186.75</td>\n",
       "      <td>Allegany</td>\n",
       "      <td>24001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1336137876</td>\n",
       "      <td>MAVROMATIS</td>\n",
       "      <td>BLANCHE</td>\n",
       "      <td>MD</td>\n",
       "      <td>F</td>\n",
       "      <td>CUMBERLAND</td>\n",
       "      <td>MD</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>21</td>\n",
       "      <td>2393</td>\n",
       "      <td>...</td>\n",
       "      <td>185.44</td>\n",
       "      <td>107.36</td>\n",
       "      <td>366.00</td>\n",
       "      <td>209.84</td>\n",
       "      <td>39.04</td>\n",
       "      <td>219.60</td>\n",
       "      <td>19.52</td>\n",
       "      <td>34.16</td>\n",
       "      <td>Allegany</td>\n",
       "      <td>24001</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>1164609749</td>\n",
       "      <td>HANSON</td>\n",
       "      <td>BRITT</td>\n",
       "      <td>DO</td>\n",
       "      <td>F</td>\n",
       "      <td>EVANSTON</td>\n",
       "      <td>IL</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>20</td>\n",
       "      <td>829</td>\n",
       "      <td>...</td>\n",
       "      <td>78.59</td>\n",
       "      <td>92.14</td>\n",
       "      <td>203.25</td>\n",
       "      <td>135.50</td>\n",
       "      <td>37.94</td>\n",
       "      <td>111.11</td>\n",
       "      <td>16.26</td>\n",
       "      <td>24.39</td>\n",
       "      <td>Cook</td>\n",
       "      <td>17031</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>1235156811</td>\n",
       "      <td>MERKEL</td>\n",
       "      <td>DOUGLAS</td>\n",
       "      <td>MD</td>\n",
       "      <td>M</td>\n",
       "      <td>EVANSTON</td>\n",
       "      <td>IL</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>10</td>\n",
       "      <td>1672</td>\n",
       "      <td>...</td>\n",
       "      <td>133.74</td>\n",
       "      <td>66.87</td>\n",
       "      <td>334.35</td>\n",
       "      <td>104.02</td>\n",
       "      <td>126.31</td>\n",
       "      <td>274.91</td>\n",
       "      <td>14.86</td>\n",
       "      <td>22.29</td>\n",
       "      <td>Cook</td>\n",
       "      <td>17031</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>1548285372</td>\n",
       "      <td>GRINBLATT</td>\n",
       "      <td>DAVID</td>\n",
       "      <td>MD</td>\n",
       "      <td>M</td>\n",
       "      <td>EVANSTON</td>\n",
       "      <td>IL</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>21</td>\n",
       "      <td>1680</td>\n",
       "      <td>...</td>\n",
       "      <td>113.28</td>\n",
       "      <td>118.00</td>\n",
       "      <td>306.80</td>\n",
       "      <td>169.92</td>\n",
       "      <td>56.64</td>\n",
       "      <td>184.08</td>\n",
       "      <td>18.88</td>\n",
       "      <td>18.88</td>\n",
       "      <td>Cook</td>\n",
       "      <td>17031</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows × 76 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "          npi   last_name first_name credentials gender        city state  \\\n",
       "0  1093893331       ZAMAN      QAMAR          MD      M  CUMBERLAND    MD   \n",
       "1  1336137876  MAVROMATIS    BLANCHE          MD      F  CUMBERLAND    MD   \n",
       "2  1164609749      HANSON      BRITT          DO      F    EVANSTON    IL   \n",
       "3  1235156811      MERKEL    DOUGLAS          MD      M    EVANSTON    IL   \n",
       "4  1548285372   GRINBLATT      DAVID          MD      M    EVANSTON    IL   \n",
       "\n",
       "         provider_type  num_hcpcs  num_services     ...       num_diabetes  \\\n",
       "0  Hematology/Oncology         21         15174     ...             522.90   \n",
       "1  Hematology/Oncology         21          2393     ...             185.44   \n",
       "2  Hematology/Oncology         20           829     ...              78.59   \n",
       "3  Hematology/Oncology         10          1672     ...             133.74   \n",
       "4  Hematology/Oncology         21          1680     ...             113.28   \n",
       "\n",
       "   num_heart_failure  num_hypertension  num_ischemic_heart  num_osteoporosis  \\\n",
       "0             385.95            933.75              709.65            161.85   \n",
       "1             107.36            366.00              209.84             39.04   \n",
       "2              92.14            203.25              135.50             37.94   \n",
       "3              66.87            334.35              104.02            126.31   \n",
       "4             118.00            306.80              169.92             56.64   \n",
       "\n",
       "   num_rheumatoid_arthritis_osteoarthirtis  num_schizophrenia_psychotic  \\\n",
       "0                                   622.50                        99.60   \n",
       "1                                   219.60                        19.52   \n",
       "2                                   111.11                        16.26   \n",
       "3                                   274.91                        14.86   \n",
       "4                                   184.08                        18.88   \n",
       "\n",
       "   num_stroke    county  county_fips  \n",
       "0      186.75  Allegany        24001  \n",
       "1       34.16  Allegany        24001  \n",
       "2       24.39      Cook        17031  \n",
       "3       22.29      Cook        17031  \n",
       "4       18.88      Cook        17031  \n",
       "\n",
       "[5 rows x 76 columns]"
      ]
     },
     "execution_count": 34,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_hema.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 35,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "hist_data = df_hema['total_submitted_charges'] / df_hema['num_unique_bene']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 40,
   "metadata": {
    "collapsed": false,
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(0, 30000)"
      ]
     },
     "execution_count": 40,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAYoAAAEACAYAAACtVTGuAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\ne431o41jAAAAAElFTkSuQmCC\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7f857ce40910>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.hist(hist_data, bins=800)\n",
    "plt.xlim(0,30000)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Costs per patient are not close to normally distributed"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 73,
   "metadata": {
    "collapsed": false,
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(0, 40000)"
      ]
     },
     "execution_count": 73,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAYcAAAEACAYAAABYq7oeAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\ngqCDPwFpWnFvVR230AAAAABJRU5ErkJggg==\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7f8572a11e90>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.scatter(df_hema['pcnt_cancer'], hist_data)\n",
    "plt.ylim(0,40000)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Costs per patient are no longer dependent on pcnt of cancer patients"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {
    "collapsed": true
   },
   "source": [
    "##### df_hema.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 43,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(array([  79.,  119.,  105., ...,    0.,    0.,    1.]),\n",
       " array([  2.04000000e+02,   7.35288258e+03,   1.45017652e+04, ...,\n",
       "          3.57303192e+07,   3.57374680e+07,   3.57446169e+07]),\n",
       " <a list of 5000 Patch objects>)"
      ]
     },
     "execution_count": 43,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAXwAAAENCAYAAAAMmd6uAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz\nAAALEgAACxIB0t1+/AAAE/VJREFUeJzt3X+M5PV93/HnC+7YYJPcEUfstZzZA1uGcyRCrAo7taWb\nxvLPSGApFsbND3CaKCpJY6WVVaCVdvmnsSu1lqPIlSwTC7d1XOyq4ZzYgaC7aWWlgFtMwT5MSVMf\nhPauqgpp3VYI6nf/mNnz3NzuzezM7M7sfZ4PabTfH5/vfN98xL32M5/vd76bqkKSdOG7aN4FSJJ2\nhoEvSY0w8CWpEQa+JDXCwJekRhj4ktSIkYGf5N4kp5M8ucG+v5Pk+0l+dGDbXUmeTfJ0knfPumBJ\n0mTGGeF/DnjP8MYkB4F3AScHth0GbgEOA+8DPp0ksylVkjSNkYFfVV8HXtxg1yeBjw1tuxn4YlW9\nWlXfBZ4Fbpy2SEnS9Caaw09yE/B8VT01tOtK4PmB9Rf62yRJc7ZnqwckuRS4m950jiRpl9hy4ANv\nAA4B/6E/P38QeDzJjfRG9FcNtD3Y33aOJD7ER5ImUFUTXRsdd0on/RdV9a2qOlBV11TV1cCfAz9Z\nVf8NOAp8KMklSa4G3gg8dp6iF/61uro69xqs0zp3c527ocbdVOc0xrkt8wvAnwBvSvJcko8M5zY/\n+GVwArgfOAF8Fbijpq1QkjQTI6d0quqvj9h/zdD6bwG/NWVdkqQZ85u2I3Q6nXmXMBbrnC3rnJ3d\nUCPsnjqnkXnNuCRxtkeStigJtc0XbSVJu5yBL0mNMPAlqREGviQ1wsCXpEYY+JLUCANfkhph4EtS\nIwx8SWqEgS9JjTDwJakRBr4kNcLAl6RGGPiS1Ii5Bv7a2to8Ty9JTZnr8/CBqf9GoyS1xOfhS5JG\nMvAlqREGviQ1wsCXpEYY+JLUiJGBn+TeJKeTPDmw7R8meTrJE0n+ZZIfGdh3V5Jn+/vfvV2FS5K2\nZpwR/ueA9wxtewj48aq6AXgWuAsgyZuBW4DDwPuATyeZ6PYhSdJsjQz8qvo68OLQtoer6vv91UeA\ng/3lm4AvVtWrVfVder8MbpxduZKkSc1iDv+XgK/2l68Enh/Y90J/myRpzvZMc3CSvwe8UlW/N+l7\nrD9eodPp0Ol0pilHki443W6Xbrc7k/ca69EKSVaAr1TV9QPbbgd+Bfjpqnq5v+1OoKrqE/31PwJW\nq+rRDd7TRytI0hbtxKMV0n+tn/C9wMeAm9bDvu8ocGuSS5JcDbwReGySwiRJszVySifJF4AO8Lok\nzwGrwN3AJcAf92/CeaSq7qiqE0nuB04ArwB3lEN4SVoIPi1TknYRn5YpSRrJwJekRhj4ktQIA1+S\nGmHgS1IjDHxJaoSBL0mNMPAlqREGviQ1wsCXpEYY+JLUCANfkhph4EtSI+Yc+EscOHBoviVIUiPm\n/nhk8BHJkjQuH48sSRrJwJekRhj4ktQIA1+SGmHgS1IjDHxJaoSBL0mNMPAlqREjAz/JvUlOJ3ly\nYNvlSR5K8kySB5PsG9h3V5Jnkzyd5N3bVbgkaWvGGeF/DnjP0LY7gYer6lrgGHAXQJI3A7cAh4H3\nAZ9OMtE3wiRJszUy8Kvq68CLQ5tvBu7rL98HfKC/fBPwxap6taq+CzwL3DibUiVJ05h0Dv+KqjoN\nUFWngCv6268Enh9o90J/myRpzvbM6H2mevrZ2toanU6HTqczo3Ik6cLQ7Xbpdrszea+xnpaZZAX4\nSlVd319/GuhU1ekkB4DjVXU4yZ1AVdUn+u3+CFitqkc3eE+flilJW7QTT8tM/7XuKHB7f/k24IGB\n7bcmuSTJ1cAbgccmKUySNFsjp3SSfAHoAK9L8hywCnwc+FKSXwJO0rszh6o6keR+4ATwCnBHOXyX\npIXgH0CRpF3EP4AiSRrJwJekRhj4ktQIA1+SGmHgS1IjDHxJaoSBL0mNMPAlqREGviQ1wsCXpEYY\n+JLUCANfkhph4EtSIwx8SWqEgS9JjTDwJakRBr4kNcLAl6RGGPiS1AgDX5IaYeBLUiMMfElqhIEv\nSY2YKvCT/GaSbyV5Msk/T3JJksuTPJTkmSQPJtk3q2IlSZObOPCT/GXgbwFvqarrgT3Ah4E7gYer\n6lrgGHDXLAqVJE1n2imdi4HXJtkDXAq8ANwM3Nfffx/wgSnPIUmagYkDv6r+C/CPgOfoBf1fVNXD\nwHJVne63OQVcMYtCJUnT2TPpgUn20xvNrwB/AXwpyc8BNdR0eP0ca2trdDodOp3OpOVI0gWp2+3S\n7XZn8l6pGpnHGx+YfBB4T1X9Sn/9F4C3AT8NdKrqdJIDwPGqOrzB8WdOPGkNktSaJFRVJjl2mjn8\n54C3JfmhJAHeCZwAjgK399vcBjwwxTkkSTMy8QgfIMkqcCvwCvBN4JeBHwbuB14PnARuqaqXNjjW\nEb4kbdE0I/ypAn8aBr4kbd28pnQkSbuIgS9JjTDwJakRBr4kNcLAl6RGGPiS1AgDX5IaYeBLUiMM\nfElqhIEvSY0w8CWpEQa+JDXCwJekRhj4ktQIA1+SGmHgS1IjDHxJaoSBL0mNMPAlqREGviQ1wsCX\npEYY+JLUCANfkhoxVeAn2ZfkS0meTvLtJG9NcnmSh5I8k+TBJPtmVawkaXLTjvA/BXy1qg4DPwF8\nB7gTeLiqrgWOAXdNeQ5J0gykqiY7MPkR4JtV9Yah7d8BjlTV6SQHgG5VXbfB8WdOPGkNktSaJFRV\nJjl2mhH+1cB/T/K5JI8n+UyS1wDLVXUaoKpOAVdMcQ5J0ozsmfLYtwC/VlX/Lskn6U3nDA/XRw7f\n19bW6HQ6dDqdKcqRpAtPt9ul2+3O5L2mmdJZBv5tVV3TX38HvcB/A9AZmNI53p/jHz7eKR1J2qK5\nTOn0p22eT/Km/qZ3At8GjgK397fdBjww6TkkSbMz8QgfIMlPAJ8F9gJ/BnwEuBi4H3g9cBK4pape\n2uBYR/iStEXTjPCnCvxpGPiStHXzuktHkrSLGPiS1AgDX5IaYeBLUiMMfElqhIEvSY0w8CWpEQa+\nJDXCwJekRhj4ktQIA1+SGrEAgb/EgQOH5l2EJF3wFuLhaeAD1CRpHD48TZI0koEvSY0w8CWpEQa+\nJDXCwJekRhj4ktQIA1+SGmHgS1IjDHxJaoSBL0mNmDrwk1yU5PEkR/vrlyd5KMkzSR5Msm/6MiVJ\n05rFCP+jwImB9TuBh6vqWuAYcNcMziFJmtJUgZ/kIPB+4LMDm28G7usv3wd8YJpzSJJmY9oR/ieB\njwGDj7pcrqrTAFV1CrhiynNIkmZgz6QHJvkZ4HRVPZGkc56mYz33uNvt0umc720kqT3dbpdutzuT\n95r4efhJ/gHw88CrwKXADwP/CvgrQKeqTic5AByvqsMbHO/z8CVpi+byPPyquruqrqqqa4BbgWNV\n9QvAV4Db+81uAx6Y9BySpNnZjvvwPw68K8kzwDv765KkOfNPHErSLuKfOJQkjWTgS1IjDHxJaoSB\nL0mNMPAlqREGviQ1wsCXpEYY+JLUCANfkhph4EtSIwx8SWqEgS9JjTDwJakRBr4kNcLAl6RGGPiS\n1AgDX5IaYeBLUiMMfElqhIEvSY0w8CWpEQa+JDXCwJekRkwc+EkOJjmW5NtJnkryG/3tlyd5KMkz\nSR5Msm925UqSJjXNCP9V4G9X1Y8DPwX8WpLrgDuBh6vqWuAYcNc4b9bpdKYoRZI0SqpqNm+U/D7w\nO/3Xkao6neQA0K2q6zZof86JZ1WLJF2oklBVmeTYmczhJzkE3AA8AixX1WmAqjoFXDGLc0iSprNn\n2jdIchnwZeCjVfW9DUbuDtslaULdbpdutzuT95pqSifJHuAPgK9V1af6254GOgNTOser6vAGxzql\nI0lbNM8pnd8FTqyHfd9R4Pb+8m3AA1OeQ5I0AxOP8JO8Hfg3wFP0pm0KuBt4DLgfeD1wErilql7a\n4HhH+JK0RdOM8Gd2l86WT2zgS9KWzf0uHUnS4jPwJakRBr4kNWKhAn9tbe2sn5Kk2Vmoi7bQu3Db\nvygB9MLfXwCS1HPB3KUD5wb+4LIktc67dCRJIxn4ktSIBQn8pXO2OG8vSbO1IIH/8jlb7rnnnrPW\n/QUgSdNZ2Iu2g8vDF3IlqVUX0EXbJS67bP+Z5QMHDp21d3iUP2p91D4/NUhqycKN8DeyurrKPfd8\nHHj5rFF+EpaXVwA4deq7Zz4FDN+7v7a2xj333HPOJwQ/NUjabS6o+/BHGQ78we2bTf8MThEN1WDg\nS9pVLqApnWHj372zlemdcY6XpAvNrhvhA2d9C3ejfcMj+nFG+I72Je0GF8gIf2no5+b7Dh06RKfT\n2WB/b9/g8mWX/diZ9bW1taHjzuVIX9KFas+8C/iBl4d+br7v5MmTnDx5cmj/EvByf/v68qmz9q3f\n29/pdM4E/+Dy+sXddYa/pAvJrpzS2SlO8UhaNBfIlM6gjaZ1dv7916eH1m/zHPwkMHzb50bLkrRQ\nqmouL6DGey1tsD74Gve44W3nO/YHryNHjpy1Xr3izyyvrq4WUKurq2f2DVrfPvxzlHHbSWpLP2Mm\nyl2ndLaoNnj0w/C+wT4d/m7AuHcDedeQpI0s5JROkvcm+U6S/5jk727Xec52vqma890FNLx/adN2\n+/fvP7Pcm+LZ+A6hwamdwQvE6z83mgba6l/3GqftRm0OHDh0zmMrJDVg0o8G53vR+0Xyp8AKsBd4\nArhuqM2YUzq77zXwsWtku43aDm4b46NdVVUdP358ZJvBbeO8/3bYrM5FY52zsxtqrNo9dTLFlM52\njfBvBJ6tqpNV9QrwReDmbTrXkK1c8B3Vdgm4eGB5nPY/GMn3RvxL5+xf/7l///6zLgwPfs9gfdv6\nxeL15Y0+BQxuG3UBeZyR/aSfHMbR7XYnOm4nDP43LXKdg3ZDnbuhRtg9dU5l0t8U53sBPwt8ZmD9\n54HfHmoz95E4Y1+83azN0ib7hy8qb3aBebPjNzv3uRes9+3bd87y8vJKf7l3zN69vW2Qs957dXW1\nLrroNbV371JV9S4ULy313mtlZaWSSwt+qPbuXaqlpaVaWVmp1dXV6l9/OetC9PLySu3du1Srq6u1\nstI7//pyVdVrX/u6Wl5e2fTi9erq6pnXuiNHjpy1nlxay8srdeTIkbOOGWWwzWbt1y++D557o/o2\ne59JL7JPe3F+mpsAdurGgEnOM4+bFjY75/LySi0vr+xoLefDFCN8A9/XmaDbruMG22x2N9Nw+8Ft\nm7UZ3j/iH8iG5z3fuba6fxKTHrdu3GDc6DzTnntck4T3TtU2aLM6x/3/bKf0a5kom7flLp0kbwPW\nquq9/fU7+0V+YqDN7E8sSQ2oRXo8cpKLgWeAdwL/FXgM+HBVPT3zk0mSxrItz9Kpqv+X5NeBh+jd\nsXOvYS9J8zW3L15JknbWtj9LZ5wvYCX57STPJnkiyQ3bXdMmNZy3ziRHkryU5PH+6+/PocZ7k5xO\n8uR52ixCX563zgXpy4NJjiX5dpKnkvzGJu3m2p/j1Lkg/bmU5NEk3+zXubpJu3n358g6F6E/B2q5\nqF/D0U32b60/J73aO86L8b6A9T7gD/vLbwUe2c6apqjzCHB0p2sbquEdwA3Ak5vsn3tfjlnnIvTl\nAeCG/vJl9K45LeL/m+PUOff+7Nfxmv7Pi4FHgBsXrT/HrHMh+rNfy28C/2yjeibpz+0e4Y/zBayb\ngc8DVNWjwL4ky9tc17Bxvyg20ZXxWamqrwMvnqfJIvTlOHXC/PvyVFU90V/+HvA0cOVQs7n355h1\nwpz7E6Cq/k9/cYne9cHh+eK592f/3KPqhAXozyQHgfcDn92kyZb7c7sD/0rg+YH1P+fc/1mH27yw\nQZvtNk6dAD/V/+j0h0nevDOlbcki9OW4FqYvkxyi94nk0aFdC9Wf56kTFqA/+9MP3wROAX9cVd8Y\narIQ/TlGnbAA/Ql8EvgYG/9Cggn6c0Gfh7+Q/j1wVVXdAPwO8Ptzrmc3W5i+THIZ8GXgo/0R9EIa\nUedC9GdVfb+qfhI4CLx13r/INzNGnXPvzyQ/A5zuf7oLM/rEsd2B/wJw1cD6wf624TavH9Fmu42s\ns6q+t/5RsKq+BuxN8qM7V+JYFqEvR1qUvkyyh16I/tOqemCDJgvRn6PqXJT+HKjnfwLHgfcO7VqI\n/ly3WZ0L0p9vB25K8mfA7wF/Lcnnh9psuT+3O/C/AbwxyUqSS4BbgeGrzUeBX4Qz39B9qapOb3Nd\nw0bWOTg3luRGere0/o+dLbN3ejb/bb8Ifblu0zoXqC9/FzhRVZ/aZP+i9Od561yE/kzyY0n29Zcv\nBd4FfGeo2dz7c5w6F6E/q+ruqrqqqq6hl0fHquoXh5ptuT+39Y+Y1yZfwEryq73d9Zmq+mqS9yf5\nU+B/Ax/ZzpomrRP4YJK/CbwC/F/gQztdZ5IvAB3gdUmeA1aBS1igvhynThajL98O/BzwVH8+t4C7\n6d2ptTD9OU6dLEB/An8JuC/JRfT+Df2Lfv8t1L/1cepkMfpzQ9P2p1+8kqRGeNFWkhph4EtSIwx8\nSWqEgS9JjTDwJWkHZIyHHw60/cf9B7w9nuSZJDO5LdS7dCRpByR5B/A94PNVdf0Wjvt1eg/Q++Vp\na3CEL0k7YKOHCia5JsnXknwjyb9O8qYNDv0wvW/bTm1bv3glSTqvzwC/WlX/qf+t3n9C70/DApDk\nKuAQcGwWJzPwJWkOkrwW+KvAl5KsP4Zk71CzW4Ev14zm3g18SZqPi4AXq+ot52lzK3DHLE8oSdoZ\nZx4qWFX/C/jPST54Zmdy/cDydcD+qnpkVic38CVpB/QfKvgnwJuSPJfkI/QejPc3+n9s5VvATQOH\nfIjeX9+bXQ3elilJbXCEL0mNMPAlqREGviQ1wsCXpEYY+JLUCANfkhph4EtSIwx8SWrE/wfXpWIK\nosxwUQAAAABJRU5ErkJggg==\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7f857ca87590>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.hist(df_hema['total_submitted_charges'], bins=5000)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 45,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.collections.PathCollection at 0x7f857ccd92d0>"
      ]
     },
     "execution_count": 45,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAYYAAAEGCAYAAABhMDI9AAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\nwzCMGP8fWEeMGXQU1+YAAAAASUVORK5CYII=\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7f857df7a450>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.scatter(df_hema['num_unique_bene'], df_hema['total_submitted_charges'])"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Total costs only very loosely associated with num of beneficiaries"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 50,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.axes._subplots.AxesSubplot at 0x7f857b221cd0>"
      ]
     },
     "execution_count": 50,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAYQAAAEACAYAAACznAEdAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\nsCBIkhoWBEkSAP8PLFpSyUcYksEAAAAASUVORK5CYII=\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7f857a9feed0>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "df_hema['num_hcpcs'].hist(bins=30)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 48,
   "metadata": {
    "collapsed": false,
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>0</th>\n",
       "      <th>1</th>\n",
       "      <th>2</th>\n",
       "      <th>3</th>\n",
       "      <th>4</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>npi</th>\n",
       "      <td>1093893331</td>\n",
       "      <td>1336137876</td>\n",
       "      <td>1164609749</td>\n",
       "      <td>1235156811</td>\n",
       "      <td>1548285372</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>last_name</th>\n",
       "      <td>ZAMAN</td>\n",
       "      <td>MAVROMATIS</td>\n",
       "      <td>HANSON</td>\n",
       "      <td>MERKEL</td>\n",
       "      <td>GRINBLATT</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>first_name</th>\n",
       "      <td>QAMAR</td>\n",
       "      <td>BLANCHE</td>\n",
       "      <td>BRITT</td>\n",
       "      <td>DOUGLAS</td>\n",
       "      <td>DAVID</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>credentials</th>\n",
       "      <td>MD</td>\n",
       "      <td>MD</td>\n",
       "      <td>DO</td>\n",
       "      <td>MD</td>\n",
       "      <td>MD</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>gender</th>\n",
       "      <td>M</td>\n",
       "      <td>F</td>\n",
       "      <td>F</td>\n",
       "      <td>M</td>\n",
       "      <td>M</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>city</th>\n",
       "      <td>CUMBERLAND</td>\n",
       "      <td>CUMBERLAND</td>\n",
       "      <td>EVANSTON</td>\n",
       "      <td>EVANSTON</td>\n",
       "      <td>EVANSTON</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>state</th>\n",
       "      <td>MD</td>\n",
       "      <td>MD</td>\n",
       "      <td>IL</td>\n",
       "      <td>IL</td>\n",
       "      <td>IL</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>provider_type</th>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_hcpcs</th>\n",
       "      <td>21</td>\n",
       "      <td>21</td>\n",
       "      <td>20</td>\n",
       "      <td>10</td>\n",
       "      <td>21</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_services</th>\n",
       "      <td>15174</td>\n",
       "      <td>2393</td>\n",
       "      <td>829</td>\n",
       "      <td>1672</td>\n",
       "      <td>1680</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_unique_bene</th>\n",
       "      <td>1245</td>\n",
       "      <td>488</td>\n",
       "      <td>271</td>\n",
       "      <td>743</td>\n",
       "      <td>472</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_submitted_charges</th>\n",
       "      <td>973655</td>\n",
       "      <td>242685</td>\n",
       "      <td>126562</td>\n",
       "      <td>142056</td>\n",
       "      <td>240378</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_medicare_allowed_amt</th>\n",
       "      <td>697141</td>\n",
       "      <td>166199</td>\n",
       "      <td>75396.6</td>\n",
       "      <td>105468</td>\n",
       "      <td>147131</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_medicare_payment_amt</th>\n",
       "      <td>528634</td>\n",
       "      <td>123542</td>\n",
       "      <td>57782.6</td>\n",
       "      <td>74640.8</td>\n",
       "      <td>109632</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>drug_suppress_indicator</th>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_hcpcs_associated_drug_srvc</th>\n",
       "      <td>4</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_drug_srvc</th>\n",
       "      <td>9110</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_unique_bene_with_drug_srvc</th>\n",
       "      <td>28</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_drug_submitted_charges</th>\n",
       "      <td>130250</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_drug_medicare_allowed_amt</th>\n",
       "      <td>81854.9</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_drug_medicare_payment_amt</th>\n",
       "      <td>64455.5</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>medical_suppress_indicator</th>\n",
       "      <td>0</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_hcpcs_associated_med_srvc</th>\n",
       "      <td>17</td>\n",
       "      <td>NaN</td>\n",
       "      <td>20</td>\n",
       "      <td>10</td>\n",
       "      <td>21</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_med_srvc</th>\n",
       "      <td>6064</td>\n",
       "      <td>NaN</td>\n",
       "      <td>829</td>\n",
       "      <td>1672</td>\n",
       "      <td>1680</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_unique_bene_with_med_srvc</th>\n",
       "      <td>1245</td>\n",
       "      <td>NaN</td>\n",
       "      <td>271</td>\n",
       "      <td>743</td>\n",
       "      <td>472</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_med_submitted_charges</th>\n",
       "      <td>843405</td>\n",
       "      <td>NaN</td>\n",
       "      <td>126562</td>\n",
       "      <td>142056</td>\n",
       "      <td>240378</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_med_medicare_allowed_amt</th>\n",
       "      <td>615286</td>\n",
       "      <td>NaN</td>\n",
       "      <td>75396.6</td>\n",
       "      <td>105468</td>\n",
       "      <td>147131</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_med_medicare_payment_amt</th>\n",
       "      <td>464179</td>\n",
       "      <td>NaN</td>\n",
       "      <td>57782.6</td>\n",
       "      <td>74640.8</td>\n",
       "      <td>109632</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>avg_age_bene</th>\n",
       "      <td>75</td>\n",
       "      <td>73</td>\n",
       "      <td>77</td>\n",
       "      <td>74</td>\n",
       "      <td>77</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_bene_le65</th>\n",
       "      <td>142</td>\n",
       "      <td>61</td>\n",
       "      <td>15</td>\n",
       "      <td>29</td>\n",
       "      <td>28</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_chronic_obstructive_pulmonary</th>\n",
       "      <td>29</td>\n",
       "      <td>21</td>\n",
       "      <td>19</td>\n",
       "      <td>6</td>\n",
       "      <td>13</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_depression</th>\n",
       "      <td>29</td>\n",
       "      <td>22</td>\n",
       "      <td>26</td>\n",
       "      <td>15</td>\n",
       "      <td>21</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_diabetes</th>\n",
       "      <td>42</td>\n",
       "      <td>38</td>\n",
       "      <td>29</td>\n",
       "      <td>18</td>\n",
       "      <td>24</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_heart_failure</th>\n",
       "      <td>31</td>\n",
       "      <td>22</td>\n",
       "      <td>34</td>\n",
       "      <td>9</td>\n",
       "      <td>25</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_hyperlipidemia</th>\n",
       "      <td>66</td>\n",
       "      <td>62</td>\n",
       "      <td>59</td>\n",
       "      <td>46</td>\n",
       "      <td>51</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_hypertension</th>\n",
       "      <td>75</td>\n",
       "      <td>75</td>\n",
       "      <td>75</td>\n",
       "      <td>45</td>\n",
       "      <td>65</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_ischemic_heart</th>\n",
       "      <td>57</td>\n",
       "      <td>43</td>\n",
       "      <td>50</td>\n",
       "      <td>14</td>\n",
       "      <td>36</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_osteoporosis</th>\n",
       "      <td>13</td>\n",
       "      <td>8</td>\n",
       "      <td>14</td>\n",
       "      <td>17</td>\n",
       "      <td>12</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_rheumatoid_arthritis_osteoarthirtis</th>\n",
       "      <td>50</td>\n",
       "      <td>45</td>\n",
       "      <td>41</td>\n",
       "      <td>37</td>\n",
       "      <td>39</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_schizophrenia_psychotic</th>\n",
       "      <td>8</td>\n",
       "      <td>4</td>\n",
       "      <td>6</td>\n",
       "      <td>2</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>pcnt_stroke</th>\n",
       "      <td>15</td>\n",
       "      <td>7</td>\n",
       "      <td>9</td>\n",
       "      <td>3</td>\n",
       "      <td>4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>avg_hcc_risk_score</th>\n",
       "      <td>1.9757</td>\n",
       "      <td>1.9816</td>\n",
       "      <td>2.0048</td>\n",
       "      <td>1.0559</td>\n",
       "      <td>1.8789</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>zip_1</th>\n",
       "      <td>21502</td>\n",
       "      <td>21502</td>\n",
       "      <td>60201</td>\n",
       "      <td>60201</td>\n",
       "      <td>60201</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>drug_srvc_bin</th>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_asthma</th>\n",
       "      <td>136.95</td>\n",
       "      <td>43.92</td>\n",
       "      <td>21.68</td>\n",
       "      <td>37.15</td>\n",
       "      <td>37.76</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_alzheimers_dementia</th>\n",
       "      <td>224.1</td>\n",
       "      <td>34.16</td>\n",
       "      <td>35.23</td>\n",
       "      <td>22.29</td>\n",
       "      <td>42.48</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_artrial_fibrillation</th>\n",
       "      <td>211.65</td>\n",
       "      <td>53.68</td>\n",
       "      <td>59.62</td>\n",
       "      <td>66.87</td>\n",
       "      <td>80.24</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_cancer</th>\n",
       "      <td>435.75</td>\n",
       "      <td>214.72</td>\n",
       "      <td>84.01</td>\n",
       "      <td>557.25</td>\n",
       "      <td>80.24</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_chronic_obstructive_pulmonary</th>\n",
       "      <td>361.05</td>\n",
       "      <td>102.48</td>\n",
       "      <td>51.49</td>\n",
       "      <td>44.58</td>\n",
       "      <td>61.36</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_depression</th>\n",
       "      <td>361.05</td>\n",
       "      <td>107.36</td>\n",
       "      <td>70.46</td>\n",
       "      <td>111.45</td>\n",
       "      <td>99.12</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_diabetes</th>\n",
       "      <td>522.9</td>\n",
       "      <td>185.44</td>\n",
       "      <td>78.59</td>\n",
       "      <td>133.74</td>\n",
       "      <td>113.28</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_heart_failure</th>\n",
       "      <td>385.95</td>\n",
       "      <td>107.36</td>\n",
       "      <td>92.14</td>\n",
       "      <td>66.87</td>\n",
       "      <td>118</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_hypertension</th>\n",
       "      <td>933.75</td>\n",
       "      <td>366</td>\n",
       "      <td>203.25</td>\n",
       "      <td>334.35</td>\n",
       "      <td>306.8</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_ischemic_heart</th>\n",
       "      <td>709.65</td>\n",
       "      <td>209.84</td>\n",
       "      <td>135.5</td>\n",
       "      <td>104.02</td>\n",
       "      <td>169.92</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_osteoporosis</th>\n",
       "      <td>161.85</td>\n",
       "      <td>39.04</td>\n",
       "      <td>37.94</td>\n",
       "      <td>126.31</td>\n",
       "      <td>56.64</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_rheumatoid_arthritis_osteoarthirtis</th>\n",
       "      <td>622.5</td>\n",
       "      <td>219.6</td>\n",
       "      <td>111.11</td>\n",
       "      <td>274.91</td>\n",
       "      <td>184.08</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_schizophrenia_psychotic</th>\n",
       "      <td>99.6</td>\n",
       "      <td>19.52</td>\n",
       "      <td>16.26</td>\n",
       "      <td>14.86</td>\n",
       "      <td>18.88</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_stroke</th>\n",
       "      <td>186.75</td>\n",
       "      <td>34.16</td>\n",
       "      <td>24.39</td>\n",
       "      <td>22.29</td>\n",
       "      <td>18.88</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>county</th>\n",
       "      <td>Allegany</td>\n",
       "      <td>Allegany</td>\n",
       "      <td>Cook</td>\n",
       "      <td>Cook</td>\n",
       "      <td>Cook</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>county_fips</th>\n",
       "      <td>24001</td>\n",
       "      <td>24001</td>\n",
       "      <td>17031</td>\n",
       "      <td>17031</td>\n",
       "      <td>17031</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>76 rows × 5 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                            0  \\\n",
       "npi                                                1093893331   \n",
       "last_name                                               ZAMAN   \n",
       "first_name                                              QAMAR   \n",
       "credentials                                                MD   \n",
       "gender                                                      M   \n",
       "city                                               CUMBERLAND   \n",
       "state                                                      MD   \n",
       "provider_type                             Hematology/Oncology   \n",
       "num_hcpcs                                                  21   \n",
       "num_services                                            15174   \n",
       "num_unique_bene                                          1245   \n",
       "total_submitted_charges                                973655   \n",
       "total_medicare_allowed_amt                             697141   \n",
       "total_medicare_payment_amt                             528634   \n",
       "drug_suppress_indicator                                     0   \n",
       "num_hcpcs_associated_drug_srvc                              4   \n",
       "num_drug_srvc                                            9110   \n",
       "num_unique_bene_with_drug_srvc                             28   \n",
       "total_drug_submitted_charges                           130250   \n",
       "total_drug_medicare_allowed_amt                       81854.9   \n",
       "total_drug_medicare_payment_amt                       64455.5   \n",
       "medical_suppress_indicator                                  0   \n",
       "num_hcpcs_associated_med_srvc                              17   \n",
       "num_med_srvc                                             6064   \n",
       "num_unique_bene_with_med_srvc                            1245   \n",
       "total_med_submitted_charges                            843405   \n",
       "total_med_medicare_allowed_amt                         615286   \n",
       "total_med_medicare_payment_amt                         464179   \n",
       "avg_age_bene                                               75   \n",
       "num_bene_le65                                             142   \n",
       "...                                                       ...   \n",
       "pcnt_chronic_obstructive_pulmonary                         29   \n",
       "pcnt_depression                                            29   \n",
       "pcnt_diabetes                                              42   \n",
       "pcnt_heart_failure                                         31   \n",
       "pcnt_hyperlipidemia                                        66   \n",
       "pcnt_hypertension                                          75   \n",
       "pcnt_ischemic_heart                                        57   \n",
       "pcnt_osteoporosis                                          13   \n",
       "pcnt_rheumatoid_arthritis_osteoarthirtis                   50   \n",
       "pcnt_schizophrenia_psychotic                                8   \n",
       "pcnt_stroke                                                15   \n",
       "avg_hcc_risk_score                                     1.9757   \n",
       "zip_1                                                   21502   \n",
       "drug_srvc_bin                                               1   \n",
       "num_asthma                                             136.95   \n",
       "num_alzheimers_dementia                                 224.1   \n",
       "num_artrial_fibrillation                               211.65   \n",
       "num_cancer                                             435.75   \n",
       "num_chronic_obstructive_pulmonary                      361.05   \n",
       "num_depression                                         361.05   \n",
       "num_diabetes                                            522.9   \n",
       "num_heart_failure                                      385.95   \n",
       "num_hypertension                                       933.75   \n",
       "num_ischemic_heart                                     709.65   \n",
       "num_osteoporosis                                       161.85   \n",
       "num_rheumatoid_arthritis_osteoarthirtis                 622.5   \n",
       "num_schizophrenia_psychotic                              99.6   \n",
       "num_stroke                                             186.75   \n",
       "county                                               Allegany   \n",
       "county_fips                                             24001   \n",
       "\n",
       "                                                            1  \\\n",
       "npi                                                1336137876   \n",
       "last_name                                          MAVROMATIS   \n",
       "first_name                                            BLANCHE   \n",
       "credentials                                                MD   \n",
       "gender                                                      F   \n",
       "city                                               CUMBERLAND   \n",
       "state                                                      MD   \n",
       "provider_type                             Hematology/Oncology   \n",
       "num_hcpcs                                                  21   \n",
       "num_services                                             2393   \n",
       "num_unique_bene                                           488   \n",
       "total_submitted_charges                                242685   \n",
       "total_medicare_allowed_amt                             166199   \n",
       "total_medicare_payment_amt                             123542   \n",
       "drug_suppress_indicator                                     1   \n",
       "num_hcpcs_associated_drug_srvc                            NaN   \n",
       "num_drug_srvc                                             NaN   \n",
       "num_unique_bene_with_drug_srvc                            NaN   \n",
       "total_drug_submitted_charges                              NaN   \n",
       "total_drug_medicare_allowed_amt                           NaN   \n",
       "total_drug_medicare_payment_amt                           NaN   \n",
       "medical_suppress_indicator                                  1   \n",
       "num_hcpcs_associated_med_srvc                             NaN   \n",
       "num_med_srvc                                              NaN   \n",
       "num_unique_bene_with_med_srvc                             NaN   \n",
       "total_med_submitted_charges                               NaN   \n",
       "total_med_medicare_allowed_amt                            NaN   \n",
       "total_med_medicare_payment_amt                            NaN   \n",
       "avg_age_bene                                               73   \n",
       "num_bene_le65                                              61   \n",
       "...                                                       ...   \n",
       "pcnt_chronic_obstructive_pulmonary                         21   \n",
       "pcnt_depression                                            22   \n",
       "pcnt_diabetes                                              38   \n",
       "pcnt_heart_failure                                         22   \n",
       "pcnt_hyperlipidemia                                        62   \n",
       "pcnt_hypertension                                          75   \n",
       "pcnt_ischemic_heart                                        43   \n",
       "pcnt_osteoporosis                                           8   \n",
       "pcnt_rheumatoid_arthritis_osteoarthirtis                   45   \n",
       "pcnt_schizophrenia_psychotic                                4   \n",
       "pcnt_stroke                                                 7   \n",
       "avg_hcc_risk_score                                     1.9816   \n",
       "zip_1                                                   21502   \n",
       "drug_srvc_bin                                               1   \n",
       "num_asthma                                              43.92   \n",
       "num_alzheimers_dementia                                 34.16   \n",
       "num_artrial_fibrillation                                53.68   \n",
       "num_cancer                                             214.72   \n",
       "num_chronic_obstructive_pulmonary                      102.48   \n",
       "num_depression                                         107.36   \n",
       "num_diabetes                                           185.44   \n",
       "num_heart_failure                                      107.36   \n",
       "num_hypertension                                          366   \n",
       "num_ischemic_heart                                     209.84   \n",
       "num_osteoporosis                                        39.04   \n",
       "num_rheumatoid_arthritis_osteoarthirtis                 219.6   \n",
       "num_schizophrenia_psychotic                             19.52   \n",
       "num_stroke                                              34.16   \n",
       "county                                               Allegany   \n",
       "county_fips                                             24001   \n",
       "\n",
       "                                                            2  \\\n",
       "npi                                                1164609749   \n",
       "last_name                                              HANSON   \n",
       "first_name                                              BRITT   \n",
       "credentials                                                DO   \n",
       "gender                                                      F   \n",
       "city                                                 EVANSTON   \n",
       "state                                                      IL   \n",
       "provider_type                             Hematology/Oncology   \n",
       "num_hcpcs                                                  20   \n",
       "num_services                                              829   \n",
       "num_unique_bene                                           271   \n",
       "total_submitted_charges                                126562   \n",
       "total_medicare_allowed_amt                            75396.6   \n",
       "total_medicare_payment_amt                            57782.6   \n",
       "drug_suppress_indicator                                     0   \n",
       "num_hcpcs_associated_drug_srvc                              0   \n",
       "num_drug_srvc                                               0   \n",
       "num_unique_bene_with_drug_srvc                              0   \n",
       "total_drug_submitted_charges                                0   \n",
       "total_drug_medicare_allowed_amt                             0   \n",
       "total_drug_medicare_payment_amt                             0   \n",
       "medical_suppress_indicator                                  0   \n",
       "num_hcpcs_associated_med_srvc                              20   \n",
       "num_med_srvc                                              829   \n",
       "num_unique_bene_with_med_srvc                             271   \n",
       "total_med_submitted_charges                            126562   \n",
       "total_med_medicare_allowed_amt                        75396.6   \n",
       "total_med_medicare_payment_amt                        57782.6   \n",
       "avg_age_bene                                               77   \n",
       "num_bene_le65                                              15   \n",
       "...                                                       ...   \n",
       "pcnt_chronic_obstructive_pulmonary                         19   \n",
       "pcnt_depression                                            26   \n",
       "pcnt_diabetes                                              29   \n",
       "pcnt_heart_failure                                         34   \n",
       "pcnt_hyperlipidemia                                        59   \n",
       "pcnt_hypertension                                          75   \n",
       "pcnt_ischemic_heart                                        50   \n",
       "pcnt_osteoporosis                                          14   \n",
       "pcnt_rheumatoid_arthritis_osteoarthirtis                   41   \n",
       "pcnt_schizophrenia_psychotic                                6   \n",
       "pcnt_stroke                                                 9   \n",
       "avg_hcc_risk_score                                     2.0048   \n",
       "zip_1                                                   60201   \n",
       "drug_srvc_bin                                               0   \n",
       "num_asthma                                              21.68   \n",
       "num_alzheimers_dementia                                 35.23   \n",
       "num_artrial_fibrillation                                59.62   \n",
       "num_cancer                                              84.01   \n",
       "num_chronic_obstructive_pulmonary                       51.49   \n",
       "num_depression                                          70.46   \n",
       "num_diabetes                                            78.59   \n",
       "num_heart_failure                                       92.14   \n",
       "num_hypertension                                       203.25   \n",
       "num_ischemic_heart                                      135.5   \n",
       "num_osteoporosis                                        37.94   \n",
       "num_rheumatoid_arthritis_osteoarthirtis                111.11   \n",
       "num_schizophrenia_psychotic                             16.26   \n",
       "num_stroke                                              24.39   \n",
       "county                                                   Cook   \n",
       "county_fips                                             17031   \n",
       "\n",
       "                                                            3  \\\n",
       "npi                                                1235156811   \n",
       "last_name                                              MERKEL   \n",
       "first_name                                            DOUGLAS   \n",
       "credentials                                                MD   \n",
       "gender                                                      M   \n",
       "city                                                 EVANSTON   \n",
       "state                                                      IL   \n",
       "provider_type                             Hematology/Oncology   \n",
       "num_hcpcs                                                  10   \n",
       "num_services                                             1672   \n",
       "num_unique_bene                                           743   \n",
       "total_submitted_charges                                142056   \n",
       "total_medicare_allowed_amt                             105468   \n",
       "total_medicare_payment_amt                            74640.8   \n",
       "drug_suppress_indicator                                     0   \n",
       "num_hcpcs_associated_drug_srvc                              0   \n",
       "num_drug_srvc                                               0   \n",
       "num_unique_bene_with_drug_srvc                              0   \n",
       "total_drug_submitted_charges                                0   \n",
       "total_drug_medicare_allowed_amt                             0   \n",
       "total_drug_medicare_payment_amt                             0   \n",
       "medical_suppress_indicator                                  0   \n",
       "num_hcpcs_associated_med_srvc                              10   \n",
       "num_med_srvc                                             1672   \n",
       "num_unique_bene_with_med_srvc                             743   \n",
       "total_med_submitted_charges                            142056   \n",
       "total_med_medicare_allowed_amt                         105468   \n",
       "total_med_medicare_payment_amt                        74640.8   \n",
       "avg_age_bene                                               74   \n",
       "num_bene_le65                                              29   \n",
       "...                                                       ...   \n",
       "pcnt_chronic_obstructive_pulmonary                          6   \n",
       "pcnt_depression                                            15   \n",
       "pcnt_diabetes                                              18   \n",
       "pcnt_heart_failure                                          9   \n",
       "pcnt_hyperlipidemia                                        46   \n",
       "pcnt_hypertension                                          45   \n",
       "pcnt_ischemic_heart                                        14   \n",
       "pcnt_osteoporosis                                          17   \n",
       "pcnt_rheumatoid_arthritis_osteoarthirtis                   37   \n",
       "pcnt_schizophrenia_psychotic                                2   \n",
       "pcnt_stroke                                                 3   \n",
       "avg_hcc_risk_score                                     1.0559   \n",
       "zip_1                                                   60201   \n",
       "drug_srvc_bin                                               0   \n",
       "num_asthma                                              37.15   \n",
       "num_alzheimers_dementia                                 22.29   \n",
       "num_artrial_fibrillation                                66.87   \n",
       "num_cancer                                             557.25   \n",
       "num_chronic_obstructive_pulmonary                       44.58   \n",
       "num_depression                                         111.45   \n",
       "num_diabetes                                           133.74   \n",
       "num_heart_failure                                       66.87   \n",
       "num_hypertension                                       334.35   \n",
       "num_ischemic_heart                                     104.02   \n",
       "num_osteoporosis                                       126.31   \n",
       "num_rheumatoid_arthritis_osteoarthirtis                274.91   \n",
       "num_schizophrenia_psychotic                             14.86   \n",
       "num_stroke                                              22.29   \n",
       "county                                                   Cook   \n",
       "county_fips                                             17031   \n",
       "\n",
       "                                                            4  \n",
       "npi                                                1548285372  \n",
       "last_name                                           GRINBLATT  \n",
       "first_name                                              DAVID  \n",
       "credentials                                                MD  \n",
       "gender                                                      M  \n",
       "city                                                 EVANSTON  \n",
       "state                                                      IL  \n",
       "provider_type                             Hematology/Oncology  \n",
       "num_hcpcs                                                  21  \n",
       "num_services                                             1680  \n",
       "num_unique_bene                                           472  \n",
       "total_submitted_charges                                240378  \n",
       "total_medicare_allowed_amt                             147131  \n",
       "total_medicare_payment_amt                             109632  \n",
       "drug_suppress_indicator                                     0  \n",
       "num_hcpcs_associated_drug_srvc                              0  \n",
       "num_drug_srvc                                               0  \n",
       "num_unique_bene_with_drug_srvc                              0  \n",
       "total_drug_submitted_charges                                0  \n",
       "total_drug_medicare_allowed_amt                             0  \n",
       "total_drug_medicare_payment_amt                             0  \n",
       "medical_suppress_indicator                                  0  \n",
       "num_hcpcs_associated_med_srvc                              21  \n",
       "num_med_srvc                                             1680  \n",
       "num_unique_bene_with_med_srvc                             472  \n",
       "total_med_submitted_charges                            240378  \n",
       "total_med_medicare_allowed_amt                         147131  \n",
       "total_med_medicare_payment_amt                         109632  \n",
       "avg_age_bene                                               77  \n",
       "num_bene_le65                                              28  \n",
       "...                                                       ...  \n",
       "pcnt_chronic_obstructive_pulmonary                         13  \n",
       "pcnt_depression                                            21  \n",
       "pcnt_diabetes                                              24  \n",
       "pcnt_heart_failure                                         25  \n",
       "pcnt_hyperlipidemia                                        51  \n",
       "pcnt_hypertension                                          65  \n",
       "pcnt_ischemic_heart                                        36  \n",
       "pcnt_osteoporosis                                          12  \n",
       "pcnt_rheumatoid_arthritis_osteoarthirtis                   39  \n",
       "pcnt_schizophrenia_psychotic                                4  \n",
       "pcnt_stroke                                                 4  \n",
       "avg_hcc_risk_score                                     1.8789  \n",
       "zip_1                                                   60201  \n",
       "drug_srvc_bin                                               0  \n",
       "num_asthma                                              37.76  \n",
       "num_alzheimers_dementia                                 42.48  \n",
       "num_artrial_fibrillation                                80.24  \n",
       "num_cancer                                              80.24  \n",
       "num_chronic_obstructive_pulmonary                       61.36  \n",
       "num_depression                                          99.12  \n",
       "num_diabetes                                           113.28  \n",
       "num_heart_failure                                         118  \n",
       "num_hypertension                                        306.8  \n",
       "num_ischemic_heart                                     169.92  \n",
       "num_osteoporosis                                        56.64  \n",
       "num_rheumatoid_arthritis_osteoarthirtis                184.08  \n",
       "num_schizophrenia_psychotic                             18.88  \n",
       "num_stroke                                              18.88  \n",
       "county                                                   Cook  \n",
       "county_fips                                             17031  \n",
       "\n",
       "[76 rows x 5 columns]"
      ]
     },
     "execution_count": 48,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_hema.head().T"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 59,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.axes._subplots.AxesSubplot at 0x7f8573811910>"
      ]
     },
     "execution_count": 59,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAYoAAAEACAYAAACtVTGuAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz\nAAALEgAACxIB0t1+/AAAF3lJREFUeJzt3X+MXXd55/H3Y7txNrawHerMLDb1ZBUKDlJ3SIVhN5U6\n2rIhVVcEbdU0BdQEVG23KYWAtBu7/8xktVIIEqy72g39AWVMFpq47LZJKggmSmalZpukLRnFxSZ1\ni2yCiweXkOwapCjBz/5xz53v9fjOnRnPj3Pu3PdLGuWcc8+993s+uZ5n7vc5597ITCRJms+Gugcg\nSWo2C4UkqScLhSSpJwuFJKknC4UkqScLhSSppwULRURsjoinIuKZiDgaEePV9h0RcSQinouIr0TE\nto77HIiIExFxPCJuWM0DkCStrljMdRQRcUVm/jAiNgJPAB8CfhH4XmZ+PCLuBHZk5v6IuBb4PPBW\nYDfwKPCG9IINSepLi5p6yswfVoubgU1AAjcBh6rth4B3V8vvAu7PzFcz8yRwAti3UgOWJK2tRRWK\niNgQEc8AZ4CvZuZfAkOZOQOQmWeAq6rddwHPd9z9dLVNktSHFvuO4nxmvoXWVNK+iHgzrXcVF+y2\n0oOTJNVv01J2zsz/GxFTwI3ATEQMZeZMRAwD3612Ow28vuNuu6ttF4gIC4skXYLMjLV8vsWc9fTj\n7TOaIuKfAP8aOA48BNxW7XYr8GC1/BBwS0RcFhFXA9cAT3d77Mz0J5Px8fHax9CUH7MwC7Po/VOH\nxbyj+KfAoYjYQKuwPJCZX4qIJ4HDEfEB4BRwM0BmHouIw8Ax4BXg9qzr6PrEyZMn6x5CY5hFYRaF\nWdRrwUKRmUeB67psfwF4xzz3uRu4e9mjkyTVrtYrsx9++Et1Pn1j3HbbbXUPoTHMojCLwizqtagL\n7lbliSPyfe/7d9x33+/V8vyS1I8igmxaM1urb2pqqu4hNIZZFGZRmEW9LBSSpJ6cepKkPuLUkySp\ncSwUDeD8a2EWhVkUZlEvC4UkqSd7FJLUR+xRSJIax0LRAM6/FmZRmEVhFvWyUEiSerJHIUl9xB6F\nJKlxLBQN4PxrYRaFWRRmUS8LhSSpJ3sUktRH7FFIkhrHQtEAzr8WZlGYRWEW9bJQSJJ6skchSX3E\nHoUkqXEsFA3g/GthFoVZFGZRLwuFJKknexSS1EfsUUiSGsdC0QDOvxZmUZhFYRb1slBIknpasFBE\nxO6IeCwivh4RRyPit6rt4xHx7Yj4WvVzY8d9DkTEiYg4HhE3rOYBrAdjY2N1D6ExzKIwi8Is6rVp\nEfu8Cnw0M6cjYivw1xHx1eq2T2bmJzt3joi9wM3AXmA38GhEvCHr6ppLkpZlwXcUmXkmM6er5XPA\ncWBXdXO3zvtNwP2Z+WpmngROAPtWZrjrk/OvhVkUZlGYRb2W1KOIiBFgFHiq2vTBiJiOiE9HxLZq\n2y7g+Y67naYUFklSn1l0oaimnb4IfLh6Z3Ev8M8ycxQ4A3xidYa4/jn/WphFYRaFWdRrMT0KImIT\nrSJxX2Y+CJCZZzt2+QPg4Wr5NPD6jtt2V9su8sQTjzMxMQHA9u3bGR0dnX1BtN9quu66664P8vrU\n1BSTk5MAjIyMUIdFXZkdEZ8D/jEzP9qxbTgzz1TLHwHempnviYhrgc8Db6M15fRV4KJmtldmF1NT\nU7MvkEFnFoVZFGZR1HFl9oLvKCLieuC9wNGIeAZI4LeB90TEKHAeOAn8OkBmHouIw8Ax4BXgds94\nkqT+5Wc9SVIf8bOeJEmNY6FogHbjSmbRySwKs6iXhUKS1JM9CknqI/YoJEmNY6FoAOdfC7MozKIw\ni3pZKCRJPdmjkKQ+Yo9CktQ4FooGcP61MIvCLAqzqJeFQpLUkz0KSeoj9igkSY1joWgA518LsyjM\nojCLelkoJEk92aOQpD5ij0KS1DgWigZw/rUwi8IsCrOol4VCktSTPQpJ6iP2KCRJjWOhaADnXwuz\nKMyiMIt6WSgkST3Zo5CkPmKPQpLUOBaKBnD+tTCLwiwKs6iXhUKS1JM9CknqI/YoJEmNs2ChiIjd\nEfFYRHw9Io5GxIeq7Tsi4khEPBcRX4mIbR33ORARJyLieETcsJoHsB44/1qYRWEWhVnUazHvKF4F\nPpqZbwb+BfCbEfEmYD/waGa+EXgMOAAQEdcCNwN7gZ8H7o2INX2bJElaOQsWisw8k5nT1fI54Diw\nG7gJOFTtdgh4d7X8LuD+zHw1M08CJ4B9KzzudWVsbKzuITSGWRRmUZhFvZbUo4iIEWAUeBIYyswZ\naBUT4Kpqt13A8x13O11tkyT1oU2L3TEitgJfBD6cmeciYu7pUks+feqJJx5nYmICgO3btzM6Ojr7\nl0N7TnIQ1jvnX5swnjrX29uaMp4616enp7njjjsaM5461w8ePDjQvx8mJycBGBkZoQ6LOj02IjYB\nfwZ8OTN/p9p2HBjLzJmIGAYez8y9EbEfyMy8p9rvEWA8M5+a85ieHluZmpqafYEMOrMozKIwi6LJ\np8f+IXCsXSQqDwG3Vcu3Ag92bL8lIi6LiKuBa4CnV2Cs65b/AAqzKMyiMIt6LTj1FBHXA+8FjkbE\nM7SmmH4buAc4HBEfAE7ROtOJzDwWEYeBY8ArwO1Z11V9kqRlW8xZT09k5sbMHM3Mt2TmdZn5SGa+\nkJnvyMw3ZuYNmflix33uzsxrMnNvZh5Z3UPof53z84POLAqzKMyiXl6ZLUnqyc96kqQ+0uRmtiRp\nQFkoGsD518IsCrMozKJeFgpJUk/2KCSpj9ijkCQ1joWiAZx/LcyiMIvCLOploZAk9WSPQpL6iD0K\nSVLjWCgawPnXwiwKsyjMol4WCklST/YoJKmP2KOQJDWOhaIBnH8tzKIwi8Is6mWhkCT1ZI9CkvqI\nPQpJUuNYKBrA+dfCLAqzKMyiXhYKSVJP9igkqY/Yo5AkNY6FogGcfy3MojCLwizqZaGQJPVkj0KS\n+og9CklS41goGsD518IsCrMozKJeCxaKiPhMRMxExLMd28Yj4tsR8bXq58aO2w5ExImIOB4RN6zW\nwCVJa2PBHkVE/AxwDvhcZv5UtW0c+H+Z+ck5++4FvgC8FdgNPAq8Ibs8iT0KSVq6RvYoMvPPge93\nuanbQG8C7s/MVzPzJHAC2LesEUqSarWcHsUHI2I6Ij4dEduqbbuA5zv2OV1tUw/OvxZmUZhFYRb1\n2nSJ97sX+E+ZmRHxn4FPAL+21Ad54onHmZiYAGD79u2Mjo4yNjYGlBeG64O13taU8dS5Pj093ajx\n1Lk+PT3dqPGs5frU1BSTk5MAjIyMUIdFXUcREXuAh9s9ivlui4j9QGbmPdVtjwDjmflUl/vZo5Ck\nJWpkj6ISdPQkImK447Z/C/xNtfwQcEtEXBYRVwPXAE+vxEAlSfVYzOmxXwD+D/CTEfGtiHg/8PGI\neDYipoGfBT4CkJnHgMPAMeBLwO3dznjSheZOuwwysyjMojCLei3Yo8jM93TZ/Nke+98N3L2cQUmS\nmsPPepKkPtLkHoUkaUBZKBrA+dfCLAqzKMyiXhYKSVJP9igkqY/Yo5AkNY6FogGcfy3MojCLwizq\nZaGQJPVkj0KS+og9CklS41goGsD518IsCrMozKJeFgpJUk+19iguv3wH27a9hjNnTtYyBknqN3X0\nKGotFO1lP4lckhbHZvaAcv61MIvCLAqzqJeFQpLUk1NPktRHnHqSJDWOhaIBnH8tzKIwi8Is6mWh\nkCT11Igexfj4OBMTE7WMQ5L6ycBeRwE2tCVpMWxmDyjnXwuzKMyiMIt6WSgkST059SRJfcSpJ0lS\n41goGsD518IsCrMozKJeFgpJUk8L9igi4jPAvwFmMvOnqm07gAeAPcBJ4ObMfKm67QDwAeBV4MOZ\neWSex7VHIUlL1NQexWeBd87Zth94NDPfCDwGHACIiGuBm4G9wM8D90bEmh6QJGllLVgoMvPPge/P\n2XwTcKhaPgS8u1p+F3B/Zr6amSeBE8C+lRnq+uX8a2EWhVkUZlGvS+1RXJWZMwCZeQa4qtq+C3i+\nY7/T1TZJUp/atEKPs+wGw8GDBxkdHWVsbAwof0EMwvrY2FijxuN6c9bbmjKeutbb25oynrVcn5qa\nYnJyEoCRkRHqsKgL7iJiD/BwRzP7ODCWmTMRMQw8npl7I2I/kJl5T7XfI8B4Zj7V5TFtZkvSEjW1\nmQ0Q1U/bQ8Bt1fKtwIMd22+JiMsi4mrgGuDp3g+9eZFDWL/m/vU4yMyiMIvCLOq14NRTRHwBGANe\nGxHfAsaBjwF/HBEfAE7ROtOJzDwWEYeBY8ArwO254FuFl5cxfEnSavOzniSpjzR56mnNDQ+PMDw8\nUvcwJGngNbZQzMycYmbmVN3DWBPOvxZmUZhFYRb1amyhkCQ1Q2N7FO1P/hga2gPAmTMn12ZgktRg\nA/+d2e2exJkzJ5n7EVE2uyXJZvZA9SU6Of9amEVhFoVZ1KtRhaJlMxs3brlom2dASVI9GjX1tNAn\nkjv9JGnQDfzUkySpeSwUDeD8a2EWhVkUZlEvC4UkqafG9CiGhvYseMbT+Pg4v/u7k4DXVUgaTAN8\nHcVmlvYpspsZGhq2WEgaOAPczF7qR42/vK6ut3D+tTCLwiwKs6hXQwqFJKmpGjL1dGm8rkLSoBng\nqafF8mtTJWmt9VmhuLCXsV6+3Mj518IsCrMozKJeC35ndpOtp4a2JDVVw3sUiztt1l6FpEFhj+Ii\nSz1tVpK00hpeKDqt30a286+FWRRmUZhFvfqoUMz/7mK9NLUlqYka3qNYjNLH8Pu1Ja13A/xZTyur\nfUyd38EtSeuBzewV1i/fwe38a2EWhVkUZlGvdV0oJEnLt66nntrfwe11FpLWizqmnpZ1ZXZEnARe\nAs4Dr2TmvojYATwA7AFOAjdn5kvLHOeyDA+PcPbsWXbu3Dm7zb6FJC3OcqeezgNjmfmWzNxXbdsP\nPJqZbwQeAw4s8zmWbWbmFOfP/3C2Z9G0voXzr4VZFGZRmEW9llsoostj3AQcqpYPAe9e5nPMY/4L\n8CYmJlbnKSVpAC2rRxER3wReBH4E/F5mfjoivp+ZOzr2eSEzr+xy31VqHLSuq8jM2R5FN/YtJPWj\nvutRANdn5nciYidwJCKeA+b+Bl7j38hzr+Be6vdxS5I6LatQZOZ3qv+ejYg/BfYBMxExlJkzETEM\nfHcFxrlkV145XC11LxLtOc+xsbHa1zvnX5swnjrX29uaMp4616enp7njjjsaM5461w8ePMjo6Ghj\nxrOW61NTU0xOTgIwMjJCHS556ikirgA2ZOa5iNgCHAHuAn4OeCEz74mIO4Edmbm/y/1X+J3G0t45\nNGnqaWpqavYFMujMojCLwiyKvvoIj4i4GvgTWlNLm4DPZ+bHIuJK4DDweuAUrdNjX+xy/1X8Tb1w\n0WhSoZCkxeqrQrHsJ17VQjGfUkAsFJL6kZ/1tOqa2dTunJ8fdGZRmEVhFvUasEIhSVqqAZt6atvM\n0NCwH+Mhqe/Yo1hj9ikk9Rt7FAPK+dfCLAqzKMyiXgNcKDb7PduStAgDPfUEreknvzJVUr+wR1GD\nzg8PtGchqensUQwo518LsyjMojCLelkoJEk9DfjUU+t6ivY33jn1JKnp7FHUyovwJDWfPYpavczM\nzCmGh0fW/LRZ518LsyjMojCLei33G+7WnfY0lCSpxamnedivkNRETj3VbnPdA5CkxrFQXFAcXp7d\n1u5TtHsWq9m7cP61MIvCLAqzqJeFouuXGZXG9szMqQt+JiYm1nqAklQrexSXwP6FpLrYo2iUzV2W\nL+5hdL7DqOPUWklabRaKeb3cZfniaaq77rprdrk9PbVUzr8WZlGYRWEW9bJQXALfOUgaJPYolqH9\nEeVDQ3s4e/Ys58//ED8KRNJq8rOe+kyrUFzOxVNS8xcLvyRJ0nLYzO5L859e2023Pobzr4VZFGZR\nmEW9/KynZejdp9jMxo1b2Llz5+wW30VI6kdOPa2huV+72jkN1W1KamJiwgv8JF3AHkVf2Uz3aaf5\n95/7JUmtojH/lydVL4iVG7KkvreuehQRcWNEfCMi/jYi7lyt51l77YvullIkWvvPzJyZfYwybXVh\nP2O+U28nJiYG4rRc56ILsyjMol6rUigiYgPw34B3Am8GfiUi3rQaz7X2llogun3o4ELN7jMXFYS7\n7rrrki/o6yfT09N1D6ExzKIwi3qt1juKfcCJzDyVma8A9wM3rdJzNdx8haXbR5qXdysXF4QL9+98\nhzH3nUa7r9F528aNWy4qPr3eodT17uXFF19c8+dsKrMozKJeq3XW0y7g+Y71b9MqHprVWUA2Aj+a\ns63VAxkeHuHs2bMX3Nb+VNvO/TrPsmp/yu3cYjPfenkO2LlzJ+fOneMHP/je7H5bt/44W7dunV1v\nN9w7m+1zi0pTzvDyuhVpBWTmiv8Avwj8fsf6+4D/Omef9Gehn82L3Db39s25YcMVXW/bsOGK2Z/F\nPN7Q0J6u29r3z8yu+2zZ8trcsOGKHBrak1u2vDaHhvbM7rtly7ZsGxraM/uzYcMVefnlW2a3t+8/\n1/j4+Ox92uudOm9rj6fbYzRB51jnuvXWWxfc51Ifu9+0s2iitc65ej2vyu/u+X5W5ayniHg7MJGZ\nN1br+6uDu6djH0/nkaRLkOvh9NiI2Ag8B/wc8B3gaeBXMvP4ij+ZJGlVrUqPIjN/FBEfBI7Qaph/\nxiIhSf2ptgvuJEn9oZYPBVwvF+NFxO6IeCwivh4RRyPiQ9X2HRFxJCKei4ivRMS2jvsciIgTEXE8\nIm7o2H5dRDxbZXKwY/tlEXF/dZ+/iIif6Ljt1mr/5yLiV9fquHuJiA0R8bWIeKhaH8gsImJbRPxx\ndWxfj4i3DXAWH4mIv6mO4/PV2Acii4j4TETMRMSzHdtqPfaIGImIJ6vb/igiFp5ZWuvuOa3i9HfA\nHuDHgGngTWs9jhU6lmFgtFreSqsv8ybgHuA/VtvvBD5WLV8LPENrym+kyqH9ru4p4K3V8peAd1bL\nvwHcWy3/MnB/tbwD+HtgG7C9vdyATD4C/A/goWp9ILMAJoH3V8ubqrENXBbA64BvApdV6w8Atw5K\nFsDPAKPAsx3baj326v/BL1XLnwJ+fcHjqOGF83bgyx3r+4E763ohr/Cx/SnwDuAbwFC1bRj4Rrdj\nBb4MvK3a51jH9luAT1XLjwBvq5Y3At+du0/H//Bfrvn4dwNfBcYohWLgsgBeA/x9l+2DmMXrgFPV\nL65NwEOD9m+E1h/FnYWi1mMHzgIbquW3A48sdAx1TD11uxhvVw3jWFERMULrL4cnab0IZgAy8wxw\nVbXb3GM/XW3bRSuHts5MZu+TmT8CXoqIK3s8Vp3+C/AfaF270DaIWVwN/GNEfLaahvv9iLiCAcwi\nM/8B+ATwrWosL2XmowxgFh2uquvYI+K1wPcz83zHY71uoQH7xUUrICK2Al8EPpyZ57jwFyVd1pf1\ndCv4WCsmIn4BmMnMaXqPcd1nQesv5+uA/56Z1wE/oPXX4iC+LrbT+viePbR+IW2JiPcygFn0sNbH\nvuR86igUp4Gf6FjfXW3rS1Uj6IvAfZn5YLV5JiKGqtuHge9W208Dr++4e/vY59t+wX2idX3KazLz\nBZqX4/XAuyLim8AfAf8qIu4DzgxgFt8Gns/Mv6rW/yetwjGIr4t3AN/MzBeqv3j/BPiXDGYWbbUd\ne2Z+D9gWrQ9unftY86thvm4jpZl9Ga1m9t61HscKHs/ngE/O2XYP1Vwj3ZtVl9GanuhsVj1J6/Ow\nglaz6sZq++2UZtUtdG9WtZe3151HNbafpfQoPj6IWQD/G/jJanm8ek0M3OuiGvtR4PLqGCaB3xyk\nLGg1po92rNd67LSa2e1+xaeAf7/gMdT04rmR1hlCJ4D9db2IV+A4rqf1aX7T1f/gr1XHdiXwaHWM\nRzpfnMCB6gVwHLihY/tPV/+gTgC/07F9M3C42v4kMNJx223V9r8FfrXuPDrG1VkoBjIL4J8Df1m9\nNv5X9Q92ULMYr47rWeAQrbMdByIL4AvAP9D65M5vAe+n9Yu7tmOnVYSeqrY/APzYQsfhBXeSpJ5s\nZkuSerJQSJJ6slBIknqyUEiSerJQSJJ6slBIknqyUEiSerJQSJJ6+v9juIysbZTluwAAAABJRU5E\nrkJggg==\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7f85796c7e10>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "df_hema['num_drug_srvc'][df_hema['num_drug_srvc']>0].hist(bins=400)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 56,
   "metadata": {
    "collapsed": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0         3046\n",
       "21           5\n",
       "24           5\n",
       "94           4\n",
       "11           4\n",
       "31           4\n",
       "59           3\n",
       "101          3\n",
       "107          3\n",
       "40           3\n",
       "38           3\n",
       "23           3\n",
       "19           3\n",
       "1759         2\n",
       "30873        2\n",
       "55983        2\n",
       "110692       2\n",
       "5810         2\n",
       "3328         2\n",
       "92222        2\n",
       "12663        2\n",
       "133255       2\n",
       "139          2\n",
       "51244        2\n",
       "16178        2\n",
       "78618        2\n",
       "33867        2\n",
       "45871        2\n",
       "8850         2\n",
       "90           2\n",
       "          ... \n",
       "21807        1\n",
       "38255        1\n",
       "87373        1\n",
       "13678        1\n",
       "30057        1\n",
       "5480         1\n",
       "5475         1\n",
       "177506       1\n",
       "185697       1\n",
       "46427        1\n",
       "62810        1\n",
       "5461         1\n",
       "13651        1\n",
       "62802        1\n",
       "2395         1\n",
       "13644        1\n",
       "169264       1\n",
       "87371        1\n",
       "87370        1\n",
       "5445         1\n",
       "175002       1\n",
       "46396        1\n",
       "38203        1\n",
       "114854       1\n",
       "54584        1\n",
       "21815        1\n",
       "136502       1\n",
       "21813        1\n",
       "70964        1\n",
       "94046        1\n",
       "Name: num_drug_srvc, dtype: int64"
      ]
     },
     "execution_count": 56,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_hema['num_drug_srvc'].value_counts()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 62,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.axes._subplots.AxesSubplot at 0x7f857786b6d0>"
      ]
     },
     "execution_count": 62,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAY0AAAEACAYAAABPiSrXAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\nMYuGJGliFg1J0sQsGpKkiVk0JEkT+/8a0eHBApjcigAAAABJRU5ErkJggg==\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7f857328da50>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "df_hema['num_med_srvc'].hist(bins=100)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 63,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "0"
      ]
     },
     "execution_count": 63,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "np.sum(df_hema['num_med_srvc']==0)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Seems to be two types of oncologists here, 0 drugs and all medical services. And ones that do drugs"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 60,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.collections.PathCollection at 0x7f8572e2c3d0>"
      ]
     },
     "execution_count": 60,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAZ8AAAEACAYAAABs0nsCAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7f852fc49a90>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.scatter(df_hema['num_drug_srvc'], df_hema['num_med_srvc'])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 64,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "def normalize_numerics(df, normalize_col):\n",
    "    numerics = ['int64', 'float64']\n",
    "    for col in df[1:]:\n",
    "        if df[col].dtypes in numerics:\n",
    "            df[col+'_norm'] = df[col] / df[normalize_col]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 65,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "normalize_numerics(df_hema, 'num_unique_bene')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 66,
   "metadata": {
    "collapsed": false,
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>npi</th>\n",
       "      <th>last_name</th>\n",
       "      <th>first_name</th>\n",
       "      <th>credentials</th>\n",
       "      <th>gender</th>\n",
       "      <th>city</th>\n",
       "      <th>state</th>\n",
       "      <th>provider_type</th>\n",
       "      <th>num_hcpcs</th>\n",
       "      <th>num_services</th>\n",
       "      <th>...</th>\n",
       "      <th>num_depression_norm</th>\n",
       "      <th>num_diabetes_norm</th>\n",
       "      <th>num_heart_failure_norm</th>\n",
       "      <th>num_hypertension_norm</th>\n",
       "      <th>num_ischemic_heart_norm</th>\n",
       "      <th>num_osteoporosis_norm</th>\n",
       "      <th>num_rheumatoid_arthritis_osteoarthirtis_norm</th>\n",
       "      <th>num_schizophrenia_psychotic_norm</th>\n",
       "      <th>num_stroke_norm</th>\n",
       "      <th>county_fips_norm</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>0</th>\n",
       "      <td>1093893331</td>\n",
       "      <td>ZAMAN</td>\n",
       "      <td>QAMAR</td>\n",
       "      <td>MD</td>\n",
       "      <td>M</td>\n",
       "      <td>CUMBERLAND</td>\n",
       "      <td>MD</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>21</td>\n",
       "      <td>15174</td>\n",
       "      <td>...</td>\n",
       "      <td>0.29</td>\n",
       "      <td>0.42</td>\n",
       "      <td>0.31</td>\n",
       "      <td>0.75</td>\n",
       "      <td>0.57</td>\n",
       "      <td>0.13</td>\n",
       "      <td>0.50</td>\n",
       "      <td>0.08</td>\n",
       "      <td>0.15</td>\n",
       "      <td>19.277912</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1</th>\n",
       "      <td>1336137876</td>\n",
       "      <td>MAVROMATIS</td>\n",
       "      <td>BLANCHE</td>\n",
       "      <td>MD</td>\n",
       "      <td>F</td>\n",
       "      <td>CUMBERLAND</td>\n",
       "      <td>MD</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>21</td>\n",
       "      <td>2393</td>\n",
       "      <td>...</td>\n",
       "      <td>0.22</td>\n",
       "      <td>0.38</td>\n",
       "      <td>0.22</td>\n",
       "      <td>0.75</td>\n",
       "      <td>0.43</td>\n",
       "      <td>0.08</td>\n",
       "      <td>0.45</td>\n",
       "      <td>0.04</td>\n",
       "      <td>0.07</td>\n",
       "      <td>49.182377</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2</th>\n",
       "      <td>1164609749</td>\n",
       "      <td>HANSON</td>\n",
       "      <td>BRITT</td>\n",
       "      <td>DO</td>\n",
       "      <td>F</td>\n",
       "      <td>EVANSTON</td>\n",
       "      <td>IL</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>20</td>\n",
       "      <td>829</td>\n",
       "      <td>...</td>\n",
       "      <td>0.26</td>\n",
       "      <td>0.29</td>\n",
       "      <td>0.34</td>\n",
       "      <td>0.75</td>\n",
       "      <td>0.50</td>\n",
       "      <td>0.14</td>\n",
       "      <td>0.41</td>\n",
       "      <td>0.06</td>\n",
       "      <td>0.09</td>\n",
       "      <td>62.845018</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3</th>\n",
       "      <td>1235156811</td>\n",
       "      <td>MERKEL</td>\n",
       "      <td>DOUGLAS</td>\n",
       "      <td>MD</td>\n",
       "      <td>M</td>\n",
       "      <td>EVANSTON</td>\n",
       "      <td>IL</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>10</td>\n",
       "      <td>1672</td>\n",
       "      <td>...</td>\n",
       "      <td>0.15</td>\n",
       "      <td>0.18</td>\n",
       "      <td>0.09</td>\n",
       "      <td>0.45</td>\n",
       "      <td>0.14</td>\n",
       "      <td>0.17</td>\n",
       "      <td>0.37</td>\n",
       "      <td>0.02</td>\n",
       "      <td>0.03</td>\n",
       "      <td>22.921938</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4</th>\n",
       "      <td>1548285372</td>\n",
       "      <td>GRINBLATT</td>\n",
       "      <td>DAVID</td>\n",
       "      <td>MD</td>\n",
       "      <td>M</td>\n",
       "      <td>EVANSTON</td>\n",
       "      <td>IL</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>21</td>\n",
       "      <td>1680</td>\n",
       "      <td>...</td>\n",
       "      <td>0.21</td>\n",
       "      <td>0.24</td>\n",
       "      <td>0.25</td>\n",
       "      <td>0.65</td>\n",
       "      <td>0.36</td>\n",
       "      <td>0.12</td>\n",
       "      <td>0.39</td>\n",
       "      <td>0.04</td>\n",
       "      <td>0.04</td>\n",
       "      <td>36.082627</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows × 144 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "          npi   last_name first_name credentials gender        city state  \\\n",
       "0  1093893331       ZAMAN      QAMAR          MD      M  CUMBERLAND    MD   \n",
       "1  1336137876  MAVROMATIS    BLANCHE          MD      F  CUMBERLAND    MD   \n",
       "2  1164609749      HANSON      BRITT          DO      F    EVANSTON    IL   \n",
       "3  1235156811      MERKEL    DOUGLAS          MD      M    EVANSTON    IL   \n",
       "4  1548285372   GRINBLATT      DAVID          MD      M    EVANSTON    IL   \n",
       "\n",
       "         provider_type  num_hcpcs  num_services        ...         \\\n",
       "0  Hematology/Oncology         21         15174        ...          \n",
       "1  Hematology/Oncology         21          2393        ...          \n",
       "2  Hematology/Oncology         20           829        ...          \n",
       "3  Hematology/Oncology         10          1672        ...          \n",
       "4  Hematology/Oncology         21          1680        ...          \n",
       "\n",
       "   num_depression_norm  num_diabetes_norm  num_heart_failure_norm  \\\n",
       "0                 0.29               0.42                    0.31   \n",
       "1                 0.22               0.38                    0.22   \n",
       "2                 0.26               0.29                    0.34   \n",
       "3                 0.15               0.18                    0.09   \n",
       "4                 0.21               0.24                    0.25   \n",
       "\n",
       "   num_hypertension_norm  num_ischemic_heart_norm  num_osteoporosis_norm  \\\n",
       "0                   0.75                     0.57                   0.13   \n",
       "1                   0.75                     0.43                   0.08   \n",
       "2                   0.75                     0.50                   0.14   \n",
       "3                   0.45                     0.14                   0.17   \n",
       "4                   0.65                     0.36                   0.12   \n",
       "\n",
       "   num_rheumatoid_arthritis_osteoarthirtis_norm  \\\n",
       "0                                          0.50   \n",
       "1                                          0.45   \n",
       "2                                          0.41   \n",
       "3                                          0.37   \n",
       "4                                          0.39   \n",
       "\n",
       "   num_schizophrenia_psychotic_norm  num_stroke_norm  county_fips_norm  \n",
       "0                              0.08             0.15         19.277912  \n",
       "1                              0.04             0.07         49.182377  \n",
       "2                              0.06             0.09         62.845018  \n",
       "3                              0.02             0.03         22.921938  \n",
       "4                              0.04             0.04         36.082627  \n",
       "\n",
       "[5 rows x 144 columns]"
      ]
     },
     "execution_count": 66,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_hema.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 72,
   "metadata": {
    "collapsed": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "Int64Index: 7597 entries, 0 to 7596\n",
      "Data columns (total 76 columns):\n",
      "npi                                         7597 non-null int64\n",
      "last_name                                   7597 non-null object\n",
      "first_name                                  7597 non-null object\n",
      "credentials                                 7597 non-null object\n",
      "gender                                      7597 non-null object\n",
      "city                                        7597 non-null object\n",
      "state                                       7597 non-null object\n",
      "provider_type                               7597 non-null object\n",
      "num_hcpcs                                   7597 non-null int64\n",
      "num_services                                7597 non-null float64\n",
      "num_unique_bene                             7597 non-null int64\n",
      "total_submitted_charges                     7597 non-null float64\n",
      "total_medicare_allowed_amt                  7597 non-null float64\n",
      "total_medicare_payment_amt                  7597 non-null float64\n",
      "drug_suppress_indicator                     7597 non-null int64\n",
      "num_hcpcs_associated_drug_srvc              7020 non-null float64\n",
      "num_drug_srvc                               7020 non-null float64\n",
      "num_unique_bene_with_drug_srvc              7020 non-null float64\n",
      "total_drug_submitted_charges                7020 non-null float64\n",
      "total_drug_medicare_allowed_amt             7020 non-null float64\n",
      "total_drug_medicare_payment_amt             7020 non-null float64\n",
      "medical_suppress_indicator                  7597 non-null int64\n",
      "num_hcpcs_associated_med_srvc               7020 non-null float64\n",
      "num_med_srvc                                7020 non-null float64\n",
      "num_unique_bene_with_med_srvc               7020 non-null float64\n",
      "total_med_submitted_charges                 7020 non-null float64\n",
      "total_med_medicare_allowed_amt              7020 non-null float64\n",
      "total_med_medicare_payment_amt              7020 non-null float64\n",
      "avg_age_bene                                7597 non-null float64\n",
      "num_bene_le65                               6333 non-null float64\n",
      "num_bene_65to74                             7268 non-null float64\n",
      "num_bene_75to84                             6628 non-null float64\n",
      "num_bene_ge84                               5957 non-null float64\n",
      "num_female                                  7270 non-null float64\n",
      "num_male                                    7270 non-null float64\n",
      "num_non_his_white                           7597 non-null float64\n",
      "num_african_american                        7597 non-null float64\n",
      "num_asian                                   7593 non-null float64\n",
      "num_hispanic                                7597 non-null float64\n",
      "num_american_indian                         7530 non-null float64\n",
      "num_no_race                                 7597 non-null float64\n",
      "pcnt_alzheimers_dementia                    6067 non-null float64\n",
      "pcnt_asthma                                 6092 non-null float64\n",
      "pcnt_artrial_fibrillation                   6537 non-null float64\n",
      "pcnt_cancer                                 7107 non-null float64\n",
      "pcnt_chronic_kidney                         7319 non-null float64\n",
      "pcnt_chronic_obstructive_pulmonary          6911 non-null float64\n",
      "pcnt_depression                             7154 non-null float64\n",
      "pcnt_diabetes                               7260 non-null float64\n",
      "pcnt_heart_failure                          7077 non-null float64\n",
      "pcnt_hyperlipidemia                         7434 non-null float64\n",
      "pcnt_hypertension                           7513 non-null float64\n",
      "pcnt_ischemic_heart                         7313 non-null float64\n",
      "pcnt_osteoporosis                           6174 non-null float64\n",
      "pcnt_rheumatoid_arthritis_osteoarthirtis    7312 non-null float64\n",
      "pcnt_schizophrenia_psychotic                4427 non-null float64\n",
      "pcnt_stroke                                 5270 non-null float64\n",
      "avg_hcc_risk_score                          7597 non-null float64\n",
      "zip_1                                       7597 non-null int64\n",
      "drug_srvc_bin                               7597 non-null int64\n",
      "num_asthma                                  6092 non-null float64\n",
      "num_alzheimers_dementia                     6067 non-null float64\n",
      "num_artrial_fibrillation                    6537 non-null float64\n",
      "num_cancer                                  7107 non-null float64\n",
      "num_chronic_obstructive_pulmonary           6911 non-null float64\n",
      "num_depression                              7154 non-null float64\n",
      "num_diabetes                                7260 non-null float64\n",
      "num_heart_failure                           7077 non-null float64\n",
      "num_hypertension                            7513 non-null float64\n",
      "num_ischemic_heart                          7313 non-null float64\n",
      "num_osteoporosis                            6174 non-null float64\n",
      "num_rheumatoid_arthritis_osteoarthirtis     7312 non-null float64\n",
      "num_schizophrenia_psychotic                 4427 non-null float64\n",
      "num_stroke                                  5270 non-null float64\n",
      "county                                      7597 non-null object\n",
      "county_fips                                 7597 non-null int64\n",
      "dtypes: float64(60), int64(8), object(8)\n",
      "memory usage: 4.5+ MB\n"
     ]
    }
   ],
   "source": [
    "df_hema.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 77,
   "metadata": {
    "collapsed": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "'npi',\n",
      "'last_name',\n",
      "'first_name',\n",
      "'credentials',\n",
      "'gender',\n",
      "'city',\n",
      "'state',\n",
      "'provider_type',\n",
      "'num_hcpcs',\n",
      "'num_services',\n",
      "'num_unique_bene',\n",
      "'total_submitted_charges',\n",
      "'total_medicare_allowed_amt',\n",
      "'total_medicare_payment_amt',\n",
      "'drug_suppress_indicator',\n",
      "'num_hcpcs_associated_drug_srvc',\n",
      "'num_drug_srvc',\n",
      "'num_unique_bene_with_drug_srvc',\n",
      "'total_drug_submitted_charges',\n",
      "'total_drug_medicare_allowed_amt',\n",
      "'total_drug_medicare_payment_amt',\n",
      "'medical_suppress_indicator',\n",
      "'num_hcpcs_associated_med_srvc',\n",
      "'num_med_srvc',\n",
      "'num_unique_bene_with_med_srvc',\n",
      "'total_med_submitted_charges',\n",
      "'total_med_medicare_allowed_amt',\n",
      "'total_med_medicare_payment_amt',\n",
      "'avg_age_bene',\n",
      "'num_bene_le65',\n",
      "'num_bene_65to74',\n",
      "'num_bene_75to84',\n",
      "'num_bene_ge84',\n",
      "'num_female',\n",
      "'num_male',\n",
      "'num_non_his_white',\n",
      "'num_african_american',\n",
      "'num_asian',\n",
      "'num_hispanic',\n",
      "'num_american_indian',\n",
      "'num_no_race',\n",
      "'pcnt_alzheimers_dementia',\n",
      "'pcnt_asthma',\n",
      "'pcnt_artrial_fibrillation',\n",
      "'pcnt_cancer',\n",
      "'pcnt_chronic_kidney',\n",
      "'pcnt_chronic_obstructive_pulmonary',\n",
      "'pcnt_depression',\n",
      "'pcnt_diabetes',\n",
      "'pcnt_heart_failure',\n",
      "'pcnt_hyperlipidemia',\n",
      "'pcnt_hypertension',\n",
      "'pcnt_ischemic_heart',\n",
      "'pcnt_osteoporosis',\n",
      "'pcnt_rheumatoid_arthritis_osteoarthirtis',\n",
      "'pcnt_schizophrenia_psychotic',\n",
      "'pcnt_stroke',\n",
      "'avg_hcc_risk_score',\n",
      "'zip_1',\n",
      "'drug_srvc_bin',\n",
      "'num_asthma',\n",
      "'num_alzheimers_dementia',\n",
      "'num_artrial_fibrillation',\n",
      "'num_cancer',\n",
      "'num_chronic_obstructive_pulmonary',\n",
      "'num_depression',\n",
      "'num_diabetes',\n",
      "'num_heart_failure',\n",
      "'num_hypertension',\n",
      "'num_ischemic_heart',\n",
      "'num_osteoporosis',\n",
      "'num_rheumatoid_arthritis_osteoarthirtis',\n",
      "'num_schizophrenia_psychotic',\n",
      "'num_stroke',\n",
      "'county',\n",
      "'county_fips',\n"
     ]
    }
   ],
   "source": [
    "for i in df_hema.columns:\n",
    "    print \"'{}',\".format(i)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 79,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "keep_cols = ['npi',\n",
    "                'last_name',\n",
    "                'first_name',\n",
    "                'credentials',\n",
    "                'state',\n",
    "                'provider_type',\n",
    "                'num_hcpcs',\n",
    "                'num_services',\n",
    "                'num_unique_bene',\n",
    "                'total_submitted_charges',\n",
    "                'total_medicare_payment_amt',\n",
    "                'drug_suppress_indicator',\n",
    "                'num_hcpcs_associated_drug_srvc',\n",
    "                'num_drug_srvc',\n",
    "                'num_unique_bene_with_drug_srvc',\n",
    "                'total_drug_submitted_charges',\n",
    "                'total_drug_medicare_payment_amt',\n",
    "                'medical_suppress_indicator',\n",
    "                'num_hcpcs_associated_med_srvc',\n",
    "                'num_med_srvc',\n",
    "                'num_unique_bene_with_med_srvc',\n",
    "                'total_med_submitted_charges',\n",
    "                'total_med_medicare_payment_amt',\n",
    "                'avg_age_bene',\n",
    "                'num_female',\n",
    "                'num_male',\n",
    "                'num_non_his_white',\n",
    "                'num_african_american',\n",
    "                'num_asian',\n",
    "                'num_hispanic',\n",
    "                'num_american_indian',\n",
    "                'avg_hcc_risk_score',\n",
    "                'zip_1',\n",
    "                'drug_srvc_bin',\n",
    "                'num_asthma',\n",
    "                'num_alzheimers_dementia',\n",
    "                'num_artrial_fibrillation',\n",
    "                'num_cancer',\n",
    "                'num_chronic_obstructive_pulmonary',\n",
    "                'num_depression',\n",
    "                'num_diabetes',\n",
    "                'num_heart_failure',\n",
    "                'num_hypertension',\n",
    "                'num_ischemic_heart',\n",
    "                'num_osteoporosis',\n",
    "                'num_rheumatoid_arthritis_osteoarthirtis',\n",
    "                'num_schizophrenia_psychotic',\n",
    "                'num_stroke',\n",
    "                'county',\n",
    "                'county_fips']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 81,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "df_hema = df_hema[keep_cols]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 83,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "normalize_numerics(df_hema, 'num_unique_bene')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 85,
   "metadata": {
    "collapsed": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "'npi',\n",
      "'last_name',\n",
      "'first_name',\n",
      "'credentials',\n",
      "'state',\n",
      "'provider_type',\n",
      "'num_hcpcs',\n",
      "'num_services',\n",
      "'num_unique_bene',\n",
      "'total_submitted_charges',\n",
      "'total_medicare_payment_amt',\n",
      "'drug_suppress_indicator',\n",
      "'num_hcpcs_associated_drug_srvc',\n",
      "'num_drug_srvc',\n",
      "'num_unique_bene_with_drug_srvc',\n",
      "'total_drug_submitted_charges',\n",
      "'total_drug_medicare_payment_amt',\n",
      "'medical_suppress_indicator',\n",
      "'num_hcpcs_associated_med_srvc',\n",
      "'num_med_srvc',\n",
      "'num_unique_bene_with_med_srvc',\n",
      "'total_med_submitted_charges',\n",
      "'total_med_medicare_payment_amt',\n",
      "'avg_age_bene',\n",
      "'num_female',\n",
      "'num_male',\n",
      "'num_non_his_white',\n",
      "'num_african_american',\n",
      "'num_asian',\n",
      "'num_hispanic',\n",
      "'num_american_indian',\n",
      "'avg_hcc_risk_score',\n",
      "'zip_1',\n",
      "'drug_srvc_bin',\n",
      "'num_asthma',\n",
      "'num_alzheimers_dementia',\n",
      "'num_artrial_fibrillation',\n",
      "'num_cancer',\n",
      "'num_chronic_obstructive_pulmonary',\n",
      "'num_depression',\n",
      "'num_diabetes',\n",
      "'num_heart_failure',\n",
      "'num_hypertension',\n",
      "'num_ischemic_heart',\n",
      "'num_osteoporosis',\n",
      "'num_rheumatoid_arthritis_osteoarthirtis',\n",
      "'num_schizophrenia_psychotic',\n",
      "'num_stroke',\n",
      "'county',\n",
      "'county_fips',\n",
      "'npi_norm',\n",
      "'num_hcpcs_norm',\n",
      "'num_services_norm',\n",
      "'num_unique_bene_norm',\n",
      "'total_submitted_charges_norm',\n",
      "'total_medicare_payment_amt_norm',\n",
      "'drug_suppress_indicator_norm',\n",
      "'num_hcpcs_associated_drug_srvc_norm',\n",
      "'num_drug_srvc_norm',\n",
      "'num_unique_bene_with_drug_srvc_norm',\n",
      "'total_drug_submitted_charges_norm',\n",
      "'total_drug_medicare_payment_amt_norm',\n",
      "'medical_suppress_indicator_norm',\n",
      "'num_hcpcs_associated_med_srvc_norm',\n",
      "'num_med_srvc_norm',\n",
      "'num_unique_bene_with_med_srvc_norm',\n",
      "'total_med_submitted_charges_norm',\n",
      "'total_med_medicare_payment_amt_norm',\n",
      "'avg_age_bene_norm',\n",
      "'num_female_norm',\n",
      "'num_male_norm',\n",
      "'num_non_his_white_norm',\n",
      "'num_african_american_norm',\n",
      "'num_asian_norm',\n",
      "'num_hispanic_norm',\n",
      "'num_american_indian_norm',\n",
      "'avg_hcc_risk_score_norm',\n",
      "'zip_1_norm',\n",
      "'drug_srvc_bin_norm',\n",
      "'num_asthma_norm',\n",
      "'num_alzheimers_dementia_norm',\n",
      "'num_artrial_fibrillation_norm',\n",
      "'num_cancer_norm',\n",
      "'num_chronic_obstructive_pulmonary_norm',\n",
      "'num_depression_norm',\n",
      "'num_diabetes_norm',\n",
      "'num_heart_failure_norm',\n",
      "'num_hypertension_norm',\n",
      "'num_ischemic_heart_norm',\n",
      "'num_osteoporosis_norm',\n",
      "'num_rheumatoid_arthritis_osteoarthirtis_norm',\n",
      "'num_schizophrenia_psychotic_norm',\n",
      "'num_stroke_norm',\n",
      "'county_fips_norm',\n"
     ]
    }
   ],
   "source": [
    "for i in df_hema.columns:\n",
    "    print \"'{}',\".format(i)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 89,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "keep_cols_2 = ['npi',\n",
    "'last_name',\n",
    "'first_name',\n",
    "'credentials',\n",
    "'state',\n",
    "'provider_type',\n",
    "'num_hcpcs',\n",
    "'num_services',\n",
    "'num_unique_bene',\n",
    "'total_submitted_charges',\n",
    "'total_medicare_payment_amt',\n",
    "'drug_suppress_indicator',\n",
    "'num_hcpcs_associated_drug_srvc',\n",
    "'num_drug_srvc',\n",
    "'num_unique_bene_with_drug_srvc',\n",
    "'total_drug_submitted_charges',\n",
    "'total_drug_medicare_payment_amt',\n",
    "'medical_suppress_indicator',\n",
    "'num_hcpcs_associated_med_srvc',\n",
    "'num_med_srvc',\n",
    "'num_unique_bene_with_med_srvc',\n",
    "'total_med_submitted_charges',\n",
    "'total_med_medicare_payment_amt',\n",
    "'avg_age_bene',\n",
    "'num_female',\n",
    "'num_male',\n",
    "'num_non_his_white',\n",
    "'num_african_american',\n",
    "'num_asian',\n",
    "'num_hispanic',\n",
    "'num_american_indian',\n",
    "'avg_hcc_risk_score',\n",
    "'zip_1',\n",
    "'drug_srvc_bin',\n",
    "'county',\n",
    "'county_fips',\n",
    "'num_hcpcs_norm',\n",
    "'num_services_norm',\n",
    "'total_submitted_charges_norm',\n",
    "'total_medicare_payment_amt_norm',\n",
    "'num_hcpcs_associated_drug_srvc_norm',\n",
    "'num_drug_srvc_norm',\n",
    "'num_unique_bene_with_drug_srvc_norm',\n",
    "'total_drug_submitted_charges_norm',\n",
    "'total_drug_medicare_payment_amt_norm',\n",
    "'num_hcpcs_associated_med_srvc_norm',\n",
    "'num_med_srvc_norm',\n",
    "'num_unique_bene_with_med_srvc_norm',\n",
    "'total_med_submitted_charges_norm',\n",
    "'total_med_medicare_payment_amt_norm',\n",
    "'num_female_norm',\n",
    "'num_male_norm',\n",
    "'num_non_his_white_norm',\n",
    "'num_african_american_norm',\n",
    "'num_asian_norm',\n",
    "'num_hispanic_norm',\n",
    "'num_american_indian_norm',\n",
    "'num_asthma_norm',\n",
    "'num_alzheimers_dementia_norm',\n",
    "'num_artrial_fibrillation_norm',\n",
    "'num_cancer_norm',\n",
    "'num_chronic_obstructive_pulmonary_norm',\n",
    "'num_depression_norm',\n",
    "'num_diabetes_norm',\n",
    "'num_heart_failure_norm',\n",
    "'num_hypertension_norm',\n",
    "'num_ischemic_heart_norm',\n",
    "'num_osteoporosis_norm',\n",
    "'num_rheumatoid_arthritis_osteoarthirtis_norm',\n",
    "'num_schizophrenia_psychotic_norm',\n",
    "'num_stroke_norm']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 90,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "df_hema = df_hema[keep_cols_2]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 91,
   "metadata": {
    "collapsed": false,
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "Int64Index: 7597 entries, 0 to 7596\n",
      "Data columns (total 71 columns):\n",
      "npi                                             7597 non-null int64\n",
      "last_name                                       7597 non-null object\n",
      "first_name                                      7597 non-null object\n",
      "credentials                                     7597 non-null object\n",
      "state                                           7597 non-null object\n",
      "provider_type                                   7597 non-null object\n",
      "num_hcpcs                                       7597 non-null int64\n",
      "num_services                                    7597 non-null float64\n",
      "num_unique_bene                                 7597 non-null int64\n",
      "total_submitted_charges                         7597 non-null float64\n",
      "total_medicare_payment_amt                      7597 non-null float64\n",
      "drug_suppress_indicator                         7597 non-null int64\n",
      "num_hcpcs_associated_drug_srvc                  7020 non-null float64\n",
      "num_drug_srvc                                   7020 non-null float64\n",
      "num_unique_bene_with_drug_srvc                  7020 non-null float64\n",
      "total_drug_submitted_charges                    7020 non-null float64\n",
      "total_drug_medicare_payment_amt                 7020 non-null float64\n",
      "medical_suppress_indicator                      7597 non-null int64\n",
      "num_hcpcs_associated_med_srvc                   7020 non-null float64\n",
      "num_med_srvc                                    7020 non-null float64\n",
      "num_unique_bene_with_med_srvc                   7020 non-null float64\n",
      "total_med_submitted_charges                     7020 non-null float64\n",
      "total_med_medicare_payment_amt                  7020 non-null float64\n",
      "avg_age_bene                                    7597 non-null float64\n",
      "num_female                                      7270 non-null float64\n",
      "num_male                                        7270 non-null float64\n",
      "num_non_his_white                               7597 non-null float64\n",
      "num_african_american                            7597 non-null float64\n",
      "num_asian                                       7593 non-null float64\n",
      "num_hispanic                                    7597 non-null float64\n",
      "num_american_indian                             7530 non-null float64\n",
      "avg_hcc_risk_score                              7597 non-null float64\n",
      "zip_1                                           7597 non-null int64\n",
      "drug_srvc_bin                                   7597 non-null int64\n",
      "county                                          7597 non-null object\n",
      "county_fips                                     7597 non-null int64\n",
      "num_hcpcs_norm                                  7597 non-null float64\n",
      "num_services_norm                               7597 non-null float64\n",
      "total_submitted_charges_norm                    7597 non-null float64\n",
      "total_medicare_payment_amt_norm                 7597 non-null float64\n",
      "num_hcpcs_associated_drug_srvc_norm             7020 non-null float64\n",
      "num_drug_srvc_norm                              7020 non-null float64\n",
      "num_unique_bene_with_drug_srvc_norm             7020 non-null float64\n",
      "total_drug_submitted_charges_norm               7020 non-null float64\n",
      "total_drug_medicare_payment_amt_norm            7020 non-null float64\n",
      "num_hcpcs_associated_med_srvc_norm              7020 non-null float64\n",
      "num_med_srvc_norm                               7020 non-null float64\n",
      "num_unique_bene_with_med_srvc_norm              7020 non-null float64\n",
      "total_med_submitted_charges_norm                7020 non-null float64\n",
      "total_med_medicare_payment_amt_norm             7020 non-null float64\n",
      "num_female_norm                                 7270 non-null float64\n",
      "num_male_norm                                   7270 non-null float64\n",
      "num_non_his_white_norm                          7597 non-null float64\n",
      "num_african_american_norm                       7597 non-null float64\n",
      "num_asian_norm                                  7593 non-null float64\n",
      "num_hispanic_norm                               7597 non-null float64\n",
      "num_american_indian_norm                        7530 non-null float64\n",
      "num_asthma_norm                                 6092 non-null float64\n",
      "num_alzheimers_dementia_norm                    6067 non-null float64\n",
      "num_artrial_fibrillation_norm                   6537 non-null float64\n",
      "num_cancer_norm                                 7107 non-null float64\n",
      "num_chronic_obstructive_pulmonary_norm          6911 non-null float64\n",
      "num_depression_norm                             7154 non-null float64\n",
      "num_diabetes_norm                               7260 non-null float64\n",
      "num_heart_failure_norm                          7077 non-null float64\n",
      "num_hypertension_norm                           7513 non-null float64\n",
      "num_ischemic_heart_norm                         7313 non-null float64\n",
      "num_osteoporosis_norm                           6174 non-null float64\n",
      "num_rheumatoid_arthritis_osteoarthirtis_norm    7312 non-null float64\n",
      "num_schizophrenia_psychotic_norm                4427 non-null float64\n",
      "num_stroke_norm                                 5270 non-null float64\n",
      "dtypes: float64(57), int64(8), object(6)\n",
      "memory usage: 4.2+ MB\n"
     ]
    }
   ],
   "source": [
    "df_hema.info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 181,
   "metadata": {
    "collapsed": false,
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.axes._subplots.AxesSubplot at 0x7f85313e70d0>"
      ]
     },
     "execution_count": 181,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAYcAAAEACAYAAABYq7oeAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\nTkSuQmCC\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7f8530cc02d0>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "df_hema['total_submitted_charges_norm'].hist(bins=3000)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 184,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "df_hema['drug_charge_per_srvc'] = df_hema['total_drug_submitted_charges'] / df_hema['num_drug_srvc']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 185,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "df_hema['med_charge_per_srvc'] = df_hema['total_med_submitted_charges'] / df_hema['num_med_srvc']"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 183,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>4237</th>\n",
       "      <th>5827</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>npi</th>\n",
       "      <td>1043201817</td>\n",
       "      <td>1760487177</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>last_name</th>\n",
       "      <td>ASHTAR</td>\n",
       "      <td>WEINREB</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>first_name</th>\n",
       "      <td>ED</td>\n",
       "      <td>NEAL</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>credentials</th>\n",
       "      <td>MD, FACP</td>\n",
       "      <td>MD</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>state</th>\n",
       "      <td>MD</td>\n",
       "      <td>FL</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>provider_type</th>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_hcpcs</th>\n",
       "      <td>68</td>\n",
       "      <td>48</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_services</th>\n",
       "      <td>251031</td>\n",
       "      <td>68952</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_unique_bene</th>\n",
       "      <td>82</td>\n",
       "      <td>30</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_submitted_charges</th>\n",
       "      <td>9.65699e+06</td>\n",
       "      <td>8.62125e+06</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_medicare_payment_amt</th>\n",
       "      <td>2.00076e+06</td>\n",
       "      <td>4.05876e+06</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>drug_suppress_indicator</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_hcpcs_associated_drug_srvc</th>\n",
       "      <td>34</td>\n",
       "      <td>15</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_drug_srvc</th>\n",
       "      <td>242712</td>\n",
       "      <td>67604</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_unique_bene_with_drug_srvc</th>\n",
       "      <td>42</td>\n",
       "      <td>24</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_drug_submitted_charges</th>\n",
       "      <td>8.29237e+06</td>\n",
       "      <td>8.49914e+06</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_drug_medicare_payment_amt</th>\n",
       "      <td>1.67858e+06</td>\n",
       "      <td>4.01688e+06</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>medical_suppress_indicator</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_hcpcs_associated_med_srvc</th>\n",
       "      <td>34</td>\n",
       "      <td>33</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_med_srvc</th>\n",
       "      <td>8319</td>\n",
       "      <td>1348</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_unique_bene_with_med_srvc</th>\n",
       "      <td>82</td>\n",
       "      <td>30</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_med_submitted_charges</th>\n",
       "      <td>1.36462e+06</td>\n",
       "      <td>122101</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_med_medicare_payment_amt</th>\n",
       "      <td>322177</td>\n",
       "      <td>41879.4</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>avg_age_bene</th>\n",
       "      <td>77</td>\n",
       "      <td>69</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_female</th>\n",
       "      <td>48</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_male</th>\n",
       "      <td>34</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_non_his_white</th>\n",
       "      <td>45</td>\n",
       "      <td>16</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_african_american</th>\n",
       "      <td>24</td>\n",
       "      <td>5</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_asian</th>\n",
       "      <td>5</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_hispanic</th>\n",
       "      <td>7</td>\n",
       "      <td>7</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_drug_srvc_norm</th>\n",
       "      <td>2959.9</td>\n",
       "      <td>2253.47</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_unique_bene_with_drug_srvc_norm</th>\n",
       "      <td>0.512195</td>\n",
       "      <td>0.8</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_drug_submitted_charges_norm</th>\n",
       "      <td>101126</td>\n",
       "      <td>283305</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_drug_medicare_payment_amt_norm</th>\n",
       "      <td>20470.5</td>\n",
       "      <td>133896</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_hcpcs_associated_med_srvc_norm</th>\n",
       "      <td>0.414634</td>\n",
       "      <td>1.1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_med_srvc_norm</th>\n",
       "      <td>101.451</td>\n",
       "      <td>44.9333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_unique_bene_with_med_srvc_norm</th>\n",
       "      <td>1</td>\n",
       "      <td>1</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_med_submitted_charges_norm</th>\n",
       "      <td>16641.7</td>\n",
       "      <td>4070.03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_med_medicare_payment_amt_norm</th>\n",
       "      <td>3928.99</td>\n",
       "      <td>1395.98</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_female_norm</th>\n",
       "      <td>0.585366</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_male_norm</th>\n",
       "      <td>0.414634</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_non_his_white_norm</th>\n",
       "      <td>0.54878</td>\n",
       "      <td>0.533333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_african_american_norm</th>\n",
       "      <td>0.292683</td>\n",
       "      <td>0.166667</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_asian_norm</th>\n",
       "      <td>0.0609756</td>\n",
       "      <td>0.0333333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_hispanic_norm</th>\n",
       "      <td>0.0853659</td>\n",
       "      <td>0.233333</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_american_indian_norm</th>\n",
       "      <td>0</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_asthma_norm</th>\n",
       "      <td>NaN</td>\n",
       "      <td>0</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_alzheimers_dementia_norm</th>\n",
       "      <td>0.17</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_artrial_fibrillation_norm</th>\n",
       "      <td>0.22</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_cancer_norm</th>\n",
       "      <td>0.29</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_chronic_obstructive_pulmonary_norm</th>\n",
       "      <td>0.3</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_depression_norm</th>\n",
       "      <td>0.27</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_diabetes_norm</th>\n",
       "      <td>0.59</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_heart_failure_norm</th>\n",
       "      <td>0.48</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_hypertension_norm</th>\n",
       "      <td>0.75</td>\n",
       "      <td>0.67</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_ischemic_heart_norm</th>\n",
       "      <td>0.6</td>\n",
       "      <td>0.47</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_osteoporosis_norm</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_rheumatoid_arthritis_osteoarthirtis_norm</th>\n",
       "      <td>0.63</td>\n",
       "      <td>0.53</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_schizophrenia_psychotic_norm</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_stroke_norm</th>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>71 rows × 2 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "                                                             4237  \\\n",
       "npi                                                    1043201817   \n",
       "last_name                                                  ASHTAR   \n",
       "first_name                                                     ED   \n",
       "credentials                                              MD, FACP   \n",
       "state                                                          MD   \n",
       "provider_type                                 Hematology/Oncology   \n",
       "num_hcpcs                                                      68   \n",
       "num_services                                               251031   \n",
       "num_unique_bene                                                82   \n",
       "total_submitted_charges                               9.65699e+06   \n",
       "total_medicare_payment_amt                            2.00076e+06   \n",
       "drug_suppress_indicator                                         0   \n",
       "num_hcpcs_associated_drug_srvc                                 34   \n",
       "num_drug_srvc                                              242712   \n",
       "num_unique_bene_with_drug_srvc                                 42   \n",
       "total_drug_submitted_charges                          8.29237e+06   \n",
       "total_drug_medicare_payment_amt                       1.67858e+06   \n",
       "medical_suppress_indicator                                      0   \n",
       "num_hcpcs_associated_med_srvc                                  34   \n",
       "num_med_srvc                                                 8319   \n",
       "num_unique_bene_with_med_srvc                                  82   \n",
       "total_med_submitted_charges                           1.36462e+06   \n",
       "total_med_medicare_payment_amt                             322177   \n",
       "avg_age_bene                                                   77   \n",
       "num_female                                                     48   \n",
       "num_male                                                       34   \n",
       "num_non_his_white                                              45   \n",
       "num_african_american                                           24   \n",
       "num_asian                                                       5   \n",
       "num_hispanic                                                    7   \n",
       "...                                                           ...   \n",
       "num_drug_srvc_norm                                         2959.9   \n",
       "num_unique_bene_with_drug_srvc_norm                      0.512195   \n",
       "total_drug_submitted_charges_norm                          101126   \n",
       "total_drug_medicare_payment_amt_norm                      20470.5   \n",
       "num_hcpcs_associated_med_srvc_norm                       0.414634   \n",
       "num_med_srvc_norm                                         101.451   \n",
       "num_unique_bene_with_med_srvc_norm                              1   \n",
       "total_med_submitted_charges_norm                          16641.7   \n",
       "total_med_medicare_payment_amt_norm                       3928.99   \n",
       "num_female_norm                                          0.585366   \n",
       "num_male_norm                                            0.414634   \n",
       "num_non_his_white_norm                                    0.54878   \n",
       "num_african_american_norm                                0.292683   \n",
       "num_asian_norm                                          0.0609756   \n",
       "num_hispanic_norm                                       0.0853659   \n",
       "num_american_indian_norm                                        0   \n",
       "num_asthma_norm                                               NaN   \n",
       "num_alzheimers_dementia_norm                                 0.17   \n",
       "num_artrial_fibrillation_norm                                0.22   \n",
       "num_cancer_norm                                              0.29   \n",
       "num_chronic_obstructive_pulmonary_norm                        0.3   \n",
       "num_depression_norm                                          0.27   \n",
       "num_diabetes_norm                                            0.59   \n",
       "num_heart_failure_norm                                       0.48   \n",
       "num_hypertension_norm                                        0.75   \n",
       "num_ischemic_heart_norm                                       0.6   \n",
       "num_osteoporosis_norm                                         NaN   \n",
       "num_rheumatoid_arthritis_osteoarthirtis_norm                 0.63   \n",
       "num_schizophrenia_psychotic_norm                              NaN   \n",
       "num_stroke_norm                                               NaN   \n",
       "\n",
       "                                                             5827  \n",
       "npi                                                    1760487177  \n",
       "last_name                                                 WEINREB  \n",
       "first_name                                                   NEAL  \n",
       "credentials                                                    MD  \n",
       "state                                                          FL  \n",
       "provider_type                                 Hematology/Oncology  \n",
       "num_hcpcs                                                      48  \n",
       "num_services                                                68952  \n",
       "num_unique_bene                                                30  \n",
       "total_submitted_charges                               8.62125e+06  \n",
       "total_medicare_payment_amt                            4.05876e+06  \n",
       "drug_suppress_indicator                                         0  \n",
       "num_hcpcs_associated_drug_srvc                                 15  \n",
       "num_drug_srvc                                               67604  \n",
       "num_unique_bene_with_drug_srvc                                 24  \n",
       "total_drug_submitted_charges                          8.49914e+06  \n",
       "total_drug_medicare_payment_amt                       4.01688e+06  \n",
       "medical_suppress_indicator                                      0  \n",
       "num_hcpcs_associated_med_srvc                                  33  \n",
       "num_med_srvc                                                 1348  \n",
       "num_unique_bene_with_med_srvc                                  30  \n",
       "total_med_submitted_charges                                122101  \n",
       "total_med_medicare_payment_amt                            41879.4  \n",
       "avg_age_bene                                                   69  \n",
       "num_female                                                    NaN  \n",
       "num_male                                                      NaN  \n",
       "num_non_his_white                                              16  \n",
       "num_african_american                                            5  \n",
       "num_asian                                                       1  \n",
       "num_hispanic                                                    7  \n",
       "...                                                           ...  \n",
       "num_drug_srvc_norm                                        2253.47  \n",
       "num_unique_bene_with_drug_srvc_norm                           0.8  \n",
       "total_drug_submitted_charges_norm                          283305  \n",
       "total_drug_medicare_payment_amt_norm                       133896  \n",
       "num_hcpcs_associated_med_srvc_norm                            1.1  \n",
       "num_med_srvc_norm                                         44.9333  \n",
       "num_unique_bene_with_med_srvc_norm                              1  \n",
       "total_med_submitted_charges_norm                          4070.03  \n",
       "total_med_medicare_payment_amt_norm                       1395.98  \n",
       "num_female_norm                                               NaN  \n",
       "num_male_norm                                                 NaN  \n",
       "num_non_his_white_norm                                   0.533333  \n",
       "num_african_american_norm                                0.166667  \n",
       "num_asian_norm                                          0.0333333  \n",
       "num_hispanic_norm                                        0.233333  \n",
       "num_american_indian_norm                                        0  \n",
       "num_asthma_norm                                                 0  \n",
       "num_alzheimers_dementia_norm                                  NaN  \n",
       "num_artrial_fibrillation_norm                                 NaN  \n",
       "num_cancer_norm                                               NaN  \n",
       "num_chronic_obstructive_pulmonary_norm                        NaN  \n",
       "num_depression_norm                                           NaN  \n",
       "num_diabetes_norm                                             NaN  \n",
       "num_heart_failure_norm                                        NaN  \n",
       "num_hypertension_norm                                        0.67  \n",
       "num_ischemic_heart_norm                                      0.47  \n",
       "num_osteoporosis_norm                                         NaN  \n",
       "num_rheumatoid_arthritis_osteoarthirtis_norm                 0.53  \n",
       "num_schizophrenia_psychotic_norm                              NaN  \n",
       "num_stroke_norm                                               NaN  \n",
       "\n",
       "[71 rows x 2 columns]"
      ]
     },
     "execution_count": 183,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_hema[df_hema['total_submitted_charges_norm']>100000].T"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 97,
   "metadata": {
    "collapsed": false,
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr>\n",
       "      <th>num_drug_srvc</th>\n",
       "      <th colspan=\"8\" halign=\"left\">False</th>\n",
       "      <th colspan=\"8\" halign=\"left\">True</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th></th>\n",
       "      <th>count</th>\n",
       "      <th>mean</th>\n",
       "      <th>std</th>\n",
       "      <th>min</th>\n",
       "      <th>25%</th>\n",
       "      <th>50%</th>\n",
       "      <th>75%</th>\n",
       "      <th>max</th>\n",
       "      <th>count</th>\n",
       "      <th>mean</th>\n",
       "      <th>std</th>\n",
       "      <th>min</th>\n",
       "      <th>25%</th>\n",
       "      <th>50%</th>\n",
       "      <th>75%</th>\n",
       "      <th>max</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>npi</th>\n",
       "      <td>3623</td>\n",
       "      <td>1.502523e+09</td>\n",
       "      <td>2.877838e+08</td>\n",
       "      <td>1.003015e+09</td>\n",
       "      <td>1.245527e+09</td>\n",
       "      <td>1.497836e+09</td>\n",
       "      <td>1.750385e+09</td>\n",
       "      <td>1.992999e+09</td>\n",
       "      <td>3974</td>\n",
       "      <td>1.495638e+09</td>\n",
       "      <td>2.863853e+08</td>\n",
       "      <td>1.003031e+09</td>\n",
       "      <td>1.245431e+09</td>\n",
       "      <td>1.497727e+09</td>\n",
       "      <td>1.740254e+09</td>\n",
       "      <td>1.992965e+09</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_hcpcs</th>\n",
       "      <td>3623</td>\n",
       "      <td>1.634861e+01</td>\n",
       "      <td>9.439872e+00</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>1.100000e+01</td>\n",
       "      <td>1.500000e+01</td>\n",
       "      <td>1.900000e+01</td>\n",
       "      <td>1.230000e+02</td>\n",
       "      <td>3974</td>\n",
       "      <td>1.065023e+02</td>\n",
       "      <td>4.230439e+01</td>\n",
       "      <td>1.000000e+01</td>\n",
       "      <td>8.000000e+01</td>\n",
       "      <td>1.050000e+02</td>\n",
       "      <td>1.310000e+02</td>\n",
       "      <td>3.880000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_services</th>\n",
       "      <td>3623</td>\n",
       "      <td>9.465551e+02</td>\n",
       "      <td>1.377693e+03</td>\n",
       "      <td>1.200000e+01</td>\n",
       "      <td>3.075000e+02</td>\n",
       "      <td>6.480000e+02</td>\n",
       "      <td>1.158500e+03</td>\n",
       "      <td>3.619800e+04</td>\n",
       "      <td>3974</td>\n",
       "      <td>7.383461e+04</td>\n",
       "      <td>7.304449e+04</td>\n",
       "      <td>3.040000e+02</td>\n",
       "      <td>2.265825e+04</td>\n",
       "      <td>5.559400e+04</td>\n",
       "      <td>1.003410e+05</td>\n",
       "      <td>9.195270e+05</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_unique_bene</th>\n",
       "      <td>3623</td>\n",
       "      <td>2.189845e+02</td>\n",
       "      <td>1.729782e+02</td>\n",
       "      <td>1.100000e+01</td>\n",
       "      <td>8.600000e+01</td>\n",
       "      <td>1.810000e+02</td>\n",
       "      <td>3.080000e+02</td>\n",
       "      <td>1.596000e+03</td>\n",
       "      <td>3974</td>\n",
       "      <td>5.080088e+02</td>\n",
       "      <td>3.186551e+02</td>\n",
       "      <td>1.300000e+01</td>\n",
       "      <td>3.000000e+02</td>\n",
       "      <td>4.550000e+02</td>\n",
       "      <td>6.460000e+02</td>\n",
       "      <td>4.946000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_submitted_charges</th>\n",
       "      <td>3623</td>\n",
       "      <td>1.635423e+05</td>\n",
       "      <td>1.609505e+05</td>\n",
       "      <td>2.040000e+02</td>\n",
       "      <td>6.157649e+04</td>\n",
       "      <td>1.266400e+05</td>\n",
       "      <td>2.132265e+05</td>\n",
       "      <td>2.250864e+06</td>\n",
       "      <td>3974</td>\n",
       "      <td>3.341412e+06</td>\n",
       "      <td>3.125171e+06</td>\n",
       "      <td>3.112000e+04</td>\n",
       "      <td>1.103360e+06</td>\n",
       "      <td>2.587361e+06</td>\n",
       "      <td>4.564674e+06</td>\n",
       "      <td>3.574462e+07</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_medicare_payment_amt</th>\n",
       "      <td>3623</td>\n",
       "      <td>5.231779e+04</td>\n",
       "      <td>5.606416e+04</td>\n",
       "      <td>3.582000e+01</td>\n",
       "      <td>2.017978e+04</td>\n",
       "      <td>4.108129e+04</td>\n",
       "      <td>6.888412e+04</td>\n",
       "      <td>1.225143e+06</td>\n",
       "      <td>3974</td>\n",
       "      <td>1.080608e+06</td>\n",
       "      <td>1.024786e+06</td>\n",
       "      <td>1.174203e+04</td>\n",
       "      <td>4.052417e+05</td>\n",
       "      <td>8.786494e+05</td>\n",
       "      <td>1.464679e+06</td>\n",
       "      <td>2.804806e+07</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>drug_suppress_indicator</th>\n",
       "      <td>3623</td>\n",
       "      <td>1.592603e-01</td>\n",
       "      <td>3.659691e-01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>3974</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_hcpcs_associated_drug_srvc</th>\n",
       "      <td>3046</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>3974</td>\n",
       "      <td>5.205838e+01</td>\n",
       "      <td>2.148976e+01</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>4.000000e+01</td>\n",
       "      <td>5.600000e+01</td>\n",
       "      <td>6.700000e+01</td>\n",
       "      <td>1.100000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_drug_srvc</th>\n",
       "      <td>3046</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>3974</td>\n",
       "      <td>6.663352e+04</td>\n",
       "      <td>6.804169e+04</td>\n",
       "      <td>1.100000e+01</td>\n",
       "      <td>1.936075e+04</td>\n",
       "      <td>4.940450e+04</td>\n",
       "      <td>9.071400e+04</td>\n",
       "      <td>9.192350e+05</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_unique_bene_with_drug_srvc</th>\n",
       "      <td>3046</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>3974</td>\n",
       "      <td>1.470518e+02</td>\n",
       "      <td>1.250096e+02</td>\n",
       "      <td>1.100000e+01</td>\n",
       "      <td>5.900000e+01</td>\n",
       "      <td>1.170000e+02</td>\n",
       "      <td>1.920000e+02</td>\n",
       "      <td>9.500000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_drug_submitted_charges</th>\n",
       "      <td>3046</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>3974</td>\n",
       "      <td>2.481549e+06</td>\n",
       "      <td>2.466301e+06</td>\n",
       "      <td>4.200000e+01</td>\n",
       "      <td>7.054046e+05</td>\n",
       "      <td>1.875306e+06</td>\n",
       "      <td>3.499134e+06</td>\n",
       "      <td>3.556785e+07</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_drug_medicare_payment_amt</th>\n",
       "      <td>3046</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>3974</td>\n",
       "      <td>8.071928e+05</td>\n",
       "      <td>8.637869e+05</td>\n",
       "      <td>8.450000e+00</td>\n",
       "      <td>2.588127e+05</td>\n",
       "      <td>6.422083e+05</td>\n",
       "      <td>1.117330e+06</td>\n",
       "      <td>2.797682e+07</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>medical_suppress_indicator</th>\n",
       "      <td>3623</td>\n",
       "      <td>1.592603e-01</td>\n",
       "      <td>3.659691e-01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>3974</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_hcpcs_associated_med_srvc</th>\n",
       "      <td>3046</td>\n",
       "      <td>1.427610e+01</td>\n",
       "      <td>6.150141e+00</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>1.100000e+01</td>\n",
       "      <td>1.400000e+01</td>\n",
       "      <td>1.700000e+01</td>\n",
       "      <td>1.140000e+02</td>\n",
       "      <td>3974</td>\n",
       "      <td>5.444389e+01</td>\n",
       "      <td>2.600593e+01</td>\n",
       "      <td>5.000000e+00</td>\n",
       "      <td>3.700000e+01</td>\n",
       "      <td>4.700000e+01</td>\n",
       "      <td>6.875000e+01</td>\n",
       "      <td>3.130000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_med_srvc</th>\n",
       "      <td>3046</td>\n",
       "      <td>7.918838e+02</td>\n",
       "      <td>1.116424e+03</td>\n",
       "      <td>1.200000e+01</td>\n",
       "      <td>2.762500e+02</td>\n",
       "      <td>5.750000e+02</td>\n",
       "      <td>1.028000e+03</td>\n",
       "      <td>3.619800e+04</td>\n",
       "      <td>3974</td>\n",
       "      <td>7.201095e+03</td>\n",
       "      <td>6.978069e+03</td>\n",
       "      <td>3.700000e+01</td>\n",
       "      <td>2.769500e+03</td>\n",
       "      <td>5.366000e+03</td>\n",
       "      <td>9.393750e+03</td>\n",
       "      <td>9.189700e+04</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_unique_bene_with_med_srvc</th>\n",
       "      <td>3046</td>\n",
       "      <td>2.178109e+02</td>\n",
       "      <td>1.706383e+02</td>\n",
       "      <td>1.100000e+01</td>\n",
       "      <td>8.625000e+01</td>\n",
       "      <td>1.780000e+02</td>\n",
       "      <td>3.050000e+02</td>\n",
       "      <td>1.560000e+03</td>\n",
       "      <td>3974</td>\n",
       "      <td>5.077267e+02</td>\n",
       "      <td>3.185718e+02</td>\n",
       "      <td>1.300000e+01</td>\n",
       "      <td>2.992500e+02</td>\n",
       "      <td>4.545000e+02</td>\n",
       "      <td>6.457500e+02</td>\n",
       "      <td>4.945000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_med_submitted_charges</th>\n",
       "      <td>3046</td>\n",
       "      <td>1.554833e+05</td>\n",
       "      <td>1.440358e+05</td>\n",
       "      <td>2.040000e+02</td>\n",
       "      <td>5.923250e+04</td>\n",
       "      <td>1.238025e+05</td>\n",
       "      <td>2.064218e+05</td>\n",
       "      <td>1.856770e+06</td>\n",
       "      <td>3974</td>\n",
       "      <td>8.598633e+05</td>\n",
       "      <td>8.126277e+05</td>\n",
       "      <td>4.306000e+03</td>\n",
       "      <td>3.577137e+05</td>\n",
       "      <td>6.606872e+05</td>\n",
       "      <td>1.093646e+06</td>\n",
       "      <td>1.127809e+07</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_med_medicare_payment_amt</th>\n",
       "      <td>3046</td>\n",
       "      <td>4.819442e+04</td>\n",
       "      <td>4.500165e+04</td>\n",
       "      <td>3.582000e+01</td>\n",
       "      <td>1.876575e+04</td>\n",
       "      <td>3.835312e+04</td>\n",
       "      <td>6.482306e+04</td>\n",
       "      <td>7.717201e+05</td>\n",
       "      <td>3974</td>\n",
       "      <td>2.734152e+05</td>\n",
       "      <td>2.240229e+05</td>\n",
       "      <td>1.303380e+03</td>\n",
       "      <td>1.298497e+05</td>\n",
       "      <td>2.259548e+05</td>\n",
       "      <td>3.484419e+05</td>\n",
       "      <td>3.283833e+06</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>avg_age_bene</th>\n",
       "      <td>3623</td>\n",
       "      <td>7.070466e+01</td>\n",
       "      <td>4.256609e+00</td>\n",
       "      <td>2.600000e+01</td>\n",
       "      <td>6.900000e+01</td>\n",
       "      <td>7.200000e+01</td>\n",
       "      <td>7.300000e+01</td>\n",
       "      <td>8.800000e+01</td>\n",
       "      <td>3974</td>\n",
       "      <td>7.337771e+01</td>\n",
       "      <td>2.243545e+00</td>\n",
       "      <td>4.800000e+01</td>\n",
       "      <td>7.200000e+01</td>\n",
       "      <td>7.300000e+01</td>\n",
       "      <td>7.500000e+01</td>\n",
       "      <td>8.500000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_female</th>\n",
       "      <td>3317</td>\n",
       "      <td>1.347492e+02</td>\n",
       "      <td>1.090165e+02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>5.000000e+01</td>\n",
       "      <td>1.060000e+02</td>\n",
       "      <td>1.910000e+02</td>\n",
       "      <td>1.044000e+03</td>\n",
       "      <td>3953</td>\n",
       "      <td>3.027055e+02</td>\n",
       "      <td>1.918530e+02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.760000e+02</td>\n",
       "      <td>2.700000e+02</td>\n",
       "      <td>3.880000e+02</td>\n",
       "      <td>3.096000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_male</th>\n",
       "      <td>3317</td>\n",
       "      <td>1.006672e+02</td>\n",
       "      <td>7.258997e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>4.500000e+01</td>\n",
       "      <td>8.500000e+01</td>\n",
       "      <td>1.390000e+02</td>\n",
       "      <td>6.350000e+02</td>\n",
       "      <td>3953</td>\n",
       "      <td>2.064996e+02</td>\n",
       "      <td>1.350969e+02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.160000e+02</td>\n",
       "      <td>1.850000e+02</td>\n",
       "      <td>2.660000e+02</td>\n",
       "      <td>1.849000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_non_his_white</th>\n",
       "      <td>3623</td>\n",
       "      <td>1.709274e+02</td>\n",
       "      <td>1.521177e+02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>5.500000e+01</td>\n",
       "      <td>1.310000e+02</td>\n",
       "      <td>2.480000e+02</td>\n",
       "      <td>1.217000e+03</td>\n",
       "      <td>3974</td>\n",
       "      <td>4.131600e+02</td>\n",
       "      <td>2.892631e+02</td>\n",
       "      <td>7.000000e+00</td>\n",
       "      <td>2.210000e+02</td>\n",
       "      <td>3.645000e+02</td>\n",
       "      <td>5.450000e+02</td>\n",
       "      <td>4.375000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_african_american</th>\n",
       "      <td>3623</td>\n",
       "      <td>2.581010e+01</td>\n",
       "      <td>4.024530e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>5.000000e+00</td>\n",
       "      <td>1.200000e+01</td>\n",
       "      <td>2.900000e+01</td>\n",
       "      <td>4.990000e+02</td>\n",
       "      <td>3974</td>\n",
       "      <td>4.812506e+01</td>\n",
       "      <td>7.089056e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.100000e+01</td>\n",
       "      <td>2.500000e+01</td>\n",
       "      <td>5.600000e+01</td>\n",
       "      <td>1.418000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_asian</th>\n",
       "      <td>3623</td>\n",
       "      <td>5.988131e+00</td>\n",
       "      <td>1.021101e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>2.000000e+00</td>\n",
       "      <td>4.000000e+00</td>\n",
       "      <td>7.000000e+00</td>\n",
       "      <td>2.440000e+02</td>\n",
       "      <td>3970</td>\n",
       "      <td>1.289950e+01</td>\n",
       "      <td>3.052587e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>3.000000e+00</td>\n",
       "      <td>6.000000e+00</td>\n",
       "      <td>1.400000e+01</td>\n",
       "      <td>7.930000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_hispanic</th>\n",
       "      <td>3623</td>\n",
       "      <td>1.467403e+01</td>\n",
       "      <td>3.129648e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>6.000000e+00</td>\n",
       "      <td>1.000000e+01</td>\n",
       "      <td>1.600000e+01</td>\n",
       "      <td>1.184000e+03</td>\n",
       "      <td>3974</td>\n",
       "      <td>3.038903e+01</td>\n",
       "      <td>5.555220e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.000000e+01</td>\n",
       "      <td>1.500000e+01</td>\n",
       "      <td>2.800000e+01</td>\n",
       "      <td>8.450000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_american_indian</th>\n",
       "      <td>3621</td>\n",
       "      <td>4.407622e-01</td>\n",
       "      <td>2.972923e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>6.700000e+01</td>\n",
       "      <td>3909</td>\n",
       "      <td>1.246355e+00</td>\n",
       "      <td>6.696593e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>2.000000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>avg_hcc_risk_score</th>\n",
       "      <td>3623</td>\n",
       "      <td>2.076673e+00</td>\n",
       "      <td>4.793343e-01</td>\n",
       "      <td>8.220000e-01</td>\n",
       "      <td>1.773750e+00</td>\n",
       "      <td>2.013200e+00</td>\n",
       "      <td>2.314400e+00</td>\n",
       "      <td>5.672300e+00</td>\n",
       "      <td>3974</td>\n",
       "      <td>1.948033e+00</td>\n",
       "      <td>3.248053e-01</td>\n",
       "      <td>8.379000e-01</td>\n",
       "      <td>1.750500e+00</td>\n",
       "      <td>1.911650e+00</td>\n",
       "      <td>2.102050e+00</td>\n",
       "      <td>4.400800e+00</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>zip_1</th>\n",
       "      <td>3623</td>\n",
       "      <td>4.419568e+04</td>\n",
       "      <td>2.950022e+04</td>\n",
       "      <td>1.199000e+03</td>\n",
       "      <td>1.910400e+04</td>\n",
       "      <td>4.321000e+04</td>\n",
       "      <td>6.540100e+04</td>\n",
       "      <td>9.950800e+04</td>\n",
       "      <td>3974</td>\n",
       "      <td>4.879482e+04</td>\n",
       "      <td>2.956635e+04</td>\n",
       "      <td>1.020000e+03</td>\n",
       "      <td>2.350200e+04</td>\n",
       "      <td>4.487000e+04</td>\n",
       "      <td>7.702400e+04</td>\n",
       "      <td>9.964500e+04</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>drug_srvc_bin</th>\n",
       "      <td>3623</td>\n",
       "      <td>1.592603e-01</td>\n",
       "      <td>3.659691e-01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>3974</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>1.000000e+00</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>county_fips</th>\n",
       "      <td>3623</td>\n",
       "      <td>2.906056e+04</td>\n",
       "      <td>1.486215e+04</td>\n",
       "      <td>1.001000e+03</td>\n",
       "      <td>1.703100e+04</td>\n",
       "      <td>2.710900e+04</td>\n",
       "      <td>4.106700e+04</td>\n",
       "      <td>5.603700e+04</td>\n",
       "      <td>3974</td>\n",
       "      <td>2.750389e+04</td>\n",
       "      <td>1.584039e+04</td>\n",
       "      <td>1.003000e+03</td>\n",
       "      <td>1.209200e+04</td>\n",
       "      <td>2.710900e+04</td>\n",
       "      <td>4.101700e+04</td>\n",
       "      <td>5.602100e+04</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_drug_srvc_norm</th>\n",
       "      <td>3046</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>3974</td>\n",
       "      <td>1.303876e+02</td>\n",
       "      <td>2.536595e+02</td>\n",
       "      <td>1.150628e-02</td>\n",
       "      <td>5.938434e+01</td>\n",
       "      <td>1.076916e+02</td>\n",
       "      <td>1.675456e+02</td>\n",
       "      <td>1.436305e+04</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_unique_bene_with_drug_srvc_norm</th>\n",
       "      <td>3046</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>3974</td>\n",
       "      <td>2.804463e-01</td>\n",
       "      <td>1.278234e-01</td>\n",
       "      <td>1.072125e-02</td>\n",
       "      <td>1.881812e-01</td>\n",
       "      <td>2.770643e-01</td>\n",
       "      <td>3.669956e-01</td>\n",
       "      <td>9.230769e-01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_drug_submitted_charges_norm</th>\n",
       "      <td>3046</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>3974</td>\n",
       "      <td>4.908380e+03</td>\n",
       "      <td>6.395934e+03</td>\n",
       "      <td>8.235294e-02</td>\n",
       "      <td>2.138557e+03</td>\n",
       "      <td>4.117435e+03</td>\n",
       "      <td>6.500552e+03</td>\n",
       "      <td>2.833048e+05</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_drug_medicare_payment_amt_norm</th>\n",
       "      <td>3046</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>3974</td>\n",
       "      <td>1.606435e+03</td>\n",
       "      <td>2.771230e+03</td>\n",
       "      <td>1.492933e-02</td>\n",
       "      <td>8.070022e+02</td>\n",
       "      <td>1.390263e+03</td>\n",
       "      <td>2.026291e+03</td>\n",
       "      <td>1.338959e+05</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_hcpcs_associated_med_srvc_norm</th>\n",
       "      <td>3046</td>\n",
       "      <td>1.155877e-01</td>\n",
       "      <td>1.102858e-01</td>\n",
       "      <td>5.725191e-03</td>\n",
       "      <td>5.041860e-02</td>\n",
       "      <td>7.882554e-02</td>\n",
       "      <td>1.359506e-01</td>\n",
       "      <td>1.071429e+00</td>\n",
       "      <td>3974</td>\n",
       "      <td>1.405880e-01</td>\n",
       "      <td>1.160538e-01</td>\n",
       "      <td>1.365462e-02</td>\n",
       "      <td>7.770332e-02</td>\n",
       "      <td>1.108047e-01</td>\n",
       "      <td>1.673010e-01</td>\n",
       "      <td>3.238095e+00</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_med_srvc_norm</th>\n",
       "      <td>3046</td>\n",
       "      <td>3.488886e+00</td>\n",
       "      <td>1.776073e+00</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>2.520679e+00</td>\n",
       "      <td>3.145433e+00</td>\n",
       "      <td>3.992141e+00</td>\n",
       "      <td>2.436000e+01</td>\n",
       "      <td>3974</td>\n",
       "      <td>1.377022e+01</td>\n",
       "      <td>9.913270e+00</td>\n",
       "      <td>1.304511e+00</td>\n",
       "      <td>7.626490e+00</td>\n",
       "      <td>1.172103e+01</td>\n",
       "      <td>1.737144e+01</td>\n",
       "      <td>2.144310e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_unique_bene_with_med_srvc_norm</th>\n",
       "      <td>3046</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>3974</td>\n",
       "      <td>9.993155e-01</td>\n",
       "      <td>3.607267e-03</td>\n",
       "      <td>9.200000e-01</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>1.000000e+00</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_med_submitted_charges_norm</th>\n",
       "      <td>3046</td>\n",
       "      <td>7.895507e+02</td>\n",
       "      <td>6.339814e+02</td>\n",
       "      <td>1.700000e+01</td>\n",
       "      <td>4.615317e+02</td>\n",
       "      <td>6.404172e+02</td>\n",
       "      <td>9.300633e+02</td>\n",
       "      <td>1.247453e+04</td>\n",
       "      <td>3974</td>\n",
       "      <td>1.682763e+03</td>\n",
       "      <td>1.171308e+03</td>\n",
       "      <td>1.785043e+02</td>\n",
       "      <td>9.481486e+02</td>\n",
       "      <td>1.429204e+03</td>\n",
       "      <td>2.074914e+03</td>\n",
       "      <td>1.928637e+04</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_med_medicare_payment_amt_norm</th>\n",
       "      <td>3046</td>\n",
       "      <td>2.317757e+02</td>\n",
       "      <td>1.296522e+02</td>\n",
       "      <td>2.985000e+00</td>\n",
       "      <td>1.558581e+02</td>\n",
       "      <td>2.051864e+02</td>\n",
       "      <td>2.717242e+02</td>\n",
       "      <td>2.360189e+03</td>\n",
       "      <td>3974</td>\n",
       "      <td>5.430112e+02</td>\n",
       "      <td>3.265488e+02</td>\n",
       "      <td>6.516900e+01</td>\n",
       "      <td>3.431000e+02</td>\n",
       "      <td>4.779195e+02</td>\n",
       "      <td>6.567560e+02</td>\n",
       "      <td>6.002191e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_female_norm</th>\n",
       "      <td>3317</td>\n",
       "      <td>5.505633e-01</td>\n",
       "      <td>1.301346e-01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>4.728682e-01</td>\n",
       "      <td>5.515464e-01</td>\n",
       "      <td>6.178862e-01</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>3953</td>\n",
       "      <td>5.929653e-01</td>\n",
       "      <td>7.727352e-02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>5.513627e-01</td>\n",
       "      <td>5.880399e-01</td>\n",
       "      <td>6.297468e-01</td>\n",
       "      <td>1.000000e+00</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_male_norm</th>\n",
       "      <td>3317</td>\n",
       "      <td>4.494000e-01</td>\n",
       "      <td>1.301535e-01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>3.820225e-01</td>\n",
       "      <td>4.484536e-01</td>\n",
       "      <td>5.271318e-01</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>3953</td>\n",
       "      <td>4.070014e-01</td>\n",
       "      <td>7.728076e-02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>3.702422e-01</td>\n",
       "      <td>4.119548e-01</td>\n",
       "      <td>4.484536e-01</td>\n",
       "      <td>1.000000e+00</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_non_his_white_norm</th>\n",
       "      <td>3623</td>\n",
       "      <td>7.354761e-01</td>\n",
       "      <td>1.865181e-01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>6.402247e-01</td>\n",
       "      <td>7.840000e-01</td>\n",
       "      <td>8.747990e-01</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>3974</td>\n",
       "      <td>7.915785e-01</td>\n",
       "      <td>1.772107e-01</td>\n",
       "      <td>1.717791e-02</td>\n",
       "      <td>7.346401e-01</td>\n",
       "      <td>8.416488e-01</td>\n",
       "      <td>9.147420e-01</td>\n",
       "      <td>1.000000e+00</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_african_american_norm</th>\n",
       "      <td>3623</td>\n",
       "      <td>1.251834e-01</td>\n",
       "      <td>1.372094e-01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>3.658537e-02</td>\n",
       "      <td>8.227848e-02</td>\n",
       "      <td>1.538462e-01</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>3974</td>\n",
       "      <td>9.679655e-02</td>\n",
       "      <td>1.128044e-01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>2.783997e-02</td>\n",
       "      <td>6.053159e-02</td>\n",
       "      <td>1.245426e-01</td>\n",
       "      <td>9.311475e-01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_asian_norm</th>\n",
       "      <td>3623</td>\n",
       "      <td>3.684886e-02</td>\n",
       "      <td>5.138356e-02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.092896e-02</td>\n",
       "      <td>2.307692e-02</td>\n",
       "      <td>4.615385e-02</td>\n",
       "      <td>7.485380e-01</td>\n",
       "      <td>3970</td>\n",
       "      <td>3.216276e-02</td>\n",
       "      <td>6.850143e-02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>7.491275e-03</td>\n",
       "      <td>1.586463e-02</td>\n",
       "      <td>3.244017e-02</td>\n",
       "      <td>9.730061e-01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_hispanic_norm</th>\n",
       "      <td>3623</td>\n",
       "      <td>9.085254e-02</td>\n",
       "      <td>9.823518e-02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>3.174603e-02</td>\n",
       "      <td>6.134969e-02</td>\n",
       "      <td>1.111111e-01</td>\n",
       "      <td>8.732394e-01</td>\n",
       "      <td>3974</td>\n",
       "      <td>7.199493e-02</td>\n",
       "      <td>1.094006e-01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>2.060408e-02</td>\n",
       "      <td>3.622342e-02</td>\n",
       "      <td>7.284768e-02</td>\n",
       "      <td>9.396226e-01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_american_indian_norm</th>\n",
       "      <td>3621</td>\n",
       "      <td>2.184167e-03</td>\n",
       "      <td>1.921340e-02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>3909</td>\n",
       "      <td>2.816047e-03</td>\n",
       "      <td>1.687912e-02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>5.877193e-01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_asthma_norm</th>\n",
       "      <td>2382</td>\n",
       "      <td>9.305626e-02</td>\n",
       "      <td>3.989776e-02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>7.000000e-02</td>\n",
       "      <td>9.000000e-02</td>\n",
       "      <td>1.100000e-01</td>\n",
       "      <td>4.200000e-01</td>\n",
       "      <td>3710</td>\n",
       "      <td>8.421024e-02</td>\n",
       "      <td>2.806338e-02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>7.000000e-02</td>\n",
       "      <td>8.000000e-02</td>\n",
       "      <td>1.000000e-01</td>\n",
       "      <td>2.500000e-01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_alzheimers_dementia_norm</th>\n",
       "      <td>2324</td>\n",
       "      <td>1.071773e-01</td>\n",
       "      <td>7.157620e-02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>7.000000e-02</td>\n",
       "      <td>9.000000e-02</td>\n",
       "      <td>1.300000e-01</td>\n",
       "      <td>7.500000e-01</td>\n",
       "      <td>3743</td>\n",
       "      <td>1.145739e-01</td>\n",
       "      <td>5.644723e-02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>8.000000e-02</td>\n",
       "      <td>1.000000e-01</td>\n",
       "      <td>1.300000e-01</td>\n",
       "      <td>7.500000e-01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_artrial_fibrillation_norm</th>\n",
       "      <td>2683</td>\n",
       "      <td>1.394111e-01</td>\n",
       "      <td>5.033397e-02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.100000e-01</td>\n",
       "      <td>1.300000e-01</td>\n",
       "      <td>1.700000e-01</td>\n",
       "      <td>4.500000e-01</td>\n",
       "      <td>3854</td>\n",
       "      <td>1.421328e-01</td>\n",
       "      <td>4.150888e-02</td>\n",
       "      <td>3.000000e-02</td>\n",
       "      <td>1.125000e-01</td>\n",
       "      <td>1.400000e-01</td>\n",
       "      <td>1.600000e-01</td>\n",
       "      <td>5.300000e-01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_cancer_norm</th>\n",
       "      <td>3151</td>\n",
       "      <td>4.349222e-01</td>\n",
       "      <td>1.795562e-01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>3.300000e-01</td>\n",
       "      <td>4.400000e-01</td>\n",
       "      <td>5.400000e-01</td>\n",
       "      <td>7.500000e-01</td>\n",
       "      <td>3956</td>\n",
       "      <td>4.285617e-01</td>\n",
       "      <td>1.116441e-01</td>\n",
       "      <td>5.000000e-02</td>\n",
       "      <td>3.700000e-01</td>\n",
       "      <td>4.300000e-01</td>\n",
       "      <td>4.900000e-01</td>\n",
       "      <td>7.500000e-01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_chronic_obstructive_pulmonary_norm</th>\n",
       "      <td>3009</td>\n",
       "      <td>2.231771e-01</td>\n",
       "      <td>8.898554e-02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.600000e-01</td>\n",
       "      <td>2.100000e-01</td>\n",
       "      <td>2.700000e-01</td>\n",
       "      <td>6.800000e-01</td>\n",
       "      <td>3902</td>\n",
       "      <td>2.188134e-01</td>\n",
       "      <td>7.381050e-02</td>\n",
       "      <td>3.000000e-02</td>\n",
       "      <td>1.700000e-01</td>\n",
       "      <td>2.100000e-01</td>\n",
       "      <td>2.600000e-01</td>\n",
       "      <td>6.000000e-01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_depression_norm</th>\n",
       "      <td>3222</td>\n",
       "      <td>2.568405e-01</td>\n",
       "      <td>7.201417e-02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>2.100000e-01</td>\n",
       "      <td>2.500000e-01</td>\n",
       "      <td>3.000000e-01</td>\n",
       "      <td>7.500000e-01</td>\n",
       "      <td>3932</td>\n",
       "      <td>2.201017e-01</td>\n",
       "      <td>5.551122e-02</td>\n",
       "      <td>5.000000e-02</td>\n",
       "      <td>1.800000e-01</td>\n",
       "      <td>2.100000e-01</td>\n",
       "      <td>2.500000e-01</td>\n",
       "      <td>5.700000e-01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_diabetes_norm</th>\n",
       "      <td>3298</td>\n",
       "      <td>3.397665e-01</td>\n",
       "      <td>8.466623e-02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>2.800000e-01</td>\n",
       "      <td>3.300000e-01</td>\n",
       "      <td>3.900000e-01</td>\n",
       "      <td>7.500000e-01</td>\n",
       "      <td>3962</td>\n",
       "      <td>3.529758e-01</td>\n",
       "      <td>8.776103e-02</td>\n",
       "      <td>1.300000e-01</td>\n",
       "      <td>3.000000e-01</td>\n",
       "      <td>3.400000e-01</td>\n",
       "      <td>4.000000e-01</td>\n",
       "      <td>7.500000e-01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_heart_failure_norm</th>\n",
       "      <td>3148</td>\n",
       "      <td>2.603335e-01</td>\n",
       "      <td>1.009405e-01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.900000e-01</td>\n",
       "      <td>2.400000e-01</td>\n",
       "      <td>3.100000e-01</td>\n",
       "      <td>7.500000e-01</td>\n",
       "      <td>3929</td>\n",
       "      <td>2.560524e-01</td>\n",
       "      <td>8.794131e-02</td>\n",
       "      <td>6.000000e-02</td>\n",
       "      <td>1.900000e-01</td>\n",
       "      <td>2.400000e-01</td>\n",
       "      <td>3.000000e-01</td>\n",
       "      <td>7.500000e-01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_hypertension_norm</th>\n",
       "      <td>3542</td>\n",
       "      <td>6.849294e-01</td>\n",
       "      <td>7.589647e-02</td>\n",
       "      <td>3.000000e-01</td>\n",
       "      <td>6.400000e-01</td>\n",
       "      <td>7.100000e-01</td>\n",
       "      <td>7.500000e-01</td>\n",
       "      <td>7.500000e-01</td>\n",
       "      <td>3971</td>\n",
       "      <td>6.942130e-01</td>\n",
       "      <td>6.907342e-02</td>\n",
       "      <td>3.000000e-01</td>\n",
       "      <td>6.600000e-01</td>\n",
       "      <td>7.200000e-01</td>\n",
       "      <td>7.500000e-01</td>\n",
       "      <td>7.500000e-01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_ischemic_heart_norm</th>\n",
       "      <td>3350</td>\n",
       "      <td>3.959642e-01</td>\n",
       "      <td>1.108258e-01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>3.200000e-01</td>\n",
       "      <td>3.900000e-01</td>\n",
       "      <td>4.600000e-01</td>\n",
       "      <td>7.500000e-01</td>\n",
       "      <td>3963</td>\n",
       "      <td>4.112945e-01</td>\n",
       "      <td>1.062087e-01</td>\n",
       "      <td>1.300000e-01</td>\n",
       "      <td>3.400000e-01</td>\n",
       "      <td>4.000000e-01</td>\n",
       "      <td>4.800000e-01</td>\n",
       "      <td>7.500000e-01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_osteoporosis_norm</th>\n",
       "      <td>2375</td>\n",
       "      <td>1.066526e-01</td>\n",
       "      <td>4.208392e-02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>8.000000e-02</td>\n",
       "      <td>1.000000e-01</td>\n",
       "      <td>1.300000e-01</td>\n",
       "      <td>4.600000e-01</td>\n",
       "      <td>3799</td>\n",
       "      <td>1.141011e-01</td>\n",
       "      <td>4.538846e-02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>8.000000e-02</td>\n",
       "      <td>1.100000e-01</td>\n",
       "      <td>1.300000e-01</td>\n",
       "      <td>5.800000e-01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_rheumatoid_arthritis_osteoarthirtis_norm</th>\n",
       "      <td>3349</td>\n",
       "      <td>3.672589e-01</td>\n",
       "      <td>8.056112e-02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>3.100000e-01</td>\n",
       "      <td>3.600000e-01</td>\n",
       "      <td>4.100000e-01</td>\n",
       "      <td>7.500000e-01</td>\n",
       "      <td>3963</td>\n",
       "      <td>3.845874e-01</td>\n",
       "      <td>7.057241e-02</td>\n",
       "      <td>1.800000e-01</td>\n",
       "      <td>3.400000e-01</td>\n",
       "      <td>3.800000e-01</td>\n",
       "      <td>4.300000e-01</td>\n",
       "      <td>7.500000e-01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_schizophrenia_psychotic_norm</th>\n",
       "      <td>1548</td>\n",
       "      <td>5.513566e-02</td>\n",
       "      <td>4.346552e-02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>3.750000e-02</td>\n",
       "      <td>5.000000e-02</td>\n",
       "      <td>7.000000e-02</td>\n",
       "      <td>7.500000e-01</td>\n",
       "      <td>2879</td>\n",
       "      <td>4.756165e-02</td>\n",
       "      <td>2.684267e-02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>3.000000e-02</td>\n",
       "      <td>4.000000e-02</td>\n",
       "      <td>6.000000e-02</td>\n",
       "      <td>2.800000e-01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_stroke_norm</th>\n",
       "      <td>1838</td>\n",
       "      <td>6.926551e-02</td>\n",
       "      <td>3.955460e-02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>5.000000e-02</td>\n",
       "      <td>6.000000e-02</td>\n",
       "      <td>8.000000e-02</td>\n",
       "      <td>4.100000e-01</td>\n",
       "      <td>3432</td>\n",
       "      <td>6.558566e-02</td>\n",
       "      <td>2.784090e-02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>5.000000e-02</td>\n",
       "      <td>6.000000e-02</td>\n",
       "      <td>8.000000e-02</td>\n",
       "      <td>2.300000e-01</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>65 rows × 16 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "num_drug_srvc                                False                \\\n",
       "                                             count          mean   \n",
       "npi                                           3623  1.502523e+09   \n",
       "num_hcpcs                                     3623  1.634861e+01   \n",
       "num_services                                  3623  9.465551e+02   \n",
       "num_unique_bene                               3623  2.189845e+02   \n",
       "total_submitted_charges                       3623  1.635423e+05   \n",
       "total_medicare_payment_amt                    3623  5.231779e+04   \n",
       "drug_suppress_indicator                       3623  1.592603e-01   \n",
       "num_hcpcs_associated_drug_srvc                3046  0.000000e+00   \n",
       "num_drug_srvc                                 3046  0.000000e+00   \n",
       "num_unique_bene_with_drug_srvc                3046  0.000000e+00   \n",
       "total_drug_submitted_charges                  3046  0.000000e+00   \n",
       "total_drug_medicare_payment_amt               3046  0.000000e+00   \n",
       "medical_suppress_indicator                    3623  1.592603e-01   \n",
       "num_hcpcs_associated_med_srvc                 3046  1.427610e+01   \n",
       "num_med_srvc                                  3046  7.918838e+02   \n",
       "num_unique_bene_with_med_srvc                 3046  2.178109e+02   \n",
       "total_med_submitted_charges                   3046  1.554833e+05   \n",
       "total_med_medicare_payment_amt                3046  4.819442e+04   \n",
       "avg_age_bene                                  3623  7.070466e+01   \n",
       "num_female                                    3317  1.347492e+02   \n",
       "num_male                                      3317  1.006672e+02   \n",
       "num_non_his_white                             3623  1.709274e+02   \n",
       "num_african_american                          3623  2.581010e+01   \n",
       "num_asian                                     3623  5.988131e+00   \n",
       "num_hispanic                                  3623  1.467403e+01   \n",
       "num_american_indian                           3621  4.407622e-01   \n",
       "avg_hcc_risk_score                            3623  2.076673e+00   \n",
       "zip_1                                         3623  4.419568e+04   \n",
       "drug_srvc_bin                                 3623  1.592603e-01   \n",
       "county_fips                                   3623  2.906056e+04   \n",
       "...                                            ...           ...   \n",
       "num_drug_srvc_norm                            3046  0.000000e+00   \n",
       "num_unique_bene_with_drug_srvc_norm           3046  0.000000e+00   \n",
       "total_drug_submitted_charges_norm             3046  0.000000e+00   \n",
       "total_drug_medicare_payment_amt_norm          3046  0.000000e+00   \n",
       "num_hcpcs_associated_med_srvc_norm            3046  1.155877e-01   \n",
       "num_med_srvc_norm                             3046  3.488886e+00   \n",
       "num_unique_bene_with_med_srvc_norm            3046  1.000000e+00   \n",
       "total_med_submitted_charges_norm              3046  7.895507e+02   \n",
       "total_med_medicare_payment_amt_norm           3046  2.317757e+02   \n",
       "num_female_norm                               3317  5.505633e-01   \n",
       "num_male_norm                                 3317  4.494000e-01   \n",
       "num_non_his_white_norm                        3623  7.354761e-01   \n",
       "num_african_american_norm                     3623  1.251834e-01   \n",
       "num_asian_norm                                3623  3.684886e-02   \n",
       "num_hispanic_norm                             3623  9.085254e-02   \n",
       "num_american_indian_norm                      3621  2.184167e-03   \n",
       "num_asthma_norm                               2382  9.305626e-02   \n",
       "num_alzheimers_dementia_norm                  2324  1.071773e-01   \n",
       "num_artrial_fibrillation_norm                 2683  1.394111e-01   \n",
       "num_cancer_norm                               3151  4.349222e-01   \n",
       "num_chronic_obstructive_pulmonary_norm        3009  2.231771e-01   \n",
       "num_depression_norm                           3222  2.568405e-01   \n",
       "num_diabetes_norm                             3298  3.397665e-01   \n",
       "num_heart_failure_norm                        3148  2.603335e-01   \n",
       "num_hypertension_norm                         3542  6.849294e-01   \n",
       "num_ischemic_heart_norm                       3350  3.959642e-01   \n",
       "num_osteoporosis_norm                         2375  1.066526e-01   \n",
       "num_rheumatoid_arthritis_osteoarthirtis_norm  3349  3.672589e-01   \n",
       "num_schizophrenia_psychotic_norm              1548  5.513566e-02   \n",
       "num_stroke_norm                               1838  6.926551e-02   \n",
       "\n",
       "num_drug_srvc                                                             \\\n",
       "                                                       std           min   \n",
       "npi                                           2.877838e+08  1.003015e+09   \n",
       "num_hcpcs                                     9.439872e+00  1.000000e+00   \n",
       "num_services                                  1.377693e+03  1.200000e+01   \n",
       "num_unique_bene                               1.729782e+02  1.100000e+01   \n",
       "total_submitted_charges                       1.609505e+05  2.040000e+02   \n",
       "total_medicare_payment_amt                    5.606416e+04  3.582000e+01   \n",
       "drug_suppress_indicator                       3.659691e-01  0.000000e+00   \n",
       "num_hcpcs_associated_drug_srvc                0.000000e+00  0.000000e+00   \n",
       "num_drug_srvc                                 0.000000e+00  0.000000e+00   \n",
       "num_unique_bene_with_drug_srvc                0.000000e+00  0.000000e+00   \n",
       "total_drug_submitted_charges                  0.000000e+00  0.000000e+00   \n",
       "total_drug_medicare_payment_amt               0.000000e+00  0.000000e+00   \n",
       "medical_suppress_indicator                    3.659691e-01  0.000000e+00   \n",
       "num_hcpcs_associated_med_srvc                 6.150141e+00  1.000000e+00   \n",
       "num_med_srvc                                  1.116424e+03  1.200000e+01   \n",
       "num_unique_bene_with_med_srvc                 1.706383e+02  1.100000e+01   \n",
       "total_med_submitted_charges                   1.440358e+05  2.040000e+02   \n",
       "total_med_medicare_payment_amt                4.500165e+04  3.582000e+01   \n",
       "avg_age_bene                                  4.256609e+00  2.600000e+01   \n",
       "num_female                                    1.090165e+02  0.000000e+00   \n",
       "num_male                                      7.258997e+01  0.000000e+00   \n",
       "num_non_his_white                             1.521177e+02  0.000000e+00   \n",
       "num_african_american                          4.024530e+01  0.000000e+00   \n",
       "num_asian                                     1.021101e+01  0.000000e+00   \n",
       "num_hispanic                                  3.129648e+01  0.000000e+00   \n",
       "num_american_indian                           2.972923e+00  0.000000e+00   \n",
       "avg_hcc_risk_score                            4.793343e-01  8.220000e-01   \n",
       "zip_1                                         2.950022e+04  1.199000e+03   \n",
       "drug_srvc_bin                                 3.659691e-01  0.000000e+00   \n",
       "county_fips                                   1.486215e+04  1.001000e+03   \n",
       "...                                                    ...           ...   \n",
       "num_drug_srvc_norm                            0.000000e+00  0.000000e+00   \n",
       "num_unique_bene_with_drug_srvc_norm           0.000000e+00  0.000000e+00   \n",
       "total_drug_submitted_charges_norm             0.000000e+00  0.000000e+00   \n",
       "total_drug_medicare_payment_amt_norm          0.000000e+00  0.000000e+00   \n",
       "num_hcpcs_associated_med_srvc_norm            1.102858e-01  5.725191e-03   \n",
       "num_med_srvc_norm                             1.776073e+00  1.000000e+00   \n",
       "num_unique_bene_with_med_srvc_norm            0.000000e+00  1.000000e+00   \n",
       "total_med_submitted_charges_norm              6.339814e+02  1.700000e+01   \n",
       "total_med_medicare_payment_amt_norm           1.296522e+02  2.985000e+00   \n",
       "num_female_norm                               1.301346e-01  0.000000e+00   \n",
       "num_male_norm                                 1.301535e-01  0.000000e+00   \n",
       "num_non_his_white_norm                        1.865181e-01  0.000000e+00   \n",
       "num_african_american_norm                     1.372094e-01  0.000000e+00   \n",
       "num_asian_norm                                5.138356e-02  0.000000e+00   \n",
       "num_hispanic_norm                             9.823518e-02  0.000000e+00   \n",
       "num_american_indian_norm                      1.921340e-02  0.000000e+00   \n",
       "num_asthma_norm                               3.989776e-02  0.000000e+00   \n",
       "num_alzheimers_dementia_norm                  7.157620e-02  0.000000e+00   \n",
       "num_artrial_fibrillation_norm                 5.033397e-02  0.000000e+00   \n",
       "num_cancer_norm                               1.795562e-01  0.000000e+00   \n",
       "num_chronic_obstructive_pulmonary_norm        8.898554e-02  0.000000e+00   \n",
       "num_depression_norm                           7.201417e-02  0.000000e+00   \n",
       "num_diabetes_norm                             8.466623e-02  0.000000e+00   \n",
       "num_heart_failure_norm                        1.009405e-01  0.000000e+00   \n",
       "num_hypertension_norm                         7.589647e-02  3.000000e-01   \n",
       "num_ischemic_heart_norm                       1.108258e-01  0.000000e+00   \n",
       "num_osteoporosis_norm                         4.208392e-02  0.000000e+00   \n",
       "num_rheumatoid_arthritis_osteoarthirtis_norm  8.056112e-02  0.000000e+00   \n",
       "num_schizophrenia_psychotic_norm              4.346552e-02  0.000000e+00   \n",
       "num_stroke_norm                               3.955460e-02  0.000000e+00   \n",
       "\n",
       "num_drug_srvc                                                             \\\n",
       "                                                       25%           50%   \n",
       "npi                                           1.245527e+09  1.497836e+09   \n",
       "num_hcpcs                                     1.100000e+01  1.500000e+01   \n",
       "num_services                                  3.075000e+02  6.480000e+02   \n",
       "num_unique_bene                               8.600000e+01  1.810000e+02   \n",
       "total_submitted_charges                       6.157649e+04  1.266400e+05   \n",
       "total_medicare_payment_amt                    2.017978e+04  4.108129e+04   \n",
       "drug_suppress_indicator                       0.000000e+00  0.000000e+00   \n",
       "num_hcpcs_associated_drug_srvc                0.000000e+00  0.000000e+00   \n",
       "num_drug_srvc                                 0.000000e+00  0.000000e+00   \n",
       "num_unique_bene_with_drug_srvc                0.000000e+00  0.000000e+00   \n",
       "total_drug_submitted_charges                  0.000000e+00  0.000000e+00   \n",
       "total_drug_medicare_payment_amt               0.000000e+00  0.000000e+00   \n",
       "medical_suppress_indicator                    0.000000e+00  0.000000e+00   \n",
       "num_hcpcs_associated_med_srvc                 1.100000e+01  1.400000e+01   \n",
       "num_med_srvc                                  2.762500e+02  5.750000e+02   \n",
       "num_unique_bene_with_med_srvc                 8.625000e+01  1.780000e+02   \n",
       "total_med_submitted_charges                   5.923250e+04  1.238025e+05   \n",
       "total_med_medicare_payment_amt                1.876575e+04  3.835312e+04   \n",
       "avg_age_bene                                  6.900000e+01  7.200000e+01   \n",
       "num_female                                    5.000000e+01  1.060000e+02   \n",
       "num_male                                      4.500000e+01  8.500000e+01   \n",
       "num_non_his_white                             5.500000e+01  1.310000e+02   \n",
       "num_african_american                          5.000000e+00  1.200000e+01   \n",
       "num_asian                                     2.000000e+00  4.000000e+00   \n",
       "num_hispanic                                  6.000000e+00  1.000000e+01   \n",
       "num_american_indian                           0.000000e+00  0.000000e+00   \n",
       "avg_hcc_risk_score                            1.773750e+00  2.013200e+00   \n",
       "zip_1                                         1.910400e+04  4.321000e+04   \n",
       "drug_srvc_bin                                 0.000000e+00  0.000000e+00   \n",
       "county_fips                                   1.703100e+04  2.710900e+04   \n",
       "...                                                    ...           ...   \n",
       "num_drug_srvc_norm                            0.000000e+00  0.000000e+00   \n",
       "num_unique_bene_with_drug_srvc_norm           0.000000e+00  0.000000e+00   \n",
       "total_drug_submitted_charges_norm             0.000000e+00  0.000000e+00   \n",
       "total_drug_medicare_payment_amt_norm          0.000000e+00  0.000000e+00   \n",
       "num_hcpcs_associated_med_srvc_norm            5.041860e-02  7.882554e-02   \n",
       "num_med_srvc_norm                             2.520679e+00  3.145433e+00   \n",
       "num_unique_bene_with_med_srvc_norm            1.000000e+00  1.000000e+00   \n",
       "total_med_submitted_charges_norm              4.615317e+02  6.404172e+02   \n",
       "total_med_medicare_payment_amt_norm           1.558581e+02  2.051864e+02   \n",
       "num_female_norm                               4.728682e-01  5.515464e-01   \n",
       "num_male_norm                                 3.820225e-01  4.484536e-01   \n",
       "num_non_his_white_norm                        6.402247e-01  7.840000e-01   \n",
       "num_african_american_norm                     3.658537e-02  8.227848e-02   \n",
       "num_asian_norm                                1.092896e-02  2.307692e-02   \n",
       "num_hispanic_norm                             3.174603e-02  6.134969e-02   \n",
       "num_american_indian_norm                      0.000000e+00  0.000000e+00   \n",
       "num_asthma_norm                               7.000000e-02  9.000000e-02   \n",
       "num_alzheimers_dementia_norm                  7.000000e-02  9.000000e-02   \n",
       "num_artrial_fibrillation_norm                 1.100000e-01  1.300000e-01   \n",
       "num_cancer_norm                               3.300000e-01  4.400000e-01   \n",
       "num_chronic_obstructive_pulmonary_norm        1.600000e-01  2.100000e-01   \n",
       "num_depression_norm                           2.100000e-01  2.500000e-01   \n",
       "num_diabetes_norm                             2.800000e-01  3.300000e-01   \n",
       "num_heart_failure_norm                        1.900000e-01  2.400000e-01   \n",
       "num_hypertension_norm                         6.400000e-01  7.100000e-01   \n",
       "num_ischemic_heart_norm                       3.200000e-01  3.900000e-01   \n",
       "num_osteoporosis_norm                         8.000000e-02  1.000000e-01   \n",
       "num_rheumatoid_arthritis_osteoarthirtis_norm  3.100000e-01  3.600000e-01   \n",
       "num_schizophrenia_psychotic_norm              3.750000e-02  5.000000e-02   \n",
       "num_stroke_norm                               5.000000e-02  6.000000e-02   \n",
       "\n",
       "num_drug_srvc                                                             \\\n",
       "                                                       75%           max   \n",
       "npi                                           1.750385e+09  1.992999e+09   \n",
       "num_hcpcs                                     1.900000e+01  1.230000e+02   \n",
       "num_services                                  1.158500e+03  3.619800e+04   \n",
       "num_unique_bene                               3.080000e+02  1.596000e+03   \n",
       "total_submitted_charges                       2.132265e+05  2.250864e+06   \n",
       "total_medicare_payment_amt                    6.888412e+04  1.225143e+06   \n",
       "drug_suppress_indicator                       0.000000e+00  1.000000e+00   \n",
       "num_hcpcs_associated_drug_srvc                0.000000e+00  0.000000e+00   \n",
       "num_drug_srvc                                 0.000000e+00  0.000000e+00   \n",
       "num_unique_bene_with_drug_srvc                0.000000e+00  0.000000e+00   \n",
       "total_drug_submitted_charges                  0.000000e+00  0.000000e+00   \n",
       "total_drug_medicare_payment_amt               0.000000e+00  0.000000e+00   \n",
       "medical_suppress_indicator                    0.000000e+00  1.000000e+00   \n",
       "num_hcpcs_associated_med_srvc                 1.700000e+01  1.140000e+02   \n",
       "num_med_srvc                                  1.028000e+03  3.619800e+04   \n",
       "num_unique_bene_with_med_srvc                 3.050000e+02  1.560000e+03   \n",
       "total_med_submitted_charges                   2.064218e+05  1.856770e+06   \n",
       "total_med_medicare_payment_amt                6.482306e+04  7.717201e+05   \n",
       "avg_age_bene                                  7.300000e+01  8.800000e+01   \n",
       "num_female                                    1.910000e+02  1.044000e+03   \n",
       "num_male                                      1.390000e+02  6.350000e+02   \n",
       "num_non_his_white                             2.480000e+02  1.217000e+03   \n",
       "num_african_american                          2.900000e+01  4.990000e+02   \n",
       "num_asian                                     7.000000e+00  2.440000e+02   \n",
       "num_hispanic                                  1.600000e+01  1.184000e+03   \n",
       "num_american_indian                           0.000000e+00  6.700000e+01   \n",
       "avg_hcc_risk_score                            2.314400e+00  5.672300e+00   \n",
       "zip_1                                         6.540100e+04  9.950800e+04   \n",
       "drug_srvc_bin                                 0.000000e+00  1.000000e+00   \n",
       "county_fips                                   4.106700e+04  5.603700e+04   \n",
       "...                                                    ...           ...   \n",
       "num_drug_srvc_norm                            0.000000e+00  0.000000e+00   \n",
       "num_unique_bene_with_drug_srvc_norm           0.000000e+00  0.000000e+00   \n",
       "total_drug_submitted_charges_norm             0.000000e+00  0.000000e+00   \n",
       "total_drug_medicare_payment_amt_norm          0.000000e+00  0.000000e+00   \n",
       "num_hcpcs_associated_med_srvc_norm            1.359506e-01  1.071429e+00   \n",
       "num_med_srvc_norm                             3.992141e+00  2.436000e+01   \n",
       "num_unique_bene_with_med_srvc_norm            1.000000e+00  1.000000e+00   \n",
       "total_med_submitted_charges_norm              9.300633e+02  1.247453e+04   \n",
       "total_med_medicare_payment_amt_norm           2.717242e+02  2.360189e+03   \n",
       "num_female_norm                               6.178862e-01  1.000000e+00   \n",
       "num_male_norm                                 5.271318e-01  1.000000e+00   \n",
       "num_non_his_white_norm                        8.747990e-01  1.000000e+00   \n",
       "num_african_american_norm                     1.538462e-01  1.000000e+00   \n",
       "num_asian_norm                                4.615385e-02  7.485380e-01   \n",
       "num_hispanic_norm                             1.111111e-01  8.732394e-01   \n",
       "num_american_indian_norm                      0.000000e+00  1.000000e+00   \n",
       "num_asthma_norm                               1.100000e-01  4.200000e-01   \n",
       "num_alzheimers_dementia_norm                  1.300000e-01  7.500000e-01   \n",
       "num_artrial_fibrillation_norm                 1.700000e-01  4.500000e-01   \n",
       "num_cancer_norm                               5.400000e-01  7.500000e-01   \n",
       "num_chronic_obstructive_pulmonary_norm        2.700000e-01  6.800000e-01   \n",
       "num_depression_norm                           3.000000e-01  7.500000e-01   \n",
       "num_diabetes_norm                             3.900000e-01  7.500000e-01   \n",
       "num_heart_failure_norm                        3.100000e-01  7.500000e-01   \n",
       "num_hypertension_norm                         7.500000e-01  7.500000e-01   \n",
       "num_ischemic_heart_norm                       4.600000e-01  7.500000e-01   \n",
       "num_osteoporosis_norm                         1.300000e-01  4.600000e-01   \n",
       "num_rheumatoid_arthritis_osteoarthirtis_norm  4.100000e-01  7.500000e-01   \n",
       "num_schizophrenia_psychotic_norm              7.000000e-02  7.500000e-01   \n",
       "num_stroke_norm                               8.000000e-02  4.100000e-01   \n",
       "\n",
       "num_drug_srvc                                True                 \\\n",
       "                                             count          mean   \n",
       "npi                                           3974  1.495638e+09   \n",
       "num_hcpcs                                     3974  1.065023e+02   \n",
       "num_services                                  3974  7.383461e+04   \n",
       "num_unique_bene                               3974  5.080088e+02   \n",
       "total_submitted_charges                       3974  3.341412e+06   \n",
       "total_medicare_payment_amt                    3974  1.080608e+06   \n",
       "drug_suppress_indicator                       3974  0.000000e+00   \n",
       "num_hcpcs_associated_drug_srvc                3974  5.205838e+01   \n",
       "num_drug_srvc                                 3974  6.663352e+04   \n",
       "num_unique_bene_with_drug_srvc                3974  1.470518e+02   \n",
       "total_drug_submitted_charges                  3974  2.481549e+06   \n",
       "total_drug_medicare_payment_amt               3974  8.071928e+05   \n",
       "medical_suppress_indicator                    3974  0.000000e+00   \n",
       "num_hcpcs_associated_med_srvc                 3974  5.444389e+01   \n",
       "num_med_srvc                                  3974  7.201095e+03   \n",
       "num_unique_bene_with_med_srvc                 3974  5.077267e+02   \n",
       "total_med_submitted_charges                   3974  8.598633e+05   \n",
       "total_med_medicare_payment_amt                3974  2.734152e+05   \n",
       "avg_age_bene                                  3974  7.337771e+01   \n",
       "num_female                                    3953  3.027055e+02   \n",
       "num_male                                      3953  2.064996e+02   \n",
       "num_non_his_white                             3974  4.131600e+02   \n",
       "num_african_american                          3974  4.812506e+01   \n",
       "num_asian                                     3970  1.289950e+01   \n",
       "num_hispanic                                  3974  3.038903e+01   \n",
       "num_american_indian                           3909  1.246355e+00   \n",
       "avg_hcc_risk_score                            3974  1.948033e+00   \n",
       "zip_1                                         3974  4.879482e+04   \n",
       "drug_srvc_bin                                 3974  1.000000e+00   \n",
       "county_fips                                   3974  2.750389e+04   \n",
       "...                                            ...           ...   \n",
       "num_drug_srvc_norm                            3974  1.303876e+02   \n",
       "num_unique_bene_with_drug_srvc_norm           3974  2.804463e-01   \n",
       "total_drug_submitted_charges_norm             3974  4.908380e+03   \n",
       "total_drug_medicare_payment_amt_norm          3974  1.606435e+03   \n",
       "num_hcpcs_associated_med_srvc_norm            3974  1.405880e-01   \n",
       "num_med_srvc_norm                             3974  1.377022e+01   \n",
       "num_unique_bene_with_med_srvc_norm            3974  9.993155e-01   \n",
       "total_med_submitted_charges_norm              3974  1.682763e+03   \n",
       "total_med_medicare_payment_amt_norm           3974  5.430112e+02   \n",
       "num_female_norm                               3953  5.929653e-01   \n",
       "num_male_norm                                 3953  4.070014e-01   \n",
       "num_non_his_white_norm                        3974  7.915785e-01   \n",
       "num_african_american_norm                     3974  9.679655e-02   \n",
       "num_asian_norm                                3970  3.216276e-02   \n",
       "num_hispanic_norm                             3974  7.199493e-02   \n",
       "num_american_indian_norm                      3909  2.816047e-03   \n",
       "num_asthma_norm                               3710  8.421024e-02   \n",
       "num_alzheimers_dementia_norm                  3743  1.145739e-01   \n",
       "num_artrial_fibrillation_norm                 3854  1.421328e-01   \n",
       "num_cancer_norm                               3956  4.285617e-01   \n",
       "num_chronic_obstructive_pulmonary_norm        3902  2.188134e-01   \n",
       "num_depression_norm                           3932  2.201017e-01   \n",
       "num_diabetes_norm                             3962  3.529758e-01   \n",
       "num_heart_failure_norm                        3929  2.560524e-01   \n",
       "num_hypertension_norm                         3971  6.942130e-01   \n",
       "num_ischemic_heart_norm                       3963  4.112945e-01   \n",
       "num_osteoporosis_norm                         3799  1.141011e-01   \n",
       "num_rheumatoid_arthritis_osteoarthirtis_norm  3963  3.845874e-01   \n",
       "num_schizophrenia_psychotic_norm              2879  4.756165e-02   \n",
       "num_stroke_norm                               3432  6.558566e-02   \n",
       "\n",
       "num_drug_srvc                                                             \\\n",
       "                                                       std           min   \n",
       "npi                                           2.863853e+08  1.003031e+09   \n",
       "num_hcpcs                                     4.230439e+01  1.000000e+01   \n",
       "num_services                                  7.304449e+04  3.040000e+02   \n",
       "num_unique_bene                               3.186551e+02  1.300000e+01   \n",
       "total_submitted_charges                       3.125171e+06  3.112000e+04   \n",
       "total_medicare_payment_amt                    1.024786e+06  1.174203e+04   \n",
       "drug_suppress_indicator                       0.000000e+00  0.000000e+00   \n",
       "num_hcpcs_associated_drug_srvc                2.148976e+01  1.000000e+00   \n",
       "num_drug_srvc                                 6.804169e+04  1.100000e+01   \n",
       "num_unique_bene_with_drug_srvc                1.250096e+02  1.100000e+01   \n",
       "total_drug_submitted_charges                  2.466301e+06  4.200000e+01   \n",
       "total_drug_medicare_payment_amt               8.637869e+05  8.450000e+00   \n",
       "medical_suppress_indicator                    0.000000e+00  0.000000e+00   \n",
       "num_hcpcs_associated_med_srvc                 2.600593e+01  5.000000e+00   \n",
       "num_med_srvc                                  6.978069e+03  3.700000e+01   \n",
       "num_unique_bene_with_med_srvc                 3.185718e+02  1.300000e+01   \n",
       "total_med_submitted_charges                   8.126277e+05  4.306000e+03   \n",
       "total_med_medicare_payment_amt                2.240229e+05  1.303380e+03   \n",
       "avg_age_bene                                  2.243545e+00  4.800000e+01   \n",
       "num_female                                    1.918530e+02  0.000000e+00   \n",
       "num_male                                      1.350969e+02  0.000000e+00   \n",
       "num_non_his_white                             2.892631e+02  7.000000e+00   \n",
       "num_african_american                          7.089056e+01  0.000000e+00   \n",
       "num_asian                                     3.052587e+01  0.000000e+00   \n",
       "num_hispanic                                  5.555220e+01  0.000000e+00   \n",
       "num_american_indian                           6.696593e+00  0.000000e+00   \n",
       "avg_hcc_risk_score                            3.248053e-01  8.379000e-01   \n",
       "zip_1                                         2.956635e+04  1.020000e+03   \n",
       "drug_srvc_bin                                 0.000000e+00  1.000000e+00   \n",
       "county_fips                                   1.584039e+04  1.003000e+03   \n",
       "...                                                    ...           ...   \n",
       "num_drug_srvc_norm                            2.536595e+02  1.150628e-02   \n",
       "num_unique_bene_with_drug_srvc_norm           1.278234e-01  1.072125e-02   \n",
       "total_drug_submitted_charges_norm             6.395934e+03  8.235294e-02   \n",
       "total_drug_medicare_payment_amt_norm          2.771230e+03  1.492933e-02   \n",
       "num_hcpcs_associated_med_srvc_norm            1.160538e-01  1.365462e-02   \n",
       "num_med_srvc_norm                             9.913270e+00  1.304511e+00   \n",
       "num_unique_bene_with_med_srvc_norm            3.607267e-03  9.200000e-01   \n",
       "total_med_submitted_charges_norm              1.171308e+03  1.785043e+02   \n",
       "total_med_medicare_payment_amt_norm           3.265488e+02  6.516900e+01   \n",
       "num_female_norm                               7.727352e-02  0.000000e+00   \n",
       "num_male_norm                                 7.728076e-02  0.000000e+00   \n",
       "num_non_his_white_norm                        1.772107e-01  1.717791e-02   \n",
       "num_african_american_norm                     1.128044e-01  0.000000e+00   \n",
       "num_asian_norm                                6.850143e-02  0.000000e+00   \n",
       "num_hispanic_norm                             1.094006e-01  0.000000e+00   \n",
       "num_american_indian_norm                      1.687912e-02  0.000000e+00   \n",
       "num_asthma_norm                               2.806338e-02  0.000000e+00   \n",
       "num_alzheimers_dementia_norm                  5.644723e-02  0.000000e+00   \n",
       "num_artrial_fibrillation_norm                 4.150888e-02  3.000000e-02   \n",
       "num_cancer_norm                               1.116441e-01  5.000000e-02   \n",
       "num_chronic_obstructive_pulmonary_norm        7.381050e-02  3.000000e-02   \n",
       "num_depression_norm                           5.551122e-02  5.000000e-02   \n",
       "num_diabetes_norm                             8.776103e-02  1.300000e-01   \n",
       "num_heart_failure_norm                        8.794131e-02  6.000000e-02   \n",
       "num_hypertension_norm                         6.907342e-02  3.000000e-01   \n",
       "num_ischemic_heart_norm                       1.062087e-01  1.300000e-01   \n",
       "num_osteoporosis_norm                         4.538846e-02  0.000000e+00   \n",
       "num_rheumatoid_arthritis_osteoarthirtis_norm  7.057241e-02  1.800000e-01   \n",
       "num_schizophrenia_psychotic_norm              2.684267e-02  0.000000e+00   \n",
       "num_stroke_norm                               2.784090e-02  0.000000e+00   \n",
       "\n",
       "num_drug_srvc                                                             \\\n",
       "                                                       25%           50%   \n",
       "npi                                           1.245431e+09  1.497727e+09   \n",
       "num_hcpcs                                     8.000000e+01  1.050000e+02   \n",
       "num_services                                  2.265825e+04  5.559400e+04   \n",
       "num_unique_bene                               3.000000e+02  4.550000e+02   \n",
       "total_submitted_charges                       1.103360e+06  2.587361e+06   \n",
       "total_medicare_payment_amt                    4.052417e+05  8.786494e+05   \n",
       "drug_suppress_indicator                       0.000000e+00  0.000000e+00   \n",
       "num_hcpcs_associated_drug_srvc                4.000000e+01  5.600000e+01   \n",
       "num_drug_srvc                                 1.936075e+04  4.940450e+04   \n",
       "num_unique_bene_with_drug_srvc                5.900000e+01  1.170000e+02   \n",
       "total_drug_submitted_charges                  7.054046e+05  1.875306e+06   \n",
       "total_drug_medicare_payment_amt               2.588127e+05  6.422083e+05   \n",
       "medical_suppress_indicator                    0.000000e+00  0.000000e+00   \n",
       "num_hcpcs_associated_med_srvc                 3.700000e+01  4.700000e+01   \n",
       "num_med_srvc                                  2.769500e+03  5.366000e+03   \n",
       "num_unique_bene_with_med_srvc                 2.992500e+02  4.545000e+02   \n",
       "total_med_submitted_charges                   3.577137e+05  6.606872e+05   \n",
       "total_med_medicare_payment_amt                1.298497e+05  2.259548e+05   \n",
       "avg_age_bene                                  7.200000e+01  7.300000e+01   \n",
       "num_female                                    1.760000e+02  2.700000e+02   \n",
       "num_male                                      1.160000e+02  1.850000e+02   \n",
       "num_non_his_white                             2.210000e+02  3.645000e+02   \n",
       "num_african_american                          1.100000e+01  2.500000e+01   \n",
       "num_asian                                     3.000000e+00  6.000000e+00   \n",
       "num_hispanic                                  1.000000e+01  1.500000e+01   \n",
       "num_american_indian                           0.000000e+00  0.000000e+00   \n",
       "avg_hcc_risk_score                            1.750500e+00  1.911650e+00   \n",
       "zip_1                                         2.350200e+04  4.487000e+04   \n",
       "drug_srvc_bin                                 1.000000e+00  1.000000e+00   \n",
       "county_fips                                   1.209200e+04  2.710900e+04   \n",
       "...                                                    ...           ...   \n",
       "num_drug_srvc_norm                            5.938434e+01  1.076916e+02   \n",
       "num_unique_bene_with_drug_srvc_norm           1.881812e-01  2.770643e-01   \n",
       "total_drug_submitted_charges_norm             2.138557e+03  4.117435e+03   \n",
       "total_drug_medicare_payment_amt_norm          8.070022e+02  1.390263e+03   \n",
       "num_hcpcs_associated_med_srvc_norm            7.770332e-02  1.108047e-01   \n",
       "num_med_srvc_norm                             7.626490e+00  1.172103e+01   \n",
       "num_unique_bene_with_med_srvc_norm            1.000000e+00  1.000000e+00   \n",
       "total_med_submitted_charges_norm              9.481486e+02  1.429204e+03   \n",
       "total_med_medicare_payment_amt_norm           3.431000e+02  4.779195e+02   \n",
       "num_female_norm                               5.513627e-01  5.880399e-01   \n",
       "num_male_norm                                 3.702422e-01  4.119548e-01   \n",
       "num_non_his_white_norm                        7.346401e-01  8.416488e-01   \n",
       "num_african_american_norm                     2.783997e-02  6.053159e-02   \n",
       "num_asian_norm                                7.491275e-03  1.586463e-02   \n",
       "num_hispanic_norm                             2.060408e-02  3.622342e-02   \n",
       "num_american_indian_norm                      0.000000e+00  0.000000e+00   \n",
       "num_asthma_norm                               7.000000e-02  8.000000e-02   \n",
       "num_alzheimers_dementia_norm                  8.000000e-02  1.000000e-01   \n",
       "num_artrial_fibrillation_norm                 1.125000e-01  1.400000e-01   \n",
       "num_cancer_norm                               3.700000e-01  4.300000e-01   \n",
       "num_chronic_obstructive_pulmonary_norm        1.700000e-01  2.100000e-01   \n",
       "num_depression_norm                           1.800000e-01  2.100000e-01   \n",
       "num_diabetes_norm                             3.000000e-01  3.400000e-01   \n",
       "num_heart_failure_norm                        1.900000e-01  2.400000e-01   \n",
       "num_hypertension_norm                         6.600000e-01  7.200000e-01   \n",
       "num_ischemic_heart_norm                       3.400000e-01  4.000000e-01   \n",
       "num_osteoporosis_norm                         8.000000e-02  1.100000e-01   \n",
       "num_rheumatoid_arthritis_osteoarthirtis_norm  3.400000e-01  3.800000e-01   \n",
       "num_schizophrenia_psychotic_norm              3.000000e-02  4.000000e-02   \n",
       "num_stroke_norm                               5.000000e-02  6.000000e-02   \n",
       "\n",
       "num_drug_srvc                                                             \n",
       "                                                       75%           max  \n",
       "npi                                           1.740254e+09  1.992965e+09  \n",
       "num_hcpcs                                     1.310000e+02  3.880000e+02  \n",
       "num_services                                  1.003410e+05  9.195270e+05  \n",
       "num_unique_bene                               6.460000e+02  4.946000e+03  \n",
       "total_submitted_charges                       4.564674e+06  3.574462e+07  \n",
       "total_medicare_payment_amt                    1.464679e+06  2.804806e+07  \n",
       "drug_suppress_indicator                       0.000000e+00  0.000000e+00  \n",
       "num_hcpcs_associated_drug_srvc                6.700000e+01  1.100000e+02  \n",
       "num_drug_srvc                                 9.071400e+04  9.192350e+05  \n",
       "num_unique_bene_with_drug_srvc                1.920000e+02  9.500000e+02  \n",
       "total_drug_submitted_charges                  3.499134e+06  3.556785e+07  \n",
       "total_drug_medicare_payment_amt               1.117330e+06  2.797682e+07  \n",
       "medical_suppress_indicator                    0.000000e+00  0.000000e+00  \n",
       "num_hcpcs_associated_med_srvc                 6.875000e+01  3.130000e+02  \n",
       "num_med_srvc                                  9.393750e+03  9.189700e+04  \n",
       "num_unique_bene_with_med_srvc                 6.457500e+02  4.945000e+03  \n",
       "total_med_submitted_charges                   1.093646e+06  1.127809e+07  \n",
       "total_med_medicare_payment_amt                3.484419e+05  3.283833e+06  \n",
       "avg_age_bene                                  7.500000e+01  8.500000e+01  \n",
       "num_female                                    3.880000e+02  3.096000e+03  \n",
       "num_male                                      2.660000e+02  1.849000e+03  \n",
       "num_non_his_white                             5.450000e+02  4.375000e+03  \n",
       "num_african_american                          5.600000e+01  1.418000e+03  \n",
       "num_asian                                     1.400000e+01  7.930000e+02  \n",
       "num_hispanic                                  2.800000e+01  8.450000e+02  \n",
       "num_american_indian                           0.000000e+00  2.000000e+02  \n",
       "avg_hcc_risk_score                            2.102050e+00  4.400800e+00  \n",
       "zip_1                                         7.702400e+04  9.964500e+04  \n",
       "drug_srvc_bin                                 1.000000e+00  1.000000e+00  \n",
       "county_fips                                   4.101700e+04  5.602100e+04  \n",
       "...                                                    ...           ...  \n",
       "num_drug_srvc_norm                            1.675456e+02  1.436305e+04  \n",
       "num_unique_bene_with_drug_srvc_norm           3.669956e-01  9.230769e-01  \n",
       "total_drug_submitted_charges_norm             6.500552e+03  2.833048e+05  \n",
       "total_drug_medicare_payment_amt_norm          2.026291e+03  1.338959e+05  \n",
       "num_hcpcs_associated_med_srvc_norm            1.673010e-01  3.238095e+00  \n",
       "num_med_srvc_norm                             1.737144e+01  2.144310e+02  \n",
       "num_unique_bene_with_med_srvc_norm            1.000000e+00  1.000000e+00  \n",
       "total_med_submitted_charges_norm              2.074914e+03  1.928637e+04  \n",
       "total_med_medicare_payment_amt_norm           6.567560e+02  6.002191e+03  \n",
       "num_female_norm                               6.297468e-01  1.000000e+00  \n",
       "num_male_norm                                 4.484536e-01  1.000000e+00  \n",
       "num_non_his_white_norm                        9.147420e-01  1.000000e+00  \n",
       "num_african_american_norm                     1.245426e-01  9.311475e-01  \n",
       "num_asian_norm                                3.244017e-02  9.730061e-01  \n",
       "num_hispanic_norm                             7.284768e-02  9.396226e-01  \n",
       "num_american_indian_norm                      0.000000e+00  5.877193e-01  \n",
       "num_asthma_norm                               1.000000e-01  2.500000e-01  \n",
       "num_alzheimers_dementia_norm                  1.300000e-01  7.500000e-01  \n",
       "num_artrial_fibrillation_norm                 1.600000e-01  5.300000e-01  \n",
       "num_cancer_norm                               4.900000e-01  7.500000e-01  \n",
       "num_chronic_obstructive_pulmonary_norm        2.600000e-01  6.000000e-01  \n",
       "num_depression_norm                           2.500000e-01  5.700000e-01  \n",
       "num_diabetes_norm                             4.000000e-01  7.500000e-01  \n",
       "num_heart_failure_norm                        3.000000e-01  7.500000e-01  \n",
       "num_hypertension_norm                         7.500000e-01  7.500000e-01  \n",
       "num_ischemic_heart_norm                       4.800000e-01  7.500000e-01  \n",
       "num_osteoporosis_norm                         1.300000e-01  5.800000e-01  \n",
       "num_rheumatoid_arthritis_osteoarthirtis_norm  4.300000e-01  7.500000e-01  \n",
       "num_schizophrenia_psychotic_norm              6.000000e-02  2.800000e-01  \n",
       "num_stroke_norm                               8.000000e-02  2.300000e-01  \n",
       "\n",
       "[65 rows x 16 columns]"
      ]
     },
     "execution_count": 97,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_hema.groupby(df_hema['num_drug_srvc']>0).describe().T"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 104,
   "metadata": {
    "collapsed": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(0, 4000)"
      ]
     },
     "execution_count": 104,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAYEAAAEACAYAAABVtcpZAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\nBMzM5tj/By/PGyVnTtXbAAAAAElFTkSuQmCC\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7f85749b7f90>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "#df_hema['total_submitted_charges_norm'][df_hema['num_drug_srvc']>0].hist(bins=400)\n",
    "df_hema['total_submitted_charges_norm'][df_hema['num_drug_srvc']==0].hist(bins=400)\n",
    "plt.xlim(0,4000)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 103,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(0, 50000)"
      ]
     },
     "execution_count": 103,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAYQAAAEACAYAAACznAEdAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7f8531cfd810>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "df_hema['total_submitted_charges_norm'][df_hema['num_drug_srvc']>0].hist(bins=400)\n",
    "plt.xlim(0,50000)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### Doctors who don't have drug services are fairly normally distributed, much lower mean than those who do drug services"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 109,
   "metadata": {
    "collapsed": false,
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(0, 100000)"
      ]
     },
     "execution_count": 109,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAZQAAAEACAYAAACUMoD1AAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7f856d851690>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "plt.scatter(df_hema['num_drug_srvc_norm'], df_hema['total_submitted_charges_norm'])\n",
    "plt.xlim(0,2000)\n",
    "plt.ylim(0,100000)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 186,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "Index([u'npi', u'last_name', u'first_name', u'credentials', u'state',\n",
       "       u'provider_type', u'num_hcpcs', u'num_services', u'num_unique_bene',\n",
       "       u'total_submitted_charges', u'total_medicare_payment_amt',\n",
       "       u'drug_suppress_indicator', u'num_hcpcs_associated_drug_srvc',\n",
       "       u'num_drug_srvc', u'num_unique_bene_with_drug_srvc',\n",
       "       u'total_drug_submitted_charges', u'total_drug_medicare_payment_amt',\n",
       "       u'medical_suppress_indicator', u'num_hcpcs_associated_med_srvc',\n",
       "       u'num_med_srvc', u'num_unique_bene_with_med_srvc',\n",
       "       u'total_med_submitted_charges', u'total_med_medicare_payment_amt',\n",
       "       u'avg_age_bene', u'num_female', u'num_male', u'num_non_his_white',\n",
       "       u'num_african_american', u'num_asian', u'num_hispanic',\n",
       "       u'num_american_indian', u'avg_hcc_risk_score', u'zip_1',\n",
       "       u'drug_srvc_bin', u'county', u'county_fips', u'num_hcpcs_norm',\n",
       "       u'num_services_norm', u'total_submitted_charges_norm',\n",
       "       u'total_medicare_payment_amt_norm',\n",
       "       u'num_hcpcs_associated_drug_srvc_norm', u'num_drug_srvc_norm',\n",
       "       u'num_unique_bene_with_drug_srvc_norm',\n",
       "       u'total_drug_submitted_charges_norm',\n",
       "       u'total_drug_medicare_payment_amt_norm',\n",
       "       u'num_hcpcs_associated_med_srvc_norm', u'num_med_srvc_norm',\n",
       "       u'num_unique_bene_with_med_srvc_norm',\n",
       "       u'total_med_submitted_charges_norm',\n",
       "       u'total_med_medicare_payment_amt_norm', u'num_female_norm',\n",
       "       u'num_male_norm', u'num_non_his_white_norm',\n",
       "       u'num_african_american_norm', u'num_asian_norm', u'num_hispanic_norm',\n",
       "       u'num_american_indian_norm', u'num_asthma_norm',\n",
       "       u'num_alzheimers_dementia_norm', u'num_artrial_fibrillation_norm',\n",
       "       u'num_cancer_norm', u'num_chronic_obstructive_pulmonary_norm',\n",
       "       u'num_depression_norm', u'num_diabetes_norm', u'num_heart_failure_norm',\n",
       "       u'num_hypertension_norm', u'num_ischemic_heart_norm',\n",
       "       u'num_osteoporosis_norm',\n",
       "       u'num_rheumatoid_arthritis_osteoarthirtis_norm',\n",
       "       u'num_schizophrenia_psychotic_norm', u'num_stroke_norm',\n",
       "       u'drug_charge_per_srvc', u'med_charge_per_srvc'],\n",
       "      dtype='object')"
      ]
     },
     "execution_count": 186,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_hema.columns"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 187,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "pca_cols = [\n",
    "                'num_services_norm',\n",
    "                'total_submitted_charges_norm',\n",
    "                'total_medicare_payment_amt_norm',\n",
    "                'num_drug_srvc_norm',\n",
    "                'total_drug_submitted_charges_norm',\n",
    "                'total_drug_medicare_payment_amt_norm',\n",
    "                'num_med_srvc_norm',\n",
    "                'total_med_submitted_charges_norm',\n",
    "                'total_med_medicare_payment_amt_norm',\n",
    "                'drug_charge_per_srvc',\n",
    "                'med_charge_per_srvc'\n",
    "        ]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 155,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "from sklearn.cluster import KMeans\n",
    "from sklearn.decomposition import PCA\n",
    "from sklearn.preprocessing import StandardScaler"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 125,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(0, 5000)"
      ]
     },
     "execution_count": 125,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAYEAAAEACAYAAABVtcpZAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\nswhIUo9ZBCSpxywCktRjFgFJ6rH/DwTtxGWFcHq8AAAAAElFTkSuQmCC\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7f856c8eb350>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "df_hema['total_submitted_charges_norm'][df_hema['num_drug_srvc_norm'].isnull()].hist(bins=200)\n",
    "plt.xlim(0,5000)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 133,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(0, 20000)"
      ]
     },
     "execution_count": 133,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAYQAAAEACAYAAACznAEdAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz\nAAALEgAACxIB0t1+/AAAGERJREFUeJzt3W2MXPd13/HvT1bERn4QaTTiFmLilSsZlgK0ql0pNewA\ni+ghdgqIQos2cp+0LowCVQwHLdCKClCwr0JRSBEbKPKijWPSgRxBCZCILlSJFqw14DQW3UhrqybL\nsk2pyKy5SWTHgGPAiOzTF3OXHC73YZb8D2fu8PsBFrz3P3fu/PdoNGfvOffeSVUhSdI1k56AJGk6\nmBAkSYAJQZLUMSFIkgATgiSpY0KQJAEjJIQk70rycpKXun+/k+TjSXYlOZrkZJLnktww9JxHk5xK\nciLJfeP9FSRJLWQ71yEkuQb4BvBTwMeA16vq8SSPALuqal+S24EngDuBPcDzwK3lBQ+SNNW2WzK6\nB/g/VfUasBc43I0fBh7olu8HnqyqN6rqNHAKuKvBXCVJY7TdhPDzwGe75d1VtQJQVWeBG7vxm4DX\nhp5zphuTJE2xkRNCkh9h8Nf/b3dDa0tAloQkqceu3ca2HwL+sKr+rFtfSbK7qlaSzAF/0o2fAX58\n6Hl7urELJDGBSNIlqKqMY7/bKRl9GPitofUjwGK3/BDw9ND4g0muS3IzcAtwbL0dVpU/jX72798/\n8TnM0o/xNJbT+jNOIx0hJLmeQUP5XwwNHwSeSvLPgVeBfwhQVceTPAUcB/4SeLjG/VuI06dPT3oK\nM8V4tmMs+2OkhFBV3wN+bM3YtxgkifW2PwAcuOzZSZKuGK9UnhGLi4uTnsJMMZ7tGMv+2NaFaU1f\nOLGSJEnblISagqayptjS0tKkpzBTjGc7xrI/TAiSJMCSkST1iiUjSdLYmRBmhHXatoxnO8ayP0wI\nkiTAHoIk9Yo9BEnS2JkQZoR12raMZzvGsj9MCJIkYIp7CHNz86ysvMru3e/g7NnTV25ikjTFxtlD\nmNqEkITBl7Bl7PcAl6S+sKmsLVmnbct4tmMs+8OEIEkCLBlJUq9YMpIkjZ0JYUZYp23LeLZjLPvD\nhCBJAuwhSFKv2EOQJI2dCWFGWKdty3i2Yyz7Y6SEkOSGJL+d5ESSryf5qSS7khxNcjLJc0luGNr+\n0SSnuu3vG9/0JUmtjNRDSHII+GJVfTrJtcCbgV8CXq+qx5M8Auyqqn1JbgeeAO4E9gDPA7eubRjY\nQ5Ck7ZtoDyHJ24CfrqpPA1TVG1X1HWAvcLjb7DDwQLd8P/Bkt91p4BRwV+uJS5LaGqVkdDPwZ0k+\nneSlJP8pyfXA7qpaAaiqs8CN3fY3Aa8NPf9MN6Yxsk7blvFsx1j2x7UjbvMe4Beq6r8n+VVgH4N6\nzrBt13UWFxeZn58HYOfOndxxxx0sLCwMbbF0fql7U60+7vqF68vLy1M1n76vG0/Xp2V9aWmJQ4cO\nAZz7vByXLXsISXYDf1BV7+zWP8AgIfx1YKGqVpLMAS9U1W1J9gFVVQe77Z8F9lfVi2v2aw9BkrZp\noj2Eriz0WpJ3dUN3A18HjgCL3dhDwNPd8hHgwSTXJbkZuAU41nLSkqT2Rr0O4ePAE0mWgb8J/DJw\nELg3yUkGSeIxgKo6DjwFHAeeAR7e9FBATaweYqoN49mOseyPUXoIVNVXGZxGutY9G2x/ADhwGfOS\nJF1h3stIknrEexlJksbOhDAjrNO2ZTzbMZb90YOEsIMkJGFubn7Sk5GkmdWLHsL5a97sJ0i6utlD\nkCSNnQlhRlinbct4tmMs+8OEIEkC7CFIUq/YQ5AkjZ0JYUZYp23LeLZjLPvDhCBJAuwhSFKv2EOQ\nJI2dCWFGWKdty3i2Yyz7w4QgSQLsIUhSr9hDkCSNnQlhRlinbct4tmMs+8OEIEkC7CFIUq/YQ5Ak\njd1UJYS5uflzX5ep7bFO25bxbMdY9sdICSHJ6SRfTfJykmPd2K4kR5OcTPJckhuGtn80yakkJ5Lc\nN+pkVlZeZVAesiwkSVfaSD2EJH8EvLeqvj00dhB4vaoeT/IIsKuq9iW5HXgCuBPYAzwP3Lq2YbBe\nD+F83wDO9w7sIUjSqmnoIWSdbfcCh7vlw8AD3fL9wJNV9UZVnQZOAXdd5jwlSWM2akIo4PNJvpLk\no93Y7qpaAaiqs8CN3fhNwGtDzz3TjWmMrNO2ZTzbMZb9ce2I272/qr6Z5MeAo0lOcnGhf9u1nMXF\nRebn5wHYuXPnOlssbbB8/k22sLDgOrC8vDxV8+n7uvF0fVrWl5aWOHToEMC5z8tx2fZ1CEn2A98F\nPgosVNVKkjnghaq6Lck+oKrqYLf9s8D+qnpxzX7sIUjSNk20h5Dk+iRv6ZbfDNwHvAIcARa7zR4C\nnu6WjwAPJrkuyc3ALcCxxvOWJDU2Sg9hN/ClJC8DXwY+V1VHgYPAvV356G7gMYCqOg48BRwHngEe\n3vSSZDWxeoipNoxnO8ayP7bsIVTV/wXuWGf8W8A9GzznAHDgsmcnSbpipupeRvYQJGlz03AdgiRp\nxpkQZoR12raMZzvGsj9MCJIkwB6CJPWKPQRJ0tiZEGaEddq2jGc7xrI/TAiSJMAegiT1ij0ESdLY\nmRBmhHXatoxnO8ayP0wIkiTAHoIk9Yo9BEnS2JkQZoR12raMZzvGsj9MCJIkwB6CJPWKPQRJ0tiZ\nEGaEddq2jGc7xrI/TAiSJMAegiT1ij2Ec3aQhLm5+UlPRJJmTs8SwveBYmXl1UlPZOpYp23LeLZj\nLPtj5ISQ5JokLyU50q3vSnI0yckkzyW5YWjbR5OcSnIiyX3jmLgkqa2RewhJ/hXwXuBtVXV/koPA\n61X1eJJHgF1VtS/J7cATwJ3AHuB54Na1DYNL7SGsjtlLkHQ1mngPIcke4OeAXx8a3gsc7pYPAw90\ny/cDT1bVG1V1GjgF3NVktpKksRm1ZPSrwL/h/J/qALuragWgqs4CN3bjNwGvDW13phvTGFmnbct4\ntmMs++ParTZI8neBlapaTrKwyabbruEsLi4yPz8PwM6dO9fZYmmD5fNvsoWFBdeB5eXlqZpP39eN\np+vTsr60tMShQ4cAzn1ejsuWPYQkvwz8E+AN4EeBtwK/C/xtYKGqVpLMAS9U1W1J9gFVVQe75z8L\n7K+qF9fs1x6CJG3TRHsIVfVLVfUTVfVO4EHgC1X1T4HPAYvdZg8BT3fLR4AHk1yX5GbgFuBY85lL\nkpq6nOsQHgPuTXISuLtbp6qOA08Bx4FngIcvOhRQc6uHmGrDeLZjLPtjyx7CsKr6IvDFbvlbwD0b\nbHcAOHDZs5MkXTG9u5eRPQRJV7OJX4cgSZp9JoQZYZ22LePZjrHsDxOCJAmwhyBJvWIPQZI0diaE\nGWGdti3j2Y6x7A8TgiQJsIcgSb1iD0GSNHYmhBlhnbYt49mOsewPE4IkCbCHIEm9Yg9BkjR2JoQZ\nYZ22LePZjrHsDxOCJAmwhyBJvWIPQZI0diaEGWGdti3j2Y6x7A8TgiQJsIcgSb1iD0GSNHYmhBlh\nnbYt49mOseyPLRNCkh1JXkzycpJXkuzvxnclOZrkZJLnktww9JxHk5xKciLJfeP8BSRJbYzUQ0hy\nfVV9L8mbgN8HPg78feD1qno8ySPArqral+R24AngTmAP8Dxw69qGgT0ESdq+ifcQqup73eIO4FoG\nn8p7gcPd+GHggW75fuDJqnqjqk4Dp4C7Wk1YkjQeIyWEJNckeRk4C3y+qr4C7K6qFYCqOgvc2G1+\nE/Da0NPPdGMaI+u0bRnPdoxlf1w7ykZV9UPgbyV5G/C7SX6S83Wcc5tt98UXFxeZn58HYOfOnets\nsbTB8vk32cLCguvA8vLyVM2n7+vG0/VpWV9aWuLQoUMA5z4vx2Xb1yEk+XfA94CPAgtVtZJkDnih\nqm5Lsg+oqjrYbf8ssL+qXlyzH3sIkrRNE+0hJPmrq2cQJflR4F7gBHAEWOw2ewh4uls+AjyY5Lok\nNwO3AMcaz1uS1NgoPYS/BryQZBl4EXiuqp4BDgL3JjkJ3A08BlBVx4GngOPAM8DDFx0KqLnVQ0y1\nYTzbMZb9sWUPoapeAd6zzvi3gHs2eM4B4MBlz06SdMV4LyNJ6pGJX4cgSZp9JoQZYZ22LePZjrHs\nDxOCJAmwhyBJvWIP4SI7SMLc3PykJyJJM6OnCeH7QLGy8uqkJzI1rNO2ZTzbMZb90dOEIElqrbc9\nBHsJkq5G9hAkSWNnQpgR1mnbMp7tGMv+MCFIkgB7CJLUK/YQJEljZ0KYEdZp2zKe7RjL/jAhSJIA\newiS1Cv2ECRJY2dCmBHWadsynu0Yy/7oeUIY3PXUO59K0uXrfQ9h+DH7CZJmnT0ESdLYmRBmhHXa\ntoxnO8ayP7ZMCEn2JPlCkq8neSXJx7vxXUmOJjmZ5LkkNww959Ekp5KcSHLfOH8BSVIbW/YQkswB\nc1W1nOQtwB8Ce4GPAK9X1eNJHgF2VdW+JLcDTwB3AnuA54Fb1zYM7CFI0vZNtIdQVWerarlb/i5w\ngsEH/V7gcLfZYeCBbvl+4MmqeqOqTgOngLsaz1uS1Ni2eghJ5oE7gC8Du6tqBQZJA7ix2+wm4LWh\np53pxjRG1mnbMp7tGMv+uHbUDbty0e8Av1hV302ytj6z7XrN4uIi8/Pz/MqvfIK/+IvvrLPF0gbL\n660P3ngLCwvnloGrZn15eXmq5tP3dePp+rSsLy0tcejQIQDm5+cZp5GuQ0hyLfBfgP9aVZ/sxk4A\nC1W10vUZXqiq25LsA6qqDnbbPQvsr6oX1+zzXA/hfO/AHoIkbWYarkP4DeD4ajLoHAEWu+WHgKeH\nxh9Mcl2Sm4FbgGMN5ipJGqNRTjt9P/CPgZ9J8nKSl5J8EDgI3JvkJHA38BhAVR0HngKOA88AD190\nOpGaWz3EVBvGsx1j2R9b9hCq6veBN23w8D0bPOcAcOAy5iVJusKm4l5G9hAkaTTT0EOQJM04E8KM\nsE7blvFsx1j2hwlBkgTYQ5CkXrGHIEkauxlKCDuu6q/StE7blvFsx1j2x8j3Mpp+3weKlZWxHElJ\n0sybqR7C6pi9BEmzyh6CJGnsTAgzwjptW8azHWPZHyYESRJgD0GSesUegiRp7EwIM8I6bVvGsx1j\n2R8mBEkSYA9BknrFHoIkaexMCDPCOm1bxrMdY9kfJgRJEjCTPYS/wuBGd7B79zs4e/b0eH8RSbqC\nxtlDmMGE4JfmSJpdNpW1Jeu0bRnPdoxlf2yZEJJ8KslKkq8Nje1KcjTJySTPJblh6LFHk5xKciLJ\nfeOauCSprS1LRkk+AHwX+ExV/Y1u7CDwelU9nuQRYFdV7UtyO/AEcCewB3geuLXWeRFLRpK0fRMt\nGVXVl4BvrxneCxzulg8DD3TL9wNPVtUbVXUaOAXc1WaqkqRxutQewo1VtQJQVWeBG7vxm4DXhrY7\n041pzKzTtmU82zGW/dHqO5UvqS6zuLjI/Px8t/aJdbZY2mB5vfXNt199Uy4sLMzk+vLy8lTNp+/r\nxtP1aVlfWlri0KFDAEOfl+Mx0mmnSd4BfG6oh3ACWKiqlSRzwAtVdVuSfUBV1cFuu2eB/VX14jr7\nvAI9hME1CV6PIGlWTMNpp+l+Vh0BFrvlh4Cnh8YfTHJdkpuBW4BjDeZ5ib4PFCsrZ0nC3Nz85KYi\nSVNulNNOPwv8N+BdSf44yUeAx4B7k5wE7u7WqarjwFPAceAZ4OH1zjC68lYTw6uTnsjYrB5iqg3j\n2Y6x7I8tewhV9Y82eOieDbY/ABy4nElJkq68mb91xYVj3udIUr95L6NmCcGL1iT12zQ0lWfQjplq\nNFunbct4tmMs+6PVdQg9tNpoHkuilaTeuYqPENqZm5snybpHHJs9Nvz45R6prF7Qcinz2WqOV6Ph\neOryGMv+uKp7CBs1mufm5llZeXXkxvP5+Q/2OxzTzR678PHBPK655np++MPvXTCf7drufLaao6Tp\nYQ9hrAalo+HrFAb/rn/dwvj+mh7MY5AMLpzPKDau085Wr+RKse7djrHsDxPCBXZ0fy1vbDVZDF8B\nPe75XN6H+eVdlGc5Sbp6WDLaYvuNSzwb7+PSSkaX9j3Rq+Ut4IJy02b72LxkdOH9nywnSdPFktEU\nWP1L+fJc6l/8F5e1Vg0fsZwvN222j9Feq+URhUcZUj+YEEZ0/oN3NOsnkAtvtndpCWaQVN70pjev\nef7SJe9r9Me2TmgXltReXWesHzcatO7djrHsj6v4OoRRbN1T2Pw5qyWgtYb/Wt/u/lebz8Mlpku1\nOo/N5piLxta7dmO4dDXKa3r9hzR97CE03b4Pc2yz/ep/uwsTwfr9lI36Lpf63tvstODtnjIs9Y33\nMpqyD8Ppes3JJoStmuJbJYThhLL96z4u3sfA5SUcaZrZVNYIliY9gXVs3aNYr+ewXcP7aMW6dzvG\nsj/sIegSjNpb2W6PQtIkWTKyZDRV22/0ftysLLRVj8K+gmaJJSNdJTY+rXX7ZaEd507tPX8rkks7\n5dXrKHS1MCHMjKVJT6CBiy+Ku/QLAs9fzLfZ/tez+pqr13q06HNczewh9MdEE8L73vch3ve+D01y\nCppKF/91v9l2rQ1e84Utrvw+b+0tzD2iUF9NtIcAh4Hngd+kD/Xt6XzNq237Fvs4f1+n1fs/XXgf\nKDbd/2b3o9roduKXcnqttJ4Z7iH8DPCuyU5BV6Hz5aTVo4Dh245v7sJbh2x9hLLe6bVnL9jH8L5G\n+RKlFkcgHsVoPWNLCEk+mOR/JvlfSR4Z1+to1dKkJzBjljYYv/h7Kza33k0FL9zHhd+BcXHje21T\nvPW1G+Pui7z97XMmnp4YS0JIcg3wH4GfBX4S+HCSd4/jtbRqedITmDGXEs8WPY3NGt8b37F2+C/+\ntUcek/4g/va3V7Ah3w/jOkK4CzhVVa9W1V8CTwJ7x/RaAuDPJz2BGXMp8Rz1FuOj2DFiSWpgvdug\nr/47fHfdi++Se/61hktXmyWTtWdhtU46rb5nvLWrocw2roRwE/Da0Po3ujFJI1nvtNn1jHJUcnHP\nZL3Hh0tXa5PJ8If/avLZqtQ1ivU+/NeWyFr0Slp8gF8Npx9PtKn81rcusmPHb05yCjPk9KQnMGNO\nT3oCI2p5VLLx/rfumVz4XR/rN913XHQEst6H/9p9btWI32xsvf2Pso/1HrvQjkuaz3onBmx3H+M0\nltNOk/wd4N9X1Qe79X1AVdXBoW0mc76rJPVcr25/neRNwEngbuCbwDHgw1V1ovmLSZKaGMvdTqvq\nB0k+BhxlUJb6lMlAkqbbxK5UliRNl4k0lb1obTRJTif5apKXkxzrxnYlOZrkZJLnktwwtP2jSU4l\nOZHkvqHx9yT5WhfvT0zid5mEJJ9KspLka0NjzeKX5LokT3bP+YMkP3Hlfrsrb4N47k/yjSQvdT8f\nHHrMeG4gyZ4kX0jy9SSvJPl4Nz7Z92dVXdEfBknofwPvAH6EwRVA777S8+jDD/BHwK41YweBf9st\nPwI81i3fDrzMoAw438V49QjwReDObvkZ4Gcn/btdofh9ALgD+No44gf8S+DXuuWfB56c9O88gXju\nB/71OtveZjw3jeUccEe3/BYGPdd3T/r9OYkjBC9aG124+ChuL4O7AtL9+0C3fD+D/+BvVNVp4BRw\nV5I54K1V9ZVuu88MPWemVdWXgG+vGW4Zv+F9/Q6Dkyhm1gbxhMH7dK29GM8NVdXZqlrulr8LnAD2\nMOH35yQSghetja6Azyf5SpKPdmO7q2oFBm8q4MZufG1cz3RjNzGI8aqrPd43NozfuedU1Q+AP0/y\n9vFNfWp9LMlykl8fKnEYzxElmWdw5PVl2v7/ve14+gU50+39VfUe4OeAX0jy01x8ZZBnBVyelvEb\n71VD0+nXgHdW1R3AWeA/NNz3zMczyVsY/PX+i92Rwjj//94ynpNICGeA4ebGnm5Ma1TVN7t//xT4\nPQbltpUkuwG6w8U/6TY/A/z40NNX47rR+NWqZfzOPdZde/O2qvrW+KY+farqT6srUgP/mcF7FIzn\nlpJcyyAZ/GZVPd0NT/T9OYmE8BXgliTvSHId8CBwZALzmGpJru/+eiDJm4H7gFcYxGqx2+whYPWN\ndAR4sDuz4GbgFuBYd9j5nSR3ZXDd+z8bes7VIFz4l1HL+B3p9gHwD4AvjO23mB4XxLP70Fr194D/\n0S0bz639BnC8qj45NDbZ9+eEOuwfZNBVPwXsm3THfxp/gJsZnIH1MoNEsK8bfzuDr5k7yeDCv51D\nz3mUwdkHJ4D7hsbf2+3jFPDJSf9uVzCGnwX+H4Ob4vwx8BFgV6v4ATuAp7rxLwPzk/6dJxDPzwBf\n696rv8egBm48t47l+4EfDP0//lL3udjs/+9LiacXpkmSAJvKkqSOCUGSBJgQJEkdE4IkCTAhSJI6\nJgRJEmBCkCR1TAiSJAD+P4DaOoNOcqhdAAAAAElFTkSuQmCC\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7f856d856c10>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "df_hema['total_submitted_charges_norm'][df_hema['num_drug_srvc_norm'].isnull()==False].hist(bins=2000)\n",
    "plt.xlim(0,20000)\n",
    "#plt.ylim(0,150000)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 191,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "<class 'pandas.core.frame.DataFrame'>\n",
      "Int64Index: 7597 entries, 0 to 7596\n",
      "Data columns (total 11 columns):\n",
      "num_services_norm                       7597 non-null float64\n",
      "total_submitted_charges_norm            7597 non-null float64\n",
      "total_medicare_payment_amt_norm         7597 non-null float64\n",
      "num_drug_srvc_norm                      7020 non-null float64\n",
      "total_drug_submitted_charges_norm       7020 non-null float64\n",
      "total_drug_medicare_payment_amt_norm    7020 non-null float64\n",
      "num_med_srvc_norm                       7020 non-null float64\n",
      "total_med_submitted_charges_norm        7020 non-null float64\n",
      "total_med_medicare_payment_amt_norm     7020 non-null float64\n",
      "drug_charge_per_srvc                    3974 non-null float64\n",
      "med_charge_per_srvc                     7020 non-null float64\n",
      "dtypes: float64(11)\n",
      "memory usage: 712.2 KB\n"
     ]
    }
   ],
   "source": [
    "df_hema[pca_cols].info()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 201,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "df_hema['drug_charge_per_srvc'].fillna(0, inplace=True)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 202,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "df_hema_drop = df_hema[pca_cols].dropna(axis=0, how='any')"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 203,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(7597, 73)"
      ]
     },
     "execution_count": 203,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_hema.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 204,
   "metadata": {
    "collapsed": false,
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(7020, 11)"
      ]
     },
     "execution_count": 204,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_hema_drop.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 205,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "scale = StandardScaler()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 206,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "df_hema_drop = scale.fit_transform(df_hema_drop)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 207,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "pca = PCA()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 208,
   "metadata": {
    "collapsed": false,
    "scrolled": false
   },
   "outputs": [],
   "source": [
    "df_hema_pca = pca.fit_transform(df_hema_drop)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 209,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([  5.15998706e-01,   1.37523528e-01,   1.26233902e-01,\n",
       "         9.96714713e-02,   8.63877592e-02,   1.78562855e-02,\n",
       "         1.14255614e-02,   4.90278689e-03,   9.65776035e-28,\n",
       "         1.78208918e-29,   2.83723550e-31])"
      ]
     },
     "execution_count": 209,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pca.explained_variance_ratio_"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 221,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(11,)"
      ]
     },
     "execution_count": 221,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "pca.explained_variance_ratio_.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 214,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "km_mod = KMeans(n_clusters=4)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 215,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "pred = km_mod.fit_predict(df_hema_drop)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 216,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "1\n",
      "2205\n",
      "4813\n",
      "1\n"
     ]
    }
   ],
   "source": [
    "print sum(pred==1)\n",
    "print sum(pred==0)\n",
    "print sum(pred==2)\n",
    "print sum(pred==3)"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "#### Graph PCA to visualize doctors"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 224,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "def graph_3d(pca_vector):\n",
    "    \"\"\"\n",
    "    Example\n",
    "    -------\n",
    "    ax1 = graph_3d(X_pca_transformed, test_df)\n",
    "    ax.set_xlim(-5000000,20000000)\n",
    "    ax.set_ylim(-1000000,8000000)\n",
    "    ax.set_zlim(-3000000,3000000)\n",
    "    plt.show()\n",
    "    \"\"\"\n",
    "\n",
    "    xs = pca_vector[:,0]\n",
    "    ys = pca_vector[:,1]\n",
    "    zs = pca_vector[:,2]\n",
    "\n",
    "    fig = plt.figure()\n",
    "    ax = fig.add_subplot(111, projection='3d')\n",
    "    ax.set_xlabel('x')\n",
    "    ax.set_ylabel('y')\n",
    "    ax.set_zlabel('z')\n",
    "    ax.scatter(xs, ys, zs, alpha=.3)\n",
    "\n",
    "    return ax"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 225,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "import matplotlib.pyplot as plt\n",
    "from mpl_toolkits.mplot3d import Axes3D"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 239,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7f854420d910>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAV0AAADtCAYAAAAcNaZ2AAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\nYII=\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7f854420da10>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "fig = plt.figure(figsize=(15,15))\n",
    "ax = graph_3d(df_hema_pca)\n",
    "ax.set_xlim(-20,0)\n",
    "ax.set_ylim(0,60)\n",
    "ax.set_zlim(-40,0)\n",
    "#ax.view_init(120, 120)\n",
    "plt.show()"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "### scatter matrix"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 244,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "df_hema_drop_drug = df_hema[df_hema['num_drug_srvc']>0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 245,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "df_hema_drop_no_drug = df_hema[df_hema['num_drug_srvc']==0]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 251,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([[<matplotlib.axes._subplots.AxesSubplot object at 0x7f852f0163d0>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f85357b4690>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8537010190>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f85350e8f10>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8535799150>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8535797d10>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8535d58610>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8539b85810>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f85380a0c50>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8536147c10>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8537200910>],\n",
       "       [<matplotlib.axes._subplots.AxesSubplot object at 0x7f853a3a9850>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f853a26b790>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f85371279d0>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8539dcf890>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8539d208d0>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8539941890>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8537110990>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8539244790>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8538d91650>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8538b63f50>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8538b52e10>],\n",
       "       [<matplotlib.axes._subplots.AxesSubplot object at 0x7f8538a61e90>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8538932e50>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8538834fd0>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8538657d50>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8538280c10>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8537953d90>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8537515c50>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f853545c990>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f853531bad0>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f85350c5990>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8534fdb450>],\n",
       "       [<matplotlib.axes._subplots.AxesSubplot object at 0x7f8534d6e310>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8534d02390>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8534a32350>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f853477d4d0>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f853445d250>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f853417c110>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8534009290>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8533debad0>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8533c39e50>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8533b23f90>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8533684e50>],\n",
       "       [<matplotlib.axes._subplots.AxesSubplot object at 0x7f85335a4910>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f85333a47d0>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f85331fc850>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8532fc7810>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8532e1d990>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8532a34710>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f85326fd5d0>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8539000210>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f853a444610>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f853a4f3350>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f853a60d490>],\n",
       "       [<matplotlib.axes._subplots.AxesSubplot object at 0x7f853a6b3350>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f853a5a3dd0>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8536927c90>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f85366b5d10>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8532ae3cd0>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8532728e50>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f852f5c4a90>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f853282ca90>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8532bcec10>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f85327d1ad0>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f852f6c7810>],\n",
       "       [<matplotlib.axes._subplots.AxesSubplot object at 0x7f85330bd950>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f85336e6810>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f852fa7c2d0>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f853423b190>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8534355210>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f85340281d0>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8530064350>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f85302f30d0>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8535190f50>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f85358b8110>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f85357eff90>],\n",
       "       [<matplotlib.axes._subplots.AxesSubplot object at 0x7f8535588cd0>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8537eb5e10>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f853a049cd0>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f853985cd50>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8539ae7650>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8538f08950>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8538802690>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f85386aa810>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8537fa5590>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8537c996d0>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8539e555d0>],\n",
       "       [<matplotlib.axes._subplots.AxesSubplot object at 0x7f853aa92490>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f853a9b91d0>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f853a944310>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f853a8c61d0>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f853a829c50>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f853a7abb10>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f853a790b90>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f853a713b50>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f853a520b10>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f853a404a50>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f853a349910>],\n",
       "       [<matplotlib.axes._subplots.AxesSubplot object at 0x7f853a2ada90>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f853a16f950>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f853a158690>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8539fe17d0>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8539f65690>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8539f12150>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8539e89fd0>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8539cfb090>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8539c3e050>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8539bf51d0>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8539aa1f10>],\n",
       "       [<matplotlib.axes._subplots.AxesSubplot object at 0x7f85399a4dd0>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8539987f50>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f853988ce10>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f8539774b50>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f85396bcc90>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f85395c1b50>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f853952f610>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f85394b44d0>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f853949a550>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f853941c510>,\n",
       "        <matplotlib.axes._subplots.AxesSubplot object at 0x7f85393d4690>]], dtype=object)"
      ]
     },
     "execution_count": 251,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAA5YAAAORCAYAAACJDj3GAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\ndb8HAwIAAAAASUVORK5CYII=\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7f8535fa62d0>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "pd.scatter_matrix(df_hema_drop_drug[pca_cols], alpha=0.2, figsize=(15, 15), diagonal='kde')"
   ]
  },
  {
   "cell_type": "markdown",
   "metadata": {},
   "source": [
    "Need to remove outliers"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 253,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(0, 40000)"
      ]
     },
     "execution_count": 253,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAYoAAAEACAYAAACtVTGuAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\n04n/AAAAAElFTkSuQmCC\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7f85370275d0>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "df_hema['total_submitted_charges_norm'].hist(bins=400)\n",
    "plt.xlim(0,40000)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 256,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(0, 40000)"
      ]
     },
     "execution_count": 256,
     "metadata": {},
     "output_type": "execute_result"
    },
    {
     "data": {
      "image/png": "iVBORw0KGgoAAAANSUhEUgAAAYQAAAEACAYAAACznAEdAAAABHNCSVQICAgIfAhkiAAAAAlwSFlz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\nmJlZyQXBzMwA+P9LhIfHX2TpOwAAAABJRU5ErkJggg==\n",
      "text/plain": [
       "<matplotlib.figure.Figure at 0x7f852f65e290>"
      ]
     },
     "metadata": {},
     "output_type": "display_data"
    }
   ],
   "source": [
    "df_hema_drop_drug['total_submitted_charges_norm'].hist(bins=400)\n",
    "plt.xlim(0,40000)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 259,
   "metadata": {
    "collapsed": false,
    "scrolled": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "count      3974.000000\n",
      "mean       6591.142791\n",
      "std        7007.750683\n",
      "min         218.552632\n",
      "25%        3185.981675\n",
      "50%        5590.617390\n",
      "75%        8568.982399\n",
      "max      287374.866667\n",
      "Name: total_submitted_charges_norm, dtype: float64\n"
     ]
    },
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>npi</th>\n",
       "      <th>last_name</th>\n",
       "      <th>first_name</th>\n",
       "      <th>credentials</th>\n",
       "      <th>state</th>\n",
       "      <th>provider_type</th>\n",
       "      <th>num_hcpcs</th>\n",
       "      <th>num_services</th>\n",
       "      <th>num_unique_bene</th>\n",
       "      <th>total_submitted_charges</th>\n",
       "      <th>...</th>\n",
       "      <th>num_diabetes_norm</th>\n",
       "      <th>num_heart_failure_norm</th>\n",
       "      <th>num_hypertension_norm</th>\n",
       "      <th>num_ischemic_heart_norm</th>\n",
       "      <th>num_osteoporosis_norm</th>\n",
       "      <th>num_rheumatoid_arthritis_osteoarthirtis_norm</th>\n",
       "      <th>num_schizophrenia_psychotic_norm</th>\n",
       "      <th>num_stroke_norm</th>\n",
       "      <th>drug_charge_per_srvc</th>\n",
       "      <th>med_charge_per_srvc</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>76</th>\n",
       "      <td>1609946169</td>\n",
       "      <td>ASHOURI</td>\n",
       "      <td>SHAHRYAR</td>\n",
       "      <td>MD</td>\n",
       "      <td>CA</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>111</td>\n",
       "      <td>130082.0</td>\n",
       "      <td>365</td>\n",
       "      <td>12891085.41</td>\n",
       "      <td>...</td>\n",
       "      <td>0.30</td>\n",
       "      <td>0.20</td>\n",
       "      <td>0.66</td>\n",
       "      <td>0.38</td>\n",
       "      <td>0.13</td>\n",
       "      <td>0.37</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.05</td>\n",
       "      <td>92.448644</td>\n",
       "      <td>255.505731</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>361</th>\n",
       "      <td>1700839933</td>\n",
       "      <td>LEISSINGER</td>\n",
       "      <td>CINDY</td>\n",
       "      <td>None</td>\n",
       "      <td>LA</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>17</td>\n",
       "      <td>8246.1</td>\n",
       "      <td>50</td>\n",
       "      <td>3868389.24</td>\n",
       "      <td>...</td>\n",
       "      <td>0.40</td>\n",
       "      <td>0.26</td>\n",
       "      <td>0.56</td>\n",
       "      <td>0.28</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.42</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>471.656603</td>\n",
       "      <td>180.847222</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>386</th>\n",
       "      <td>1235171281</td>\n",
       "      <td>BECERRA</td>\n",
       "      <td>CARLOS</td>\n",
       "      <td>MD</td>\n",
       "      <td>TX</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>121</td>\n",
       "      <td>88502.0</td>\n",
       "      <td>183</td>\n",
       "      <td>4703267.00</td>\n",
       "      <td>...</td>\n",
       "      <td>0.38</td>\n",
       "      <td>0.20</td>\n",
       "      <td>0.74</td>\n",
       "      <td>0.39</td>\n",
       "      <td>0.07</td>\n",
       "      <td>0.34</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.07</td>\n",
       "      <td>42.809843</td>\n",
       "      <td>228.950743</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>723</th>\n",
       "      <td>1013980853</td>\n",
       "      <td>UDHRAIN</td>\n",
       "      <td>ASHISH</td>\n",
       "      <td>MD</td>\n",
       "      <td>IL</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>66</td>\n",
       "      <td>27399.0</td>\n",
       "      <td>60</td>\n",
       "      <td>1650257.60</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.42</td>\n",
       "      <td>0.18</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.20</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>54.808653</td>\n",
       "      <td>204.561996</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>1093</th>\n",
       "      <td>1427190115</td>\n",
       "      <td>KONECNY</td>\n",
       "      <td>GOTTFRIED</td>\n",
       "      <td>MD</td>\n",
       "      <td>MN</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>48</td>\n",
       "      <td>9202.0</td>\n",
       "      <td>49</td>\n",
       "      <td>1534749.00</td>\n",
       "      <td>...</td>\n",
       "      <td>0.29</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.57</td>\n",
       "      <td>0.22</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.29</td>\n",
       "      <td>0.00</td>\n",
       "      <td>NaN</td>\n",
       "      <td>153.312240</td>\n",
       "      <td>312.451861</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2054</th>\n",
       "      <td>1457334914</td>\n",
       "      <td>TETREAULT</td>\n",
       "      <td>SCOTT</td>\n",
       "      <td>MD</td>\n",
       "      <td>FL</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>138</td>\n",
       "      <td>176653.0</td>\n",
       "      <td>234</td>\n",
       "      <td>5916474.00</td>\n",
       "      <td>...</td>\n",
       "      <td>0.30</td>\n",
       "      <td>0.25</td>\n",
       "      <td>0.70</td>\n",
       "      <td>0.42</td>\n",
       "      <td>0.12</td>\n",
       "      <td>0.33</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.06</td>\n",
       "      <td>29.813687</td>\n",
       "      <td>102.101680</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>2289</th>\n",
       "      <td>1740316272</td>\n",
       "      <td>NGUYEN</td>\n",
       "      <td>MINH</td>\n",
       "      <td>MD</td>\n",
       "      <td>CA</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>128</td>\n",
       "      <td>517160.0</td>\n",
       "      <td>828</td>\n",
       "      <td>23101879.14</td>\n",
       "      <td>...</td>\n",
       "      <td>0.26</td>\n",
       "      <td>0.19</td>\n",
       "      <td>0.63</td>\n",
       "      <td>0.37</td>\n",
       "      <td>0.11</td>\n",
       "      <td>0.37</td>\n",
       "      <td>0.04</td>\n",
       "      <td>0.06</td>\n",
       "      <td>40.380366</td>\n",
       "      <td>96.640043</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3219</th>\n",
       "      <td>1063477073</td>\n",
       "      <td>GREIST</td>\n",
       "      <td>ANNE</td>\n",
       "      <td>MD</td>\n",
       "      <td>IN</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>60</td>\n",
       "      <td>41681.0</td>\n",
       "      <td>448</td>\n",
       "      <td>35744616.92</td>\n",
       "      <td>...</td>\n",
       "      <td>0.29</td>\n",
       "      <td>0.18</td>\n",
       "      <td>0.56</td>\n",
       "      <td>0.33</td>\n",
       "      <td>0.08</td>\n",
       "      <td>0.33</td>\n",
       "      <td>0.04</td>\n",
       "      <td>0.04</td>\n",
       "      <td>895.464525</td>\n",
       "      <td>90.140745</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>3667</th>\n",
       "      <td>1013991678</td>\n",
       "      <td>WITTA</td>\n",
       "      <td>SAMIR</td>\n",
       "      <td>MD PHD</td>\n",
       "      <td>CO</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>92</td>\n",
       "      <td>48569.0</td>\n",
       "      <td>153</td>\n",
       "      <td>4211182.64</td>\n",
       "      <td>...</td>\n",
       "      <td>0.20</td>\n",
       "      <td>0.16</td>\n",
       "      <td>0.56</td>\n",
       "      <td>0.25</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.31</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.08</td>\n",
       "      <td>80.973467</td>\n",
       "      <td>162.039953</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4237</th>\n",
       "      <td>1043201817</td>\n",
       "      <td>ASHTAR</td>\n",
       "      <td>ED</td>\n",
       "      <td>MD, FACP</td>\n",
       "      <td>MD</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>68</td>\n",
       "      <td>251031.0</td>\n",
       "      <td>82</td>\n",
       "      <td>9656994.52</td>\n",
       "      <td>...</td>\n",
       "      <td>0.59</td>\n",
       "      <td>0.48</td>\n",
       "      <td>0.75</td>\n",
       "      <td>0.60</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.63</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>34.165482</td>\n",
       "      <td>164.036784</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4464</th>\n",
       "      <td>1912984766</td>\n",
       "      <td>OZA</td>\n",
       "      <td>YAGNESH</td>\n",
       "      <td>MD</td>\n",
       "      <td>IL</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>163</td>\n",
       "      <td>244158.0</td>\n",
       "      <td>1013</td>\n",
       "      <td>26863982.00</td>\n",
       "      <td>...</td>\n",
       "      <td>0.33</td>\n",
       "      <td>0.20</td>\n",
       "      <td>0.68</td>\n",
       "      <td>0.40</td>\n",
       "      <td>0.11</td>\n",
       "      <td>0.32</td>\n",
       "      <td>0.04</td>\n",
       "      <td>0.05</td>\n",
       "      <td>75.773916</td>\n",
       "      <td>382.510545</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4635</th>\n",
       "      <td>1073517835</td>\n",
       "      <td>HEMROCK</td>\n",
       "      <td>LORI</td>\n",
       "      <td>MD</td>\n",
       "      <td>OH</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>113</td>\n",
       "      <td>226734.0</td>\n",
       "      <td>534</td>\n",
       "      <td>13879009.00</td>\n",
       "      <td>...</td>\n",
       "      <td>0.34</td>\n",
       "      <td>0.24</td>\n",
       "      <td>0.75</td>\n",
       "      <td>0.45</td>\n",
       "      <td>0.08</td>\n",
       "      <td>0.43</td>\n",
       "      <td>0.04</td>\n",
       "      <td>0.07</td>\n",
       "      <td>53.500871</td>\n",
       "      <td>221.743193</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4638</th>\n",
       "      <td>1942204672</td>\n",
       "      <td>KNIGHT</td>\n",
       "      <td>CHRIS</td>\n",
       "      <td>MD</td>\n",
       "      <td>OH</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>117</td>\n",
       "      <td>275524.0</td>\n",
       "      <td>686</td>\n",
       "      <td>17378659.00</td>\n",
       "      <td>...</td>\n",
       "      <td>0.37</td>\n",
       "      <td>0.27</td>\n",
       "      <td>0.75</td>\n",
       "      <td>0.40</td>\n",
       "      <td>0.07</td>\n",
       "      <td>0.41</td>\n",
       "      <td>0.04</td>\n",
       "      <td>0.07</td>\n",
       "      <td>54.908280</td>\n",
       "      <td>262.521314</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4686</th>\n",
       "      <td>1366408627</td>\n",
       "      <td>MASCI</td>\n",
       "      <td>PAUL</td>\n",
       "      <td>DO</td>\n",
       "      <td>OH</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>121</td>\n",
       "      <td>100085.0</td>\n",
       "      <td>399</td>\n",
       "      <td>11015343.82</td>\n",
       "      <td>...</td>\n",
       "      <td>0.30</td>\n",
       "      <td>0.19</td>\n",
       "      <td>0.66</td>\n",
       "      <td>0.32</td>\n",
       "      <td>0.07</td>\n",
       "      <td>0.31</td>\n",
       "      <td>0.03</td>\n",
       "      <td>0.04</td>\n",
       "      <td>107.560942</td>\n",
       "      <td>144.957315</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4729</th>\n",
       "      <td>1972627446</td>\n",
       "      <td>REDDY</td>\n",
       "      <td>SRINI</td>\n",
       "      <td>MD</td>\n",
       "      <td>TX</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>147</td>\n",
       "      <td>110798.0</td>\n",
       "      <td>328</td>\n",
       "      <td>9578848.00</td>\n",
       "      <td>...</td>\n",
       "      <td>0.26</td>\n",
       "      <td>0.17</td>\n",
       "      <td>0.71</td>\n",
       "      <td>0.36</td>\n",
       "      <td>0.11</td>\n",
       "      <td>0.38</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.05</td>\n",
       "      <td>69.805013</td>\n",
       "      <td>223.764794</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4949</th>\n",
       "      <td>1144251562</td>\n",
       "      <td>MAGNIFICO</td>\n",
       "      <td>MICHAEL</td>\n",
       "      <td>MD</td>\n",
       "      <td>CT</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>178</td>\n",
       "      <td>137567.0</td>\n",
       "      <td>504</td>\n",
       "      <td>16284526.36</td>\n",
       "      <td>...</td>\n",
       "      <td>0.27</td>\n",
       "      <td>0.20</td>\n",
       "      <td>0.73</td>\n",
       "      <td>0.36</td>\n",
       "      <td>0.13</td>\n",
       "      <td>0.38</td>\n",
       "      <td>0.03</td>\n",
       "      <td>0.02</td>\n",
       "      <td>107.070196</td>\n",
       "      <td>286.323392</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4981</th>\n",
       "      <td>1770549511</td>\n",
       "      <td>ATIQ</td>\n",
       "      <td>OMAR</td>\n",
       "      <td>MD</td>\n",
       "      <td>AR</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>105</td>\n",
       "      <td>203973.0</td>\n",
       "      <td>551</td>\n",
       "      <td>14783823.89</td>\n",
       "      <td>...</td>\n",
       "      <td>0.33</td>\n",
       "      <td>0.27</td>\n",
       "      <td>0.75</td>\n",
       "      <td>0.51</td>\n",
       "      <td>0.09</td>\n",
       "      <td>0.33</td>\n",
       "      <td>0.03</td>\n",
       "      <td>0.06</td>\n",
       "      <td>68.489643</td>\n",
       "      <td>143.555222</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>4994</th>\n",
       "      <td>1518070812</td>\n",
       "      <td>O'DAY</td>\n",
       "      <td>STEVEN</td>\n",
       "      <td>MD</td>\n",
       "      <td>CA</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>79</td>\n",
       "      <td>25677.0</td>\n",
       "      <td>104</td>\n",
       "      <td>6973794.24</td>\n",
       "      <td>...</td>\n",
       "      <td>0.22</td>\n",
       "      <td>0.17</td>\n",
       "      <td>0.57</td>\n",
       "      <td>0.40</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.33</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>282.875642</td>\n",
       "      <td>185.036581</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5147</th>\n",
       "      <td>1922090745</td>\n",
       "      <td>WASSEF</td>\n",
       "      <td>EMIL</td>\n",
       "      <td>MD, PHD</td>\n",
       "      <td>NY</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>42</td>\n",
       "      <td>149784.0</td>\n",
       "      <td>85</td>\n",
       "      <td>5349445.00</td>\n",
       "      <td>...</td>\n",
       "      <td>0.73</td>\n",
       "      <td>0.54</td>\n",
       "      <td>0.75</td>\n",
       "      <td>0.74</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.47</td>\n",
       "      <td>0.18</td>\n",
       "      <td>0.18</td>\n",
       "      <td>32.876223</td>\n",
       "      <td>166.475487</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5359</th>\n",
       "      <td>1063495232</td>\n",
       "      <td>KALRA</td>\n",
       "      <td>KAVITA</td>\n",
       "      <td>MD</td>\n",
       "      <td>MD</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>65</td>\n",
       "      <td>36652.0</td>\n",
       "      <td>149</td>\n",
       "      <td>3976533.21</td>\n",
       "      <td>...</td>\n",
       "      <td>0.57</td>\n",
       "      <td>0.38</td>\n",
       "      <td>0.75</td>\n",
       "      <td>0.50</td>\n",
       "      <td>0.08</td>\n",
       "      <td>0.35</td>\n",
       "      <td>0.10</td>\n",
       "      <td>NaN</td>\n",
       "      <td>101.750086</td>\n",
       "      <td>229.827326</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5827</th>\n",
       "      <td>1760487177</td>\n",
       "      <td>WEINREB</td>\n",
       "      <td>NEAL</td>\n",
       "      <td>MD</td>\n",
       "      <td>FL</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>48</td>\n",
       "      <td>68952.0</td>\n",
       "      <td>30</td>\n",
       "      <td>8621246.00</td>\n",
       "      <td>...</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.67</td>\n",
       "      <td>0.47</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.53</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>125.719558</td>\n",
       "      <td>90.579377</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>5980</th>\n",
       "      <td>1770583197</td>\n",
       "      <td>KARIMI</td>\n",
       "      <td>MISAGH</td>\n",
       "      <td>MD</td>\n",
       "      <td>CA</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>96</td>\n",
       "      <td>50302.0</td>\n",
       "      <td>170</td>\n",
       "      <td>4260961.00</td>\n",
       "      <td>...</td>\n",
       "      <td>0.33</td>\n",
       "      <td>0.20</td>\n",
       "      <td>0.59</td>\n",
       "      <td>0.34</td>\n",
       "      <td>0.13</td>\n",
       "      <td>0.36</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>72.330312</td>\n",
       "      <td>289.643281</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6453</th>\n",
       "      <td>1760495048</td>\n",
       "      <td>BRUCKNER</td>\n",
       "      <td>HOWARD</td>\n",
       "      <td>MD</td>\n",
       "      <td>NY</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>66</td>\n",
       "      <td>73288.0</td>\n",
       "      <td>117</td>\n",
       "      <td>4612897.03</td>\n",
       "      <td>...</td>\n",
       "      <td>0.46</td>\n",
       "      <td>0.24</td>\n",
       "      <td>0.73</td>\n",
       "      <td>0.44</td>\n",
       "      <td>0.10</td>\n",
       "      <td>0.28</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>37.193453</td>\n",
       "      <td>227.172637</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6634</th>\n",
       "      <td>1346238474</td>\n",
       "      <td>SUAREZ</td>\n",
       "      <td>JOSE</td>\n",
       "      <td>MD</td>\n",
       "      <td>AK</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>92</td>\n",
       "      <td>31291.0</td>\n",
       "      <td>215</td>\n",
       "      <td>6083513.66</td>\n",
       "      <td>...</td>\n",
       "      <td>0.30</td>\n",
       "      <td>0.15</td>\n",
       "      <td>0.64</td>\n",
       "      <td>0.29</td>\n",
       "      <td>0.06</td>\n",
       "      <td>0.38</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>193.309794</td>\n",
       "      <td>205.264574</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6635</th>\n",
       "      <td>1740221225</td>\n",
       "      <td>ZIMMERMANN</td>\n",
       "      <td>JOHN</td>\n",
       "      <td>MD</td>\n",
       "      <td>AK</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>93</td>\n",
       "      <td>30443.0</td>\n",
       "      <td>201</td>\n",
       "      <td>6795582.86</td>\n",
       "      <td>...</td>\n",
       "      <td>0.33</td>\n",
       "      <td>0.17</td>\n",
       "      <td>0.65</td>\n",
       "      <td>0.28</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.38</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>225.193087</td>\n",
       "      <td>206.280984</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6862</th>\n",
       "      <td>1730121690</td>\n",
       "      <td>WEISBERG</td>\n",
       "      <td>ROBERT</td>\n",
       "      <td>MD</td>\n",
       "      <td>TX</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>113</td>\n",
       "      <td>116773.0</td>\n",
       "      <td>229</td>\n",
       "      <td>6466436.00</td>\n",
       "      <td>...</td>\n",
       "      <td>0.33</td>\n",
       "      <td>0.22</td>\n",
       "      <td>0.66</td>\n",
       "      <td>0.34</td>\n",
       "      <td>0.08</td>\n",
       "      <td>0.38</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.06</td>\n",
       "      <td>49.911019</td>\n",
       "      <td>157.547478</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>6884</th>\n",
       "      <td>1952349920</td>\n",
       "      <td>POPATIA</td>\n",
       "      <td>AMIRALI</td>\n",
       "      <td>MD</td>\n",
       "      <td>TX</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>90</td>\n",
       "      <td>174347.0</td>\n",
       "      <td>271</td>\n",
       "      <td>8880225.95</td>\n",
       "      <td>...</td>\n",
       "      <td>0.34</td>\n",
       "      <td>0.30</td>\n",
       "      <td>0.75</td>\n",
       "      <td>0.41</td>\n",
       "      <td>0.08</td>\n",
       "      <td>0.35</td>\n",
       "      <td>0.04</td>\n",
       "      <td>0.04</td>\n",
       "      <td>47.374337</td>\n",
       "      <td>125.014129</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7097</th>\n",
       "      <td>1750350633</td>\n",
       "      <td>ZAYDAN</td>\n",
       "      <td>MUHAMMAD-ALI</td>\n",
       "      <td>MD</td>\n",
       "      <td>KY</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>104</td>\n",
       "      <td>87925.0</td>\n",
       "      <td>293</td>\n",
       "      <td>18467330.91</td>\n",
       "      <td>...</td>\n",
       "      <td>0.40</td>\n",
       "      <td>0.32</td>\n",
       "      <td>0.75</td>\n",
       "      <td>0.48</td>\n",
       "      <td>0.13</td>\n",
       "      <td>0.41</td>\n",
       "      <td>0.06</td>\n",
       "      <td>0.08</td>\n",
       "      <td>174.705140</td>\n",
       "      <td>539.175573</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7234</th>\n",
       "      <td>1922076686</td>\n",
       "      <td>BLUMENREICH</td>\n",
       "      <td>MARTIN</td>\n",
       "      <td>MD</td>\n",
       "      <td>MN</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>91</td>\n",
       "      <td>54445.0</td>\n",
       "      <td>153</td>\n",
       "      <td>4215515.00</td>\n",
       "      <td>...</td>\n",
       "      <td>0.22</td>\n",
       "      <td>0.17</td>\n",
       "      <td>0.57</td>\n",
       "      <td>0.24</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.22</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>69.717893</td>\n",
       "      <td>263.407014</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7276</th>\n",
       "      <td>1023088853</td>\n",
       "      <td>NAQVI</td>\n",
       "      <td>SHAGUFTA</td>\n",
       "      <td>MD</td>\n",
       "      <td>TX</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>62</td>\n",
       "      <td>36866.0</td>\n",
       "      <td>175</td>\n",
       "      <td>4427465.29</td>\n",
       "      <td>...</td>\n",
       "      <td>0.29</td>\n",
       "      <td>0.18</td>\n",
       "      <td>0.67</td>\n",
       "      <td>0.34</td>\n",
       "      <td>0.31</td>\n",
       "      <td>0.37</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>115.449241</td>\n",
       "      <td>187.248722</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7277</th>\n",
       "      <td>1982644498</td>\n",
       "      <td>RAKKHIT</td>\n",
       "      <td>RONJAY</td>\n",
       "      <td>MD</td>\n",
       "      <td>TX</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>136</td>\n",
       "      <td>271378.0</td>\n",
       "      <td>563</td>\n",
       "      <td>14317835.64</td>\n",
       "      <td>...</td>\n",
       "      <td>0.33</td>\n",
       "      <td>0.25</td>\n",
       "      <td>0.75</td>\n",
       "      <td>0.42</td>\n",
       "      <td>0.10</td>\n",
       "      <td>0.39</td>\n",
       "      <td>0.03</td>\n",
       "      <td>0.09</td>\n",
       "      <td>47.137009</td>\n",
       "      <td>171.405152</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>7394</th>\n",
       "      <td>1124051560</td>\n",
       "      <td>BERENSON</td>\n",
       "      <td>JAMES</td>\n",
       "      <td>MD</td>\n",
       "      <td>CA</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>92</td>\n",
       "      <td>177840.0</td>\n",
       "      <td>192</td>\n",
       "      <td>11404946.47</td>\n",
       "      <td>...</td>\n",
       "      <td>0.23</td>\n",
       "      <td>0.19</td>\n",
       "      <td>0.62</td>\n",
       "      <td>0.35</td>\n",
       "      <td>0.14</td>\n",
       "      <td>0.49</td>\n",
       "      <td>NaN</td>\n",
       "      <td>NaN</td>\n",
       "      <td>48.991714</td>\n",
       "      <td>200.361338</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>32 rows × 73 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "             npi    last_name    first_name credentials state  \\\n",
       "76    1609946169      ASHOURI      SHAHRYAR          MD    CA   \n",
       "361   1700839933   LEISSINGER         CINDY        None    LA   \n",
       "386   1235171281      BECERRA        CARLOS          MD    TX   \n",
       "723   1013980853      UDHRAIN        ASHISH          MD    IL   \n",
       "1093  1427190115      KONECNY     GOTTFRIED          MD    MN   \n",
       "2054  1457334914    TETREAULT         SCOTT          MD    FL   \n",
       "2289  1740316272       NGUYEN          MINH          MD    CA   \n",
       "3219  1063477073       GREIST          ANNE          MD    IN   \n",
       "3667  1013991678        WITTA         SAMIR      MD PHD    CO   \n",
       "4237  1043201817       ASHTAR            ED    MD, FACP    MD   \n",
       "4464  1912984766          OZA       YAGNESH          MD    IL   \n",
       "4635  1073517835      HEMROCK          LORI          MD    OH   \n",
       "4638  1942204672       KNIGHT         CHRIS          MD    OH   \n",
       "4686  1366408627        MASCI          PAUL          DO    OH   \n",
       "4729  1972627446        REDDY         SRINI          MD    TX   \n",
       "4949  1144251562    MAGNIFICO       MICHAEL          MD    CT   \n",
       "4981  1770549511         ATIQ          OMAR          MD    AR   \n",
       "4994  1518070812        O'DAY        STEVEN          MD    CA   \n",
       "5147  1922090745       WASSEF          EMIL     MD, PHD    NY   \n",
       "5359  1063495232        KALRA        KAVITA          MD    MD   \n",
       "5827  1760487177      WEINREB          NEAL          MD    FL   \n",
       "5980  1770583197       KARIMI        MISAGH          MD    CA   \n",
       "6453  1760495048     BRUCKNER        HOWARD          MD    NY   \n",
       "6634  1346238474       SUAREZ          JOSE          MD    AK   \n",
       "6635  1740221225   ZIMMERMANN          JOHN          MD    AK   \n",
       "6862  1730121690     WEISBERG        ROBERT          MD    TX   \n",
       "6884  1952349920      POPATIA       AMIRALI          MD    TX   \n",
       "7097  1750350633       ZAYDAN  MUHAMMAD-ALI          MD    KY   \n",
       "7234  1922076686  BLUMENREICH        MARTIN          MD    MN   \n",
       "7276  1023088853        NAQVI      SHAGUFTA          MD    TX   \n",
       "7277  1982644498      RAKKHIT        RONJAY          MD    TX   \n",
       "7394  1124051560     BERENSON         JAMES          MD    CA   \n",
       "\n",
       "            provider_type  num_hcpcs  num_services  num_unique_bene  \\\n",
       "76    Hematology/Oncology        111      130082.0              365   \n",
       "361   Hematology/Oncology         17        8246.1               50   \n",
       "386   Hematology/Oncology        121       88502.0              183   \n",
       "723   Hematology/Oncology         66       27399.0               60   \n",
       "1093  Hematology/Oncology         48        9202.0               49   \n",
       "2054  Hematology/Oncology        138      176653.0              234   \n",
       "2289  Hematology/Oncology        128      517160.0              828   \n",
       "3219  Hematology/Oncology         60       41681.0              448   \n",
       "3667  Hematology/Oncology         92       48569.0              153   \n",
       "4237  Hematology/Oncology         68      251031.0               82   \n",
       "4464  Hematology/Oncology        163      244158.0             1013   \n",
       "4635  Hematology/Oncology        113      226734.0              534   \n",
       "4638  Hematology/Oncology        117      275524.0              686   \n",
       "4686  Hematology/Oncology        121      100085.0              399   \n",
       "4729  Hematology/Oncology        147      110798.0              328   \n",
       "4949  Hematology/Oncology        178      137567.0              504   \n",
       "4981  Hematology/Oncology        105      203973.0              551   \n",
       "4994  Hematology/Oncology         79       25677.0              104   \n",
       "5147  Hematology/Oncology         42      149784.0               85   \n",
       "5359  Hematology/Oncology         65       36652.0              149   \n",
       "5827  Hematology/Oncology         48       68952.0               30   \n",
       "5980  Hematology/Oncology         96       50302.0              170   \n",
       "6453  Hematology/Oncology         66       73288.0              117   \n",
       "6634  Hematology/Oncology         92       31291.0              215   \n",
       "6635  Hematology/Oncology         93       30443.0              201   \n",
       "6862  Hematology/Oncology        113      116773.0              229   \n",
       "6884  Hematology/Oncology         90      174347.0              271   \n",
       "7097  Hematology/Oncology        104       87925.0              293   \n",
       "7234  Hematology/Oncology         91       54445.0              153   \n",
       "7276  Hematology/Oncology         62       36866.0              175   \n",
       "7277  Hematology/Oncology        136      271378.0              563   \n",
       "7394  Hematology/Oncology         92      177840.0              192   \n",
       "\n",
       "      total_submitted_charges         ...           num_diabetes_norm  \\\n",
       "76                12891085.41         ...                        0.30   \n",
       "361                3868389.24         ...                        0.40   \n",
       "386                4703267.00         ...                        0.38   \n",
       "723                1650257.60         ...                         NaN   \n",
       "1093               1534749.00         ...                        0.29   \n",
       "2054               5916474.00         ...                        0.30   \n",
       "2289              23101879.14         ...                        0.26   \n",
       "3219              35744616.92         ...                        0.29   \n",
       "3667               4211182.64         ...                        0.20   \n",
       "4237               9656994.52         ...                        0.59   \n",
       "4464              26863982.00         ...                        0.33   \n",
       "4635              13879009.00         ...                        0.34   \n",
       "4638              17378659.00         ...                        0.37   \n",
       "4686              11015343.82         ...                        0.30   \n",
       "4729               9578848.00         ...                        0.26   \n",
       "4949              16284526.36         ...                        0.27   \n",
       "4981              14783823.89         ...                        0.33   \n",
       "4994               6973794.24         ...                        0.22   \n",
       "5147               5349445.00         ...                        0.73   \n",
       "5359               3976533.21         ...                        0.57   \n",
       "5827               8621246.00         ...                         NaN   \n",
       "5980               4260961.00         ...                        0.33   \n",
       "6453               4612897.03         ...                        0.46   \n",
       "6634               6083513.66         ...                        0.30   \n",
       "6635               6795582.86         ...                        0.33   \n",
       "6862               6466436.00         ...                        0.33   \n",
       "6884               8880225.95         ...                        0.34   \n",
       "7097              18467330.91         ...                        0.40   \n",
       "7234               4215515.00         ...                        0.22   \n",
       "7276               4427465.29         ...                        0.29   \n",
       "7277              14317835.64         ...                        0.33   \n",
       "7394              11404946.47         ...                        0.23   \n",
       "\n",
       "      num_heart_failure_norm  num_hypertension_norm  num_ischemic_heart_norm  \\\n",
       "76                      0.20                   0.66                     0.38   \n",
       "361                     0.26                   0.56                     0.28   \n",
       "386                     0.20                   0.74                     0.39   \n",
       "723                      NaN                   0.42                     0.18   \n",
       "1093                     NaN                   0.57                     0.22   \n",
       "2054                    0.25                   0.70                     0.42   \n",
       "2289                    0.19                   0.63                     0.37   \n",
       "3219                    0.18                   0.56                     0.33   \n",
       "3667                    0.16                   0.56                     0.25   \n",
       "4237                    0.48                   0.75                     0.60   \n",
       "4464                    0.20                   0.68                     0.40   \n",
       "4635                    0.24                   0.75                     0.45   \n",
       "4638                    0.27                   0.75                     0.40   \n",
       "4686                    0.19                   0.66                     0.32   \n",
       "4729                    0.17                   0.71                     0.36   \n",
       "4949                    0.20                   0.73                     0.36   \n",
       "4981                    0.27                   0.75                     0.51   \n",
       "4994                    0.17                   0.57                     0.40   \n",
       "5147                    0.54                   0.75                     0.74   \n",
       "5359                    0.38                   0.75                     0.50   \n",
       "5827                     NaN                   0.67                     0.47   \n",
       "5980                    0.20                   0.59                     0.34   \n",
       "6453                    0.24                   0.73                     0.44   \n",
       "6634                    0.15                   0.64                     0.29   \n",
       "6635                    0.17                   0.65                     0.28   \n",
       "6862                    0.22                   0.66                     0.34   \n",
       "6884                    0.30                   0.75                     0.41   \n",
       "7097                    0.32                   0.75                     0.48   \n",
       "7234                    0.17                   0.57                     0.24   \n",
       "7276                    0.18                   0.67                     0.34   \n",
       "7277                    0.25                   0.75                     0.42   \n",
       "7394                    0.19                   0.62                     0.35   \n",
       "\n",
       "      num_osteoporosis_norm  num_rheumatoid_arthritis_osteoarthirtis_norm  \\\n",
       "76                     0.13                                          0.37   \n",
       "361                     NaN                                          0.42   \n",
       "386                    0.07                                          0.34   \n",
       "723                     NaN                                          0.20   \n",
       "1093                    NaN                                          0.29   \n",
       "2054                   0.12                                          0.33   \n",
       "2289                   0.11                                          0.37   \n",
       "3219                   0.08                                          0.33   \n",
       "3667                    NaN                                          0.31   \n",
       "4237                    NaN                                          0.63   \n",
       "4464                   0.11                                          0.32   \n",
       "4635                   0.08                                          0.43   \n",
       "4638                   0.07                                          0.41   \n",
       "4686                   0.07                                          0.31   \n",
       "4729                   0.11                                          0.38   \n",
       "4949                   0.13                                          0.38   \n",
       "4981                   0.09                                          0.33   \n",
       "4994                    NaN                                          0.33   \n",
       "5147                    NaN                                          0.47   \n",
       "5359                   0.08                                          0.35   \n",
       "5827                    NaN                                          0.53   \n",
       "5980                   0.13                                          0.36   \n",
       "6453                   0.10                                          0.28   \n",
       "6634                   0.06                                          0.38   \n",
       "6635                    NaN                                          0.38   \n",
       "6862                   0.08                                          0.38   \n",
       "6884                   0.08                                          0.35   \n",
       "7097                   0.13                                          0.41   \n",
       "7234                    NaN                                          0.22   \n",
       "7276                   0.31                                          0.37   \n",
       "7277                   0.10                                          0.39   \n",
       "7394                   0.14                                          0.49   \n",
       "\n",
       "      num_schizophrenia_psychotic_norm  num_stroke_norm  drug_charge_per_srvc  \\\n",
       "76                                 NaN             0.05             92.448644   \n",
       "361                                NaN              NaN            471.656603   \n",
       "386                                NaN             0.07             42.809843   \n",
       "723                                NaN              NaN             54.808653   \n",
       "1093                              0.00              NaN            153.312240   \n",
       "2054                               NaN             0.06             29.813687   \n",
       "2289                              0.04             0.06             40.380366   \n",
       "3219                              0.04             0.04            895.464525   \n",
       "3667                               NaN             0.08             80.973467   \n",
       "4237                               NaN              NaN             34.165482   \n",
       "4464                              0.04             0.05             75.773916   \n",
       "4635                              0.04             0.07             53.500871   \n",
       "4638                              0.04             0.07             54.908280   \n",
       "4686                              0.03             0.04            107.560942   \n",
       "4729                               NaN             0.05             69.805013   \n",
       "4949                              0.03             0.02            107.070196   \n",
       "4981                              0.03             0.06             68.489643   \n",
       "4994                               NaN              NaN            282.875642   \n",
       "5147                              0.18             0.18             32.876223   \n",
       "5359                              0.10              NaN            101.750086   \n",
       "5827                               NaN              NaN            125.719558   \n",
       "5980                               NaN              NaN             72.330312   \n",
       "6453                               NaN              NaN             37.193453   \n",
       "6634                               NaN              NaN            193.309794   \n",
       "6635                               NaN              NaN            225.193087   \n",
       "6862                               NaN             0.06             49.911019   \n",
       "6884                              0.04             0.04             47.374337   \n",
       "7097                              0.06             0.08            174.705140   \n",
       "7234                               NaN              NaN             69.717893   \n",
       "7276                               NaN              NaN            115.449241   \n",
       "7277                              0.03             0.09             47.137009   \n",
       "7394                               NaN              NaN             48.991714   \n",
       "\n",
       "      med_charge_per_srvc  \n",
       "76             255.505731  \n",
       "361            180.847222  \n",
       "386            228.950743  \n",
       "723            204.561996  \n",
       "1093           312.451861  \n",
       "2054           102.101680  \n",
       "2289            96.640043  \n",
       "3219            90.140745  \n",
       "3667           162.039953  \n",
       "4237           164.036784  \n",
       "4464           382.510545  \n",
       "4635           221.743193  \n",
       "4638           262.521314  \n",
       "4686           144.957315  \n",
       "4729           223.764794  \n",
       "4949           286.323392  \n",
       "4981           143.555222  \n",
       "4994           185.036581  \n",
       "5147           166.475487  \n",
       "5359           229.827326  \n",
       "5827            90.579377  \n",
       "5980           289.643281  \n",
       "6453           227.172637  \n",
       "6634           205.264574  \n",
       "6635           206.280984  \n",
       "6862           157.547478  \n",
       "6884           125.014129  \n",
       "7097           539.175573  \n",
       "7234           263.407014  \n",
       "7276           187.248722  \n",
       "7277           171.405152  \n",
       "7394           200.361338  \n",
       "\n",
       "[32 rows x 73 columns]"
      ]
     },
     "execution_count": 259,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "print df_hema_drop_drug['total_submitted_charges_norm'].describe()\n",
    "df_hema_drop_drug[df_hema_drop_drug['total_submitted_charges_norm']>25000]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 260,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "out_limit = 5590+1.5*(8568-3185)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 261,
   "metadata": {
    "collapsed": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "13664.5"
      ]
     },
     "execution_count": 261,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "out_limit"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 263,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "outliers = df_hema_drop_drug[df_hema_drop_drug['total_submitted_charges_norm']>out_limit]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 267,
   "metadata": {
    "collapsed": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr>\n",
       "      <th>total_submitted_charges_norm</th>\n",
       "      <th colspan=\"8\" halign=\"left\">False</th>\n",
       "      <th colspan=\"8\" halign=\"left\">True</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th></th>\n",
       "      <th>count</th>\n",
       "      <th>mean</th>\n",
       "      <th>std</th>\n",
       "      <th>min</th>\n",
       "      <th>25%</th>\n",
       "      <th>50%</th>\n",
       "      <th>75%</th>\n",
       "      <th>max</th>\n",
       "      <th>count</th>\n",
       "      <th>mean</th>\n",
       "      <th>std</th>\n",
       "      <th>min</th>\n",
       "      <th>25%</th>\n",
       "      <th>50%</th>\n",
       "      <th>75%</th>\n",
       "      <th>max</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>npi</th>\n",
       "      <td>3710</td>\n",
       "      <td>1.497290e+09</td>\n",
       "      <td>2.849349e+08</td>\n",
       "      <td>1.003031e+09</td>\n",
       "      <td>1.255370e+09</td>\n",
       "      <td>1.497754e+09</td>\n",
       "      <td>1.740254e+09</td>\n",
       "      <td>1.992965e+09</td>\n",
       "      <td>264</td>\n",
       "      <td>1.472422e+09</td>\n",
       "      <td>3.056708e+08</td>\n",
       "      <td>1.003875e+09</td>\n",
       "      <td>1.182134e+09</td>\n",
       "      <td>1.477587e+09</td>\n",
       "      <td>1.740252e+09</td>\n",
       "      <td>1.992774e+09</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_hcpcs</th>\n",
       "      <td>3710</td>\n",
       "      <td>1.053474e+02</td>\n",
       "      <td>4.233851e+01</td>\n",
       "      <td>1.000000e+01</td>\n",
       "      <td>8.000000e+01</td>\n",
       "      <td>1.030000e+02</td>\n",
       "      <td>1.300000e+02</td>\n",
       "      <td>3.880000e+02</td>\n",
       "      <td>264</td>\n",
       "      <td>1.227311e+02</td>\n",
       "      <td>3.837378e+01</td>\n",
       "      <td>1.700000e+01</td>\n",
       "      <td>9.575000e+01</td>\n",
       "      <td>1.200000e+02</td>\n",
       "      <td>1.410000e+02</td>\n",
       "      <td>2.520000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_services</th>\n",
       "      <td>3710</td>\n",
       "      <td>6.850941e+04</td>\n",
       "      <td>6.540629e+04</td>\n",
       "      <td>3.040000e+02</td>\n",
       "      <td>2.080050e+04</td>\n",
       "      <td>5.191750e+04</td>\n",
       "      <td>9.495900e+04</td>\n",
       "      <td>6.961420e+05</td>\n",
       "      <td>264</td>\n",
       "      <td>1.486699e+05</td>\n",
       "      <td>1.193646e+05</td>\n",
       "      <td>5.618000e+03</td>\n",
       "      <td>6.574900e+04</td>\n",
       "      <td>1.194870e+05</td>\n",
       "      <td>1.910295e+05</td>\n",
       "      <td>9.195270e+05</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_unique_bene</th>\n",
       "      <td>3710</td>\n",
       "      <td>5.128154e+02</td>\n",
       "      <td>3.213202e+02</td>\n",
       "      <td>1.300000e+01</td>\n",
       "      <td>3.030000e+02</td>\n",
       "      <td>4.610000e+02</td>\n",
       "      <td>6.517500e+02</td>\n",
       "      <td>4.946000e+03</td>\n",
       "      <td>264</td>\n",
       "      <td>4.404621e+02</td>\n",
       "      <td>2.701264e+02</td>\n",
       "      <td>2.600000e+01</td>\n",
       "      <td>2.430000e+02</td>\n",
       "      <td>4.085000e+02</td>\n",
       "      <td>5.502500e+02</td>\n",
       "      <td>1.890000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_submitted_charges</th>\n",
       "      <td>3710</td>\n",
       "      <td>3.006973e+06</td>\n",
       "      <td>2.648000e+06</td>\n",
       "      <td>3.112000e+04</td>\n",
       "      <td>1.021366e+06</td>\n",
       "      <td>2.385279e+06</td>\n",
       "      <td>4.208654e+06</td>\n",
       "      <td>2.101331e+07</td>\n",
       "      <td>264</td>\n",
       "      <td>8.041295e+06</td>\n",
       "      <td>4.990289e+06</td>\n",
       "      <td>4.422754e+05</td>\n",
       "      <td>4.705258e+06</td>\n",
       "      <td>7.035009e+06</td>\n",
       "      <td>9.794655e+06</td>\n",
       "      <td>3.574462e+07</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_medicare_payment_amt</th>\n",
       "      <td>3710</td>\n",
       "      <td>1.003865e+06</td>\n",
       "      <td>8.468966e+05</td>\n",
       "      <td>1.174203e+04</td>\n",
       "      <td>3.737831e+05</td>\n",
       "      <td>8.280982e+05</td>\n",
       "      <td>1.395577e+06</td>\n",
       "      <td>7.362975e+06</td>\n",
       "      <td>264</td>\n",
       "      <td>2.159084e+06</td>\n",
       "      <td>2.121102e+06</td>\n",
       "      <td>9.338352e+04</td>\n",
       "      <td>1.135081e+06</td>\n",
       "      <td>1.741165e+06</td>\n",
       "      <td>2.661291e+06</td>\n",
       "      <td>2.804806e+07</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>drug_suppress_indicator</th>\n",
       "      <td>3710</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>264</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_hcpcs_associated_drug_srvc</th>\n",
       "      <td>3710</td>\n",
       "      <td>5.136011e+01</td>\n",
       "      <td>2.166278e+01</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>3.900000e+01</td>\n",
       "      <td>5.500000e+01</td>\n",
       "      <td>6.600000e+01</td>\n",
       "      <td>1.100000e+02</td>\n",
       "      <td>264</td>\n",
       "      <td>6.187121e+01</td>\n",
       "      <td>1.596046e+01</td>\n",
       "      <td>5.000000e+00</td>\n",
       "      <td>5.300000e+01</td>\n",
       "      <td>6.300000e+01</td>\n",
       "      <td>7.100000e+01</td>\n",
       "      <td>1.060000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_drug_srvc</th>\n",
       "      <td>3710</td>\n",
       "      <td>6.160058e+04</td>\n",
       "      <td>6.058167e+04</td>\n",
       "      <td>1.100000e+01</td>\n",
       "      <td>1.744700e+04</td>\n",
       "      <td>4.567950e+04</td>\n",
       "      <td>8.623600e+04</td>\n",
       "      <td>6.499720e+05</td>\n",
       "      <td>264</td>\n",
       "      <td>1.373616e+05</td>\n",
       "      <td>1.131390e+05</td>\n",
       "      <td>5.296000e+03</td>\n",
       "      <td>6.034675e+04</td>\n",
       "      <td>1.096965e+05</td>\n",
       "      <td>1.774440e+05</td>\n",
       "      <td>9.192350e+05</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_unique_bene_with_drug_srvc</th>\n",
       "      <td>3710</td>\n",
       "      <td>1.455717e+02</td>\n",
       "      <td>1.250739e+02</td>\n",
       "      <td>1.100000e+01</td>\n",
       "      <td>5.700000e+01</td>\n",
       "      <td>1.130000e+02</td>\n",
       "      <td>1.910000e+02</td>\n",
       "      <td>9.500000e+02</td>\n",
       "      <td>264</td>\n",
       "      <td>1.678523e+02</td>\n",
       "      <td>1.224541e+02</td>\n",
       "      <td>1.200000e+01</td>\n",
       "      <td>8.700000e+01</td>\n",
       "      <td>1.355000e+02</td>\n",
       "      <td>2.102500e+02</td>\n",
       "      <td>8.340000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_drug_submitted_charges</th>\n",
       "      <td>3710</td>\n",
       "      <td>2.207162e+06</td>\n",
       "      <td>2.061565e+06</td>\n",
       "      <td>4.200000e+01</td>\n",
       "      <td>6.395529e+05</td>\n",
       "      <td>1.716169e+06</td>\n",
       "      <td>3.194983e+06</td>\n",
       "      <td>1.666585e+07</td>\n",
       "      <td>264</td>\n",
       "      <td>6.337511e+06</td>\n",
       "      <td>3.995391e+06</td>\n",
       "      <td>3.945714e+05</td>\n",
       "      <td>3.707325e+06</td>\n",
       "      <td>5.584611e+06</td>\n",
       "      <td>7.605542e+06</td>\n",
       "      <td>3.556785e+07</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_drug_medicare_payment_amt</th>\n",
       "      <td>3710</td>\n",
       "      <td>7.422393e+05</td>\n",
       "      <td>6.791083e+05</td>\n",
       "      <td>8.450000e+00</td>\n",
       "      <td>2.376489e+05</td>\n",
       "      <td>6.012845e+05</td>\n",
       "      <td>1.063267e+06</td>\n",
       "      <td>5.853764e+06</td>\n",
       "      <td>264</td>\n",
       "      <td>1.719987e+06</td>\n",
       "      <td>1.967612e+06</td>\n",
       "      <td>8.198333e+04</td>\n",
       "      <td>8.912819e+05</td>\n",
       "      <td>1.359743e+06</td>\n",
       "      <td>2.062269e+06</td>\n",
       "      <td>2.797682e+07</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>medical_suppress_indicator</th>\n",
       "      <td>3710</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>264</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_hcpcs_associated_med_srvc</th>\n",
       "      <td>3710</td>\n",
       "      <td>5.398733e+01</td>\n",
       "      <td>2.587382e+01</td>\n",
       "      <td>5.000000e+00</td>\n",
       "      <td>3.700000e+01</td>\n",
       "      <td>4.700000e+01</td>\n",
       "      <td>6.800000e+01</td>\n",
       "      <td>3.130000e+02</td>\n",
       "      <td>264</td>\n",
       "      <td>6.085985e+01</td>\n",
       "      <td>2.704213e+01</td>\n",
       "      <td>1.200000e+01</td>\n",
       "      <td>4.000000e+01</td>\n",
       "      <td>5.550000e+01</td>\n",
       "      <td>7.425000e+01</td>\n",
       "      <td>1.720000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_med_srvc</th>\n",
       "      <td>3710</td>\n",
       "      <td>6.908831e+03</td>\n",
       "      <td>6.610735e+03</td>\n",
       "      <td>3.700000e+01</td>\n",
       "      <td>2.684250e+03</td>\n",
       "      <td>5.197000e+03</td>\n",
       "      <td>9.042750e+03</td>\n",
       "      <td>7.732000e+04</td>\n",
       "      <td>264</td>\n",
       "      <td>1.130828e+04</td>\n",
       "      <td>1.005662e+04</td>\n",
       "      <td>7.200000e+01</td>\n",
       "      <td>5.341250e+03</td>\n",
       "      <td>8.975500e+03</td>\n",
       "      <td>1.364425e+04</td>\n",
       "      <td>9.189700e+04</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_unique_bene_with_med_srvc</th>\n",
       "      <td>3710</td>\n",
       "      <td>5.125356e+02</td>\n",
       "      <td>3.212343e+02</td>\n",
       "      <td>1.300000e+01</td>\n",
       "      <td>3.030000e+02</td>\n",
       "      <td>4.605000e+02</td>\n",
       "      <td>6.510000e+02</td>\n",
       "      <td>4.945000e+03</td>\n",
       "      <td>264</td>\n",
       "      <td>4.401477e+02</td>\n",
       "      <td>2.700739e+02</td>\n",
       "      <td>2.600000e+01</td>\n",
       "      <td>2.430000e+02</td>\n",
       "      <td>4.085000e+02</td>\n",
       "      <td>5.502500e+02</td>\n",
       "      <td>1.890000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_med_submitted_charges</th>\n",
       "      <td>3710</td>\n",
       "      <td>7.998107e+05</td>\n",
       "      <td>7.131648e+05</td>\n",
       "      <td>4.306000e+03</td>\n",
       "      <td>3.428740e+05</td>\n",
       "      <td>6.340405e+05</td>\n",
       "      <td>1.015890e+06</td>\n",
       "      <td>1.127809e+07</td>\n",
       "      <td>264</td>\n",
       "      <td>1.703784e+06</td>\n",
       "      <td>1.427343e+06</td>\n",
       "      <td>1.302100e+04</td>\n",
       "      <td>8.772398e+05</td>\n",
       "      <td>1.360168e+06</td>\n",
       "      <td>2.116512e+06</td>\n",
       "      <td>1.125053e+07</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_med_medicare_payment_amt</th>\n",
       "      <td>3710</td>\n",
       "      <td>2.616255e+05</td>\n",
       "      <td>2.084932e+05</td>\n",
       "      <td>1.303380e+03</td>\n",
       "      <td>1.253983e+05</td>\n",
       "      <td>2.165757e+05</td>\n",
       "      <td>3.365420e+05</td>\n",
       "      <td>3.283833e+06</td>\n",
       "      <td>264</td>\n",
       "      <td>4.390966e+05</td>\n",
       "      <td>3.399813e+05</td>\n",
       "      <td>5.552300e+03</td>\n",
       "      <td>2.289934e+05</td>\n",
       "      <td>3.541464e+05</td>\n",
       "      <td>5.493041e+05</td>\n",
       "      <td>2.532144e+06</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>avg_age_bene</th>\n",
       "      <td>3710</td>\n",
       "      <td>7.340485e+01</td>\n",
       "      <td>2.213948e+00</td>\n",
       "      <td>4.800000e+01</td>\n",
       "      <td>7.200000e+01</td>\n",
       "      <td>7.300000e+01</td>\n",
       "      <td>7.500000e+01</td>\n",
       "      <td>8.500000e+01</td>\n",
       "      <td>264</td>\n",
       "      <td>7.299621e+01</td>\n",
       "      <td>2.599354e+00</td>\n",
       "      <td>5.500000e+01</td>\n",
       "      <td>7.200000e+01</td>\n",
       "      <td>7.300000e+01</td>\n",
       "      <td>7.400000e+01</td>\n",
       "      <td>7.800000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_female</th>\n",
       "      <td>3690</td>\n",
       "      <td>3.061388e+02</td>\n",
       "      <td>1.933881e+02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.782500e+02</td>\n",
       "      <td>2.730000e+02</td>\n",
       "      <td>3.920000e+02</td>\n",
       "      <td>3.096000e+03</td>\n",
       "      <td>263</td>\n",
       "      <td>2.545361e+02</td>\n",
       "      <td>1.616368e+02</td>\n",
       "      <td>1.400000e+01</td>\n",
       "      <td>1.400000e+02</td>\n",
       "      <td>2.270000e+02</td>\n",
       "      <td>3.255000e+02</td>\n",
       "      <td>1.169000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_male</th>\n",
       "      <td>3690</td>\n",
       "      <td>2.078553e+02</td>\n",
       "      <td>1.362487e+02</td>\n",
       "      <td>1.100000e+01</td>\n",
       "      <td>1.170000e+02</td>\n",
       "      <td>1.860000e+02</td>\n",
       "      <td>2.680000e+02</td>\n",
       "      <td>1.849000e+03</td>\n",
       "      <td>263</td>\n",
       "      <td>1.874791e+02</td>\n",
       "      <td>1.163243e+02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>9.900000e+01</td>\n",
       "      <td>1.730000e+02</td>\n",
       "      <td>2.400000e+02</td>\n",
       "      <td>7.890000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_non_his_white</th>\n",
       "      <td>3710</td>\n",
       "      <td>4.167879e+02</td>\n",
       "      <td>2.916617e+02</td>\n",
       "      <td>7.000000e+00</td>\n",
       "      <td>2.240000e+02</td>\n",
       "      <td>3.665000e+02</td>\n",
       "      <td>5.500000e+02</td>\n",
       "      <td>4.375000e+03</td>\n",
       "      <td>264</td>\n",
       "      <td>3.621780e+02</td>\n",
       "      <td>2.480841e+02</td>\n",
       "      <td>7.000000e+00</td>\n",
       "      <td>1.880000e+02</td>\n",
       "      <td>3.185000e+02</td>\n",
       "      <td>4.562500e+02</td>\n",
       "      <td>1.695000e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_african_american</th>\n",
       "      <td>3710</td>\n",
       "      <td>4.905094e+01</td>\n",
       "      <td>7.248236e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.100000e+01</td>\n",
       "      <td>2.500000e+01</td>\n",
       "      <td>5.700000e+01</td>\n",
       "      <td>1.418000e+03</td>\n",
       "      <td>264</td>\n",
       "      <td>3.511364e+01</td>\n",
       "      <td>4.054658e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.200000e+01</td>\n",
       "      <td>2.300000e+01</td>\n",
       "      <td>4.625000e+01</td>\n",
       "      <td>3.140000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_asian</th>\n",
       "      <td>3706</td>\n",
       "      <td>1.301160e+01</td>\n",
       "      <td>3.133703e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>3.000000e+00</td>\n",
       "      <td>6.000000e+00</td>\n",
       "      <td>1.400000e+01</td>\n",
       "      <td>7.930000e+02</td>\n",
       "      <td>264</td>\n",
       "      <td>1.132576e+01</td>\n",
       "      <td>1.502646e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>3.000000e+00</td>\n",
       "      <td>5.500000e+00</td>\n",
       "      <td>1.400000e+01</td>\n",
       "      <td>1.110000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_hispanic</th>\n",
       "      <td>3710</td>\n",
       "      <td>3.055660e+01</td>\n",
       "      <td>5.680945e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.000000e+01</td>\n",
       "      <td>1.500000e+01</td>\n",
       "      <td>2.700000e+01</td>\n",
       "      <td>8.450000e+02</td>\n",
       "      <td>264</td>\n",
       "      <td>2.803409e+01</td>\n",
       "      <td>3.315975e+01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.000000e+01</td>\n",
       "      <td>1.700000e+01</td>\n",
       "      <td>3.225000e+01</td>\n",
       "      <td>3.130000e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_american_indian</th>\n",
       "      <td>3650</td>\n",
       "      <td>1.205479e+00</td>\n",
       "      <td>6.478708e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>2.000000e+02</td>\n",
       "      <td>259</td>\n",
       "      <td>1.822394e+00</td>\n",
       "      <td>9.233792e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>9.500000e+01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>avg_hcc_risk_score</th>\n",
       "      <td>3710</td>\n",
       "      <td>1.949176e+00</td>\n",
       "      <td>3.266759e-01</td>\n",
       "      <td>8.379000e-01</td>\n",
       "      <td>1.752450e+00</td>\n",
       "      <td>1.913200e+00</td>\n",
       "      <td>2.102900e+00</td>\n",
       "      <td>4.400800e+00</td>\n",
       "      <td>264</td>\n",
       "      <td>1.931966e+00</td>\n",
       "      <td>2.973811e-01</td>\n",
       "      <td>1.239700e+00</td>\n",
       "      <td>1.736975e+00</td>\n",
       "      <td>1.870250e+00</td>\n",
       "      <td>2.089675e+00</td>\n",
       "      <td>2.991800e+00</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>zip_1</th>\n",
       "      <td>3710</td>\n",
       "      <td>4.798789e+04</td>\n",
       "      <td>2.949692e+04</td>\n",
       "      <td>1.020000e+03</td>\n",
       "      <td>2.318800e+04</td>\n",
       "      <td>4.410000e+04</td>\n",
       "      <td>7.607725e+04</td>\n",
       "      <td>9.950800e+04</td>\n",
       "      <td>264</td>\n",
       "      <td>6.013475e+04</td>\n",
       "      <td>2.823218e+04</td>\n",
       "      <td>6.790000e+03</td>\n",
       "      <td>3.333100e+04</td>\n",
       "      <td>7.220500e+04</td>\n",
       "      <td>8.410625e+04</td>\n",
       "      <td>9.964500e+04</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>drug_srvc_bin</th>\n",
       "      <td>3710</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>264</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>1.000000e+00</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>county_fips</th>\n",
       "      <td>3710</td>\n",
       "      <td>2.753594e+04</td>\n",
       "      <td>1.572485e+04</td>\n",
       "      <td>1.003000e+03</td>\n",
       "      <td>1.209900e+04</td>\n",
       "      <td>2.710900e+04</td>\n",
       "      <td>4.010900e+04</td>\n",
       "      <td>5.602100e+04</td>\n",
       "      <td>264</td>\n",
       "      <td>2.705341e+04</td>\n",
       "      <td>1.740931e+04</td>\n",
       "      <td>1.043000e+03</td>\n",
       "      <td>9.753500e+03</td>\n",
       "      <td>2.851000e+04</td>\n",
       "      <td>4.800500e+04</td>\n",
       "      <td>5.306300e+04</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>...</th>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "      <td>...</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_drug_submitted_charges_norm</th>\n",
       "      <td>3710</td>\n",
       "      <td>4.072001e+03</td>\n",
       "      <td>2.683988e+03</td>\n",
       "      <td>8.235294e-02</td>\n",
       "      <td>2.005427e+03</td>\n",
       "      <td>3.841290e+03</td>\n",
       "      <td>5.870912e+03</td>\n",
       "      <td>1.214537e+04</td>\n",
       "      <td>264</td>\n",
       "      <td>1.666204e+04</td>\n",
       "      <td>1.917917e+04</td>\n",
       "      <td>7.025645e+03</td>\n",
       "      <td>1.163139e+04</td>\n",
       "      <td>1.346002e+04</td>\n",
       "      <td>1.620758e+04</td>\n",
       "      <td>2.833048e+05</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_drug_medicare_payment_amt_norm</th>\n",
       "      <td>3710</td>\n",
       "      <td>1.378862e+03</td>\n",
       "      <td>8.948534e+02</td>\n",
       "      <td>1.492933e-02</td>\n",
       "      <td>7.521343e+02</td>\n",
       "      <td>1.323019e+03</td>\n",
       "      <td>1.882857e+03</td>\n",
       "      <td>8.051133e+03</td>\n",
       "      <td>264</td>\n",
       "      <td>4.804521e+03</td>\n",
       "      <td>9.681078e+03</td>\n",
       "      <td>1.006044e+03</td>\n",
       "      <td>2.731071e+03</td>\n",
       "      <td>3.326392e+03</td>\n",
       "      <td>4.454613e+03</td>\n",
       "      <td>1.338959e+05</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_hcpcs_associated_med_srvc_norm</th>\n",
       "      <td>3710</td>\n",
       "      <td>1.378680e-01</td>\n",
       "      <td>1.147995e-01</td>\n",
       "      <td>1.365462e-02</td>\n",
       "      <td>7.636364e-02</td>\n",
       "      <td>1.084240e-01</td>\n",
       "      <td>1.616844e-01</td>\n",
       "      <td>3.238095e+00</td>\n",
       "      <td>264</td>\n",
       "      <td>1.788119e-01</td>\n",
       "      <td>1.266189e-01</td>\n",
       "      <td>3.756614e-02</td>\n",
       "      <td>1.041317e-01</td>\n",
       "      <td>1.507977e-01</td>\n",
       "      <td>2.200033e-01</td>\n",
       "      <td>1.100000e+00</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_med_srvc_norm</th>\n",
       "      <td>3710</td>\n",
       "      <td>1.293109e+01</td>\n",
       "      <td>8.979080e+00</td>\n",
       "      <td>1.304511e+00</td>\n",
       "      <td>7.397699e+00</td>\n",
       "      <td>1.125593e+01</td>\n",
       "      <td>1.648238e+01</td>\n",
       "      <td>2.144310e+02</td>\n",
       "      <td>264</td>\n",
       "      <td>2.556250e+01</td>\n",
       "      <td>1.407216e+01</td>\n",
       "      <td>1.440000e+00</td>\n",
       "      <td>1.630999e+01</td>\n",
       "      <td>2.359056e+01</td>\n",
       "      <td>3.120652e+01</td>\n",
       "      <td>1.014512e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_unique_bene_with_med_srvc_norm</th>\n",
       "      <td>3710</td>\n",
       "      <td>9.993483e-01</td>\n",
       "      <td>3.312904e-03</td>\n",
       "      <td>9.298643e-01</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>264</td>\n",
       "      <td>9.988545e-01</td>\n",
       "      <td>6.446786e-03</td>\n",
       "      <td>9.200000e-01</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>1.000000e+00</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_med_submitted_charges_norm</th>\n",
       "      <td>3710</td>\n",
       "      <td>1.521404e+03</td>\n",
       "      <td>8.352141e+02</td>\n",
       "      <td>1.785043e+02</td>\n",
       "      <td>9.278708e+02</td>\n",
       "      <td>1.363809e+03</td>\n",
       "      <td>1.916782e+03</td>\n",
       "      <td>9.357041e+03</td>\n",
       "      <td>264</td>\n",
       "      <td>3.950347e+03</td>\n",
       "      <td>2.314939e+03</td>\n",
       "      <td>2.604200e+02</td>\n",
       "      <td>2.652764e+03</td>\n",
       "      <td>3.524988e+03</td>\n",
       "      <td>4.341155e+03</td>\n",
       "      <td>1.928637e+04</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_med_medicare_payment_amt_norm</th>\n",
       "      <td>3710</td>\n",
       "      <td>5.085228e+02</td>\n",
       "      <td>2.642328e+02</td>\n",
       "      <td>6.516900e+01</td>\n",
       "      <td>3.355549e+02</td>\n",
       "      <td>4.624349e+02</td>\n",
       "      <td>6.198459e+02</td>\n",
       "      <td>4.825011e+03</td>\n",
       "      <td>264</td>\n",
       "      <td>1.027678e+03</td>\n",
       "      <td>6.112743e+02</td>\n",
       "      <td>1.110460e+02</td>\n",
       "      <td>6.963114e+02</td>\n",
       "      <td>9.091525e+02</td>\n",
       "      <td>1.182878e+03</td>\n",
       "      <td>6.002191e+03</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_female_norm</th>\n",
       "      <td>3690</td>\n",
       "      <td>5.943171e-01</td>\n",
       "      <td>7.649824e-02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>5.526485e-01</td>\n",
       "      <td>5.887941e-01</td>\n",
       "      <td>6.308248e-01</td>\n",
       "      <td>9.676550e-01</td>\n",
       "      <td>263</td>\n",
       "      <td>5.739984e-01</td>\n",
       "      <td>8.535646e-02</td>\n",
       "      <td>2.256098e-01</td>\n",
       "      <td>5.353748e-01</td>\n",
       "      <td>5.798611e-01</td>\n",
       "      <td>6.173186e-01</td>\n",
       "      <td>1.000000e+00</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_male_norm</th>\n",
       "      <td>3690</td>\n",
       "      <td>4.056486e-01</td>\n",
       "      <td>7.650451e-02</td>\n",
       "      <td>3.234501e-02</td>\n",
       "      <td>3.691111e-01</td>\n",
       "      <td>4.111068e-01</td>\n",
       "      <td>4.473515e-01</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>263</td>\n",
       "      <td>4.259819e-01</td>\n",
       "      <td>8.537281e-02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>3.826814e-01</td>\n",
       "      <td>4.201389e-01</td>\n",
       "      <td>4.646252e-01</td>\n",
       "      <td>7.743902e-01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_non_his_white_norm</th>\n",
       "      <td>3710</td>\n",
       "      <td>7.918695e-01</td>\n",
       "      <td>1.784932e-01</td>\n",
       "      <td>1.717791e-02</td>\n",
       "      <td>7.360140e-01</td>\n",
       "      <td>8.423904e-01</td>\n",
       "      <td>9.161338e-01</td>\n",
       "      <td>1.000000e+00</td>\n",
       "      <td>264</td>\n",
       "      <td>7.874888e-01</td>\n",
       "      <td>1.583393e-01</td>\n",
       "      <td>1.081081e-01</td>\n",
       "      <td>7.274979e-01</td>\n",
       "      <td>8.319314e-01</td>\n",
       "      <td>8.990656e-01</td>\n",
       "      <td>9.861751e-01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_african_american_norm</th>\n",
       "      <td>3710</td>\n",
       "      <td>9.711775e-02</td>\n",
       "      <td>1.137776e-01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>2.759981e-02</td>\n",
       "      <td>6.038243e-02</td>\n",
       "      <td>1.250000e-01</td>\n",
       "      <td>9.311475e-01</td>\n",
       "      <td>264</td>\n",
       "      <td>9.228271e-02</td>\n",
       "      <td>9.819131e-02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>3.300680e-02</td>\n",
       "      <td>6.351565e-02</td>\n",
       "      <td>1.199118e-01</td>\n",
       "      <td>7.181208e-01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_asian_norm</th>\n",
       "      <td>3706</td>\n",
       "      <td>3.206737e-02</td>\n",
       "      <td>6.920061e-02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>7.518797e-03</td>\n",
       "      <td>1.578428e-02</td>\n",
       "      <td>3.195786e-02</td>\n",
       "      <td>9.730061e-01</td>\n",
       "      <td>264</td>\n",
       "      <td>3.350189e-02</td>\n",
       "      <td>5.789679e-02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>7.284654e-03</td>\n",
       "      <td>1.773139e-02</td>\n",
       "      <td>4.109775e-02</td>\n",
       "      <td>7.500000e-01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_hispanic_norm</th>\n",
       "      <td>3710</td>\n",
       "      <td>7.161201e-02</td>\n",
       "      <td>1.108256e-01</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>2.031755e-02</td>\n",
       "      <td>3.529770e-02</td>\n",
       "      <td>7.187261e-02</td>\n",
       "      <td>9.396226e-01</td>\n",
       "      <td>264</td>\n",
       "      <td>7.737616e-02</td>\n",
       "      <td>8.693022e-02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>2.852657e-02</td>\n",
       "      <td>5.439007e-02</td>\n",
       "      <td>8.968542e-02</td>\n",
       "      <td>6.466942e-01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_american_indian_norm</th>\n",
       "      <td>3650</td>\n",
       "      <td>2.703389e-03</td>\n",
       "      <td>1.653350e-02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>5.877193e-01</td>\n",
       "      <td>259</td>\n",
       "      <td>4.403709e-03</td>\n",
       "      <td>2.113355e-02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>2.214452e-01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_asthma_norm</th>\n",
       "      <td>3469</td>\n",
       "      <td>8.479101e-02</td>\n",
       "      <td>2.826272e-02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>7.000000e-02</td>\n",
       "      <td>8.000000e-02</td>\n",
       "      <td>1.000000e-01</td>\n",
       "      <td>2.500000e-01</td>\n",
       "      <td>241</td>\n",
       "      <td>7.585062e-02</td>\n",
       "      <td>2.352752e-02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>6.000000e-02</td>\n",
       "      <td>7.000000e-02</td>\n",
       "      <td>9.000000e-02</td>\n",
       "      <td>1.500000e-01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_alzheimers_dementia_norm</th>\n",
       "      <td>3502</td>\n",
       "      <td>1.152599e-01</td>\n",
       "      <td>5.718202e-02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>8.000000e-02</td>\n",
       "      <td>1.000000e-01</td>\n",
       "      <td>1.300000e-01</td>\n",
       "      <td>7.500000e-01</td>\n",
       "      <td>241</td>\n",
       "      <td>1.046058e-01</td>\n",
       "      <td>4.330067e-02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>8.000000e-02</td>\n",
       "      <td>1.000000e-01</td>\n",
       "      <td>1.300000e-01</td>\n",
       "      <td>4.200000e-01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_artrial_fibrillation_norm</th>\n",
       "      <td>3603</td>\n",
       "      <td>1.430086e-01</td>\n",
       "      <td>4.194529e-02</td>\n",
       "      <td>3.000000e-02</td>\n",
       "      <td>1.200000e-01</td>\n",
       "      <td>1.400000e-01</td>\n",
       "      <td>1.700000e-01</td>\n",
       "      <td>5.300000e-01</td>\n",
       "      <td>251</td>\n",
       "      <td>1.295618e-01</td>\n",
       "      <td>3.217774e-02</td>\n",
       "      <td>6.000000e-02</td>\n",
       "      <td>1.100000e-01</td>\n",
       "      <td>1.300000e-01</td>\n",
       "      <td>1.500000e-01</td>\n",
       "      <td>2.700000e-01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_cancer_norm</th>\n",
       "      <td>3696</td>\n",
       "      <td>4.283604e-01</td>\n",
       "      <td>1.106637e-01</td>\n",
       "      <td>5.000000e-02</td>\n",
       "      <td>3.700000e-01</td>\n",
       "      <td>4.300000e-01</td>\n",
       "      <td>4.900000e-01</td>\n",
       "      <td>7.500000e-01</td>\n",
       "      <td>260</td>\n",
       "      <td>4.314231e-01</td>\n",
       "      <td>1.249521e-01</td>\n",
       "      <td>5.000000e-02</td>\n",
       "      <td>3.700000e-01</td>\n",
       "      <td>4.400000e-01</td>\n",
       "      <td>4.925000e-01</td>\n",
       "      <td>7.500000e-01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_chronic_obstructive_pulmonary_norm</th>\n",
       "      <td>3646</td>\n",
       "      <td>2.201070e-01</td>\n",
       "      <td>7.421072e-02</td>\n",
       "      <td>3.000000e-02</td>\n",
       "      <td>1.700000e-01</td>\n",
       "      <td>2.100000e-01</td>\n",
       "      <td>2.700000e-01</td>\n",
       "      <td>6.000000e-01</td>\n",
       "      <td>256</td>\n",
       "      <td>2.003906e-01</td>\n",
       "      <td>6.525248e-02</td>\n",
       "      <td>8.000000e-02</td>\n",
       "      <td>1.500000e-01</td>\n",
       "      <td>1.900000e-01</td>\n",
       "      <td>2.400000e-01</td>\n",
       "      <td>4.000000e-01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_depression_norm</th>\n",
       "      <td>3673</td>\n",
       "      <td>2.207841e-01</td>\n",
       "      <td>5.612763e-02</td>\n",
       "      <td>5.000000e-02</td>\n",
       "      <td>1.800000e-01</td>\n",
       "      <td>2.100000e-01</td>\n",
       "      <td>2.500000e-01</td>\n",
       "      <td>5.700000e-01</td>\n",
       "      <td>259</td>\n",
       "      <td>2.104247e-01</td>\n",
       "      <td>4.487076e-02</td>\n",
       "      <td>6.000000e-02</td>\n",
       "      <td>1.800000e-01</td>\n",
       "      <td>2.100000e-01</td>\n",
       "      <td>2.400000e-01</td>\n",
       "      <td>3.500000e-01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_diabetes_norm</th>\n",
       "      <td>3701</td>\n",
       "      <td>3.541232e-01</td>\n",
       "      <td>8.858204e-02</td>\n",
       "      <td>1.300000e-01</td>\n",
       "      <td>3.000000e-01</td>\n",
       "      <td>3.400000e-01</td>\n",
       "      <td>4.000000e-01</td>\n",
       "      <td>7.500000e-01</td>\n",
       "      <td>261</td>\n",
       "      <td>3.367050e-01</td>\n",
       "      <td>7.339478e-02</td>\n",
       "      <td>1.600000e-01</td>\n",
       "      <td>2.900000e-01</td>\n",
       "      <td>3.300000e-01</td>\n",
       "      <td>3.700000e-01</td>\n",
       "      <td>7.300000e-01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_heart_failure_norm</th>\n",
       "      <td>3671</td>\n",
       "      <td>2.571888e-01</td>\n",
       "      <td>8.902345e-02</td>\n",
       "      <td>6.000000e-02</td>\n",
       "      <td>2.000000e-01</td>\n",
       "      <td>2.400000e-01</td>\n",
       "      <td>3.000000e-01</td>\n",
       "      <td>7.500000e-01</td>\n",
       "      <td>258</td>\n",
       "      <td>2.398837e-01</td>\n",
       "      <td>6.890744e-02</td>\n",
       "      <td>1.100000e-01</td>\n",
       "      <td>1.900000e-01</td>\n",
       "      <td>2.300000e-01</td>\n",
       "      <td>2.700000e-01</td>\n",
       "      <td>5.400000e-01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_hypertension_norm</th>\n",
       "      <td>3707</td>\n",
       "      <td>6.951335e-01</td>\n",
       "      <td>6.890714e-02</td>\n",
       "      <td>3.000000e-01</td>\n",
       "      <td>6.600000e-01</td>\n",
       "      <td>7.200000e-01</td>\n",
       "      <td>7.500000e-01</td>\n",
       "      <td>7.500000e-01</td>\n",
       "      <td>264</td>\n",
       "      <td>6.812879e-01</td>\n",
       "      <td>7.023486e-02</td>\n",
       "      <td>4.200000e-01</td>\n",
       "      <td>6.400000e-01</td>\n",
       "      <td>7.000000e-01</td>\n",
       "      <td>7.500000e-01</td>\n",
       "      <td>7.500000e-01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_ischemic_heart_norm</th>\n",
       "      <td>3701</td>\n",
       "      <td>4.125912e-01</td>\n",
       "      <td>1.071368e-01</td>\n",
       "      <td>1.300000e-01</td>\n",
       "      <td>3.400000e-01</td>\n",
       "      <td>4.000000e-01</td>\n",
       "      <td>4.800000e-01</td>\n",
       "      <td>7.500000e-01</td>\n",
       "      <td>262</td>\n",
       "      <td>3.929771e-01</td>\n",
       "      <td>9.030977e-02</td>\n",
       "      <td>1.800000e-01</td>\n",
       "      <td>3.300000e-01</td>\n",
       "      <td>3.900000e-01</td>\n",
       "      <td>4.600000e-01</td>\n",
       "      <td>7.400000e-01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_osteoporosis_norm</th>\n",
       "      <td>3556</td>\n",
       "      <td>1.139623e-01</td>\n",
       "      <td>4.519771e-02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>8.000000e-02</td>\n",
       "      <td>1.100000e-01</td>\n",
       "      <td>1.300000e-01</td>\n",
       "      <td>5.800000e-01</td>\n",
       "      <td>243</td>\n",
       "      <td>1.161317e-01</td>\n",
       "      <td>4.814595e-02</td>\n",
       "      <td>5.000000e-02</td>\n",
       "      <td>8.000000e-02</td>\n",
       "      <td>1.100000e-01</td>\n",
       "      <td>1.300000e-01</td>\n",
       "      <td>3.700000e-01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_rheumatoid_arthritis_osteoarthirtis_norm</th>\n",
       "      <td>3701</td>\n",
       "      <td>3.850770e-01</td>\n",
       "      <td>7.086398e-02</td>\n",
       "      <td>1.800000e-01</td>\n",
       "      <td>3.400000e-01</td>\n",
       "      <td>3.800000e-01</td>\n",
       "      <td>4.300000e-01</td>\n",
       "      <td>7.500000e-01</td>\n",
       "      <td>262</td>\n",
       "      <td>3.776718e-01</td>\n",
       "      <td>6.605698e-02</td>\n",
       "      <td>2.000000e-01</td>\n",
       "      <td>3.300000e-01</td>\n",
       "      <td>3.750000e-01</td>\n",
       "      <td>4.200000e-01</td>\n",
       "      <td>6.300000e-01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_schizophrenia_psychotic_norm</th>\n",
       "      <td>2716</td>\n",
       "      <td>4.785714e-02</td>\n",
       "      <td>2.702382e-02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>3.000000e-02</td>\n",
       "      <td>4.000000e-02</td>\n",
       "      <td>6.000000e-02</td>\n",
       "      <td>2.800000e-01</td>\n",
       "      <td>163</td>\n",
       "      <td>4.263804e-02</td>\n",
       "      <td>2.314283e-02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>3.000000e-02</td>\n",
       "      <td>4.000000e-02</td>\n",
       "      <td>5.000000e-02</td>\n",
       "      <td>1.800000e-01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>num_stroke_norm</th>\n",
       "      <td>3217</td>\n",
       "      <td>6.600249e-02</td>\n",
       "      <td>2.823802e-02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>5.000000e-02</td>\n",
       "      <td>6.000000e-02</td>\n",
       "      <td>8.000000e-02</td>\n",
       "      <td>2.300000e-01</td>\n",
       "      <td>215</td>\n",
       "      <td>5.934884e-02</td>\n",
       "      <td>2.005936e-02</td>\n",
       "      <td>0.000000e+00</td>\n",
       "      <td>5.000000e-02</td>\n",
       "      <td>6.000000e-02</td>\n",
       "      <td>7.000000e-02</td>\n",
       "      <td>1.800000e-01</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>drug_charge_per_srvc</th>\n",
       "      <td>3710</td>\n",
       "      <td>4.497059e+01</td>\n",
       "      <td>1.145465e+02</td>\n",
       "      <td>2.300827e-01</td>\n",
       "      <td>2.552477e+01</td>\n",
       "      <td>3.645607e+01</td>\n",
       "      <td>5.023662e+01</td>\n",
       "      <td>5.705395e+03</td>\n",
       "      <td>264</td>\n",
       "      <td>6.482360e+01</td>\n",
       "      <td>6.945910e+01</td>\n",
       "      <td>1.547108e+00</td>\n",
       "      <td>3.725855e+01</td>\n",
       "      <td>5.075081e+01</td>\n",
       "      <td>6.973967e+01</td>\n",
       "      <td>8.954645e+02</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>med_charge_per_srvc</th>\n",
       "      <td>3710</td>\n",
       "      <td>1.338802e+02</td>\n",
       "      <td>6.169332e+01</td>\n",
       "      <td>1.932753e+01</td>\n",
       "      <td>9.222768e+01</td>\n",
       "      <td>1.227056e+02</td>\n",
       "      <td>1.600535e+02</td>\n",
       "      <td>8.506043e+02</td>\n",
       "      <td>264</td>\n",
       "      <td>1.700999e+02</td>\n",
       "      <td>6.972150e+01</td>\n",
       "      <td>4.190707e+01</td>\n",
       "      <td>1.245047e+02</td>\n",
       "      <td>1.590501e+02</td>\n",
       "      <td>2.052591e+02</td>\n",
       "      <td>5.391756e+02</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>67 rows × 16 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "total_submitted_charges_norm                 False                \\\n",
       "                                             count          mean   \n",
       "npi                                           3710  1.497290e+09   \n",
       "num_hcpcs                                     3710  1.053474e+02   \n",
       "num_services                                  3710  6.850941e+04   \n",
       "num_unique_bene                               3710  5.128154e+02   \n",
       "total_submitted_charges                       3710  3.006973e+06   \n",
       "total_medicare_payment_amt                    3710  1.003865e+06   \n",
       "drug_suppress_indicator                       3710  0.000000e+00   \n",
       "num_hcpcs_associated_drug_srvc                3710  5.136011e+01   \n",
       "num_drug_srvc                                 3710  6.160058e+04   \n",
       "num_unique_bene_with_drug_srvc                3710  1.455717e+02   \n",
       "total_drug_submitted_charges                  3710  2.207162e+06   \n",
       "total_drug_medicare_payment_amt               3710  7.422393e+05   \n",
       "medical_suppress_indicator                    3710  0.000000e+00   \n",
       "num_hcpcs_associated_med_srvc                 3710  5.398733e+01   \n",
       "num_med_srvc                                  3710  6.908831e+03   \n",
       "num_unique_bene_with_med_srvc                 3710  5.125356e+02   \n",
       "total_med_submitted_charges                   3710  7.998107e+05   \n",
       "total_med_medicare_payment_amt                3710  2.616255e+05   \n",
       "avg_age_bene                                  3710  7.340485e+01   \n",
       "num_female                                    3690  3.061388e+02   \n",
       "num_male                                      3690  2.078553e+02   \n",
       "num_non_his_white                             3710  4.167879e+02   \n",
       "num_african_american                          3710  4.905094e+01   \n",
       "num_asian                                     3706  1.301160e+01   \n",
       "num_hispanic                                  3710  3.055660e+01   \n",
       "num_american_indian                           3650  1.205479e+00   \n",
       "avg_hcc_risk_score                            3710  1.949176e+00   \n",
       "zip_1                                         3710  4.798789e+04   \n",
       "drug_srvc_bin                                 3710  1.000000e+00   \n",
       "county_fips                                   3710  2.753594e+04   \n",
       "...                                            ...           ...   \n",
       "total_drug_submitted_charges_norm             3710  4.072001e+03   \n",
       "total_drug_medicare_payment_amt_norm          3710  1.378862e+03   \n",
       "num_hcpcs_associated_med_srvc_norm            3710  1.378680e-01   \n",
       "num_med_srvc_norm                             3710  1.293109e+01   \n",
       "num_unique_bene_with_med_srvc_norm            3710  9.993483e-01   \n",
       "total_med_submitted_charges_norm              3710  1.521404e+03   \n",
       "total_med_medicare_payment_amt_norm           3710  5.085228e+02   \n",
       "num_female_norm                               3690  5.943171e-01   \n",
       "num_male_norm                                 3690  4.056486e-01   \n",
       "num_non_his_white_norm                        3710  7.918695e-01   \n",
       "num_african_american_norm                     3710  9.711775e-02   \n",
       "num_asian_norm                                3706  3.206737e-02   \n",
       "num_hispanic_norm                             3710  7.161201e-02   \n",
       "num_american_indian_norm                      3650  2.703389e-03   \n",
       "num_asthma_norm                               3469  8.479101e-02   \n",
       "num_alzheimers_dementia_norm                  3502  1.152599e-01   \n",
       "num_artrial_fibrillation_norm                 3603  1.430086e-01   \n",
       "num_cancer_norm                               3696  4.283604e-01   \n",
       "num_chronic_obstructive_pulmonary_norm        3646  2.201070e-01   \n",
       "num_depression_norm                           3673  2.207841e-01   \n",
       "num_diabetes_norm                             3701  3.541232e-01   \n",
       "num_heart_failure_norm                        3671  2.571888e-01   \n",
       "num_hypertension_norm                         3707  6.951335e-01   \n",
       "num_ischemic_heart_norm                       3701  4.125912e-01   \n",
       "num_osteoporosis_norm                         3556  1.139623e-01   \n",
       "num_rheumatoid_arthritis_osteoarthirtis_norm  3701  3.850770e-01   \n",
       "num_schizophrenia_psychotic_norm              2716  4.785714e-02   \n",
       "num_stroke_norm                               3217  6.600249e-02   \n",
       "drug_charge_per_srvc                          3710  4.497059e+01   \n",
       "med_charge_per_srvc                           3710  1.338802e+02   \n",
       "\n",
       "total_submitted_charges_norm                                              \\\n",
       "                                                       std           min   \n",
       "npi                                           2.849349e+08  1.003031e+09   \n",
       "num_hcpcs                                     4.233851e+01  1.000000e+01   \n",
       "num_services                                  6.540629e+04  3.040000e+02   \n",
       "num_unique_bene                               3.213202e+02  1.300000e+01   \n",
       "total_submitted_charges                       2.648000e+06  3.112000e+04   \n",
       "total_medicare_payment_amt                    8.468966e+05  1.174203e+04   \n",
       "drug_suppress_indicator                       0.000000e+00  0.000000e+00   \n",
       "num_hcpcs_associated_drug_srvc                2.166278e+01  1.000000e+00   \n",
       "num_drug_srvc                                 6.058167e+04  1.100000e+01   \n",
       "num_unique_bene_with_drug_srvc                1.250739e+02  1.100000e+01   \n",
       "total_drug_submitted_charges                  2.061565e+06  4.200000e+01   \n",
       "total_drug_medicare_payment_amt               6.791083e+05  8.450000e+00   \n",
       "medical_suppress_indicator                    0.000000e+00  0.000000e+00   \n",
       "num_hcpcs_associated_med_srvc                 2.587382e+01  5.000000e+00   \n",
       "num_med_srvc                                  6.610735e+03  3.700000e+01   \n",
       "num_unique_bene_with_med_srvc                 3.212343e+02  1.300000e+01   \n",
       "total_med_submitted_charges                   7.131648e+05  4.306000e+03   \n",
       "total_med_medicare_payment_amt                2.084932e+05  1.303380e+03   \n",
       "avg_age_bene                                  2.213948e+00  4.800000e+01   \n",
       "num_female                                    1.933881e+02  0.000000e+00   \n",
       "num_male                                      1.362487e+02  1.100000e+01   \n",
       "num_non_his_white                             2.916617e+02  7.000000e+00   \n",
       "num_african_american                          7.248236e+01  0.000000e+00   \n",
       "num_asian                                     3.133703e+01  0.000000e+00   \n",
       "num_hispanic                                  5.680945e+01  0.000000e+00   \n",
       "num_american_indian                           6.478708e+00  0.000000e+00   \n",
       "avg_hcc_risk_score                            3.266759e-01  8.379000e-01   \n",
       "zip_1                                         2.949692e+04  1.020000e+03   \n",
       "drug_srvc_bin                                 0.000000e+00  1.000000e+00   \n",
       "county_fips                                   1.572485e+04  1.003000e+03   \n",
       "...                                                    ...           ...   \n",
       "total_drug_submitted_charges_norm             2.683988e+03  8.235294e-02   \n",
       "total_drug_medicare_payment_amt_norm          8.948534e+02  1.492933e-02   \n",
       "num_hcpcs_associated_med_srvc_norm            1.147995e-01  1.365462e-02   \n",
       "num_med_srvc_norm                             8.979080e+00  1.304511e+00   \n",
       "num_unique_bene_with_med_srvc_norm            3.312904e-03  9.298643e-01   \n",
       "total_med_submitted_charges_norm              8.352141e+02  1.785043e+02   \n",
       "total_med_medicare_payment_amt_norm           2.642328e+02  6.516900e+01   \n",
       "num_female_norm                               7.649824e-02  0.000000e+00   \n",
       "num_male_norm                                 7.650451e-02  3.234501e-02   \n",
       "num_non_his_white_norm                        1.784932e-01  1.717791e-02   \n",
       "num_african_american_norm                     1.137776e-01  0.000000e+00   \n",
       "num_asian_norm                                6.920061e-02  0.000000e+00   \n",
       "num_hispanic_norm                             1.108256e-01  0.000000e+00   \n",
       "num_american_indian_norm                      1.653350e-02  0.000000e+00   \n",
       "num_asthma_norm                               2.826272e-02  0.000000e+00   \n",
       "num_alzheimers_dementia_norm                  5.718202e-02  0.000000e+00   \n",
       "num_artrial_fibrillation_norm                 4.194529e-02  3.000000e-02   \n",
       "num_cancer_norm                               1.106637e-01  5.000000e-02   \n",
       "num_chronic_obstructive_pulmonary_norm        7.421072e-02  3.000000e-02   \n",
       "num_depression_norm                           5.612763e-02  5.000000e-02   \n",
       "num_diabetes_norm                             8.858204e-02  1.300000e-01   \n",
       "num_heart_failure_norm                        8.902345e-02  6.000000e-02   \n",
       "num_hypertension_norm                         6.890714e-02  3.000000e-01   \n",
       "num_ischemic_heart_norm                       1.071368e-01  1.300000e-01   \n",
       "num_osteoporosis_norm                         4.519771e-02  0.000000e+00   \n",
       "num_rheumatoid_arthritis_osteoarthirtis_norm  7.086398e-02  1.800000e-01   \n",
       "num_schizophrenia_psychotic_norm              2.702382e-02  0.000000e+00   \n",
       "num_stroke_norm                               2.823802e-02  0.000000e+00   \n",
       "drug_charge_per_srvc                          1.145465e+02  2.300827e-01   \n",
       "med_charge_per_srvc                           6.169332e+01  1.932753e+01   \n",
       "\n",
       "total_submitted_charges_norm                                              \\\n",
       "                                                       25%           50%   \n",
       "npi                                           1.255370e+09  1.497754e+09   \n",
       "num_hcpcs                                     8.000000e+01  1.030000e+02   \n",
       "num_services                                  2.080050e+04  5.191750e+04   \n",
       "num_unique_bene                               3.030000e+02  4.610000e+02   \n",
       "total_submitted_charges                       1.021366e+06  2.385279e+06   \n",
       "total_medicare_payment_amt                    3.737831e+05  8.280982e+05   \n",
       "drug_suppress_indicator                       0.000000e+00  0.000000e+00   \n",
       "num_hcpcs_associated_drug_srvc                3.900000e+01  5.500000e+01   \n",
       "num_drug_srvc                                 1.744700e+04  4.567950e+04   \n",
       "num_unique_bene_with_drug_srvc                5.700000e+01  1.130000e+02   \n",
       "total_drug_submitted_charges                  6.395529e+05  1.716169e+06   \n",
       "total_drug_medicare_payment_amt               2.376489e+05  6.012845e+05   \n",
       "medical_suppress_indicator                    0.000000e+00  0.000000e+00   \n",
       "num_hcpcs_associated_med_srvc                 3.700000e+01  4.700000e+01   \n",
       "num_med_srvc                                  2.684250e+03  5.197000e+03   \n",
       "num_unique_bene_with_med_srvc                 3.030000e+02  4.605000e+02   \n",
       "total_med_submitted_charges                   3.428740e+05  6.340405e+05   \n",
       "total_med_medicare_payment_amt                1.253983e+05  2.165757e+05   \n",
       "avg_age_bene                                  7.200000e+01  7.300000e+01   \n",
       "num_female                                    1.782500e+02  2.730000e+02   \n",
       "num_male                                      1.170000e+02  1.860000e+02   \n",
       "num_non_his_white                             2.240000e+02  3.665000e+02   \n",
       "num_african_american                          1.100000e+01  2.500000e+01   \n",
       "num_asian                                     3.000000e+00  6.000000e+00   \n",
       "num_hispanic                                  1.000000e+01  1.500000e+01   \n",
       "num_american_indian                           0.000000e+00  0.000000e+00   \n",
       "avg_hcc_risk_score                            1.752450e+00  1.913200e+00   \n",
       "zip_1                                         2.318800e+04  4.410000e+04   \n",
       "drug_srvc_bin                                 1.000000e+00  1.000000e+00   \n",
       "county_fips                                   1.209900e+04  2.710900e+04   \n",
       "...                                                    ...           ...   \n",
       "total_drug_submitted_charges_norm             2.005427e+03  3.841290e+03   \n",
       "total_drug_medicare_payment_amt_norm          7.521343e+02  1.323019e+03   \n",
       "num_hcpcs_associated_med_srvc_norm            7.636364e-02  1.084240e-01   \n",
       "num_med_srvc_norm                             7.397699e+00  1.125593e+01   \n",
       "num_unique_bene_with_med_srvc_norm            1.000000e+00  1.000000e+00   \n",
       "total_med_submitted_charges_norm              9.278708e+02  1.363809e+03   \n",
       "total_med_medicare_payment_amt_norm           3.355549e+02  4.624349e+02   \n",
       "num_female_norm                               5.526485e-01  5.887941e-01   \n",
       "num_male_norm                                 3.691111e-01  4.111068e-01   \n",
       "num_non_his_white_norm                        7.360140e-01  8.423904e-01   \n",
       "num_african_american_norm                     2.759981e-02  6.038243e-02   \n",
       "num_asian_norm                                7.518797e-03  1.578428e-02   \n",
       "num_hispanic_norm                             2.031755e-02  3.529770e-02   \n",
       "num_american_indian_norm                      0.000000e+00  0.000000e+00   \n",
       "num_asthma_norm                               7.000000e-02  8.000000e-02   \n",
       "num_alzheimers_dementia_norm                  8.000000e-02  1.000000e-01   \n",
       "num_artrial_fibrillation_norm                 1.200000e-01  1.400000e-01   \n",
       "num_cancer_norm                               3.700000e-01  4.300000e-01   \n",
       "num_chronic_obstructive_pulmonary_norm        1.700000e-01  2.100000e-01   \n",
       "num_depression_norm                           1.800000e-01  2.100000e-01   \n",
       "num_diabetes_norm                             3.000000e-01  3.400000e-01   \n",
       "num_heart_failure_norm                        2.000000e-01  2.400000e-01   \n",
       "num_hypertension_norm                         6.600000e-01  7.200000e-01   \n",
       "num_ischemic_heart_norm                       3.400000e-01  4.000000e-01   \n",
       "num_osteoporosis_norm                         8.000000e-02  1.100000e-01   \n",
       "num_rheumatoid_arthritis_osteoarthirtis_norm  3.400000e-01  3.800000e-01   \n",
       "num_schizophrenia_psychotic_norm              3.000000e-02  4.000000e-02   \n",
       "num_stroke_norm                               5.000000e-02  6.000000e-02   \n",
       "drug_charge_per_srvc                          2.552477e+01  3.645607e+01   \n",
       "med_charge_per_srvc                           9.222768e+01  1.227056e+02   \n",
       "\n",
       "total_submitted_charges_norm                                              \\\n",
       "                                                       75%           max   \n",
       "npi                                           1.740254e+09  1.992965e+09   \n",
       "num_hcpcs                                     1.300000e+02  3.880000e+02   \n",
       "num_services                                  9.495900e+04  6.961420e+05   \n",
       "num_unique_bene                               6.517500e+02  4.946000e+03   \n",
       "total_submitted_charges                       4.208654e+06  2.101331e+07   \n",
       "total_medicare_payment_amt                    1.395577e+06  7.362975e+06   \n",
       "drug_suppress_indicator                       0.000000e+00  0.000000e+00   \n",
       "num_hcpcs_associated_drug_srvc                6.600000e+01  1.100000e+02   \n",
       "num_drug_srvc                                 8.623600e+04  6.499720e+05   \n",
       "num_unique_bene_with_drug_srvc                1.910000e+02  9.500000e+02   \n",
       "total_drug_submitted_charges                  3.194983e+06  1.666585e+07   \n",
       "total_drug_medicare_payment_amt               1.063267e+06  5.853764e+06   \n",
       "medical_suppress_indicator                    0.000000e+00  0.000000e+00   \n",
       "num_hcpcs_associated_med_srvc                 6.800000e+01  3.130000e+02   \n",
       "num_med_srvc                                  9.042750e+03  7.732000e+04   \n",
       "num_unique_bene_with_med_srvc                 6.510000e+02  4.945000e+03   \n",
       "total_med_submitted_charges                   1.015890e+06  1.127809e+07   \n",
       "total_med_medicare_payment_amt                3.365420e+05  3.283833e+06   \n",
       "avg_age_bene                                  7.500000e+01  8.500000e+01   \n",
       "num_female                                    3.920000e+02  3.096000e+03   \n",
       "num_male                                      2.680000e+02  1.849000e+03   \n",
       "num_non_his_white                             5.500000e+02  4.375000e+03   \n",
       "num_african_american                          5.700000e+01  1.418000e+03   \n",
       "num_asian                                     1.400000e+01  7.930000e+02   \n",
       "num_hispanic                                  2.700000e+01  8.450000e+02   \n",
       "num_american_indian                           0.000000e+00  2.000000e+02   \n",
       "avg_hcc_risk_score                            2.102900e+00  4.400800e+00   \n",
       "zip_1                                         7.607725e+04  9.950800e+04   \n",
       "drug_srvc_bin                                 1.000000e+00  1.000000e+00   \n",
       "county_fips                                   4.010900e+04  5.602100e+04   \n",
       "...                                                    ...           ...   \n",
       "total_drug_submitted_charges_norm             5.870912e+03  1.214537e+04   \n",
       "total_drug_medicare_payment_amt_norm          1.882857e+03  8.051133e+03   \n",
       "num_hcpcs_associated_med_srvc_norm            1.616844e-01  3.238095e+00   \n",
       "num_med_srvc_norm                             1.648238e+01  2.144310e+02   \n",
       "num_unique_bene_with_med_srvc_norm            1.000000e+00  1.000000e+00   \n",
       "total_med_submitted_charges_norm              1.916782e+03  9.357041e+03   \n",
       "total_med_medicare_payment_amt_norm           6.198459e+02  4.825011e+03   \n",
       "num_female_norm                               6.308248e-01  9.676550e-01   \n",
       "num_male_norm                                 4.473515e-01  1.000000e+00   \n",
       "num_non_his_white_norm                        9.161338e-01  1.000000e+00   \n",
       "num_african_american_norm                     1.250000e-01  9.311475e-01   \n",
       "num_asian_norm                                3.195786e-02  9.730061e-01   \n",
       "num_hispanic_norm                             7.187261e-02  9.396226e-01   \n",
       "num_american_indian_norm                      0.000000e+00  5.877193e-01   \n",
       "num_asthma_norm                               1.000000e-01  2.500000e-01   \n",
       "num_alzheimers_dementia_norm                  1.300000e-01  7.500000e-01   \n",
       "num_artrial_fibrillation_norm                 1.700000e-01  5.300000e-01   \n",
       "num_cancer_norm                               4.900000e-01  7.500000e-01   \n",
       "num_chronic_obstructive_pulmonary_norm        2.700000e-01  6.000000e-01   \n",
       "num_depression_norm                           2.500000e-01  5.700000e-01   \n",
       "num_diabetes_norm                             4.000000e-01  7.500000e-01   \n",
       "num_heart_failure_norm                        3.000000e-01  7.500000e-01   \n",
       "num_hypertension_norm                         7.500000e-01  7.500000e-01   \n",
       "num_ischemic_heart_norm                       4.800000e-01  7.500000e-01   \n",
       "num_osteoporosis_norm                         1.300000e-01  5.800000e-01   \n",
       "num_rheumatoid_arthritis_osteoarthirtis_norm  4.300000e-01  7.500000e-01   \n",
       "num_schizophrenia_psychotic_norm              6.000000e-02  2.800000e-01   \n",
       "num_stroke_norm                               8.000000e-02  2.300000e-01   \n",
       "drug_charge_per_srvc                          5.023662e+01  5.705395e+03   \n",
       "med_charge_per_srvc                           1.600535e+02  8.506043e+02   \n",
       "\n",
       "total_submitted_charges_norm                 True                 \\\n",
       "                                             count          mean   \n",
       "npi                                            264  1.472422e+09   \n",
       "num_hcpcs                                      264  1.227311e+02   \n",
       "num_services                                   264  1.486699e+05   \n",
       "num_unique_bene                                264  4.404621e+02   \n",
       "total_submitted_charges                        264  8.041295e+06   \n",
       "total_medicare_payment_amt                     264  2.159084e+06   \n",
       "drug_suppress_indicator                        264  0.000000e+00   \n",
       "num_hcpcs_associated_drug_srvc                 264  6.187121e+01   \n",
       "num_drug_srvc                                  264  1.373616e+05   \n",
       "num_unique_bene_with_drug_srvc                 264  1.678523e+02   \n",
       "total_drug_submitted_charges                   264  6.337511e+06   \n",
       "total_drug_medicare_payment_amt                264  1.719987e+06   \n",
       "medical_suppress_indicator                     264  0.000000e+00   \n",
       "num_hcpcs_associated_med_srvc                  264  6.085985e+01   \n",
       "num_med_srvc                                   264  1.130828e+04   \n",
       "num_unique_bene_with_med_srvc                  264  4.401477e+02   \n",
       "total_med_submitted_charges                    264  1.703784e+06   \n",
       "total_med_medicare_payment_amt                 264  4.390966e+05   \n",
       "avg_age_bene                                   264  7.299621e+01   \n",
       "num_female                                     263  2.545361e+02   \n",
       "num_male                                       263  1.874791e+02   \n",
       "num_non_his_white                              264  3.621780e+02   \n",
       "num_african_american                           264  3.511364e+01   \n",
       "num_asian                                      264  1.132576e+01   \n",
       "num_hispanic                                   264  2.803409e+01   \n",
       "num_american_indian                            259  1.822394e+00   \n",
       "avg_hcc_risk_score                             264  1.931966e+00   \n",
       "zip_1                                          264  6.013475e+04   \n",
       "drug_srvc_bin                                  264  1.000000e+00   \n",
       "county_fips                                    264  2.705341e+04   \n",
       "...                                            ...           ...   \n",
       "total_drug_submitted_charges_norm              264  1.666204e+04   \n",
       "total_drug_medicare_payment_amt_norm           264  4.804521e+03   \n",
       "num_hcpcs_associated_med_srvc_norm             264  1.788119e-01   \n",
       "num_med_srvc_norm                              264  2.556250e+01   \n",
       "num_unique_bene_with_med_srvc_norm             264  9.988545e-01   \n",
       "total_med_submitted_charges_norm               264  3.950347e+03   \n",
       "total_med_medicare_payment_amt_norm            264  1.027678e+03   \n",
       "num_female_norm                                263  5.739984e-01   \n",
       "num_male_norm                                  263  4.259819e-01   \n",
       "num_non_his_white_norm                         264  7.874888e-01   \n",
       "num_african_american_norm                      264  9.228271e-02   \n",
       "num_asian_norm                                 264  3.350189e-02   \n",
       "num_hispanic_norm                              264  7.737616e-02   \n",
       "num_american_indian_norm                       259  4.403709e-03   \n",
       "num_asthma_norm                                241  7.585062e-02   \n",
       "num_alzheimers_dementia_norm                   241  1.046058e-01   \n",
       "num_artrial_fibrillation_norm                  251  1.295618e-01   \n",
       "num_cancer_norm                                260  4.314231e-01   \n",
       "num_chronic_obstructive_pulmonary_norm         256  2.003906e-01   \n",
       "num_depression_norm                            259  2.104247e-01   \n",
       "num_diabetes_norm                              261  3.367050e-01   \n",
       "num_heart_failure_norm                         258  2.398837e-01   \n",
       "num_hypertension_norm                          264  6.812879e-01   \n",
       "num_ischemic_heart_norm                        262  3.929771e-01   \n",
       "num_osteoporosis_norm                          243  1.161317e-01   \n",
       "num_rheumatoid_arthritis_osteoarthirtis_norm   262  3.776718e-01   \n",
       "num_schizophrenia_psychotic_norm               163  4.263804e-02   \n",
       "num_stroke_norm                                215  5.934884e-02   \n",
       "drug_charge_per_srvc                           264  6.482360e+01   \n",
       "med_charge_per_srvc                            264  1.700999e+02   \n",
       "\n",
       "total_submitted_charges_norm                                              \\\n",
       "                                                       std           min   \n",
       "npi                                           3.056708e+08  1.003875e+09   \n",
       "num_hcpcs                                     3.837378e+01  1.700000e+01   \n",
       "num_services                                  1.193646e+05  5.618000e+03   \n",
       "num_unique_bene                               2.701264e+02  2.600000e+01   \n",
       "total_submitted_charges                       4.990289e+06  4.422754e+05   \n",
       "total_medicare_payment_amt                    2.121102e+06  9.338352e+04   \n",
       "drug_suppress_indicator                       0.000000e+00  0.000000e+00   \n",
       "num_hcpcs_associated_drug_srvc                1.596046e+01  5.000000e+00   \n",
       "num_drug_srvc                                 1.131390e+05  5.296000e+03   \n",
       "num_unique_bene_with_drug_srvc                1.224541e+02  1.200000e+01   \n",
       "total_drug_submitted_charges                  3.995391e+06  3.945714e+05   \n",
       "total_drug_medicare_payment_amt               1.967612e+06  8.198333e+04   \n",
       "medical_suppress_indicator                    0.000000e+00  0.000000e+00   \n",
       "num_hcpcs_associated_med_srvc                 2.704213e+01  1.200000e+01   \n",
       "num_med_srvc                                  1.005662e+04  7.200000e+01   \n",
       "num_unique_bene_with_med_srvc                 2.700739e+02  2.600000e+01   \n",
       "total_med_submitted_charges                   1.427343e+06  1.302100e+04   \n",
       "total_med_medicare_payment_amt                3.399813e+05  5.552300e+03   \n",
       "avg_age_bene                                  2.599354e+00  5.500000e+01   \n",
       "num_female                                    1.616368e+02  1.400000e+01   \n",
       "num_male                                      1.163243e+02  0.000000e+00   \n",
       "num_non_his_white                             2.480841e+02  7.000000e+00   \n",
       "num_african_american                          4.054658e+01  0.000000e+00   \n",
       "num_asian                                     1.502646e+01  0.000000e+00   \n",
       "num_hispanic                                  3.315975e+01  0.000000e+00   \n",
       "num_american_indian                           9.233792e+00  0.000000e+00   \n",
       "avg_hcc_risk_score                            2.973811e-01  1.239700e+00   \n",
       "zip_1                                         2.823218e+04  6.790000e+03   \n",
       "drug_srvc_bin                                 0.000000e+00  1.000000e+00   \n",
       "county_fips                                   1.740931e+04  1.043000e+03   \n",
       "...                                                    ...           ...   \n",
       "total_drug_submitted_charges_norm             1.917917e+04  7.025645e+03   \n",
       "total_drug_medicare_payment_amt_norm          9.681078e+03  1.006044e+03   \n",
       "num_hcpcs_associated_med_srvc_norm            1.266189e-01  3.756614e-02   \n",
       "num_med_srvc_norm                             1.407216e+01  1.440000e+00   \n",
       "num_unique_bene_with_med_srvc_norm            6.446786e-03  9.200000e-01   \n",
       "total_med_submitted_charges_norm              2.314939e+03  2.604200e+02   \n",
       "total_med_medicare_payment_amt_norm           6.112743e+02  1.110460e+02   \n",
       "num_female_norm                               8.535646e-02  2.256098e-01   \n",
       "num_male_norm                                 8.537281e-02  0.000000e+00   \n",
       "num_non_his_white_norm                        1.583393e-01  1.081081e-01   \n",
       "num_african_american_norm                     9.819131e-02  0.000000e+00   \n",
       "num_asian_norm                                5.789679e-02  0.000000e+00   \n",
       "num_hispanic_norm                             8.693022e-02  0.000000e+00   \n",
       "num_american_indian_norm                      2.113355e-02  0.000000e+00   \n",
       "num_asthma_norm                               2.352752e-02  0.000000e+00   \n",
       "num_alzheimers_dementia_norm                  4.330067e-02  0.000000e+00   \n",
       "num_artrial_fibrillation_norm                 3.217774e-02  6.000000e-02   \n",
       "num_cancer_norm                               1.249521e-01  5.000000e-02   \n",
       "num_chronic_obstructive_pulmonary_norm        6.525248e-02  8.000000e-02   \n",
       "num_depression_norm                           4.487076e-02  6.000000e-02   \n",
       "num_diabetes_norm                             7.339478e-02  1.600000e-01   \n",
       "num_heart_failure_norm                        6.890744e-02  1.100000e-01   \n",
       "num_hypertension_norm                         7.023486e-02  4.200000e-01   \n",
       "num_ischemic_heart_norm                       9.030977e-02  1.800000e-01   \n",
       "num_osteoporosis_norm                         4.814595e-02  5.000000e-02   \n",
       "num_rheumatoid_arthritis_osteoarthirtis_norm  6.605698e-02  2.000000e-01   \n",
       "num_schizophrenia_psychotic_norm              2.314283e-02  0.000000e+00   \n",
       "num_stroke_norm                               2.005936e-02  0.000000e+00   \n",
       "drug_charge_per_srvc                          6.945910e+01  1.547108e+00   \n",
       "med_charge_per_srvc                           6.972150e+01  4.190707e+01   \n",
       "\n",
       "total_submitted_charges_norm                                              \\\n",
       "                                                       25%           50%   \n",
       "npi                                           1.182134e+09  1.477587e+09   \n",
       "num_hcpcs                                     9.575000e+01  1.200000e+02   \n",
       "num_services                                  6.574900e+04  1.194870e+05   \n",
       "num_unique_bene                               2.430000e+02  4.085000e+02   \n",
       "total_submitted_charges                       4.705258e+06  7.035009e+06   \n",
       "total_medicare_payment_amt                    1.135081e+06  1.741165e+06   \n",
       "drug_suppress_indicator                       0.000000e+00  0.000000e+00   \n",
       "num_hcpcs_associated_drug_srvc                5.300000e+01  6.300000e+01   \n",
       "num_drug_srvc                                 6.034675e+04  1.096965e+05   \n",
       "num_unique_bene_with_drug_srvc                8.700000e+01  1.355000e+02   \n",
       "total_drug_submitted_charges                  3.707325e+06  5.584611e+06   \n",
       "total_drug_medicare_payment_amt               8.912819e+05  1.359743e+06   \n",
       "medical_suppress_indicator                    0.000000e+00  0.000000e+00   \n",
       "num_hcpcs_associated_med_srvc                 4.000000e+01  5.550000e+01   \n",
       "num_med_srvc                                  5.341250e+03  8.975500e+03   \n",
       "num_unique_bene_with_med_srvc                 2.430000e+02  4.085000e+02   \n",
       "total_med_submitted_charges                   8.772398e+05  1.360168e+06   \n",
       "total_med_medicare_payment_amt                2.289934e+05  3.541464e+05   \n",
       "avg_age_bene                                  7.200000e+01  7.300000e+01   \n",
       "num_female                                    1.400000e+02  2.270000e+02   \n",
       "num_male                                      9.900000e+01  1.730000e+02   \n",
       "num_non_his_white                             1.880000e+02  3.185000e+02   \n",
       "num_african_american                          1.200000e+01  2.300000e+01   \n",
       "num_asian                                     3.000000e+00  5.500000e+00   \n",
       "num_hispanic                                  1.000000e+01  1.700000e+01   \n",
       "num_american_indian                           0.000000e+00  0.000000e+00   \n",
       "avg_hcc_risk_score                            1.736975e+00  1.870250e+00   \n",
       "zip_1                                         3.333100e+04  7.220500e+04   \n",
       "drug_srvc_bin                                 1.000000e+00  1.000000e+00   \n",
       "county_fips                                   9.753500e+03  2.851000e+04   \n",
       "...                                                    ...           ...   \n",
       "total_drug_submitted_charges_norm             1.163139e+04  1.346002e+04   \n",
       "total_drug_medicare_payment_amt_norm          2.731071e+03  3.326392e+03   \n",
       "num_hcpcs_associated_med_srvc_norm            1.041317e-01  1.507977e-01   \n",
       "num_med_srvc_norm                             1.630999e+01  2.359056e+01   \n",
       "num_unique_bene_with_med_srvc_norm            1.000000e+00  1.000000e+00   \n",
       "total_med_submitted_charges_norm              2.652764e+03  3.524988e+03   \n",
       "total_med_medicare_payment_amt_norm           6.963114e+02  9.091525e+02   \n",
       "num_female_norm                               5.353748e-01  5.798611e-01   \n",
       "num_male_norm                                 3.826814e-01  4.201389e-01   \n",
       "num_non_his_white_norm                        7.274979e-01  8.319314e-01   \n",
       "num_african_american_norm                     3.300680e-02  6.351565e-02   \n",
       "num_asian_norm                                7.284654e-03  1.773139e-02   \n",
       "num_hispanic_norm                             2.852657e-02  5.439007e-02   \n",
       "num_american_indian_norm                      0.000000e+00  0.000000e+00   \n",
       "num_asthma_norm                               6.000000e-02  7.000000e-02   \n",
       "num_alzheimers_dementia_norm                  8.000000e-02  1.000000e-01   \n",
       "num_artrial_fibrillation_norm                 1.100000e-01  1.300000e-01   \n",
       "num_cancer_norm                               3.700000e-01  4.400000e-01   \n",
       "num_chronic_obstructive_pulmonary_norm        1.500000e-01  1.900000e-01   \n",
       "num_depression_norm                           1.800000e-01  2.100000e-01   \n",
       "num_diabetes_norm                             2.900000e-01  3.300000e-01   \n",
       "num_heart_failure_norm                        1.900000e-01  2.300000e-01   \n",
       "num_hypertension_norm                         6.400000e-01  7.000000e-01   \n",
       "num_ischemic_heart_norm                       3.300000e-01  3.900000e-01   \n",
       "num_osteoporosis_norm                         8.000000e-02  1.100000e-01   \n",
       "num_rheumatoid_arthritis_osteoarthirtis_norm  3.300000e-01  3.750000e-01   \n",
       "num_schizophrenia_psychotic_norm              3.000000e-02  4.000000e-02   \n",
       "num_stroke_norm                               5.000000e-02  6.000000e-02   \n",
       "drug_charge_per_srvc                          3.725855e+01  5.075081e+01   \n",
       "med_charge_per_srvc                           1.245047e+02  1.590501e+02   \n",
       "\n",
       "total_submitted_charges_norm                                              \n",
       "                                                       75%           max  \n",
       "npi                                           1.740252e+09  1.992774e+09  \n",
       "num_hcpcs                                     1.410000e+02  2.520000e+02  \n",
       "num_services                                  1.910295e+05  9.195270e+05  \n",
       "num_unique_bene                               5.502500e+02  1.890000e+03  \n",
       "total_submitted_charges                       9.794655e+06  3.574462e+07  \n",
       "total_medicare_payment_amt                    2.661291e+06  2.804806e+07  \n",
       "drug_suppress_indicator                       0.000000e+00  0.000000e+00  \n",
       "num_hcpcs_associated_drug_srvc                7.100000e+01  1.060000e+02  \n",
       "num_drug_srvc                                 1.774440e+05  9.192350e+05  \n",
       "num_unique_bene_with_drug_srvc                2.102500e+02  8.340000e+02  \n",
       "total_drug_submitted_charges                  7.605542e+06  3.556785e+07  \n",
       "total_drug_medicare_payment_amt               2.062269e+06  2.797682e+07  \n",
       "medical_suppress_indicator                    0.000000e+00  0.000000e+00  \n",
       "num_hcpcs_associated_med_srvc                 7.425000e+01  1.720000e+02  \n",
       "num_med_srvc                                  1.364425e+04  9.189700e+04  \n",
       "num_unique_bene_with_med_srvc                 5.502500e+02  1.890000e+03  \n",
       "total_med_submitted_charges                   2.116512e+06  1.125053e+07  \n",
       "total_med_medicare_payment_amt                5.493041e+05  2.532144e+06  \n",
       "avg_age_bene                                  7.400000e+01  7.800000e+01  \n",
       "num_female                                    3.255000e+02  1.169000e+03  \n",
       "num_male                                      2.400000e+02  7.890000e+02  \n",
       "num_non_his_white                             4.562500e+02  1.695000e+03  \n",
       "num_african_american                          4.625000e+01  3.140000e+02  \n",
       "num_asian                                     1.400000e+01  1.110000e+02  \n",
       "num_hispanic                                  3.225000e+01  3.130000e+02  \n",
       "num_american_indian                           0.000000e+00  9.500000e+01  \n",
       "avg_hcc_risk_score                            2.089675e+00  2.991800e+00  \n",
       "zip_1                                         8.410625e+04  9.964500e+04  \n",
       "drug_srvc_bin                                 1.000000e+00  1.000000e+00  \n",
       "county_fips                                   4.800500e+04  5.306300e+04  \n",
       "...                                                    ...           ...  \n",
       "total_drug_submitted_charges_norm             1.620758e+04  2.833048e+05  \n",
       "total_drug_medicare_payment_amt_norm          4.454613e+03  1.338959e+05  \n",
       "num_hcpcs_associated_med_srvc_norm            2.200033e-01  1.100000e+00  \n",
       "num_med_srvc_norm                             3.120652e+01  1.014512e+02  \n",
       "num_unique_bene_with_med_srvc_norm            1.000000e+00  1.000000e+00  \n",
       "total_med_submitted_charges_norm              4.341155e+03  1.928637e+04  \n",
       "total_med_medicare_payment_amt_norm           1.182878e+03  6.002191e+03  \n",
       "num_female_norm                               6.173186e-01  1.000000e+00  \n",
       "num_male_norm                                 4.646252e-01  7.743902e-01  \n",
       "num_non_his_white_norm                        8.990656e-01  9.861751e-01  \n",
       "num_african_american_norm                     1.199118e-01  7.181208e-01  \n",
       "num_asian_norm                                4.109775e-02  7.500000e-01  \n",
       "num_hispanic_norm                             8.968542e-02  6.466942e-01  \n",
       "num_american_indian_norm                      0.000000e+00  2.214452e-01  \n",
       "num_asthma_norm                               9.000000e-02  1.500000e-01  \n",
       "num_alzheimers_dementia_norm                  1.300000e-01  4.200000e-01  \n",
       "num_artrial_fibrillation_norm                 1.500000e-01  2.700000e-01  \n",
       "num_cancer_norm                               4.925000e-01  7.500000e-01  \n",
       "num_chronic_obstructive_pulmonary_norm        2.400000e-01  4.000000e-01  \n",
       "num_depression_norm                           2.400000e-01  3.500000e-01  \n",
       "num_diabetes_norm                             3.700000e-01  7.300000e-01  \n",
       "num_heart_failure_norm                        2.700000e-01  5.400000e-01  \n",
       "num_hypertension_norm                         7.500000e-01  7.500000e-01  \n",
       "num_ischemic_heart_norm                       4.600000e-01  7.400000e-01  \n",
       "num_osteoporosis_norm                         1.300000e-01  3.700000e-01  \n",
       "num_rheumatoid_arthritis_osteoarthirtis_norm  4.200000e-01  6.300000e-01  \n",
       "num_schizophrenia_psychotic_norm              5.000000e-02  1.800000e-01  \n",
       "num_stroke_norm                               7.000000e-02  1.800000e-01  \n",
       "drug_charge_per_srvc                          6.973967e+01  8.954645e+02  \n",
       "med_charge_per_srvc                           2.052591e+02  5.391756e+02  \n",
       "\n",
       "[67 rows x 16 columns]"
      ]
     },
     "execution_count": 267,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_hema_drop_drug.groupby(df_hema_drop_drug['total_submitted_charges_norm']>out_limit).describe().T"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 294,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "d = get_psql([1760495048,1750350633])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 346,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th>npi</th>\n",
       "      <th>last_name</th>\n",
       "      <th>first_name</th>\n",
       "      <th>credentials</th>\n",
       "      <th>state</th>\n",
       "      <th>provider_type</th>\n",
       "      <th>num_hcpcs</th>\n",
       "      <th>num_services</th>\n",
       "      <th>num_unique_bene</th>\n",
       "      <th>total_submitted_charges</th>\n",
       "      <th>...</th>\n",
       "      <th>num_diabetes_norm</th>\n",
       "      <th>num_heart_failure_norm</th>\n",
       "      <th>num_hypertension_norm</th>\n",
       "      <th>num_ischemic_heart_norm</th>\n",
       "      <th>num_osteoporosis_norm</th>\n",
       "      <th>num_rheumatoid_arthritis_osteoarthirtis_norm</th>\n",
       "      <th>num_schizophrenia_psychotic_norm</th>\n",
       "      <th>num_stroke_norm</th>\n",
       "      <th>drug_charge_per_srvc</th>\n",
       "      <th>med_charge_per_srvc</th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th>65</th>\n",
       "      <td>1073755278</td>\n",
       "      <td>KIRIMIS</td>\n",
       "      <td>EVANGELIA</td>\n",
       "      <td>MD</td>\n",
       "      <td>CA</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>100</td>\n",
       "      <td>55702</td>\n",
       "      <td>310</td>\n",
       "      <td>6374130.00</td>\n",
       "      <td>...</td>\n",
       "      <td>0.33</td>\n",
       "      <td>0.24</td>\n",
       "      <td>0.71</td>\n",
       "      <td>0.43</td>\n",
       "      <td>0.16</td>\n",
       "      <td>0.48</td>\n",
       "      <td>0.05</td>\n",
       "      <td>0.06</td>\n",
       "      <td>99.118294</td>\n",
       "      <td>319.827943</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>73</th>\n",
       "      <td>1528088549</td>\n",
       "      <td>ROSOVE</td>\n",
       "      <td>MICHAEL</td>\n",
       "      <td>MD</td>\n",
       "      <td>CA</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>110</td>\n",
       "      <td>78584</td>\n",
       "      <td>489</td>\n",
       "      <td>8437817.00</td>\n",
       "      <td>...</td>\n",
       "      <td>0.28</td>\n",
       "      <td>0.25</td>\n",
       "      <td>0.65</td>\n",
       "      <td>0.42</td>\n",
       "      <td>0.13</td>\n",
       "      <td>0.43</td>\n",
       "      <td>0.04</td>\n",
       "      <td>0.08</td>\n",
       "      <td>95.119215</td>\n",
       "      <td>217.199417</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>76</th>\n",
       "      <td>1609946169</td>\n",
       "      <td>ASHOURI</td>\n",
       "      <td>SHAHRYAR</td>\n",
       "      <td>MD</td>\n",
       "      <td>CA</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>111</td>\n",
       "      <td>130082</td>\n",
       "      <td>365</td>\n",
       "      <td>12891085.41</td>\n",
       "      <td>...</td>\n",
       "      <td>0.30</td>\n",
       "      <td>0.20</td>\n",
       "      <td>0.66</td>\n",
       "      <td>0.38</td>\n",
       "      <td>0.13</td>\n",
       "      <td>0.37</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.05</td>\n",
       "      <td>92.448644</td>\n",
       "      <td>255.505731</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>77</th>\n",
       "      <td>1639104250</td>\n",
       "      <td>GLASPY</td>\n",
       "      <td>JOHN</td>\n",
       "      <td>MD</td>\n",
       "      <td>CA</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>107</td>\n",
       "      <td>55624</td>\n",
       "      <td>408</td>\n",
       "      <td>8601407.00</td>\n",
       "      <td>...</td>\n",
       "      <td>0.26</td>\n",
       "      <td>0.19</td>\n",
       "      <td>0.58</td>\n",
       "      <td>0.31</td>\n",
       "      <td>0.18</td>\n",
       "      <td>0.39</td>\n",
       "      <td>0.03</td>\n",
       "      <td>0.05</td>\n",
       "      <td>140.388166</td>\n",
       "      <td>331.525567</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>78</th>\n",
       "      <td>1669492252</td>\n",
       "      <td>PINTER-BROWN</td>\n",
       "      <td>LAUREN</td>\n",
       "      <td>MD</td>\n",
       "      <td>CA</td>\n",
       "      <td>Hematology/Oncology</td>\n",
       "      <td>89</td>\n",
       "      <td>20749</td>\n",
       "      <td>290</td>\n",
       "      <td>5774170.00</td>\n",
       "      <td>...</td>\n",
       "      <td>0.27</td>\n",
       "      <td>0.18</td>\n",
       "      <td>0.63</td>\n",
       "      <td>0.38</td>\n",
       "      <td>0.10</td>\n",
       "      <td>0.33</td>\n",
       "      <td>NaN</td>\n",
       "      <td>0.06</td>\n",
       "      <td>311.715577</td>\n",
       "      <td>174.093254</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "<p>5 rows × 73 columns</p>\n",
       "</div>"
      ],
      "text/plain": [
       "           npi     last_name first_name credentials state  \\\n",
       "65  1073755278       KIRIMIS  EVANGELIA          MD    CA   \n",
       "73  1528088549        ROSOVE    MICHAEL          MD    CA   \n",
       "76  1609946169       ASHOURI   SHAHRYAR          MD    CA   \n",
       "77  1639104250        GLASPY       JOHN          MD    CA   \n",
       "78  1669492252  PINTER-BROWN     LAUREN          MD    CA   \n",
       "\n",
       "          provider_type  num_hcpcs  num_services  num_unique_bene  \\\n",
       "65  Hematology/Oncology        100         55702              310   \n",
       "73  Hematology/Oncology        110         78584              489   \n",
       "76  Hematology/Oncology        111        130082              365   \n",
       "77  Hematology/Oncology        107         55624              408   \n",
       "78  Hematology/Oncology         89         20749              290   \n",
       "\n",
       "    total_submitted_charges         ...           num_diabetes_norm  \\\n",
       "65               6374130.00         ...                        0.33   \n",
       "73               8437817.00         ...                        0.28   \n",
       "76              12891085.41         ...                        0.30   \n",
       "77               8601407.00         ...                        0.26   \n",
       "78               5774170.00         ...                        0.27   \n",
       "\n",
       "    num_heart_failure_norm  num_hypertension_norm  num_ischemic_heart_norm  \\\n",
       "65                    0.24                   0.71                     0.43   \n",
       "73                    0.25                   0.65                     0.42   \n",
       "76                    0.20                   0.66                     0.38   \n",
       "77                    0.19                   0.58                     0.31   \n",
       "78                    0.18                   0.63                     0.38   \n",
       "\n",
       "    num_osteoporosis_norm  num_rheumatoid_arthritis_osteoarthirtis_norm  \\\n",
       "65                   0.16                                          0.48   \n",
       "73                   0.13                                          0.43   \n",
       "76                   0.13                                          0.37   \n",
       "77                   0.18                                          0.39   \n",
       "78                   0.10                                          0.33   \n",
       "\n",
       "    num_schizophrenia_psychotic_norm  num_stroke_norm  drug_charge_per_srvc  \\\n",
       "65                              0.05             0.06             99.118294   \n",
       "73                              0.04             0.08             95.119215   \n",
       "76                               NaN             0.05             92.448644   \n",
       "77                              0.03             0.05            140.388166   \n",
       "78                               NaN             0.06            311.715577   \n",
       "\n",
       "    med_charge_per_srvc  \n",
       "65           319.827943  \n",
       "73           217.199417  \n",
       "76           255.505731  \n",
       "77           331.525567  \n",
       "78           174.093254  \n",
       "\n",
       "[5 rows x 73 columns]"
      ]
     },
     "execution_count": 346,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "outliers.head()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 492,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "import pandas as pd\n",
    "import numpy as np\n",
    "import psycopg2 as pg2\n",
    "import string\n",
    "from nltk import word_tokenize\n",
    "from nltk.stem import PorterStemmer\n",
    "from nltk.corpus import stopwords\n",
    "from sklearn.feature_extraction.text import TfidfVectorizer, CountVectorizer\n",
    "\n",
    "\n",
    "def get_psql(npi_list):\n",
    "    \"\"\"\n",
    "    retrieves hcpcs descriptions from a psql database\n",
    "\n",
    "    Input:\n",
    "    list of npi identifiers\n",
    "\n",
    "    Output:\n",
    "    dictionary with npi as key and a list of hcpcs descriptions\n",
    "    \"\"\"\n",
    "\n",
    "    npi_dict = {}\n",
    "    conn = pg2.connect(dbname='medicare', user='postgres')\n",
    "    cur = conn.cursor()\n",
    "\n",
    "    for dr in npi_list:\n",
    "        query = \"SELECT hcpcs_desc FROM util_payments_2013 WHERE npi='{0}';\".format(dr)\n",
    "        cur.execute(query)\n",
    "        npi_dict[dr] = cur.fetchall()\n",
    "        \n",
    "    return npi_dict\n",
    "\n",
    "def flatten_dic(desc_list):\n",
    "    \"\"\"\n",
    "    takes values from one entry of dictionary and flattens\n",
    "    \"\"\"\n",
    "    corp_list = [desc for c in desc_list for desc in c]\n",
    "    return ' '.join(corp_list)\n",
    "\n",
    "\n",
    "def process_text(text, stem=True):\n",
    "    \"\"\" Tokenize text and stem words removing punctuation \"\"\"\n",
    "    table = string.maketrans(\"\",\"\")\n",
    "    text = text.translate(table, string.punctuation)\n",
    "    tokens = word_tokenize(text)\n",
    " \n",
    "    if stem:\n",
    "        stemmer = PorterStemmer()\n",
    "        tokens = [stemmer.stem(t) for t in tokens]\n",
    " \n",
    "    return tokens \n",
    "\n",
    "\n",
    "#def perform_tfidf(npi_list):\n",
    "#    \"\"\" Runs TFIDF process \"\"\"\n",
    "#    npi_dict = get_psql(npi_list)\n",
    "#    corpus = []\n",
    "#    for dr in npi_list:\n",
    "#        corpus.append(flatten_dic(npi_dict[dr]))\n",
    "#    \n",
    "#    vectorizer = TfidfVectorizer(stop_words='english')\n",
    "# \n",
    "#    tfidf_model = vectorizer.fit_transform(corpus)\n",
    "#\n",
    "#    return tfidf_model, vectorizer, corpus\n",
    "\n",
    "def perform_tfidf(npi_list, tfidf=False):\n",
    "    \"\"\" Runs TFIDF process \"\"\"\n",
    "    npi_dict = get_psql(npi_list)\n",
    "    corpus = []\n",
    "    for dr in npi_list:\n",
    "        corpus.append(flatten_dic(npi_dict[dr]))\n",
    "\n",
    "    #corpus = [desc for c in corpus for desc in c]\n",
    "    #corpus = process_text(corpus)\n",
    "    \n",
    "    if tfidf:\n",
    "        vectorizer = TfidfVectorizer(stop_words='english')\n",
    "        tfidf_model = vectorizer.fit_transform(corpus)\n",
    "        return tfidf_model, vectorizer, corpus\n",
    "    else:\n",
    "        vectorizer = CountVectorizer(stop_words='english')\n",
    "        count_model = vectorizer.fit_transform(corpus)\n",
    "        return count_model, vectorizer, corpus"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 435,
   "metadata": {
    "collapsed": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[(array([ 0.        ,  0.        ,  0.        ,  0.78443476,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.62021134]),\n",
       "  'Insertion of needle into vein for collection of blood sample'),\n",
       " (array([ 0.38601383,  0.38601383,  0.        ,  0.83784643,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Complete blood cell count (red cells, white blood cell, platelets), automated test'),\n",
       " (array([ 0.        ,  0.        ,  0.46382526,  0.        ,  0.47846846,\n",
       "          0.42675171,  0.        ,  0.        ,  0.44761895,  0.        ,\n",
       "          0.        ,  0.        ,  0.41647848]),\n",
       "  'Hydration infusion into a vein 31 minutes to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.62583491,\n",
       "          0.5581896 ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.54475227]),\n",
       "  'Hydration infusion into a vein each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.36415565,  0.        ,  0.37565223,\n",
       "          0.67009738,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.4127077 ,  0.        ,  0.32698304]),\n",
       "  'Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.54720501,  0.        ,  0.        ,  0.        ,\n",
       "          0.83699861,  0.        ,  0.        ]),\n",
       "  'Injection into tissue or muscle for therapy, diagnosis, or prevention'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.45604233,  0.        ,  0.        ,  0.        ,\n",
       "          0.6975572 ,  0.        ,  0.55266567]),\n",
       "  'Injection of drug or substance into a vein for therapy'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.45604233,  0.        ,  0.        ,  0.        ,\n",
       "          0.6975572 ,  0.        ,  0.55266567]),\n",
       "  'Injection of different drug or substance into a vein for therapy'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.71566848,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.69844014]),\n",
       "  'Infusion of additional chemotherapy drug or substance into a vein'),\n",
       " (array([ 0.        ,  0.        ,  0.51869   ,  0.        ,  0.53506531,\n",
       "          0.47723111,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.4657427 ]),\n",
       "  'Infusion of chemotherapy into a vein up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.62583491,\n",
       "          0.5581896 ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.54475227]),\n",
       "  'Infusion of chemotherapy into a vein each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.51869   ,  0.        ,  0.53506531,\n",
       "          0.47723111,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.4657427 ]),\n",
       "  'Infusion of different chemotherapy drug or substance into a vein up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'New patient office or other outpatient visit, typically 45 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'New patient office or other outpatient visit, typically 60 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient visit, typically 15 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 25 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 40 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Initial hospital inpatient care, typically 50 minutes per day'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Initial hospital inpatient care, typically 70 minutes per day'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Subsequent hospital inpatient care, typically 25 minutes per day'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Subsequent hospital inpatient care, typically 35 minutes per day'),\n",
       " (array([ 0.54117412,  0.54117412,  0.51714613,  0.        ,  0.        ,\n",
       "          0.        ,  0.38317232,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, darbepoetin alfa, 1 microgram (non-esrd use)'),\n",
       " (array([ 0.        ,  0.        ,  0.64676423,  0.        ,  0.        ,\n",
       "          0.        ,  0.47921107,  0.59334036,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, denosumab, 1 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, dexamethasone sodium phosphate, 1mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, diphenhydramine hcl, up to 50 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, granisetron hydrochloride, 100 mcg'),\n",
       " (array([ 0.        ,  0.        ,  0.64676423,  0.        ,  0.        ,\n",
       "          0.        ,  0.47921107,  0.59334036,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, ondansetron hydrochloride, per 1 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, palonosetron hcl, 25 mcg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, pegfilgrastim, 6 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Infusion, normal saline solution , 1000 cc'),\n",
       " (array([ 0.60051382,  0.60051382,  0.        ,  0.        ,  0.        ,\n",
       "          0.52798324,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Infusion, normal saline solution, sterile (500 ml=1 unit)'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Infusion, normal saline solution , 250 cc'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Cyclophosphamide, 100 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.64676423,  0.        ,  0.        ,\n",
       "          0.        ,  0.47921107,  0.59334036,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, docetaxel, 1 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, fluorouracil, 500 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, rituximab, 100 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.78443476,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.62021134]),\n",
       "  'Insertion of needle into vein for collection of blood sample'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Stool analysis for blood to screen for colon tumors'),\n",
       " (array([ 0.38601383,  0.38601383,  0.        ,  0.83784643,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Complete blood cell count (red cells, white blood cell, platelets), automated test'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Blood test, clotting time'),\n",
       " (array([ 0.        ,  0.        ,  0.46382526,  0.        ,  0.47846846,\n",
       "          0.42675171,  0.        ,  0.        ,  0.44761895,  0.        ,\n",
       "          0.        ,  0.        ,  0.41647848]),\n",
       "  'Hydration infusion into a vein 31 minutes to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.62583491,\n",
       "          0.5581896 ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.54475227]),\n",
       "  'Hydration infusion into a vein each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.44715276,  0.        ,  0.4612696 ,\n",
       "          0.41141184,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.50677063,  0.        ,  0.4015079 ]),\n",
       "  'Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.36415565,  0.        ,  0.37565223,\n",
       "          0.67009738,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.4127077 ,  0.        ,  0.32698304]),\n",
       "  'Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.54720501,  0.        ,  0.        ,  0.        ,\n",
       "          0.83699861,  0.        ,  0.        ]),\n",
       "  'Injection into tissue or muscle for therapy, diagnosis, or prevention'),\n",
       " (array([ 0.        ,  0.        ,  0.51869   ,  0.        ,  0.53506531,\n",
       "          0.47723111,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.4657427 ]),\n",
       "  'Infusion of chemotherapy into a vein up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.62583491,\n",
       "          0.5581896 ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.54475227]),\n",
       "  'Infusion of chemotherapy into a vein each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.51869   ,  0.        ,  0.53506531,\n",
       "          0.47723111,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.4657427 ]),\n",
       "  'Infusion of different chemotherapy drug or substance into a vein up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'New patient office or other outpatient visit, typically 30 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'New patient office or other outpatient visit, typically 45 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'New patient office or other outpatient visit, typically 60 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient visit, typically 10 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient visit, typically 15 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 25 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 40 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Initial hospital inpatient care, typically 30 minutes per day'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Initial hospital inpatient care, typically 50 minutes per day'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Initial hospital inpatient care, typically 70 minutes per day'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Subsequent hospital inpatient care, typically 15 minutes per day'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Subsequent hospital inpatient care, typically 25 minutes per day'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Subsequent hospital inpatient care, typically 35 minutes per day'),\n",
       " (array([ 0.54117412,  0.54117412,  0.51714613,  0.        ,  0.        ,\n",
       "          0.        ,  0.38317232,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, darbepoetin alfa, 1 microgram (non-esrd use)'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, dexamethasone sodium phosphate, 1mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, diphenhydramine hcl, up to 50 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.64676423,  0.        ,  0.        ,\n",
       "          0.        ,  0.47921107,  0.59334036,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, ondansetron hydrochloride, per 1 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, pegfilgrastim, 6 mg'),\n",
       " (array([ 0.60051382,  0.60051382,  0.        ,  0.        ,  0.        ,\n",
       "          0.52798324,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Infusion, normal saline solution, sterile (500 ml=1 unit)'),\n",
       " (array([ 0.58589116,  0.58589116,  0.55987775,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  '5% dextrose/normal saline (500 ml = 1 unit)'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Infusion, normal saline solution , 250 cc'),\n",
       " (array([ 0.        ,  0.        ,  0.64676423,  0.        ,  0.        ,\n",
       "          0.        ,  0.47921107,  0.59334036,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, bendamustine hcl, 1 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, carboplatin, 50 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, rituximab, 100 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.78443476,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.62021134]),\n",
       "  'Insertion of needle into vein for collection of blood sample'),\n",
       " (array([ 0.38601383,  0.38601383,  0.        ,  0.83784643,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Complete blood cell count (red cells, white blood cell, platelets), automated test'),\n",
       " (array([ 0.        ,  0.        ,  0.46382526,  0.        ,  0.47846846,\n",
       "          0.42675171,  0.        ,  0.        ,  0.44761895,  0.        ,\n",
       "          0.        ,  0.        ,  0.41647848]),\n",
       "  'Hydration infusion into a vein 31 minutes to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.62583491,\n",
       "          0.5581896 ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.54475227]),\n",
       "  'Hydration infusion into a vein each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.44715276,  0.        ,  0.4612696 ,\n",
       "          0.41141184,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.50677063,  0.        ,  0.4015079 ]),\n",
       "  'Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.36415565,  0.        ,  0.37565223,\n",
       "          0.67009738,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.4127077 ,  0.        ,  0.32698304]),\n",
       "  'Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.78629779,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.48427462,  0.        ,  0.3836846 ]),\n",
       "  'Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.54720501,  0.        ,  0.        ,  0.        ,\n",
       "          0.83699861,  0.        ,  0.        ]),\n",
       "  'Injection into tissue or muscle for therapy, diagnosis, or prevention'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.45604233,  0.        ,  0.        ,  0.        ,\n",
       "          0.6975572 ,  0.        ,  0.55266567]),\n",
       "  'Injection of drug or substance into a vein for therapy'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.45604233,  0.        ,  0.        ,  0.        ,\n",
       "          0.6975572 ,  0.        ,  0.55266567]),\n",
       "  'Injection of different drug or substance into a vein for therapy'),\n",
       " (array([ 0.        ,  0.        ,  0.51869   ,  0.        ,  0.53506531,\n",
       "          0.47723111,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.4657427 ]),\n",
       "  'Infusion of chemotherapy into a vein up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.62583491,\n",
       "          0.5581896 ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.54475227]),\n",
       "  'Infusion of chemotherapy into a vein each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.51869   ,  0.        ,  0.53506531,\n",
       "          0.47723111,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.4657427 ]),\n",
       "  'Infusion of different chemotherapy drug or substance into a vein up to 1 hour'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Irrigation of implanted venous access drug delivery device'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'New patient office or other outpatient visit, typically 45 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'New patient office or other outpatient visit, typically 60 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient visit, typically 10 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient visit, typically 15 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 25 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 40 minutes'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Administration of influenza virus vaccine'),\n",
       " (array([ 0.        ,  0.        ,  0.64676423,  0.        ,  0.        ,\n",
       "          0.        ,  0.47921107,  0.59334036,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, denosumab, 1 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, dexamethasone sodium phosphate, 1mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, diphenhydramine hcl, up to 50 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.64676423,  0.        ,  0.        ,\n",
       "          0.        ,  0.47921107,  0.59334036,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, fosaprepitant, 1 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.64676423,  0.        ,  0.        ,\n",
       "          0.        ,  0.47921107,  0.59334036,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, ondansetron hydrochloride, per 1 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, palonosetron hcl, 25 mcg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, pegfilgrastim, 6 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Unclassified drugs'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Infusion, normal saline solution , 1000 cc'),\n",
       " (array([ 0.60051382,  0.60051382,  0.        ,  0.        ,  0.        ,\n",
       "          0.52798324,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Infusion, normal saline solution, sterile (500 ml=1 unit)'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Infusion, normal saline solution , 250 cc'),\n",
       " (array([ 0.58589116,  0.58589116,  0.55987775,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  '5% dextrose/water (500 ml = 1 unit)'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, carboplatin, 50 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.64676423,  0.        ,  0.        ,\n",
       "          0.        ,  0.47921107,  0.59334036,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, docetaxel, 1 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, gemcitabine hydrochloride, 200 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, oxaliplatin, 0. 5 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.64676423,  0.        ,  0.        ,\n",
       "          0.        ,  0.47921107,  0.59334036,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, paclitaxel protein-bound particles, 1 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.78443476,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.62021134]),\n",
       "  'Insertion of needle into vein for collection of blood sample'),\n",
       " (array([ 0.38601383,  0.38601383,  0.        ,  0.83784643,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Complete blood cell count (red cells, white blood cell, platelets), automated test'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.62583491,\n",
       "          0.5581896 ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.54475227]),\n",
       "  'Hydration infusion into a vein each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.44715276,  0.        ,  0.4612696 ,\n",
       "          0.41141184,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.50677063,  0.        ,  0.4015079 ]),\n",
       "  'Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.36415565,  0.        ,  0.37565223,\n",
       "          0.67009738,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.4127077 ,  0.        ,  0.32698304]),\n",
       "  'Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.54720501,  0.        ,  0.        ,  0.        ,\n",
       "          0.83699861,  0.        ,  0.        ]),\n",
       "  'Injection into tissue or muscle for therapy, diagnosis, or prevention'),\n",
       " (array([ 0.        ,  0.        ,  0.51869   ,  0.        ,  0.53506531,\n",
       "          0.47723111,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.4657427 ]),\n",
       "  'Infusion of chemotherapy into a vein up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.62583491,\n",
       "          0.5581896 ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.54475227]),\n",
       "  'Infusion of chemotherapy into a vein each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.51869   ,  0.        ,  0.53506531,\n",
       "          0.47723111,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.4657427 ]),\n",
       "  'Infusion of different chemotherapy drug or substance into a vein up to 1 hour'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Irrigation of implanted venous access drug delivery device'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'New patient office or other outpatient visit, typically 45 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'New patient office or other outpatient visit, typically 60 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient visit, typically 15 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 25 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 40 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Initial hospital inpatient care, typically 50 minutes per day'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Initial hospital inpatient care, typically 70 minutes per day'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Subsequent hospital inpatient care, typically 15 minutes per day'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Subsequent hospital inpatient care, typically 25 minutes per day'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Subsequent hospital inpatient care, typically 35 minutes per day'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Administration of influenza virus vaccine'),\n",
       " (array([ 0.        ,  0.        ,  0.64676423,  0.        ,  0.        ,\n",
       "          0.        ,  0.47921107,  0.59334036,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, denosumab, 1 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, dexamethasone sodium phosphate, 1mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, diphenhydramine hcl, up to 50 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.64676423,  0.        ,  0.        ,\n",
       "          0.        ,  0.47921107,  0.59334036,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, ondansetron hydrochloride, per 1 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, palonosetron hcl, 25 mcg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, pegfilgrastim, 6 mg'),\n",
       " (array([ 0.60051382,  0.60051382,  0.        ,  0.        ,  0.        ,\n",
       "          0.52798324,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Infusion, normal saline solution, sterile (500 ml=1 unit)'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Infusion, normal saline solution , 250 cc'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, carboplatin, 50 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, trastuzumab, 10 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.78443476,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.62021134]),\n",
       "  'Insertion of needle into vein for collection of blood sample'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Blood test, comprehensive group of blood chemicals'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Vitamin D-3 level'),\n",
       " (array([ 0.70710678,  0.70710678,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Lactate dehydrogenase (enzyme) level'),\n",
       " (array([ 0.56096825,  0.56096825,  0.        ,  0.60879327,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Blood test, thyroid stimulating hormone (TSH)'),\n",
       " (array([ 0.38601383,  0.38601383,  0.        ,  0.83784643,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Complete blood cell count (red cells, white blood cell, platelets), automated test'),\n",
       " (array([ 0.        ,  0.        ,  0.36415565,  0.        ,  0.37565223,\n",
       "          0.67009738,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.4127077 ,  0.        ,  0.32698304]),\n",
       "  'Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.54720501,  0.        ,  0.        ,  0.        ,\n",
       "          0.83699861,  0.        ,  0.        ]),\n",
       "  'Injection into tissue or muscle for therapy, diagnosis, or prevention'),\n",
       " (array([ 0.        ,  0.        ,  0.51869   ,  0.        ,  0.53506531,\n",
       "          0.47723111,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.4657427 ]),\n",
       "  'Infusion of chemotherapy into a vein up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.62583491,\n",
       "          0.5581896 ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.54475227]),\n",
       "  'Infusion of chemotherapy into a vein each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'New patient office or other outpatient visit, typically 60 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient visit, typically 15 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 25 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 40 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Subsequent hospital inpatient care, typically 25 minutes per day'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Administration of influenza virus vaccine'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, diphenhydramine hcl, up to 50 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Infusion, normal saline solution , 1000 cc'),\n",
       " (array([ 0.60051382,  0.60051382,  0.        ,  0.        ,  0.        ,\n",
       "          0.52798324,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Infusion, normal saline solution, sterile (500 ml=1 unit)'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Infusion, normal saline solution , 250 cc'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, rituximab, 100 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.78443476,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.62021134]),\n",
       "  'Insertion of needle into vein for collection of blood sample'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Needle or trocar bone marrow biopsy'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Blood test, comprehensive group of blood chemicals'),\n",
       " (array([ 0.70710678,  0.70710678,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Lactate dehydrogenase (enzyme) level'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Magnesium level'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Phosphate level'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Uric acid level, blood'),\n",
       " (array([ 0.38601383,  0.38601383,  0.        ,  0.83784643,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Complete blood cell count (red cells, white blood cell, platelets), automated test'),\n",
       " (array([ 0.        ,  0.        ,  0.36415565,  0.        ,  0.37565223,\n",
       "          0.67009738,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.4127077 ,  0.        ,  0.32698304]),\n",
       "  'Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.54720501,  0.        ,  0.        ,  0.        ,\n",
       "          0.83699861,  0.        ,  0.        ]),\n",
       "  'Injection into tissue or muscle for therapy, diagnosis, or prevention'),\n",
       " (array([ 0.        ,  0.        ,  0.51869   ,  0.        ,  0.53506531,\n",
       "          0.47723111,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.4657427 ]),\n",
       "  'Infusion of chemotherapy into a vein up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'New patient office or other outpatient visit, typically 60 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient visit, typically 15 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 25 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 25 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 40 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 40 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Subsequent hospital inpatient care, typically 25 minutes per day'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Subsequent hospital inpatient care, typically 35 minutes per day'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, diphenhydramine hcl, up to 50 mg'),\n",
       " (array([ 0.60051382,  0.60051382,  0.        ,  0.        ,  0.        ,\n",
       "          0.52798324,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Infusion, normal saline solution, sterile (500 ml=1 unit)'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Infusion, normal saline solution , 250 cc'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, rituximab, 100 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.78443476,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.62021134]),\n",
       "  'Insertion of needle into vein for collection of blood sample'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Needle or trocar bone marrow biopsy'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'CT scan chest'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'CT scan chest with contrast'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'CT scan abdomen before and after contrast'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'CT scan of abdomen and pelvis'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'CT scan of abdomen and pelvis'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Nuclear medicine study with CT imaging skull base to mid-thigh'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Blood test, basic group of blood chemicals'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Blood test, comprehensive group of blood chemicals'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Manual urinalysis test with examination using microscope'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Stool analysis for blood'),\n",
       " (array([ 0.70710678,  0.70710678,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Carcinoembryonic antigen (CEA) protein level'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Blood creatinine level'),\n",
       " (array([ 0.70710678,  0.70710678,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Cyanocobalamin (vitamin B-12) level'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Electrophoresis, laboratory testing technique'),\n",
       " (array([ 0.56096825,  0.56096825,  0.        ,  0.60879327,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Ferritin (blood protein) level'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Folic acid level'),\n",
       " (array([ 0.70710678,  0.70710678,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Gammaglobulin (immune system protein) measurement'),\n",
       " (array([ 0.70710678,  0.70710678,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Glutamyltransferase (liver enzyme) level'),\n",
       " (array([ 0.70710678,  0.70710678,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Haptoglobin (serum protein) level'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Iron level'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Iron binding capacity'),\n",
       " (array([ 0.70710678,  0.70710678,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Lactate dehydrogenase (enzyme) level'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Magnesium level'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Phosphate level'),\n",
       " (array([ 0.70710678,  0.70710678,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'PSA (prostate specific antigen) measurement'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Protein measurement, serum'),\n",
       " (array([ 0.70710678,  0.70710678,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Thyroxine (thyroid chemical) measurement'),\n",
       " (array([ 0.56096825,  0.56096825,  0.        ,  0.60879327,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Blood test, thyroid stimulating hormone (TSH)'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Urea nitrogen level to assess kidney function'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Uric acid level, blood'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Microscopic examination for white blood cells with manual cell count'),\n",
       " (array([ 0.38601383,  0.38601383,  0.        ,  0.83784643,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Complete blood cell count (red cells, white blood cell, platelets), automated test'),\n",
       " (array([ 0.38601383,  0.38601383,  0.        ,  0.83784643,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Complete blood cell count (red cells, white blood cell, platelets), automated test'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Red blood count, automated test'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Immunologic analysis for detection of tumor antigen'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Immunologic analysis technique on serum'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.54238587,  0.        ,  0.        ,  0.8401295 ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Vaccine for pneumococcal polysaccharide for injection into muscle, patient 2 years or older'),\n",
       " (array([ 0.        ,  0.        ,  0.46382526,  0.        ,  0.47846846,\n",
       "          0.42675171,  0.        ,  0.        ,  0.44761895,  0.        ,\n",
       "          0.        ,  0.        ,  0.41647848]),\n",
       "  'Hydration infusion into a vein 31 minutes to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.62583491,\n",
       "          0.5581896 ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.54475227]),\n",
       "  'Hydration infusion into a vein each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.44715276,  0.        ,  0.4612696 ,\n",
       "          0.41141184,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.50677063,  0.        ,  0.4015079 ]),\n",
       "  'Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.51569755,\n",
       "          0.45995678,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.56656752,  0.        ,  0.44888421]),\n",
       "  'Infusion into a vein for therapy, prevention, or diagnosis each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.36415565,  0.        ,  0.37565223,\n",
       "          0.67009738,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.4127077 ,  0.        ,  0.32698304]),\n",
       "  'Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.54720501,  0.        ,  0.        ,  0.        ,\n",
       "          0.83699861,  0.        ,  0.        ]),\n",
       "  'Injection into tissue or muscle for therapy, diagnosis, or prevention'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.45604233,  0.        ,  0.        ,  0.        ,\n",
       "          0.6975572 ,  0.        ,  0.55266567]),\n",
       "  'Injection of drug or substance into a vein for therapy'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.45604233,  0.        ,  0.        ,  0.        ,\n",
       "          0.6975572 ,  0.        ,  0.55266567]),\n",
       "  'Injection of different drug or substance into a vein for therapy'),\n",
       " (array([ 0.        ,  0.        ,  0.51869   ,  0.        ,  0.53506531,\n",
       "          0.47723111,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.4657427 ]),\n",
       "  'Infusion of chemotherapy into a vein up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.62583491,\n",
       "          0.5581896 ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.54475227]),\n",
       "  'Infusion of chemotherapy into a vein each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.51869   ,  0.        ,  0.53506531,\n",
       "          0.47723111,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.4657427 ]),\n",
       "  'Infusion of different chemotherapy drug or substance into a vein up to 1 hour'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Irrigation of implanted venous access drug delivery device'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Therapeutic removal of whole blood to correct blood level imbalance'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'New patient office or other outpatient visit, typically 45 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'New patient office or other outpatient visit, typically 60 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient visit, typically 5 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient visit, typically 10 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient visit, typically 15 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 25 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 40 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Initial hospital inpatient care, typically 70 minutes per day'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Subsequent hospital inpatient care, typically 25 minutes per day'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Subsequent hospital inpatient care, typically 35 minutes per day'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.]),\n",
       "  'Hospital discharge day management, more than 30 minutes'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Administration of influenza virus vaccine'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Administration of pneumococcal vaccine'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service'),\n",
       " (array([ 0.54117412,  0.54117412,  0.51714613,  0.        ,  0.        ,\n",
       "          0.        ,  0.38317232,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, darbepoetin alfa, 1 microgram (non-esrd use)'),\n",
       " (array([ 0.        ,  0.        ,  0.64676423,  0.        ,  0.        ,\n",
       "          0.        ,  0.47921107,  0.59334036,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, testosterone cypionate, 1 cc, 200 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, dexamethasone sodium phosphate, 1mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, diphenhydramine hcl, up to 50 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, iron dextran, 50 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, meperidine hydrochloride, per 100 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, morphine sulfate, up to 10 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, palonosetron hcl, 25 mcg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, pegfilgrastim, 6 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, hydroxyzine hcl, up to 25 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, potassium chloride, per 2 meq'),\n",
       " (array([ 0.48893856,  0.48893856,  0.46722982,  0.        ,  0.        ,\n",
       "          0.        ,  0.34618751,  0.42863581,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, zoledronic acid (zometa), 1 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Infusion, normal saline solution , 1000 cc'),\n",
       " (array([ 0.60051382,  0.60051382,  0.        ,  0.        ,  0.        ,\n",
       "          0.52798324,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Infusion, normal saline solution, sterile (500 ml=1 unit)'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Infusion, normal saline solution , 250 cc'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, carboplatin, 50 mg'),\n",
       " (array([ 0.48893856,  0.48893856,  0.46722982,  0.        ,  0.        ,\n",
       "          0.        ,  0.34618751,  0.42863581,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)'),\n",
       " (array([ 0.70710678,  0.70710678,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria)'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Zoldedronic acid 1mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.78443476,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.62021134]),\n",
       "  'Insertion of needle into vein for collection of blood sample'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'X-ray of chest, 2 views, front and side'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'CT scan chest with contrast'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'CT scan of abdomen and pelvis'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Nuclear medicine study with CT imaging skull base to mid-thigh'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Blood test, basic group of blood chemicals'),\n",
       " (array([ 0.56096825,  0.56096825,  0.        ,  0.60879327,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Blood glucose (sugar) test performed by hand-held instrument'),\n",
       " (array([ 0.38601383,  0.38601383,  0.        ,  0.83784643,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Complete blood cell count (red cells, white blood cell, platelets), automated test'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Blood test, clotting time'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function'),\n",
       " (array([ 0.        ,  0.        ,  0.46382526,  0.        ,  0.47846846,\n",
       "          0.42675171,  0.        ,  0.        ,  0.44761895,  0.        ,\n",
       "          0.        ,  0.        ,  0.41647848]),\n",
       "  'Hydration infusion into a vein 31 minutes to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.62583491,\n",
       "          0.5581896 ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.54475227]),\n",
       "  'Hydration infusion into a vein each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.44715276,  0.        ,  0.4612696 ,\n",
       "          0.41141184,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.50677063,  0.        ,  0.4015079 ]),\n",
       "  'Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.51569755,\n",
       "          0.45995678,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.56656752,  0.        ,  0.44888421]),\n",
       "  'Infusion into a vein for therapy, prevention, or diagnosis each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.36415565,  0.        ,  0.37565223,\n",
       "          0.67009738,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.4127077 ,  0.        ,  0.32698304]),\n",
       "  'Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.54720501,  0.        ,  0.        ,  0.        ,\n",
       "          0.83699861,  0.        ,  0.        ]),\n",
       "  'Injection into tissue or muscle for therapy, diagnosis, or prevention'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.45604233,  0.        ,  0.        ,  0.        ,\n",
       "          0.6975572 ,  0.        ,  0.55266567]),\n",
       "  'Injection of different drug or substance into a vein for therapy'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.71566848,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.69844014]),\n",
       "  'Infusion of additional chemotherapy drug or substance into a vein'),\n",
       " (array([ 0.        ,  0.        ,  0.51869   ,  0.        ,  0.53506531,\n",
       "          0.47723111,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.4657427 ]),\n",
       "  'Infusion of chemotherapy into a vein up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.62583491,\n",
       "          0.5581896 ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.54475227]),\n",
       "  'Infusion of chemotherapy into a vein each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.62583491,\n",
       "          0.5581896 ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.54475227]),\n",
       "  'Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours'),\n",
       " (array([ 0.        ,  0.        ,  0.51869   ,  0.        ,  0.53506531,\n",
       "          0.47723111,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.4657427 ]),\n",
       "  'Infusion of different chemotherapy drug or substance into a vein up to 1 hour'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Irrigation of implanted venous access drug delivery device'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'New patient office or other outpatient visit, typically 30 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'New patient office or other outpatient visit, typically 45 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'New patient office or other outpatient visit, typically 60 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient visit, typically 15 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 25 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Initial hospital inpatient care, typically 70 minutes per day'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Subsequent hospital inpatient care, typically 25 minutes per day'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Subsequent hospital inpatient care, typically 35 minutes per day'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, dexamethasone sodium phosphate, 1mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, palonosetron hcl, 25 mcg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, pegfilgrastim, 6 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, magnesium sulfate, per 500 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Infusion, normal saline solution , 1000 cc'),\n",
       " (array([ 0.60051382,  0.60051382,  0.        ,  0.        ,  0.        ,\n",
       "          0.52798324,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Infusion, normal saline solution, sterile (500 ml=1 unit)'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Infusion, normal saline solution , 250 cc'),\n",
       " (array([ 0.58589116,  0.58589116,  0.55987775,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  '5% dextrose/water (500 ml = 1 unit)'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Cyclophosphamide, 100 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.64676423,  0.        ,  0.        ,\n",
       "          0.        ,  0.47921107,  0.59334036,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, docetaxel, 1 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, fluorouracil, 500 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.78443476,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.62021134]),\n",
       "  'Insertion of needle into vein for collection of blood sample'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Blood test, comprehensive group of blood chemicals'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Manual urinalysis test with examination using microscope'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Stool analysis for blood'),\n",
       " (array([ 0.70710678,  0.70710678,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Carcinoembryonic antigen (CEA) protein level'),\n",
       " (array([ 0.56096825,  0.56096825,  0.        ,  0.60879327,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Ferritin (blood protein) level'),\n",
       " (array([ 0.70710678,  0.70710678,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Lactate dehydrogenase (enzyme) level'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Microscopic examination for white blood cells with manual cell count'),\n",
       " (array([ 0.38601383,  0.38601383,  0.        ,  0.83784643,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Complete blood cell count (red cells, white blood cell, platelets), automated test'),\n",
       " (array([ 0.38601383,  0.38601383,  0.        ,  0.83784643,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Complete blood cell count (red cells, white blood cell, platelets), automated test'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Blood test, clotting time'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Immunologic analysis for detection of tumor antigen'),\n",
       " (array([ 0.        ,  0.        ,  0.46382526,  0.        ,  0.47846846,\n",
       "          0.42675171,  0.        ,  0.        ,  0.44761895,  0.        ,\n",
       "          0.        ,  0.        ,  0.41647848]),\n",
       "  'Hydration infusion into a vein 31 minutes to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.62583491,\n",
       "          0.5581896 ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.54475227]),\n",
       "  'Hydration infusion into a vein each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.44715276,  0.        ,  0.4612696 ,\n",
       "          0.41141184,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.50677063,  0.        ,  0.4015079 ]),\n",
       "  'Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.51569755,\n",
       "          0.45995678,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.56656752,  0.        ,  0.44888421]),\n",
       "  'Infusion into a vein for therapy, prevention, or diagnosis each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.36415565,  0.        ,  0.37565223,\n",
       "          0.67009738,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.4127077 ,  0.        ,  0.32698304]),\n",
       "  'Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.54720501,  0.        ,  0.        ,  0.        ,\n",
       "          0.83699861,  0.        ,  0.        ]),\n",
       "  'Injection into tissue or muscle for therapy, diagnosis, or prevention'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.45604233,  0.        ,  0.        ,  0.        ,\n",
       "          0.6975572 ,  0.        ,  0.55266567]),\n",
       "  'Injection of different drug or substance into a vein for therapy'),\n",
       " (array([ 0.        ,  0.        ,  0.51869   ,  0.        ,  0.53506531,\n",
       "          0.47723111,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.4657427 ]),\n",
       "  'Infusion of chemotherapy into a vein up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.62583491,\n",
       "          0.5581896 ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.54475227]),\n",
       "  'Infusion of chemotherapy into a vein each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.51869   ,  0.        ,  0.53506531,\n",
       "          0.47723111,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.4657427 ]),\n",
       "  'Infusion of different chemotherapy drug or substance into a vein up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'New patient office or other outpatient visit, typically 45 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'New patient office or other outpatient visit, typically 60 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient visit, typically 15 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 25 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 40 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Initial hospital inpatient care, typically 70 minutes per day'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Subsequent hospital inpatient care, typically 25 minutes per day'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Subsequent hospital inpatient care, typically 35 minutes per day'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Administration of influenza virus vaccine'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, dexamethasone sodium phosphate, 1mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, diphenhydramine hcl, up to 50 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, granisetron hydrochloride, 100 mcg'),\n",
       " (array([ 0.        ,  0.        ,  0.64676423,  0.        ,  0.        ,\n",
       "          0.        ,  0.47921107,  0.59334036,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, iron sucrose, 1 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, palonosetron hcl, 25 mcg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, pegfilgrastim, 6 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, ranitidine hydrochloride, 25 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Infusion, normal saline solution , 1000 cc'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, carboplatin, 50 mg'),\n",
       " (array([ 0.70710678,  0.70710678,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.78443476,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.62021134]),\n",
       "  'Insertion of needle into vein for collection of blood sample'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Collection of blood specimen from a completely implantable venous access device'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Needle or trocar bone marrow biopsy'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Blood test, comprehensive group of blood chemicals'),\n",
       " (array([ 0.70710678,  0.70710678,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Carcinoembryonic antigen (CEA) protein level'),\n",
       " (array([ 0.70710678,  0.70710678,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Cyanocobalamin (vitamin B-12) level'),\n",
       " (array([ 0.56096825,  0.56096825,  0.        ,  0.60879327,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Ferritin (blood protein) level'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Folic acid level'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Iron level'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Iron binding capacity'),\n",
       " (array([ 0.70710678,  0.70710678,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Lactate dehydrogenase (enzyme) level'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Magnesium level'),\n",
       " (array([ 0.70710678,  0.70710678,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'PSA (prostate specific antigen) measurement'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Uric acid level, blood'),\n",
       " (array([ 0.38601383,  0.38601383,  0.        ,  0.83784643,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Complete blood cell count (red cells, white blood cell, platelets), automated test'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Blood test, clotting time'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Immunologic analysis for detection of tumor antigen'),\n",
       " (array([ 0.        ,  0.        ,  0.46382526,  0.        ,  0.47846846,\n",
       "          0.42675171,  0.        ,  0.        ,  0.44761895,  0.        ,\n",
       "          0.        ,  0.        ,  0.41647848]),\n",
       "  'Hydration infusion into a vein 31 minutes to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.62583491,\n",
       "          0.5581896 ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.54475227]),\n",
       "  'Hydration infusion into a vein each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.44715276,  0.        ,  0.4612696 ,\n",
       "          0.41141184,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.50677063,  0.        ,  0.4015079 ]),\n",
       "  'Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.51569755,\n",
       "          0.45995678,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.56656752,  0.        ,  0.44888421]),\n",
       "  'Infusion into a vein for therapy, prevention, or diagnosis each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.36415565,  0.        ,  0.37565223,\n",
       "          0.67009738,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.4127077 ,  0.        ,  0.32698304]),\n",
       "  'Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.78629779,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.48427462,  0.        ,  0.3836846 ]),\n",
       "  'Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.54720501,  0.        ,  0.        ,  0.        ,\n",
       "          0.83699861,  0.        ,  0.        ]),\n",
       "  'Injection into tissue or muscle for therapy, diagnosis, or prevention'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.45604233,  0.        ,  0.        ,  0.        ,\n",
       "          0.6975572 ,  0.        ,  0.55266567]),\n",
       "  'Injection of drug or substance into a vein for therapy'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.45604233,  0.        ,  0.        ,  0.        ,\n",
       "          0.6975572 ,  0.        ,  0.55266567]),\n",
       "  'Injection of different drug or substance into a vein for therapy'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Non-hormonal anti-neoplastic chemotherapy into tissue or muscle'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.71566848,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.69844014]),\n",
       "  'Infusion of additional chemotherapy drug or substance into a vein'),\n",
       " (array([ 0.        ,  0.        ,  0.51869   ,  0.        ,  0.53506531,\n",
       "          0.47723111,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.4657427 ]),\n",
       "  'Infusion of chemotherapy into a vein up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.62583491,\n",
       "          0.5581896 ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.54475227]),\n",
       "  'Infusion of chemotherapy into a vein each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.62583491,\n",
       "          0.5581896 ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.54475227]),\n",
       "  'Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours'),\n",
       " (array([ 0.        ,  0.        ,  0.51869   ,  0.        ,  0.53506531,\n",
       "          0.47723111,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.4657427 ]),\n",
       "  'Infusion of different chemotherapy drug or substance into a vein up to 1 hour'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Refilling and maintenance of implantable pump or reservoir for drug delivery'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'New patient office or other outpatient visit, typically 60 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient visit, typically 15 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 25 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 40 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Initial hospital inpatient care, typically 70 minutes per day'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Subsequent hospital inpatient care, typically 25 minutes per day'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Subsequent hospital inpatient care, typically 35 minutes per day'),\n",
       " (array([ 0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Prolonged inpatient or observation hospital service first hour'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Administration of influenza virus vaccine'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, leucovorin calcium, per 50 mg'),\n",
       " (array([ 0.54117412,  0.54117412,  0.51714613,  0.        ,  0.        ,\n",
       "          0.        ,  0.38317232,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, darbepoetin alfa, 1 microgram (non-esrd use)'),\n",
       " (array([ 0.        ,  0.        ,  0.64676423,  0.        ,  0.        ,\n",
       "          0.        ,  0.47921107,  0.59334036,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, denosumab, 1 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, dexamethasone sodium phosphate, 1mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, diphenhydramine hcl, up to 50 mg'),\n",
       " (array([ 0.63228875,  0.63228875,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.44768502,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, filgrastim (g-csf), 480 mcg'),\n",
       " (array([ 0.63228875,  0.63228875,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.44768502,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, heparin sodium, (heparin lock flush), per 10 units'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, heparin sodium, per 1000 units'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, iron dextran, 50 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, palonosetron hcl, 25 mcg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, pegfilgrastim, 6 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, ranitidine hydrochloride, 25 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Infusion, normal saline solution , 1000 cc'),\n",
       " (array([ 0.60051382,  0.60051382,  0.        ,  0.        ,  0.        ,\n",
       "          0.52798324,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Infusion, normal saline solution, sterile (500 ml=1 unit)'),\n",
       " (array([ 0.58589116,  0.58589116,  0.55987775,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  '5% dextrose/normal saline (500 ml = 1 unit)'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Infusion, normal saline solution , 250 cc'),\n",
       " (array([ 0.58589116,  0.58589116,  0.55987775,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  '5% dextrose/water (500 ml = 1 unit)'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, carboplatin, 50 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Cyclophosphamide, 100 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.64676423,  0.        ,  0.        ,\n",
       "          0.        ,  0.47921107,  0.59334036,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, docetaxel, 1 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, fluorouracil, 500 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, gemcitabine hydrochloride, 200 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, oxaliplatin, 0. 5 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, rituximab, 100 mg'),\n",
       " (array([ 0.48893856,  0.48893856,  0.46722982,  0.        ,  0.        ,\n",
       "          0.        ,  0.34618751,  0.42863581,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)'),\n",
       " (array([ 0.70710678,  0.70710678,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.78443476,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.62021134]),\n",
       "  'Insertion of needle into vein for collection of blood sample'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Blood test, comprehensive group of blood chemicals'),\n",
       " (array([ 0.70710678,  0.70710678,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Carcinoembryonic antigen (CEA) protein level'),\n",
       " (array([ 0.70710678,  0.70710678,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Cyanocobalamin (vitamin B-12) level'),\n",
       " (array([ 0.56096825,  0.56096825,  0.        ,  0.60879327,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Ferritin (blood protein) level'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Folic acid level'),\n",
       " (array([ 0.70710678,  0.70710678,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Lactate dehydrogenase (enzyme) level'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Magnesium level'),\n",
       " (array([ 0.70710678,  0.70710678,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'PSA (prostate specific antigen) measurement'),\n",
       " (array([ 0.38601383,  0.38601383,  0.        ,  0.83784643,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Complete blood cell count (red cells, white blood cell, platelets), automated test'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Immunologic analysis for detection of tumor antigen'),\n",
       " (array([ 0.        ,  0.        ,  0.44715276,  0.        ,  0.4612696 ,\n",
       "          0.41141184,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.50677063,  0.        ,  0.4015079 ]),\n",
       "  'Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.36415565,  0.        ,  0.37565223,\n",
       "          0.67009738,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.4127077 ,  0.        ,  0.32698304]),\n",
       "  'Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.54720501,  0.        ,  0.        ,  0.        ,\n",
       "          0.83699861,  0.        ,  0.        ]),\n",
       "  'Injection into tissue or muscle for therapy, diagnosis, or prevention'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.45604233,  0.        ,  0.        ,  0.        ,\n",
       "          0.6975572 ,  0.        ,  0.55266567]),\n",
       "  'Injection of drug or substance into a vein for therapy'),\n",
       " (array([ 0.        ,  0.        ,  0.51869   ,  0.        ,  0.53506531,\n",
       "          0.47723111,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.4657427 ]),\n",
       "  'Infusion of chemotherapy into a vein up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'New patient office or other outpatient visit, typically 60 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient visit, typically 10 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient visit, typically 15 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 25 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 40 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Initial hospital inpatient care, typically 70 minutes per day'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Administration of influenza virus vaccine'),\n",
       " (array([ 0.54117412,  0.54117412,  0.51714613,  0.        ,  0.        ,\n",
       "          0.        ,  0.38317232,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, darbepoetin alfa, 1 microgram (non-esrd use)'),\n",
       " (array([ 0.63228875,  0.63228875,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.44768502,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, epoetin alfa, (for non-esrd use), 1000 units'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, diphenhydramine hcl, up to 50 mg'),\n",
       " (array([ 0.63228875,  0.63228875,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.44768502,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, filgrastim (g-csf), 480 mcg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, iron dextran, 50 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Infusion, normal saline solution , 250 cc'),\n",
       " (array([ 0.70710678,  0.70710678,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.78443476,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.62021134]),\n",
       "  'Insertion of needle into vein for collection of blood sample'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'X-ray of chest, 2 views, front and side'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'CT scan chest'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'CT scan chest with contrast'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'CT scan of abdomen and pelvis'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'CT scan of abdomen and pelvis'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Bone and joint imaging, whole body'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Nuclear medicine study with CT imaging whole body'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Blood test, comprehensive group of blood chemicals'),\n",
       " (array([ 0.56096825,  0.56096825,  0.        ,  0.60879327,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Ferritin (blood protein) level'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Iron level'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Iron binding capacity'),\n",
       " (array([ 0.70710678,  0.70710678,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Lactate dehydrogenase (enzyme) level'),\n",
       " (array([ 0.70710678,  0.70710678,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'PSA (prostate specific antigen) measurement'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Microscopic examination for white blood cells with manual cell count'),\n",
       " (array([ 0.38601383,  0.38601383,  0.        ,  0.83784643,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Complete blood cell count (red cells, white blood cell, platelets), automated test'),\n",
       " (array([ 0.38601383,  0.38601383,  0.        ,  0.83784643,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Complete blood cell count (red cells, white blood cell, platelets), automated test'),\n",
       " (array([ 0.        ,  0.        ,  0.44715276,  0.        ,  0.4612696 ,\n",
       "          0.41141184,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.50677063,  0.        ,  0.4015079 ]),\n",
       "  'Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.54720501,  0.        ,  0.        ,  0.        ,\n",
       "          0.83699861,  0.        ,  0.        ]),\n",
       "  'Injection into tissue or muscle for therapy, diagnosis, or prevention'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.45604233,  0.        ,  0.        ,  0.        ,\n",
       "          0.6975572 ,  0.        ,  0.55266567]),\n",
       "  'Injection of drug or substance into a vein for therapy'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.45604233,  0.        ,  0.        ,  0.        ,\n",
       "          0.6975572 ,  0.        ,  0.55266567]),\n",
       "  'Injection of different drug or substance into a vein for therapy'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Hormonal anti-neoplastic chemotherapy into tissue or muscle'),\n",
       " (array([ 0.        ,  0.        ,  0.51869   ,  0.        ,  0.53506531,\n",
       "          0.47723111,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.4657427 ]),\n",
       "  'Infusion of chemotherapy into a vein up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.62583491,\n",
       "          0.5581896 ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.54475227]),\n",
       "  'Infusion of chemotherapy into a vein each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.51869   ,  0.        ,  0.53506531,\n",
       "          0.47723111,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.4657427 ]),\n",
       "  'Infusion of different chemotherapy drug or substance into a vein up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'New patient office or other outpatient visit, typically 60 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient visit, typically 15 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 25 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 40 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Initial hospital inpatient care, typically 70 minutes per day'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Subsequent hospital inpatient care, typically 15 minutes per day'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Subsequent hospital inpatient care, typically 25 minutes per day'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Subsequent hospital inpatient care, typically 35 minutes per day'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.]),\n",
       "  'Hospital discharge day management, more than 30 minutes'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Technetium tc-99m oxidronate, diagnostic, per study dose, up to 30 millicuries'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Administration of influenza virus vaccine'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, dexamethasone sodium phosphate, 1mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, granisetron hydrochloride, 100 mcg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Infusion, normal saline solution , 1000 cc'),\n",
       " (array([ 0.60099982,  0.60099982,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.52687611,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Leuprolide acetate (for depot suspension), 7. 5 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.64676423,  0.        ,  0.        ,\n",
       "          0.        ,  0.47921107,  0.59334036,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, ipilimumab, 1 mg'),\n",
       " (array([ 0.70710678,  0.70710678,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.78443476,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.62021134]),\n",
       "  'Insertion of needle into vein for collection of blood sample'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Needle or trocar bone marrow biopsy'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'X-ray of chest, 2 views, front and side'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'CT scan chest with contrast'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'CT scan of abdomen and pelvis'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'X-ray survey of forearm or wrist bone density'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Nuclear medicine study with CT imaging whole body'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Blood test, basic group of blood chemicals'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Blood test, comprehensive group of blood chemicals'),\n",
       " (array([ 0.56096825,  0.56096825,  0.        ,  0.60879327,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Ferritin (blood protein) level'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Iron level'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Iron binding capacity'),\n",
       " (array([ 0.70710678,  0.70710678,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Lactate dehydrogenase (enzyme) level'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Uric acid level, blood'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Microscopic examination for white blood cells with manual cell count'),\n",
       " (array([ 0.38601383,  0.38601383,  0.        ,  0.83784643,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Complete blood cell count (red cells, white blood cell, platelets), automated test'),\n",
       " (array([ 0.38601383,  0.38601383,  0.        ,  0.83784643,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Complete blood cell count (red cells, white blood cell, platelets), automated test'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Red blood count, automated test'),\n",
       " (array([ 0.        ,  0.        ,  0.44715276,  0.        ,  0.4612696 ,\n",
       "          0.41141184,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.50677063,  0.        ,  0.4015079 ]),\n",
       "  'Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.51569755,\n",
       "          0.45995678,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.56656752,  0.        ,  0.44888421]),\n",
       "  'Infusion into a vein for therapy, prevention, or diagnosis each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.54720501,  0.        ,  0.        ,  0.        ,\n",
       "          0.83699861,  0.        ,  0.        ]),\n",
       "  'Injection into tissue or muscle for therapy, diagnosis, or prevention'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.45604233,  0.        ,  0.        ,  0.        ,\n",
       "          0.6975572 ,  0.        ,  0.55266567]),\n",
       "  'Injection of drug or substance into a vein for therapy'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.45604233,  0.        ,  0.        ,  0.        ,\n",
       "          0.6975572 ,  0.        ,  0.55266567]),\n",
       "  'Injection of different drug or substance into a vein for therapy'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Non-hormonal anti-neoplastic chemotherapy into tissue or muscle'),\n",
       " (array([ 0.        ,  0.        ,  0.51869   ,  0.        ,  0.53506531,\n",
       "          0.47723111,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.4657427 ]),\n",
       "  'Infusion of chemotherapy into a vein up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.62583491,\n",
       "          0.5581896 ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.54475227]),\n",
       "  'Infusion of chemotherapy into a vein each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.51869   ,  0.        ,  0.53506531,\n",
       "          0.47723111,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.4657427 ]),\n",
       "  'Infusion of different chemotherapy drug or substance into a vein up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'New patient office or other outpatient visit, typically 45 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'New patient office or other outpatient visit, typically 60 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient visit, typically 15 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 25 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 40 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Initial hospital inpatient care, typically 70 minutes per day'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Subsequent hospital inpatient care, typically 25 minutes per day'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Subsequent hospital inpatient care, typically 35 minutes per day'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Administration of influenza virus vaccine'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, dexamethasone sodium phosphate, 1mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, diphenhydramine hcl, up to 50 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.64676423,  0.        ,  0.        ,\n",
       "          0.        ,  0.47921107,  0.59334036,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, iron sucrose, 1 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, pamidronate disodium, per 30 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, pegfilgrastim, 6 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.64676423,  0.        ,  0.        ,\n",
       "          0.        ,  0.47921107,  0.59334036,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, bortezomib, 0. 1 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, rituximab, 100 mg'),\n",
       " (array([ 0.70710678,  0.70710678,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.78443476,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.62021134]),\n",
       "  'Insertion of needle into vein for collection of blood sample'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'CT scan chest with contrast'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'CT scan of abdomen and pelvis'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Nuclear medicine study with CT imaging skull base to mid-thigh'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Blood test, comprehensive group of blood chemicals'),\n",
       " (array([ 0.70710678,  0.70710678,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Carcinoembryonic antigen (CEA) protein level'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Microscopic examination for white blood cells with manual cell count'),\n",
       " (array([ 0.38601383,  0.38601383,  0.        ,  0.83784643,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Complete blood cell count (red cells, white blood cell, platelets), automated test'),\n",
       " (array([ 0.38601383,  0.38601383,  0.        ,  0.83784643,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Complete blood cell count (red cells, white blood cell, platelets), automated test'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.62583491,\n",
       "          0.5581896 ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.54475227]),\n",
       "  'Hydration infusion into a vein each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.44715276,  0.        ,  0.4612696 ,\n",
       "          0.41141184,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.50677063,  0.        ,  0.4015079 ]),\n",
       "  'Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.36415565,  0.        ,  0.37565223,\n",
       "          0.67009738,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.4127077 ,  0.        ,  0.32698304]),\n",
       "  'Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.54720501,  0.        ,  0.        ,  0.        ,\n",
       "          0.83699861,  0.        ,  0.        ]),\n",
       "  'Injection into tissue or muscle for therapy, diagnosis, or prevention'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.45604233,  0.        ,  0.        ,  0.        ,\n",
       "          0.6975572 ,  0.        ,  0.55266567]),\n",
       "  'Injection of different drug or substance into a vein for therapy'),\n",
       " (array([ 0.        ,  0.        ,  0.51869   ,  0.        ,  0.53506531,\n",
       "          0.47723111,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.4657427 ]),\n",
       "  'Infusion of chemotherapy into a vein up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.62583491,\n",
       "          0.5581896 ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.54475227]),\n",
       "  'Infusion of chemotherapy into a vein each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.62583491,\n",
       "          0.5581896 ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.54475227]),\n",
       "  'Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours'),\n",
       " (array([ 0.        ,  0.        ,  0.51869   ,  0.        ,  0.53506531,\n",
       "          0.47723111,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.4657427 ]),\n",
       "  'Infusion of different chemotherapy drug or substance into a vein up to 1 hour'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Refilling and maintenance of portable pump'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'New patient office or other outpatient visit, typically 60 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient visit, typically 5 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient visit, typically 15 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 25 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 40 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Initial hospital inpatient care, typically 70 minutes per day'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Subsequent hospital inpatient care, typically 35 minutes per day'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.]),\n",
       "  'Hospital discharge day management, 30 minutes or less'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, atropine sulfate, 0. 01 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, calcium gluconate, per 10 ml'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, dexamethasone sodium phosphate, 1mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, granisetron hydrochloride, 100 mcg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, palonosetron hcl, 25 mcg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, magnesium sulfate, per 500 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Infusion, normal saline solution , 1000 cc'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, gemcitabine hydrochloride, 200 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, irinotecan, 20 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, oxaliplatin, 0. 5 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.78443476,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.62021134]),\n",
       "  'Insertion of needle into vein for collection of blood sample'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Needle or trocar bone marrow biopsy'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'CT scan chest with contrast'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'X-ray of upper arm, minimum of 2 views'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'CT scan of abdomen and pelvis'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'X-ray survey of forearm or wrist bone density'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Nuclear medicine study with CT imaging skull base to mid-thigh'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Blood test, basic group of blood chemicals'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Blood test, comprehensive group of blood chemicals'),\n",
       " (array([ 0.56096825,  0.56096825,  0.        ,  0.60879327,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Ferritin (blood protein) level'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Iron level'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Iron binding capacity'),\n",
       " (array([ 0.70710678,  0.70710678,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Lactate dehydrogenase (enzyme) level'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Uric acid level, blood'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Microscopic examination for white blood cells with manual cell count'),\n",
       " (array([ 0.38601383,  0.38601383,  0.        ,  0.83784643,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Complete blood cell count (red cells, white blood cell, platelets), automated test'),\n",
       " (array([ 0.38601383,  0.38601383,  0.        ,  0.83784643,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Complete blood cell count (red cells, white blood cell, platelets), automated test'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Red blood count, automated test'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Flow cytometry technique for DNA or cell analysis'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Flow cytometry technique for DNA or cell analysis'),\n",
       " (array([ 0.        ,  0.        ,  0.44715276,  0.        ,  0.4612696 ,\n",
       "          0.41141184,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.50677063,  0.        ,  0.4015079 ]),\n",
       "  'Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.51569755,\n",
       "          0.45995678,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.56656752,  0.        ,  0.44888421]),\n",
       "  'Infusion into a vein for therapy, prevention, or diagnosis each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.54720501,  0.        ,  0.        ,  0.        ,\n",
       "          0.83699861,  0.        ,  0.        ]),\n",
       "  'Injection into tissue or muscle for therapy, diagnosis, or prevention'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.45604233,  0.        ,  0.        ,  0.        ,\n",
       "          0.6975572 ,  0.        ,  0.55266567]),\n",
       "  'Injection of different drug or substance into a vein for therapy'),\n",
       " (array([ 0.        ,  0.        ,  0.51869   ,  0.        ,  0.53506531,\n",
       "          0.47723111,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.4657427 ]),\n",
       "  'Infusion of chemotherapy into a vein up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.62583491,\n",
       "          0.5581896 ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.54475227]),\n",
       "  'Infusion of chemotherapy into a vein each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'New patient office or other outpatient visit, typically 60 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient visit, typically 15 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 25 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 40 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Initial hospital inpatient care, typically 70 minutes per day'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Subsequent hospital inpatient care, typically 25 minutes per day'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Subsequent hospital inpatient care, typically 35 minutes per day'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Administration of influenza virus vaccine'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service'),\n",
       " (array([ 0.54117412,  0.54117412,  0.51714613,  0.        ,  0.        ,\n",
       "          0.        ,  0.38317232,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, darbepoetin alfa, 1 microgram (non-esrd use)'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, dexamethasone sodium phosphate, 1mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, diphenhydramine hcl, up to 50 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, granisetron hydrochloride, 100 mcg'),\n",
       " (array([ 0.        ,  0.        ,  0.64676423,  0.        ,  0.        ,\n",
       "          0.        ,  0.47921107,  0.59334036,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, iron sucrose, 1 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, pamidronate disodium, per 30 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, rituximab, 100 mg'),\n",
       " (array([ 0.70710678,  0.70710678,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.78443476,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.62021134]),\n",
       "  'Insertion of needle into vein for collection of blood sample'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'X-ray of chest, 2 views, front and side'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'CT scan chest'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'CT scan chest with contrast'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'CT scan of abdomen and pelvis'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'CT scan of abdomen and pelvis'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Nuclear medicine study with CT imaging skull base to mid-thigh'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Blood test, comprehensive group of blood chemicals'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Manual urinalysis test with examination using microscope'),\n",
       " (array([ 0.70710678,  0.70710678,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Carcinoembryonic antigen (CEA) protein level'),\n",
       " (array([ 0.56096825,  0.56096825,  0.        ,  0.60879327,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Ferritin (blood protein) level'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Iron level'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Iron binding capacity'),\n",
       " (array([ 0.70710678,  0.70710678,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Lactate dehydrogenase (enzyme) level'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Microscopic examination for white blood cells with manual cell count'),\n",
       " (array([ 0.38601383,  0.38601383,  0.        ,  0.83784643,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Complete blood cell count (red cells, white blood cell, platelets), automated test'),\n",
       " (array([ 0.38601383,  0.38601383,  0.        ,  0.83784643,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Complete blood cell count (red cells, white blood cell, platelets), automated test'),\n",
       " (array([ 0.        ,  0.        ,  0.46382526,  0.        ,  0.47846846,\n",
       "          0.42675171,  0.        ,  0.        ,  0.44761895,  0.        ,\n",
       "          0.        ,  0.        ,  0.41647848]),\n",
       "  'Hydration infusion into a vein 31 minutes to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.62583491,\n",
       "          0.5581896 ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.54475227]),\n",
       "  'Hydration infusion into a vein each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.44715276,  0.        ,  0.4612696 ,\n",
       "          0.41141184,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.50677063,  0.        ,  0.4015079 ]),\n",
       "  'Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.36415565,  0.        ,  0.37565223,\n",
       "          0.67009738,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.4127077 ,  0.        ,  0.32698304]),\n",
       "  'Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.78629779,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.48427462,  0.        ,  0.3836846 ]),\n",
       "  'Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.54720501,  0.        ,  0.        ,  0.        ,\n",
       "          0.83699861,  0.        ,  0.        ]),\n",
       "  'Injection into tissue or muscle for therapy, diagnosis, or prevention'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.45604233,  0.        ,  0.        ,  0.        ,\n",
       "          0.6975572 ,  0.        ,  0.55266567]),\n",
       "  'Injection of drug or substance into a vein for therapy'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.45604233,  0.        ,  0.        ,  0.        ,\n",
       "          0.6975572 ,  0.        ,  0.55266567]),\n",
       "  'Injection of different drug or substance into a vein for therapy'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.71566848,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.69844014]),\n",
       "  'Infusion of chemotherapy into a vein using push technique'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.71566848,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.69844014]),\n",
       "  'Infusion of additional chemotherapy drug or substance into a vein'),\n",
       " (array([ 0.        ,  0.        ,  0.51869   ,  0.        ,  0.53506531,\n",
       "          0.47723111,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.4657427 ]),\n",
       "  'Infusion of chemotherapy into a vein up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.62583491,\n",
       "          0.5581896 ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.54475227]),\n",
       "  'Infusion of chemotherapy into a vein each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.62583491,\n",
       "          0.5581896 ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.54475227]),\n",
       "  'Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours'),\n",
       " (array([ 0.        ,  0.        ,  0.51869   ,  0.        ,  0.53506531,\n",
       "          0.47723111,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.4657427 ]),\n",
       "  'Infusion of different chemotherapy drug or substance into a vein up to 1 hour'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Refilling and maintenance of portable pump'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'New patient office or other outpatient visit, typically 60 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient visit, typically 5 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient visit, typically 15 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 25 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 40 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Initial hospital inpatient care, typically 70 minutes per day'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Subsequent hospital inpatient care, typically 25 minutes per day'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Subsequent hospital inpatient care, typically 35 minutes per day'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.]),\n",
       "  'Hospital discharge day management, more than 30 minutes'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Administration of influenza virus vaccine'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, levoleucovorin calcium, 0. 5 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, dexamethasone sodium phosphate, 1mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, granisetron hydrochloride, 100 mcg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, palonosetron hcl, 25 mcg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Infusion, normal saline solution , 1000 cc'),\n",
       " (array([ 0.60051382,  0.60051382,  0.        ,  0.        ,  0.        ,\n",
       "          0.52798324,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Infusion, normal saline solution, sterile (500 ml=1 unit)'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, bevacizumab, 10 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, fluorouracil, 500 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, gemcitabine hydrochloride, 200 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, oxaliplatin, 0. 5 mg'),\n",
       " (array([ 0.70710678,  0.70710678,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.78443476,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.62021134]),\n",
       "  'Insertion of needle into vein for collection of blood sample'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'CT scan chest'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'CT scan chest with contrast'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'CT scan of abdomen and pelvis'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'CT scan of abdomen and pelvis'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Bone and joint imaging, whole body'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Blood test, comprehensive group of blood chemicals'),\n",
       " (array([ 0.70710678,  0.70710678,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'PSA (prostate specific antigen) measurement'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Microscopic examination for white blood cells with manual cell count'),\n",
       " (array([ 0.38601383,  0.38601383,  0.        ,  0.83784643,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Complete blood cell count (red cells, white blood cell, platelets), automated test'),\n",
       " (array([ 0.38601383,  0.38601383,  0.        ,  0.83784643,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Complete blood cell count (red cells, white blood cell, platelets), automated test'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.62583491,\n",
       "          0.5581896 ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.54475227]),\n",
       "  'Hydration infusion into a vein each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.44715276,  0.        ,  0.4612696 ,\n",
       "          0.41141184,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.50677063,  0.        ,  0.4015079 ]),\n",
       "  'Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.54720501,  0.        ,  0.        ,  0.        ,\n",
       "          0.83699861,  0.        ,  0.        ]),\n",
       "  'Injection into tissue or muscle for therapy, diagnosis, or prevention'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.45604233,  0.        ,  0.        ,  0.        ,\n",
       "          0.6975572 ,  0.        ,  0.55266567]),\n",
       "  'Injection of drug or substance into a vein for therapy'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.45604233,  0.        ,  0.        ,  0.        ,\n",
       "          0.6975572 ,  0.        ,  0.55266567]),\n",
       "  'Injection of different drug or substance into a vein for therapy'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Hormonal anti-neoplastic chemotherapy into tissue or muscle'),\n",
       " (array([ 0.        ,  0.        ,  0.51869   ,  0.        ,  0.53506531,\n",
       "          0.47723111,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.4657427 ]),\n",
       "  'Infusion of chemotherapy into a vein up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.51869   ,  0.        ,  0.53506531,\n",
       "          0.47723111,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.4657427 ]),\n",
       "  'Infusion of different chemotherapy drug or substance into a vein up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'New patient office or other outpatient visit, typically 60 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 25 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 40 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Initial hospital inpatient care, typically 70 minutes per day'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Subsequent hospital inpatient care, typically 25 minutes per day'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.]),\n",
       "  'Hospital discharge day management, more than 30 minutes'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Technetium tc-99m oxidronate, diagnostic, per study dose, up to 30 millicuries'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Administration of influenza virus vaccine'),\n",
       " (array([ 0.        ,  0.        ,  0.64676423,  0.        ,  0.        ,\n",
       "          0.        ,  0.47921107,  0.59334036,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, denosumab, 1 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, dexamethasone sodium phosphate, 1mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, diphenhydramine hcl, up to 50 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, granisetron hydrochloride, 100 mcg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, pegfilgrastim, 6 mg'),\n",
       " (array([ 0.48893856,  0.48893856,  0.46722982,  0.        ,  0.        ,\n",
       "          0.        ,  0.34618751,  0.42863581,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, zoledronic acid (zometa), 1 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Infusion, normal saline solution , 1000 cc'),\n",
       " (array([ 0.        ,  0.        ,  0.64676423,  0.        ,  0.        ,\n",
       "          0.        ,  0.47921107,  0.59334036,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, docetaxel, 1 mg'),\n",
       " (array([ 0.60099982,  0.60099982,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.52687611,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Leuprolide acetate (for depot suspension), 7. 5 mg'),\n",
       " (array([ 0.70710678,  0.70710678,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Zoldedronic acid 1mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.78443476,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.62021134]),\n",
       "  'Insertion of needle into vein for collection of blood sample'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Needle or trocar bone marrow biopsy'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Needle or trocar bone marrow biopsy'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'X-ray of chest, 2 views, front and side'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'CT scan chest with contrast'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'X-ray of upper arm, minimum of 2 views'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'CT scan of abdomen and pelvis'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'X-ray survey of forearm or wrist bone density'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Nuclear medicine study with CT imaging skull base to mid-thigh'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Blood test, comprehensive group of blood chemicals'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Manual urinalysis test with examination using microscope'),\n",
       " (array([ 0.56096825,  0.56096825,  0.        ,  0.60879327,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Ferritin (blood protein) level'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Iron level'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Iron binding capacity'),\n",
       " (array([ 0.70710678,  0.70710678,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Lactate dehydrogenase (enzyme) level'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Uric acid level, blood'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Microscopic examination for white blood cells with manual cell count'),\n",
       " (array([ 0.38601383,  0.38601383,  0.        ,  0.83784643,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Complete blood cell count (red cells, white blood cell, platelets), automated test'),\n",
       " (array([ 0.38601383,  0.38601383,  0.        ,  0.83784643,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Complete blood cell count (red cells, white blood cell, platelets), automated test'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Red blood count, automated test'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Blood test, clotting time'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Red blood cell sedimentation rate, to detect inflammation'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Flow cytometry technique for DNA or cell analysis'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Flow cytometry technique for DNA or cell analysis'),\n",
       " (array([ 0.        ,  0.        ,  0.44715276,  0.        ,  0.4612696 ,\n",
       "          0.41141184,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.50677063,  0.        ,  0.4015079 ]),\n",
       "  'Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.51569755,\n",
       "          0.45995678,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.56656752,  0.        ,  0.44888421]),\n",
       "  'Infusion into a vein for therapy, prevention, or diagnosis each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.36415565,  0.        ,  0.37565223,\n",
       "          0.67009738,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.4127077 ,  0.        ,  0.32698304]),\n",
       "  'Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.54720501,  0.        ,  0.        ,  0.        ,\n",
       "          0.83699861,  0.        ,  0.        ]),\n",
       "  'Injection into tissue or muscle for therapy, diagnosis, or prevention'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.45604233,  0.        ,  0.        ,  0.        ,\n",
       "          0.6975572 ,  0.        ,  0.55266567]),\n",
       "  'Injection of drug or substance into a vein for therapy'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.45604233,  0.        ,  0.        ,  0.        ,\n",
       "          0.6975572 ,  0.        ,  0.55266567]),\n",
       "  'Injection of different drug or substance into a vein for therapy'),\n",
       " (array([ 0.        ,  0.        ,  0.51869   ,  0.        ,  0.53506531,\n",
       "          0.47723111,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.4657427 ]),\n",
       "  'Infusion of chemotherapy into a vein up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.62583491,\n",
       "          0.5581896 ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.54475227]),\n",
       "  'Infusion of chemotherapy into a vein each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.51869   ,  0.        ,  0.53506531,\n",
       "          0.47723111,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.4657427 ]),\n",
       "  'Infusion of different chemotherapy drug or substance into a vein up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'New patient office or other outpatient visit, typically 60 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 25 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 40 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Hospital observation care typically 70 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Initial hospital inpatient care, typically 70 minutes per day'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Subsequent hospital inpatient care, typically 25 minutes per day'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Subsequent hospital inpatient care, typically 35 minutes per day'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Administration of influenza virus vaccine'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service'),\n",
       " (array([ 0.54117412,  0.54117412,  0.51714613,  0.        ,  0.        ,\n",
       "          0.        ,  0.38317232,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, darbepoetin alfa, 1 microgram (non-esrd use)'),\n",
       " (array([ 0.63228875,  0.63228875,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.44768502,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, epoetin alfa, (for non-esrd use), 1000 units'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, dexamethasone sodium phosphate, 1mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, diphenhydramine hcl, up to 50 mg'),\n",
       " (array([ 0.65689106,  0.65689106,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.23255221,  0.28793703,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e. g. liquid), 500 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, granisetron hydrochloride, 100 mcg'),\n",
       " (array([ 0.        ,  0.        ,  0.64676423,  0.        ,  0.        ,\n",
       "          0.        ,  0.47921107,  0.59334036,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, iron sucrose, 1 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, rituximab, 100 mg'),\n",
       " (array([ 0.70710678,  0.70710678,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Collection of blood specimen from a completely implantable venous access device'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'CT scan chest with contrast'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'CT scan of abdomen and pelvis'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Nuclear medicine study with CT imaging skull base to mid-thigh'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Nuclear medicine study with CT imaging whole body'),\n",
       " (array([ 0.        ,  0.        ,  0.46382526,  0.        ,  0.47846846,\n",
       "          0.42675171,  0.        ,  0.        ,  0.44761895,  0.        ,\n",
       "          0.        ,  0.        ,  0.41647848]),\n",
       "  'Hydration infusion into a vein 31 minutes to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.62583491,\n",
       "          0.5581896 ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.54475227]),\n",
       "  'Hydration infusion into a vein each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.44715276,  0.        ,  0.4612696 ,\n",
       "          0.41141184,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.50677063,  0.        ,  0.4015079 ]),\n",
       "  'Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.51569755,\n",
       "          0.45995678,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.56656752,  0.        ,  0.44888421]),\n",
       "  'Infusion into a vein for therapy, prevention, or diagnosis each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.36415565,  0.        ,  0.37565223,\n",
       "          0.67009738,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.4127077 ,  0.        ,  0.32698304]),\n",
       "  'Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.54720501,  0.        ,  0.        ,  0.        ,\n",
       "          0.83699861,  0.        ,  0.        ]),\n",
       "  'Injection into tissue or muscle for therapy, diagnosis, or prevention'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.45604233,  0.        ,  0.        ,  0.        ,\n",
       "          0.6975572 ,  0.        ,  0.55266567]),\n",
       "  'Injection of different drug or substance into a vein for therapy'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Non-hormonal anti-neoplastic chemotherapy into tissue or muscle'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.71566848,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.69844014]),\n",
       "  'Infusion of additional chemotherapy drug or substance into a vein'),\n",
       " (array([ 0.        ,  0.        ,  0.51869   ,  0.        ,  0.53506531,\n",
       "          0.47723111,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.4657427 ]),\n",
       "  'Infusion of chemotherapy into a vein up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.62583491,\n",
       "          0.5581896 ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.54475227]),\n",
       "  'Infusion of chemotherapy into a vein each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.51869   ,  0.        ,  0.53506531,\n",
       "          0.47723111,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.4657427 ]),\n",
       "  'Infusion of different chemotherapy drug or substance into a vein up to 1 hour'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Irrigation of implanted venous access drug delivery device'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'New patient office or other outpatient visit, typically 45 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'New patient office or other outpatient visit, typically 60 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient visit, typically 15 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 25 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 40 minutes'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries'),\n",
       " (array([ 0.54117412,  0.54117412,  0.51714613,  0.        ,  0.        ,\n",
       "          0.        ,  0.38317232,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, darbepoetin alfa, 1 microgram (non-esrd use)'),\n",
       " (array([ 0.63228875,  0.63228875,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.44768502,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, epoetin alfa, (for non-esrd use), 1000 units'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, dexamethasone sodium phosphate, 1mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, diphenhydramine hcl, up to 50 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.64676423,  0.        ,  0.        ,\n",
       "          0.        ,  0.47921107,  0.59334036,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, fosaprepitant, 1 mg'),\n",
       " (array([ 0.63228875,  0.63228875,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.44768502,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, heparin sodium, (heparin lock flush), per 10 units'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, lorazepam, 2 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.64676423,  0.        ,  0.        ,\n",
       "          0.        ,  0.47921107,  0.59334036,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, ondansetron hydrochloride, per 1 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, palonosetron hcl, 25 mcg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, pegfilgrastim, 6 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, magnesium sulfate, per 500 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, potassium chloride, per 2 meq'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Infusion, normal saline solution , 1000 cc'),\n",
       " (array([ 0.60051382,  0.60051382,  0.        ,  0.        ,  0.        ,\n",
       "          0.52798324,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Infusion, normal saline solution, sterile (500 ml=1 unit)'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Infusion, normal saline solution , 250 cc'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, bevacizumab, 10 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, carboplatin, 50 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.64676423,  0.        ,  0.        ,\n",
       "          0.        ,  0.47921107,  0.59334036,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, docetaxel, 1 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.78443476,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.62021134]),\n",
       "  'Insertion of needle into vein for collection of blood sample'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Blood test, basic group of blood chemicals'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Blood test, comprehensive group of blood chemicals'),\n",
       " (array([ 0.70710678,  0.70710678,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Carcinoembryonic antigen (CEA) protein level'),\n",
       " (array([ 0.70710678,  0.70710678,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Cyanocobalamin (vitamin B-12) level'),\n",
       " (array([ 0.56096825,  0.56096825,  0.        ,  0.60879327,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Ferritin (blood protein) level'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Folic acid level'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Iron level'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Iron binding capacity'),\n",
       " (array([ 0.70710678,  0.70710678,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Lactate dehydrogenase (enzyme) level'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Magnesium level'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Phosphate level'),\n",
       " (array([ 0.56096825,  0.56096825,  0.        ,  0.60879327,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Blood test, thyroid stimulating hormone (TSH)'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Uric acid level, blood'),\n",
       " (array([ 0.38601383,  0.38601383,  0.        ,  0.83784643,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Complete blood cell count (red cells, white blood cell, platelets), automated test'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Immunologic analysis for detection of tumor antigen'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Immunologic analysis for detection of tumor antigen'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.54238587,  0.        ,  0.        ,  0.8401295 ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Vaccine for pneumococcal polysaccharide for injection into muscle, patient 2 years or older'),\n",
       " (array([ 0.        ,  0.        ,  0.46382526,  0.        ,  0.47846846,\n",
       "          0.42675171,  0.        ,  0.        ,  0.44761895,  0.        ,\n",
       "          0.        ,  0.        ,  0.41647848]),\n",
       "  'Hydration infusion into a vein 31 minutes to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.62583491,\n",
       "          0.5581896 ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.54475227]),\n",
       "  'Hydration infusion into a vein each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.44715276,  0.        ,  0.4612696 ,\n",
       "          0.41141184,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.50677063,  0.        ,  0.4015079 ]),\n",
       "  'Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.51569755,\n",
       "          0.45995678,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.56656752,  0.        ,  0.44888421]),\n",
       "  'Infusion into a vein for therapy, prevention, or diagnosis each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.36415565,  0.        ,  0.37565223,\n",
       "          0.67009738,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.4127077 ,  0.        ,  0.32698304]),\n",
       "  'Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.54720501,  0.        ,  0.        ,  0.        ,\n",
       "          0.83699861,  0.        ,  0.        ]),\n",
       "  'Injection into tissue or muscle for therapy, diagnosis, or prevention'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.45604233,  0.        ,  0.        ,  0.        ,\n",
       "          0.6975572 ,  0.        ,  0.55266567]),\n",
       "  'Injection of different drug or substance into a vein for therapy'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.71566848,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.69844014]),\n",
       "  'Infusion of additional chemotherapy drug or substance into a vein'),\n",
       " (array([ 0.        ,  0.        ,  0.51869   ,  0.        ,  0.53506531,\n",
       "          0.47723111,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.4657427 ]),\n",
       "  'Infusion of chemotherapy into a vein up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.62583491,\n",
       "          0.5581896 ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.54475227]),\n",
       "  'Infusion of chemotherapy into a vein each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.62583491,\n",
       "          0.5581896 ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.54475227]),\n",
       "  'Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours'),\n",
       " (array([ 0.        ,  0.        ,  0.51869   ,  0.        ,  0.53506531,\n",
       "          0.47723111,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.4657427 ]),\n",
       "  'Infusion of different chemotherapy drug or substance into a vein up to 1 hour'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Irrigation of implanted venous access drug delivery device'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'New patient office or other outpatient visit, typically 60 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient visit, typically 10 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient visit, typically 15 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 25 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 40 minutes'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.]),\n",
       "  'Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Administration of influenza virus vaccine'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Administration of pneumococcal vaccine'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, calcium gluconate, per 10 ml'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, cefepime hydrochloride, 500 mg'),\n",
       " (array([ 0.63228875,  0.63228875,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.44768502,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, epoetin alfa, (for non-esrd use), 1000 units'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, dexamethasone sodium phosphate, 1mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, diphenhydramine hcl, up to 50 mg'),\n",
       " (array([ 0.65689106,  0.65689106,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.23255221,  0.28793703,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, immune globulin, (gammagard liquid), non-lyophilized, (e. g. liquid), 500 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, granisetron hydrochloride, 100 mcg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, fondaparinux sodium, 0. 5 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, hydrocortisone sodium succinate, up to 100 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.64676423,  0.        ,  0.        ,\n",
       "          0.        ,  0.47921107,  0.59334036,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, iron sucrose, 1 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, furosemide, up to 20 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, lorazepam, 2 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, pegfilgrastim, 6 mg'),\n",
       " (array([ 0.63228875,  0.63228875,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.44768502,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, sargramostim (gm-csf), 50 mcg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, magnesium sulfate, per 500 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, potassium chloride, per 2 meq'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Unclassified drugs'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Infusion, normal saline solution , 1000 cc'),\n",
       " (array([ 0.58589116,  0.58589116,  0.55987775,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  '5% dextrose/normal saline (500 ml = 1 unit)'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Infusion, normal saline solution , 250 cc'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, carboplatin, 50 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, fluorouracil, 500 mg'),\n",
       " (array([ 0.70710678,  0.70710678,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Zoldedronic acid 1mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.78443476,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.62021134]),\n",
       "  'Insertion of needle into vein for collection of blood sample'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Collection of blood specimen from a completely implantable venous access device'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Needle or trocar bone marrow biopsy'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Blood test, clotting time'),\n",
       " (array([ 0.        ,  0.        ,  0.46382526,  0.        ,  0.47846846,\n",
       "          0.42675171,  0.        ,  0.        ,  0.44761895,  0.        ,\n",
       "          0.        ,  0.        ,  0.41647848]),\n",
       "  'Hydration infusion into a vein 31 minutes to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.62583491,\n",
       "          0.5581896 ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.54475227]),\n",
       "  'Hydration infusion into a vein each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.44715276,  0.        ,  0.4612696 ,\n",
       "          0.41141184,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.50677063,  0.        ,  0.4015079 ]),\n",
       "  'Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.51569755,\n",
       "          0.45995678,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.56656752,  0.        ,  0.44888421]),\n",
       "  'Infusion into a vein for therapy, prevention, or diagnosis each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.36415565,  0.        ,  0.37565223,\n",
       "          0.67009738,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.4127077 ,  0.        ,  0.32698304]),\n",
       "  'Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.54720501,  0.        ,  0.        ,  0.        ,\n",
       "          0.83699861,  0.        ,  0.        ]),\n",
       "  'Injection into tissue or muscle for therapy, diagnosis, or prevention'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.45604233,  0.        ,  0.        ,  0.        ,\n",
       "          0.6975572 ,  0.        ,  0.55266567]),\n",
       "  'Injection of drug or substance into a vein for therapy'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.45604233,  0.        ,  0.        ,  0.        ,\n",
       "          0.6975572 ,  0.        ,  0.55266567]),\n",
       "  'Injection of different drug or substance into a vein for therapy'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Non-hormonal anti-neoplastic chemotherapy into tissue or muscle'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Hormonal anti-neoplastic chemotherapy into tissue or muscle'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.71566848,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.69844014]),\n",
       "  'Infusion of additional chemotherapy drug or substance into a vein'),\n",
       " (array([ 0.        ,  0.        ,  0.51869   ,  0.        ,  0.53506531,\n",
       "          0.47723111,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.4657427 ]),\n",
       "  'Infusion of chemotherapy into a vein up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.62583491,\n",
       "          0.5581896 ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.54475227]),\n",
       "  'Infusion of chemotherapy into a vein each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.62583491,\n",
       "          0.5581896 ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.54475227]),\n",
       "  'Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours'),\n",
       " (array([ 0.        ,  0.        ,  0.51869   ,  0.        ,  0.53506531,\n",
       "          0.47723111,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.4657427 ]),\n",
       "  'Infusion of different chemotherapy drug or substance into a vein up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'New patient office or other outpatient visit, typically 60 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient visit, typically 15 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 25 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Initial hospital inpatient care, typically 70 minutes per day'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Subsequent hospital inpatient care, typically 15 minutes per day'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Subsequent hospital inpatient care, typically 25 minutes per day'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.]),\n",
       "  'Hospital discharge day management, more than 30 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, levoleucovorin calcium, 0. 5 mg'),\n",
       " (array([ 0.54117412,  0.54117412,  0.51714613,  0.        ,  0.        ,\n",
       "          0.        ,  0.38317232,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, darbepoetin alfa, 1 microgram (non-esrd use)'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, dexamethasone sodium phosphate, 1mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, diphenhydramine hcl, up to 50 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.64676423,  0.        ,  0.        ,\n",
       "          0.        ,  0.47921107,  0.59334036,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, fosaprepitant, 1 mg'),\n",
       " (array([ 0.65689106,  0.65689106,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.23255221,  0.28793703,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, immune globulin, (octagam), intravenous, non-lyophilized (e. g. liquid), 500 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, granisetron hydrochloride, 100 mcg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, iron dextran, 50 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, palonosetron hcl, 25 mcg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, pegfilgrastim, 6 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg'),\n",
       " (array([ 0.48893856,  0.48893856,  0.46722982,  0.        ,  0.        ,\n",
       "          0.        ,  0.34618751,  0.42863581,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, zoledronic acid (zometa), 1 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Infusion, normal saline solution , 1000 cc'),\n",
       " (array([ 0.        ,  0.        ,  0.64676423,  0.        ,  0.        ,\n",
       "          0.        ,  0.47921107,  0.59334036,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, bortezomib, 0. 1 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, carboplatin, 50 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Cyclophosphamide, 100 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.64676423,  0.        ,  0.        ,\n",
       "          0.        ,  0.47921107,  0.59334036,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, docetaxel, 1 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, etoposide, 10 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, fluorouracil, 500 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, paclitaxel, 30 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Zoldedronic acid 1mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.78443476,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.62021134]),\n",
       "  'Insertion of needle into vein for collection of blood sample'),\n",
       " (array([ 0.38601383,  0.38601383,  0.        ,  0.83784643,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Complete blood cell count (red cells, white blood cell, platelets), automated test'),\n",
       " (array([ 0.        ,  0.        ,  0.46382526,  0.        ,  0.47846846,\n",
       "          0.42675171,  0.        ,  0.        ,  0.44761895,  0.        ,\n",
       "          0.        ,  0.        ,  0.41647848]),\n",
       "  'Hydration infusion into a vein 31 minutes to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.62583491,\n",
       "          0.5581896 ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.54475227]),\n",
       "  'Hydration infusion into a vein each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.44715276,  0.        ,  0.4612696 ,\n",
       "          0.41141184,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.50677063,  0.        ,  0.4015079 ]),\n",
       "  'Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.51569755,\n",
       "          0.45995678,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.56656752,  0.        ,  0.44888421]),\n",
       "  'Infusion into a vein for therapy, prevention, or diagnosis each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.36415565,  0.        ,  0.37565223,\n",
       "          0.67009738,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.4127077 ,  0.        ,  0.32698304]),\n",
       "  'Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.54720501,  0.        ,  0.        ,  0.        ,\n",
       "          0.83699861,  0.        ,  0.        ]),\n",
       "  'Injection into tissue or muscle for therapy, diagnosis, or prevention'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.45604233,  0.        ,  0.        ,  0.        ,\n",
       "          0.6975572 ,  0.        ,  0.55266567]),\n",
       "  'Injection of different drug or substance into a vein for therapy'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Non-hormonal anti-neoplastic chemotherapy into tissue or muscle'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Hormonal anti-neoplastic chemotherapy into tissue or muscle'),\n",
       " (array([ 0.        ,  0.        ,  0.51869   ,  0.        ,  0.53506531,\n",
       "          0.47723111,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.4657427 ]),\n",
       "  'Infusion of chemotherapy into a vein up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.62583491,\n",
       "          0.5581896 ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.54475227]),\n",
       "  'Infusion of chemotherapy into a vein each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.51869   ,  0.        ,  0.53506531,\n",
       "          0.47723111,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.4657427 ]),\n",
       "  'Infusion of different chemotherapy drug or substance into a vein up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'New patient office or other outpatient visit, typically 30 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'New patient office or other outpatient visit, typically 45 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient visit, typically 10 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient visit, typically 15 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 25 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.53434915,  0.63546227,\n",
       "          0.        ,  0.55736764,  0.        ]),\n",
       "  'Established patient office or other outpatient, visit typically 40 minutes'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Initial hospital inpatient care, typically 50 minutes per day'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Initial hospital inpatient care, typically 70 minutes per day'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Subsequent hospital inpatient care, typically 15 minutes per day'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Subsequent hospital inpatient care, typically 25 minutes per day'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.69204386,  0.        ,\n",
       "          0.        ,  0.72185546,  0.        ]),\n",
       "  'Subsequent hospital inpatient care, typically 35 minutes per day'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.]),\n",
       "  'Hospital discharge day management, more than 30 minutes'),\n",
       " (array([ 0.54117412,  0.54117412,  0.51714613,  0.        ,  0.        ,\n",
       "          0.        ,  0.38317232,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, darbepoetin alfa, 1 microgram (non-esrd use)'),\n",
       " (array([ 0.        ,  0.        ,  0.64676423,  0.        ,  0.        ,\n",
       "          0.        ,  0.47921107,  0.59334036,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, denosumab, 1 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, dexamethasone sodium phosphate, 1mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, diphenhydramine hcl, up to 50 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.64676423,  0.        ,  0.        ,\n",
       "          0.        ,  0.47921107,  0.59334036,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, fosaprepitant, 1 mg'),\n",
       " (array([ 0.65689106,  0.65689106,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.23255221,  0.28793703,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e. g. liquid), 500 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, iron dextran, 50 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, palonosetron hcl, 25 mcg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, pegfilgrastim, 6 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg'),\n",
       " (array([ 0.48893856,  0.48893856,  0.46722982,  0.        ,  0.        ,\n",
       "          0.        ,  0.34618751,  0.42863581,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, zoledronic acid (zometa), 1 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Unclassified drugs'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, carboplatin, 50 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.64676423,  0.        ,  0.        ,\n",
       "          0.        ,  0.47921107,  0.59334036,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, docetaxel, 1 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, paclitaxel, 30 mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.62831697,  0.77795745,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Injection, rituximab, 100 mg'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Zoldedronic acid 1mg'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.78443476,  0.        ,\n",
       "          0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.62021134]),\n",
       "  'Insertion of needle into vein for collection of blood sample'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Needle or trocar bone marrow biopsy'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.54238587,  0.        ,  0.        ,  0.8401295 ,\n",
       "          0.        ,  0.        ,  0.        ]),\n",
       "  'Vaccine for influenza injection into muscle, patient 3 years and older'),\n",
       " (array([ 0.        ,  0.        ,  0.46382526,  0.        ,  0.47846846,\n",
       "          0.42675171,  0.        ,  0.        ,  0.44761895,  0.        ,\n",
       "          0.        ,  0.        ,  0.41647848]),\n",
       "  'Hydration infusion into a vein 31 minutes to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.62583491,\n",
       "          0.5581896 ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.54475227]),\n",
       "  'Hydration infusion into a vein each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.44715276,  0.        ,  0.4612696 ,\n",
       "          0.41141184,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.50677063,  0.        ,  0.4015079 ]),\n",
       "  'Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.36415565,  0.        ,  0.37565223,\n",
       "          0.67009738,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.4127077 ,  0.        ,  0.32698304]),\n",
       "  'Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.54720501,  0.        ,  0.        ,  0.        ,\n",
       "          0.83699861,  0.        ,  0.        ]),\n",
       "  'Injection into tissue or muscle for therapy, diagnosis, or prevention'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.45604233,  0.        ,  0.        ,  0.        ,\n",
       "          0.6975572 ,  0.        ,  0.55266567]),\n",
       "  'Injection of drug or substance into a vein for therapy'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.45604233,  0.        ,  0.        ,  0.        ,\n",
       "          0.6975572 ,  0.        ,  0.55266567]),\n",
       "  'Injection of different drug or substance into a vein for therapy'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Non-hormonal anti-neoplastic chemotherapy into tissue or muscle'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Hormonal anti-neoplastic chemotherapy into tissue or muscle'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.71566848,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.69844014]),\n",
       "  'Infusion of chemotherapy into a vein using push technique'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.71566848,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.69844014]),\n",
       "  'Infusion of additional chemotherapy drug or substance into a vein'),\n",
       " (array([ 0.        ,  0.        ,  0.51869   ,  0.        ,  0.53506531,\n",
       "          0.47723111,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.4657427 ]),\n",
       "  'Infusion of chemotherapy into a vein up to 1 hour'),\n",
       " (array([ 0.        ,  0.        ,  0.        ,  0.        ,  0.62583491,\n",
       "          0.5581896 ,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.54475227]),\n",
       "  'Infusion of chemotherapy into a vein each additional hour'),\n",
       " (array([ 0.        ,  0.        ,  0.51869   ,  0.        ,  0.53506531,\n",
       "          0.47723111,  0.        ,  0.        ,  0.        ,  0.        ,\n",
       "          0.        ,  0.        ,  0.4657427 ]),\n",
       "  'Infusion of different chemotherapy drug or substance into a vein up to 1 hour'),\n",
       " (array([ 0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Irrigation of implanted venous access drug delivery device'),\n",
       " (array([ 0.,  0.,  0.,  1.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.,  0.]),\n",
       "  'Therapeutic removal of whole blood to correct blood level imbalance'),\n",
       " ...]"
      ]
     },
     "execution_count": 435,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "zip(mod_tfidf.toarray(), corp)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 342,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(74, 18)"
      ]
     },
     "execution_count": 342,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "mod_tfidf.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 345,
   "metadata": {
    "collapsed": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[u'1',\n",
       " u'addit',\n",
       " u'chemotherapi',\n",
       " u'diagnosi',\n",
       " u'hour',\n",
       " u'infus',\n",
       " u'inject',\n",
       " u'mg',\n",
       " u'minut',\n",
       " u'offic',\n",
       " u'outpati',\n",
       " u'patient',\n",
       " u'per',\n",
       " u'prevent',\n",
       " u'therapi',\n",
       " u'typic',\n",
       " u'vein',\n",
       " u'visit']"
      ]
     },
     "execution_count": 345,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "vec.get_feature_names()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 354,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "outliers_list = [i for i in outliers.index]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 357,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "outliers_list = outliers['npi'].values"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 358,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "numpy.ndarray"
      ]
     },
     "execution_count": 358,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "type(outliers_list)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 456,
   "metadata": {
    "collapsed": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "first stop ['Insertion of needle into vein for collection of blood sample Blood test, comprehensive group of blood chemicals Vitamin D-3 level Lactate dehydrogenase (enzyme) level Blood test, thyroid stimulating hormone (TSH) Complete blood cell count (red cells, white blood cell, platelets), automated test Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Subsequent hospital inpatient care, typically 25 minutes per day Administration of influenza virus vaccine Injection, diphenhydramine hcl, up to 50 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Injection, rituximab, 100 mg', 'Insertion of needle into vein for collection of blood sample Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, granisetron hydrochloride, 100 mcg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Cyclophosphamide, 100 mg Injection, docetaxel, 1 mg Injection, fluorouracil, 500 mg Injection, rituximab, 100 mg']\n"
     ]
    }
   ],
   "source": [
    "mod_tfidf, vec, corp = perform_tfidf([1669492252, 1073755278])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 457,
   "metadata": {
    "collapsed": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "[u'100',\n",
       " u'1000',\n",
       " u'15',\n",
       " u'1mg',\n",
       " u'25',\n",
       " u'250',\n",
       " u'31',\n",
       " u'35',\n",
       " u'40',\n",
       " u'45',\n",
       " u'50',\n",
       " u'500',\n",
       " u'60',\n",
       " u'70',\n",
       " u'additional',\n",
       " u'administration',\n",
       " u'alfa',\n",
       " u'automated',\n",
       " u'blood',\n",
       " u'care',\n",
       " u'cc',\n",
       " u'cell',\n",
       " u'cells',\n",
       " u'chemicals',\n",
       " u'chemotherapy',\n",
       " u'collection',\n",
       " u'complete',\n",
       " u'comprehensive',\n",
       " u'count',\n",
       " u'cyclophosphamide',\n",
       " u'darbepoetin',\n",
       " u'day',\n",
       " u'dehydrogenase',\n",
       " u'denosumab',\n",
       " u'dexamethasone',\n",
       " u'diagnosis',\n",
       " u'different',\n",
       " u'diphenhydramine',\n",
       " u'docetaxel',\n",
       " u'drug',\n",
       " u'enzyme',\n",
       " u'esrd',\n",
       " u'established',\n",
       " u'fluorouracil',\n",
       " u'granisetron',\n",
       " u'group',\n",
       " u'hcl',\n",
       " u'hormone',\n",
       " u'hospital',\n",
       " u'hour',\n",
       " u'hydration',\n",
       " u'hydrochloride',\n",
       " u'influenza',\n",
       " u'infusion',\n",
       " u'initial',\n",
       " u'injection',\n",
       " u'inpatient',\n",
       " u'insertion',\n",
       " u'lactate',\n",
       " u'level',\n",
       " u'mcg',\n",
       " u'mg',\n",
       " u'microgram',\n",
       " u'minutes',\n",
       " u'ml',\n",
       " u'muscle',\n",
       " u'needle',\n",
       " u'new',\n",
       " u'non',\n",
       " u'normal',\n",
       " u'office',\n",
       " u'ondansetron',\n",
       " u'outpatient',\n",
       " u'palonosetron',\n",
       " u'patient',\n",
       " u'pegfilgrastim',\n",
       " u'phosphate',\n",
       " u'platelets',\n",
       " u'prevention',\n",
       " u'red',\n",
       " u'rituximab',\n",
       " u'saline',\n",
       " u'sample',\n",
       " u'sequential',\n",
       " u'sodium',\n",
       " u'solution',\n",
       " u'sterile',\n",
       " u'stimulating',\n",
       " u'subsequent',\n",
       " u'substance',\n",
       " u'test',\n",
       " u'therapy',\n",
       " u'thyroid',\n",
       " u'tissue',\n",
       " u'tsh',\n",
       " u'typically',\n",
       " u'unit',\n",
       " u'use',\n",
       " u'vaccine',\n",
       " u'vein',\n",
       " u'virus',\n",
       " u'visit',\n",
       " u'vitamin',\n",
       " u'white']"
      ]
     },
     "execution_count": 457,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "vec.get_feature_names()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 372,
   "metadata": {
    "collapsed": true
   },
   "outputs": [
    {
     "data": {
      "text/html": [
       "<div>\n",
       "<table border=\"1\" class=\"dataframe\">\n",
       "  <thead>\n",
       "    <tr style=\"text-align: right;\">\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th>num_services_norm</th>\n",
       "      <th>total_submitted_charges_norm</th>\n",
       "      <th>total_medicare_payment_amt_norm</th>\n",
       "      <th>num_drug_srvc_norm</th>\n",
       "      <th>total_drug_submitted_charges_norm</th>\n",
       "      <th>total_drug_medicare_payment_amt_norm</th>\n",
       "      <th>num_med_srvc_norm</th>\n",
       "      <th>total_med_submitted_charges_norm</th>\n",
       "      <th>total_med_medicare_payment_amt_norm</th>\n",
       "      <th>drug_charge_per_srvc</th>\n",
       "      <th>med_charge_per_srvc</th>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>total_submitted_charges_norm</th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "      <th></th>\n",
       "    </tr>\n",
       "  </thead>\n",
       "  <tbody>\n",
       "    <tr>\n",
       "      <th rowspan=\"8\" valign=\"top\">False</th>\n",
       "      <th>count</th>\n",
       "      <td>3710.000000</td>\n",
       "      <td>3710.000000</td>\n",
       "      <td>3710.000000</td>\n",
       "      <td>3710.000000</td>\n",
       "      <td>3710.000000</td>\n",
       "      <td>3710.000000</td>\n",
       "      <td>3710.000000</td>\n",
       "      <td>3710.000000</td>\n",
       "      <td>3710.000000</td>\n",
       "      <td>3710.000000</td>\n",
       "      <td>3710.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>mean</th>\n",
       "      <td>125.932862</td>\n",
       "      <td>5593.404645</td>\n",
       "      <td>1887.384639</td>\n",
       "      <td>113.001773</td>\n",
       "      <td>4072.000667</td>\n",
       "      <td>1378.861841</td>\n",
       "      <td>12.931089</td>\n",
       "      <td>1521.403978</td>\n",
       "      <td>508.522797</td>\n",
       "      <td>44.970594</td>\n",
       "      <td>133.880204</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>std</th>\n",
       "      <td>83.905113</td>\n",
       "      <td>3220.052510</td>\n",
       "      <td>1037.729357</td>\n",
       "      <td>79.875599</td>\n",
       "      <td>2683.987889</td>\n",
       "      <td>894.853356</td>\n",
       "      <td>8.979080</td>\n",
       "      <td>835.214070</td>\n",
       "      <td>264.232847</td>\n",
       "      <td>114.546549</td>\n",
       "      <td>61.693320</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>min</th>\n",
       "      <td>1.379699</td>\n",
       "      <td>218.552632</td>\n",
       "      <td>76.383571</td>\n",
       "      <td>0.011506</td>\n",
       "      <td>0.082353</td>\n",
       "      <td>0.014929</td>\n",
       "      <td>1.304511</td>\n",
       "      <td>178.504274</td>\n",
       "      <td>65.169000</td>\n",
       "      <td>0.230083</td>\n",
       "      <td>19.327533</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25%</th>\n",
       "      <td>65.615672</td>\n",
       "      <td>3043.160482</td>\n",
       "      <td>1157.987445</td>\n",
       "      <td>55.668383</td>\n",
       "      <td>2005.427397</td>\n",
       "      <td>752.134258</td>\n",
       "      <td>7.397699</td>\n",
       "      <td>927.870802</td>\n",
       "      <td>335.554944</td>\n",
       "      <td>25.524766</td>\n",
       "      <td>92.227677</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50%</th>\n",
       "      <td>114.751642</td>\n",
       "      <td>5294.706667</td>\n",
       "      <td>1813.600895</td>\n",
       "      <td>102.028747</td>\n",
       "      <td>3841.290342</td>\n",
       "      <td>1323.019013</td>\n",
       "      <td>11.255929</td>\n",
       "      <td>1363.809288</td>\n",
       "      <td>462.434855</td>\n",
       "      <td>36.456068</td>\n",
       "      <td>122.705599</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75%</th>\n",
       "      <td>171.527915</td>\n",
       "      <td>7740.781814</td>\n",
       "      <td>2489.894784</td>\n",
       "      <td>156.611469</td>\n",
       "      <td>5870.911785</td>\n",
       "      <td>1882.857451</td>\n",
       "      <td>16.482379</td>\n",
       "      <td>1916.781738</td>\n",
       "      <td>619.845931</td>\n",
       "      <td>50.236622</td>\n",
       "      <td>160.053455</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>max</th>\n",
       "      <td>602.759615</td>\n",
       "      <td>13645.764793</td>\n",
       "      <td>9125.698211</td>\n",
       "      <td>576.548077</td>\n",
       "      <td>12145.369863</td>\n",
       "      <td>8051.133431</td>\n",
       "      <td>214.431034</td>\n",
       "      <td>9357.041190</td>\n",
       "      <td>4825.011071</td>\n",
       "      <td>5705.394737</td>\n",
       "      <td>850.604301</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th rowspan=\"8\" valign=\"top\">True</th>\n",
       "      <th>count</th>\n",
       "      <td>264.000000</td>\n",
       "      <td>264.000000</td>\n",
       "      <td>264.000000</td>\n",
       "      <td>264.000000</td>\n",
       "      <td>264.000000</td>\n",
       "      <td>264.000000</td>\n",
       "      <td>264.000000</td>\n",
       "      <td>264.000000</td>\n",
       "      <td>264.000000</td>\n",
       "      <td>264.000000</td>\n",
       "      <td>264.000000</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>mean</th>\n",
       "      <td>400.273959</td>\n",
       "      <td>20612.387199</td>\n",
       "      <td>5832.198855</td>\n",
       "      <td>374.711460</td>\n",
       "      <td>16662.039790</td>\n",
       "      <td>4804.520758</td>\n",
       "      <td>25.562499</td>\n",
       "      <td>3950.347409</td>\n",
       "      <td>1027.678097</td>\n",
       "      <td>64.823603</td>\n",
       "      <td>170.099938</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>std</th>\n",
       "      <td>905.073657</td>\n",
       "      <td>19602.155488</td>\n",
       "      <td>9730.968166</td>\n",
       "      <td>904.342588</td>\n",
       "      <td>19179.166852</td>\n",
       "      <td>9681.077551</td>\n",
       "      <td>14.072159</td>\n",
       "      <td>2314.939064</td>\n",
       "      <td>611.274314</td>\n",
       "      <td>69.459097</td>\n",
       "      <td>69.721496</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>min</th>\n",
       "      <td>69.533088</td>\n",
       "      <td>13687.718223</td>\n",
       "      <td>1547.613932</td>\n",
       "      <td>43.863971</td>\n",
       "      <td>7025.644976</td>\n",
       "      <td>1006.044250</td>\n",
       "      <td>1.440000</td>\n",
       "      <td>260.420000</td>\n",
       "      <td>111.046000</td>\n",
       "      <td>1.547108</td>\n",
       "      <td>41.907066</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>25%</th>\n",
       "      <td>223.498212</td>\n",
       "      <td>15002.844803</td>\n",
       "      <td>3611.258604</td>\n",
       "      <td>201.192220</td>\n",
       "      <td>11631.386365</td>\n",
       "      <td>2731.070654</td>\n",
       "      <td>16.309995</td>\n",
       "      <td>2652.763698</td>\n",
       "      <td>696.311429</td>\n",
       "      <td>37.258545</td>\n",
       "      <td>124.504695</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>50%</th>\n",
       "      <td>297.123320</td>\n",
       "      <td>17014.529650</td>\n",
       "      <td>4371.936248</td>\n",
       "      <td>275.464277</td>\n",
       "      <td>13460.017219</td>\n",
       "      <td>3326.391842</td>\n",
       "      <td>23.590558</td>\n",
       "      <td>3524.987880</td>\n",
       "      <td>909.152474</td>\n",
       "      <td>50.750807</td>\n",
       "      <td>159.050095</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>75%</th>\n",
       "      <td>394.088368</td>\n",
       "      <td>20369.074559</td>\n",
       "      <td>5526.921204</td>\n",
       "      <td>367.922368</td>\n",
       "      <td>16207.580042</td>\n",
       "      <td>4454.612994</td>\n",
       "      <td>31.206525</td>\n",
       "      <td>4341.154501</td>\n",
       "      <td>1182.878102</td>\n",
       "      <td>69.739673</td>\n",
       "      <td>205.259058</td>\n",
       "    </tr>\n",
       "    <tr>\n",
       "      <th>max</th>\n",
       "      <td>14367.609375</td>\n",
       "      <td>287374.866667</td>\n",
       "      <td>135291.912333</td>\n",
       "      <td>14363.046875</td>\n",
       "      <td>283304.833333</td>\n",
       "      <td>133895.931333</td>\n",
       "      <td>101.451220</td>\n",
       "      <td>19286.374359</td>\n",
       "      <td>6002.191458</td>\n",
       "      <td>895.464525</td>\n",
       "      <td>539.175573</td>\n",
       "    </tr>\n",
       "  </tbody>\n",
       "</table>\n",
       "</div>"
      ],
      "text/plain": [
       "                                    num_services_norm  \\\n",
       "total_submitted_charges_norm                            \n",
       "False                        count        3710.000000   \n",
       "                             mean          125.932862   \n",
       "                             std            83.905113   \n",
       "                             min             1.379699   \n",
       "                             25%            65.615672   \n",
       "                             50%           114.751642   \n",
       "                             75%           171.527915   \n",
       "                             max           602.759615   \n",
       "True                         count         264.000000   \n",
       "                             mean          400.273959   \n",
       "                             std           905.073657   \n",
       "                             min            69.533088   \n",
       "                             25%           223.498212   \n",
       "                             50%           297.123320   \n",
       "                             75%           394.088368   \n",
       "                             max         14367.609375   \n",
       "\n",
       "                                    total_submitted_charges_norm  \\\n",
       "total_submitted_charges_norm                                       \n",
       "False                        count                   3710.000000   \n",
       "                             mean                    5593.404645   \n",
       "                             std                     3220.052510   \n",
       "                             min                      218.552632   \n",
       "                             25%                     3043.160482   \n",
       "                             50%                     5294.706667   \n",
       "                             75%                     7740.781814   \n",
       "                             max                    13645.764793   \n",
       "True                         count                    264.000000   \n",
       "                             mean                   20612.387199   \n",
       "                             std                    19602.155488   \n",
       "                             min                    13687.718223   \n",
       "                             25%                    15002.844803   \n",
       "                             50%                    17014.529650   \n",
       "                             75%                    20369.074559   \n",
       "                             max                   287374.866667   \n",
       "\n",
       "                                    total_medicare_payment_amt_norm  \\\n",
       "total_submitted_charges_norm                                          \n",
       "False                        count                      3710.000000   \n",
       "                             mean                       1887.384639   \n",
       "                             std                        1037.729357   \n",
       "                             min                          76.383571   \n",
       "                             25%                        1157.987445   \n",
       "                             50%                        1813.600895   \n",
       "                             75%                        2489.894784   \n",
       "                             max                        9125.698211   \n",
       "True                         count                       264.000000   \n",
       "                             mean                       5832.198855   \n",
       "                             std                        9730.968166   \n",
       "                             min                        1547.613932   \n",
       "                             25%                        3611.258604   \n",
       "                             50%                        4371.936248   \n",
       "                             75%                        5526.921204   \n",
       "                             max                      135291.912333   \n",
       "\n",
       "                                    num_drug_srvc_norm  \\\n",
       "total_submitted_charges_norm                             \n",
       "False                        count         3710.000000   \n",
       "                             mean           113.001773   \n",
       "                             std             79.875599   \n",
       "                             min              0.011506   \n",
       "                             25%             55.668383   \n",
       "                             50%            102.028747   \n",
       "                             75%            156.611469   \n",
       "                             max            576.548077   \n",
       "True                         count          264.000000   \n",
       "                             mean           374.711460   \n",
       "                             std            904.342588   \n",
       "                             min             43.863971   \n",
       "                             25%            201.192220   \n",
       "                             50%            275.464277   \n",
       "                             75%            367.922368   \n",
       "                             max          14363.046875   \n",
       "\n",
       "                                    total_drug_submitted_charges_norm  \\\n",
       "total_submitted_charges_norm                                            \n",
       "False                        count                        3710.000000   \n",
       "                             mean                         4072.000667   \n",
       "                             std                          2683.987889   \n",
       "                             min                             0.082353   \n",
       "                             25%                          2005.427397   \n",
       "                             50%                          3841.290342   \n",
       "                             75%                          5870.911785   \n",
       "                             max                         12145.369863   \n",
       "True                         count                         264.000000   \n",
       "                             mean                        16662.039790   \n",
       "                             std                         19179.166852   \n",
       "                             min                          7025.644976   \n",
       "                             25%                         11631.386365   \n",
       "                             50%                         13460.017219   \n",
       "                             75%                         16207.580042   \n",
       "                             max                        283304.833333   \n",
       "\n",
       "                                    total_drug_medicare_payment_amt_norm  \\\n",
       "total_submitted_charges_norm                                               \n",
       "False                        count                           3710.000000   \n",
       "                             mean                            1378.861841   \n",
       "                             std                              894.853356   \n",
       "                             min                                0.014929   \n",
       "                             25%                              752.134258   \n",
       "                             50%                             1323.019013   \n",
       "                             75%                             1882.857451   \n",
       "                             max                             8051.133431   \n",
       "True                         count                            264.000000   \n",
       "                             mean                            4804.520758   \n",
       "                             std                             9681.077551   \n",
       "                             min                             1006.044250   \n",
       "                             25%                             2731.070654   \n",
       "                             50%                             3326.391842   \n",
       "                             75%                             4454.612994   \n",
       "                             max                           133895.931333   \n",
       "\n",
       "                                    num_med_srvc_norm  \\\n",
       "total_submitted_charges_norm                            \n",
       "False                        count        3710.000000   \n",
       "                             mean           12.931089   \n",
       "                             std             8.979080   \n",
       "                             min             1.304511   \n",
       "                             25%             7.397699   \n",
       "                             50%            11.255929   \n",
       "                             75%            16.482379   \n",
       "                             max           214.431034   \n",
       "True                         count         264.000000   \n",
       "                             mean           25.562499   \n",
       "                             std            14.072159   \n",
       "                             min             1.440000   \n",
       "                             25%            16.309995   \n",
       "                             50%            23.590558   \n",
       "                             75%            31.206525   \n",
       "                             max           101.451220   \n",
       "\n",
       "                                    total_med_submitted_charges_norm  \\\n",
       "total_submitted_charges_norm                                           \n",
       "False                        count                       3710.000000   \n",
       "                             mean                        1521.403978   \n",
       "                             std                          835.214070   \n",
       "                             min                          178.504274   \n",
       "                             25%                          927.870802   \n",
       "                             50%                         1363.809288   \n",
       "                             75%                         1916.781738   \n",
       "                             max                         9357.041190   \n",
       "True                         count                        264.000000   \n",
       "                             mean                        3950.347409   \n",
       "                             std                         2314.939064   \n",
       "                             min                          260.420000   \n",
       "                             25%                         2652.763698   \n",
       "                             50%                         3524.987880   \n",
       "                             75%                         4341.154501   \n",
       "                             max                        19286.374359   \n",
       "\n",
       "                                    total_med_medicare_payment_amt_norm  \\\n",
       "total_submitted_charges_norm                                              \n",
       "False                        count                          3710.000000   \n",
       "                             mean                            508.522797   \n",
       "                             std                             264.232847   \n",
       "                             min                              65.169000   \n",
       "                             25%                             335.554944   \n",
       "                             50%                             462.434855   \n",
       "                             75%                             619.845931   \n",
       "                             max                            4825.011071   \n",
       "True                         count                           264.000000   \n",
       "                             mean                           1027.678097   \n",
       "                             std                             611.274314   \n",
       "                             min                             111.046000   \n",
       "                             25%                             696.311429   \n",
       "                             50%                             909.152474   \n",
       "                             75%                            1182.878102   \n",
       "                             max                            6002.191458   \n",
       "\n",
       "                                    drug_charge_per_srvc  med_charge_per_srvc  \n",
       "total_submitted_charges_norm                                                   \n",
       "False                        count           3710.000000          3710.000000  \n",
       "                             mean              44.970594           133.880204  \n",
       "                             std              114.546549            61.693320  \n",
       "                             min                0.230083            19.327533  \n",
       "                             25%               25.524766            92.227677  \n",
       "                             50%               36.456068           122.705599  \n",
       "                             75%               50.236622           160.053455  \n",
       "                             max             5705.394737           850.604301  \n",
       "True                         count            264.000000           264.000000  \n",
       "                             mean              64.823603           170.099938  \n",
       "                             std               69.459097            69.721496  \n",
       "                             min                1.547108            41.907066  \n",
       "                             25%               37.258545           124.504695  \n",
       "                             50%               50.750807           159.050095  \n",
       "                             75%               69.739673           205.259058  \n",
       "                             max              895.464525           539.175573  "
      ]
     },
     "execution_count": 372,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "df_hema_drop_drug[pca_cols].groupby(df_hema_drop_drug['total_submitted_charges_norm']>out_limit).describe()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 377,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "non_outliers = df_hema_drop_drug[df_hema_drop_drug['total_submitted_charges_norm']<out_limit]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 378,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "non_out_list = non_outliers['npi'].values"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 395,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "words = vec2.get_feature_names()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 406,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(13,)"
      ]
     },
     "execution_count": 406,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "vec.idf_.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 407,
   "metadata": {
    "collapsed": false,
    "scrolled": true
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(17,)"
      ]
     },
     "execution_count": 407,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "vec2.idf_.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 408,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "mod1_ind = np.argsort(np.sum(mod_tfidf.toarray(), axis=0)[-20:])"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 413,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([u'therapi', u'patient', u'hour', u'(', u')', u'1', u'blood',\n",
       "       u'typic', u'minut', u'vein', u'infus', u'mg', u'inject'], \n",
       "      dtype='<U7')"
      ]
     },
     "execution_count": 413,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "np.array(vec.get_feature_names())[mod1_ind]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 459,
   "metadata": {
    "collapsed": true
   },
   "outputs": [
    {
     "name": "stdout",
     "output_type": "stream",
     "text": [
      "first stop ['Insertion of needle into vein for collection of blood sample Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, granisetron hydrochloride, 100 mcg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Cyclophosphamide, 100 mg Injection, docetaxel, 1 mg Injection, fluorouracil, 500 mg Injection, rituximab, 100 mg', 'Insertion of needle into vein for collection of blood sample Stool analysis for blood to screen for colon tumors Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 30 minutes New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 30 minutes per day Initial hospital inpatient care, typically 50 minutes per day Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, ondansetron hydrochloride, per 1 mg Injection, pegfilgrastim, 6 mg Infusion, normal saline solution, sterile (500 ml=1 unit) 5% dextrose/normal saline (500 ml = 1 unit) Infusion, normal saline solution , 250 cc Injection, bendamustine hcl, 1 mg Injection, carboplatin, 50 mg Injection, rituximab, 100 mg', 'Insertion of needle into vein for collection of blood sample Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Administration of influenza virus vaccine Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Unclassified drugs Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc 5% dextrose/water (500 ml = 1 unit) Injection, carboplatin, 50 mg Injection, docetaxel, 1 mg Injection, gemcitabine hydrochloride, 200 mg Injection, oxaliplatin, 0. 5 mg Injection, paclitaxel protein-bound particles, 1 mg', 'Insertion of needle into vein for collection of blood sample Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Administration of influenza virus vaccine Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Injection, carboplatin, 50 mg Injection, trastuzumab, 10 mg', 'Insertion of needle into vein for collection of blood sample Blood test, comprehensive group of blood chemicals Vitamin D-3 level Lactate dehydrogenase (enzyme) level Blood test, thyroid stimulating hormone (TSH) Complete blood cell count (red cells, white blood cell, platelets), automated test Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Subsequent hospital inpatient care, typically 25 minutes per day Administration of influenza virus vaccine Injection, diphenhydramine hcl, up to 50 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Injection, rituximab, 100 mg', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy Blood test, comprehensive group of blood chemicals Lactate dehydrogenase (enzyme) level Magnesium level Phosphate level Uric acid level, blood Complete blood cell count (red cells, white blood cell, platelets), automated test Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Infusion of chemotherapy into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Established patient office or other outpatient, visit typically 40 minutes Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Injection, diphenhydramine hcl, up to 50 mg Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Injection, rituximab, 100 mg', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy CT scan chest CT scan chest with contrast CT scan abdomen before and after contrast CT scan of abdomen and pelvis CT scan of abdomen and pelvis Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Manual urinalysis test with examination using microscope Stool analysis for blood Carcinoembryonic antigen (CEA) protein level Blood creatinine level Cyanocobalamin (vitamin B-12) level Electrophoresis, laboratory testing technique Ferritin (blood protein) level Folic acid level Gammaglobulin (immune system protein) measurement Glutamyltransferase (liver enzyme) level Haptoglobin (serum protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level Phosphate level PSA (prostate specific antigen) measurement Protein measurement, serum Thyroxine (thyroid chemical) measurement Blood test, thyroid stimulating hormone (TSH) Urea nitrogen level to assess kidney function Uric acid level, blood Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Red blood count, automated test Immunologic analysis for detection of tumor antigen Immunologic analysis technique on serum Vaccine for pneumococcal polysaccharide for injection into muscle, patient 2 years or older Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Hospital discharge day management, more than 30 minutes Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Administration of influenza virus vaccine Administration of pneumococcal vaccine Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, testosterone cypionate, 1 cc, 200 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, iron dextran, 50 mg Injection, meperidine hydrochloride, per 100 mg Injection, morphine sulfate, up to 10 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, hydroxyzine hcl, up to 25 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, potassium chloride, per 2 meq Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Injection, carboplatin, 50 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) Zoldedronic acid 1mg Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample X-ray of chest, 2 views, front and side CT scan chest with contrast CT scan of abdomen and pelvis Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, basic group of blood chemicals Blood glucose (sugar) test performed by hand-held instrument Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 30 minutes New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Injection, dexamethasone sodium phosphate, 1mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, magnesium sulfate, per 500 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc 5% dextrose/water (500 ml = 1 unit) Cyclophosphamide, 100 mg Injection, docetaxel, 1 mg Injection, fluorouracil, 500 mg Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Blood test, comprehensive group of blood chemicals Manual urinalysis test with examination using microscope Stool analysis for blood Carcinoembryonic antigen (CEA) protein level Ferritin (blood protein) level Lactate dehydrogenase (enzyme) level Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Immunologic analysis for detection of tumor antigen Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Administration of influenza virus vaccine Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, granisetron hydrochloride, 100 mcg Injection, iron sucrose, 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Infusion, normal saline solution , 1000 cc Injection, carboplatin, 50 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)', 'Insertion of needle into vein for collection of blood sample Collection of blood specimen from a completely implantable venous access device Needle or trocar bone marrow biopsy Blood test, comprehensive group of blood chemicals Carcinoembryonic antigen (CEA) protein level Cyanocobalamin (vitamin B-12) level Ferritin (blood protein) level Folic acid level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level PSA (prostate specific antigen) measurement Uric acid level, blood Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Immunologic analysis for detection of tumor antigen Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Refilling and maintenance of implantable pump or reservoir for drug delivery New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Prolonged inpatient or observation hospital service first hour Administration of influenza virus vaccine Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, leucovorin calcium, per 50 mg Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, heparin sodium, (heparin lock flush), per 10 units Injection, heparin sodium, per 1000 units Injection, iron dextran, 50 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) 5% dextrose/normal saline (500 ml = 1 unit) Infusion, normal saline solution , 250 cc 5% dextrose/water (500 ml = 1 unit) Injection, carboplatin, 50 mg Cyclophosphamide, 100 mg Injection, docetaxel, 1 mg Injection, fluorouracil, 500 mg Injection, gemcitabine hydrochloride, 200 mg Injection, oxaliplatin, 0. 5 mg Injection, rituximab, 100 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)', 'Insertion of needle into vein for collection of blood sample Blood test, comprehensive group of blood chemicals Carcinoembryonic antigen (CEA) protein level Cyanocobalamin (vitamin B-12) level Ferritin (blood protein) level Folic acid level Lactate dehydrogenase (enzyme) level Magnesium level PSA (prostate specific antigen) measurement Complete blood cell count (red cells, white blood cell, platelets), automated test Immunologic analysis for detection of tumor antigen Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Administration of influenza virus vaccine Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, iron dextran, 50 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Infusion, normal saline solution , 250 cc Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)', '', 'Insertion of needle into vein for collection of blood sample X-ray of chest, 2 views, front and side CT scan chest CT scan chest with contrast CT scan of abdomen and pelvis CT scan of abdomen and pelvis Bone and joint imaging, whole body Nuclear medicine study with CT imaging whole body Blood test, comprehensive group of blood chemicals Ferritin (blood protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level PSA (prostate specific antigen) measurement Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Hospital discharge day management, more than 30 minutes Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Technetium tc-99m oxidronate, diagnostic, per study dose, up to 30 millicuries Administration of influenza virus vaccine Injection, dexamethasone sodium phosphate, 1mg Injection, granisetron hydrochloride, 100 mcg Infusion, normal saline solution , 1000 cc Leuprolide acetate (for depot suspension), 7. 5 mg Injection, ipilimumab, 1 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy X-ray of chest, 2 views, front and side CT scan chest with contrast CT scan of abdomen and pelvis X-ray survey of forearm or wrist bone density Nuclear medicine study with CT imaging whole body Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Ferritin (blood protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Uric acid level, blood Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Red blood count, automated test Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Administration of influenza virus vaccine Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, iron sucrose, 1 mg Injection, pamidronate disodium, per 30 mg Injection, pegfilgrastim, 6 mg Injection, bortezomib, 0. 1 mg Injection, rituximab, 100 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample CT scan chest with contrast CT scan of abdomen and pelvis Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, comprehensive group of blood chemicals Carcinoembryonic antigen (CEA) protein level Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Refilling and maintenance of portable pump New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Hospital discharge day management, 30 minutes or less Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Injection, atropine sulfate, 0. 01 mg Injection, calcium gluconate, per 10 ml Injection, dexamethasone sodium phosphate, 1mg Injection, granisetron hydrochloride, 100 mcg Injection, palonosetron hcl, 25 mcg Injection, magnesium sulfate, per 500 mg Infusion, normal saline solution , 1000 cc Injection, gemcitabine hydrochloride, 200 mg Injection, irinotecan, 20 mg Injection, oxaliplatin, 0. 5 mg Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy CT scan chest with contrast X-ray of upper arm, minimum of 2 views CT scan of abdomen and pelvis X-ray survey of forearm or wrist bone density Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Ferritin (blood protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Uric acid level, blood Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Red blood count, automated test Flow cytometry technique for DNA or cell analysis Flow cytometry technique for DNA or cell analysis Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Administration of influenza virus vaccine Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, granisetron hydrochloride, 100 mcg Injection, iron sucrose, 1 mg Injection, pamidronate disodium, per 30 mg Injection, rituximab, 100 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample X-ray of chest, 2 views, front and side CT scan chest CT scan chest with contrast CT scan of abdomen and pelvis CT scan of abdomen and pelvis Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, comprehensive group of blood chemicals Manual urinalysis test with examination using microscope Carcinoembryonic antigen (CEA) protein level Ferritin (blood protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Refilling and maintenance of portable pump New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Hospital discharge day management, more than 30 minutes Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Administration of influenza virus vaccine Injection, levoleucovorin calcium, 0. 5 mg Injection, dexamethasone sodium phosphate, 1mg Injection, granisetron hydrochloride, 100 mcg Injection, palonosetron hcl, 25 mcg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Injection, bevacizumab, 10 mg Injection, fluorouracil, 500 mg Injection, gemcitabine hydrochloride, 200 mg Injection, oxaliplatin, 0. 5 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample CT scan chest CT scan chest with contrast CT scan of abdomen and pelvis CT scan of abdomen and pelvis Bone and joint imaging, whole body Blood test, comprehensive group of blood chemicals PSA (prostate specific antigen) measurement Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein up to 1 hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Hospital discharge day management, more than 30 minutes Technetium tc-99m oxidronate, diagnostic, per study dose, up to 30 millicuries Administration of influenza virus vaccine Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, granisetron hydrochloride, 100 mcg Injection, pegfilgrastim, 6 mg Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution , 1000 cc Injection, docetaxel, 1 mg Leuprolide acetate (for depot suspension), 7. 5 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) Zoldedronic acid 1mg Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy Needle or trocar bone marrow biopsy X-ray of chest, 2 views, front and side CT scan chest with contrast X-ray of upper arm, minimum of 2 views CT scan of abdomen and pelvis X-ray survey of forearm or wrist bone density Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, comprehensive group of blood chemicals Manual urinalysis test with examination using microscope Ferritin (blood protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Uric acid level, blood Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Red blood count, automated test Blood test, clotting time Red blood cell sedimentation rate, to detect inflammation Flow cytometry technique for DNA or cell analysis Flow cytometry technique for DNA or cell analysis Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Hospital observation care typically 70 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Administration of influenza virus vaccine Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e. g. liquid), 500 mg Injection, granisetron hydrochloride, 100 mcg Injection, iron sucrose, 1 mg Injection, rituximab, 100 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Collection of blood specimen from a completely implantable venous access device CT scan chest with contrast CT scan of abdomen and pelvis Nuclear medicine study with CT imaging skull base to mid-thigh Nuclear medicine study with CT imaging whole body Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, heparin sodium, (heparin lock flush), per 10 units Injection, lorazepam, 2 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Injection, docetaxel, 1 mg Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Carcinoembryonic antigen (CEA) protein level Cyanocobalamin (vitamin B-12) level Ferritin (blood protein) level Folic acid level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level Phosphate level Blood test, thyroid stimulating hormone (TSH) Uric acid level, blood Complete blood cell count (red cells, white blood cell, platelets), automated test Immunologic analysis for detection of tumor antigen Immunologic analysis for detection of tumor antigen Vaccine for pneumococcal polysaccharide for injection into muscle, patient 2 years or older Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes Administration of influenza virus vaccine Administration of pneumococcal vaccine Injection, calcium gluconate, per 10 ml Injection, cefepime hydrochloride, 500 mg Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, immune globulin, (gammagard liquid), non-lyophilized, (e. g. liquid), 500 mg Injection, granisetron hydrochloride, 100 mcg Injection, fondaparinux sodium, 0. 5 mg Injection, hydrocortisone sodium succinate, up to 100 mg Injection, iron sucrose, 1 mg Injection, furosemide, up to 20 mg Injection, lorazepam, 2 mg Injection, pegfilgrastim, 6 mg Injection, sargramostim (gm-csf), 50 mcg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Unclassified drugs Infusion, normal saline solution , 1000 cc 5% dextrose/normal saline (500 ml = 1 unit) Infusion, normal saline solution , 250 cc Injection, carboplatin, 50 mg Injection, fluorouracil, 500 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Collection of blood specimen from a completely implantable venous access device Needle or trocar bone marrow biopsy Blood test, clotting time Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Hospital discharge day management, more than 30 minutes Injection, levoleucovorin calcium, 0. 5 mg Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, immune globulin, (octagam), intravenous, non-lyophilized (e. g. liquid), 500 mg Injection, granisetron hydrochloride, 100 mcg Injection, iron dextran, 50 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution , 1000 cc Injection, bortezomib, 0. 1 mg Injection, carboplatin, 50 mg Cyclophosphamide, 100 mg Injection, docetaxel, 1 mg Injection, etoposide, 10 mg Injection, fluorouracil, 500 mg Injection, paclitaxel, 30 mg Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 30 minutes New patient office or other outpatient visit, typically 45 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Hospital discharge day management, more than 30 minutes Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e. g. liquid), 500 mg Injection, iron dextran, 50 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, zoledronic acid (zometa), 1 mg Unclassified drugs Injection, carboplatin, 50 mg Injection, docetaxel, 1 mg Injection, paclitaxel, 30 mg Injection, rituximab, 100 mg Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy Vaccine for influenza injection into muscle, patient 3 years and older Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Administration of influenza virus vaccine Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, fosaprepitant, 1 mg Injection, granisetron hydrochloride, 100 mcg Injection, iron sucrose, 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, methylprednisolone sodium succinate, up to 125 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, zoledronic acid (zometa), 1 mg Unclassified drugs Infusion, normal saline solution , 1000 cc Injection, carboplatin, 50 mg Cyclophosphamide, 100 mg Injection, fluorouracil, 500 mg Injection, paclitaxel, 30 mg Injection, rituximab, 100 mg Injection, fulvestrant, 25 mg Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Carcinoembryonic antigen (CEA) protein level Cyanocobalamin (vitamin B-12) level Ferritin (blood protein) level Folic acid level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Complete blood cell count (red cells, white blood cell, platelets), automated test Red blood count, automated test Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, granisetron hydrochloride, 100 mcg Injection, ranitidine hydrochloride, 25 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc', 'Insertion of needle into vein for collection of blood sample Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, comprehensive group of blood chemicals Lactate dehydrogenase (enzyme) level Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Immunologic analysis for detection of tumor antigen Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, granisetron hydrochloride, 100 mcg Injection, iron dextran, 50 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Infusion, normal saline solution , 1000 cc Injection, carboplatin, 50 mg', 'Insertion of needle into vein for collection of blood sample CT scan of neck CT scan chest CT scan chest with contrast CT scan of abdomen and pelvis CT scan of abdomen and pelvis Nuclear medicine study with CT imaging skull base to mid-thigh Nuclear medicine study with CT imaging whole body Urinalysis, manual test Stool analysis for blood to screen for colon tumors Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, granisetron hydrochloride, 100 mcg Injection, heparin sodium, (heparin lock flush), per 10 units Injection, iron dextran, 50 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, zoledronic acid (zometa), 1 mg Injection, zoledronic acid (reclast), 1 mg Infusion, normal saline solution , 1000 cc Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Injection, paclitaxel, 30 mg Injection, rituximab, 100 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, comprehensive group of blood chemicals Manual urinalysis test with examination using microscope Carcinoembryonic antigen (CEA) protein level Ferritin (blood protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level PSA (prostate specific antigen) measurement Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Administration of influenza virus vaccine Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, granisetron hydrochloride, 100 mcg Infusion, normal saline solution , 1000 cc Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, comprehensive group of blood chemicals Manual urinalysis test with examination using microscope Ferritin (blood protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Red blood cell sedimentation rate, to detect inflammation Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Administration of influenza virus vaccine Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, granisetron hydrochloride, 100 mcg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Infusion, normal saline solution , 1000 cc Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)', 'Insertion of needle into vein for collection of blood sample Collection of blood specimen from a completely implantable venous access device Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Injection, atropine sulfate, 0. 01 mg Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, iron dextran, 50 mg Injection, lorazepam, 2 mg Injection, ondansetron hydrochloride, per 1 mg Injection, ranitidine hydrochloride, 25 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Injection, bevacizumab, 10 mg Injection, docetaxel, 1 mg Zoldedronic acid 1mg', 'Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient, visit typically 40 minutes Prolonged office or other outpatient service first hour Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, carboplatin, 50 mg', 'Insertion of needle into vein for collection of blood sample Blood test, comprehensive group of blood chemicals Lactate dehydrogenase (enzyme) level Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Immunologic analysis for detection of tumor antigen Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, granisetron hydrochloride, 100 mcg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Injection, rituximab, 100 mg', 'Insertion of needle into vein for collection of blood sample Blood test, comprehensive group of blood chemicals Carcinoembryonic antigen (CEA) protein level Ferritin (blood protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Immunologic analysis for detection of tumor antigen Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, granisetron hydrochloride, 100 mcg Injection, lorazepam, 2 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Unclassified drugs Infusion, normal saline solution , 1000 cc Infusion, normal saline solution , 250 cc Injection, carboplatin, 50 mg Injection, fluorouracil, 500 mg Injection, paclitaxel, 30 mg', 'Insertion of needle into vein for collection of blood sample CT scan of neck CT scan chest with contrast CT scan of abdomen and pelvis Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Carcinoembryonic antigen (CEA) protein level Blood creatinine level Ferritin (blood protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level PSA (prostate specific antigen) measurement Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Immunologic analysis for detection of tumor antigen Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Initial hospital inpatient care, typically 30 minutes per day Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Hospital discharge day management, 30 minutes or less Injection, leucovorin calcium, per 50 mg Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, dexamethasone sodium phosphate, 1mg Injection, hydromorphone, up to 4 mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 300 mcg Injection, filgrastim (g-csf), 480 mcg Injection, fosaprepitant, 1 mg Injection, granisetron hydrochloride, 100 mcg Injection, iron dextran, 50 mg Injection, furosemide, up to 20 mg Injection, mannitol, 25% in 50 ml Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Injection, zoledronic acid (zometa), 1 mg Unclassified drugs Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) 5% dextrose/water (500 ml = 1 unit) Injection, doxorubicin hydrochloride, 10 mg Injection, bendamustine hcl, 1 mg Injection, bevacizumab, 10 mg Injection, bortezomib, 0. 1 mg Injection, carboplatin, 50 mg Injection, cisplatin, powder or solution, 10 mg Cyclophosphamide, 100 mg Injection, docetaxel, 1 mg Injection, etoposide, 10 mg Injection, fluorouracil, 500 mg Injection, gemcitabine hydrochloride, 200 mg Injection, oxaliplatin, 0. 5 mg Injection, paclitaxel, 30 mg Injection, rituximab, 100 mg Zoldedronic acid 1mg Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy X-ray of chest, 2 views, front and side Blood test, comprehensive group of blood chemicals Blood test, lipids (cholesterol and triglycerides) Urinalysis, manual test Vitamin D-3 level Carcinoembryonic antigen (CEA) protein level Cyanocobalamin (vitamin B-12) level Ferritin (blood protein) level Folic acid level Gammaglobulin (immune system protein) measurement Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level Phosphate level PSA (prostate specific antigen) measurement Thyroxine (thyroid chemical) measurement Blood test, thyroid stimulating hormone (TSH) Uric acid level, blood Complete blood cell count (red cells, white blood cell, platelets), automated test Red blood count, automated test Red blood count automated, with additional calculations Blood test, clotting time Red blood cell sedimentation rate, to detect inflammation Immunologic analysis for detection of tumor antigen Immunologic analysis for detection of tumor antigen Immunologic analysis for detection of tumor antigen Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 30 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Initial hospital inpatient care, typically 30 minutes per day Initial hospital inpatient care, typically 50 minutes per day Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Hospital discharge day management, 30 minutes or less Prostate cancer screening; prostate specific antigen test (psa) Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, atropine sulfate, 0. 01 mg Injection, calcium gluconate, per 10 ml Injection, leucovorin calcium, per 50 mg Injection, cefepime hydrochloride, 500 mg Injection, ceftriaxone sodium, per 250 mg Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, hydromorphone, up to 4 mg Injection, diphenhydramine hcl, up to 50 mg Injection fluconazole, 200 mg Injection, fosaprepitant, 1 mg Injection, granisetron hydrochloride, 100 mcg Injection, iron dextran, 50 mg Injection, ketorolac tromethamine, per 15 mg Injection, furosemide, up to 20 mg Injection, levofloxacin, 250 mg Injection, lorazepam, 2 mg Injection, pamidronate disodium, per 30 mg Injection, methylprednisolone sodium succinate, up to 125 mg Injection, vancomycin hcl, 500 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Injection, zoledronic acid (zometa), 1 mg Injection, zoledronic acid (reclast), 1 mg Unclassified drugs Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Injection, bendamustine hcl, 1 mg Injection, bevacizumab, 10 mg Injection, bortezomib, 0. 1 mg Injection, carboplatin, 50 mg Injection, cisplatin, powder or solution, 10 mg Cyclophosphamide, 100 mg Injection, docetaxel, 1 mg Injection, etoposide, 10 mg Injection, fludarabine phosphate, 50 mg Injection, fluorouracil, 500 mg Injection, gemcitabine hydrochloride, 200 mg Leuprolide acetate (for depot suspension), 7. 5 mg Injection, oxaliplatin, 0. 5 mg Injection, paclitaxel protein-bound particles, 1 mg Injection, paclitaxel, 30 mg Injection, rituximab, 100 mg Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy Blood test, comprehensive group of blood chemicals Automated urinalysis test Beta-2 microglobulin (protein) level Stool analysis for blood to screen for colon tumors Vitamin D-3 level Carcinoembryonic antigen (CEA) protein level Cyanocobalamin (vitamin B-12) level Ferritin (blood protein) level Folic acid level Gammaglobulin (immune system protein) measurement Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level PSA (prostate specific antigen) measurement Thyroxine (thyroid chemical) measurement Blood test, thyroid stimulating hormone (TSH) Uric acid level, blood Complete blood cell count (red cells, white blood cell, platelets), automated test Red blood count, automated test Blood test, clotting time Red blood cell sedimentation rate, to detect inflammation Measurement of antibody for rheumatoid arthritis assessment Immunologic analysis for detection of tumor antigen Immunologic analysis for detection of tumor antigen Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 30 minutes per day Initial hospital inpatient care, typically 50 minutes per day Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Hospital discharge day management, 30 minutes or less Administration of influenza virus vaccine Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, leucovorin calcium, per 50 mg Injection, levoleucovorin calcium, 0. 5 mg Injection, ceftriaxone sodium, per 250 mg Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, fosaprepitant, 1 mg Injection, immune globulin, (gammagard liquid), non-lyophilized, (e. g. liquid), 500 mg Injection, granisetron hydrochloride, 100 mcg Injection, iron dextran, 50 mg Injection, furosemide, up to 20 mg Injection, levofloxacin, 250 mg Injection, lorazepam, 2 mg Injection, meperidine hydrochloride, per 100 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, promethazine hcl, up to 50 mg Injection, methylprednisolone sodium succinate, up to 125 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Injection, zoledronic acid (zometa), 1 mg Unclassified drugs Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Injection, doxorubicin hydrochloride, 10 mg Injection, bevacizumab, 10 mg Injection, bortezomib, 0. 1 mg Injection, carboplatin, 50 mg Injection, cisplatin, powder or solution, 10 mg Cyclophosphamide, 100 mg Injection, docetaxel, 1 mg Injection, fluorouracil, 500 mg Injection, gemcitabine hydrochloride, 200 mg Injection, mesna, 200 mg Injection, oxaliplatin, 0. 5 mg Injection, paclitaxel protein-bound particles, 1 mg Injection, paclitaxel, 30 mg Injection, rituximab, 100 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Bone marrow aspiration Needle or trocar bone marrow biopsy Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Blood test, lipids (cholesterol and triglycerides) Liver function blood test panel Carcinoembryonic antigen (CEA) protein level Cyanocobalamin (vitamin B-12) level Ferritin (blood protein) level Folic acid level Lactate dehydrogenase (enzyme) level Magnesium level PSA (prostate specific antigen) measurement Thyroxine (thyroid chemical) measurement Blood test, thyroid stimulating hormone (TSH) Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Refilling and maintenance of portable pump New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Hospital discharge day management, 30 minutes or less Injection, calcium gluconate, per 10 ml Injection, ceftriaxone sodium, per 250 mg Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, granisetron hydrochloride, 100 mcg Injection, heparin sodium, (heparin lock flush), per 10 units Injection, levofloxacin, 250 mg Injection, morphine sulfate, up to 10 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Injection, fluorouracil, 500 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Refilling and maintenance of portable pump New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, cefepime hydrochloride, 500 mg Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, mannitol, 25% in 50 ml Injection, ondansetron hydrochloride, per 1 mg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, sodium ferric gluconate complex in sucrose injection, 12. 5 mg Injection, methylprednisolone sodium succinate, up to 125 mg Injection, magnesium sulfate, per 500 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution , 250 cc Injection, bevacizumab, 10 mg Injection, cisplatin, powder or solution, 10 mg Injection, rituximab, 100 mg Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy CT scan of neck MRI scan of brain before and after contrast X-ray of chest, 2 views, front and side CT scan chest CT scan chest with contrast CT scan of abdomen and pelvis CT scan of abdomen and pelvis Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Manual urinalysis test with examination using microscope Carcinoembryonic antigen (CEA) protein level Blood creatinine level Cyanocobalamin (vitamin B-12) level Ferritin (blood protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level PSA (prostate specific antigen) measurement Blood test, thyroid stimulating hormone (TSH) Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Red blood count, automated test Blood test, clotting time Vaccine for influenza injection Routine electrocardiogram (EKG) with tracing using at least 12 leads Ultrasound scan limited study of arm or leg veins including assessment of compression and functional maneuvers Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 30 minutes New patient office or other outpatient visit, typically 45 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 30 minutes per day Initial hospital inpatient care, typically 50 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Hospital discharge day management, 30 minutes or less Hospital discharge day management, more than 30 minutes Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml Administration of influenza virus vaccine Injection, leucovorin calcium, per 50 mg Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 300 mcg Injection, filgrastim (g-csf), 480 mcg Injection, fosaprepitant, 1 mg Injection, iron sucrose, 1 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc 5% dextrose/water (500 ml = 1 unit) Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Injection, docetaxel, 1 mg Injection, fluorouracil, 500 mg Injection, oxaliplatin, 0. 5 mg Injection, pemetrexed, 10 mg Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Declotting infusion of implanted central venous access device or catheter Urinalysis, manual test Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Critical care delivery critically ill or injured patient, first 30-74 minutes Prolonged office or other outpatient service first hour Prolonged office or other outpatient service each 30 minutes beyond first hour Administration of influenza virus vaccine Injection, calcium gluconate, per 10 ml Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, furosemide, up to 20 mg Injection, ondansetron hydrochloride, per 1 mg Injection, ranitidine hydrochloride, 25 mg Injection, sargramostim (gm-csf), 50 mcg Injection, alteplase recombinant, 1 mg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Ringers lactate infusion, up to 1000 cc Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)', 'Insertion of needle into vein for collection of blood sample Complete blood cell count (red cells, white blood cell, platelets), automated test Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour New patient office or other outpatient visit, typically 30 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, dexamethasone sodium phosphate, 1mg Injection, palonosetron hcl, 25 mcg Infusion, normal saline solution , 250 cc', 'Collection of blood specimen from a completely implantable venous access device Bone marrow aspiration Needle or trocar bone marrow biopsy CT scan chest CT scan chest with contrast CT scan of abdomen and pelvis CT scan of abdomen and pelvis Nuclear medicine study with CT imaging skull base to mid-thigh Nuclear medicine study with CT imaging whole body Urinalysis, manual test Blood test, clotting time Vaccine for influenza injection Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Prolonged office or other outpatient service first hour Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Administration of influenza virus vaccine Injection, calcium gluconate, per 10 ml Injection, levoleucovorin calcium, 0. 5 mg Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, granisetron hydrochloride, 100 mcg Injection, heparin sodium, (heparin lock flush), per 10 units Injection, hydrocortisone sodium succinate, up to 100 mg Injection, iron dextran, 50 mg Injection, furosemide, up to 20 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, alteplase recombinant, 1 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Injection, zoledronic acid (zometa), 1 mg Injection, zoledronic acid (reclast), 1 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) 5% dextrose/normal saline (500 ml = 1 unit) Infusion, normal saline solution , 250 cc Injection, cetuximab, 10 mg Injection, cisplatin, powder or solution, 10 mg Injection, fluorouracil, 500 mg Injection, gemcitabine hydrochloride, 200 mg Leuprolide acetate (for depot suspension), 7. 5 mg Injection, oxaliplatin, 0. 5 mg Injection, rituximab, 100 mg Zoldedronic acid 1mg Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Bone marrow aspiration Needle or trocar bone marrow biopsy Blood test, comprehensive group of blood chemicals Gammaglobulin (immune system protein) measurement Lactate dehydrogenase (enzyme) level Magnesium level Phosphate level Uric acid level, blood Complete blood cell count (red cells, white blood cell, platelets), automated test Flow cytometry technique for DNA or cell analysis Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 45 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Hospital discharge day management, more than 30 minutes Injection, cefepime hydrochloride, 500 mg Injection, dexamethasone sodium phosphate, 1mg Injection, filgrastim (g-csf), 480 mcg Injection, ondansetron hydrochloride, per 1 mg Infusion, normal saline solution , 250 cc Injection, cytarabine, 100 mg', 'Insertion of needle into vein for collection of blood sample Complete blood cell count (red cells, white blood cell, platelets), automated test Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient, visit typically 25 minutes Injection, dexamethasone sodium phosphate, 1mg Injection, palonosetron hcl, 25 mcg Infusion, normal saline solution, sterile (500 ml=1 unit) Injection, carboplatin, 50 mg', 'Insertion of needle into vein for collection of blood sample Collection of blood specimen from a completely implantable venous access device Needle or trocar bone marrow biopsy CT scan chest with contrast CT scan of abdomen and pelvis Radiation treatment delivery, three or more treatment areas Intensity modulated radiation treatment delivery Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Urinalysis, manual test Alpha-fetoprotein (AFP) level, serum Bilirubin level Carcinoembryonic antigen (CEA) protein level Cyanocobalamin (vitamin B-12) level Ferritin (blood protein) level Gammaglobulin (immune system protein) measurement Glutamyltransferase (liver enzyme) level Haptoglobin (serum protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level Nephelometry, test method using light Phosphate level PSA (prostate specific antigen) measurement Thyroxine (thyroid chemical) measurement Thyroxine (thyroid chemical) measurement Blood test, thyroid stimulating hormone (TSH) Thyroid hormone evaluation Thyroid hormone, T3 measurement Uric acid level, blood Complete blood cell count (red cells, white blood cell, platelets), automated test Red blood count, automated test Blood test, clotting time Immunologic analysis for detection of tumor antigen Immunologic analysis for detection of tumor antigen Thyroglobulin (thyroid protein) antibody measurement Vaccine for influenza injection Vaccine for pneumococcal polysaccharide for injection into muscle, patient 2 years or older Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Refilling and maintenance of portable pump Irrigation of implanted venous access drug delivery device Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 30 minutes New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Administration of influenza virus vaccine Administration of pneumococcal vaccine Prostate cancer screening; prostate specific antigen test (psa) Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, leucovorin calcium, per 50 mg Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, fosaprepitant, 1 mg Injection, immune globulin, (octagam), intravenous, non-lyophilized (e. g. liquid), 500 mg Injection, granisetron hydrochloride, 100 mcg Injection, hydrocortisone sodium succinate, up to 100 mg Injection, iron dextran, 50 mg Injection, iron sucrose, 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Injection, zoledronic acid (zometa), 1 mg Injection, zoledronic acid (reclast), 1 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Injection, cisplatin, powder or solution, 10 mg Injection, docetaxel, 1 mg Injection, fluorouracil, 500 mg Injection, gemcitabine hydrochloride, 200 mg Leuprolide acetate (for depot suspension), 7. 5 mg Injection, paclitaxel, 30 mg Injection, rituximab, 100 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) Zoldedronic acid 1mg Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Collection of blood specimen from a completely implantable venous access device Needle or trocar bone marrow biopsy Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Injection, carboplatin, 50 mg Injection, docetaxel, 1 mg Injection, rituximab, 100 mg', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy Blood test, comprehensive group of blood chemicals Automated urinalysis test Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Routine EKG using at least 12 leads including interpretation and report Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Subsequent hospital inpatient care, typically 25 minutes per day Administration of influenza virus vaccine Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 300 mcg Injection, filgrastim (g-csf), 480 mcg Injection, fosaprepitant, 1 mg Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e. g. liquid), 500 mg Injection, heparin sodium, per 1000 units Injection, iron dextran, 50 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Infusion, normal saline solution , 250 cc Injection, carboplatin, 50 mg Leuprolide acetate (for depot suspension), 7. 5 mg Injection, rituximab, 100 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Administration of influenza virus vaccine Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Unclassified drugs Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc 5% dextrose/water (500 ml = 1 unit) Infusion, d5w, 1000 cc Injection, carboplatin, 50 mg Injection, docetaxel, 1 mg Injection, rituximab, 100 mg', 'Bone marrow aspiration Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 300 mcg Injection, fosaprepitant, 1 mg Injection, ondansetron hydrochloride, per 1 mg Injection, pamidronate disodium, per 30 mg Injection, pegfilgrastim, 6 mg Injection, magnesium sulfate, per 500 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Injection, carboplatin, 50 mg Injection, cisplatin, powder or solution, 10 mg Injection, etoposide, 10 mg Injection, paclitaxel protein-bound particles, 1 mg Injection, rituximab, 100 mg Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Blood test, comprehensive group of blood chemicals Beta-2 microglobulin (protein) level Bilirubin level Vitamin D-3 level Carcinoembryonic antigen (CEA) protein level Cyanocobalamin (vitamin B-12) level Erythropoietin (protein) level Ferritin (blood protein) level Folic acid level Gammaglobulin (immune system protein) measurement Haptoglobin (serum protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level Parathormone (parathyroid hormone) level Phosphate level Thyroxine (thyroid chemical) measurement Blood test, thyroid stimulating hormone (TSH) Transferrin (iron binding protein) level Thyroid hormone, T3 measurement Uric acid level, blood Complete blood cell count (red cells, white blood cell, platelets), automated test Screening test for autoimmune disorder Measurement C-reactive protein for detection of infection or inflammation Measurement of antibody for assessment of autoimmune disorder Microsomal antibodies (autoantibody) measurement Rheumatoid factor level Thyroglobulin (thyroid protein) antibody measurement Flow cytometry technique for DNA or cell analysis Flow cytometry technique for DNA or cell analysis Flow cytometry technique for DNA or cell analysis Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, iron sucrose, 1 mg Injection, palonosetron hcl, 25 mcg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc', 'Insertion of needle into vein for collection of blood sample Blood test, comprehensive group of blood chemicals Complete blood cell count (red cells, white blood cell, platelets), automated test Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Subsequent hospital inpatient care, typically 25 minutes per day Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Injection, carboplatin, 50 mg', 'CT scan chest with contrast CT scan of abdomen and pelvis Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Subsequent hospital inpatient care, typically 25 minutes per day Administration of influenza virus vaccine Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Infusion, normal saline solution , 1000 cc Injection, azacitidine, 1 mg Injection, carboplatin, 50 mg Cyclophosphamide, 100 mg Injection, degarelix, 1 mg Injection, docetaxel, 1 mg Leuprolide acetate (for depot suspension), 7. 5 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 30 minutes New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Hospital discharge day management, 30 minutes or less Subsequent nursing facility visit, typically 15 minutes per day Injection, leucovorin calcium, per 50 mg Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, granisetron hydrochloride, 100 mcg Injection, ondansetron hydrochloride, per 1 mg Injection, pegfilgrastim, 6 mg Injection, methylprednisolone sodium succinate, up to 125 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Unclassified drugs Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc 5% dextrose/water (500 ml = 1 unit) Injection, carboplatin, 50 mg Cyclophosphamide, 100 mg Injection, docetaxel, 1 mg Injection, fluorouracil, 500 mg Injection, oxaliplatin, 0. 5 mg Injection, paclitaxel, 30 mg Injection, rituximab, 100 mg', 'Insertion of needle into vein for collection of blood sample Bone marrow aspiration Needle or trocar bone marrow biopsy Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Urinalysis, manual test Carcinoembryonic antigen (CEA) protein level Cyanocobalamin (vitamin B-12) level Erythropoietin (protein) level Ferritin (blood protein) level Folic acid level Gammaglobulin (immune system protein) measurement Haptoglobin (serum protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level PSA (prostate specific antigen) measurement Protein measurement, serum Testosterone (hormone) level Blood test, thyroid stimulating hormone (TSH) Complete blood cell count (red cells, white blood cell, platelets), automated test Immunologic analysis technique on serum Hepatitis B core antibody measurement Hepatitis B core antibody (IgM) measurement Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein using push technique Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, palonosetron hcl, 25 mcg Injection, potassium chloride, per 2 meq Injection, carboplatin, 50 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)', 'Insertion of needle into vein for collection of blood sample CT scan chest with contrast CT scan of abdomen and pelvis Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Manual urinalysis test with examination using microscope Urinalysis, manual test Beta-2 microglobulin (protein) level Stool analysis for blood to screen for colon tumors Carcinoembryonic antigen (CEA) protein level Cyanocobalamin (vitamin B-12) level Ferritin (blood protein) level Folic acid level Gammaglobulin (immune system protein) measurement Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level Nephelometry, test method using light PSA (prostate specific antigen) measurement Total protein level, blood Protein measurement, serum Blood test, thyroid stimulating hormone (TSH) Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Immunologic analysis for detection of tumor antigen Immunologic analysis technique on serum Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Administration of influenza virus vaccine Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, granisetron hydrochloride, 100 mcg Injection, iron dextran, 50 mg Injection, iron sucrose, 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, methylprednisolone sodium succinate, up to 40 mg Injection, magnesium sulfate, per 500 mg Unclassified drugs Infusion, normal saline solution , 1000 cc Injection, carboplatin, 50 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy CT scan chest with contrast CT scan of abdomen and pelvis Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, comprehensive group of blood chemicals Ferritin (blood protein) level Gammaglobulin (immune system protein) measurement Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Red blood cell sedimentation rate, to detect inflammation Red blood cell sedimentation rate, to detect inflammation Measurement C-reactive protein for detection of infection or inflammation Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein using push technique Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Hospital discharge day management, 30 minutes or less Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Administration of influenza virus vaccine Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, granisetron hydrochloride, 100 mcg Injection, heparin sodium, per 1000 units Injection, lorazepam, 2 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, metoclopramide hcl, up to 10 mg Injection, sodium ferric gluconate complex in sucrose injection, 12. 5 mg Injection, azacitidine, 1 mg Injection, rituximab, 100 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for diagnostic procedure Insertion of needle into vein for collection of blood sample Bone marrow aspiration Needle or trocar bone marrow biopsy Hydration infusion into a vein 31 minutes to 1 hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein using push technique Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Refilling and maintenance of implantable pump or reservoir for drug delivery Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 45 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, pamidronate disodium, per 30 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, sodium ferric gluconate complex in sucrose injection, 12. 5 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, rituximab, 100 mg', 'Blood test, comprehensive group of blood chemicals Ferritin (blood protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Complete blood cell count (red cells, white blood cell, platelets), automated test Red blood count, automated test Blood test, clotting time Immunologic analysis for detection of tumor antigen Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Hospital discharge day management, more than 30 minutes Administration of influenza virus vaccine Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, palonosetron hcl, 25 mcg Injection, ranitidine hydrochloride, 25 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)', 'Insertion of needle into vein for collection of blood sample Blood test, comprehensive group of blood chemicals Urinalysis, manual test Carcinoembryonic antigen (CEA) protein level Lactate dehydrogenase (enzyme) level Magnesium level Phosphate level Complete blood cell count (red cells, white blood cell, platelets), automated test Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Hospital discharge day management, more than 30 minutes Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, ondansetron hydrochloride, per 1 mg Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc 5% dextrose/water (500 ml = 1 unit)', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy Blood test, basic group of blood chemicals Manual urinalysis test with examination using microscope Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Refilling and maintenance of portable pump Refilling and maintenance of implantable pump or reservoir for drug delivery Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Injection, calcium gluconate, per 10 ml Injection, leucovorin calcium, per 50 mg Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, fosaprepitant, 1 mg Injection, heparin sodium, (heparin lock flush), per 10 units Injection, iron dextran, 50 mg Injection, levofloxacin, 250 mg Injection, lorazepam, 2 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, sargramostim (gm-csf), 50 mcg Injection, methylprednisolone sodium succinate, up to 40 mg Injection, alteplase recombinant, 1 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Injection, zoledronic acid (zometa), 1 mg Injection, zoledronic acid (reclast), 1 mg Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc 5% dextrose/water (500 ml = 1 unit) Injection, doxorubicin hydrochloride, 10 mg Injection, bendamustine hcl, 1 mg Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Injection, cisplatin, powder or solution, 10 mg Cyclophosphamide, 100 mg Injection, docetaxel, 1 mg Injection, fluorouracil, 500 mg Injection, gemcitabine hydrochloride, 200 mg Injection, irinotecan, 20 mg Leuprolide acetate (for depot suspension), 7. 5 mg Injection, oxaliplatin, 0. 5 mg Injection, paclitaxel protein-bound particles, 1 mg Injection, paclitaxel, 30 mg Injection, pemetrexed, 10 mg Injection, rituximab, 100 mg Injection, trastuzumab, 10 mg Vincristine sulfate, 1 mg Injection, vinorelbine tartrate, 10 mg Injection, fulvestrant, 25 mg Zoldedronic acid 1mg', 'Needle or trocar bone marrow biopsy Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Initial hospital inpatient care, typically 30 minutes per day Initial hospital inpatient care, typically 50 minutes per day Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Hospital observation or inpatient care low severity Administration of influenza virus vaccine Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, leucovorin calcium, per 50 mg Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 300 mcg Injection, filgrastim (g-csf), 480 mcg Injection, fosaprepitant, 1 mg Injection, furosemide, up to 20 mg Injection, lorazepam, 2 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Injection, zoledronic acid (zometa), 1 mg Unclassified drugs Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) 5% dextrose/normal saline (500 ml = 1 unit) Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Injection, cisplatin, powder or solution, 10 mg Cyclophosphamide, 100 mg Injection, docetaxel, 1 mg Injection, fluorouracil, 500 mg Injection, gemcitabine hydrochloride, 200 mg Injection, pemetrexed, 10 mg Injection, rituximab, 100 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)', 'Hydration infusion into a vein 31 minutes to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Injection, leucovorin calcium, per 50 mg Injection, dexamethasone sodium phosphate, 1mg Injection, fosaprepitant, 1 mg Injection, palonosetron hcl, 25 mcg Injection, bevacizumab, 10 mg Injection, fluorouracil, 500 mg Injection, gemcitabine hydrochloride, 200 mg Injection, oxaliplatin, 0. 5 mg', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy Hydration infusion into a vein 31 minutes to 1 hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein up to 1 hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Subsequent hospital inpatient care, typically 35 minutes per day Administration of influenza virus vaccine Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, immune globulin, (gammagard liquid), non-lyophilized, (e. g. liquid), 500 mg Injection, pegfilgrastim, 6 mg Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Injection, bortezomib, 0. 1 mg Cyclophosphamide, 100 mg Not otherwise classified, antineoplastic drugs Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy CT scan chest CT scan chest with contrast CT scan of abdomen and pelvis Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, comprehensive group of blood chemicals Stool analysis for blood to screen for colon tumors Carcinoembryonic antigen (CEA) protein level Ferritin (blood protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level PSA (prostate specific antigen) measurement Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Red blood cell sedimentation rate, to detect inflammation Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Administration of influenza virus vaccine Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, granisetron hydrochloride, 100 mcg Injection, iron sucrose, 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Blood test, comprehensive group of blood chemicals Complete blood cell count (red cells, white blood cell, platelets), automated test Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, palonosetron hcl, 25 mcg', 'Insertion of needle into vein for collection of blood sample Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Hospital discharge day management, 30 minutes or less Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes Injection, dexamethasone sodium phosphate, 1mg Leuprolide acetate (for depot suspension), 7. 5 mg', 'Insertion of needle into vein for collection of blood sample Blood test, comprehensive group of blood chemicals Lactate dehydrogenase (enzyme) level Uric acid level, blood Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Hydration infusion into a vein 31 minutes to 1 hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Subsequent hospital inpatient care, typically 25 minutes per day Administration of influenza virus vaccine Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, palonosetron hcl, 25 mcg Injection, methylprednisolone sodium succinate, up to 125 mg Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Injection, rituximab, 100 mg Zoldedronic acid 1mg', 'Needle or trocar bone marrow biopsy Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, ondansetron hydrochloride, per 1 mg', 'Insertion of needle into vein for collection of blood sample Collection of blood specimen from central or peripheral venous catheter Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, iron dextran, 50 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Injection, rituximab, 100 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (for esrd on dialysis) Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, heparin sodium, per 1000 units Injection, ondansetron hydrochloride, per 1 mg Injection, pegfilgrastim, 6 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Injection, bevacizumab, 10 mg', 'Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Administration of influenza virus vaccine Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, granisetron hydrochloride, 100 mcg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution, sterile (500 ml=1 unit) Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Complete blood cell count (red cells, white blood cell, platelets), automated test Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Injection into tissue or muscle for therapy, diagnosis, or prevention New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy CT scan chest CT scan chest with contrast CT scan of abdomen and pelvis Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Beta-2 microglobulin (protein) level Carcinoembryonic antigen (CEA) protein level Ferritin (blood protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level PSA (prostate specific antigen) measurement Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Hospital discharge day management, 30 minutes or less Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, granisetron hydrochloride, 100 mcg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, zoledronic acid (zometa), 1 mg Unclassified drugs Infusion, normal saline solution , 1000 cc Injection, doxorubicin hydrochloride, 10 mg Injection, carboplatin, 50 mg Cyclophosphamide, 100 mg Injection, fluorouracil, 500 mg Injection, gemcitabine hydrochloride, 200 mg Injection, paclitaxel, 30 mg Injection, rituximab, 100 mg Vincristine sulfate, 1 mg Zoldedronic acid 1mg Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Blood test, comprehensive group of blood chemicals Carcinoembryonic antigen (CEA) protein level Cyanocobalamin (vitamin B-12) level Ferritin (blood protein) level Folic acid level Gammaglobulin (immune system protein) measurement Measurement of substance using immunoassay technique Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level Protein measurement, serum Complete blood cell count (red cells, white blood cell, platelets), automated test Red blood count, automated test Immunologic analysis for detection of tumor antigen Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Administration of influenza virus vaccine Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, ranitidine hydrochloride, 25 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Infusion, normal saline solution , 1000 cc Injection, carboplatin, 50 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)', 'Insertion of needle into vein for collection of blood sample Blood test, clotting time Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 25 minutes Initial hospital inpatient care, typically 30 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Administration of influenza virus vaccine Injection, diphenhydramine hcl, up to 50 mg Injection, ondansetron hydrochloride, per 1 mg Injection, von willebrand factor complex (humate-p), per iu vwf:rco Factor viii (antihemophilic factor, recombinant) per i. u. , not otherwise specified Factor ix (antihemophilic factor, recombinant) per i. u. Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy CT scan chest with contrast CT scan of abdomen and pelvis Blood test, comprehensive group of blood chemicals Carcinoembryonic antigen (CEA) protein level Ferritin (blood protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Complete blood cell count (red cells, white blood cell, platelets), automated test Immunologic analysis for detection of tumor antigen Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Refilling and maintenance of portable pump Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Subsequent hospital inpatient care, typically 25 minutes per day Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, leucovorin calcium, per 50 mg Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, granisetron hydrochloride, 100 mcg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, zoledronic acid (zometa), 1 mg Unclassified drugs Infusion, normal saline solution , 1000 cc Injection, carboplatin, 50 mg Injection, docetaxel, 1 mg Injection, fluorouracil, 500 mg Injection, paclitaxel, 30 mg Zoldedronic acid 1mg Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy CT scan of neck MRI scan of brain before and after contrast X-ray of chest, 2 views, front and side CT scan chest CT scan chest with contrast MRI scan of lower spinal canal before and after contrast CT scan abdomen with contrast CT scan of abdomen and pelvis CT scan of abdomen and pelvis Computer analysis of screening mammogram to assist detection of cancer Bone density measurement spine or hips using dedicated X-ray machine Bone and joint imaging, whole body Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Blood test, lipids (cholesterol and triglycerides) Manual urinalysis test with examination using microscope Stool analysis for blood Vitamin D-3 level Calcium level Carcinoembryonic antigen (CEA) protein level Blood creatinine level Cyanocobalamin (vitamin B-12) level Ferritin (blood protein) level Folic acid level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level Parathormone (parathyroid hormone) level Blood potassium level PSA (prostate specific antigen) measurement Thyroxine (thyroid chemical) measurement Blood test, thyroid stimulating hormone (TSH) Uric acid level, blood Complete blood cell count (red cells, white blood cell, platelets), automated test Red blood count, manual test Blood test, clotting time Flu vac no prsv 4 val 3 yrs+ Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries Injection, gadobenate dimeglumine (multihance), per ml Administration of influenza virus vaccine Screening mammography, producing direct digital image, bilateral, all views Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, leucovorin calcium, per 50 mg Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, iron dextran, 50 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, zoledronic acid (zometa), 1 mg Unclassified drugs Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Injection, carboplatin, 50 mg Injection, fluorouracil, 500 mg Injection, paclitaxel, 30 mg Zoldedronic acid 1mg', \"Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy Transplantation of patient's bone marrow or blood-derived stem cells X-ray of chest, 2 views, front and side Blood test, comprehensive group of blood chemicals Tacrolimus level Manual urinalysis test with examination using microscope Urinalysis, manual test Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Vaccine for pneumococcal polysaccharide for injection into muscle, patient 2 years or older Vaccine for Hepatitis B adult dosage (3 dose schedule) injection into muscle Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Irrigation of implanted venous access drug delivery device Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes Moderate sedation services by physician also performing a procedure, each additional 15 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Hospital discharge day management, 30 minutes or less Prolonged office or other outpatient service first hour Administration of influenza virus vaccine Administration of pneumococcal vaccine Administration of hepatitis b vaccine Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, ceftriaxone sodium, per 250 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, granisetron hydrochloride, 100 mcg Injection, lorazepam, 2 mg Injection, meperidine hydrochloride, per 100 mg Injection, pamidronate disodium, per 30 mg Injection, pegfilgrastim, 6 mg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Injection, bortezomib, 0. 1 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml\", 'Needle or trocar bone marrow biopsy Hydration infusion into a vein 31 minutes to 1 hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein up to 1 hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, iron sucrose, 1 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Infusion, normal saline solution , 250 cc', 'Insertion of needle into vein for collection of blood sample Bone marrow aspiration Needle or trocar bone marrow biopsy Carcinoembryonic antigen (CEA) protein level Ferritin (blood protein) level Complete blood cell count (red cells, white blood cell, platelets), automated test Immunologic analysis for detection of tumor antigen Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Subsequent hospital inpatient care, typically 35 minutes per day Administration of influenza virus vaccine Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, leucovorin calcium, per 50 mg Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, heparin sodium, per 1000 units Injection, iron sucrose, 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution , 250 cc Infusion, d5w, 1000 cc Injection, fluorouracil, 500 mg Injection, oxaliplatin, 0. 5 mg Injection, rituximab, 100 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Flow cytometry technique for DNA or cell analysis Flow cytometry technique for DNA or cell analysis Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Refilling and maintenance of portable pump Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Subsequent hospital inpatient care, typically 25 minutes per day Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, granisetron hydrochloride, 100 mcg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, potassium chloride, per 2 meq Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Injection, carboplatin, 50 mg Injection, fluorouracil, 500 mg Injection, gemcitabine hydrochloride, 200 mg Injection, rituximab, 100 mg', 'Insertion of needle into vein for collection of blood sample Collection of blood specimen from a completely implantable venous access device Needle or trocar bone marrow biopsy CT scan head or brain before and after contrast CT scan of neck CT scan chest with contrast CT scan chest before and after contrast CT scan of abdomen and pelvis Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Manual urinalysis test with examination using microscope Urinalysis, manual test Bilirubin level Carcinoembryonic antigen (CEA) protein level Cyanocobalamin (vitamin B-12) level Ferritin (blood protein) level Folic acid level Gammaglobulin (immune system protein) measurement Glutamyltransferase (liver enzyme) level Haptoglobin (serum protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level Nephelometry, test method using light Phosphate level PSA (prostate specific antigen) measurement Blood test, thyroid stimulating hormone (TSH) Complete blood cell count (red cells, white blood cell, platelets), automated test Red blood count, automated test Blood test, clotting time Red blood cell sedimentation rate, to detect inflammation Immunologic analysis for detection of tumor antigen Thyroglobulin (thyroid protein) antibody measurement Vaccine for influenza injection Vaccine for pneumococcal polysaccharide for injection into muscle, patient 2 years or older Hydration infusion into a vein 31 minutes to 1 hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Refilling and maintenance of portable pump Irrigation of implanted venous access drug delivery device Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Administration of influenza virus vaccine Administration of pneumococcal vaccine Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, calcium gluconate, per 10 ml Injection, leucovorin calcium, per 50 mg Injection, ceftriaxone sodium, per 250 mg Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 300 mcg Injection, filgrastim (g-csf), 480 mcg Injection, fosaprepitant, 1 mg Injection, immune globulin, (octagam), intravenous, non-lyophilized (e. g. liquid), 500 mg Injection, granisetron hydrochloride, 100 mcg Injection, enoxaparin sodium, 10 mg Injection, iron sucrose, 1 mg Injection, lorazepam, 2 mg Injection, meperidine hydrochloride, per 100 mg Injection, octreotide, depot form for intramuscular injection, 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, triamcinolone  acetonide, not otherwise specified, 10 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Injection, zoledronic acid (reclast), 1 mg Injection, carboplatin, 50 mg Injection, cetuximab, 10 mg Injection, fluorouracil, 500 mg Injection, oxaliplatin, 0. 5 mg Injection, paclitaxel, 30 mg Injection, rituximab, 100 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) Zoldedronic acid 1mg Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Collection of blood specimen from a completely implantable venous access device Declotting infusion of implanted central venous access device or catheter Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Prolonged office or other outpatient service first hour Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 300 mcg Injection, iron dextran, 50 mg Injection, ketorolac tromethamine, per 15 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, ranitidine hydrochloride, 25 mg Injection, sargramostim (gm-csf), 50 mcg Injection, alteplase recombinant, 1 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, potassium chloride, per 2 meq Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Injection, cisplatin, powder or solution, 10 mg Cyclophosphamide, 100 mg Injection, docetaxel, 1 mg Injection, gemcitabine hydrochloride, 200 mg Leuprolide acetate (for depot suspension), 7. 5 mg Injection, paclitaxel, 30 mg Injection, rituximab, 100 mg', 'Insertion of needle into vein for collection of blood sample Collection of blood specimen from a completely implantable venous access device Declotting infusion of implanted central venous access device or catheter Bone marrow aspiration Needle or trocar bone marrow biopsy Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection of different drug or substance into a vein for therapy Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Initial hospital inpatient care, typically 70 minutes per day Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, granisetron hydrochloride, 100 mcg Injection, ondansetron hydrochloride, per 1 mg Injection, pamidronate disodium, per 30 mg Injection, ranitidine hydrochloride, 25 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Infusion, d5w, 1000 cc Cyclophosphamide, 100 mg Injection, fluorouracil, 500 mg Injection, gemcitabine hydrochloride, 200 mg Injection, paclitaxel, 30 mg Injection, rituximab, 100 mg', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy Blood test, comprehensive group of blood chemicals Beta-2 microglobulin (protein) level Vitamin D-3 level Carcinoembryonic antigen (CEA) protein level Cyanocobalamin (vitamin B-12) level Ferritin (blood protein) level Folic acid level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level PSA (prostate specific antigen) measurement Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Immunologic analysis for detection of tumor antigen Special stained specimen slides to examine tissue including interpretation and report Antibody evaluation Microscopic genetic analysis of tumor Hydration infusion into a vein 31 minutes to 1 hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Administration of influenza virus vaccine Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, fosaprepitant, 1 mg Injection, immune globulin, (octagam), intravenous, non-lyophilized (e. g. liquid), 500 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, zoledronic acid (zometa), 1 mg Unclassified drugs Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Injection, carboplatin, 50 mg Injection, rituximab, 100 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy Blood test, comprehensive group of blood chemicals Beta-2 microglobulin (protein) level Vitamin D-3 level Carcinoembryonic antigen (CEA) protein level Cyanocobalamin (vitamin B-12) level Ferritin (blood protein) level Folic acid level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level PSA (prostate specific antigen) measurement Uric acid level, blood Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Immunologic analysis for detection of tumor antigen Immunologic analysis for detection of tumor antigen Immunologic analysis for detection of tumor antigen Flow cytometry technique for DNA or cell analysis Flow cytometry technique for DNA or cell analysis Special stained specimen slides to examine tissue including interpretation and report Antibody evaluation Microscopic genetic analysis of tumor Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Hospital discharge day management, more than 30 minutes Administration of influenza virus vaccine Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, fosaprepitant, 1 mg Injection, immune globulin, (octagam), intravenous, non-lyophilized (e. g. liquid), 500 mg Injection, iron dextran, 50 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, methylprednisolone sodium succinate, up to 125 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, zoledronic acid (zometa), 1 mg Unclassified drugs Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Injection, carboplatin, 50 mg Injection, gemcitabine hydrochloride, 200 mg Leuprolide acetate (for depot suspension), 7. 5 mg Injection, rituximab, 100 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 30 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Hospital discharge day management, 30 minutes or less Hospital discharge day management, more than 30 minutes Injection, levoleucovorin calcium, 0. 5 mg Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, heparin sodium, (heparin lock flush), per 10 units Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, zoledronic acid (zometa), 1 mg Unclassified drugs Infusion, normal saline solution , 1000 cc Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Injection, fluorouracil, 500 mg Injection, gemcitabine hydrochloride, 200 mg Injection, rituximab, 100 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)', 'Insertion of needle into vein for collection of blood sample Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Routine EKG using at least 12 leads including interpretation and report Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein using push technique Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Administration of influenza virus vaccine Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, ondansetron hydrochloride, per 1 mg Injection, pamidronate disodium, per 30 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, potassium chloride, per 2 meq Unclassified drugs Infusion, normal saline solution, sterile (500 ml=1 unit) Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Urinalysis, manual test Carcinoembryonic antigen (CEA) protein level Cyanocobalamin (vitamin B-12) level Ferritin (blood protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level PSA (prostate specific antigen) measurement Uric acid level, blood Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 30 minutes New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Critical care delivery critically ill or injured patient, first 30-74 minutes Administration of influenza virus vaccine Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, hydrocortisone sodium succinate, up to 100 mg Injection, iron dextran, 50 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, methylprednisolone sodium succinate, up to 125 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Infusion, normal saline solution , 1000 cc Injection, carboplatin, 50 mg Injection, fluorouracil, 500 mg Injection, rituximab, 100 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy Blood test, clotting time Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Refilling and maintenance of portable pump Irrigation of implanted venous access drug delivery device Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Subsequent hospital inpatient care, typically 35 minutes per day Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, calcium gluconate, per 10 ml Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, iron dextran, 50 mg Injection, ondansetron hydrochloride, per 1 mg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Cyclophosphamide, 100 mg Injection, fluorouracil, 500 mg Injection, gemcitabine hydrochloride, 200 mg Injection, paclitaxel, 30 mg Injection, rituximab, 100 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Manual urinalysis test with examination using microscope Beta-2 microglobulin (protein) level Stool analysis for blood to screen for colon tumors Carcinoembryonic antigen (CEA) protein level Cyanocobalamin (vitamin B-12) level Ferritin (blood protein) level Folic acid level Gammaglobulin (immune system protein) measurement Haptoglobin (serum protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level PSA (prostate specific antigen) measurement Blood test, thyroid stimulating hormone (TSH) Uric acid level, blood Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Red blood count, manual test Blood test, clotting time Red blood cell sedimentation rate, to detect inflammation Immunologic analysis for detection of tumor antigen Flow cytometry technique for DNA or cell analysis Flow cytometry technique for DNA or cell analysis Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Refilling and maintenance of portable pump Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, leucovorin calcium, per 50 mg Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, granisetron hydrochloride, 100 mcg Injection, iron sucrose, 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Infusion, normal saline solution , 1000 cc Injection, fluorouracil, 500 mg Injection, gemcitabine hydrochloride, 200 mg Injection, rituximab, 100 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)', 'Insertion of needle into vein for collection of blood sample Collection of blood specimen from a completely implantable venous access device Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, clotting time Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Refilling and maintenance of portable pump Irrigation of implanted venous access drug delivery device Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Prolonged office or other outpatient service first hour Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Injection, leucovorin calcium, per 50 mg Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 300 mcg Injection, filgrastim (g-csf), 480 mcg Injection, fosaprepitant, 1 mg Injection, immune globulin, (gammagard liquid), non-lyophilized, (e. g. liquid), 500 mg Injection, iron sucrose, 1 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, magnesium sulfate, per 500 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Cyclophosphamide, 100 mg Injection, fluorouracil, 500 mg Injection, rituximab, 100 mg', 'Needle or trocar bone marrow biopsy Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, clotting time Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Administration of influenza virus vaccine Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, leucovorin calcium, per 50 mg Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, testosterone cypionate, 1 cc, 200 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, immune globulin, (gammagard liquid), non-lyophilized, (e. g. liquid), 500 mg Injection, granisetron hydrochloride, 100 mcg Injection, iron sucrose, 1 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, magnesium sulfate, per 500 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Injection, fluorouracil, 500 mg Injection, rituximab, 100 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) Zoldedronic acid 1mg Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Bone marrow aspiration Needle or trocar bone marrow biopsy Complete blood cell count (red cells, white blood cell, platelets), automated test Pneumococcal vaccine for injection Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Administration of pneumococcal vaccine Injection, atropine sulfate, 0. 01 mg Injection, leucovorin calcium, per 50 mg Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, fosaprepitant, 1 mg Injection, iron sucrose, 1 mg Injection, oprelvekin, 5 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Injection, zoledronic acid (zometa), 1 mg Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Cyclophosphamide, 100 mg Injection, fluorouracil, 500 mg Injection, irinotecan, 20 mg Injection, paclitaxel, 30 mg Injection, rituximab, 100 mg Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Complete blood cell count (red cells, white blood cell, platelets), automated test Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, granisetron hydrochloride, 100 mcg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc 5% dextrose/water (500 ml = 1 unit) Infusion, d5w, 1000 cc Injection, carboplatin, 50 mg Injection, fluorouracil, 500 mg', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, calcium gluconate, per 10 ml Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, iron sucrose, 1 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, sodium ferric gluconate complex in sucrose injection, 12. 5 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Unclassified drugs Infusion, normal saline solution , 250 cc Injection, carboplatin, 50 mg', 'Insertion of needle into vein for collection of blood sample Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 45 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Subsequent hospital inpatient care, typically 25 minutes per day Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Infusion, normal saline solution , 1000 cc', 'Insertion of needle into vein for collection of blood sample Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Manual urinalysis test with examination using microscope Lactate dehydrogenase (enzyme) level Magnesium level Phosphate level Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution , 1000 cc Injection, carboplatin, 50 mg Injection, docetaxel, 1 mg Injection, etoposide, 10 mg Injection, gemcitabine hydrochloride, 200 mg Injection, paclitaxel, 30 mg Injection, rituximab, 100 mg Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Manual urinalysis test with examination using microscope Urinalysis, manual test Lactate dehydrogenase (enzyme) level Magnesium level Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 30 minutes New patient office or other outpatient visit, typically 45 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Initial hospital inpatient care, typically 50 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, iron dextran, 50 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, ranitidine hydrochloride, 25 mg Injection, magnesium sulfate, per 500 mg Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution , 1000 cc Injection, carboplatin, 50 mg Injection, fluorouracil, 500 mg Injection, paclitaxel, 30 mg Injection, rituximab, 100 mg', 'Hydration infusion into a vein each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 45 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Injection, calcium gluconate, per 10 ml Injection, dexamethasone sodium phosphate, 1mg Injection, filgrastim (g-csf), 480 mcg Injection, fosaprepitant, 1 mg Injection, palonosetron hcl, 25 mcg Injection, magnesium sulfate, per 500 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) 5% dextrose/normal saline (500 ml = 1 unit) Infusion, normal saline solution , 250 cc Injection, oxaliplatin, 0. 5 mg', 'Insertion of needle into vein for collection of blood sample Bone marrow aspiration Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Liver function blood test panel Carcinoembryonic antigen (CEA) protein level Blood creatinine level Ferritin (blood protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level PSA (prostate specific antigen) measurement Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Red blood cell sedimentation rate, to detect inflammation Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 30 minutes New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Injection, leucovorin calcium, per 50 mg Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, iron dextran, 50 mg Injection, lorazepam, 2 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, methylprednisolone sodium succinate, up to 40 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, zoledronic acid (zometa), 1 mg Unclassified drugs Infusion, normal saline solution , 1000 cc Infusion, normal saline solution , 250 cc Injection, doxorubicin hydrochloride, 10 mg Injection, bortezomib, 0. 1 mg Injection, carboplatin, 50 mg Cyclophosphamide, 100 mg Injection, fluorouracil, 500 mg Injection, gemcitabine hydrochloride, 200 mg Injection, paclitaxel, 30 mg Injection, pemetrexed, 10 mg Injection, rituximab, 100 mg Injection, trastuzumab, 10 mg Vincristine sulfate, 1 mg Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Collection of blood specimen from a completely implantable venous access device Needle or trocar bone marrow biopsy Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Automated urinalysis test Carcinoembryonic antigen (CEA) protein level Blood creatinine level Ferritin (blood protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level PSA (prostate specific antigen) measurement Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 30 minutes New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Initial hospital inpatient care, typically 50 minutes per day Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Administration of influenza virus vaccine Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, iron dextran, 50 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, methylprednisolone sodium succinate, up to 40 mg Injection, triptorelin pamoate, 3. 75 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Unclassified drugs Infusion, normal saline solution , 1000 cc Infusion, normal saline solution , 250 cc Injection, bendamustine hcl, 1 mg Injection, bortezomib, 0. 1 mg Injection, carboplatin, 50 mg Cyclophosphamide, 100 mg Injection, docetaxel, 1 mg Injection, etoposide, 10 mg Injection, gemcitabine hydrochloride, 200 mg Injection, paclitaxel, 30 mg Injection, pemetrexed, 10 mg Injection, rituximab, 100 mg Injection, trastuzumab, 10 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)', 'New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy Vaccine for influenza injection into muscle, patient 3 years and older Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Administration of influenza virus vaccine Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Injection, carboplatin, 50 mg', 'Needle or trocar bone marrow biopsy CT scan chest before and after contrast CT scan of abdomen and pelvis Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, clotting time Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Administration of influenza virus vaccine Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, leucovorin calcium, per 50 mg Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, granisetron hydrochloride, 100 mcg Injection, iron sucrose, 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, magnesium sulfate, per 500 mg Infusion, normal saline solution , 1000 cc Injection, carboplatin, 50 mg Injection, fluorouracil, 500 mg Injection, rituximab, 100 mg Injection, fulvestrant, 25 mg Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy CT scan chest CT scan chest with contrast CT scan chest before and after contrast CT scan of abdomen and pelvis CT scan of abdomen and pelvis Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, clotting time Flow cytometry technique for DNA or cell analysis Flow cytometry technique for DNA or cell analysis Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, testosterone cypionate, 1 cc, 200 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 300 mcg Injection, filgrastim (g-csf), 480 mcg Injection, granisetron hydrochloride, 100 mcg Injection, iron sucrose, 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, rasburicase, 0. 5 mg Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution , 1000 cc Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Injection, fluorouracil, 500 mg Injection, paclitaxel, 30 mg Injection, rituximab, 100 mg Zoldedronic acid 1mg Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Collection of blood specimen from a completely implantable venous access device Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, comprehensive group of blood chemicals Carcinoembryonic antigen (CEA) protein level Ferritin (blood protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level PSA (prostate specific antigen) measurement Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Immunologic analysis for detection of tumor antigen Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Refilling and maintenance of portable pump New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Subsequent hospital inpatient care, typically 25 minutes per day Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 300 mcg Injection, granisetron hydrochloride, 100 mcg Injection, iron sucrose, 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Infusion, normal saline solution , 1000 cc Injection, carboplatin, 50 mg', 'Insertion of needle into vein for collection of blood sample Transfusion of blood or blood products Collection of blood specimen from central or peripheral venous catheter Needle or trocar bone marrow biopsy Blood test, comprehensive group of blood chemicals Magnesium level Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Refilling and maintenance of portable pump Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes Moderate sedation services by physician also performing a procedure, each additional 15 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Hospital discharge day management, 30 minutes or less Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, daptomycin, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, ertapenem sodium, 500 mg Injection, filgrastim (g-csf), 300 mcg Injection, filgrastim (g-csf), 480 mcg Injection, immune globulin (privigen), intravenous, non-lyophilized (e. g. liquid), 500 mg Injection, lorazepam, 2 mg Injection, micafungin sodium, 1 mg Injection, midazolam hydrochloride, per 1 mg Injection, ondansetron hydrochloride, per 1 mg Injection, fentanyl citrate, 0. 1 mg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc', 'Insertion of needle into vein for collection of blood sample Transfusion of blood or blood products Collection of blood specimen from central or peripheral venous catheter Needle or trocar bone marrow biopsy Blood test, comprehensive group of blood chemicals Magnesium level Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Refilling and maintenance of portable pump Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Hospital discharge day management, 30 minutes or less Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, daptomycin, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 300 mcg Injection, filgrastim (g-csf), 480 mcg Injection, lorazepam, 2 mg Injection, micafungin sodium, 1 mg Injection, midazolam hydrochloride, per 1 mg Injection, ondansetron hydrochloride, per 1 mg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc', 'Insertion of needle into vein for collection of blood sample Collection of blood specimen from central or peripheral venous catheter Needle or trocar bone marrow biopsy Blood test, comprehensive group of blood chemicals Magnesium level Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Refilling and maintenance of portable pump New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Hospital discharge day management, 30 minutes or less Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, daptomycin, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, ertapenem sodium, 500 mg Injection, filgrastim (g-csf), 300 mcg Injection, filgrastim (g-csf), 480 mcg Injection, furosemide, up to 20 mg Injection, lorazepam, 2 mg Injection, micafungin sodium, 1 mg Injection, midazolam hydrochloride, per 1 mg Injection, ondansetron hydrochloride, per 1 mg Injection, fentanyl citrate, 0. 1 mg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc', 'Insertion of needle into vein for collection of blood sample Bone marrow aspiration Needle or trocar bone marrow biopsy Blood test, comprehensive group of blood chemicals Phenobarbital level Manual urinalysis test with examination using microscope Carcinoembryonic antigen (CEA) protein level Cyanocobalamin (vitamin B-12) level Ferritin (blood protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level PSA (prostate specific antigen) measurement Blood test, thyroid stimulating hormone (TSH) Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Red blood count, automated test Blood test, clotting time Coagulation assessment blood test Vaccine for influenza injection Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 30 minutes New patient office or other outpatient visit, typically 45 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Initial hospital inpatient care, typically 30 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Administration of influenza virus vaccine Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 300 mcg Injection, granisetron hydrochloride, 100 mcg Injection, iron dextran, 50 mg Injection, levofloxacin, 250 mg Injection, pamidronate disodium, per 30 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Unclassified drugs Infusion, normal saline solution , 250 cc Injection, carboplatin, 50 mg Injection, fluorouracil, 500 mg Injection, paclitaxel, 30 mg', 'Insertion of needle into vein for collection of blood sample Declotting infusion of implanted central venous access device or catheter Needle or trocar bone marrow biopsy CT scan head or brain before and after contrast X-ray of chest, 2 views, front and side CT scan chest with contrast CT scan of abdomen and pelvis CT scan of abdomen and pelvis Nuclear medicine study with CT imaging skull base to mid-thigh Manual urinalysis test with examination using microscope Blood creatinine level Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 30 minutes per day Initial hospital inpatient care, typically 50 minutes per day Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Hospital discharge day management, 30 minutes or less Hospital discharge day management, more than 30 minutes Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Administration of influenza virus vaccine Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, leucovorin calcium, per 50 mg Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, granisetron hydrochloride, 100 mcg Injection, lorazepam, 2 mg Injection, midazolam hydrochloride, per 1 mg Injection, morphine sulfate, up to 10 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, alteplase recombinant, 1 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, zoledronic acid (zometa), 1 mg Unclassified drugs Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Injection, doxorubicin hydrochloride, 10 mg Injection, carboplatin, 50 mg Cyclophosphamide, 100 mg Injection, fluorouracil, 500 mg Injection, irinotecan, 20 mg Injection, paclitaxel, 30 mg Injection, rituximab, 100 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) Zoldedronic acid 1mg Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml', 'Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Administration of influenza virus vaccine Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, granisetron hydrochloride, 100 mcg Injection, iron sucrose, 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, sargramostim (gm-csf), 50 mcg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution , 1000 cc Leuprolide acetate (for depot suspension), 7. 5 mg Injection, rituximab, 100 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Hospital observation care typically 50 minutes Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 300 mcg Injection, fosaprepitant, 1 mg Injection, mannitol, 25% in 50 ml Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Injection, zoledronic acid (zometa), 1 mg Unclassified drugs Injection, carboplatin, 50 mg Injection, cisplatin, powder or solution, 10 mg Injection, rituximab, 100 mg Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Complete blood cell count (red cells, white blood cell, platelets), automated test Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Unclassified drugs Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc', 'Insertion of needle into vein for collection of blood sample CT scan chest CT scan chest with contrast CT scan of abdomen and pelvis CT scan of abdomen and pelvis CT scan of abdomen and pelvis Bone and joint imaging, whole body Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Manual urinalysis test with examination using microscope Urinalysis, manual test Carcinoembryonic antigen (CEA) protein level Blood creatinine level Ferritin (blood protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level Phosphate level PSA (prostate specific antigen) measurement Blood test, thyroid stimulating hormone (TSH) Uric acid level, blood Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Hydration infusion into a vein 31 minutes to 1 hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 30 minutes New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Subsequent hospital inpatient care, typically 25 minutes per day Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Technetium tc-99m oxidronate, diagnostic, per study dose, up to 30 millicuries Administration of influenza virus vaccine Injection, ceftriaxone sodium, per 250 mg Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, fosaprepitant, 1 mg Injection, granisetron hydrochloride, 100 mcg Injection, enoxaparin sodium, 10 mg Injection, iron sucrose, 1 mg Injection, meperidine hydrochloride, per 100 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, zoledronic acid (zometa), 1 mg 5% dextrose/normal saline (500 ml = 1 unit) Injection, cabazitaxel, 1 mg Injection, cisplatin, powder or solution, 10 mg Injection, degarelix, 1 mg Injection, docetaxel, 1 mg Injection, gemcitabine hydrochloride, 200 mg Leuprolide acetate (for depot suspension), 7. 5 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) Zoldedronic acid 1mg Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Collection of blood specimen from a completely implantable venous access device X-ray of chest, 2 views, front and side CT scan chest CT scan chest with contrast CT scan abdomen with contrast CT scan of abdomen and pelvis CT scan of abdomen and pelvis Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, comprehensive group of blood chemicals Blood creatinine level Ferritin (blood protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Administration of influenza virus vaccine Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, immune globulin, (octagam), intravenous, non-lyophilized (e. g. liquid), 500 mg Injection, granisetron hydrochloride, 100 mcg Injection, iron sucrose, 1 mg Injection, levofloxacin, 250 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, potassium chloride, per 2 meq Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution , 1000 cc Injection, carboplatin, 50 mg Cyclophosphamide, 100 mg Injection, docetaxel, 1 mg Injection, paclitaxel, 30 mg Injection, pemetrexed, 10 mg Injection, rituximab, 100 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) Zoldedronic acid 1mg Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein using push technique Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, ondansetron hydrochloride, per 1 mg Injection, ranitidine hydrochloride, 25 mg Injection, magnesium sulfate, per 500 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution , 250 cc', 'Insertion of needle into vein for collection of blood sample Blood test, comprehensive group of blood chemicals Carcinoembryonic antigen (CEA) protein level Gammaglobulin (immune system protein) measurement Lactate dehydrogenase (enzyme) level Complete blood cell count (red cells, white blood cell, platelets), automated test Immunologic analysis for detection of tumor antigen Vaccine for influenza injection Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 45 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Subsequent hospital inpatient care, typically 15 minutes per day Administration of influenza virus vaccine Injection, leucovorin calcium, per 50 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, lorazepam, 2 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, zoledronic acid (zometa), 1 mg Unclassified drugs Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Injection, docetaxel, 1 mg Injection, fluorouracil, 500 mg Injection, gemcitabine hydrochloride, 200 mg Injection, paclitaxel, 30 mg Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Blood test, comprehensive group of blood chemicals Carcinoembryonic antigen (CEA) protein level Cyanocobalamin (vitamin B-12) level Ferritin (blood protein) level Gammaglobulin (immune system protein) measurement Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level PSA (prostate specific antigen) measurement Complete blood cell count (red cells, white blood cell, platelets), automated test Immunologic analysis for detection of tumor antigen Vaccine for influenza injection Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 45 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Administration of influenza virus vaccine Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, lorazepam, 2 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, zoledronic acid (zometa), 1 mg Unclassified drugs Infusion, normal saline solution , 1000 cc Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Cyclophosphamide, 100 mg Injection, docetaxel, 1 mg Injection, gemcitabine hydrochloride, 200 mg Injection, oxaliplatin, 0. 5 mg Injection, paclitaxel, 30 mg Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, granisetron hydrochloride, 100 mcg Injection, ondansetron hydrochloride, per 1 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Injection, carboplatin, 50 mg', 'Collection of blood specimen from a completely implantable venous access device Needle or trocar bone marrow biopsy Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, iron sucrose, 1 mg Injection, pegfilgrastim, 6 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Infusion, normal saline solution , 1000 cc', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy CT scan of neck CT scan of neck CT scan chest CT scan chest with contrast CT scan of abdomen and pelvis CT scan of abdomen and pelvis Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, comprehensive group of blood chemicals Carcinoembryonic antigen (CEA) protein level Ferritin (blood protein) level Lactate dehydrogenase (enzyme) level Thyroxine (thyroid chemical) measurement Blood test, thyroid stimulating hormone (TSH) Uric acid level, blood Complete blood cell count (red cells, white blood cell, platelets), automated test Bone marrow, smear interpretation Blood test, clotting time Immunologic analysis for detection of tumor antigen Routine electrocardiogram (EKG) using at least 12 leads with interpretation and report Respiratory inhaled pressure or nonpressure treatment to relieve airway obstruction or for sputum specimen Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Refilling and maintenance of portable pump Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Administration of influenza virus vaccine Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, calcium gluconate, per 10 ml Injection, leucovorin calcium, per 50 mg Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, fosaprepitant, 1 mg Injection, furosemide, up to 20 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, sodium ferric gluconate complex in sucrose injection, 12. 5 mg Injection, vancomycin hcl, 500 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Injection, zoledronic acid (zometa), 1 mg Injection, zoledronic acid (reclast), 1 mg Unclassified drugs Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc 5% dextrose/water (500 ml = 1 unit) Albuterol, up to 2. 5 mg and ipratropium bromide, up to 0. 5 mg, fda-approved final product, non-compounded, administered through dme Injection, doxorubicin hydrochloride, 10 mg Injection, bevacizumab, 10 mg Injection, bortezomib, 0. 1 mg Injection, carboplatin, 50 mg Injection, cisplatin, powder or solution, 10 mg Cyclophosphamide, 100 mg Injection, docetaxel, 1 mg Injection, etoposide, 10 mg Injection, fluorouracil, 500 mg Injection, gemcitabine hydrochloride, 200 mg Injection, oxaliplatin, 0. 5 mg Injection, paclitaxel, 30 mg Injection, pemetrexed, 10 mg Injection, rituximab, 100 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria) Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Complete blood cell count (red cells, white blood cell, platelets), automated test Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, palonosetron hcl, 25 mcg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Infusion, normal saline solution , 250 cc Injection, rituximab, 100 mg', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy X-ray of chest, 2 views, front and side CT scan chest CT scan chest with contrast CT scan of abdomen and pelvis CT scan of abdomen and pelvis Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Kidney function blood test panel Urinalysis, manual test Stool analysis for blood to screen for colon tumors Carcinoembryonic antigen (CEA) protein level Ferritin (blood protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level PSA (prostate specific antigen) measurement Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Red blood count, manual test Blood test, clotting time Red blood cell sedimentation rate, to detect inflammation Immunologic analysis for detection of tumor antigen Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Hospital discharge day management, more than 30 minutes Critical care delivery critically ill or injured patient, first 30-74 minutes Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Administration of influenza virus vaccine Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, granisetron hydrochloride, 100 mcg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, methylprednisolone sodium succinate, up to 125 mg Infusion, normal saline solution , 1000 cc Injection, carboplatin, 50 mg Injection, paclitaxel, 30 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Declotting infusion of implanted central venous access device or catheter CT scan chest with contrast CT scan abdomen with contrast Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, granisetron hydrochloride, 100 mcg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, sargramostim (gm-csf), 50 mcg Injection, sodium ferric gluconate complex in sucrose injection, 12. 5 mg Injection, alteplase recombinant, 1 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Cyclophosphamide, 100 mg Injection, fluorouracil, 500 mg Injection, pemetrexed, 10 mg Injection, rituximab, 100 mg Zoldedronic acid 1mg Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Needle or trocar bone marrow biopsy CT scan head or brain before and after contrast CT scan of neck CT scan of neck CT scan chest CT scan chest with contrast CT scan of abdomen and pelvis CT scan of abdomen and pelvis Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, leucovorin calcium, per 50 mg Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, dexamethasone sodium phosphate, 1mg Injection, hydromorphone, up to 4 mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, granisetron hydrochloride, 100 mcg Injection, hydrocortisone sodium succinate, up to 100 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, sargramostim (gm-csf), 50 mcg Injection, sodium ferric gluconate complex in sucrose injection, 12. 5 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution , 1000 cc 5% dextrose/normal saline (500 ml = 1 unit) Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Injection, docetaxel, 1 mg Injection, etoposide, 10 mg Injection, fluorouracil, 500 mg Injection, gemcitabine hydrochloride, 200 mg Injection, paclitaxel, 30 mg Injection, rituximab, 100 mg Zoldedronic acid 1mg Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Bone marrow aspiration Needle or trocar bone marrow biopsy X-ray of chest, 2 views, front and side CT scan chest CT scan chest with contrast CT scan of abdomen and pelvis CT scan of abdomen and pelvis Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Urinalysis, manual test Beta-2 microglobulin (protein) level Carcinoembryonic antigen (CEA) protein level Blood creatinine level Cyanocobalamin (vitamin B-12) level Erythropoietin (protein) level Ferritin (blood protein) level Folic acid level Gammaglobulin (immune system protein) measurement Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level Nephelometry, test method using light PSA (prostate specific antigen) measurement Protein measurement, serum Blood test, thyroid stimulating hormone (TSH) Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Measurement C-reactive protein for detection of infection or inflammation Immunologic analysis for detection of tumor antigen Immunologic analysis for detection of tumor antigen Immunologic analysis technique on serum Hepatitis B core antibody measurement Hepatitis B core antibody (IgM) measurement Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Refilling and maintenance of portable pump Irrigation of implanted venous access drug delivery device Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Administration of influenza virus vaccine Injection, levoleucovorin calcium, 0. 5 mg Injection, ceftriaxone sodium, per 250 mg Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, decitabine, 1 mg Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 300 mcg Injection, filgrastim (g-csf), 480 mcg Injection fluconazole, 200 mg Injection, immune globulin, (octagam), intravenous, non-lyophilized (e. g. liquid), 500 mg Injection, granisetron hydrochloride, 100 mcg Injection, fondaparinux sodium, 0. 5 mg Injection, iron dextran, 50 mg Injection, iron sucrose, 1 mg Injection, furosemide, up to 20 mg Injection, levofloxacin, 250 mg Injection, lorazepam, 2 mg Injection, meperidine hydrochloride, per 100 mg Injection, octreotide, depot form for intramuscular injection, 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, metoclopramide hcl, up to 10 mg Injection, methylprednisolone sodium succinate, up to 40 mg Injection, triptorelin pamoate, 3. 75 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Injection, azacitidine, 1 mg Injection, bevacizumab, 10 mg Injection, bortezomib, 0. 1 mg Injection, carboplatin, 50 mg Injection, cisplatin, powder or solution, 10 mg Cyclophosphamide, 100 mg Injection, etoposide, 10 mg Injection, fluorouracil, 500 mg Injection, gemcitabine hydrochloride, 200 mg Injection, oxaliplatin, 0. 5 mg Injection, paclitaxel protein-bound particles, 1 mg Injection, paclitaxel, 30 mg Injection, pemetrexed, 10 mg Injection, rituximab, 100 mg Injection, fulvestrant, 25 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Bone marrow aspiration Needle or trocar bone marrow biopsy X-ray of chest, 2 views, front and side CT scan chest CT scan chest with contrast CT scan of abdomen and pelvis CT scan of abdomen and pelvis CT scan of abdomen and pelvis Nuclear medicine study with CT imaging skull base to mid-thigh Nuclear medicine study with CT imaging whole body Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Blood test, lipids (cholesterol and triglycerides) Urinalysis, manual test Beta-2 microglobulin (protein) level Carcinoembryonic antigen (CEA) protein level Blood creatinine level Cyanocobalamin (vitamin B-12) level Erythropoietin (protein) level Ferritin (blood protein) level Folic acid level Gammaglobulin (immune system protein) measurement Haptoglobin (serum protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level Nephelometry, test method using light PSA (prostate specific antigen) measurement Protein measurement, serum Thyroxine (thyroid chemical) measurement Blood test, thyroid stimulating hormone (TSH) Uric acid level, blood Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Immunologic analysis for detection of tumor antigen Immunologic analysis for detection of tumor antigen Immunologic analysis for detection of tumor antigen Immunologic analysis technique on serum Hepatitis B core antibody measurement Hepatitis B core antibody (IgM) measurement Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Refilling and maintenance of portable pump Irrigation of implanted venous access drug delivery device Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Administration of influenza virus vaccine Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous Injection, atropine sulfate, 0. 01 mg Injection, levoleucovorin calcium, 0. 5 mg Injection, ceftriaxone sodium, per 250 mg Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, decitabine, 1 mg Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 300 mcg Injection, filgrastim (g-csf), 480 mcg Injection fluconazole, 200 mg Injection, immune globulin, (octagam), intravenous, non-lyophilized (e. g. liquid), 500 mg Injection, granisetron hydrochloride, 100 mcg Injection, fondaparinux sodium, 0. 5 mg Injection, iron dextran, 50 mg Injection, iron sucrose, 1 mg Injection, furosemide, up to 20 mg Injection, levofloxacin, 250 mg Injection, lorazepam, 2 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, metoclopramide hcl, up to 10 mg Injection, alteplase recombinant, 1 mg Injection, triptorelin pamoate, 3. 75 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Injection, zoledronic acid (zometa), 1 mg Injection, zoledronic acid (reclast), 1 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Injection, doxorubicin hydrochloride, 10 mg Injection, azacitidine, 1 mg Injection, bevacizumab, 10 mg Injection, bortezomib, 0. 1 mg Injection, carboplatin, 50 mg Injection, cisplatin, powder or solution, 10 mg Cyclophosphamide, 100 mg Injection, docetaxel, 1 mg Injection, etoposide, 10 mg Injection, fluorouracil, 500 mg Injection, gemcitabine hydrochloride, 200 mg Injection, irinotecan, 20 mg Injection, oxaliplatin, 0. 5 mg Injection, paclitaxel protein-bound particles, 1 mg Injection, paclitaxel, 30 mg Injection, pemetrexed, 10 mg Injection, rituximab, 100 mg Injection, trastuzumab, 10 mg Injection, fulvestrant, 25 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) Zoldedronic acid 1mg', 'Collection of blood specimen from a completely implantable venous access device Needle or trocar bone marrow biopsy Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 30 minutes New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, granisetron hydrochloride, 100 mcg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Infusion, normal saline solution , 1000 cc Injection, carboplatin, 50 mg Injection, fluorouracil, 500 mg', 'Insertion of needle into vein for collection of blood sample Collection of blood specimen from a completely implantable venous access device Blood test, basic group of blood chemicals Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Complete blood cell count (red cells, white blood cell, platelets), automated test Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Administration of influenza virus vaccine Injection, leucovorin calcium, per 50 mg Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, magnesium sulfate, per 500 mg Unclassified drugs Injection, carboplatin, 50 mg Injection, fluorouracil, 500 mg Injection, oxaliplatin, 0. 5 mg Injection, paclitaxel, 30 mg Injection, rituximab, 100 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)', 'Insertion of needle into vein for collection of blood sample Collection of blood specimen from a completely implantable venous access device Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Red blood cell concentration measurement Hemoglobin measurement Complete blood cell count (red cells, white blood cell, platelets), automated test Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Subsequent hospital inpatient care, typically 25 minutes per day Administration of influenza virus vaccine Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Unclassified drugs Injection, carboplatin, 50 mg', 'Insertion of needle into vein for collection of blood sample CT scan chest with contrast CT scan of abdomen and pelvis Radiation treatment delivery, three or more treatment areas Intensity modulated radiation treatment delivery Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Blood test, lipids (cholesterol and triglycerides) Manual urinalysis test with examination using microscope Beta-2 microglobulin (protein) level Carcinoembryonic antigen (CEA) protein level Cyanocobalamin (vitamin B-12) level Ferritin (blood protein) level Gammaglobulin (immune system protein) measurement Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Thyroxine (thyroid chemical) measurement Blood test, thyroid stimulating hormone (TSH) Uric acid level, blood Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Immunologic analysis for detection of tumor antigen Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, granisetron hydrochloride, 100 mcg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, magnesium sulfate, per 500 mg Infusion, normal saline solution , 1000 cc Injection, carboplatin, 50 mg Injection, fluorouracil, 500 mg Injection, paclitaxel, 30 mg Injection, rituximab, 100 mg Zoldedronic acid 1mg Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Hydration infusion into a vein each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Refilling and maintenance of portable pump New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Hospital discharge day management, 30 minutes or less Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, heparin sodium, (heparin lock flush), per 10 units Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Unclassified drugs Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Injection, fluorouracil, 500 mg Leuprolide acetate (for depot suspension), 7. 5 mg', 'Insertion of needle into vein for collection of blood sample CT scan chest CT scan chest with contrast CT scan abdomen with contrast CT scan of abdomen and pelvis Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, comprehensive group of blood chemicals Manual urinalysis test with examination using microscope PSA (prostate specific antigen) measurement Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 45 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Administration of influenza virus vaccine Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, granisetron hydrochloride, 100 mcg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Infusion, normal saline solution , 1000 cc Injection, carboplatin, 50 mg Injection, paclitaxel, 30 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) Zoldedronic acid 1mg Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample CT scan chest with contrast CT scan of abdomen and pelvis Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, comprehensive group of blood chemicals Manual urinalysis test with examination using microscope Ferritin (blood protein) level Iron level Iron binding capacity Magnesium level Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Refilling and maintenance of portable pump New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Hospital discharge day management, 30 minutes or less Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Administration of influenza virus vaccine Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, granisetron hydrochloride, 100 mcg Injection, hydrocortisone sodium succinate, up to 100 mg Injection, morphine sulfate, up to 10 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, alteplase recombinant, 1 mg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Unclassified drugs Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Injection, carboplatin, 50 mg Injection, cisplatin, powder or solution, 10 mg Injection, docetaxel, 1 mg Injection, gemcitabine hydrochloride, 200 mg Injection, paclitaxel, 30 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Collection of blood specimen from a completely implantable venous access device Blood test, comprehensive group of blood chemicals Urinalysis, manual test Ferritin (blood protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Physician certification for medicare-covered home health  services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial imple Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, heparin sodium, (heparin lock flush), per 10 units Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Infusion, normal saline solution , 1000 cc', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy CT scan chest CT scan chest with contrast CT scan of abdomen and pelvis CT scan of abdomen and pelvis Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, comprehensive group of blood chemicals Manual urinalysis test with examination using microscope Beta-2 microglobulin (protein) level Lactate dehydrogenase (enzyme) level Magnesium level Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Red blood cell sedimentation rate, to detect inflammation Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Hospital discharge day management, 30 minutes or less Hospital discharge day management, more than 30 minutes Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, ondansetron hydrochloride, per 1 mg Injection, pegfilgrastim, 6 mg Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Injection, carboplatin, 50 mg Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Injection, dexamethasone sodium phosphate, 1mg Injection, palonosetron hcl, 25 mcg Injection, rituximab, 100 mg', 'Insertion of needle into vein for collection of blood sample Established patient office or other outpatient, visit typically 25 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day', 'Insertion of needle into vein for collection of blood sample Blood test, basic group of blood chemicals Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein 31 minutes to 1 hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein using push technique Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient, visit typically 25 minutes Subsequent hospital inpatient care, typically 35 minutes per day Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, heparin sodium, (heparin lock flush), per 10 units Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Infusion, normal saline solution , 1000 cc Injection, carboplatin, 50 mg Injection, docetaxel, 1 mg Injection, gemcitabine hydrochloride, 200 mg Leuprolide acetate (for depot suspension), 7. 5 mg Injection, oxaliplatin, 0. 5 mg Injection, paclitaxel, 30 mg Injection, pemetrexed, 10 mg', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy Blood test, basic group of blood chemicals Complete blood cell count (red cells, white blood cell, platelets), automated test Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 300 mcg Injection, heparin sodium, (heparin lock flush), per 10 units Injection, ondansetron hydrochloride, per 1 mg Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Injection, azacitidine, 1 mg Injection, bortezomib, 0. 1 mg Cyclophosphamide, 100 mg Injection, rituximab, 100 mg Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Blood test, basic group of blood chemicals Urinalysis, manual test Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein using push technique Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Initial hospital inpatient care, typically 50 minutes per day Injection, atropine sulfate, 0. 01 mg Injection, leucovorin calcium, per 50 mg Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 300 mcg Injection, filgrastim (g-csf), 480 mcg Injection, fosaprepitant, 1 mg Injection, heparin sodium, (heparin lock flush), per 10 units Injection, morphine sulfate, up to 10 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Injection, fluorouracil, 500 mg Injection, gemcitabine hydrochloride, 200 mg Injection, irinotecan, 20 mg Injection, oxaliplatin, 0. 5 mg Injection, paclitaxel, 30 mg', 'Insertion of needle into vein for collection of blood sample Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Urinalysis, manual test Carcinoembryonic antigen (CEA) protein level Ferritin (blood protein) level Gammaglobulin (immune system protein) measurement Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level Nephelometry, test method using light Protein measurement, serum Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Immunologic analysis for detection of tumor antigen Hydration infusion into a vein 31 minutes to 1 hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Injection, atropine sulfate, 0. 01 mg Injection, levoleucovorin calcium, 0. 5 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution , 250 cc 5% dextrose/water (500 ml = 1 unit) Infusion, d5w, 1000 cc Injection, fluorouracil, 500 mg Injection, irinotecan, 20 mg Injection, rituximab, 100 mg', 'Insertion of needle into vein for collection of blood sample Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Urinalysis, manual test Carcinoembryonic antigen (CEA) protein level Cyanocobalamin (vitamin B-12) level Ferritin (blood protein) level Gammaglobulin (immune system protein) measurement Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level Protein measurement, serum Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Red blood cell sedimentation rate, to detect inflammation Immunologic analysis for detection of tumor antigen Hydration infusion into a vein 31 minutes to 1 hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Administration of influenza virus vaccine Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, lorazepam, 2 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution , 250 cc Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)', 'Insertion of needle into vein for collection of blood sample Collection of blood specimen from a completely implantable venous access device Needle or trocar bone marrow biopsy Blood test, comprehensive group of blood chemicals Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Injection, leucovorin calcium, per 50 mg Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, heparin sodium, (heparin lock flush), per 10 units Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, magnesium sulfate, per 500 mg Injection, zoledronic acid (reclast), 1 mg Unclassified drugs Infusion, normal saline solution, sterile (500 ml=1 unit) 5% dextrose/water (500 ml = 1 unit) Injection, doxorubicin hydrochloride, 10 mg Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Injection, docetaxel, 1 mg Injection, fluorouracil, 500 mg Injection, gemcitabine hydrochloride, 200 mg Injection, oxaliplatin, 0. 5 mg Injection, paclitaxel protein-bound particles, 1 mg Injection, pemetrexed, 10 mg Injection, rituximab, 100 mg Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Beta-2 microglobulin (protein) level Bilirubin level Carcinoembryonic antigen (CEA) protein level Cyanocobalamin (vitamin B-12) level Ferritin (blood protein) level Folic acid level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level Phosphate level Thyroxine (thyroid chemical) measurement Blood test, thyroid stimulating hormone (TSH) Uric acid level, blood Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Immunologic analysis for detection of tumor antigen Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, fosaprepitant, 1 mg Injection, heparin sodium, (heparin lock flush), per 10 units Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, ranitidine hydrochloride, 25 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution , 250 cc', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy Urinalysis, manual test Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Refilling and maintenance of portable pump Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Administration of influenza virus vaccine Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, leucovorin calcium, per 50 mg Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, heparin sodium, (heparin lock flush), per 10 units Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Injection, docetaxel, 1 mg Injection, fluorouracil, 500 mg Injection, paclitaxel, 30 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Collection of blood specimen from central or peripheral venous catheter Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Blood test, lipids (cholesterol and triglycerides) Liver function blood test panel Lactate dehydrogenase (enzyme) level Magnesium level Phosphate level Testosterone (hormone) level Thyroxine (thyroid chemical) measurement Blood test, thyroid stimulating hormone (TSH) Uric acid level, blood Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Injection, dexamethasone sodium phosphate, 1mg Infusion, normal saline solution , 250 cc Injection, ipilimumab, 1 mg', 'Insertion of needle into vein for collection of blood sample Bone marrow aspiration Needle or trocar bone marrow biopsy CT scan chest with contrast CT scan of abdomen and pelvis Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, comprehensive group of blood chemicals Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Administration of influenza virus vaccine Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, granisetron hydrochloride, 100 mcg Injection, iron dextran, 50 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, rituximab, 100 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) Zoldedronic acid 1mg Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Bone marrow aspiration Needle or trocar bone marrow biopsy Blood test, comprehensive group of blood chemicals Kidney function blood test panel Beta-2 microglobulin (protein) level Vitamin D-3 level Carcinoembryonic antigen (CEA) protein level Creatine kinase (cardiac enzyme) level Cyanocobalamin (vitamin B-12) level Ferritin (blood protein) level Folic acid level Gammaglobulin (immune system protein) measurement Glutamyltransferase (liver enzyme) level Haptoglobin (serum protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level Parathormone (parathyroid hormone) level Phosphate level PSA (prostate specific antigen) measurement Thyroxine (thyroid chemical) measurement Blood test, thyroid stimulating hormone (TSH) Transferrin (iron binding protein) level Thyroid hormone, T3 measurement Uric acid level, blood Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Red blood cell sedimentation rate, to detect inflammation Screening test for autoimmune disorder Measurement C-reactive protein for detection of infection or inflammation Measurement of antibody for assessment of autoimmune disorder Immunologic analysis for detection of tumor antigen Immunologic analysis for detection of tumor antigen Microsomal antibodies (autoantibody) measurement Rheumatoid factor level Thyroglobulin (thyroid protein) antibody measurement Flow cytometry technique for DNA or cell analysis Flow cytometry technique for DNA or cell analysis Flow cytometry technique for DNA or cell analysis Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Hospital observation or inpatient care moderate severity Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, iron sucrose, 1 mg Injection, octreotide, depot form for intramuscular injection, 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc', 'Insertion of needle into vein for collection of blood sample Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour New patient office or other outpatient visit, typically 30 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Initial hospital inpatient care, typically 50 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, ondansetron hydrochloride, per 1 mg Injection, pegfilgrastim, 6 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, bevacizumab, 10 mg', 'Insertion of needle into vein for collection of blood sample Bone marrow aspiration Needle or trocar bone marrow biopsy CT scan chest CT scan chest with contrast CT scan of abdomen and pelvis Nuclear medicine study with CT imaging skull base to mid-thigh Blood glucose (sugar) measurement using reagent strip Blood glucose (sugar) test performed by hand-held instrument Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Infusion of chemotherapy into a vein using push technique Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Prolonged office or other outpatient service first hour Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, granisetron hydrochloride, 100 mcg Injection, heparin sodium, per 1000 units Injection, iron sucrose, 1 mg Injection, mannitol, 25% in 50 ml Injection, pegfilgrastim, 6 mg Injection, sargramostim (gm-csf), 50 mcg Injection, methylprednisolone sodium succinate, up to 40 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Injection, zoledronic acid (zometa), 1 mg Unclassified drugs Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Injection, carboplatin, 50 mg Injection, cisplatin, powder or solution, 10 mg Injection, docetaxel, 1 mg Injection, fluorouracil, 500 mg Injection, paclitaxel, 30 mg Zoldedronic acid 1mg High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Bone marrow aspiration Needle or trocar bone marrow biopsy CT scan chest with contrast CT scan of abdomen and pelvis Nuclear medicine study with CT imaging skull base to mid-thigh Blood glucose (sugar) measurement using reagent strip Blood glucose (sugar) test performed by hand-held instrument Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Prolonged office or other outpatient service first hour Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, granisetron hydrochloride, 100 mcg Injection, heparin sodium, per 1000 units Injection, methylprednisolone sodium succinate, up to 40 mg Unclassified drugs Injection, carboplatin, 50 mg Injection, paclitaxel, 30 mg Injection, rituximab, 100 mg High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Bone marrow aspiration Needle or trocar bone marrow biopsy CT scan chest CT scan chest with contrast CT scan of abdomen and pelvis CT scan of abdomen and pelvis Nuclear medicine study with CT imaging skull base to mid-thigh Blood glucose (sugar) measurement using reagent strip Blood glucose (sugar) test performed by hand-held instrument Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Infusion of chemotherapy into a vein using push technique Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 30 minutes New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Injection, leucovorin calcium, per 50 mg Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, granisetron hydrochloride, 100 mcg Injection, heparin sodium, per 1000 units Injection, iron sucrose, 1 mg Injection, sargramostim (gm-csf), 50 mcg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Injection, zoledronic acid (zometa), 1 mg Unclassified drugs Infusion, normal saline solution , 1000 cc Injection, carboplatin, 50 mg Injection, fluorouracil, 500 mg Injection, paclitaxel, 30 mg Zoldedronic acid 1mg High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Declotting infusion of implanted central venous access device or catheter Needle or trocar bone marrow biopsy CT scan of neck CT scan chest CT scan chest with contrast CT scan of abdomen and pelvis CT scan of abdomen and pelvis Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Manual urinalysis test with examination using microscope Automated urinalysis test Beta-2 microglobulin (protein) level Stool analysis for blood to screen for colon tumors Carcinoembryonic antigen (CEA) protein level Cyanocobalamin (vitamin B-12) level Erythropoietin (protein) level Ferritin (blood protein) level Gammaglobulin (immune system protein) measurement Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level Nephelometry, test method using light PSA (prostate specific antigen) measurement Total protein level, blood Protein measurement, serum Blood test, thyroid stimulating hormone (TSH) Uric acid level, blood Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Red blood cell sedimentation rate, to detect inflammation Immunologic analysis for detection of tumor antigen Immunologic analysis technique on serum Flow cytometry technique for DNA or cell analysis Flow cytometry technique for DNA or cell analysis Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Refilling and maintenance of portable pump Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Administration of influenza virus vaccine Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, leucovorin calcium, per 50 mg Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, testosterone cypionate, 1 cc, 200 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, immune globulin, (octagam), intravenous, non-lyophilized (e. g. liquid), 500 mg Injection, granisetron hydrochloride, 100 mcg Injection, iron dextran, 50 mg Injection, iron sucrose, 1 mg Injection, furosemide, up to 20 mg Injection, lorazepam, 2 mg Injection, mannitol, 25% in 50 ml Injection, morphine sulfate, up to 10 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, methylprednisolone sodium succinate, up to 40 mg Injection, alteplase recombinant, 1 mg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Injection, zoledronic acid (zometa), 1 mg Unclassified drugs Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Injection, doxorubicin hydrochloride, 10 mg Injection, bendamustine hcl, 1 mg Injection, cisplatin, powder or solution, 10 mg Injection, docetaxel, 1 mg Injection, fluorouracil, 500 mg Injection, gemcitabine hydrochloride, 200 mg Leuprolide acetate (for depot suspension), 7. 5 mg Injection, rituximab, 100 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) Zoldedronic acid 1mg Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Urinalysis, manual test Automated urinalysis test Beta-2 microglobulin (protein) level Carcinoembryonic antigen (CEA) protein level Blood creatinine level Cyanocobalamin (vitamin B-12) level Erythropoietin (protein) level Ferritin (blood protein) level Folic acid level Gammaglobulin (immune system protein) measurement Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level Phosphate level PSA (prostate specific antigen) measurement Protein measurement, serum Thyroxine (thyroid chemical) measurement Blood test, thyroid stimulating hormone (TSH) Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Red blood count automated, with additional calculations Blood test, clotting time Immunologic analysis for detection of tumor antigen Immunologic analysis technique on serum Vaccine for pneumococcal polysaccharide for injection into muscle, patient 2 years or older Respiratory inhaled pressure or nonpressure treatment to relieve airway obstruction or for sputum specimen Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Hospital discharge day management, 30 minutes or less Administration of influenza virus vaccine Physician re-certification for medicare-covered home health  services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial im Physician certification for medicare-covered home health  services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial imple Injection, atropine sulfate, 0. 01 mg Injection, levoleucovorin calcium, 0. 5 mg Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, ertapenem sodium, 500 mg Injection, filgrastim (g-csf), 480 mcg Injection fluconazole, 200 mg Injection, fosaprepitant, 1 mg Injection, ibandronate sodium, 1 mg Injection, iron dextran, 50 mg Injection, levofloxacin, 250 mg Injection, lorazepam, 2 mg Injection, morphine sulfate, up to 10 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, methylprednisolone sodium succinate, up to 125 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Injection, zoledronic acid (zometa), 1 mg Injection, zoledronic acid (reclast), 1 mg Unclassified drugs Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Injection, docetaxel, 1 mg Injection, fluorouracil, 500 mg Injection, gemcitabine hydrochloride, 200 mg Injection, irinotecan, 20 mg Leuprolide acetate (for depot suspension), 7. 5 mg Injection, paclitaxel protein-bound particles, 1 mg Injection, paclitaxel, 30 mg Injection, rituximab, 100 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Blood test, comprehensive group of blood chemicals Carcinoembryonic antigen (CEA) protein level Cyanocobalamin (vitamin B-12) level Ferritin (blood protein) level Folic acid level Iron level Iron binding capacity Blood test, thyroid stimulating hormone (TSH) Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, granisetron hydrochloride, 100 mcg Injection, iron sucrose, 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Injection, gemcitabine hydrochloride, 200 mg Injection, oxaliplatin, 0. 5 mg', 'Insertion of needle into vein for collection of blood sample Bone marrow aspiration Needle or trocar bone marrow biopsy Urinalysis, manual test Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Administration of influenza virus vaccine Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)', 'Insertion of needle into vein for collection of blood sample Injection for removal of blood clot from external dialysis cannula Complete blood cell count (red cells, white blood cell, platelets), automated test Special stained specimen slides to identify organisms including interpretation and report Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, lorazepam, 2 mg Injection, ondansetron hydrochloride, per 1 mg Injection, ranitidine hydrochloride, 25 mg Injection, alteplase recombinant, 1 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Urinalysis, manual test Lactate dehydrogenase (enzyme) level Magnesium level Uric acid level, blood Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 300 mcg Injection, fosaprepitant, 1 mg Injection, granisetron hydrochloride, 100 mcg Injection, heparin sodium, (heparin lock flush), per 10 units Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Leuprolide acetate (for depot suspension), 7. 5 mg Injection, paclitaxel, 30 mg', 'Insertion of needle into vein for collection of blood sample CT scan chest with contrast CT scan of abdomen and pelvis Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, comprehensive group of blood chemicals Carcinoembryonic antigen (CEA) protein level Ferritin (blood protein) level Lactate dehydrogenase (enzyme) level Magnesium level PSA (prostate specific antigen) measurement Uric acid level, blood Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Prolonged office or other outpatient service first hour Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, heparin sodium, per 1000 units Injection, ondansetron hydrochloride, per 1 mg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution , 1000 cc Injection, carboplatin, 50 mg Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Needle or trocar bone marrow biopsy Needle or trocar bone marrow biopsy Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Refilling and maintenance of portable pump Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 30 minutes New patient office or other outpatient visit, typically 45 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, magnesium sulfate, per 500 mg Infusion, normal saline solution, sterile (500 ml=1 unit) Injection, carboplatin, 50 mg Injection, cisplatin, powder or solution, 10 mg Injection, docetaxel, 1 mg Injection, fluorouracil, 500 mg Injection, paclitaxel, 30 mg Injection, rituximab, 100 mg', 'Insertion of needle into vein for collection of blood sample Hydration infusion into a vein 31 minutes to 1 hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, sodium ferric gluconate complex in sucrose injection, 12. 5 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Infusion, normal saline solution , 250 cc', 'Insertion of needle into vein for collection of blood sample Blood test, comprehensive group of blood chemicals Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 45 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Initial hospital inpatient care, typically 50 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Hospital discharge day management, 30 minutes or less Injection, ceftriaxone sodium, per 250 mg Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, ketorolac tromethamine, per 15 mg Injection, ondansetron hydrochloride, per 1 mg Injection, ranitidine hydrochloride, 25 mg Injection, methylprednisolone sodium succinate, up to 40 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)', 'Insertion of needle into vein for collection of blood sample Transfusion of blood or blood products Bone marrow aspiration Needle or trocar bone marrow biopsy CT scan head or brain with contrast CT scan of neck CT scan of neck CT scan chest CT scan chest with contrast CT scan of abdomen and pelvis CT scan of abdomen and pelvis Blood test, comprehensive group of blood chemicals Blood test, lipids (cholesterol and triglycerides) Creatinine clearance measurement to test for kidney function Ferritin (blood protein) level Glutamyltransferase (liver enzyme) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level Phosphate level Uric acid level, blood Complete blood cell count (red cells, white blood cell, platelets), automated test Bone marrow, smear interpretation Blood test, clotting time Routine EKG using at least 12 leads including interpretation and report Measurement and graphic recording of total and timed exhaled air capacity Demonstration or evaluation of patient use of aerosol generator, nebulizer, metered dose inhaler or intermittent positive pressure breathing (IPPB) device Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Prolonged office or other outpatient service first hour Injection, ceftriaxone sodium, per 250 mg Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, immune globulin, (gammagard liquid), non-lyophilized, (e. g. liquid), 500 mg Injection, fondaparinux sodium, 0. 5 mg Injection, levofloxacin, 250 mg Injection, lorazepam, 2 mg Injection, morphine sulfate, up to 10 mg Injection, morphine sulfate (preservative-free sterile solution), per 10 mg Injection, oprelvekin, 5 mg Injection, palonosetron hcl, 25 mcg Injection, promethazine hcl, up to 50 mg Injection, sargramostim (gm-csf), 50 mcg Injection, methylprednisolone sodium succinate, up to 40 mg Injection, methylprednisolone sodium succinate, up to 125 mg Injection, potassium chloride, per 2 meq Injection, zoledronic acid (zometa), 1 mg Injection, zoledronic acid (reclast), 1 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) 5% dextrose/normal saline (500 ml = 1 unit) Injection, docetaxel, 1 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Zoldedronic acid 1mg Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'CT scan chest with contrast CT scan of abdomen and pelvis Nuclear medicine study with CT imaging skull base to mid-thigh Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Administration of influenza virus vaccine Injection, atropine sulfate, 0. 01 mg Injection, leucovorin calcium, per 50 mg Injection, levoleucovorin calcium, 0. 5 mg Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, fosaprepitant, 1 mg Injection, hydrocortisone sodium succinate, up to 100 mg Injection, morphine sulfate, up to 10 mg Injection, octreotide, depot form for intramuscular injection, 1 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Unclassified drugs Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Injection, bendamustine hcl, 1 mg Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Cyclophosphamide, 100 mg Injection, docetaxel, 1 mg Injection, etoposide, 10 mg Injection, fluorouracil, 500 mg Injection, gemcitabine hydrochloride, 200 mg Injection, oxaliplatin, 0. 5 mg Injection, paclitaxel, 30 mg Injection, rituximab, 100 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) Zoldedronic acid 1mg Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Urinalysis, manual test Blood test, clotting time Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 30 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Hospital discharge day management, 30 minutes or less Injection, leucovorin calcium, per 50 mg Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, iron sucrose, 1 mg Injection, ondansetron hydrochloride, per 1 mg Injection, pegfilgrastim, 6 mg Injection, methylprednisolone sodium succinate, up to 125 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Unclassified drugs Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc 5% dextrose/water (500 ml = 1 unit) Injection, carboplatin, 50 mg Injection, docetaxel, 1 mg Injection, fluorouracil, 500 mg Injection, gemcitabine hydrochloride, 200 mg Injection, oxaliplatin, 0. 5 mg Injection, rituximab, 100 mg', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy Nuclear medicine imaging from skull base to mid-thigh Nuclear medicine imaging whole body Nuclear medicine study with CT imaging whole body Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Blood test, lipids (cholesterol and triglycerides) Manual urinalysis test with examination using microscope Carcinoembryonic antigen (CEA) protein level Blood creatinine level Cyanocobalamin (vitamin B-12) level Ferritin (blood protein) level Folic acid level Blood glucose (sugar) measurement using reagent strip Glutamyltransferase (liver enzyme) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level Phosphate level PSA (prostate specific antigen) measurement Blood test, thyroid stimulating hormone (TSH) Urea nitrogen level to assess kidney function Uric acid level, blood Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Immunologic analysis for detection of tumor antigen Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Sodium fluoride f-18, diagnostic, per study dose, up to 30 millicuries Administration of influenza virus vaccine Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 300 mcg Injection, granisetron hydrochloride, 100 mcg Injection, ibandronate sodium, 1 mg Injection, iron dextran, 50 mg Injection, furosemide, up to 20 mg Injection, meperidine hydrochloride, per 100 mg Injection, ondansetron hydrochloride, per 1 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Injection, zoledronic acid (zometa), 1 mg Unclassified drugs Infusion, normal saline solution , 1000 cc Injection, fluorouracil, 500 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Nuclear medicine imaging from skull base to mid-thigh Nuclear medicine study with CT imaging whole body Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Blood test, lipids (cholesterol and triglycerides) Manual urinalysis test with examination using microscope Carcinoembryonic antigen (CEA) protein level Cyanocobalamin (vitamin B-12) level Ferritin (blood protein) level Folic acid level Blood glucose (sugar) measurement using reagent strip Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level Phosphate level PSA (prostate specific antigen) measurement Blood test, thyroid stimulating hormone (TSH) Uric acid level, blood Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Red blood cell sedimentation rate, to detect inflammation Immunologic analysis for detection of tumor antigen Immunologic analysis for detection of tumor antigen Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein using push technique Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Sodium fluoride f-18, diagnostic, per study dose, up to 30 millicuries Injection, leucovorin calcium, per 50 mg Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 300 mcg Injection, granisetron hydrochloride, 100 mcg Injection infliximab, 10 mg Injection, ondansetron hydrochloride, per 1 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, zoledronic acid (zometa), 1 mg Injection, zoledronic acid (reclast), 1 mg Unclassified drugs Infusion, normal saline solution , 1000 cc Injection, fluorouracil, 500 mg Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Blood test, comprehensive group of blood chemicals Blood creatinine level Lactate dehydrogenase (enzyme) level PSA (prostate specific antigen) measurement Blood test, thyroid stimulating hormone (TSH) Urea nitrogen level to assess kidney function Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Immunologic analysis for detection of tumor antigen Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Hospital discharge day management, 30 minutes or less Hospital discharge day management, more than 30 minutes Administration of influenza virus vaccine Physician certification for medicare-covered home health  services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians to affirm the initial imple Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, fosaprepitant, 1 mg Injection, lorazepam, 2 mg Injection, natalizumab, 1 mg Injection, palonosetron hcl, 25 mcg Injection, zoledronic acid (reclast), 1 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Injection, carboplatin, 50 mg Injection, docetaxel, 1 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Collection of blood specimen from a completely implantable venous access device Needle or trocar bone marrow biopsy CT scan chest CT scan chest with contrast CT scan abdomen with contrast CT scan of abdomen and pelvis CT scan of abdomen and pelvis Bone density measurement spine or hips using dedicated X-ray machine Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Blood test, lipids (cholesterol and triglycerides) Liver function blood test panel Manual urinalysis test with examination using microscope Carcinoembryonic antigen (CEA) protein level Cyanocobalamin (vitamin B-12) level Ferritin (blood protein) level Folic acid level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Phosphate level PSA (prostate specific antigen) measurement Thyroxine (thyroid chemical) measurement Blood test, thyroid stimulating hormone (TSH) Thyroid hormone evaluation Uric acid level, blood Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Red blood count, automated test Blood test, clotting time Red blood cell sedimentation rate, to detect inflammation Immunologic analysis for detection of tumor antigen Immunologic analysis for detection of tumor antigen Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Refilling and maintenance of portable pump Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Hospital discharge day management, 30 minutes or less Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Prostate cancer screening; prostate specific antigen test (psa) Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, heparin sodium, per 1000 units Injection, lorazepam, 2 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, potassium chloride, per 2 meq Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) 5% dextrose/normal saline (500 ml = 1 unit) Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Cyclophosphamide, 100 mg Injection, docetaxel, 1 mg Injection, fluorouracil, 500 mg Injection, oxaliplatin, 0. 5 mg Injection, rituximab, 100 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Zoldedronic acid 1mg Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Collection of blood specimen from a completely implantable venous access device Needle or trocar bone marrow biopsy CT scan head or brain before and after contrast CT scan chest CT scan chest with contrast CT scan of abdomen and pelvis CT scan of abdomen and pelvis Bone density measurement spine or hips using dedicated X-ray machine Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Blood test, lipids (cholesterol and triglycerides) Manual urinalysis test with examination using microscope Automated urinalysis test Stool analysis for blood to screen for colon tumors Carcinoembryonic antigen (CEA) protein level Cyanocobalamin (vitamin B-12) level Ferritin (blood protein) level Folic acid level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level Phosphate level PSA (prostate specific antigen) measurement Thyroxine (thyroid chemical) measurement Blood test, thyroid stimulating hormone (TSH) Uric acid level, blood Microscopic examination for white blood cells with manual cell count Red blood cell concentration measurement Hemoglobin measurement Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Red blood count, automated test Blood test, clotting time Red blood cell sedimentation rate, to detect inflammation Immunologic analysis for detection of tumor antigen Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Refilling and maintenance of portable pump Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Hospital discharge day management, 30 minutes or less Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, leucovorin calcium, per 50 mg Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, heparin sodium, per 1000 units Injection, lorazepam, 2 mg Injection, midazolam hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Injection, fluorouracil, 500 mg Injection, rituximab, 100 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Zoldedronic acid 1mg Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Collection of blood specimen from a completely implantable venous access device Needle or trocar bone marrow biopsy CT scan chest CT scan chest with contrast CT scan of abdomen and pelvis Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Blood test, lipids (cholesterol and triglycerides) Manual urinalysis test with examination using microscope Carcinoembryonic antigen (CEA) protein level Cyanocobalamin (vitamin B-12) level Ferritin (blood protein) level Folic acid level Gammaglobulin (immune system protein) measurement Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level Phosphate level PSA (prostate specific antigen) measurement Thyroxine (thyroid chemical) measurement Blood test, thyroid stimulating hormone (TSH) Thyroid hormone evaluation Uric acid level, blood Microscopic examination for white blood cells with manual cell count Red blood cell concentration measurement Hemoglobin measurement Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Red blood count, automated test Blood test, clotting time Red blood cell sedimentation rate, to detect inflammation Immunologic analysis for detection of tumor antigen Immunologic analysis for detection of tumor antigen Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Hospital discharge day management, 30 minutes or less Critical care delivery critically ill or injured patient, first 30-74 minutes Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, granisetron hydrochloride, 100 mcg Injection, lorazepam, 2 mg Injection, midazolam hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Infusion, normal saline solution , 1000 cc Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Collection of blood specimen from a completely implantable venous access device Needle or trocar bone marrow biopsy CT scan chest CT scan chest with contrast CT scan of abdomen and pelvis Nuclear medicine study with CT imaging skull base to mid-thigh Nuclear medicine study with CT imaging whole body Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Blood test, lipids (cholesterol and triglycerides) Manual urinalysis test with examination using microscope Carcinoembryonic antigen (CEA) protein level Cyanocobalamin (vitamin B-12) level Ferritin (blood protein) level Folic acid level Gammaglobulin (immune system protein) measurement Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level Phosphate level PSA (prostate specific antigen) measurement Thyroxine (thyroid chemical) measurement Blood test, thyroid stimulating hormone (TSH) Thyroid hormone evaluation Uric acid level, blood Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Red blood count, automated test Blood test, clotting time Red blood cell sedimentation rate, to detect inflammation Immunologic analysis for detection of tumor antigen Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Hospital discharge day management, 30 minutes or less Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Sodium fluoride f-18, diagnostic, per study dose, up to 30 millicuries Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, heparin sodium, per 1000 units Injection, lorazepam, 2 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution , 1000 cc Injection, carboplatin, 50 mg Injection, gemcitabine hydrochloride, 200 mg Injection, rituximab, 100 mg Zoldedronic acid 1mg Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Collection of blood specimen from a completely implantable venous access device Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, granisetron hydrochloride, 100 mcg Injection, heparin sodium, per 1000 units Injection, palonosetron hcl, 25 mcg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc', 'Insertion of needle into vein for collection of blood sample Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Hospital discharge day management, 30 minutes or less Injection, ceftriaxone sodium, per 250 mg Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, levofloxacin, 250 mg Injection, meperidine hydrochloride, per 100 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, promethazine hcl, up to 50 mg Injection, methylprednisolone sodium succinate, up to 125 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Infusion, normal saline solution , 1000 cc Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)', 'Insertion of needle into vein for collection of blood sample Complete blood cell count (red cells, white blood cell, platelets), automated test Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, ondansetron hydrochloride, per 1 mg Leuprolide acetate (for depot suspension), 7. 5 mg', 'Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Urinalysis, manual test Carcinoembryonic antigen (CEA) protein level Cyanocobalamin (vitamin B-12) level Ferritin (blood protein) level Folic acid level Gammaglobulin (immune system protein) measurement Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level Protein measurement, serum Blood test, thyroid stimulating hormone (TSH) Complete blood cell count (red cells, white blood cell, platelets), automated test Red blood count, automated test Blood test, clotting time Immunologic analysis for detection of tumor antigen Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Administration of influenza virus vaccine Injection, atropine sulfate, 0. 01 mg Injection, leucovorin calcium, per 50 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution , 1000 cc Injection, bevacizumab, 10 mg Injection, fluorouracil, 500 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)', 'Insertion of needle into vein for collection of blood sample Bone marrow aspiration Needle or trocar bone marrow biopsy CT scan chest with contrast CT scan of abdomen and pelvis Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Urinalysis, manual test Beta-2 microglobulin (protein) level Vitamin D-3 level Carcinoembryonic antigen (CEA) protein level Cyanocobalamin (vitamin B-12) level Erythropoietin (protein) level Ferritin (blood protein) level Folic acid level Gammaglobulin (immune system protein) measurement Haptoglobin (serum protein) level Homocysteine (amino acid) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level Nephelometry, test method using light PSA (prostate specific antigen) measurement Protein measurement, serum Thyroxine (thyroid chemical) measurement Blood test, thyroid stimulating hormone (TSH) Transferrin (iron binding protein) level Uric acid level, blood Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Immunologic analysis for detection of tumor antigen Immunologic analysis for detection of tumor antigen Immunologic analysis for detection of tumor antigen Immunologic analysis technique on serum Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Refilling and maintenance of portable pump Irrigation of implanted venous access drug delivery device Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Administration of influenza virus vaccine Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous Injection, levoleucovorin calcium, 0. 5 mg Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 300 mcg Injection, filgrastim (g-csf), 480 mcg Injection, immune globulin, (octagam), intravenous, non-lyophilized (e. g. liquid), 500 mg Injection, heparin sodium, per 1000 units Injection, iron dextran, 50 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Injection, azacitidine, 1 mg Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Injection, docetaxel, 1 mg Injection, fluorouracil, 500 mg Injection, gemcitabine hydrochloride, 200 mg Injection, oxaliplatin, 0. 5 mg Injection, paclitaxel protein-bound particles, 1 mg Injection, paclitaxel, 30 mg Injection, rituximab, 100 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Bone marrow aspiration Needle or trocar bone marrow biopsy CT scan of neck X-ray of chest, 2 views, front and side CT scan chest CT scan chest with contrast CT scan of abdomen and pelvis CT scan of abdomen and pelvis Ultrasound of abdomen Computer analysis of diagnostic mammogram Computer analysis of screening mammogram to assist detection of cancer X-ray survey of forearm or wrist bone density Bone density measurement spine or hips using dedicated X-ray machine Bone and joint imaging, whole body Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Manual urinalysis test with examination using microscope Automated urinalysis test Stool analysis for blood Carcinoembryonic antigen (CEA) protein level Blood creatinine level Cyanocobalamin (vitamin B-12) level Ferritin (blood protein) level Folic acid level Blood glucose (sugar) measurement using reagent strip Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level Phosphate level Blood potassium level PSA (prostate specific antigen) measurement Blood test, thyroid stimulating hormone (TSH) Urea nitrogen level to assess kidney function Uric acid level, blood Microscopic examination for white blood cells with manual cell count Red blood cell concentration measurement Hemoglobin measurement Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Routine EKG using at least 12 leads including interpretation and report Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Refilling and maintenance of portable pump Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 20 minutes New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries Administration of influenza virus vaccine Prostate cancer screening; prostate specific antigen test (psa) Screening mammography, producing direct digital image, bilateral, all views Diagnostic mammography, producing direct digital image, unilateral, all views Injection, calcium gluconate, per 10 ml Injection, leucovorin calcium, per 50 mg Injection, levoleucovorin calcium, 0. 5 mg Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, fosaprepitant, 1 mg Injection, hydrocortisone sodium succinate, up to 100 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, sodium ferric gluconate complex in sucrose injection, 12. 5 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Injection, zoledronic acid (zometa), 1 mg Unclassified drugs Injection, bevacizumab, 10 mg Injection, bortezomib, 0. 1 mg Injection, carboplatin, 50 mg Injection, docetaxel, 1 mg Injection, fluorouracil, 500 mg Injection, gemcitabine hydrochloride, 200 mg Injection, oxaliplatin, 0. 5 mg Injection, paclitaxel protein-bound particles, 1 mg Injection, pemetrexed, 10 mg Injection, rituximab, 100 mg Injection, fulvestrant, 25 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) Zoldedronic acid 1mg Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Bone marrow aspiration Needle or trocar bone marrow biopsy Blood test, comprehensive group of blood chemicals Automated urinalysis test Bilirubin level Carcinoembryonic antigen (CEA) protein level Ferritin (blood protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level Phosphate level Blood test, thyroid stimulating hormone (TSH) Uric acid level, blood Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Immunologic analysis for detection of tumor antigen Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Hospital discharge day management, more than 30 minutes Administration of influenza virus vaccine Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, zoledronic acid (zometa), 1 mg Unclassified drugs Infusion, normal saline solution , 1000 cc Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Injection, docetaxel, 1 mg Injection, paclitaxel, 30 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, atropine sulfate, 0. 01 mg Injection, leucovorin calcium, per 50 mg Injection, levoleucovorin calcium, 0. 5 mg Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, lorazepam, 2 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Injection, bendamustine hcl, 1 mg Injection, bevacizumab, 10 mg Injection, bortezomib, 0. 1 mg Injection, carboplatin, 50 mg Injection, cisplatin, powder or solution, 10 mg Injection, docetaxel, 1 mg Injection, etoposide, 10 mg Injection, fluorouracil, 500 mg Injection, gemcitabine hydrochloride, 200 mg Injection, irinotecan, 20 mg Leuprolide acetate (for depot suspension), 7. 5 mg Injection, oxaliplatin, 0. 5 mg Injection, paclitaxel, 30 mg Injection, pemetrexed, 10 mg Injection, rituximab, 100 mg Injection, vinorelbine tartrate, 10 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Blood test, comprehensive group of blood chemicals Blood test, lipids (cholesterol and triglycerides) Vitamin D-3 level Ferritin (blood protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Blood test, thyroid stimulating hormone (TSH) Complete blood cell count (red cells, white blood cell, platelets), automated test Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Established patient office or other outpatient, visit typically 25 minutes Infusion, normal saline solution , 250 cc', 'Insertion of needle into vein for collection of blood sample Collection of blood specimen from a completely implantable venous access device Needle or trocar bone marrow biopsy Blood test, comprehensive group of blood chemicals Carcinoembryonic antigen (CEA) protein level Ferritin (blood protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level PSA (prostate specific antigen) measurement Blood test, thyroid stimulating hormone (TSH) Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Immunologic analysis for detection of tumor antigen Flow cytometry technique for DNA or cell analysis Flow cytometry technique for DNA or cell analysis Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, leucovorin calcium, per 50 mg Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, heparin sodium, (heparin lock flush), per 10 units Injection, lorazepam, 2 mg Injection, meperidine hydrochloride, per 100 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, methylprednisolone sodium succinate, up to 125 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution , 1000 cc Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Injection, fluorouracil, 500 mg Injection, gemcitabine hydrochloride, 200 mg Injection, pemetrexed, 10 mg Injection, rituximab, 100 mg Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Nuclear medicine study with CT imaging skull base to mid-thigh Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, palonosetron hcl, 25 mcg', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Stool analysis for blood to screen for colon tumors Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Refilling and maintenance of portable pump Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Hospital discharge day management, 30 minutes or less Injection, leucovorin calcium, per 50 mg Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, sodium ferric gluconate complex in sucrose injection, 12. 5 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution , 1000 cc 5% dextrose/normal saline (500 ml = 1 unit) Injection, carboplatin, 50 mg Injection, fluorouracil, 500 mg Injection, paclitaxel, 30 mg Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, comprehensive group of blood chemicals Carcinoembryonic antigen (CEA) protein level Cyanocobalamin (vitamin B-12) level Electrophoresis, laboratory testing technique Ferritin (blood protein) level Folic acid level Gammaglobulin (immune system protein) measurement Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level PSA (prostate specific antigen) measurement Protein measurement, serum Blood test, thyroid stimulating hormone (TSH) Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Immunologic analysis technique on serum Hydration infusion into a vein 31 minutes to 1 hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 300 mcg Injection, filgrastim (g-csf), 480 mcg Injection, fosaprepitant, 1 mg Injection, iron sucrose, 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, methylprednisolone sodium succinate, up to 40 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Injection, zoledronic acid (zometa), 1 mg Unclassified drugs Injection, bendamustine hcl, 1 mg Injection, bevacizumab, 10 mg Injection, bortezomib, 0. 1 mg Injection, carboplatin, 50 mg Injection, gemcitabine hydrochloride, 200 mg Injection, rituximab, 100 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Collection of blood specimen from a completely implantable venous access device Needle or trocar bone marrow biopsy CT scan chest with contrast CT scan of abdomen and pelvis Blood test, comprehensive group of blood chemicals Automated urinalysis test Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, calcium gluconate, per 10 ml Injection, leucovorin calcium, per 50 mg Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, heparin sodium, (heparin lock flush), per 10 units Injection, morphine sulfate, up to 10 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, sodium ferric gluconate complex in sucrose injection, 12. 5 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc 5% dextrose/water (500 ml = 1 unit) Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Injection, fluorouracil, 500 mg Injection, oxaliplatin, 0. 5 mg Injection, paclitaxel, 30 mg Zoldedronic acid 1mg Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Collection of blood specimen from a completely implantable venous access device CT scan chest with contrast CT scan of abdomen and pelvis Blood test, comprehensive group of blood chemicals Magnesium level Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour New patient office or other outpatient visit, typically 30 minutes New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy CT scan head or brain before and after contrast X-ray of chest, 2 views, front and side CT scan chest with contrast CT scan abdomen with contrast CT scan of abdomen and pelvis Blood test, comprehensive group of blood chemicals Urinalysis, manual test Stool analysis for blood to screen for colon tumors Carcinoembryonic antigen (CEA) protein level Blood creatinine level Ferritin (blood protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level PSA (prostate specific antigen) measurement Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Red blood count, automated test Blood test, clotting time Red blood cell sedimentation rate, to detect inflammation Immunologic analysis for detection of tumor antigen Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Refilling and maintenance of portable pump Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Hospital observation care typically 70 minutes Initial hospital inpatient care, typically 50 minutes per day Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Hospital discharge day management, 30 minutes or less Administration of influenza virus vaccine Injection, leucovorin calcium, per 50 mg Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, granisetron hydrochloride, 100 mcg Injection, iron sucrose, 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, methylprednisolone sodium succinate, up to 125 mg Injection, magnesium sulfate, per 500 mg Unclassified drugs Infusion, normal saline solution , 1000 cc Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Injection, docetaxel, 1 mg Injection, fluorouracil, 500 mg Injection, oxaliplatin, 0. 5 mg Injection, paclitaxel, 30 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) Zoldedronic acid 1mg Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy CT scan head or brain before and after contrast CT scan of neck X-ray of chest, 2 views, front and side CT scan chest CT scan chest with contrast CT scan abdomen with contrast CT scan of abdomen and pelvis CT scan of abdomen and pelvis Blood test, comprehensive group of blood chemicals Manual urinalysis test with examination using microscope Urinalysis, manual test Stool analysis for blood to screen for colon tumors Carcinoembryonic antigen (CEA) protein level Blood creatinine level Ferritin (blood protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level PSA (prostate specific antigen) measurement Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Red blood count, automated test Blood test, clotting time Red blood cell sedimentation rate, to detect inflammation Immunologic analysis for detection of tumor antigen Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 45 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Hospital observation care typically 70 minutes Initial hospital inpatient care, typically 50 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes Administration of influenza virus vaccine Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, granisetron hydrochloride, 100 mcg Injection, iron dextran, 50 mg Injection, iron sucrose, 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, magnesium sulfate, per 500 mg Injection, zoledronic acid (zometa), 1 mg Unclassified drugs Infusion, normal saline solution , 1000 cc Injection, carboplatin, 50 mg Injection, paclitaxel, 30 mg Injection, rituximab, 100 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) Zoldedronic acid 1mg Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy Needle or trocar bone marrow biopsy Complete blood cell count (red cells, white blood cell, platelets), automated test Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Refilling and maintenance of portable pump Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Hospital observation care discharge Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Hospital discharge day management, more than 30 minutes Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, leucovorin calcium, per 50 mg Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, hydrocortisone sodium succinate, up to 100 mg Injection, iron sucrose, 1 mg Injection, lorazepam, 2 mg Injection, ondansetron hydrochloride, per 1 mg Injection, promethazine hcl, up to 50 mg Injection, metoclopramide hcl, up to 10 mg Injection, ranitidine hydrochloride, 25 mg Injection, sargramostim (gm-csf), 50 mcg Injection, sodium ferric gluconate complex in sucrose injection, 12. 5 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Injection, carboplatin, 50 mg Injection, fluorouracil, 500 mg Injection, gemcitabine hydrochloride, 200 mg Injection, paclitaxel, 30 mg Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Manual urinalysis test with examination using microscope Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 30 minutes New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Hospital discharge day management, 30 minutes or less Administration of influenza virus vaccine Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, granisetron hydrochloride, 100 mcg Injection, lorazepam, 2 mg Injection, meperidine hydrochloride, per 100 mg Injection, natalizumab, 1 mg Injection, palonosetron hcl, 25 mcg Injection, ranitidine hydrochloride, 25 mg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Infusion, normal saline solution , 1000 cc Infusion, normal saline solution , 250 cc Injection, carboplatin, 50 mg Cyclophosphamide, 100 mg Injection, gemcitabine hydrochloride, 200 mg Injection, paclitaxel protein-bound particles, 1 mg Injection, paclitaxel, 30 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein 31 minutes to 1 hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 30 minutes per day Initial hospital inpatient care, typically 50 minutes per day Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Prolonged office or other outpatient service first hour Administration of influenza virus vaccine Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, iron dextran, 50 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, ranitidine hydrochloride, 25 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Infusion, normal saline solution , 250 cc Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)', 'Insertion of needle into vein for collection of blood sample Stool analysis for blood to screen for colon tumors Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Measurement of oxygen saturation in blood using ear or finger device Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, furosemide, up to 20 mg Injection, octreotide, depot form for intramuscular injection, 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, potassium chloride, per 2 meq Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc 5% dextrose/water (500 ml = 1 unit) Injection, cisplatin, powder or solution, 10 mg Injection, gemcitabine hydrochloride, 200 mg Injection, irinotecan, 20 mg Injection, paclitaxel protein-bound particles, 1 mg Injection, mitomycin, 5 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)', 'Insertion of needle into vein for collection of blood sample Complete blood cell count (red cells, white blood cell, platelets), automated test Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Injection, carboplatin, 50 mg Injection, rituximab, 100 mg', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Administration of influenza virus vaccine Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, heparin sodium, (heparin lock flush), per 10 units Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, methylprednisolone sodium succinate, up to 40 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution , 250 cc 5% dextrose/water (500 ml = 1 unit) Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Injection, gemcitabine hydrochloride, 200 mg Leuprolide acetate (for depot suspension), 7. 5 mg Injection, oxaliplatin, 0. 5 mg Injection, paclitaxel protein-bound particles, 1 mg Injection, paclitaxel, 30 mg Injection, pemetrexed, 10 mg Injection, rituximab, 100 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Manual urinalysis test with examination using microscope Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, heparin sodium, (heparin lock flush), per 10 units Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution , 250 cc Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Cyclophosphamide, 100 mg Injection, gemcitabine hydrochloride, 200 mg Injection, paclitaxel, 30 mg Injection, rituximab, 100 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Collection of blood specimen from a completely implantable venous access device CT scan chest with contrast CT scan of abdomen and pelvis Blood test, comprehensive group of blood chemicals Manual urinalysis test with examination using microscope Urinalysis, manual test Carcinoembryonic antigen (CEA) protein level Cyanocobalamin (vitamin B-12) level Ferritin (blood protein) level Folic acid level Haptoglobin (serum protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level Phosphate level PSA (prostate specific antigen) measurement Thyroxine (thyroid chemical) measurement Blood test, thyroid stimulating hormone (TSH) Complete blood cell count (red cells, white blood cell, platelets), automated test Red blood count, automated test Blood test, clotting time Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Administration of influenza virus vaccine Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 300 mcg Injection, filgrastim (g-csf), 480 mcg Injection, fosaprepitant, 1 mg Injection, granisetron hydrochloride, 100 mcg Injection, iron sucrose, 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Injection, carboplatin, 50 mg Injection, cisplatin, powder or solution, 10 mg Injection, gemcitabine hydrochloride, 200 mg Leuprolide acetate (for depot suspension), 7. 5 mg Injection, paclitaxel, 30 mg Zoldedronic acid 1mg Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Compensator-based beam modulation radiation treatment delivery Insertion of needle into vein for collection of blood sample Declotting infusion of implanted central venous access device or catheter Needle or trocar bone marrow biopsy CT scan head or brain with contrast CT scan of neck CT scan chest CT scan chest with contrast CT scan of abdomen and pelvis CT scan of abdomen and pelvis CT scan guidance for insertion of radiation therapy fields Management of radiation therapy simulation, simple Management of radiation therapy, simulation, complex Management of radiation therapy, 3D Calculation of radiation therapy dose Management of modulation radiotherapy planning Radiation treatment devices, design and construction, complex Radiation therapy consultation Radiation treatment delivery, three or more treatment areas Radiation treatment delivery, three or more treatment areas Intensity modulated radiation treatment delivery X-ray guidance for radiation therapy delivery Special radiation treatment procedure Blood test, comprehensive group of blood chemicals Manual urinalysis test with examination using microscope Manual urinalysis test with examination using microscope Beta-2 microglobulin (protein) level Stool analysis for blood to screen for colon tumors Carcinoembryonic antigen (CEA) protein level Cyanocobalamin (vitamin B-12) level Ferritin (blood protein) level Gammaglobulin (immune system protein) measurement Haptoglobin (serum protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level Phosphate level PSA (prostate specific antigen) measurement Blood test, thyroid stimulating hormone (TSH) Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Coagulation function measurement Blood test, clotting time Red blood cell sedimentation rate, to detect inflammation Coagulation assessment blood test Immunologic analysis for detection of tumor antigen Immunologic analysis for detection of tumor antigen Immunologic analysis for detection of tumor antigen Flow cytometry technique for DNA or cell analysis Flow cytometry technique for DNA or cell analysis Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Refilling and maintenance of portable pump Irrigation of implanted venous access drug delivery device Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, atropine sulfate, 0. 01 mg Injection, leucovorin calcium, per 50 mg Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, fosaprepitant, 1 mg Injection, granisetron hydrochloride, 100 mcg Injection, heparin sodium, per 1000 units Injection, iron sucrose, 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, methylprednisolone sodium succinate, up to 125 mg Injection, alteplase recombinant, 1 mg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Injection, zoledronic acid (zometa), 1 mg Unclassified drugs Infusion, normal saline solution , 1000 cc Injection, azacitidine, 1 mg Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Injection, cisplatin, powder or solution, 10 mg Injection, docetaxel, 1 mg Injection, fluorouracil, 500 mg Injection, gemcitabine hydrochloride, 200 mg Injection, irinotecan, 20 mg Injection, paclitaxel, 30 mg Injection, rituximab, 100 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Zoldedronic acid 1mg Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample CT scan of neck CT scan chest CT scan chest with contrast CT scan abdomen CT scan abdomen with contrast CT scan of abdomen and pelvis CT scan of abdomen and pelvis Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Urinalysis, manual test Carcinoembryonic antigen (CEA) protein level Blood creatinine level Cyanocobalamin (vitamin B-12) level Ferritin (blood protein) level Gammaglobulin (immune system protein) measurement Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level PSA (prostate specific antigen) measurement Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Immunologic analysis for detection of tumor antigen Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Refilling and maintenance of portable pump Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, granisetron hydrochloride, 100 mcg Injection, iron dextran, 50 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, methylprednisolone sodium succinate, up to 40 mg Injection, magnesium sulfate, per 500 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Injection, carboplatin, 50 mg Injection, fluorouracil, 500 mg Injection, paclitaxel, 30 mg Injection, rituximab, 100 mg Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample CT scan chest CT scan chest with contrast CT scan of abdomen and pelvis CT scan of abdomen and pelvis Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Stool analysis for blood to screen for colon tumors Carcinoembryonic antigen (CEA) protein level Blood creatinine level Cyanocobalamin (vitamin B-12) level Ferritin (blood protein) level Folic acid level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level PSA (prostate specific antigen) measurement Thyroxine (thyroid chemical) measurement Blood test, thyroid stimulating hormone (TSH) Thyroid hormone evaluation Urea nitrogen level to assess kidney function Uric acid level, blood Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Immunologic analysis for detection of tumor antigen Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Administration of influenza virus vaccine Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, immune globulin, intravenous, lyophilized (e. g. powder), not otherwise specified, 500 mg Injection, granisetron hydrochloride, 100 mcg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Injection, carboplatin, 50 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Collection of blood specimen from a completely implantable venous access device Declotting infusion of implanted central venous access device or catheter Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Liver function blood test panel Urinalysis, manual test Beta-2 microglobulin (protein) level Carcinoembryonic antigen (CEA) protein level Cyanocobalamin (vitamin B-12) level Erythropoietin (protein) level Ferritin (blood protein) level Folic acid level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level PSA (prostate specific antigen) measurement Thyroxine (thyroid chemical) measurement Blood test, thyroid stimulating hormone (TSH) Thyroid hormone, T3 measurement Uric acid level, blood Complete blood cell count (red cells, white blood cell, platelets), automated test Red blood cell sedimentation rate, to detect inflammation Immunologic analysis for detection of tumor antigen Immunologic analysis for detection of tumor antigen Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Refilling and maintenance of portable pump Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 30 minutes New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 30 minutes per day Initial hospital inpatient care, typically 50 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Hospital discharge day management, 30 minutes or less Hospital discharge day management, more than 30 minutes Administration of influenza virus vaccine Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, granisetron hydrochloride, 100 mcg Injection, iron dextran, 50 mg Injection, lorazepam, 2 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, alteplase recombinant, 1 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Injection, zoledronic acid (zometa), 1 mg Unclassified drugs Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Injection, bevacizumab, 10 mg Injection, bortezomib, 0. 1 mg Injection, carboplatin, 50 mg Injection, cisplatin, powder or solution, 10 mg Injection, gemcitabine hydrochloride, 200 mg Injection, irinotecan, 20 mg Injection, oxaliplatin, 0. 5 mg Injection, paclitaxel protein-bound particles, 1 mg Injection, paclitaxel, 30 mg Injection, rituximab, 100 mg Injection, trastuzumab, 10 mg Injection, fulvestrant, 25 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Blood test, comprehensive group of blood chemicals Blood test, lipids (cholesterol and triglycerides) Manual urinalysis test with examination using microscope Automated urinalysis test Carcinoembryonic antigen (CEA) protein level Lactate dehydrogenase (enzyme) level PSA (prostate specific antigen) measurement Blood test, thyroid stimulating hormone (TSH) Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Immunologic analysis for detection of tumor antigen Vaccine for influenza injection Routine EKG using at least 12 leads including interpretation and report Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Administration of influenza virus vaccine Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, fosaprepitant, 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Unclassified drugs Injection, carboplatin, 50 mg', 'Insertion of needle into vein for collection of blood sample Collection of blood specimen from a completely implantable venous access device Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 45 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, fosaprepitant, 1 mg Injection, palonosetron hcl, 25 mcg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Unclassified drugs Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc 5% dextrose/water (500 ml = 1 unit) Injection, carboplatin, 50 mg Injection, fluorouracil, 500 mg Injection, paclitaxel, 30 mg', 'Insertion of needle into vein for collection of blood sample Collection of blood specimen from a completely implantable venous access device Collection of blood specimen from central or peripheral venous catheter Needle or trocar bone marrow biopsy Blood test, comprehensive group of blood chemicals Blood test, lipids (cholesterol and triglycerides) Urinalysis, manual test Bilirubin level Stool analysis for blood to screen for colon tumors Carcinoembryonic antigen (CEA) protein level Cyanocobalamin (vitamin B-12) level Ferritin (blood protein) level Folic acid level Gammaglobulin (immune system protein) measurement Glutamyltransferase (liver enzyme) level Administration of drug for helicobacter pylori Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level PSA (prostate specific antigen) measurement Testosterone (hormone) level Thyroxine (thyroid chemical) measurement Blood test, thyroid stimulating hormone (TSH) Thyroid hormone, T3 measurement Uric acid level, blood Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Red blood cell sedimentation rate, to detect inflammation Immunologic analysis for detection of tumor antigen Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 30 minutes New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 30 minutes per day Initial hospital inpatient care, typically 50 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Critical care delivery critically ill or injured patient, first 30-74 minutes Administration of influenza virus vaccine Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, granisetron hydrochloride, 100 mcg Injection, iron dextran, 50 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Injection, zoledronic acid (zometa), 1 mg Unclassified drugs Infusion, normal saline solution , 1000 cc Infusion, normal saline solution , 250 cc 5% dextrose/water (500 ml = 1 unit) Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Injection, fluorouracil, 500 mg Injection, gemcitabine hydrochloride, 200 mg Leuprolide acetate (for depot suspension), 7. 5 mg Injection, oxaliplatin, 0. 5 mg Injection, paclitaxel protein-bound particles, 1 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) Zoldedronic acid 1mg', 'Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Injection, atropine sulfate, 0. 01 mg Injection, calcium gluconate, per 10 ml Injection, leucovorin calcium, per 50 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, furosemide, up to 20 mg Injection, ondansetron hydrochloride, per 1 mg Injection, magnesium sulfate, per 500 mg Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Cyclophosphamide, 100 mg Injection, fluorouracil, 500 mg Injection, gemcitabine hydrochloride, 200 mg Injection, irinotecan, 20 mg Injection, oxaliplatin, 0. 5 mg', 'Complete blood cell count (red cells, white blood cell, platelets), automated test Established patient office or other outpatient, visit typically 25 minutes', 'Insertion of needle into vein for collection of blood sample CT scan chest CT scan chest before and after contrast CT scan of abdomen and pelvis Nuclear medicine study with CT imaging skull base to mid-thigh Nuclear medicine study with CT imaging whole body Blood test, basic group of blood chemicals Blood glucose (sugar) test performed by hand-held instrument Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Subsequent hospital inpatient care, typically 35 minutes per day Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, magnesium sulfate, per 500 mg Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Nuclear medicine study with CT imaging skull base to mid-thigh Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Hydration infusion into a vein 31 minutes to 1 hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution , 250 cc Injection, bortezomib, 0. 1 mg Injection, rituximab, 100 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Complete blood cell count (red cells, white blood cell, platelets), automated test Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Ambulatory infusion pump, single or multiple channels, electric or battery operated, with administrative equipment, worn by patient Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, dexamethasone sodium phosphate, 1mg Injection, filgrastim (g-csf), 300 mcg Injection, heparin sodium, per 1000 units Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Injection, doxorubicin hydrochloride, 10 mg Injection, docetaxel, 1 mg Injection, gemcitabine hydrochloride, 200 mg Injection, ifosfamide, 1 gram Injection, mesna, 200 mg', 'Insertion of needle into vein for collection of blood sample Blood test, comprehensive group of blood chemicals Lactate dehydrogenase (enzyme) level Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, potassium chloride, per 2 meq Infusion, normal saline solution , 1000 cc', 'Insertion of needle into vein for collection of blood sample Blood test, comprehensive group of blood chemicals Lactate dehydrogenase (enzyme) level Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 30 minutes New patient office or other outpatient visit, typically 45 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Infusion, normal saline solution , 1000 cc', 'Insertion of needle into vein for collection of blood sample Blood test, comprehensive group of blood chemicals Lactate dehydrogenase (enzyme) level Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Infusion, normal saline solution , 1000 cc', 'Insertion of needle into vein for collection of blood sample Complete blood cell count (red cells, white blood cell, platelets), automated test Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour New patient office or other outpatient visit, typically 30 minutes New patient office or other outpatient visit, typically 45 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Initial hospital inpatient care, typically 50 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Infusion, normal saline solution , 250 cc', 'Insertion of needle into vein for collection of blood sample Collection of blood specimen from a completely implantable venous access device Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Initial hospital inpatient care, typically 70 minutes per day Injection, leucovorin calcium, per 50 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, granisetron hydrochloride, 100 mcg Injection, heparin sodium, per 1000 units Injection, palonosetron hcl, 25 mcg Injection, magnesium sulfate, per 500 mg Unclassified drugs Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc 5% dextrose/water (500 ml = 1 unit) Injection, fluorouracil, 500 mg Leuprolide acetate (for depot suspension), 7. 5 mg', 'Insertion of needle into vein for collection of blood sample Collection of blood specimen from a completely implantable venous access device Needle or trocar bone marrow biopsy CT scan chest CT scan chest with contrast CT scan of abdomen and pelvis CT scan of abdomen and pelvis Nuclear medicine study with CT imaging skull base to mid-thigh Nuclear medicine study with CT imaging whole body Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Blood test, lipids (cholesterol and triglycerides) Manual urinalysis test with examination using microscope Carcinoembryonic antigen (CEA) protein level Cyanocobalamin (vitamin B-12) level Ferritin (blood protein) level Folic acid level Gammaglobulin (immune system protein) measurement Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level PSA (prostate specific antigen) measurement Thyroxine (thyroid chemical) measurement Blood test, thyroid stimulating hormone (TSH) Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Red blood count, automated test Blood test, clotting time Immunologic analysis for detection of tumor antigen Immunologic analysis for detection of tumor antigen Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Refilling and maintenance of portable pump Irrigation of implanted venous access drug delivery device Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, levoleucovorin calcium, 0. 5 mg Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, fosaprepitant, 1 mg Injection, heparin sodium, per 1000 units Injection, lorazepam, 2 mg Injection, meperidine hydrochloride, per 100 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, triptorelin pamoate, 3. 75 mg Injection, diazepam, up to 5 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Injection, bortezomib, 0. 1 mg Injection, carboplatin, 50 mg Cyclophosphamide, 100 mg Injection, docetaxel, 1 mg Injection, etoposide, 10 mg Injection, fluorouracil, 500 mg Injection, gemcitabine hydrochloride, 200 mg Injection, paclitaxel, 30 mg Injection, pemetrexed, 10 mg Injection, rituximab, 100 mg Injection, trastuzumab, 10 mg Injection, vinorelbine tartrate, 10 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Zoldedronic acid 1mg Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Collection of blood specimen from a completely implantable venous access device Needle or trocar bone marrow biopsy CT scan chest with contrast CT scan of abdomen and pelvis Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Carcinoembryonic antigen (CEA) protein level Cyanocobalamin (vitamin B-12) level Ferritin (blood protein) level Folic acid level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level PSA (prostate specific antigen) measurement Blood test, thyroid stimulating hormone (TSH) Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Red blood count, automated test Blood test, clotting time Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Refilling and maintenance of portable pump Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 30 minutes New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, leucovorin calcium, per 50 mg Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, granisetron hydrochloride, 100 mcg Injection, heparin sodium, per 1000 units Injection, lorazepam, 2 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, methylprednisolone sodium succinate, up to 125 mg Injection, diazepam, up to 5 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, potassium chloride, per 2 meq Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Injection, fluorouracil, 500 mg Injection, oxaliplatin, 0. 5 mg Injection, pemetrexed, 10 mg Injection, rituximab, 100 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Collection of blood specimen from a completely implantable venous access device Collection of blood specimen from central or peripheral venous catheter Needle or trocar bone marrow biopsy CT scan head or brain before and after contrast CT scan of neck CT scan chest with contrast CT scan arteriogram of chest CT scan of abdomen and pelvis Nuclear medicine study with CT imaging skull base to mid-thigh Nuclear medicine study with CT imaging whole body Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Manual urinalysis test with examination using microscope Automated urinalysis test Calcium level Blood creatinine level Blood glucose (sugar) measurement using reagent strip Lactate dehydrogenase (enzyme) level Magnesium level Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Routine EKG using at least 12 leads including interpretation and report Respiratory inhaled pressure or nonpressure treatment to relieve airway obstruction or for sputum specimen Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 20 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Sodium fluoride f-18, diagnostic, per study dose, up to 30 millicuries Administration of influenza virus vaccine Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, atropine sulfate, 0. 01 mg Injection, ceftriaxone sodium, per 250 mg Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, hydromorphone, up to 4 mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, granisetron hydrochloride, 100 mcg Injection, ketorolac tromethamine, per 15 mg Injection, furosemide, up to 20 mg Injection, levofloxacin, 250 mg Injection, lorazepam, 2 mg Injection, meperidine hydrochloride, per 100 mg Injection, midazolam hydrochloride, per 1 mg Injection, morphine sulfate, up to 10 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, methylprednisolone sodium succinate, up to 125 mg Injection, fentanyl citrate, 0. 1 mg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Injection, zoledronic acid (zometa), 1 mg Injection, zoledronic acid (reclast), 1 mg Unclassified drugs Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg Injection, carboplatin, 50 mg Injection, gemcitabine hydrochloride, 200 mg Leuprolide acetate (for depot suspension), 7. 5 mg Injection, rituximab, 100 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) Zoldedronic acid 1mg Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy X-ray of chest, 2 views, front and side Bone density measurement spine or hips using dedicated X-ray machine Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, granisetron hydrochloride, 100 mcg Injection, iron sucrose, 1 mg Injection, pegfilgrastim, 6 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc 5% dextrose/water (500 ml = 1 unit) Injection, carboplatin, 50 mg Injection, paclitaxel, 30 mg Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Urinalysis, manual test Lactate dehydrogenase (enzyme) level Magnesium level Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 45 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Subsequent hospital inpatient care, typically 25 minutes per day Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, potassium chloride, per 2 meq Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Injection, carboplatin, 50 mg', 'Insertion of needle into vein for collection of blood sample Insertion of catheter in vein and implanted device for infusion Needle or trocar bone marrow biopsy Blood test, comprehensive group of blood chemicals Manual urinalysis test with examination using microscope Stool analysis for blood to screen for colon tumors Ferritin (blood protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level Phosphate level Thyroxine (thyroid chemical) measurement Blood test, thyroid stimulating hormone (TSH) Complete blood cell count (red cells, white blood cell, platelets), automated test Red blood count, manual test Red blood count, automated test Red blood count automated, with additional calculations Reticulated (young) platelet measurement Routine electrocardiogram (EKG) using at least 12 leads with interpretation and report Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Refilling and maintenance of portable pump New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 30 minutes per day Initial hospital inpatient care, typically 50 minutes per day Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Hospital discharge day management, 30 minutes or less Critical care delivery critically ill or injured patient, first 30-74 minutes Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, leucovorin calcium, per 50 mg Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, hydrocortisone sodium succinate, up to 100 mg Injection, iron dextran, 50 mg Injection, oprelvekin, 5 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, promethazine hcl, up to 50 mg Injection, metoclopramide hcl, up to 10 mg Injection, ranitidine hydrochloride, 25 mg Injection, sodium ferric gluconate complex in sucrose injection, 12. 5 mg Injection, methylprednisolone sodium succinate, up to 40 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Injection, fluorouracil, 500 mg Injection, oxaliplatin, 0. 5 mg Injection, paclitaxel, 30 mg Injection, rituximab, 100 mg Zoldedronic acid 1mg', 'CT scan chest with contrast CT scan of abdomen and pelvis Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Refilling and maintenance of portable pump Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 30 minutes New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Administration of influenza virus vaccine Injection, levoleucovorin calcium, 0. 5 mg Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, sargramostim (gm-csf), 50 mcg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, zoledronic acid (zometa), 1 mg Unclassified drugs Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Cyclophosphamide, 100 mg Injection, fluorouracil, 500 mg Injection, gemcitabine hydrochloride, 200 mg Injection, oxaliplatin, 0. 5 mg Injection, paclitaxel, 30 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) Zoldedronic acid 1mg Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml', 'Collection of blood specimen from a completely implantable venous access device Needle or trocar bone marrow biopsy Flow cytometry technique for DNA or cell analysis Flow cytometry technique for DNA or cell analysis Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Refilling and maintenance of portable pump Irrigation of implanted venous access drug delivery device Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 20 minutes New patient office or other outpatient visit, typically 30 minutes New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Smoking and tobacco use intermediate counseling, greater than 3 minutes up to 10 minutes Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, calcium gluconate, per 10 ml Injection, leucovorin calcium, per 50 mg Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, fosaprepitant, 1 mg Injection, immune globulin, (octagam), intravenous, non-lyophilized (e. g. liquid), 500 mg Injection, granisetron hydrochloride, 100 mcg Injection, hydrocortisone sodium succinate, up to 100 mg Injection, iron dextran, 50 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Injection, carboplatin, 50 mg Injection, fluorouracil, 500 mg Injection, gemcitabine hydrochloride, 200 mg Leuprolide acetate (for depot suspension), 7. 5 mg Injection, oxaliplatin, 0. 5 mg Injection, rituximab, 100 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)', 'Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Infusion, normal saline solution, sterile (500 ml=1 unit)', 'Insertion of needle into vein for collection of blood sample Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, ondansetron hydrochloride, per 1 mg Infusion, normal saline solution, sterile (500 ml=1 unit) Injection, rituximab, 100 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)', 'Insertion of needle into vein for collection of blood sample Blood test, comprehensive group of blood chemicals Manual urinalysis test with examination using microscope Stool analysis for blood to screen for colon tumors Ferritin (blood protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Red blood count, manual test Blood test, clotting time Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 45 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, dexamethasone sodium phosphate, 1mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Infusion, normal saline solution , 1000 cc', 'Insertion of needle into vein for collection of blood sample Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, comprehensive group of blood chemicals Stool analysis for blood to screen for colon tumors Ferritin (blood protein) level Iron level Iron binding capacity Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Subsequent hospital inpatient care, typically 25 minutes per day Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Infusion, normal saline solution , 1000 cc', 'Insertion of needle into vein for collection of blood sample Blood test, comprehensive group of blood chemicals Manual urinalysis test with examination using microscope Stool analysis for blood to screen for colon tumors Ferritin (blood protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Administration of influenza virus vaccine Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, granisetron hydrochloride, 100 mcg Injection, iron sucrose, 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Injection, carboplatin, 50 mg Injection, paclitaxel, 30 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)', 'Insertion of needle into vein for collection of blood sample Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Albumin (protein) level Beta-2 microglobulin (protein) level Bilirubin level Carcinoembryonic antigen (CEA) protein level Ferritin (blood protein) level Iron level Lactate dehydrogenase (enzyme) level Magnesium level Phosphatase (enzyme) level Prealbumin (protein) level Total protein level, blood Liver enzyme (SGOT), level Liver enzyme (SGPT), level Transferrin (iron binding protein) level Uric acid level, blood Complete blood cell count (red cells, white blood cell, platelets), automated test Red blood count automated, with additional calculations Psychiatric diagnostic evaluation Routine EKG using at least 12 leads including interpretation and report Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 300 mcg Injection, granisetron hydrochloride, 100 mcg Injection, iron dextran, 50 mg Injection, iron sucrose, 1 mg Injection, potassium chloride, per 2 meq Injection, zoledronic acid (zometa), 1 mg Injection, zoledronic acid (reclast), 1 mg Infusion, normal saline solution , 250 cc Injection, carboplatin, 50 mg Injection, docetaxel, 1 mg Injection, fluorouracil, 500 mg Injection, rituximab, 100 mg Zoldedronic acid 1mg', 'Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 30 minutes New patient office or other outpatient visit, typically 45 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Initial hospital inpatient care, typically 50 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Hospital discharge day management, 30 minutes or less Subsequent nursing facility visit, typically 10 minutes per day Administration of influenza virus vaccine Injection, leucovorin calcium, per 50 mg Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, granisetron hydrochloride, 100 mcg Injection, palonosetron hcl, 25 mcg Injection, magnesium sulfate, per 500 mg Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution , 250 cc Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Injection, cisplatin, powder or solution, 10 mg Injection, fluorouracil, 500 mg Injection, oxaliplatin, 0. 5 mg Injection, paclitaxel protein-bound particles, 1 mg Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample CT scan chest CT scan of abdomen and pelvis Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, comprehensive group of blood chemicals Carcinoembryonic antigen (CEA) protein level Lactate dehydrogenase (enzyme) level Complete blood cell count (red cells, white blood cell, platelets), automated test Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 20 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, granisetron hydrochloride, 100 mcg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Unclassified drugs Infusion, normal saline solution , 1000 cc Injection, carboplatin, 50 mg Injection, rituximab, 100 mg Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour New patient office or other outpatient visit, typically 30 minutes Established patient office or other outpatient visit, typically 15 minutes Initial hospital inpatient care, typically 50 minutes per day Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Injection, cefepime hydrochloride, 500 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, ondansetron hydrochloride, per 1 mg Injection, ranitidine hydrochloride, 25 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc', 'Bone marrow aspiration Needle or trocar bone marrow biopsy Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Refilling and maintenance of portable pump New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, heparin sodium, (heparin lock flush), per 10 units Injection, hydrocortisone sodium succinate, up to 100 mg Injection, furosemide, up to 20 mg Injection, lorazepam, 2 mg Injection, meperidine hydrochloride, per 100 mg Injection, ondansetron hydrochloride, per 1 mg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Injection, carboplatin, 50 mg Cyclophosphamide, 100 mg Injection, fluorouracil, 500 mg Injection, paclitaxel, 30 mg Injection, rituximab, 100 mg', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy CT scan of neck CT scan chest CT scan chest with contrast CT scan chest before and after contrast CT scan of abdomen and pelvis CT scan of abdomen and pelvis CT scan of abdomen and pelvis Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Manual urinalysis test with examination using microscope Urinalysis, manual test Alpha-fetoprotein (AFP) level, serum Beta-2 microglobulin (protein) level Stool analysis for blood to screen for colon tumors Carcinoembryonic antigen (CEA) protein level Cyanocobalamin (vitamin B-12) level Erythropoietin (protein) level Ferritin (blood protein) level Folic acid level Gammaglobulin (immune system protein) measurement Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level Nephelometry, test method using light PSA (prostate specific antigen) measurement Total protein level, blood Protein measurement, serum Blood test, thyroid stimulating hormone (TSH) Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Immunologic analysis for detection of tumor antigen Immunologic analysis technique on serum Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Refilling and maintenance of portable pump New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Administration of influenza virus vaccine Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, leucovorin calcium, per 50 mg Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, dexamethasone sodium phosphate, 1mg Injection, hydromorphone, up to 4 mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, granisetron hydrochloride, 100 mcg Injection, iron dextran, 50 mg Injection, lorazepam, 2 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, methylprednisolone sodium succinate, up to 40 mg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Unclassified drugs Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Injection, cisplatin, powder or solution, 10 mg Cyclophosphamide, 100 mg Injection, docetaxel, 1 mg Injection, fluorouracil, 500 mg Injection, gemcitabine hydrochloride, 200 mg Injection, oxaliplatin, 0. 5 mg Injection, paclitaxel, 30 mg Injection, rituximab, 100 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) Zoldedronic acid 1mg Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Infusion, normal saline solution , 1000 cc', 'Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Refilling and maintenance of portable pump Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, granisetron hydrochloride, 100 mcg Injection, hydrocortisone sodium succinate, up to 100 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, zoledronic acid (zometa), 1 mg Unclassified drugs Infusion, normal saline solution, sterile (500 ml=1 unit) Injection, carboplatin, 50 mg Cyclophosphamide, 100 mg Injection, docetaxel, 1 mg Injection, fluorouracil, 500 mg Injection, oxaliplatin, 0. 5 mg Injection, paclitaxel, 30 mg', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy CT scan chest with contrast CT scan of abdomen and pelvis Bone and joint imaging, whole body Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Urinalysis, manual test Alpha-fetoprotein (AFP) level, serum Carcinoembryonic antigen (CEA) protein level Blood creatinine level Cyanocobalamin (vitamin B-12) level Ferritin (blood protein) level Folic acid level Gammaglobulin (immune system protein) measurement Haptoglobin (serum protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Nephelometry, test method using light PSA (prostate specific antigen) measurement Blood test, thyroid stimulating hormone (TSH) Urea nitrogen level to assess kidney function Complete blood cell count (red cells, white blood cell, platelets), automated test Red blood count, automated test Blood test, clotting time Red blood cell sedimentation rate, to detect inflammation Immunologic analysis for detection of tumor antigen Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 30 minutes New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Technetium tc-99m oxidronate, diagnostic, per study dose, up to 30 millicuries Administration of influenza virus vaccine Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, granisetron hydrochloride, 100 mcg Injection, hydrocortisone sodium succinate, up to 100 mg Injection, iron sucrose, 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution , 1000 cc Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Injection, docetaxel, 1 mg Injection, fluorouracil, 500 mg Injection, gemcitabine hydrochloride, 200 mg Injection, paclitaxel, 30 mg Injection, rituximab, 100 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) Zoldedronic acid 1mg Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample CT scan of neck CT scan of neck CT scan chest CT scan chest with contrast CT scan abdomen CT scan of abdomen and pelvis CT scan of abdomen and pelvis Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Manual urinalysis test with examination using microscope Carcinoembryonic antigen (CEA) protein level Ferritin (blood protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level PSA (prostate specific antigen) measurement Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Red blood count, automated test Immunologic analysis for detection of tumor antigen Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Administration of influenza virus vaccine Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, granisetron hydrochloride, 100 mcg Injection, iron dextran, 50 mg Injection, palonosetron hcl, 25 mcg Injection, magnesium sulfate, per 500 mg Injection, zoledronic acid (zometa), 1 mg Leuprolide acetate (for depot suspension), 7. 5 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) Zoldedronic acid 1mg Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Collection of blood specimen from a completely implantable venous access device Needle or trocar bone marrow biopsy Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Manual urinalysis test with examination using microscope Carcinoembryonic antigen (CEA) protein level Blood creatinine level Ferritin (blood protein) level Gammaglobulin (immune system protein) measurement Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level PSA (prostate specific antigen) measurement Uric acid level, blood Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Immunologic analysis for detection of tumor antigen Immunologic analysis for detection of tumor antigen Flow cytometry technique for DNA or cell analysis Flow cytometry technique for DNA or cell analysis Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 30 minutes New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, granisetron hydrochloride, 100 mcg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, sodium ferric gluconate complex in sucrose injection, 12. 5 mg Injection, alteplase recombinant, 1 mg Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution , 1000 cc Injection, carboplatin, 50 mg Injection, gemcitabine hydrochloride, 200 mg Injection, rituximab, 100 mg Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Bone marrow aspiration Needle or trocar bone marrow biopsy Nuclear medicine study with CT imaging whole body Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Smoking and tobacco use intensive counseling, greater than 10 minutes Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, testosterone cypionate, up to 100 mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, iron sucrose, 1 mg Injection, ondansetron hydrochloride, per 1 mg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, methylprednisolone sodium succinate, up to 125 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc 5% dextrose/water (500 ml = 1 unit) Injection, paclitaxel, 30 mg', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Urinalysis, manual test Stool analysis for blood to screen for colon tumors Carcinoembryonic antigen (CEA) protein level Cyanocobalamin (vitamin B-12) level Ferritin (blood protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Red blood count, automated test Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Refilling and maintenance of portable pump Irrigation of implanted venous access drug delivery device Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 30 minutes New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Administration of influenza virus vaccine Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, granisetron hydrochloride, 100 mcg Injection, iron dextran, 50 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Infusion, normal saline solution , 1000 cc Injection, carboplatin, 50 mg Injection, docetaxel, 1 mg Injection, fluorouracil, 500 mg Injection, paclitaxel, 30 mg Injection, rituximab, 100 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy CT scan head or brain CT scan head or brain before and after contrast CT scan of neck CT scan of neck X-ray of chest, 1 view, front X-ray of chest, 2 views, front and side CT scan chest CT scan chest with contrast X-ray of middle spine, 3 views X-ray of lower and sacral spine, minimum of 4 views X-ray of hip 2 or more views CT scan of abdomen and pelvis CT scan of abdomen and pelvis CT scan of abdomen and pelvis Blood test, comprehensive group of blood chemicals Blood test, lipids (cholesterol and triglycerides) Stool analysis for blood Hemoglobin A1C level Complete blood cell count (red cells, white blood cell, platelets), automated test Bone marrow, smear interpretation Blood test, clotting time Red blood cell sedimentation rate, to detect inflammation Pathology examination of tissue using a microscope, intermediate complexity Special stained specimen slides to examine tissue including interpretation and report Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Hospital observation care discharge Hospital observation care typically 70 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Hospital discharge day management, more than 30 minutes Administration of influenza virus vaccine Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, leucovorin calcium, per 50 mg Injection, ceftriaxone sodium, per 250 mg Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, methylprednisolone acetate, 80 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, granisetron hydrochloride, 100 mcg Injection, iron sucrose, 1 mg Injection, ondansetron hydrochloride, per 1 mg Injection, pamidronate disodium, per 30 mg Injection, palonosetron hcl, 25 mcg Injection, sargramostim (gm-csf), 50 mcg Injection, sodium ferric gluconate complex in sucrose injection, 12. 5 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, zoledronic acid (reclast), 1 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) 5% dextrose/normal saline (500 ml = 1 unit) Infusion, normal saline solution , 250 cc Injection, carboplatin, 50 mg Cyclophosphamide, 100 mg Injection, docetaxel, 1 mg Injection, fluorouracil, 500 mg Injection, rituximab, 100 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin)', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy Complete blood cell count (red cells, white blood cell, platelets), automated test Measurement of oxygen saturation in blood using ear or finger device Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Initial hospital inpatient care, typically 70 minutes per day Injection, levoleucovorin calcium, 0. 5 mg Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, heparin sodium, (heparin lock flush), per 10 units Injection, fondaparinux sodium, 0. 5 mg Injection, iron dextran, 50 mg Injection, furosemide, up to 20 mg Injection, lorazepam, 2 mg Injection, meperidine hydrochloride, per 100 mg Injection, oprelvekin, 5 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, sargramostim (gm-csf), 50 mcg Injection, methylprednisolone sodium succinate, up to 125 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution , 1000 cc Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Injection, cetuximab, 10 mg Cyclophosphamide, 100 mg Injection, docetaxel, 1 mg Injection, fluorouracil, 500 mg Injection, oxaliplatin, 0. 5 mg Injection, rituximab, 100 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample CT scan chest with contrast CT scan of abdomen and pelvis Carcinoembryonic antigen (CEA) protein level Ferritin (blood protein) level Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, granisetron hydrochloride, 100 mcg Injection, iron sucrose, 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Infusion, normal saline solution , 1000 cc Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Urinalysis, manual test Carcinoembryonic antigen (CEA) protein level Cyanocobalamin (vitamin B-12) level Ferritin (blood protein) level Folic acid level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Immunologic analysis for detection of tumor antigen Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Administration of influenza virus vaccine Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, heparin sodium, (heparin lock flush), per 10 units Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution, sterile (500 ml=1 unit) Injection, carboplatin, 50 mg Injection, docetaxel, 1 mg Injection, rituximab, 100 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Urinalysis, manual test Carcinoembryonic antigen (CEA) protein level Cyanocobalamin (vitamin B-12) level Ferritin (blood protein) level Folic acid level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Immunologic analysis for detection of tumor antigen Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Administration of influenza virus vaccine Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, heparin sodium, (heparin lock flush), per 10 units Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Injection, carboplatin, 50 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Bone marrow aspiration Needle or trocar bone marrow biopsy Blood test, comprehensive group of blood chemicals Automated urinalysis test Bilirubin level Carcinoembryonic antigen (CEA) protein level Ferritin (blood protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Magnesium level Phosphate level Uric acid level, blood Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein using push technique Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Hospital discharge day management, 30 minutes or less Hospital discharge day management, more than 30 minutes Administration of influenza virus vaccine Injection, dexamethasone sodium phosphate, 1mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, zoledronic acid (zometa), 1 mg Unclassified drugs Infusion, normal saline solution , 1000 cc Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Injection, fluorouracil, 500 mg Injection, rituximab, 100 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) Zoldedronic acid 1mg', 'Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 20 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Administration of influenza virus vaccine Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, granisetron hydrochloride, 100 mcg Injection, palonosetron hcl, 25 mcg Unclassified drugs Injection, carboplatin, 50 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)', 'Insertion of needle into vein for collection of blood sample Collection of blood specimen from a completely implantable venous access device Blood test, basic group of blood chemicals Blood test, comprehensive group of blood chemicals Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Administration of influenza virus vaccine Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, iron sucrose, 1 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, zoledronic acid (zometa), 1 mg Unclassified drugs Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Injection, carboplatin, 50 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) Zoldedronic acid 1mg', 'Hydration infusion into a vein 31 minutes to 1 hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Injection, denosumab, 1 mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, hydrocortisone sodium succinate, up to 100 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Infusion, normal saline solution, sterile (500 ml=1 unit) Injection, carboplatin, 50 mg', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy CT scan chest with contrast CT scan chest before and after contrast CT scan of abdomen and pelvis Nuclear medicine study with CT imaging skull base to mid-thigh Blood test, basic group of blood chemicals Blood glucose (sugar) test performed by hand-held instrument Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 30 minutes New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, magnesium sulfate, per 500 mg Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution , 250 cc Injection, bortezomib, 0. 1 mg Injection, carboplatin, 50 mg Cyclophosphamide, 100 mg Injection, docetaxel, 1 mg Injection, fluorouracil, 500 mg Injection, oxaliplatin, 0. 5 mg Injection, rituximab, 100 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample CT scan of neck X-ray of chest, 2 views, front and side CT scan chest CT scan of abdomen and pelvis Blood test, lipids (cholesterol and triglycerides) Urinalysis, manual test Glutamyltransferase (liver enzyme) level Magnesium level Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Routine EKG using at least 12 leads including interpretation and report Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour New patient office or other outpatient visit, typically 45 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Administration of influenza virus vaccine Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone)', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy Blood test, comprehensive group of blood chemicals Manual urinalysis test with examination using microscope Automated urinalysis test Lactate dehydrogenase (enzyme) level Magnesium level Phosphate level Protein measurement, serum Uric acid level, blood Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Immunologic analysis technique on serum Routine EKG using at least 12 leads including interpretation and report Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein using push technique Infusion of chemotherapy into a vein up to 1 hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Administration of influenza virus vaccine Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, dexamethasone sodium phosphate, 1mg Injection, heparin sodium, (heparin lock flush), per 10 units Injection, palonosetron hcl, 25 mcg Injection, potassium chloride, per 2 meq Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution , 250 cc Injection, bendamustine hcl, 1 mg Injection, bortezomib, 0. 1 mg Not otherwise classified, antineoplastic drugs Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) Injection, doxorubicin hydrochloride, liposomal, imported lipodox, 10 mg Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Complete blood cell count (red cells, white blood cell, platelets), automated test Hydration infusion into a vein 31 minutes to 1 hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 30 minutes New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Administration of influenza virus vaccine Injection, leucovorin calcium, per 50 mg Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, heparin sodium, (heparin lock flush), per 10 units Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, zoledronic acid (reclast), 1 mg Infusion, normal saline solution , 1000 cc Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Injection, docetaxel, 1 mg Injection, fluorouracil, 500 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin) Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Hospital discharge day management, more than 30 minutes Prolonged office or other outpatient service first hour Administration of influenza virus vaccine Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, granisetron hydrochloride, 100 mcg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Unclassified drugs Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Injection, rituximab, 100 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Hospital discharge day management, more than 30 minutes Administration of influenza virus vaccine Injection, leucovorin calcium, per 50 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, granisetron hydrochloride, 100 mcg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Unclassified drugs Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Injection, bevacizumab, 10 mg Injection, fluorouracil, 500 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval)', 'Insertion of needle into vein for collection of blood sample Collection of blood specimen from a completely implantable venous access device Needle or trocar bone marrow biopsy X-ray of chest, 2 views, front and side CT scan chest with contrast CT scan of abdomen and pelvis Blood test, comprehensive group of blood chemicals Carcinoembryonic antigen (CEA) protein level Lactate dehydrogenase (enzyme) level PSA (prostate specific antigen) measurement Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Moderate sedation services by physician also performing a procedure, patient 5 years of age or older, first 30 minutes New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Administration of influenza virus vaccine Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, midazolam hydrochloride, per 1 mg Injection, ondansetron hydrochloride, per 1 mg Injection, pegfilgrastim, 6 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone) Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml', 'Insertion of needle into vein for collection of blood sample Collection of blood specimen from a completely implantable venous access device Complete blood cell count (red cells, white blood cell, platelets), automated test Vaccine for pneumococcal polysaccharide for injection into muscle, patient 2 years or older Hydration infusion into a vein 31 minutes to 1 hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Administration of influenza virus vaccine Administration of pneumococcal vaccine Injection, calcium gluconate, per 10 ml Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, garamycin, gentamicin, up to 80 mg Injection, granisetron hydrochloride, 100 mcg Injection, heparin sodium, (heparin lock flush), per 10 units Injection, iron dextran, 50 mg Injection, iron sucrose, 1 mg Injection, promethazine hcl, up to 50 mg Injection, ranitidine hydrochloride, 25 mg Injection, methylprednisolone sodium succinate, up to 125 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Infusion, normal saline solution , 250 cc Injection, rituximab, 100 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Collection of blood specimen from a completely implantable venous access device Blood test, comprehensive group of blood chemicals Manual urinalysis test with examination using microscope Blood creatinine level Ferritin (blood protein) level Iron level Iron binding capacity Lactate dehydrogenase (enzyme) level Microscopic examination for white blood cells with manual cell count Complete blood cell count (red cells, white blood cell, platelets), automated test Complete blood cell count (red cells, white blood cell, platelets), automated test Red blood count, manual test Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis, concurrent with another infusion Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Prolonged chemotherapy infusion into a vein by portable or implanted pump more than 8 hours Infusion of different chemotherapy drug or substance into a vein up to 1 hour Refilling and maintenance of portable pump Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 30 minutes New patient office or other outpatient visit, typically 45 minutes Established patient office or other outpatient visit, typically 5 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Initial hospital inpatient care, typically 50 minutes per day Initial hospital inpatient care, typically 70 minutes per day Hospital discharge day management, 30 minutes or less Administration of influenza virus vaccine Injection, leucovorin calcium, per 50 mg Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, filgrastim (g-csf), 480 mcg Injection, iron sucrose, 1 mg Injection, lorazepam, 2 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, ranitidine hydrochloride, 25 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) 5% dextrose/normal saline (500 ml = 1 unit) Injection, bevacizumab, 10 mg Injection, carboplatin, 50 mg Injection, fluorouracil, 500 mg Injection, oxaliplatin, 0. 5 mg Injection, paclitaxel, 30 mg Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) Zoldedronic acid 1mg', 'Insertion of needle into vein for collection of blood sample Declotting infusion of implanted central venous access device or catheter Needle or trocar bone marrow biopsy Respiratory inhaled pressure or nonpressure treatment to relieve airway obstruction or for sputum specimen Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy, prevention, or diagnosis each additional hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of chemotherapy into a vein using push technique Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 50 minutes per day Administration of influenza virus vaccine Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, calcium gluconate, per 10 ml Injection, darbepoetin alfa, 1 microgram (non-esrd use) Injection, denosumab, 1 mg Injection, testosterone cypionate, up to 100 mg Injection, testosterone cypionate, 1 cc, 200 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, fosaprepitant, 1 mg Injection, hydrocortisone sodium succinate, up to 100 mg Injection, lorazepam, 2 mg Injection, ondansetron hydrochloride, per 1 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, alteplase recombinant, 1 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Injection, magnesium sulfate, per 500 mg Injection, potassium chloride, per 2 meq Injection, zoledronic acid (zometa), 1 mg Infusion, normal saline solution , 1000 cc Infusion, normal saline solution, sterile (500 ml=1 unit) Injection, carboplatin, 50 mg Injection, gemcitabine hydrochloride, 200 mg Leuprolide acetate (for depot suspension), 7. 5 mg Injection, paclitaxel, 30 mg Injection, rituximab, 100 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval) Zoldedronic acid 1mg', '', 'Insertion of needle into vein for collection of blood sample Needle or trocar bone marrow biopsy Complete blood cell count (red cells, white blood cell, platelets), automated test Blood test, clotting time Hydration infusion into a vein 31 minutes to 1 hour Hydration infusion into a vein each additional hour Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour Injection into tissue or muscle for therapy, diagnosis, or prevention Injection of drug or substance into a vein for therapy Injection of different drug or substance into a vein for therapy Non-hormonal anti-neoplastic chemotherapy into tissue or muscle Infusion of additional chemotherapy drug or substance into a vein Infusion of chemotherapy into a vein up to 1 hour Infusion of chemotherapy into a vein each additional hour Infusion of different chemotherapy drug or substance into a vein up to 1 hour Irrigation of implanted venous access drug delivery device Therapeutic removal of whole blood to correct blood level imbalance New patient office or other outpatient visit, typically 45 minutes New patient office or other outpatient visit, typically 60 minutes Established patient office or other outpatient visit, typically 10 minutes Established patient office or other outpatient visit, typically 15 minutes Established patient office or other outpatient, visit typically 25 minutes Established patient office or other outpatient, visit typically 40 minutes Initial hospital inpatient care, typically 70 minutes per day Subsequent hospital inpatient care, typically 15 minutes per day Subsequent hospital inpatient care, typically 25 minutes per day Subsequent hospital inpatient care, typically 35 minutes per day Bone marrow aspiration performed with bone marrow biopsy through the same incision on the same date of service Injection, epoetin alfa, (for non-esrd use), 1000 units Injection, denosumab, 1 mg Injection, dexamethasone sodium phosphate, 1mg Injection, diphenhydramine hcl, up to 50 mg Injection, palonosetron hcl, 25 mcg Injection, pegfilgrastim, 6 mg Injection, vitamin b-12 cyanocobalamin, up  to 1000 mcg Infusion, normal saline solution , 1000 cc Injection, rituximab, 100 mg Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use)']\n"
     ]
    }
   ],
   "source": [
    "mod_tfidf_out, vec_out, corp_out = perform_tfidf(outliers_list)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 461,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "words = vec_out.get_feature_names()"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 473,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "680"
      ]
     },
     "execution_count": 473,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "len(words)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 486,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "mod_out_ind = np.argsort(np.sum(mod_tfidf_out.toarray(), axis=0))[::-1][:40]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 487,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([351, 346, 656, 421, 433, 639,  94, 315, 615, 483, 470, 463, 665,\n",
       "       127, 382, 199, 509,  39, 232, 611, 218, 314, 177, 119,  12, 113,\n",
       "       353, 598,  25, 167, 409, 580, 664, 454, 554, 597, 203, 298,  96, 558])"
      ]
     },
     "execution_count": 487,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "mod_out_ind"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 488,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([u'injection', u'infusion', u'vein', u'mg', u'minutes', u'typically',\n",
       "       u'blood', u'hour', u'therapy', u'patient', u'outpatient', u'office',\n",
       "       u'visit', u'chemotherapy', u'level', u'diagnosis', u'prevention',\n",
       "       u'additional', u'established', u'test', u'drug', u'hospital',\n",
       "       u'day', u'cell', u'25', u'care', u'inpatient', u'substance', u'50',\n",
       "       u'ct', u'mcg', u'solution', u'virus', u'normal', u'saline',\n",
       "       u'subsequent', u'different', u'hcl', u'bone', u'scan'], \n",
       "      dtype='<U19')"
      ]
     },
     "execution_count": 488,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "np.array(words)[mod_out_ind]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 493,
   "metadata": {
    "collapsed": false
   },
   "outputs": [],
   "source": [
    "mod_count_out, count_vec_out, count_corp_out = perform_tfidf(outliers_list)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 496,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "(264, 680)"
      ]
     },
     "execution_count": 496,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "mod_count_out.shape"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 497,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "count_out_ind = np.argsort(np.sum(mod_count_out.toarray(), axis=0))[::-1][:40]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 499,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([u'injection', u'infusion', u'vein', u'mg', u'minutes', u'typically',\n",
       "       u'blood', u'hour', u'therapy', u'patient', u'outpatient', u'office',\n",
       "       u'visit', u'chemotherapy', u'diagnosis', u'prevention',\n",
       "       u'additional', u'established', u'drug', u'test', u'level', u'25',\n",
       "       u'hospital', u'day', u'substance', u'care', u'inpatient', u'cell',\n",
       "       u'50', u'mcg', u'hcl', u'different', u'solution', u'muscle',\n",
       "       u'tissue', u'normal', u'saline', u'subsequent', u'1000', u'sodium'], \n",
       "      dtype='<U19')"
      ]
     },
     "execution_count": 499,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "np.array(count_vec_out.get_feature_names())[count_out_ind]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "mod_tfidf_non, vec_non, corp_non = perform_tfidf(non_out_list)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "1+1"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 502,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "mod_non_ind = np.argsort(np.sum(mod_tfidf_non.toarray(), axis=0))[::-1][:40]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": 503,
   "metadata": {
    "collapsed": false
   },
   "outputs": [
    {
     "data": {
      "text/plain": [
       "array([u'injection', u'minutes', u'infusion', u'typically', u'vein', u'mg',\n",
       "       u'blood', u'patient', u'hour', u'visit', u'outpatient', u'office',\n",
       "       u'therapy', u'established', u'chemotherapy', u'hospital', u'day',\n",
       "       u'prevention', u'diagnosis', u'care', u'inpatient', u'additional',\n",
       "       u'level', u'25', u'test', u'drug', u'substance', u'cell',\n",
       "       u'subsequent', u'50', u'new', u'mcg', u'muscle', u'tissue', u'15',\n",
       "       u'different', u'hcl', u'1000', u'sodium', u'initial'], \n",
       "      dtype='<U22')"
      ]
     },
     "execution_count": 503,
     "metadata": {},
     "output_type": "execute_result"
    }
   ],
   "source": [
    "np.array(vec_non.get_feature_names())[mod_non_ind]"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": [
    "non_out_dict = get_psql(non_out_list)"
   ]
  },
  {
   "cell_type": "code",
   "execution_count": null,
   "metadata": {
    "collapsed": true
   },
   "outputs": [],
   "source": []
  }
 ],
 "metadata": {
  "kernelspec": {
   "display_name": "Python 2",
   "language": "python",
   "name": "python2"
  },
  "language_info": {
   "codemirror_mode": {
    "name": "ipython",
    "version": 2
   },
   "file_extension": ".py",
   "mimetype": "text/x-python",
   "name": "python",
   "nbconvert_exporter": "python",
   "pygments_lexer": "ipython2",
   "version": "2.7.11"
  }
 },
 "nbformat": 4,
 "nbformat_minor": 0
}
